PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gavin, AC; Aloy, P; Grandi, P; Krause, R; Boesche, M; Marzioch, M; Rau, C; Jensen, LJ; Bastuck, S; Dumpelfeld, B; Edelmann, A; Heurtier, MA; Hoffman, V; Hoefert, C; Klein, K; Hudak, M; Michon, AM; Schelder, M; Schirle, M; Remor, M; Rudi, T; Hooper, S; Bauer, A; Bouwmeester, T; Casari, G; Drewes, G; Neubauer, G; Rick, JM; Kuster, B; Bork, P; Russell, RB; Superti-Furga, G				Gavin, AC; Aloy, P; Grandi, P; Krause, R; Boesche, M; Marzioch, M; Rau, C; Jensen, LJ; Bastuck, S; Dumpelfeld, B; Edelmann, A; Heurtier, MA; Hoffman, V; Hoefert, C; Klein, K; Hudak, M; Michon, AM; Schelder, M; Schirle, M; Remor, M; Rudi, T; Hooper, S; Bauer, A; Bouwmeester, T; Casari, G; Drewes, G; Neubauer, G; Rick, JM; Kuster, B; Bork, P; Russell, RB; Superti-Furga, G			Proteome survey reveals modularity of the yeast cell machinery	NATURE			English	Article							CAP-BINDING COMPLEX; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; IDENTIFICATION; PURIFICATION; ANNOTATION; METABOLISM; NETWORKS; PROTEINS; NUCLEAR	Protein complexes are key molecular entities that integrate multiple gene products to perform cellular functions. Here we report the first genome-wide screen for complexes in an organism, budding yeast, using affinity purification and mass spectrometry. Through systematic tagging of open reading frames (ORFs), the majority of complexes were purified several times, suggesting screen saturation. The richness of the data set enabled a de novo characterization of the composition and organization of the cellular machinery. The ensemble of cellular proteins partitions into 491 complexes, of which 257 are novel, that differentially combine with additional attachment proteins or protein modules to enable a diversification of potential functions. Support for this modular organization of the proteome comes from integration with available data on expression, localization, function, evolutionary conservation, protein structure and binary interactions. This study provides the largest collection of physically determined eukaryotic cellular machines so far and a platform for biological data integration and modelling.	Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; MPI IB, MPI MG, D-10117 Berlin, Germany; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Austrian Academy of Sciences	Russell, RB (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	russell@embl-heidelberg.de	Kuster, Bernhard/Q-6031-2016; Superti-Furga, Giulio/AAE-5681-2019; Bork, Peer/F-1813-2013; Russell, Robert/GWU-6389-2022; Aloy, Patrick/AAB-3538-2019; Superti-Furga, Giulio/F-4755-2015; Russell, Rob/AAH-9145-2019; Jensen, Lars Juhl/C-6492-2008	Kuster, Bernhard/0000-0002-9094-1677; Bork, Peer/0000-0002-2627-833X; Russell, Robert/0000-0002-7213-1398; Superti-Furga, Giulio/0000-0002-0570-1768; Russell, Rob/0000-0002-1905-4717; Jensen, Lars Juhl/0000-0001-7885-715X; Aloy, Patrick/0000-0002-3557-0236; Gavin, Anne-Claude/0000-0003-4917-2340; Drewes, Gerard/0000-0003-0575-6766; Krause, Roland/0000-0001-9938-7126				Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dezso Z, 2003, GENOME RES, V13, P2450, DOI 10.1101/gr.1073603; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kao LR, 1996, MOL CELL BIOL, V16, P168; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; ROSS J, 1988, J GEN MICROBIOL, V134, P1131; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/BJ20031797; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; Sehnke PC, 2000, SCI STKE 2000, V56, P1, DOI [10.1126/stke.2000.56.pe1, DOI 10.1126/STKE.2000.56.PE1]; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Subramanian S, 2004, MOL BIOL CELL, V15, P2593, DOI 10.1091/mbc.E03-10-0767; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Winstall E, 2000, J BIOL CHEM, V275, P21817, DOI 10.1074/jbc.M002412200	43	1964	2043	2	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					631	636		10.1038/nature04532	http://dx.doi.org/10.1038/nature04532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16429126				2022-12-01	WOS:000236350400035
J	Gabellini, D; D'Antona, G; Moggio, M; Prelle, A; Zecca, C; Adami, R; Angeletti, B; Ciscato, P; Pellegrino, MA; Bottinelli, R; Green, MR; Tupler, R				Gabellini, D; D'Antona, G; Moggio, M; Prelle, A; Zecca, C; Adami, R; Angeletti, B; Ciscato, P; Pellegrino, MA; Bottinelli, R; Green, MR; Tupler, R			Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1	NATURE			English	Article							MOLECULAR DIAGNOSIS; MYOTONIC-DYSTROPHY; SKELETAL; GENE; COMPLEX; MUSCLE; MODEL; RNA; PATHOGENESIS; EXPRESSION	Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene(1,2). Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 ( ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing(5-7). We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, Dipartimento Med Sperimentale, Sez Fisiol Umana, I-27100 Pavia, Italy; Univ Milan, IRCCS, Fdn Osped Maggiore, UO Neurol, I-20122 Milan, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Tupler, R (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, I-41100 Modena, Italy.	rossella.tupler@umassmed.edu	Pellegrino, Maria Antonietta/AAC-4680-2022; Zecca, Chiara/L-3406-2013; canepari, Monica MC/D-7677-2015; Bottinelli, Roberto/AAC-1904-2020; Tupler, Rossella/C-9500-2015; Gabellini, Davide/I-4551-2018	Pellegrino, Maria Antonietta/0000-0002-1653-1266; Bottinelli, Roberto/0000-0002-4960-7490; Tupler, Rossella/0000-0002-3797-1789; Gabellini, Davide/0000-0002-3811-4121; D'Antona, Giuseppe/0000-0002-0683-5565; Adami, Raffaella/0000-0001-9656-3219; prelle, alessandro/0000-0002-7019-5291; Zecca, Chiara/0000-0002-9990-3431	Telethon [GGP05050] Funding Source: Medline	Telethon(Fondazione Telethon)		Buj-Bello A, 2002, HUM MOL GENET, V11, P2297, DOI 10.1093/hmg/11.19.2297; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chaudhuri T, 2005, J MOL BIOL, V352, P58, DOI 10.1016/j.jmb.2005.06.066; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Flanigan KM, 2004, MYOLOGY, P1123; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KILMER DD, 1995, AM J PHYS MED REH  S, V74, P131; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Orrell RW, 1999, NEUROLOGY, V52, P1822, DOI 10.1212/WNL.52.9.1822; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Rogers MT, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P277; Tawil Rabi, 2004, Curr Neurol Neurosci Rep, V4, P51, DOI 10.1007/s11910-004-0012-x; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037	28	169	178	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					973	977		10.1038/nature04422	http://dx.doi.org/10.1038/nature04422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16341202				2022-12-01	WOS:000235486100047
J	Lee, CM; Szabo, A; Shrieve, DC; Macdonald, OK; Gaffney, DK				Lee, CM; Szabo, A; Shrieve, DC; Macdonald, OK; Gaffney, DK			Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; PROGNOSTIC FACTORS; EXTERNAL IRRADIATION; RANDOMIZED-TRIAL; CARCINOMA; CANCER; RADIOTHERAPY; SURGERY; DOXORUBICIN; SURVIVAL	Context The benefit of adjuvant radiation therapy (RT) in stage I endometrial adenocarcinoma remains controversial despite several phase 3 trials. Objective To evaluate the frequency and effect of adjuvant RT on overall and relative survival within a large US population database. Design, Setting, and Population A retrospective analysis that used data from the Surveillance, Epidemiology, and End Results program of the US National Cancer Institute from January 1, 1988, to December 31, 2001. A total of 21249 patients with American Joint Committee on Cancer stage IA-C node-negative endometrial adenocarcinoma comprised the study population. Main Outcome Measures Overall survival curves were constructed using Kaplan-Meier method and compared via stratified log-rank test within T stage/grade combinations, adjusted for age. Relative survival was performed to assess the effects of age, race, stage, grade, whether nodes were examined, and whether adjuvant RT was administered. Results Of 21249 women, 4080 received adjuvant RT (19.2%) and 17169 did not receive adjuvant RT (80.8%). The mean age at diagnosis was 63.2 years (range, 14-99 years). Adjuvant RT significantly improved overall survival for patients with stage IC/ grade 1 (P<.001) and stage IC/grades 3 and 4 (P<.001). Cox proportional hazards regression analysis revealed a statistically detectable association of adjuvant RT with improved relative survival in patients with stage IC/grade 1 and stage IC/grades 3 and 4 (hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.31-0.63; P<.001; and HR, 0.72; 95% Cl, 0.57-0.92; P=.009; respectively). A separate analysis of those patients with a surgical lymph node examination at the time of total abdominal hysterectomy and bilateral salpingo-oophorectomy revealed similar estimates (HR, 0.59; 95% Cl, 0.39-0.90; P = .01; and HR, 0.73; 95% Cl, 0.55-0.96; P = .02; respectively). Conclusions As the largest reported population analysis to date of adjuvant RT in early stage endometrial adenocarcinoma, our study reveals a statistically significant association between improved overall and relative survival and adjuvant RT in stage IC disease (grades 1 and 3-4). Future work is needed to continue to delineate clinical and biological factors, which can guide treatment decisions and account for disparities in outcome between varied subsets of patients.	Huntsman Canc Hosp, Dept Radiat Oncol, Salt Lake City, UT 84112 USA; Univ Utah, Med Ctr, Salt Lake City, UT USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; Huntsman Canc Inst, Biostat Shared Resource, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute	Lee, CM (corresponding author), Huntsman Canc Hosp, Dept Radiat Oncol, 1950 Circle Hope, Salt Lake City, UT 84112 USA.		Szabo, Aniko/F-9656-2012	Szabo, Aniko/0000-0002-8129-0614; Lee, Christopher/0000-0003-1887-119X	NCI NIH HHS [2P30CA042014-17] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Aapro MS, 2003, ANN ONCOL, V14, P441, DOI 10.1093/annonc/mdg112; ANDERSEN PK, 1985, BIOMETRICS, V41, P921, DOI 10.2307/2530964; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Creutzberg CL, 2004, J CLIN ONCOL, V22, P1234, DOI 10.1200/JCO.2004.08.159; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Creutzberg CL, 2003, GYNECOL ONCOL, V89, P201, DOI 10.1016/S0090-8258(03)00126-4; Greven KM, 1997, INT J RADIAT ONCOL, V39, P413, DOI 10.1016/S0360-3016(97)00323-4; Irwin C, 1998, GYNECOL ONCOL, V70, P247, DOI 10.1006/gyno.1998.5064; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; KUCERA H, 1990, GYNECOL ONCOL, V38, P99, DOI 10.1016/0090-8258(90)90018-G; MEERWALDT JH, 1990, INT J RADIAT ONCOL, V18, P299, DOI 10.1016/0360-3016(90)90093-Y; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; MORROW CP, 1990, GYNECOL ONCOL, V36, P166, DOI 10.1016/0090-8258(90)90166-I; *NCI CANC CONTR PO, EC SURV; Piercy C., 1990, INT CLASSIFICATION D, V2; PIVER MS, 1990, CANCER, V66, P1133, DOI 10.1002/1097-0142(19900915)66:6<1133::AID-CNCR2820660610>3.0.CO;2-H; *R FDN STAT COMP, 2005, R PROJ STAT COMP R V; *SEER, 2002, SEER STAT VERS 4 2; *SEER, DAT QUAL; *SEER PROGR PUBL U, DCCPS SURV RES PROGR	21	100	102	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2006	295	4					389	397		10.1001/jama.295.4.389	http://dx.doi.org/10.1001/jama.295.4.389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005QJ	16434629	Bronze			2022-12-01	WOS:000234838600019
J	[Anonymous]				[Anonymous]			Health and the environment after Hurricane Katrina	ANNALS OF INTERNAL MEDICINE			English	News Item														Wilson, Jennifer/0000-0003-4025-3136					0	18	18	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2006	144	2					153	153		10.7326/0003-4819-144-2-200601170-00029	http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004AX	16418428				2022-12-01	WOS:000234725500026
J	Dyhrman, ST; Chappell, PD; Haley, ST; Moffett, JW; Orchard, ED; Waterbury, JB; Webb, EA				Dyhrman, ST; Chappell, PD; Haley, ST; Moffett, JW; Orchard, ED; Waterbury, JB; Webb, EA			Phosphonate utilization by the globally important marine diazotroph Trichodesmium	NATURE			English	Article							FIXATION	The factors that control the growth and nitrogen fixation rates of marine diazotrophs such as Trichodesmium have been intensively studied because of the role that these processes have in the global cycling of carbon and nitrogen, and in the sequestration of carbon to the deep sea. Because the phosphate concentrations of many ocean gyres are low(1), the bioavailability of the larger, chemically heterogeneous pool of dissolved organic phosphorus could markedly influence Trichodesmium physiology. Here we describe the induction, by phosphorus stress, of genes from the Trichodesmium erythraeum IMS101 genome that are predicted to encode proteins associated with the high-affinity transport and hydrolysis of phosphonate compounds by a carbon - phosphorus lyase pathway. We show the importance of these genes through expression analyses with T. erythraeum from the Sargasso Sea. Phosphonates are known to be present in oligotrophic marine systems, but have not previously been considered to be bioavailable to marine diazotrophs. The apparent absence of genes encoding a carbon phosphorus lyase pathway in the other marine cyanobacterial genomes suggests that, relative to other phytoplankton, Trichodesmium is uniquely adapted for scavenging phosphorus from organic sources. This adaptation may help to explain the prevalence of Trichodesmium in low phosphate, oligotrophic systems.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Webb, EA (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	ewebb@whoi.edu	Chappell, Phoebe Dreux/AAC-8771-2022; Chappell, P. Dreux/B-9339-2016	Chappell, Phoebe Dreux/0000-0001-5212-6228; Chappell, P. Dreux/0000-0001-5212-6228; Webb, Eric/0000-0003-4085-7730				Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, DOI 10.1029/2003-O180001]; ARMSTRONG FA, 1966, NATURE, V211, P481, DOI 10.1038/211481a0; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Dyhrman ST, 2002, LIMNOL OCEANOGR, V47, P1832, DOI 10.4319/lo.2002.47.6.1832; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Karl D. M., 2002, BIOGEOCHEMISTRY MARI, P249, DOI DOI 10.1016/B978-012323841-2/50008-7]; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Lundgren P, 2005, APPL ENVIRON MICROB, V71, P190, DOI 10.1128/AEM.71.1.190-196.2005; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Paytan A, 2003, MAR CHEM, V82, P55, DOI 10.1016/S0304-4203(03)00052-5; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Stihl A, 2001, J PHYCOL, V37, P310, DOI 10.1046/j.1529-8817.2001.037002310.x; Wanner Barry L., 1994, Biodegradation, V5, P175, DOI 10.1007/BF00696458; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	24	397	431	12	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					68	71		10.1038/nature04203	http://dx.doi.org/10.1038/nature04203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397497				2022-12-01	WOS:000234378700035
J	Gore, J; Bryant, Z; Stone, MD; Nollmann, MN; Cozzarelli, NR; Bustamante, C				Gore, J; Bryant, Z; Stone, MD; Nollmann, MN; Cozzarelli, NR; Bustamante, C			Mechanochemical analysis of DNA gyrase using rotor bead tracking	NATURE			English	Article							C-TERMINAL DOMAIN; MYOSIN-V MOTOR; TOPOISOMERASES; MECHANISM; ELASTICITY; BINDING; MOLECULES; TRANSPORT; SUBSTEPS; PROTEIN	DNA gyrase is a molecular machine that uses the energy of ATP hydrolysis to introduce essential negative supercoils into DNA(1-3). The directionality of supercoiling is ensured by chiral wrapping of the DNA(4,5) around a specialized domain(6-9) of the enzyme before strand passage. Here we observe the activity of gyrase in real time by tracking the rotation of a submicrometre bead attached to the side of a stretched DNA molecule(10). In the presence of gyrase and ATP, we observe bursts of rotation corresponding to the processive, stepwise introduction of negative supercoils in strict multiples of two(11). Changes in DNA tension have no detectable effect on supercoiling velocity, but the enzyme becomes markedly less processive as tension is increased over a range of only a few tenths of piconewtons. This behaviour is quantitatively explained by a simple mechanochemical model in which processivity depends on a kinetic competition between dissociation and rapid, tension-sensitive DNA wrapping. In a high-resolution variant of our assay, we directly detect rotational pauses corresponding to two kinetic substeps: an ATP-independent step at the end of the reaction cycle, and an ATP-binding step in the middle of the cycle, subsequent to DNA wrapping.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Howard Hughes Med Inst, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ncozzare@berkeley.edu; carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Nollmann, Marcelo/0000-0003-3339-2349	NIGMS NIH HHS [R37 GM032543, R01 GM071552] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071552, R37GM032543] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bates A.D., 2005, DNA TOPOLOGY; Block SM, 1998, J CELL BIOL, V140, P1281, DOI 10.1083/jcb.140.6.1281; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; PATO ML, 1990, P NATL ACAD SCI USA, V87, P8716, DOI 10.1073/pnas.87.22.8716; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	29	155	159	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					100	104		10.1038/nature04319	http://dx.doi.org/10.1038/nature04319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397501	Green Accepted			2022-12-01	WOS:000234378700042
J	Karadottir, R; Cavelier, P; Bergersen, LH; Attwell, D				Karadottir, R; Cavelier, P; Bergersen, LH; Attwell, D			NMDA receptors are expressed in oligodendrocytes and activated in ischaemia	NATURE			English	Article							WHITE-MATTER INJURY; CA1 PYRAMIDAL CELLS; PRECURSOR CELLS; GLIAL-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; AXONAL INJURY; GLUTAMATE; VULNERABILITY; MECHANISMS; CHANNELS	Glutamate-mediated damage to oligodendrocytes contributes to mental or physical impairment in periventricular leukomalacia (pre- or perinatal white matter injury leading to cerebral palsy), spinal cord injury, multiple sclerosis and stroke(1-4). Unlike neurons(5), white matter oligodendrocytes reportedly lack NMDA (N-methyl-D- aspartate) receptors(6,7). It is believed that glutamate damages oligodendrocytes, especially their precursor cells, by acting on calcium-permeable AMPA (alpha-amino-3-hydroxy-5-methyl- 4-isoxazole propionic acid)/kainate receptors alone(1-4) or by reversing cystine - glutamate exchange and depriving cells of antioxidant protection(8). Here we show that precursor, immature and mature oligodendrocytes in the white matter of the cerebellum and corpus callosum exhibit NMDA-evoked currents, mediated by receptors that are blocked only weakly by Mg(2+) and that may contain NR1, NR2C and NR3 NMDA receptor subunits. NMDA receptors are present in the myelinating processes of oligodendrocytes, where the small intracellular space could lead to a large rise in intracellular ion concentration in response to NMDA receptor activation. Simulating ischaemia led to development of an inward current in oligodendrocytes, which was partly mediated by NMDA receptors. These results point to NMDA receptors of unusual subunit composition as a potential therapeutic target for preventing white matter damage in a variety of diseases.	UCL, Dept Physiol, London WC1E 6BT, England; Univ Oslo, Dept Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of London; University College London; University of Oslo; University of Oslo	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	D.Attwell@ucl.ac.uk	Messier, Claude/A-2322-2008; Attwell, David/ABE-6750-2020	Messier, Claude/0000-0002-4791-1763; Bergersen, Linda Hildegard/0000-0002-9964-9744; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	Wellcome Trust [017948, 075232, 065424] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agrawal SK, 1997, J NEUROSCI, V17, P1055; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Back SA, 2001, J NEUROSCI, V21, P1302; BERGER T, 1992, J NEUROSCI RES, V31, P21, DOI 10.1002/jnr.490310104; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; BORGES K, 1995, J NEUROSCI RES, V42, P579, DOI 10.1002/jnr.490420416; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Follett PL, 2000, J NEUROSCI, V20, P9235; Kirson ED, 1999, J PHYSIOL-LONDON, V521, P99, DOI 10.1111/j.1469-7793.1999.00099.x; Kuner T, 1996, J NEUROSCI, V16, P3549; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; OKA A, 1993, J NEUROSCI, V13, P1441; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wallstrom E, 1996, J NEUROL SCI, V137, P89, DOI 10.1016/0022-510X(95)00339-4; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Ziak D, 1998, PHYSIOL RES, V47, P365	28	538	562	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1162	1166		10.1038/nature04302	http://dx.doi.org/10.1038/nature04302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372011	Green Accepted			2022-12-01	WOS:000234111500052
J	Tesmer, VM; Kawano, T; Shankaranarayanan, A; Kozasa, T; Tesmer, JJG				Tesmer, VM; Kawano, T; Shankaranarayanan, A; Kozasa, T; Tesmer, JJG			Snapshot of activated G proteins at the membrane: The G alpha(q)-GRK2-G beta gamma complex	SCIENCE			English	Article							COUPLED RECEPTOR KINASE-2; BETA-GAMMA-SUBUNITS; G-ALPHA-SUBUNITS; MUSCARINIC ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; STRUCTURAL DETERMINANTS; SELECTIVE REGULATION; BINDING-SITE; 2.0 ANGSTROM	G protein-coupled receptor kinase 2 (GRK2) plays a key role in the desensitization of G protein-coupled receptor signaling by phosphorylating activated heptahelical receptors and by sequestering heterotrimeric G proteins. We report the atomic structure of GRK2 in complex with G alpha(q) and G beta gamma, in which the activated G alpha subunit of G(q) is fully dissociated from G beta gamma and dramatically reoriented from its position in the inactive G alpha beta gamma heterotrimer. G alpha(q) forms an effector-like interaction with the GRK2 regulator of G protein signaling (RGS) homology domain that is distinct from and does not overlap with that used to bind RGS proteins such as RGS4.	Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tesmer, JJG (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Chem & Biochem, Austin, TX 78712 USA.	johntesmer@umich.edu		Tesmer, John/0000-0003-1125-3727	NHLBI NIH HHS [HL071818] Funding Source: Medline; NIA NIH HHS [AG006093] Funding Source: Medline; NIGMS NIH HHS [GM61454] Funding Source: Medline; NINDS NIH HHS [NS41441] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006093] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARKINSTALL S, 1995, FEBS LETT, V364, P45, DOI 10.1016/0014-5793(95)00351-9; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gilchrist, 2002, SCI STKE; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; HAGA K, 1992, J BIOL CHEM, V267, P2222; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KREUTZ B, IN PRESS BIOCHEMISTR; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; NEER EJ, 1988, J BIOL CHEM, V263, P8996; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAO CS, 2002, SCI STKE, pPE42; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Usui K, 2000, INT J MOL MED, V5, P335; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	52	225	231	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1686	1690		10.1126/science.1118890	http://dx.doi.org/10.1126/science.1118890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339447				2022-12-01	WOS:000233961700047
J	Grogg, MW; Call, MK; Okamoto, M; Vergara, MN; Del Rio-Tsonis, K; Tsonis, PA				Grogg, MW; Call, MK; Okamoto, M; Vergara, MN; Del Rio-Tsonis, K; Tsonis, PA			BMP inhibition-driven regulation of six-3 underlies induction of newt lens regeneration	NATURE			English	Article							RETINOIC ACID; ADULT NEWT; IRIS; DORSAL; DIFFERENTIATION; CELLS; EYE	Lens regeneration in adult newts is a classic example of how cells can faithfully regenerate a complete organ through the process of transdifferentiation(1-6). After lens removal, the pigment epithelial cells of the dorsal, but not the ventral, iris dedifferentiate and then differentiate to form a new lens. Understanding how this process is regulated might provide clues about why lens regeneration does not occur in higher vertebrates. The genes six-3 and pax-6 are known to induce ectopic lenses during embryogenesis(7,8). Here we tested these genes, as well as members of the bone morphogenetic protein (BMP) pathway that regulate establishment of the dorsal ventral axis in embryos(9), for their ability to induce lens regeneration. We show that the lens can be regenerated from the ventral iris when the BMP pathway is inhibited and when the iris is transfected with six-3 and treated with retinoic acid. In intact irises, six-3 is expressed at higher levels in the ventral than in the dorsal iris. During regeneration, however, only expression in the dorsal iris is significantly increased. Such an increase is seen in ventral irises only when they are induced to transdifferentiate by six-3 and retinoic acid or by BMP inhibitors. These data suggest that lens regeneration can be achieved in noncompetent adult tissues and that this regeneration occurs through a gene regulatory mechanism that is more complex than the dorsal expression of lens regeneration-specific genes.	Univ Dayton, Dept Biol, Mol Biol Lab, Dayton, OH 45469 USA; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 464, Japan; Miami Univ, Dept Zool, Oxford, OH 45056 USA	University of Dayton; Nagoya University; University System of Ohio; Miami University	Tsonis, PA (corresponding author), Univ Dayton, Dept Biol, Mol Biol Lab, Dayton, OH 45469 USA.	panagiotis.tsonis@notes.udayton.edu	Vergara, Natalia/J-6722-2019	Vergara, Natalia/0000-0003-4545-8181	NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010540] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573; Colucci VL, 1891, MEM R ACAD SCI I BOL, V1, P593; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; EGUCHI G, 1964, EMBRYOLOGIA, V8, P247, DOI 10.1111/j.1440-169X.1964.tb00202.x; EGUCHI G, 1963, EMBRYOLOGIA, V8, P45, DOI 10.1111/j.1440-169X.1963.tb00185.x; Hayashi T, 2001, DEV GROWTH DIFFER, V43, P361; Hayashi T, 2004, MECH DEVELOP, V121, P519, DOI 10.1016/j.mod.2004.04.010; Ito M, 1999, DEV GROWTH DIFFER, V41, P429; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Maden M, 2003, DEV DYNAM, V226, P237, DOI 10.1002/dvdy.10222; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Okamoto M, 1998, DEV GROWTH DIFFER, V40, P11; Oliver G, 1996, MECH DEVELOP, V60, P233, DOI 10.1016/S0925-4773(96)00632-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAWADA K, 1993, JPN J OPHTHALMOL, V37, P355; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Tsonis PA, 2000, DEV DYNAM, V219, P588, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1082>3.0.CO;2-H; Tsonis PA, 2004, DEV BIOL, V267, P450, DOI 10.1016/j.ydbio.2003.12.005; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Tsonis PA., 1996, LIMB REGENERATION; Wolff G., 1895, W ROUX ARCH ENTWICKL, V1, P380; Yamada T, 1977, Monogr Dev Biol, V13, P1; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	23	94	96	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					858	862		10.1038/nature04175	http://dx.doi.org/10.1038/nature04175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341014	Green Accepted			2022-12-01	WOS:000233777800052
J	Bonetta, L				Bonetta, L			Going on a cancer gene hunt	CELL			English	Editorial Material								NIH is preparing to announce plans for the pilot phase of their proposed Human Cancer Genome Project. This initiative seeks to provide a complete list of the mutations that give rise to cancer.											0	9	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 2	2005	123	5					735	737		10.1016/j.cell.2005.11.013	http://dx.doi.org/10.1016/j.cell.2005.11.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325563	Bronze			2022-12-01	WOS:000233814100002
J	Drees, F; Pokutta, S; Yamada, S; Nelson, WJ; Weis, WI				Drees, F; Pokutta, S; Yamada, S; Nelson, WJ; Weis, WI			alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly	CELL			English	Article							CELL-CELL ADHESION; INTERCELLULAR-ADHESION; JUNCTIONAL COMPLEX; CYTOPLASMIC DOMAIN; ARP2/3 COMPLEX; F-ACTIN; MECHANISM; VINCULIN; PROTEIN; DYNAMICS	Epithelial cell-cell junctions, organized by adhesion proteins and the underlying actin cytoskeleton, are considered to be stable structures maintaining the structural integrity of tissues. Contrary to the idea that alpha-catenin links the adhesion protein E-cadherin through beta-catenin to the actin cytoskeleton, in the accompanying paper we report that alpha-catenin does not bind simultaneously to both E-cadherin-beta-catenin and actin filaments. Here we demonstrate that alpha-catenin exists as a monomer or a homodimer with different binding properties. Monomeric alpha-catenin binds more strongly to E-cadherin-beta-catenin, whereas the dimer preferentially binds actin filaments. Different molecular conformations are associated with these different binding states, indicating that alpha-catenin is an allosteric protein. Significantly, alpha-catenin directly regulates actin-filament organization by suppressing Arp2/3-mediated actin polymerization, likely by competing with the Arp2/3 complex for binding to actin filaments. These results indicate a new role for alpha-catenin in local regulation of actin assembly and organization at sites of cadherin-mediated cell-cell adhesion.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	wjnelson@stanford.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011; Yamada, Soichiro/B-7360-2019	Weis, William I/0000-0002-5583-6150; Yamada, Soichiro/0000-0001-6413-0814	NIGMS NIH HHS [R01 GM56169, R01 GM056169, R01 GM035527, R01 GM35527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R01GM056169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; CHOI HJ, 2006, IN PRESS J BIOL CHEM; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; GESTSIOS S, 2004, NAT REV MOL CELL BIO, V5, P271; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIROKAWA N, 1983, J CELL BIOL, V96, P1325, DOI 10.1083/jcb.96.5.1325; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maeno Y, 1999, AM J PATHOL, V154, P1323, DOI 10.1016/S0002-9440(10)65385-0; MATSUZAKI F, 1990, J CELL BIOL, V110, P1239, DOI 10.1083/jcb.110.4.1239; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; vanHengel J, 1997, J CELL BIOL, V137, P1103, DOI 10.1083/jcb.137.5.1103; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	54	755	771	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					903	915		10.1016/j.cell.2005.09.021	http://dx.doi.org/10.1016/j.cell.2005.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325583	Bronze, Green Accepted			2022-12-01	WOS:000233814100022
J	Mayr, G; Pohl, B; Peters, DS				Mayr, G; Pohl, B; Peters, DS			A well-preserved Archaeopteryx specimen with theropod features	SCIENCE			English	Article							BIRDS; DINOSAURS; EVOLUTION; ORIGIN	A nearly complete skeleton of Archaeopteryx with excellent bone preservation shows that the osteology of the urvogel is similar to that of nonavian theropod dinosaurs..The new specimen confirms the presence of a hyper-extendible second toe as in dromaeosaurs and troodontids. Archaeoptelyx had a plesiomorphic tetraradiate palatine bone and no fully reversed first toe. These observations provide further evidence for the theropod ancestry of birds. in addition, the presence of a hyperextendible second toe blurs the distinction of archaeopterygids from basal deinonychosaurs (troodontids and dromaeosaurs) and challenges the monophyly of Aves.	Forschungsinst Senckenberg, Div Ornithol, D-60325 Frankfurt, Germany; Wyoming Dinosaur Ctr, Thermopolis, WY 82443 USA	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mayr, G (corresponding author), Forschungsinst Senckenberg, Div Ornithol, Senckenberganlage 25, D-60325 Frankfurt, Germany.	Gerald.Mayr@senckenberg.de						CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; de Beer G., 1954, CRAFTSMANS HDB; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Elzanowski A, 2001, NETH J ZOOL, V51, P207, DOI 10.1163/156854201X00279; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Elzanowski Andrzej, 1999, Acta Ornithologica (Warsaw), V34, P123; Elzanowski Andrzej, 2002, P129; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Goloboff PA., 1993, NONA VERSION 2 0 COM; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Martin L.D., 1985, P177; Martin L.D., 1991, P485; MARTIN LD, 1980, AUK, V97, P86; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Ostrom J.H., 1991, P467; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Paul G. S., 2002, DINOSAURS AIR EVOLUT; ROPER M, 2004, ARCHAEOPTERYX, V22, P1; Senter P, 2003, J VERTEBR PALEONTOL, V23, P961, DOI 10.1671/22; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Tarsitano S., 1991, P541; Weishampel DB., 2004, DINOSAURIA; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; WELLNHOFER P, 1992, LOS ANGELES CITY MUS, V36, P3; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wellnhofer Peter, 2004, Archaeopteryx, V22, P3; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342	29	96	104	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1483	1486		10.1126/science.1120331	http://dx.doi.org/10.1126/science.1120331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322455				2022-12-01	WOS:000233756500041
J	Raible, F; Tessmar-Raible, K; Osoegawa, K; Wincker, P; Jubin, C; Balavoine, G; Ferrier, D; Benes, V; de Jong, P; Weissenbach, J; Bork, P; Arendt, D				Raible, F; Tessmar-Raible, K; Osoegawa, K; Wincker, P; Jubin, C; Balavoine, G; Ferrier, D; Benes, V; de Jong, P; Weissenbach, J; Bork, P; Arendt, D			Vertebrate-type intron-rich genes in the marine annelid Platynereis dumerilii	SCIENCE			English	Article							CIONA-INTESTINALIS; EVOLUTION; CONSERVATION; ARTHROPODS; CHORDATE; ANIMALS; GENOME; PAX-6	Previous genome comparisons have suggested that one important trend in vertebrate evolution has been a sharp rise in intron abundance. By using genomic data and expressed sequence tags from the marine annelid Platynereis dumerilii, we provide direct evidence that about two-thirds of human introns predate the bilaterian radiation but were lost from insect and nematode genomes to a large extent. A comparison of coding exon sequences confirms the ancestral nature of Platynereis and human genes. Thus, the urbilaterian ancestor had complex, intron-rich genes that have been retained in Platynereis and human.	European Mol Biol Lab, Dev Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Computat Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Genom Core Facil, D-69117 Heidelberg, Germany; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Ctr Natl Sequencage, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Raible, F (corresponding author), European Mol Biol Lab, Dev Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	raible@embl.de; arendt@embl.de	Tessmar-Raible, Kristin/F-9642-2011; Raible, Florian/G-6019-2011; Bork, Peer/F-1813-2013; Ferrier, David E.K./D-7595-2013	Tessmar-Raible, Kristin/0000-0002-8038-1741; Bork, Peer/0000-0002-2627-833X; Ferrier, David E.K./0000-0003-3247-6233; Benes, Vladimir/0000-0002-0352-2547; Raible, Florian/0000-0002-4515-6485	Biotechnology and Biological Sciences Research Council [BBS/B/12067] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Glardon S, 1997, DEVELOPMENT, V124, P817; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8	16	178	182	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1325	1326		10.1126/science.1119089	http://dx.doi.org/10.1126/science.1119089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311335				2022-12-01	WOS:000233600200040
J	Yoon, HY; Enquist, LW; Dulac, C				Yoon, HY; Enquist, LW; Dulac, C			Olfactory inputs to hypothalamic neurons controlling reproduction and fertility	CELL			English	Article							GONADOTROPIN-RELEASING-HORMONE; CEREBRAL HEMISPHERE REGULATION; VENTRAL TEGMENTAL AREA; MEDIAL PREOPTIC AREA; LUTEINIZING-HORMONE; PSEUDORABIES VIRUS; CORTICOMEDIAL AMYGDALA; STRIA TERMINALIS; GOLDEN-HAMSTER; NEURAL INPUTS	In order to gain insight into sensory processing modulating reproductive behavioral and endocrine changes, we have aimed at identifying afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known as gonadotropin-releasing hormone [GnRH]), a key neurohormone of reproduction. Injection of conditional pseudorabies virus into the brain of an LHRH::CRE mouse line led to the identification of neuronal networks connected to LHRH neurons. Remarkably, and in contrast to established notions on the nature of LHRH neuronal inputs, our data identify major olfactory projection pathways originating from a discrete population of olfactory sensory neurons but fail to document any synaptic connectivity with the vomeronasal system. Accordingly, chemosensory modulation of LHRH neuronal activity and mating behavior are dramatically impaired in absence of olfactory function, while they appear unaffected in mouse mutants lacking vomeronasal signaling. Further visualization of afferents to LHRH neurons across the brain offers a unique opportunity to uncover complex polysynaptic circuits modulating reproduction and fertility.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Harvard University; Howard Hughes Medical Institute; Princeton University	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Dulac, Catherine/0000-0001-5024-5418	NIDCD NIH HHS [R01 DC003903] Funding Source: Medline; NINDS NIH HHS [2R01-NS33506] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Baum B.M., 2002, BEHAV ENDOCRINOLOGY, P153; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; COQUELIN A, 1984, J NEUROSCI, V4, P2230; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dobson H, 2003, REPRODUCTION, V125, P151, DOI 10.1530/rep.0.1250151; Dong HW, 2004, J COMP NEUROL, V471, P396, DOI 10.1002/cne.20002; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Genazzani AR, 2000, ANN NY ACAD SCI, V900, P1; JANSEN ASP, 1993, BRAIN RES, V617, P103, DOI 10.1016/0006-8993(93)90619-X; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Karanth S, 2004, EXP BIOL MED, V229, P72, DOI 10.1177/153537020422900109; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; KEVETTER GA, 1981, J COMP NEUROL, V197, P99, DOI 10.1002/cne.901970108; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Marson L, 2004, NEUROSCIENCE, V127, P723, DOI 10.1016/j.neuroscience.2004.04.063; MCCARTHY MM, 2002, BEHAV ENDOCRINOLOGY, P117; MERCHENTHALER I, 1989, EXP CLIN ENDOCRINOL, V94, P133, DOI 10.1055/s-0029-1210889; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PFAUS JG, 1994, NEUROENDOCRINOLOGY, V60, P283, DOI 10.1159/000126760; Piras E, 2003, J HISTOCHEM CYTOCHEM, V51, P1545, DOI 10.1177/002215540305101114; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Richardson HN, 2004, GEN COMP ENDOCR, V138, P211, DOI 10.1016/j.ygcen.2004.06.008; RIZVI TA, 1992, J COMP NEUROL, V315, P1, DOI 10.1002/cne.903150102; SILVERMAN AJ, 1994, PHYSL REPROD, V1; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; Sipos ML, 1996, BRAIN RES, V729, P29, DOI 10.1016/0006-8993(96)00148-5; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; St John JA, 2003, CHEM SENSES, V28, P773, DOI 10.1093/chemse/bjg068; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang HB, 1998, BRAIN RES, V792, P66, DOI 10.1016/S0006-8993(98)00122-X; WITKIN JW, 1982, NEUROENDOCRINOLOGY, V35, P429, DOI 10.1159/000123419; Wu TJ, 1997, J NEUROBIOL, V33, P983, DOI 10.1002/(SICI)1097-4695(199712)33:7<983::AID-NEU9>3.0.CO;2-4; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	53	303	313	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					669	682		10.1016/j.cell.2005.08.039	http://dx.doi.org/10.1016/j.cell.2005.08.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16290037	Bronze			2022-12-01	WOS:000233497400015
J	Holmes, W				Holmes, W			Seeking rational policy settings for PMTCT	LANCET			English	Editorial Material							HIV-1 TRANSMISSION; PREGNANCY; UGANDA; RAKAI; RISK		Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia	Burnet Institute	Holmes, W (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia.	holmes@burnet.edu.au						Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; McIntyre JA, 2005, LANCET, V366, P1141, DOI 10.1016/S0140-6736(05)67458-2; Nieburg P, 2005, EXPANDED HIV TESTING; TOOLE MJ, IN PRESS SEX TRANSM; *UN, 2001, UNGASS DECL COMM HIV; UNFPA, 2004, GLION CALL ACT FAM P; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	9	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1835	1836		10.1016/S0140-6736(05)67738-0	http://dx.doi.org/10.1016/S0140-6736(05)67738-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310540				2022-12-01	WOS:000233643200008
J	Heller, DA; Jeng, ES; Yeung, TK; Martinez, BM; Moll, AE; Gastala, JB; Strano, MS				Heller, DA; Jeng, ES; Yeung, TK; Martinez, BM; Moll, AE; Gastala, JB; Strano, MS			Optical detection of DNA conformational polymorphism on single-walled carbon nanotubes	SCIENCE			English	Article							B-DNA; SPECTROSCOPY; TRANSITION; SENSORS	The transition of DNA secondary structure from an analogous B to Z conformation modulates the dielectric environment of the single-waited carbon nanotube (SWNT) around which it is adsorbed. The SWNT band-gap fluorescence undergoes a red shift when an encapsulating 30-nucleotide oligomer is exposed to counter ions that screen the charged backbone. The transition is thermodynamically identical for DNA on and off the nanotube, except that the propagation length of the former is shorter by five-sixths. The magnitude of the energy shift is described by using an effective medium model and the DNA geometry on the nanotube sidewall. We demonstrate the detection of the B-Z change in whole blood, tissue, and from within living mammalian cells.	Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Strano, MS (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	strano@uiuc.edu	Heller, Daniel A/A-4283-2008	Heller, Daniel A/0000-0002-6866-0000; Gastala, Joseph/0000-0001-8792-5302				Abascal JLF, 2004, MOL PHYS, V102, P2141, DOI 10.1080/00268970412331292704; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; DUGUID J, 1993, BIOPHYS J, V65, P1916, DOI 10.1016/S0006-3495(93)81263-3; Geballe R., 1958, AM J PHYS, V26, P287, DOI 10.1119/1.1996131; Hartschuh A, 2005, CHEMPHYSCHEM, V6, P577, DOI 10.1002/cphc.200400408; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; JOVIN TM, 1987, ANNU REV PHYS CHEM, V38, P521, DOI 10.1146/annurev.physchem.38.1.521; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3; POHL FM, 1982, COLD SPRING HARB SYM, V47, P113; Popov VN, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035436; Rich A, 1996, J BIOL CHEM, V271, P11595, DOI 10.1074/jbc.271.20.11595; Rohlfing M, 2000, PHYS REV B, V62, P4927, DOI 10.1103/PhysRevB.62.4927; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Saito R., 1998, PHYS PROPERTIES CARB; TUNG CS, 1984, NUCLEIC ACIDS RES, V12, P3343, DOI 10.1093/nar/12.7.3343; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; ZIMMERMAN SB, 1982, ANNU REV BIOCHEM, V51, P395, DOI 10.1146/annurev.bi.51.070182.002143	21	405	428	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2006	311	5760					508	511		10.1126/science.1120792	http://dx.doi.org/10.1126/science.1120792			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439657				2022-12-01	WOS:000235071400042
J	Micchelli, CA; Perrimon, N				Micchelli, CA; Perrimon, N			Evidence that stem cells reside in the adult Drosophila midgut epithelium	NATURE			English	Article							SELF-RENEWAL; NOTCH	Adult stem cells maintain organ systems throughout the course of life and facilitate repair after injury or disease(1). A fundamental property of stem and progenitor cell division is the capacity to retain a proliferative state or generate differentiated daughter cells(2); however, little is currently known about signals that regulate the balance between these processes. Here, we characterize a proliferating cellular compartment in the adult Drosophila midgut. Using genetic mosaic analysis we demonstrate that differentiated cells in the epithelium arise from a common lineage. Furthermore, we show that reduction of Notch signalling leads to an increase in the number of midgut progenitor cells, whereas activation of the Notch pathway leads to a decrease in proliferation. Thus, the midgut progenitor's default state is proliferation, which is inhibited through the Notch signalling pathway. The ability to identify, manipulate and genetically trace cell lineages in the midgut should lead to the discovery of additional genes that regulate stem and progenitor cell biology in the gastrointestinal tract.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Micchelli, CA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cmicchel@genetics.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				BOZCUK AN, 1972, EXP GERONTOL, V7, P147, DOI 10.1016/0531-5565(72)90022-8; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, COLD SPRING HARBOR M, P149; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li L, 2000, GENE DEV, V14, P147; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller A., 1950, BIOL DROSOPHILA, P420; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; OHLSTEIN B, 2005, NATURE          1207, DOI DOI 10.1038/NATURE04333; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Strasburger M, 1932, Z WISS ZOOL ABT A, V140, P539; Torii MA, 1999, DEVELOPMENT, V126, P443; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH; Xie T, 2001, COLD SPRING HARBOR M, P129; XU T, 1993, DEVELOPMENT, V117, P1223	19	756	773	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					475	479		10.1038/nature04371	http://dx.doi.org/10.1038/nature04371			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16340959				2022-12-01	WOS:000234859200047
J	Larson, EB; Wang, L; Bowen, JD; McCormick, WC; Teri, L; Crane, P; Kukull, W				Larson, EB; Wang, L; Bowen, JD; McCormick, WC; Teri, L; Crane, P; Kukull, W			Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; COGNITIVE PERFORMANCE; APOLIPOPROTEIN-E; AEROBIC FITNESS; HEALTH; PEOPLE; ADULTS; WOMEN; IMPAIRMENT	Background: Alzheimer disease and other dementing disorders are major sources of morbidity and mortality in aging societies. Proven strategies to delay onset or reduce risk for dementing disorders would be greatly beneficial. Objective: To determine whether regular exercise is associated with a reduced risk for dementia and Alzheimer disease. Design: Prospective cohort study. Setting: Group Health Cooperative, Seattle, Washington. Participants: 1740 persons older than age 65 years without cognitive impairment who scored above the 25th percentile on the Cognitive Ability Screening Instrument (CASI) in the Adult Changes in Thought study and who were followed biennially to identify incident dementia. Measurements: Baseline measurements, including exercise frequency, cognitive function, physical function, depression, health conditions, lifestyle characteristics, and other potential risk factors for dementia (for example, apolipoprotein E EURO4); biennial assessment for dementia. Results: During a mean follow-up of 6.2 years (SD, 2.0), 158 participants developed dementia (107 developed Alzheimer disease). The incidence rate of dementia was 13.0 per 1000 person-years for participants who exercised 3 or more times per week compared with 19.7 per 1000 person-years for those who exercised fewer than 3 times per week. The age- and sex-adjusted hazard ratio of dementia was 0.62 (95% Cl, 0.44 to 0.86; P = 0.004). The interaction between exercise and performance-based physical function was statistically significant (P = 0.013). The risk reduction associated with exercise was greater in those with lower performance levels. Similar results were observed in analyses restricted to participants with incident Alzheimer disease. Limitations: Exercise was measured by self-reported frequency. The study population had a relatively high proportion of regular exercisers at baseline. Conclusion: These results suggest that regular exercise is associated with a delay in onset of dementia and Alzheimer disease, further supporting its value for elderly persons.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA; VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev Ctr Excellence, Seattle, WA USA	Group Health Cooperative; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Larson, EB (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	larson.e@ghc.org		Crane, Paul/0000-0003-4278-7465; Kukull, Walter/0000-0001-8761-9014	NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER; NIA NIH HHS [AG06781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barnes DE, 2003, J AM GERIATR SOC, V51, P459, DOI 10.1046/j.1532-5415.2003.51153.x; Berg AO, 2002, ANN INTERN MED, V137, P205, DOI 10.7326/0003-4819-137-3-200208060-00014; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Brown DW, 2004, MED SCI SPORT EXER, V36, P890, DOI 10.1249/01.MSS.0000126778.77049.76; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; COX DR, 1972, J R STAT SOC B, V34, P187; DUSTMAN RE, 1984, NEUROBIOL AGING, V5, P35, DOI 10.1016/0197-4580(84)90083-6; Ewbank DC, 1999, AM J PUBLIC HEALTH, V89, P90, DOI 10.2105/AJPH.89.1.90; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAWKINS HL, 1992, PSYCHOL AGING, V7, P643, DOI 10.1037/0882-7974.7.4.643; HILL RD, 1993, J GERONTOL, V48, pP12, DOI 10.1093/geronj/48.1.P12; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson EB, 2004, ALZ DIS ASSOC DIS, V18, P54, DOI 10.1097/01.wad.0000126615.70030.70; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; MADDEN DJ, 1989, PSYCHOL AGING, V4, P307, DOI 10.1037/0882-7974.4.3.307; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOUL JL, 1995, J AGING PHYS ACTIV, V3, P135, DOI 10.1123/japa.3.2.135; Okumiya K, 1996, J AM GERIATR SOC, V44, P569, DOI 10.1111/j.1532-5415.1996.tb01444.x; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PHELAN EA, 2004, J AM GERIATR SOC, V54, P1559; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; SHAY KA, 1992, PSYCHOL AGING, V7, P15, DOI 10.1037/0882-7974.7.1.15; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Teng EL, 1994, INT PSYCHOGERIATR, V6, P62, DOI DOI 10.1017/S1041610294001602; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 1998, J REHABIL RES DEV, V35, P411; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	44	886	932	2	259	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2006	144	2					73	81		10.7326/0003-4819-144-2-200601170-00004	http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	004AX	16418406				2022-12-01	WOS:000234725500003
J	Dodwell, D; Crellin, A				Dodwell, D; Crellin, A			Cancer care - Waiting for radiotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOCAL-CONTROL; TIMES; DELAY; SURVIVAL; HEAD		Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England	Cookridge Hospital	Dodwell, D (corresponding author), Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England.	david.dodwell@leedsth.nhs.uk						Ash D, 2004, CLIN ONCOL-UK, V16, P387, DOI 10.1016/j.clon.2004.06.006; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Choan E, 2005, INT J RADIAT ONCOL, V61, P1071; Fortin A, 2002, INT J RADIAT ONCOL, V52, P929, DOI 10.1016/S0360-3016(01)02606-2; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Jones B, 2005, BRIT MED J, V330, P979, DOI 10.1136/bmj.330.7498.979; Leon X, 2003, RADIOTHER ONCOL, V66, P277, DOI 10.1016/S0167-8140(03)00022-7; Mikeljevic JS, 2004, BRIT J CANCER, V90, P1343, DOI 10.1038/sj.bjc.6601693; O'Rourke N, 2000, CLIN ONCOL-UK, V12, P141, DOI 10.1053/clon.2000.9139; Probst H, 2003, J RADIOTHER PRACT, V3, P113; *ROYAL COLL RAD, 2003, EQ WORKL STAFF RAD U; *ROYAL COLL RAD, 2000, PROV REPL RAD EQ; Schwartz DL, 2002, INT J RADIAT ONCOL, V52, P1352, DOI 10.1016/S0360-3016(01)02807-3; Waaijer A, 2003, RADIOTHER ONCOL, V66, P271, DOI 10.1016/S0167-8140(03)00036-7	14	25	25	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					107	109		10.1136/bmj.332.7533.107	http://dx.doi.org/10.1136/bmj.332.7533.107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410589	Green Published			2022-12-01	WOS:000234777000026
J	Li, T; Chen, XJ; Garbutt, KC; Zhou, PB; Zheng, N				Li, T; Chen, XJ; Garbutt, KC; Zhou, PB; Zheng, N			Structure of DDB1 in complex with a paramyxovirus V protein: Viral hijack of a propeller cluster in ubiquitin ligase	CELL			English	Article							CRYSTAL-STRUCTURE; TOMATO HOMOLOG; GENOME STABILITY; BETA-PROPELLERS; BINDING-PROTEIN; SOCS-BOX; IN-VIVO; SV5 V; STAT1; SIMIAN-VIRUS-5	The DDB1-CuI4A ubiquitin ligase complex promotes protein ubiquitination in diverse cellular functions and is reprogrammed by the V proteins of paramyxoviruses to degrade STATs and block interferon signaling. Here we report the crystal structures of DDB1 alone and in complex with the simian virus 5 V protein. The DDB1 structure reveals an intertwined three-propeller cluster, which contains two tightly coupled P propellers with a large pocket in between and a third 0 propeller flexibly attached on the side. The rigid double-propeller fold of DDB1 is targeted by the viral V protein, which inserts an entire helix into the double-propeller pocket, whereas the third propeller domain docks DDB1 to the N terminus of the CuI4A scaffold. Together, these results not only provide structural insights into how the virus hijacks the DDB1-CuI4A ubiquitin ligase but also establish a structural framework for understanding the multiple functions of DDB1 in the uniquely assembled cullin-RING E3 machinery.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA	University of Washington; University of Washington Seattle; Cornell University	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu			NCI NIH HHS [CA098210, CA107134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107134, R01CA098210, R56CA098210] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; DeLano WL., 2002, PYMOL USERS MANUAL D; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Levin I, 2003, THEOR APPL GENET, V106, P454, DOI 10.1007/s00122-002-1080-4; Lieberman M, 2004, THEOR APPL GENET, V108, P1574, DOI 10.1007/s00122-004-1584-1; Lin GY, 1997, VIROLOGY, V238, P460, DOI 10.1006/viro.1997.8866; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu W, 2000, J BIOL CHEM, V275, P21429, DOI 10.1074/jbc.M000961200; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Mustilli AC, 1999, PLANT CELL, V11, P145, DOI 10.1105/tpc.11.2.145; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Parisien JP, 2002, J VIROL, V76, P6435, DOI 10.1128/JVI.76.13.6435-6441.2002; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Randall RE, 1996, VIROLOGY, V224, P121, DOI 10.1006/viro.1996.0513; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMAS SM, 1988, CELL, V54, P891, DOI 10.1016/S0092-8674(88)91285-8; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Young DF, 2001, J VIROL, V75, P3363, DOI 10.1128/JVI.75.7.3363-3370.2001; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	65	204	211	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					105	117		10.1016/j.cell.2005.10.033	http://dx.doi.org/10.1016/j.cell.2005.10.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413485	Bronze			2022-12-01	WOS:000234969600013
J	Jarosz, DF; Godoy, VG; Delaney, JC; Essigmann, JM; Walker, GC				Jarosz, DF; Godoy, VG; Delaney, JC; Essigmann, JM; Walker, GC			A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates	NATURE			English	Article							ESCHERICHIA-COLI; LESION-BYPASS; ERROR-PRONE; POL-IV; MUTAGENESIS; RIBONUCLEOTIDES; MUTATIONS; ADDUCTS; ROLES; GENE	Translesion synthesis (TLS) by Y-family DNA polymerases is a chief mechanism of DNA damage tolerance(1). Such TLS can be accurate or error-prone, as it is for bypass of a cyclobutane pyrimidine dimer by DNA polymerase h (XP-V or Rad30) or bypass of a (6-4) TT photoproduct by DNA polymerase V (UmuD'C-2), respectively(2,3). Although DinB is the only Y-family DNA polymerase conserved among all domains of life, the biological rationale for this striking conservation has remained enigmatic(4). Here we report that the Escherichia coli dinB gene is required for resistance to some DNA-damaging agents that form adducts at the N-2-position of deoxyguanosine (dG). We show that DinB (DNA polymerase IV) catalyses accurate TLS over one such N-2-dG adduct (N-2-furfuryl-dG), and that DinB and its mammalian orthologue, DNA polymerase kappa, insert deoxycytidine (dC) opposite N-2-furfuryl-dG with 10-15-fold greater catalytic proficiency than opposite undamaged dG. We also show that mutating a single amino acid, the 'steric gate' residue of DinB (Phe13 --> Val) and that of its archaeal homologue Dbh (Phe12 --> Ala), separates the abilities of these enzymes to perform TLS over N-2-dG adducts from their abilities to replicate an undamaged template. We propose that DinB and its orthologues are specialized to catalyse relatively accurate TLS over some N-2-dG adducts that are ubiquitous in nature, that lesion bypass occurs more efficiently than synthesis on undamaged DNA, and that this specificity may be achieved at least in part through a lesion-induced conformational change.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		Jarosz, Daniel/0000-0003-3497-5888; /0000-0001-7243-8261				Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BROTCORNELANNOYE A, 1986, P NATL ACAD SCI USA, V83, P3904, DOI 10.1073/pnas.83.11.3904; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; DeCorte BL, 1996, CHEM RES TOXICOL, V9, P630, DOI 10.1021/tx9501795; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen X, 2002, J BIOL CHEM, V277, P5265, DOI 10.1074/jbc.M109575200; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; WATANABE M, 1994, MUTAT RES, V314, P39, DOI 10.1016/0921-8777(94)90059-0; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Yasui M, 2004, BIOCHEMISTRY-US, V43, P15005, DOI 10.1021/bi048279+; Zewail-Foote M, 2001, CHEM BIOL, V8, P1033, DOI 10.1016/S1074-5521(01)00071-0	28	197	201	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					225	228		10.1038/nature04318	http://dx.doi.org/10.1038/nature04318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407906				2022-12-01	WOS:000234538400045
J	Handysides, J; Handysides, S				Handysides, J; Handysides, S			Stains on the carpet	BRITISH MEDICAL JOURNAL			English	Article							BEETROOT; BEETURIA		Orchard Surg, Buntingford SG9 9DL, England; N Essex Mental Hlth Partnership NHS Trust, Child & Family Consultat Serv, Harlow CM20 1QR, Essex, England		Handysides, S (corresponding author), Orchard Surg, Buntingford SG9 9DL, England.	stuart_handysides@hotmail.com						EASTWOOD MA, 1995, QJM-INT J MED, V88, P711; FINCH AM, 1981, CLIN SCI, V60, P411, DOI 10.1042/cs0600411; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P539; Tesoriere L, 2004, AM J CLIN NUTR, V80, P941, DOI 10.1093/ajcn/80.4.941; WATTS AR, 1993, PHARMACOGENETICS, V3, P302, DOI 10.1097/00008571-199312000-00004	5	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1501	1501		10.1136/bmj.331.7531.1501	http://dx.doi.org/10.1136/bmj.331.7531.1501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373728	Green Published, Bronze			2022-12-01	WOS:000234351300008
J	Parrish, JA				Parrish, JA			Immunosuppression, skin cancer, and ultraviolet A radiation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUVA		Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Parrish, JA (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.							Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Marcil I, 2001, LANCET, V358, P1042, DOI 10.1016/S0140-6736(01)06179-7; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805	5	37	41	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2712	2713		10.1056/NEJMcibr054224	http://dx.doi.org/10.1056/NEJMcibr054224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371639				2022-12-01	WOS:000234094400015
J	Hogan, DR; Baltussen, R; Hayashi, C; Lauer, JA; Salomon, JA				Hogan, DR; Baltussen, R; Hayashi, C; Lauer, JA; Salomon, JA			Achieving the millennium development goals for health - Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries	BRITISH MEDICAL JOURNAL			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV-PREVENTION; BEHAVIOR-CHANGE; TRIAL; INTERVENTIONS; IMPACT; RAKAI; TRANSMISSION; AFRICA; MWANZA	Objective To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS. Design Cost effectiveness analysis based on an epidemiological model. Setting Analyses undertaken for two regions classified using the WHO epidemiological grouping-Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality. Data sources Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database. Main outcome measures Costs per disability adjusted life year (DALY) averted in 2000 international dollars ($Int). Results In both regions interventions focused on mass media, education and treatment of sexually transmitted infections for female sex workers, amid treatment of sexually transmitted infections in the general population cost < $Int150 per DALY averted. Voluntary counselling and testing costs < $Int350 per DALY averted in both regions, while prevention of mother to child transmission costs < $Int50 per DALY averted in Afr-E but around $Int850 per DALY in Sear-D. School based education strategies and various antiretroviral treatment strategies cost between $Int500 and $Int5000 per DALY averted. Conclusions Reducing HIV transmission could be done most efficiently through mass media campaigns, interventions for sex workers and treatment of sexually transmitted infections where resources are most scarce. However, prevention of mother to child transmission, voluntary counselling and testing, and school based education would yield further health gains at higher budget levels and would be regarded as cost effective or highly cost effective based on standard international benchmarks. Antiretroviral therapy is at least as cost effective in improving population health as some of these interventions.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Erasmus MC, Inst Med Technol Assessment, Rotterdam, Netherlands; WHO, Strateg Informat & Res, Dept HIV AIDS, CH-1211 Geneva, Switzerland; WHO, Costs Effectiveness Expenditure & Prior Setting T, Hlth Syst Financing Dept, CH-1211 Geneva, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; World Health Organization; World Health Organization	Salomon, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Univ Initiat Global Hlth, 104 Mt Auburn St,3rd Floor, Cambridge, MA 02138 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Baltussen, R.M.P.M./L-4181-2015; Salomon, Joshua A/D-3898-2009	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Lauer, Jeremy A/0000-0003-0652-0691	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bollinger L, 2004, STUD FAMILY PLANN, V35, P27, DOI 10.1111/j.1728-4465.2004.00003.x; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Gutierrez JP, 2004, LANCET, V364, P63, DOI 10.1016/S0140-6736(04)16590-2; GUTIERREZ JP, 2004, 15 INT AIDS C SAT SE; GUTIERREZ JP, 2004, 15 IN AIDS C SAT SES; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; KOREURONIP EL, 2002, AIDS, V16, P2299; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Mukherjee JS, 2003, BMJ-BRIT MED J, V327, P1104, DOI 10.1136/bmj.327.7423.1104; Orroth KK, 2003, SEX TRANSM INFECT, V79, P98, DOI 10.1136/sti.79.2.98; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UNAIDS, 2004, AIDS EP UPD DEC 2004; Walker D, 2003, HEALTH POLICY PLANN, V18, P4, DOI 10.1093/heapol/18.1.4; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; World Health Organization (WHO), 2005, ANT DRUGS PREV MOTH	25	115	117	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1431	1435		10.1136/bmj.38643.368692.68	http://dx.doi.org/10.1136/bmj.38643.368692.68			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EE	16282380	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-01	WOS:000234156400017
J	Shaw, RJ; Lamia, KA; Vasquez, D; Koo, SH; Bardeesy, N; DePinho, RA; Montminy, M; Cantley, LC				Shaw, RJ; Lamia, KA; Vasquez, D; Koo, SH; Bardeesy, N; DePinho, RA; Montminy, M; Cantley, LC			The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR TORC2; HEPATIC GLUCONEOGENESIS; FOOD-INTAKE; SNF1-ACTIVATING KINASES; INSULIN-RESISTANCE; UPSTREAM KINASES; RAT-TISSUES; AMP; PGC-1	The Peutz-Jegher syndrome tumor-suppressor gene encodes a protein-threonine kinase, LKB1, which phosphorylates and activates AMPK [adenosine monophosphate (AMP)-activated protein kinase]. The deletion of LKB1 in the liver of adult mice resulted in a nearly complete loss of AMPK activity. Loss of LKB1 function resulted in hyperglycemia with increased gluconeogenic and lipogenic gene expression. In LKB1-deficient livers, TORC2, a transcriptional coactivator of CREB (cAMP response element-binding protein), was dephosphorylated and entered the nucleus, driving the expression of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha), which in turn drives gluconeogenesis. Adenoviral small hairpin RNA (shRNA) for TORC2 reduced PGC-1 alpha expression and normalized blood glucose levels in mice with deleted liver LKB1, indicating that TORC2 is a critical target of LKB1/AMPK signals in the regulation of gluconeogenesis. Finally, we show that metformin, one of the most widely prescribed type 2 diabetes therapeutics, requires LKB1 in the liver to lower blood glucose levels.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Salk Institute; Sungkyunkwan University (SKKU); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Tsai, Yu-Chen/B-5852-2008; Cantley, Lewis C/D-1800-2014; Koo, Seung-Hoi/E-2763-2015	Cantley, Lewis C/0000-0002-1298-7653; Koo, Seung-Hoi/0000-0001-8769-2879; DePinho, Ronald/0000-0002-5625-577X	NCI NIH HHS [CA84313, U01 CA084313] Funding Source: Medline; NIGMS NIH HHS [GM056203, R01 GM056203-09, R01 GM056203, R37 GM037828, GM37828] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037828, R01GM056203, R37GM037828] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Cleasby ME, 2004, DIABETES, V53, P3258, DOI 10.2337/diabetes.53.12.3258; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; HUARD J, 1995, GENE THER, V2, P107; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	47	1461	1559	8	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1642	1646		10.1126/science.1120781	http://dx.doi.org/10.1126/science.1120781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16308421	Green Accepted			2022-12-01	WOS:000233961700035
J	Witt, BJ; Brown, RD; Jacobsen, SJ; Weston, SA; Yawn, BP; Roger, VL				Witt, BJ; Brown, RD; Jacobsen, SJ; Weston, SA; Yawn, BP; Roger, VL			A community-based study of stroke incidence after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LONG-TERM; ISCHEMIC-STROKE; THROMBOLYTIC THERAPY; FIBRINOLYTIC THERAPY; CEREBRAL INFARCTION; PRIMARY ANGIOPLASTY; SECULAR TRENDS; MEDICAL-CARE; RISK-FACTORS	Background: The rate of stroke after myocardial infarction (MI) remains unclear. Objectives: To examine the rate of stroke after incident MI; compare it with that observed in the population of Rochester, Minnesota; determine how the rate of stroke after MI has changed over time; and examine the impact of stroke on survival after incident MI. Design: Community-based cohort. Setting: Olmsted County, Minnesota. Participants: Persons with incident (first-ever) MI between 1979 and 1998. Measurements: Ischemic or hemorrhagic stroke in hospitalized and nonhospitalized patients that was identified by screening of the medical record for stroke diagnostic codes and subsequent stroke confirmation by physician review of the recorded event. Medical record review was used to ascertain baseline characteristics and death. Results: A total of 2160 persons with incident MI were hospitalized between 1979 and 1998 and followed for a median of 5.6 years (range, 0 to 22.2 years). The rate of stroke was 22.6 per 1000 person-months (95% CI, 16.3 to 30.6 per 1000 person-months) during the first 30 days after Mi, corresponding to a 44-fold increase (standardized morbidity ratio, 44 [95% CI, 32 to 59]) risk for stroke in the population of Rochester, Minnesota. The risk for stroke remained 2 to 3 times higher than expected during the first 3 years after Mi. Older age, previous stroke, and diabetes increased the risk for stroke, which did not decline over the study period. Strokes were associated with a large Increase in the risk for death after MI (hazard ratio, 2.89 [CI, 2.44 -to 3.43]). Limitations: Findings may not be generalizable to different populations. The authors measured outcomes by reviewing medical records. Conclusions: in the community, the risk for stroke is markedly increased after MI, particularly early after MI, compared with the expected risk in population without Mi. Stroke is associated with a large increase in the risk for death after Nil.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Olmsted Med Ctr, Rochester, MN USA	Mayo Clinic; Olmsted Medical Center	Roger, VL (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.		Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205, K24HL068765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68765, HL59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; *AM HEART ASS AM C, 2004, HEART STRK STAT UPD; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Azar AJ, 1996, ANN NEUROL, V39, P301, DOI 10.1002/ana.410390306; BODENHEIMER MM, 1994, J AM COLL CARDIOL, V24, P61, DOI 10.1016/0735-1097(94)90542-8; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Braunwald E, 2000, EUR HEART J, V21, P2005; Brodie BR, 2002, AM J CARDIOL, V89, P1243, DOI 10.1016/S0002-9149(02)02319-6; Brown RD, 1996, STROKE, V27, P373; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; GILES WH, 1995, ARCH INTERN MED, V155, P1319, DOI 10.1001/archinte.155.12.1319; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Goldstein LB, 2001, CIRCULATION, V103, P163; GORE JM, 1991, CIRCULATION, V83, P448, DOI 10.1161/01.CIR.83.2.448; GORE JM, 1995, CIRCULATION, V92, P2811, DOI 10.1161/01.CIR.92.10.2811; Guidry UC, 1999, CIRCULATION, V100, P2054, DOI 10.1161/01.CIR.100.20.2054; Heidenreich PA, 2001, AM J MED, V110, P165, DOI 10.1016/S0002-9343(00)00712-9; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; Herlitz J, 2005, J INTERN MED, V257, P201, DOI 10.1111/j.1365-2796.2004.01433.x; HUNT D, 1992, LANCET, V339, P753; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Kandzari DE, 2004, AM J CARDIOL, V93, P458, DOI 10.1016/j.amjcard.2003.10.043; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; Lichtman JH, 2002, CIRCULATION, V105, P1082, DOI 10.1161/hc0902.104708; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; LONGSTRETH WT, 1993, STROKE, V24, P587, DOI 10.1161/01.STR.24.4.587; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Minai K, 2002, AM HEART J, V143, P497, DOI 10.1067/mhj.2002.120778; Mooe T, 1997, STROKE, V28, P762, DOI 10.1161/01.STR.28.4.762; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; O'Connor CM, 2001, AM J CARDIOL, V88, P541, DOI 10.1016/S0002-9149(01)01735-0; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; Perschbacher JM, 2004, MAYO CLIN PROC, V79, P983, DOI 10.4065/79.8.983; Prineas R.J., 1982, MINNESOTA CODE MANUA; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Spencer FA, 2003, AM J CARDIOL, V92, P383, DOI 10.1016/S0002-9149(03)00654-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Sutton AGC, 2004, J AM COLL CARDIOL, V44, P287, DOI 10.1016/j.jacc.2003.12.059; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; TANNE D, 1995, AM J CARDIOL, V76, P825, DOI 10.1016/S0002-9149(99)80236-7; THOMPSON PL, 1978, BRIT MED J, V2, P457, DOI 10.1136/bmj.2.6135.457; VAITKUS PT, 1992, ARCH INTERN MED, V152, P2020, DOI 10.1001/archinte.152.10.2020; Wannamethee SG, 2004, HEART, V90, P1398, DOI 10.1136/hrt.2003.026104; WHISNANT JP, 1990, J CLIN EPIDEMIOL, V43, P791, DOI 10.1016/0895-4356(90)90239-L; Wienbergen H, 2001, AM J CARDIOL, V87, P782, DOI 10.1016/S0002-9149(00)01505-8	58	131	132	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2005	143	11					785	792		10.7326/0003-4819-143-11-200512060-00006	http://dx.doi.org/10.7326/0003-4819-143-11-200512060-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992LH	16330789				2022-12-01	WOS:000233884900002
J	Tosoni, D; Puri, C; Confalonieri, S; Salcini, AE; De Camilli, P; Tacchetti, C; Di Fiore, PP				Tosoni, D; Puri, C; Confalonieri, S; Salcini, AE; De Camilli, P; Tacchetti, C; Di Fiore, PP			TTP specifically regulates the internalization of the transferrin receptor	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; COATED VESICLE FORMATION; TYROSINE PHOSPHORYLATION; ALPHA-ADAPTIN; DYNAMIN; BINDING; DROSOPHILA; CELLS; REQUIREMENTS	Different plasma membrane receptors are internalized through saturable/noncompetitive pathways, suggesting cargo-specific regulation. Here, we report that TTP (SH3BP4), a SH3-containing protein, specifically regulates the internalization of the transferrin receptor (TfR). TTP interacts with endocytic proteins, including clathrin, dynamin, and the TfR, and localizes selectively to TfR-containing coated-pits (CCP) and -vesicles (CCV). Overexpression of TTP specifically inhibits TfR internalization, and causes the formation of morphologically aberrant CCP, which are probably fission impaired. This effect is mediated by the SH3 of TTP, which can bind to dynamin, and it is rescued by overexpression of dynamin. Functional ablation of TTP causes a reduction in TfR internalization, and reduced cargo loading and size of TfR-CCV. Tyrosine phosphorylation of either TTP or dynamin prevents their interaction, pointing to a possible mechanism of exclusion of TTP from some CCP. Thus, TTP might represent one of the long sought for molecules that allow cargo-specific control of clathrin endocytosis.	IFOM, Ist FIRC Oncol Mol, I-20139 Milan, Italy; Univ Genoa, Dept Expt Med, MicroScoBio Res Ctr, I-16132 Genoa, Italy; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med, New Haven, CT 06536 USA; Ist Europeo Oncol, I-20141 Milan, Italy; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Yale University; Howard Hughes Medical Institute; Yale University; IRCCS European Institute of Oncology (IEO); University of Milan	Di Fiore, PP (corresponding author), IFOM, Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it	Salcini, Anna Elisabetta/G-4472-2017; Tosoni, Daniela/K-4524-2014; Confalonieri, Stefano/AAQ-6786-2020; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; TACCHETTI, CARLO/0000-0003-4602-000X; Salcini, Anna Elisabetta/0000-0001-5828-2512	NCI NIH HHS [CA46128] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dunlevy JR, 1999, GENOMICS, V62, P519, DOI 10.1006/geno.1999.5994; FAZIOLI F, 1992, J BIOL CHEM, V267, P5155; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; LAMAZE C, 1993, MOL BIOL CELL, V4, P715, DOI 10.1091/mbc.4.7.715; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rabouille C, 1999, METH MOL B, V117, P125; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	38	81	92	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					875	888		10.1016/j.cell.2005.10.021	http://dx.doi.org/10.1016/j.cell.2005.10.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325581	Bronze			2022-12-01	WOS:000233814100020
J	Yu, DH; Keene, AC; Srivatsan, A; Waddell, S; Davis, RL				Yu, DH; Keene, AC; Srivatsan, A; Waddell, S; Davis, RL			Drosophila DPM neurons form a delayed and branch-specific memory trace after olfactory classical conditioning	CELL			English	Article							MUTANT DROSOPHILA; MUSHROOM BODY; ANTENNAL LOBE; GENE; MAP; REPRESENTATION; EXPRESSION; RECEPTORS; BRAIN	Formation of normal olfactory memory requires the expression of the wild-type amnesiac gene in the dorsal paired medial (DPM) neurons. Imaging the activity in the processes of DPM neurons revealed that the neurons respond when the fly is stimulated with electric shock or with any odor that was tested. Pairing odor and electric-shock stimulation increases odor-evoked calcium signals and synaptic release from DPM neurons. These memory traces form in only one of the two branches of the DPM neuron process. Moreover, trace formation requires the expression of the wildtype amnesiac gene in the DPM neurons. The cellular memory traces first appear at 30 min after conditioning and persist for at least 1 hr, a time window during which DPM neuron synaptic transmission is required for normal memory. DPM neurons are therefore "odor generalists" and form a delayed, branch-specific, and amnesiac-dependent memory trace that may guide behavior after acquisition.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Srivatsan, Anjana/Q-6312-2017; Srivatsan, Anjana/S-1518-2017; Davis, Ronald/J-4998-2013	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Davis, Ronald/0000-0002-5986-7608; Waddell, Scott/0000-0003-4503-6229	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073311, R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS019904, R01NS019904] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH073311, MH069883, F31 MH073311-02] Funding Source: Medline; NINDS NIH HHS [NS19904] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beck CDO, 2000, J NEUROSCI, V20, P2944; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Laissue PP, 1999, J COMP NEUROL, V405, P543; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mcguire S.E., 2001, SCIENCE, V10, P1126; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pavlov IP, 1927, CONDITIONED REFLEXES; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	34	104	105	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					945	957		10.1016/j.cell.2005.09.037	http://dx.doi.org/10.1016/j.cell.2005.09.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325586	Bronze			2022-12-01	WOS:000233814100025
J	Ferri, CP; Prince, M; Brayne, C; Brodaty, H; Fratiglioni, L; Ganguli, M; Hall, K; Hasegawa, K; Hendrie, H; Huang, YQ; Jorm, A; Mathers, C; Menezes, PR; Rimmer, E; Scazufca, M				Ferri, CP; Prince, M; Brayne, C; Brodaty, H; Fratiglioni, L; Ganguli, M; Hall, K; Hasegawa, K; Hendrie, H; Huang, YQ; Jorm, A; Mathers, C; Menezes, PR; Rimmer, E; Scazufca, M		Alzheimers Dis Intl	Global prevalence of dementia: a Delphi consensus study	LANCET			English	Article							ALZHEIMERS-DISEASE; DEVELOPING-COUNTRIES; DETERMINISTIC APPROACH; AFRICAN-AMERICANS; RURAL-COMMUNITY; INDO-US; PEOPLE; MORTALITY; HEALTH; IMPACT	Background 100 years after the first description, Alzheimer's disease is one of the most disabling and burdensome health conditions worldwide. We used the Delphi consensus method to determine dementia prevalence for each world region. Methods 12 international experts were provided with a systematic review of published studies on dementia and were asked to provide prevalence estimates for every WHO world region, for men and women combined, in 5-year age bands from 60 to 84 years, and for those aged 85 years and older. UN population estimates and projections were used to estimate numbers of people with dementia in 2001, 2020, and 2040. We estimated incidence rates from prevalence, remission, and mortality. Findings Evidence from well-planned, representative epidemiological surveys is scarce in many regions. We estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia every year (one new case every 7 seconds). The number of people affected will double every 20 years to 81.1 million by 2040. Most people with dementia live in developing countries (60% in 2001, rising to 71% by 2040). Rates of increase are not uniform; numbers in developed countries are forecast to increase by 100% between 2001 and 2040, but by more than 300% in India, China, and their south Asian and western Pacific neighbours. Interpretation We believe that the detailed estimates in this paper constitute the best currently available basis for policymaking, planning, and allocation of health and welfare resources.	Kings Coll London, Inst Psychiat, Epidemiol Sect, London SE5 8AF, England; Alzheimers Dis Int, London, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; Univ New S Wales, Sydney, NSW, Australia; Karolinska Inst, NEUROTEC, S-10401 Stockholm, Sweden; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Indiana Univ, Sch Med, Ctr Aging Res, Bloomington, IN 47405 USA; St Marianna Univ, Sch Med, Kanagawa, Japan; Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; WHO, Measurement & Hlth Informat, Evidence & Informat Policy, Geneva, Switzerland; Univ Sao Paulo, Dept Prevent Med, BR-05508 Sao Paulo, Brazil; Univ Sao Paulo, Dept Psychiat, BR-05508 Sao Paulo, Brazil	University of London; King's College London; University of Cambridge; University of New South Wales Sydney; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; Saint Marianna University; Peking University; University of Melbourne; World Health Organization; Universidade de Sao Paulo; Universidade de Sao Paulo	Ferri, CP (corresponding author), Kings Coll London, Inst Psychiat, Epidemiol Sect, POB 060,de Crespigny Pk, London SE5 8AF, England.	c.ferri@iop.kcl.ac.uk	Prince, Martin J/A-9170-2010; Ferri, Cleusa Pinheiro/B-2922-2010; Brayne, Carol/AAA-4285-2020; Ganguli, Mary/A-3638-2013; Menezes, Paulo R/C-9985-2010; Brodaty, Henry/E-2753-2010; Robles-Sardin, Alma E/M-7714-2015; MORAN, CATHERINE L/C-9539-2015; Scazufca, Marcia/K-7418-2012; Menezes, Paulo/AAM-3529-2021; Jorm, Anthony F/B-5555-2009	Prince, Martin J/0000-0003-1379-7146; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Brayne, Carol/0000-0001-5307-663X; Menezes, Paulo R/0000-0001-6330-3314; Brodaty, Henry/0000-0001-9487-6617; Robles-Sardin, Alma E/0000-0003-2044-7793; Menezes, Paulo/0000-0001-6330-3314; Jorm, Anthony F/0000-0002-1424-4116; Scazufca, Marcia/0000-0002-4545-006X; Mathers, Colin/0000-0002-0617-6731	NATIONAL INSTITUTE ON AGING [R01AG009956] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG009956-14S1, R01 AG009956] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Breteler MMB, 1998, HAEMOSTASIS, V28, P167; Chandra V, 1998, NEUROLOGY, V51, P1000, DOI 10.1212/WNL.51.4.1000; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; COMASHERRA A, 1728, 2005 PSSRU; Ferri CP, 2004, INT PSYCHOGERIATR, V16, P441, DOI 10.1017/S1041610204000833; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jagger C, 2000, NEUROLOGY, V54, pS16; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; KALACHE A, 1991, INT J GERIATR PSYCH, V6, P617, DOI 10.1002/gps.930060902; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1046/j.1525-1497.2001.10123.x; McGee MA, 1998, INT J EPIDEMIOL, V27, P87, DOI 10.1093/ije/27.1.87; McGee MA, 2001, NEUROEPIDEMIOLOGY, V20, P221, DOI 10.1159/000054793; Murphy MK, 1988, HEALTH TECHNOL ASSES, V2, p[i, 1]; Pandav RS, 2004, AM J GERIAT PSYCHIAT, V12, P523, DOI 10.1176/appi.ajgp.12.5.523; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2000, INT J GERIATR PSYCH, V15, P21, DOI 10.1002/(SICI)1099-1166(200001)15:1<21::AID-GPS71>3.3.CO;2-X; Prince M, 1997, TROP MED INT HEALTH, V2, P993, DOI 10.1046/j.1365-3156.1997.d01-156.x; Rajkumar S, 1997, INT J GERIATR PSYCH, V12, P702, DOI 10.1002/(SICI)1099-1166(199707)12:7<702::AID-GPS489>3.0.CO;2-H; Schneider J, 1999, INT J GERIATR PSYCH, V14, P651, DOI 10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.3.CO;2-2; Shaji KS, 2003, INT J GERIATR PSYCH, V18, P1, DOI 10.1002/gps.649; Shaji S, 1996, BRIT J PSYCHIAT, V168, P745, DOI 10.1192/bjp.168.6.745; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; World Health Organization, 2003, INTRO DRUG UTILIZATI; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447	27	3664	3873	25	662	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2112	2117		10.1016/S0140-6736(05)67889-0	http://dx.doi.org/10.1016/S0140-6736(05)67889-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360788	Green Accepted			2022-12-01	WOS:000234146000026
J	Gallop, JL; Butler, PJG; McMahon, HT				Gallop, JL; Butler, PJG; McMahon, HT			Endophilin and CtBP/BARS are not acyl transferases in endocytosis or Golgi fission	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN; CURVATURE; ACID; MEMBRANES; RIBEYE; DRIVEN; ROLES; CTBP	Endophilins have been proposed to have an enzymatic activity ( a lysophosphatidic acid acyl transferase or LPAAT activity) that can make phosphatidic acid in membranes(1-3). This activity is thought to change the bilayer asymmetry in such a way that negative membrane curvature at the neck of a budding vesicle will be stabilized. An LPAAT activity has also been proposed for CtBP/ BARS ( carboxy- terminal binding protein/ brefeldin A- ribosylated substrate), a transcription co- repressor that is implicated in dynamin- independent endocytosis and fission of the Golgi in mitosis(4-6). Here we show that the LPAAT activity associated with endophilin is a contaminant of the purification procedure and can be also found associated with the pleckstrin homology domain of dynamin. Likewise, the LPAAT activity associated with CtBP/ BARS is also a co- purification artefact. The proposed locus of activity in endophilins includes the BAR domain, which has no catalytic site but instead senses positive membrane curvature. These data will prompt a re- evaluation of the molecular details of membrane budding.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ac.uk		Gallop, Jennifer Louise/0000-0002-9978-1382				Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; BROWN AP, 1994, PLANT MOL BIOL, V26, P211, DOI 10.1007/BF00039533; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chinnadurai G, 2003, BIOESSAYS, V25, P9, DOI 10.1002/bies.10212; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Umezu-Goto M, 2004, J CELL BIOCHEM, V92, P1115, DOI 10.1002/jcb.20113; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zhang QH, 2002, SCIENCE, V295, P1895	26	69	75	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					675	678		10.1038/nature04136	http://dx.doi.org/10.1038/nature04136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319893				2022-12-01	WOS:000233593100052
J	Wang, LD; Kong, LZ; Wu, F; Bai, YM; Burton, R				Wang, LD; Kong, LZ; Wu, F; Bai, YM; Burton, R			Chronic diseases 4 - Preventing chronic diseases in China	LANCET			English	Article								Chronic diseases now account for an estimated 80% of deaths and 70% of disability-adjusted life-years lost in China. Cardiovascular diseases and cancer are the leading causes of both death and the burden of disease, and exposure to risk factors is high: more than 300 million men smoke cigarettes and 160 million adults are hypertensive, most of whom are not being treated. An obesity epidemic is imminent, with more than 20% of children aged 7-17 years in big cities now overweight or obese. The government of the People's Republic of China must confront these major challenges. The national cancer prevention and control plan (2004-10) is being implemented, and a national chronic disease prevention and control plan is due to be completed this year. Encouraging progress has been made in some areas, with current smoking prevalence in men declining at about 1% per year for a decade, and even better results in large demonstration programmes. Much remains to be done, and resources and sustainability are major issues. However, the surveillance and intervention mechanisms needed to ameliorate the increasing burden of chronic diseases are developing rapidly, taking account of the lessons learned over the past two decades.	WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan; Minist Hlth Peoples Republ China, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; World Hlth Org, Off Representat, Beijing, Peoples R China	World Health Organization; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization	Burton, R (corresponding author), WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan.	BurtonR@chn.wpro.who.int						ARMSTRONG T, 2003, ETHNIC DIS, V13, pS2; *CTR HLTH STAT INF, 2004, AN REP CHIN NAT HLTH; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; LEEDER S, 2005, RACE TIME CHALLENGE; Ministries of Health and Science and Technology and the National Bureau of Statistics of the Peoples Republic of China, 2004, NUTR HLTH STAT CHIN; *NAT BUR CENS CHIN, 2000, 5 NAT POP CENS; STRONG K, 2005, LANCET          1005, DOI DOI 10.1016/S0140-6736(05)67341-2; WANG WZ, 2002, CHIN J CHRON NONCOMM, V4, P49; WANG WZ, 2002, CHIN J GERIATR CARDI, V4, P30; Wang Y, 2000, CHIN J SCH HLTH, V21, P456; Wen CH, 2005, LANCET ONCOL, V6, P139, DOI 10.1016/S1470-2045(05)01761-4; *WORLD BANK LOAN C, 2004, HLTH PROM COMP EXT E; *WORLD BANK OFF, 2005, 3 WORLD BANK OFF; World Health Organization, 2005, PREVENTING CHRONIC D; Yang GH, 2005, CHIN J EPIDEMIOL, V26, P78; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813	16	326	353	4	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1821	1824		10.1016/S0140-6736(05)67344-8	http://dx.doi.org/10.1016/S0140-6736(05)67344-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298221				2022-12-01	WOS:000233517200028
J	Grishchuk, EL; Molodtsov, MI; Ataullakhanov, FI; McIntosh, JR				Grishchuk, EL; Molodtsov, MI; Ataullakhanov, FI; McIntosh, JR			Force production by disassembling microtubules	NATURE			English	Article							SLOWLY HYDROLYZABLE ANALOG; INDIVIDUAL MICROTUBULES; DYNAMIC INSTABILITY; GTP HYDROLYSIS; IN-VITRO; DEPOLYMERIZATION; COMPLEX; CHROMOSOMES; INFORMATION; GENERATION	Microtubules (MTs) are important components of the eukaryotic cytoskeleton: they contribute to cell shape and movement, as well as to the motions of organelles including mitotic chromosomes. MTs bind motor enzymes that drive many such movements, but MT dynamics can also contribute to organelle motility(1-8). Each MT polymer is a store of chemical energy that can be used to do mechanical work, but how this energy is converted to motility remains unknown. Here we show, by conjugating glass microbeads to tubulin polymers through strong inert linkages, such as biotin-avidin, that depolymerizing MTs exert a brief tug on the beads, as measured with laser tweezers. Analysis of these interactions with a molecular-mechanical model of MT structure and force production(9,10) shows that a single depolymerizing MT can generate about ten times the force that is developed by a motor enzyme; thus, this mechanism might be the primary driving force for chromosome motion. Because even the simple coupler used here slows MT disassembly, physiological couplers may modulate MT dynamics in vivo.	Univ Colorado, MCD Biol Dept, Boulder, CO 80309 USA; Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; Natl Res Ctr Haematol, Moscow 125167, Russia; Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119992, Russia; Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Russia	University of Colorado System; University of Colorado Boulder; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	McIntosh, JR (corresponding author), Univ Colorado, MCD Biol Dept, Boulder, CO 80309 USA.	richard.mcintosh@colorado.edu	McIntosh, Richard/GLN-3533-2022; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019	Molodtsov, Maxim/0000-0002-3066-0515				Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Brouhard GJ, 2003, IEEE T BIO-MED ENG, V50, P121, DOI 10.1109/TBME.2002.805463; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; GILDERSLEEVE RF, 1992, J BIOL CHEM, V267, P7995; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hunt AJ, 1998, MOL BIOL CELL, V9, P2857, DOI 10.1091/mbc.9.10.2857; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; OBRIEN ET, 1990, BIOCHEMISTRY-US, V29, P6648, DOI 10.1021/bi00480a014; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; VIGERS GPA, 1988, J CELL BIOL, V107, P1011, DOI 10.1083/jcb.107.3.1011; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	30	210	217	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					384	388		10.1038/nature04132	http://dx.doi.org/10.1038/nature04132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292315				2022-12-01	WOS:000233300200054
J	Cleland, J; Sinding, S				Cleland, J; Sinding, S			What would Malthus say about AIDS in Africa?	LANCET			English	Editorial Material									London Sch Hyg & Trop Med, London WC1B 3DP, England; Int Planned Parenthood Federat, London SE1 3UZ, England	University of London; London School of Hygiene & Tropical Medicine	Cleland, J (corresponding author), London Sch Hyg & Trop Med, 49-50 Bedford Sq, London WC1B 3DP, England.	john.Cleland@lshtm.ac.uk						Alexandratos N, 2005, POPUL DEV REV, V31, P237, DOI 10.1111/j.1728-4457.2005.00064.x; [Anonymous], 2004, 2004 REP GLOB AIDS E; BIRDSALL N, 2000, POPULATION MATTERS D; BLACKER J, 1997, HLTH T REV S2, V7, P45; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Commission for Africa, 2005, OUR COMMON INTEREST; *J SNOW INC DELIVE, 2003, FUT PROJ POLICY PROJ; KINGDON G, 2005, AFRICA REGION EMPLOY; MAULDIN WP, 1965, STUD FAMILY PLANN, V1, P1; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; Piotrow PT, 1997, HLTH COMMUNICATION L; REYNOLDS HW, 2004, 15 INT AIDS C JUL 13; *UK DEP INT DEV, 2003, CALL ACT HIV AIDS; *UN DEP EC SOC AFF, 2002, WORLD POP PROSP 2000, V3; UN Department of Economic and Social Affairs Population Division, 2005, WORLD POP PROSP 2004; *UN MILL PROJ, 2005, INV DEV PRACT GUID A; *UN POP FUND, 2004, FIN RES FLOWS POP AC; *WHO REG OFF AFR, 2003, HIV AIDS EP SURV UPD	18	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1899	1901		10.1016/S0140-6736(05)67603-9	http://dx.doi.org/10.1016/S0140-6736(05)67603-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310558				2022-12-01	WOS:000233643200030
J	Wood, E; Montaner, J; Kerr, T				Wood, E; Montaner, J; Kerr, T			HIV risks in incarcerated injection-drug users	LANCET			English	Editorial Material							PRISON; TRANSMISSION; INFECTION; INMATES		St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Wood, E (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	ewood@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					[Anonymous], 2001, LANCET, V357, P971; Ball A, 1995, MULTICENTRE STUDY DR; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; McCoy CB, 2005, LANCET, V365, P1008; *OFF HIGH COMM HUM, 1990, BAS PRINC TREATM PRI; Small W, 2005, SUBST USE MISUSE, V40, P831, DOI 10.1081/JA-200030795; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; 2005, LANCET, V365, P629	12	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1834	1835		10.1016/S0140-6736(05)67737-9	http://dx.doi.org/10.1016/S0140-6736(05)67737-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310539				2022-12-01	WOS:000233643200007
J	Henry, CR; Satran, D; Lindgren, B; Adkinson, C; Nicholson, CI; Henry, TD				Henry, CR; Satran, D; Lindgren, B; Adkinson, C; Nicholson, CI; Henry, TD			Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC TROPONIN-T; STAGE RENAL-DISEASE; HYPERBARIC-OXYGEN; PROGNOSTIC VALUE; VITAL STATUS; INTOXICATION; SEQUELAE; ISCHEMIA; SURVIVAL; RISK	Context Carbon monoxide (CO) poisoning is a common cause of toxicological morbidity and mortality. Myocardial injury is a frequent consequence of moderate to severe CO poisoning. While the in-hospital mortality for these patients is low, the long-term outcome of myocardial injury in this setting is unknown. Objective To determine the association between myocardial injury and long-term mortality in patients following moderate to severe CO poisoning. Design, Setting, and Participants Prospective cohort study of 230 consecutive adult patients treated for moderate to severe CO poisoning with hyperbaric oxygen and admitted to the Hennepin County Medical Center, a regional center for treatment of CO poisoning, between January 1, 1994, and January 1, 2002. Follow-up was through November 11, 2005. Main Outcome Measure All-cause mortality. Results Myocardial injury (cardiac troponin I level >= 0.7 ng/mL or creatine kinase-MB level >= 5.0 ng/mL and/or diagnostic electrocardiogram changes) occurred in 85 (37%) of 230 patients. At a median follow-up of 7.6 years (range: in-hospital only to 11.8 years), there were 54 deaths (24%). Twelve of those deaths (5%) occurred in the hospital as a result of a combination of burn injury and anoxic brain injury (n=8) or cardiac arrest and anoxic brain injury (n=4). Among the 85 patients who sustained myocardial injury from CO poisoning, 32 (38%) eventually died compared with 22 (15%) of 145 patients who did not sustain myocardial injury (adjusted hazard ratio, 2.1; 95% confidence interval, 1.2-3.7; P=.009). Conclusion Myocardial injury occurs frequently in patients hospitalized for moderate to severe CO poisoning and is a significant predictor of mortality.	Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA; Hennepin Cty Med Ctr, Dept Internal Med, Minneapolis, MN 55415 USA; Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Minneapolis Heart Institute Foundation; Hennepin County Medical Center; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin	Henry, TD (corresponding author), Minneapolis Heart Inst Fdn, 920 E 28th St,Suite 40, Minneapolis, MN 55407 USA.	henry003@umn.edu		/0000-0003-4011-3758				Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Annane D, 2001, INTENS CARE MED, V27, P1776, DOI 10.1007/s00134-001-1127-z; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; BRUNO A, 1993, ACTA NEUROL SCAND, V87, P205; *CDCP, WONDER COMPR MORT DA; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754; Deschamps D, 2003, OCCUP ENVIRON MED, V60, P212, DOI 10.1136/oem.60.3.212; Dierkes J, 2000, CIRCULATION, V102, P1964, DOI 10.1161/01.CIR.102.16.1964; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; GORMAN DF, 1992, ANAESTH INTENS CARE, V20, P311, DOI 10.1177/0310057X9202000306; Hsiao Cheng-Lung, 2004, Acta Neurol Taiwan, V13, P64; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Landesberg G, 2005, CRIT CARE MED, V33, P1281, DOI 10.1097/01.CCM.0000166607.22550.87; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; MIN SK, 1986, ACTA PSYCHIAT SCAND, V73, P80, DOI 10.1111/j.1600-0447.1986.tb02671.x; Mott JA, 2002, JAMA-J AM MED ASSOC, V288, P988, DOI 10.1001/jama.288.8.988; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Pavese N, 1999, ITAL J NEUROL SCI, V20, P171, DOI 10.1007/s100720050028; Raskin N, 1940, J NERV MENT DIS, V92, P640, DOI 10.1097/00005053-194011000-00008; Roohi F, 2001, CLIN NEUROL NEUROSUR, V103, P92, DOI 10.1016/S0303-8467(01)00119-6; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; SAWADA Y, 1980, LANCET, V1, P783; Shillito FH, 1936, J AMER MED ASSOC, V106, P669; SMITH JS, 1973, BRIT MED J, V1, P318, DOI 10.1136/bmj.1.5849.318; SMITH JS, 1970, POSTGRAD MED J, V46, P65, DOI 10.1136/pgmj.46.532.65; Spies C, 1998, CHEST, V113, P1055, DOI 10.1378/chest.113.4.1055; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; VIEREGGE P, 1989, J NEUROL, V236, P478, DOI 10.1007/BF00328511; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Weaver LK, 1999, CRIT CARE CLIN, V15, P297, DOI 10.1016/S0749-0704(05)70056-7; World Health Organisation, 1977, INT CLASS DIS 9 REV; World Health Organization, 1992, INT STAT CLASS DIS 1	40	202	212	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2006	295	4					398	402		10.1001/jama.295.4.398	http://dx.doi.org/10.1001/jama.295.4.398			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005QJ	16434630	Bronze			2022-12-01	WOS:000234838600020
J	Forget, F; Haberle, RM; Montmessin, F; Levrard, B; Heads, JW				Forget, F; Haberle, RM; Montmessin, F; Levrard, B; Heads, JW			Formation of glaciers on Mars by atmospheric precipitation at high obliquity	SCIENCE			English	Article							DEBRIS APRONS; ICE; CIRCULATION; LATITUDES; DEPOSITS; GULLIES; SURFACE; FLOWS; SNOW	Surface conditions on Mars are currently cold and dry, with water ice unstable on the surface except near the poles. However, geologically recent glacierlike landforms have been identified in the tropics and the midlatitudes of Mars. The ice has been proposed to originate from either a subsurface reservoir or the atmosphere. We present high-resolution climate simulations performed with a model designed to simulate the present-day Mars water cycle but assuming a 45 degrees obliquity as experienced by Mars a few million years ago. The model predicts ice accumulation in regions where glacier landforms are observed, on the western flanks of the great volcanoes and in the eastern Hellas region. This agreement points to an atmospheric origin for the ice and reveals how precipitation could have formed glaciers on Mars.	Univ Paris 06, Inst Pierre Simon Laplace, Meteorol Dynam Lab, F-75252 Paris 05, France; NASA, Div Space Sci, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Paris 06, Inst Pierre Simon Laplace, Serv Aeron, F-75252 Paris 05, France; Inst Mecan Celeste, F-75014 Paris, France; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Brown University	Forget, F (corresponding author), Univ Paris 06, Inst Pierre Simon Laplace, Meteorol Dynam Lab, Boite Postale 99, F-75252 Paris 05, France.	forget@lmd.jussieu.fr		Montmessin, Franck/0000-0002-4187-1457				Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Clancy R. T., 2003, Journal of Geophysical Research, V108, P2, DOI 10.1029/2003JE002058; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hartmann WK, 2003, ICARUS, V162, P259, DOI 10.1016/S0019-1035(02)00065-9; Hauber E, 2005, NATURE, V434, P356, DOI 10.1038/nature03423; Head JW, 2005, NATURE, V434, P346, DOI 10.1038/nature03359; Head JW, 2003, GEOLOGY, V31, P641, DOI 10.1130/0091-7613(2003)031<0641:CMGOMW>2.0.CO;2; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; LUCCHITTA BK, 1984, J GEOPHYS RES S, V89, P409, DOI DOI 10.1029/JB089IS02P0B409; Mangold N, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001885; MILKOVICH SM, IN PRESS ICARUS; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Montmessin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002284; MONTMESSIN F, 2004, P LUNAR PLANET SCI C, V35, P1312; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; Newman CE, 2005, ICARUS, V174, P135, DOI 10.1016/j.icarus.2004.10.023; Pierce TL, 2003, ICARUS, V163, P46, DOI 10.1016/S0019-1035(03)00046-0; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001536; Shean DE, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002360; SQUYRES SW, 1979, J GEOPHYS RES, V84, P8087, DOI 10.1029/JB084iB14p08087; Thomas P., 1992, MARS, P767	26	314	315	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					368	371		10.1126/science.1120335	http://dx.doi.org/10.1126/science.1120335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424337				2022-12-01	WOS:000234938500041
J	Zhang, JF; Kaasik, K; Blackburn, MR; Lee, CC				Zhang, JF; Kaasik, K; Blackburn, MR; Lee, CC			Constant darkness is a circadian metabolic signal in mammals	NATURE			English	Article							RAT; HIBERNATION; 5'-NUCLEOTIDASE; 5-NUCLEOTIDASE; ADENOSINE; TISSUES; TORPOR; ACID	Environmental light is the 'zeitgeber' (time-giver) of circadian behaviour(1). Constant darkness is considered a 'free-running' circadian state. Mammals encounter constant darkness during hibernation(2). Ablation of the master clock synchronizer, the suprachiasmatic nucleus, abolishes torpor, a hibernation-like state, implicating the circadian clock in this phenomenon(2,3). Here we report a mechanism by which constant darkness regulates the gene expression of fat catabolic enzymes in mice. Genes for murine procolipase (mClps) and pancreatic lipase-related protein 2 (mPlrp2) are activated in a circadian manner in peripheral organs during 12 h dark: 12 h dark (DD) but not light-dark (LD) cycles. This mechanism is deregulated in circadian-deficient mPer1(-/-)/mPer2(m/m) mice. We identified circadian-regulated 5'-AMP, which is elevated in the blood of DD mice, as a key mediator of this response. Synthetic 5'-AMP induced torpor and mClps expression in LD animals. Torpor induced by metabolic stress was associated with elevated 5'-AMP levels in DD mice. Levels of glucose and non-esterified fatty acid in the blood are reversed in DD and LD mice. Induction of mClps expression by 5'-AMP in LD mice was reciprocally linked to blood glucose levels. Our findings uncover a circadian metabolic rhythm in mammals.	Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-51010 Tartu, Estonia	University of Texas System; University of Texas Health Science Center Houston; University of Tartu	Lee, CC (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	cheng.c.lee@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966				AHLERSOVA E, 1982, PHYSIOL BOHEMOSLOV, V31, P57; Alila-Johansson A, 2004, COMP BIOCHEM PHYS A, V138, P119, DOI 10.1016/j.cbpb.2004.02.021; ARCH JRS, 1978, BIOCHEM J, V174, P965, DOI 10.1042/bj1740965; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; D'Agostino D, 2002, J BIOL CHEM, V277, P7170, DOI 10.1074/jbc.M108328200; ERLANSONALBERTSSON C, 1988, REGUL PEPTIDES, V22, P325, DOI 10.1016/0167-0115(88)90109-7; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GarciaFuentes L, 1996, J BIOL CHEM, V271, P27569, DOI 10.1074/jbc.271.44.27569; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Heller HC, 2004, ANNU REV PHYSIOL, V66, P275, DOI 10.1146/annurev.physiol.66.032102.115313; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kaushik VK, 2001, AM J PHYSIOL-ENDOC M, V281, pE335, DOI 10.1152/ajpendo.2001.281.2.E335; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; LeBlanc PJ, 2001, J COMP PHYSIOL B, V171, P327, DOI 10.1007/s003600100180; Lehninger A.L., 1977, BIOCH MOL BASIS CELL, P623; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lowe ME, 1997, J NUTR, V127, P549, DOI 10.1093/jn/127.4.549; Lowe ME, 1998, METHODS MOL BIOL LIP, P59; OGATA S, 1990, BIOCHEMISTRY-US, V29, P7923, DOI 10.1021/bi00486a021; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Ruby NF, 1996, P NATL ACAD SCI USA, V93, P9864, DOI 10.1073/pnas.93.18.9864; STOYNEV A G, 1983, Acta Physiologica et Pharmacologica Bulgarica, V9, P58; THOMPSON LF, 1989, J IMMUNOL, V143, P1815; Thorn JA, 1996, GEN PHARMACOL, V27, P613, DOI 10.1016/0306-3623(95)02053-5; VONMAYERSBACH H, 1979, CELL MOL BIOL, V24, P73; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	29	159	169	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					340	343		10.1038/nature04368	http://dx.doi.org/10.1038/nature04368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421573				2022-12-01	WOS:000234682100046
J	Kishore, S; Stamm, S				Kishore, S; Stamm, S			The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; PRADER-WILLI; IDENTIFICATION; PROTEIN; ORGANIZATION; SELECTION; GENE	The Prader-Willi syndrome is a congenital disease that is caused by the loss of paternal gene expression from a maternally imprinted region on chromosome 15. This region contains a small nucleolar RNA (snoRNA), HBII-52, that exhibits sequence complementarity, to the alternatively spliced exon Vb of the serotonin receptor 5-HT2CR. We found that HBII-52 regulates alternative splicing of 5-HT2CR by binding to a silencing element in exon Vb. Prader-Willi syndrome patients do not express HBII-52. They have different 5-HT2CR messenger RNA (mRNA) isoforms than healthy individuals. Our results show that a snoRNA regulates the processing of an mRNA expressed from a gene located on a different chromosome, and the results indicate that a defect in pre-mRNA processing contributes to the Prader-Willi syndrome.	Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Stamm, S (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	stefan@stamms-lab.net			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013138] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-1-3138] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Dykens E, 2003, CNS DRUGS, V17, P167, DOI 10.2165/00023210-200317030-00003; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Stamm S, 1999, MOL BRAIN RES, V64, P108, DOI 10.1016/S0169-328X(98)00313-1; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Zhang L, 1996, RNA, V2, P682	16	481	507	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					230	232		10.1126/science.1118265	http://dx.doi.org/10.1126/science.1118265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16357227				2022-12-01	WOS:000234722200042
J	Garczarek, F; Gerwert, K				Garczarek, F; Gerwert, K			Functional waters in intraprotein proton transfer monitored by FTIR difference spectroscopy	NATURE			English	Article							HYDROGEN-BONDED NETWORK; ANGSTROM RESOLUTION; STRUCTURAL-CHANGES; ENERGY-STORAGE; EXCESS PROTON; IR-SPECTRA; BACTERIORHODOPSIN; DYNAMICS; ASSIGNMENT; MOLECULES	Much progress has been made in our understanding of water molecule reactions on surfaces(1), proton solvation in gas-phase water clusters(2,3) and proton transfer through liquids(4). Compared with our advanced understanding of these physico-chemical systems, much less is known about individual water molecules and their cooperative behaviour in heterogeneous proteins during enzymatic reactions. Here we use time-resolved Fourier transform infrared(5) spectroscopy (trFTIR) and in situ H-2 O-18/H-2 O-16 exchange FTIR to determine how the membrane protein bacteriorhodopsin(6) uses the interplay among strongly hydrogen-bonded water molecules, a water molecule with a dangling hydroxyl group and a protonated water cluster(7) to transfer protons. The precise arrangement of water molecules in the protein matrix results in a controlled Grotthuss proton transfer, in contrast to the random proton migration that occurs in liquid water. Our findings support the emerging paradigm that intraprotein water molecules are as essential for biological functions as amino acids.	Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany	Ruhr University Bochum	Gerwert, K (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biophys, D-44780 Bochum, Germany.	gerwert@bph.ruhr-uni-bochum.de	Gerwert, Klaus/G-7311-2015					[Anonymous], 1806, ANN CHIM-ROME; BIRGE RR, 1991, J AM CHEM SOC, V113, P4327, DOI 10.1021/ja00011a043; Dencher NA, 2000, BBA-BIOENERGETICS, V1460, P192, DOI 10.1016/S0005-2728(00)00139-0; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Garczarek F, 2004, BIOPHYS J, V87, P2676, DOI 10.1529/biophysj.104.046433; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Grudinin S, 2005, BIOPHYS J, V88, P3252, DOI 10.1529/biophysj.104.047993; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Hayashi S, 2004, J AM CHEM SOC, V126, P10516, DOI 10.1021/ja047506s; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Kandt C, 2004, BIOPHYS J, V86, P705, DOI 10.1016/S0006-3495(04)74149-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LECOUTRE J, 1995, P NATL ACAD SCI USA, V92, P4962, DOI 10.1073/pnas.92.11.4962; Liu K, 1996, SCIENCE, V271, P62, DOI 10.1126/science.271.5245.62; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Marx D, 2004, SCIENCE, V303, P634, DOI 10.1126/science.1094001; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Rousseau R, 2004, ANGEW CHEM INT EDIT, V43, P4804, DOI 10.1002/anie.200453857; Rozenberg M, 2000, PHYS CHEM CHEM PHYS, V2, P2699, DOI 10.1039/b002216k; Shibata N, 2005, BIOCHEMISTRY-US, V44, P7406, DOI 10.1021/bi050122+; Spassov VZ, 2001, J MOL BIOL, V312, P203, DOI 10.1006/jmbi.2001.4902; Tanimoto T, 2003, BIOCHEMISTRY-US, V42, P2300, DOI 10.1021/bi026990d; Zundel G., 1976, Hydrogen bond. Recent developments in theory and experiments. II. Structure and spectroscopy, P683; Zwier TS, 2004, SCIENCE, V304, P1119, DOI 10.1126/science.1098129	30	439	444	4	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					109	112		10.1038/nature04231	http://dx.doi.org/10.1038/nature04231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16280982				2022-12-01	WOS:000234378700044
J	Whitehead, GG; Makino, S; Lien, CL; Keating, MT				Whitehead, GG; Makino, S; Lien, CL; Keating, MT			fgf20 is essential for initiating zebrafish fin regeneration	SCIENCE			English	Article							CELL-PROLIFERATION; DIFFERENTIATION; INDUCTION	Epimorphic regeneration requires the presence or creation of pluripotent cells capable of reproducing lost organs. Zebrafish fin regeneration is mediated by the creation of blastema cells. Here, we characterize the devoid of blastema (dob) mutant that fails fin regeneration during initial steps, forms abnormai regeneration epithelium, and does not form blastema. This mutation has no impact on embryonic survival. Dob results from an fgf20a null mutation, Y148S. Fgf20a is expressed during initiation of fin regeneration at the epithelial-mesenchymal boundary and later overlaps with the blastema marker msxb. Thus, fgf20a has a regeneration-specific requirement, initiating fin regeneration, and controlling blastema formation.	Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol,Dept Cell Biol,Howard Hughes Med Ins, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Keating, MT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Cardiol,Dept Cell Biol,Howard Hughes Med Ins, Boston, MA 02115 USA.	mark.keating@novartis.com			NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; JOHNSON SL, 1995, GENETICS, V141, P1583; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Makino S, 2005, P NATL ACAD SCI USA, V102, P14599, DOI 10.1073/pnas.0507408102; Nechiporuk A, 2003, DEV BIOL, V258, P291, DOI 10.1016/S0012-1606(03)00129-5; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Ohmachi S, 2003, J NEUROSCI RES, V72, P436, DOI 10.1002/jnr.10592; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857	17	217	222	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1957	1960		10.1126/science.1117637	http://dx.doi.org/10.1126/science.1117637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373575				2022-12-01	WOS:000234275400043
J	Leibfried, A; To, JPC; Busch, W; Stehling, S; Kehle, A; Demar, M; Kieber, JJ; Lohmann, JU				Leibfried, A; To, JPC; Busch, W; Stehling, S; Kehle, A; Demar, M; Kieber, JJ; Lohmann, JU			WUSCHEL controls meristem function by direct regulation of cytokinin-inducible response regulators	NATURE			English	Article							ARABIDOPSIS SHOOT MERISTEM; STEM-CELL FATE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CLAVATA1; THALIANA; CLV3; ENCODES; KINASE; FAMILY	Plants continuously maintain pools of totipotent stem cells in their apical meristems from which elaborate root and shoot systems are produced. In Arabidopsis thaliana, stem cell fate in the shoot apical meristem is controlled by a regulatory network that includes the CLAVATA (CLV) ligand - receptor system and the homeodomain protein WUSCHEL (WUS)(1,2). Phytohormones such as auxin and cytokinin are also important for meristem regulation(3). Here we show a mechanistic link between the CLV/WUS network and hormonal control. WUS, a positive regulator of stem cells, directly represses the transcription of several two-component ARABIDOPSIS RESPONSE REGULATOR genes (ARR5, ARR6, ARR7 and ARR15), which act in the negative-feedback loop of cytokinin signalling(4,5). These data indicate that ARR genes might negatively influence meristem size and that their repression by WUS might be necessary for proper meristem function. Consistent with this hypothesis is our observation that a mutant ARR7 allele, which mimics the active, phosphorylated form, causes the formation of aberrant shoot apical meristems. Conversely, a loss-of-function mutation in a maize ARR homologue was recently shown to cause enlarged meristems(6).	Ag Lohmann, Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill	Lohmann, JU (corresponding author), Ag Lohmann, Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	jlohmann@tuebingen.mpg.de	Ding, Cheng-Qiang/B-6287-2011; Lohmann, Jan/T-3776-2019; Kieber, Joseph/GLN-6328-2022; Busch, Wolfgang/B-8593-2008	Lohmann, Jan/0000-0003-3667-187X; Kieber, Joseph/0000-0002-5766-812X; Busch, Wolfgang/0000-0003-2042-7290; To, Jennifer/0000-0001-6149-9835; Leibfried, Andrea/0000-0001-7713-024X	NIGMS NIH HHS [R01 GM064425-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064425] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Laux T, 1996, DEVELOPMENT, V122, P87; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Leyser O, 2003, TRENDS PLANT SCI, V8, P541, DOI 10.1016/j.tplants.2003.09.008; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; WU Z, 2004, 1 J HOPK U DEPT BIOS	30	581	640	11	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1172	1175		10.1038/nature04270	http://dx.doi.org/10.1038/nature04270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372013				2022-12-01	WOS:000234111500054
J	Hunter, A; Humphries, SE				Hunter, A; Humphries, SE			Family history of breast cancer and cost of life assurance: a test case comparison of current UK industry practice	BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, London IDEAS Genet Knowledge Pk, London WC1N 1EH, England; BHF Labs, Ctr Cardiovasc Genet, London WC1E 6JF, England	University of London; University College London; University of London; University College London	Hunter, A (corresponding author), Inst Child Hlth, London IDEAS Genet Knowledge Pk, 30 Guilford St, London WC1N 1EH, England.	a.hunter@ich.ucl.ac.uk	Humphries, Stephen E/C-5075-2008	Humphries, Stephen E/0000-0002-8221-6547				Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; *DEP HLTH ASS BRIT, 2005, CONC MOR GEN INS; *NAT I CLIN EXC, 2004, CLIN GUID CLASS CAR; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1	5	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1438	1439		10.1136/bmj.331.7530.1438	http://dx.doi.org/10.1136/bmj.331.7530.1438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356979	Green Published, Bronze			2022-12-01	WOS:000234156400020
J	Lee, CC; Sui, GD; Elizarov, A; Shu, CYJ; Shin, YS; Dooley, AN; Huang, J; Daridon, A; Wyatt, P; Stout, D; Kolb, HC; Witte, ON; Satyamurthy, N; Heath, JR; Phelps, ME; Quake, SR; Tseng, HR				Lee, CC; Sui, GD; Elizarov, A; Shu, CYJ; Shin, YS; Dooley, AN; Huang, J; Daridon, A; Wyatt, P; Stout, D; Kolb, HC; Witte, ON; Satyamurthy, N; Heath, JR; Phelps, ME; Quake, SR; Tseng, HR			Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics	SCIENCE			English	Article							CHEMISTRY; DEVICE	Microreactor technology has shown potential for optimizing synthetic efficiency, particularly in preparing sensitive compounds. We achieved the synthesis of an [F-18]fluoride-radiolabeled molecular imaging probe, 2-deoxy-2-[F-18]fluoro-D-glucose ([F-18]FDG), in an integrated microfluidic device. Five sequential processes-[F-18]fluoride concentration, water evaporation, radiofluorination, solvent exchange, and hydrolytic deprotection-proceeded with high radiochemical yield and purity and with shorter synthesis time relative to conventional automated synthesis. Multiple doses of [F-18[FDG for positron emission tomography imaging studies in mice were prepared. These results, which constitute a proof of principle for automated multistep syntheses at the nanogram to microgram scale, could be generalized to a range of radiolabeled substrates.	Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mass Spect Facil, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Fluidigm Corp, San Francisco, CA 94080 USA; Siemens Med Solut USA Inc, Culver City, CA 90230 USA; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; California Institute of Technology; California Institute of Technology; Siemens AG; Stanford University	Quake, SR (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	quake@stanford.edu; hrtseng@mednet.ucla.edu	Tseng, Hsian-Rong/G-2222-2010; Kolb, Hartmuth C/P-4309-2018	Tseng, Hsian-Rong/0000-0003-0942-5905; Shin, Young Shik/0000-0002-1097-9035	NIGMS NIH HHS [5T32-GM07616] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chan EM, 2003, NANO LETT, V3, P199, DOI 10.1021/nl0259481; Chou HP, 2001, BIOMED MICRODEVICES, V3, P323, DOI 10.1023/A:1012412916446; de Mello A, 2002, LAB CHIP, V2, p7N, DOI 10.1039/b200736n; Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; HAMACHER K, 1986, J NUCL MED, V27, P235; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Kawaguchi T, 2005, ANGEW CHEM INT EDIT, V44, P2413, DOI 10.1002/anie.200462466; Kikutani Y, 2004, MACROMOL RAPID COMM, V25, P158, DOI 10.1002/marc.200300192; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; PADGETT HC, 1989, APPL RADIAT ISOTOPES, V40, P433, DOI 10.1016/0883-2889(89)90213-X; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; SATYAMURTHY N, 2004, PET MOL IMAGING ITS, P217; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Watts P, 2003, CURR OPIN CHEM BIOL, V7, P380, DOI 10.1016/S1367-5931(03)00050-4; Worz O, 2001, CHEM ENG SCI, V56, P1029, DOI 10.1016/S0009-2509(00)00318-3	18	411	449	11	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1793	1796		10.1126/science.1118919	http://dx.doi.org/10.1126/science.1118919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357255				2022-12-01	WOS:000234093600040
J	Finger, TE; Danilova, V; Barrows, J; Bartel, DL; Vigers, AJ; Stone, L; Hellekant, G; Kinnamon, SC				Finger, TE; Danilova, V; Barrows, J; Bartel, DL; Vigers, AJ; Stone, L; Hellekant, G; Kinnamon, SC			ATP signaling is crucial for communication from taste buds to gustatory nerves	SCIENCE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; FOS-LIKE IMMUNOREACTIVITY; SUPERIOR LARYNGEAL NERVE; P2X(2) RECEPTOR SUBUNIT; SOLITARY TRACT; RAT; SEROTONIN; CELLS; LOCALIZATION; ORGANIZATION	Taste receptor cells detect chemicals in the oral cavity and transmit this information to taste nerves, but the neurotransmitter(s) have not been identified. We report that adenosine 5'-triphosphate (ATP) is the key neurotransmitter in this system. Genetic elimination of ionotropic purinergic receptors (P2X(2) and P2X(3)) eliminates taste responses in the taste nerves, although the nerves remain responsive to touch, temperature, and menthol. Similarly, P2X-knockout mice show greatly reduced behavioral responses to sweeteners, glutamate, and bitter substances. Finally, stimulation of taste buds in vitro evokes release of ATP. Thus, ATP fulfils the criteria for a neurotransmitter linking taste buds to the nervous system.,	Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Aurora, CO 80045 USA; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; Univ Minnesota, Dept Physiol, Duluth, MN 55812 USA; Univ Minnesota, Dept Pharmacol, Duluth, MN 55812 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; Colorado State University; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Kinnamon, SC (corresponding author), Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA.	sue.kinnamon@colostate.edu	Finger, Thomas/R-2974-2017	Finger, Thomas/0000-0001-5923-5099	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006070, P30DC004657, R01DC000766] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30 DC04657, R01 DC06070, R01 DC00766] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARRY MA, 1992, J HISTOCHEM CYTOCHEM, V40, P1919, DOI 10.1177/40.12.1453008; BARTEL DL, IN PRESS CHEM SENSES, P20601; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DICKMAN JD, 1988, BRAIN RES, V450, P25; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Harrer MI, 1996, BRAIN RES, V711, P125, DOI 10.1016/0006-8993(95)01410-1; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; IWAYAMA T, 1967, EXP CELL RES, V46, P607, DOI 10.1016/0014-4827(67)90388-6; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sbarbati A, 2004, J COMP NEUROL, V475, P188, DOI 10.1002/cne.20172; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; SMITH DV, 1991, J NEUROPHYSIOL, V65, P1098, DOI 10.1152/jn.1991.65.5.1098; Travers SP, 2002, AM J PHYSIOL-REG I, V282, pR1798, DOI 10.1152/ajpregu.00590.2001; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002	20	546	577	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1495	1499		10.1126/science.1118435	http://dx.doi.org/10.1126/science.1118435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322458				2022-12-01	WOS:000233756500045
J	Frieden, TR; Das-Douglas, M; Kellerman, SE; Henning, KJ				Frieden, TR; Das-Douglas, M; Kellerman, SE; Henning, KJ			Applying public health principles to the HIV epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEXUAL-BEHAVIOR; PARTNER NOTIFICATION; COST-EFFECTIVENESS; UNITED-STATES; PREVENTION; INFECTION; PROGRAMS; AIDS; CARE		New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Frieden, TR (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.		Abrams, William R/A-5782-2008	Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P597; BAYER R, 1991, NEW ENGL J MED, V324, P1500, DOI 10.1056/NEJM199105233242111; Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Blake SM, 2003, AM J PUBLIC HEALTH, V93, P955, DOI 10.2105/AJPH.93.6.955; *CDCP, 2004, HIV AIDS SURV REP, V15; *CDCP, 2005, DIFF EFF BEH INT PRO; *CDCP, 2003, ADV HIV PREV 4 STRAT; Cohen DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1404, DOI 10.1097/01.qai.0000123271.76723.96; Golden MR, 2004, SEX TRANSM DIS, V31, P709, DOI 10.1097/01.olq.0000145847.65523.43; HOLTGRAVE DR, IN PRESS ANN REV PUB; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; LANDIS SE, 1992, NEW ENGL J MED, V326, P101, DOI 10.1056/NEJM199201093260205; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MARTIN JL, 1987, AM J PUBLIC HEALTH, V77, P578, DOI 10.2105/AJPH.77.5.578; Morin SF, 2004, JAIDS-J ACQ IMM DEF, V36, P960, DOI 10.1097/00126334-200408010-00010; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Remafedi G, 2001, AIDS PATIENT CARE ST, V15, P147, DOI 10.1089/108729101750123625; Schreibman T, 2003, CLIN INFECT DIS, V36, P1171, DOI 10.1086/374359; SHALALA D, 2000, EVIDENCE BASED FINDI; Shlay JC, 2004, SEX TRANSM DIS, V31, P154, DOI 10.1097/01.OLQ.0000114338.60980.12; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *SUBST AB MENT HLT, 2005, INJ DRUG US UPD 2002; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; 2003, MMWR MORB MORTAL WKL, V52, P329	30	112	115	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2397	2402		10.1056/NEJMsb053133	http://dx.doi.org/10.1056/NEJMsb053133			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988EO	16319391				2022-12-01	WOS:000233574600014
J	Picozzi, K; Fevre, EM; Odiit, M; Carrington, M; Eisler, MC; Maudlin, I; Welburn, SC				Picozzi, K; Fevre, EM; Odiit, M; Carrington, M; Eisler, MC; Maudlin, I; Welburn, SC			Sleeping sickness in Uganda: a thin line between two fatal diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRYPANOSOMA-BRUCEI-GAMBIENSE; RHODESIENSE; EPIDEMIC; COUNTY	Objective To determine, through the use of molecular diagnostic tools, whether the two species of parasite that cause human African trypanosomiasis have become sympatric. Design Blood sampling of all available patients between June 2001 and June 2005 in central Uganda and between July and September 2003 in northwest Uganda and analysis of subcounty sleeping sickness records in Uganda between 1985 and 2005. Setting Sleeping sickness treatment centres in central and northwest Uganda and in south Sudan. Participants Patients presenting at the treatment centres and diagnosed as having sleeping sickness. Main outcome measure Classification of parasites from patients from each disease focus as either Trypanosoma brucei rhodesiense (acute form) or T b gambiense (chronic form). Results Blood from 231 patients with sleeping sickness in central Uganda and from 91 patients with sleeping sickness in northwest Uganda and south Sudan were screened for T b rhodesiense (detection of SRA gene) and T b gambiense (detection of TgsGP gene). All samples from central Uganda were classified as T b rhodesiense, and all samples from northwest Uganda and south Sudan were identified as T b gambiense. Conclusions The two focuses of human African trypanosomiasis remain discrete, but the area of Uganda affected by the acute form of human sleeping sickness has increased 2.5-fold since 1985, spreading to three new districts within the past five years through movement of infected livestock. Without preventive action targeted at the livestock reservoir of this zoonotic disease, it is likely that the two disease focuses will converge. This will have a major impact on diagnosis and treatment of this neglected disease. Real time monitoring is recommended, using molecular diagnostic tools (at a regional surveillance centre, for example) targeted at both livestock and human patients.	Univ Edinburgh, Coll Med & Vet Med, Royal Dick Sch Vet Studies, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Minist Hlth Uganda, Kampala, Uganda; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Edinburgh; University of Cambridge	Welburn, SC (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Royal Dick Sch Vet Studies, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland.	sue.welburn@ed.ac.uk	Carrington, Mark/N-4892-2018; Eisler, Mark/AAK-1119-2020; Carrington, Mark/N-3653-2019	Carrington, Mark/0000-0002-6435-7266; Eisler, Mark/0000-0001-6843-3345; Carrington, Mark/0000-0002-6435-7266; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086				ABARU DE, 1985, TROP MED PARASITOL, V36, P72; APTED FIC, 1980, PHARMACOL THERAPEUT, V11, P391, DOI 10.1016/0163-7258(80)90035-2; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; CATTAND P, 1994, B SOC PATHOL EXOT, V87, P307; COOK JH, 1901, J TROP MED, V4, P236; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; *GOV UG, 2005, 2002 UG POP HOUS CEN, P120; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Hutin YJF, 2004, AM J TROP MED HYG, V70, P390, DOI 10.4269/ajtmh.2004.70.390; Kioy D, 2005, LANCET, V366, P695, DOI 10.1016/S0140-6736(05)67153-X; Langlands BW, 1967, 1 MAK U COLL; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Moore A, 1999, AM J TROP MED HYG, V61, P315, DOI 10.4269/ajtmh.1999.61.315; Moore A, 2001, TROP MED INT HEALTH, V6, P342, DOI 10.1046/j.1365-3156.2001.00714.x; MORRIS K. R. S., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P384, DOI 10.1016/0035-9203(59)90039-2; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; Ochan Benjamin, 2004, BMJ, V328, P70, DOI 10.1136/bmj.328.7431.70-e; OKIRIA R, 1985, E AFR MED J, V62, P813; PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38; Picozzi K., 2002, African Journal of Biotechnology, V1, P39; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Rogers David J., 2004, P139, DOI 10.1079/9780851994758.0139; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Shaw APM, 2005, TRYPANOSOMIASES, P369, DOI 10.1079/9780851994758.0369; Solano P, 2003, Med Trop (Mars), V63, P577; Stich A, 2002, BRIT MED J, V325, P203, DOI 10.1136/bmj.325.7357.203; *UG FOR DEP, 1996, NAT BIOM STUD PHAS 3; Welburn SC, 2002, CURR OPIN INFECT DIS, V15, P477, DOI 10.1097/00001432-200210000-00004; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Wendo C, 2002, LANCET, V359, P239, DOI 10.1016/S0140-6736(02)07489-5	34	122	123	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2005	331	7527					1238	1241		10.1136/bmj.331.7527.1238	http://dx.doi.org/10.1136/bmj.331.7527.1238			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	16308383	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000233606800018
J	Samejima, K; Ueda, Y; Doya, K; Kimura, M				Samejima, K; Ueda, Y; Doya, K; Kimura, M			Representation of action-specific reward values in the striatum	SCIENCE			English	Article							BASAL GANGLIA; PREFRONTAL CORTEX; DECISION-MAKING; NEURONS; PREDICTION; CEREBELLUM; DOPAMINE; SIGNALS; MONKEY; ROLES	The estimation of the reward an action will yield is critical in decision-making. To elucidate the role of the basal ganglia in this process, we recorded striatal neurons of monkeys who chose between left and right handle turns, based on the estimated reward probabilities of the actions. During a delay period before the choices, the activity of more than one-third of striatal projection neurons was selective to the values of one of the two actions. Fewer neurons were tuned to relative values or action choice. These results suggest representation of action values in the striatum, which can guide action selection in the basal ganglia circuit.	ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Kyoto Prefectural Univ Med, Dept Physiol, Kyoto 6028566, Japan; Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan	Kyoto Prefectural University of Medicine; Okinawa Institute of Science & Technology Graduate University	Samejima, K (corresponding author), Tamagawa Univ Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan.	samejima@tab.tamagawa.ac.jp; mkimura@koto.kpu-m.ac.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820				Arkadir D, 2004, J NEUROSCI, V24, P10047, DOI 10.1523/JNEUROSCI.2583-04.2004; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Barto A, 1998, REINFORCEMENT LEARNI, V1st; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; HOUK J, 1995, MODELS INFORMATION P; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; LAU B, 2003, SOC NEUR ABSTR, V29; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; SAMEJIMA K, 2004, ADV NEURAL INFORMATI, V16; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Thorndike E, 1898, PSYCHOL REV SER MO S, V2, P1, DOI [DOI 10.1037/H0092987, DOI 10.1037/0003-066X.53.10.1125]; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013	26	628	636	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1337	1340		10.1126/science.1115270	http://dx.doi.org/10.1126/science.1115270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311337				2022-12-01	WOS:000233600200044
J	Menezes, AMB; Perez-Padilla, R; Jardim, JRB; Muino, A; Lopez, MV; Valdivia, G; de Oca, MM; Talamo, C; Hallal, PC; Victora, CG				Menezes, AMB; Perez-Padilla, R; Jardim, JRB; Muino, A; Lopez, MV; Valdivia, G; de Oca, MM; Talamo, C; Hallal, PC; Victora, CG		PLATINO Team	Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study	LANCET			English	Article							HIGH-ALTITUDE RESIDENTS; COPD; BURDEN; EPIDEMIOLOGY; IMPACT; SCOPE	Background Both the prevalence and mortality attributable to chronic obstructive pulmonary disease (COPD) seem to be increasing in low-income and middle-income countries, but few data are available. The aim of the PLATINO study, launched in 2002, was to describe the epidemiology of COPD in five major Latin American cities: Sao Paulo (Brazil), Santiago (Chile), Mexico City (Mexico), Montevideo (Uruguay), and Caracas (Venezuela). Methods A two-stage sampling strategy was used in the five areas to obtain probability samples of adults aged 40 years or older. These individuals were invited to answer a questionnaire and undergo anthropometry, followed by prebronchodilator and postbronchodilator spirometry. We defined COPD as a ratio less than 0.7 of postbronchodilator forced expiratory volume in the first second over forced vital capacity. Findings Complete information, including spirometry, was obtained from 963 people in Sao Paulo, 1173 in Santiago, 1000 in Mexico City, 885 in Montevideo, and 1294 in Caracas. Crude rates of COPD ranged from 7.8% (78 of 1000; 95% CI 5.9-9.7) in Mexico City to 19.7% (174 of 885; 17.2-22.2) in Montevideo. After adjustment for key risk factors, the prevalence of COPD in Mexico City remained significantly lower than that in other cities. Interpretation These results suggest that COPD is a greater health problem in Latin America than previously realised. Altitude may explain part of the difference in prevalence. Given the high rates of tobacco use in the region, increasing public awareness of the burden of COPD is important.	Univ Fed Pelotas, Fac Med, Duque Caxias,250-3 Piso, BR-96030002 Pelotas, RS, Brazil; Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; Univ Fed Sao Paulo, Sao Paulo, Brazil; Univ Republica, Montevideo, Uruguay; Pontificia Univ Catolica Chile, Santiago, Chile; Cent Univ Venezuela, Caracas, Venezuela	Universidade Federal de Pelotas; Universidade Federal de Sao Paulo (UNIFESP); Universidad de la Republica, Uruguay; Pontificia Universidad Catolica de Chile; University of Central Venezuela	Menezes, AMB (corresponding author), Univ Fed Pelotas, Fac Med, Duque Caxias,250-3 Piso, BR-96030002 Pelotas, RS, Brazil.	anamene@terra.com.br	Menezes, Ana MB/G-7266-2012; Victora, Cesar Gomes/Y-2455-2019; Hallal, Pedro C/A-3249-2011; Jardim, Jose R/E-3205-2016; de, Maria Montes/AAP-7687-2021	Menezes, Ana MB/0000-0002-2996-9427; Victora, Cesar Gomes/0000-0002-2465-2180; Hallal, Pedro C/0000-0003-1470-6461; Valdivia, Gonzalo/0000-0001-5368-6745				Ahmad OB, AGE STANDARDIZATION; *BC CANC RES CTR, 2004, LUNG HLTH STUD QUEST; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; *GLOB IN CHRON OBS, 2005, GUENT GOLD DOC RES; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Havryk AP, 2002, RESP PHYSIOL NEUROBI, V132, P223, DOI 10.1016/S1569-9048(02)00072-1; Hurd S, 2000, CHEST, V117, P1; *I NAC EST, 2004, GEOGR INF ENC NAC AD; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Keller S.D., 1995, SCORE SF12 PHYS MENT, VSecond; Lohman TG, 1988, ANTROPOMETRIC STANDA; Menezes Ana, 2004, COPD, V1, P173; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; *MIN SAUD, INF SAUD MORT; Pauwels R, 2000, CHEST, V117, p332S, DOI 10.1378/chest.117.5_suppl_2.332S; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Perez-Padilla R, 2003, PEDIATR PULM, V35, P177, DOI 10.1002/ppul.10232; Petty TL, 2000, CHEST, V117, p326S, DOI 10.1378/chest.117.5_suppl_2.326S; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Tzanakis N, 2004, CHEST, V125, P892, DOI 10.1378/chest.125.3.892; *WHO, TOB ATL; Wood S, 2003, HIGH ALT MED BIOL, V4, P445, DOI 10.1089/152702903322616191; World Bank Group, WORLD DEV IND	27	612	679	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1875	1881		10.1016/S0140-6736(05)67632-5	http://dx.doi.org/10.1016/S0140-6736(05)67632-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ZR	16310554				2022-12-01	WOS:000233643200026
J	Voss, TS; Healer, J; Marty, AJ; Duffy, MF; Thompson, JK; Beeson, JG; Reeder, JC; Crabb, BS; Cowman, AF				Voss, TS; Healer, J; Marty, AJ; Duffy, MF; Thompson, JK; Beeson, JG; Reeder, JC; Crabb, BS; Cowman, AF			A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria	NATURE			English	Article							ANTIGENIC VARIATION; INFECTED ERYTHROCYTES; EXPRESSION; PROTEINS; DISTINCT; TRANSCRIPTION; CHROMOSOMES; PHENOTYPES; PARASITES; SWITCHES	Mono-allelic expression of gene families is used by many organisms to mediate phenotypic variation of surface proteins. In the apicomplexan parasite Plasmodium falciparum, responsible for the severe form of malaria in humans, this is exemplified by antigenic variation of the highly polymorphic P. falciparum erythrocyte membrane protein 1 ( PfEMP1)(1,2). PfEMP1, encoded by the 60-member var gene family(3-6), represents a major virulence factor due to its central role in immune evasion and intravascular parasite sequestration. Mutually exclusive expression of PfEMP1 is controlled by epigenetic mechanisms involving chromatin modification and perinuclear var locus repositioning(7,8). Here we show that a var promoter mediates the nucleation and spreading of stably inherited silenced chromatin. Transcriptional activation of this promoter occurs at the nuclear periphery in association with chromosome-end clusters. Additionally, the var promoter sequence is sufficient to infiltrate a transgene into the allelic exclusion programme of var gene expression, as transcriptional activation of this transgene results in silencing of endogenous var gene transcription. These results show that a var promoter is sufficient for epigenetic silencing and mono-allelic transcription of this virulence gene family, and are fundamental for our understanding of antigenic variation in P. falciparum. Furthermore, the PfEMP1 knockdown parasites obtained in this study will be important tools to increase our understanding of P. falciparum-mediated virulence and immune evasion.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; Papua New Guinea Inst Med Res, Goroka EHP 441, Papua N Guinea	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Monash University; Royal Melbourne Hospital; University of Melbourne; PNG Institute Of Medical Research	Cowman, AF (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	cowman@wehi.edu.au	Duffy, Michael/A-8618-2012; Crabb, Brendan/F-5287-2013; Cowman, Alan F/C-7642-2013; Jackson, Allison/D-6528-2012	Duffy, Michael/0000-0001-5635-4033; Cowman, Alan F/0000-0001-5145-9004; Jackson, Allison/0000-0002-9614-6471; Reeder, John/0000-0003-1395-1289	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; de Koning-Ward TF, 2001, MOL BIOCHEM PARASIT, V117, P155, DOI 10.1016/S0166-6851(01)00344-9; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gannoun-Zaki L, 2005, EUKARYOT CELL, V4, P490, DOI 10.1128/EC.4.2.490-492.2005; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rubio JP, 1996, EMBO J, V15, P4069, DOI 10.1002/j.1460-2075.1996.tb00780.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6	29	203	208	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					1004	1008		10.1038/nature04407	http://dx.doi.org/10.1038/nature04407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16382237				2022-12-01	WOS:000235486100053
J	Haiman, CA; Stram, DO; Wilkens, LR; Pike, MC; Kolonel, LN; Henderson, BE; Le Marchand, L				Haiman, CA; Stram, DO; Wilkens, LR; Pike, MC; Kolonel, LN; Henderson, BE; Le Marchand, L			Ethnic and racial differences in the smoking-related risk of lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERUM COTININE LEVELS; CIGARETTE-SMOKING; JAPANESE MEN; SMOKERS; WHITE; WOMEN; CARCINOMA; AMERICANS; NUTRITION; HAWAII	BACKGROUND There is remarkable variation in the incidence of lung cancer among ethnic and racial groups in the United States. METHODS We investigated differences in the risk of lung cancer associated with cigarette smoking among 183,813 African-American, Japanese-American, Latino, Native Hawaiian, and white men and women in the Multiethnic Cohort Study. Our analysis included 1979 cases of incident lung cancer identified prospectively over an eight-year period, between baseline (1993 through 1996) and 2001. RESULTS The risk of lung cancer among ethnic and racial groups was modified by the number of cigarettes smoked per day. Among participants who smoked no more than 30 cigarettes per day, African Americans and Native Hawaiians had significantly greater risks of lung cancer than did the other groups. Among those who smoked no more than 10 and those who smoked 11 to 20 cigarettes per day, relative risks ranged from 0.21 to 0.39 (P<0.001) among Japanese Americans and Latinos and from 0.45 to 0.57 (P<0.001) among whites, as compared with African Americans. However, at levels exceeding 30 cigarettes per day, these differences were not significant. Differences in risk associated with smoking were observed among both men and women and for all histologic types of lung cancer. CONCLUSIONS Among cigarette smokers, African Americans and Native Hawaiians are more susceptible to lung cancer than whites, Japanese Americans, and Latinos.	Univ So Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA	University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System	Haiman, CA (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, 1441 Eastlake Ave,Rm 4441, Los Angeles, CA 90089 USA.	haiman@usc.edu			NATIONAL CANCER INSTITUTE [R37CA054281, R01CA054281] Funding Source: NIH RePORTER; NCI NIH HHS [CA 54281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Carpenter CL, 1999, ANN EPIDEMIOL, V9, P114, DOI 10.1016/S1047-2797(98)00042-8; Clark PI, 1996, ANN EPIDEMIOL, V6, P483, DOI 10.1016/S1047-2797(96)00049-X; Department of Health and Human Services PHS, 1998, TOB US US RAC ETHN M; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; DOLL R, 1971, J R STAT SOC SER A-G, V134, P133, DOI 10.2307/2343871; Gadgeel SM, 2001, CHEST, V120, P55, DOI 10.1378/chest.120.1.55; HARRIS RE, 1993, INT J EPIDEMIOL, V22, P592, DOI 10.1093/ije/22.4.592; HINDS MW, 1981, INT J CANCER, V27, P297, DOI 10.1002/ijc.2910270307; HUMBLE CG, 1985, AM J PUBLIC HEALTH, V75, P145, DOI 10.2105/AJPH.75.2.145; Kolonel L, 1979, Natl Cancer Inst Monogr, P81; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; LEMARCHAND L, 1992, CANCER EPIDEM BIOMAR, V1, P103; Menck H R, 1982, Natl Cancer Inst Monogr, V62, P101; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Richiardi L, 2004, CANCER CAUSE CONTROL, V15, P285, DOI 10.1023/B:CACO.0000024223.91059.ed; Schwartz AG, 1997, CANCER, V79, P45, DOI 10.1002/(SICI)1097-0142(19970101)79:1<45::AID-CNCR7>3.0.CO;2-L; Smith-Warner SA, 2003, INT J CANCER, V107, P1001, DOI 10.1002/ijc.11490; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Stellman SD, 2003, ANN EPIDEMIOL, V13, P294, DOI 10.1016/S1047-2797(02)00420-9; Stellman SD, 2001, CANCER EPIDEM BIOMAR, V10, P1193; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Wills TA, 1997, AM J PUBLIC HEALTH, V87, P56, DOI 10.2105/AJPH.87.1.56; Ziegler RG, 1996, CANCER CAUSE CONTROL, V7, P157, DOI 10.1007/BF00115646	24	536	543	2	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2006	354	4					333	342		10.1056/NEJMoa033250	http://dx.doi.org/10.1056/NEJMoa033250			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005VY	16436765				2022-12-01	WOS:000234854000005
J	Choudhry, NK; Anderson, GM; Laupacis, A; Ross-Degnan, D; Normand, SLT; Soumerai, SB				Choudhry, NK; Anderson, GM; Laupacis, A; Ross-Degnan, D; Normand, SLT; Soumerai, SB			Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STROKE PREVENTION; ANTICOAGULATION; PREVALENCE; MANAGEMENT; THERAPY; TRENDS; CARE	Objectives To quantify the influence of physicians' experiences of adverse events in patients with atrial fibrillation who were taking warfarin. Design Population based, matched pair before and after analysis. Setting Database study in Ontario, Canada. Participants The physicians of patients with atrial fibrillation admitted to hospital for adverse events (major haemorrhage while taking warfarin and thromboembolic strokes while not taking warfarin). Pairs of other patients with atrial fibrillation treated by the same physicians. Main outcome measures Odds of receiving warfarin by matched pairs of a given physician's patients (one treated after and one treated before the event) were compared, with adjustment for stroke and bleeding risk factors that might also influence warfarin use. The odds of prescriptions for angiotensin converting enzyme (ACE) inhibitor before and after die event was assessed as a neutral control. Results For the 530 physicians who had a patient with an adverse bleeding event (exposure) and who treated other patients with atrial fibrillation during the 90 days before mid the 90 days after the exposure, the odds of prescribing warfarin was 21% lower for patients after the exposure (adjusted odds ratio 0.79, 95% confidence interval 0.62 to 1.00). Greater reductions in warfarin prescribing were found in analyses with patients for whom more time had elapsed between the physician's exposure and the patient's treatment. There were no significant changes in warfarin prescribing after a physician had a patient who had a stroke while not on warfarin or in the prescribing of ACE inhibitors by physicians who had patients with either bleeding events or strokes. Conclusions A physician's experience with bleeding events associated with warfarin can influence prescribing warfarin. Adverse events that are possibly associated with underuse of warfarin may not affect subsequent prescribing.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02120 USA; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02120 USA.	nchoudhry@partners.org		Normand, Sharon-Lise/0000-0001-7027-4769	NATIONAL INSTITUTE ON AGING [R01AG022362] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG022362-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Beyth RJ, 1996, J GEN INTERN MED, V11, P721, DOI 10.1007/BF02598985; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Cohen N, 2000, STROKE, V31, P1217, DOI 10.1161/01.STR.31.6.1217; Damoiseaux RAMJ, 1999, FAM PRACT, V16, P50, DOI 10.1093/fampra/16.1.50; Fang MC, 2004, ARCH INTERN MED, V164, P55, DOI 10.1001/archinte.164.1.55; FEINSTEIN AR, 1985, ARCH INTERN MED, V145, P1257, DOI 10.1001/archinte.145.7.1257; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gross CP, 2003, CLIN THER, V25, P1750, DOI 10.1016/S0149-2918(03)80167-4; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kellen JC, 1998, CAN J CARDIOL, V14, P365; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; Raiford DS, 1996, EPIDEMIOLOGY, V7, P101, DOI 10.1097/00001648-199601000-00018; SALEMSCHATZ SR, 1990, JAMA-J AM MED ASSOC, V264, P476, DOI 10.1001/jama.264.4.476; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	24	128	131	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					141	143		10.1136/bmj.38698.709572.55	http://dx.doi.org/10.1136/bmj.38698.709572.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16403771	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000234905800014
J	Loo, VG; Poirier, L; Miller, MA; Oughton, M; Libman, MD; Michaud, S; Bourgault, AM; Nguyen, T; Frenette, C; Kelly, M; Vibien, A; Brassard, P; Fenn, S; Dewar, K; Hudson, TJ; Horn, R; Rene, P; Monczak, Y; Dascal, A				Loo, VG; Poirier, L; Miller, MA; Oughton, M; Libman, MD; Michaud, S; Bourgault, AM; Nguyen, T; Frenette, C; Kelly, M; Vibien, A; Brassard, P; Fenn, S; Dewar, K; Hudson, TJ; Horn, R; Rene, P; Monczak, Y; Dascal, A			A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; PATHOGENICITY LOCUS; ADP-RIBOSYLTRANSFERASE; TOXIN PRODUCTION; SEVERE DISEASE; RISK-FACTORS; STRAIN; EPIDEMIOLOGY; PREVALENCE; INFECTION	BACKGROUND: In March 2003, several hospitals in Quebec, Canada, noted a marked increase in the incidence of Clostridium difficile-associated diarrhea. METHODS: In 2004 we conducted a prospective study at 12 Quebec hospitals to determine the incidence of nosocomial C. difficile-associated diarrhea and its complications and a case-control study to identify risk factors for the disease. Isolates of C. difficile were typed by pulsed-field gel electrophoresis and analyzed for binary toxin genes and partial deletions in the toxin A and B repressor gene tcdC. Antimicrobial susceptibility was evaluated in a subgroup of isolates. RESULTS: A total of 1703 patients with 1719 episodes of nosocomial C. difficile-associated diarrhea were identified. The incidence was 22.5 per 1000 admissions. The 30-day attributable mortality rate was 6.9 percent. Case patients were more likely than matched controls to have received fluoroquinolones (odds ratio, 3.9; 95 percent confidence interval, 2.3 to 6.6) or cephalosporins (odds ratio, 3.8; 95 percent confidence interval, 2.2 to 6.6). A predominant strain, resistant to fluoroquinolones, was found in 129 of 157 isolates (82.2 percent), and the binary toxin genes and partial deletions in the tcdC gene were present in 132 isolates (84.1 percent). CONCLUSIONS: A strain of C. difficile that was resistant to fluoroquinolones and had binary toxin and a partial deletion of the tcdC gene was responsible for this outbreak of C. difficile-associated diarrhea. Exposure to fluoroquinolones or cephalosporins was a risk factor.	McGill Univ, Ctr Hlth, Dept Microbiol, Montreal, PQ H3G 1A4, Canada; Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; Univ Montreal, Montreal, PQ, Canada; Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; St Marys Hosp, Montreal, PQ, Canada; Ctr Hosp Univ Montreal, Hop St Luc, Montreal, PQ, Canada; Hop Jean Talon, Montreal, PQ, Canada; Genome Quebec Innovat Ctr, Montreal, PQ, Canada; Cite SAnte Laval, Laval, PQ, Canada; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; Hop Charles LeMoyne, Longueuil, PQ, Canada; Reseau Sante Richelieu Yamaska, St Hyacinthe, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Loo, VG (corresponding author), McGill Univ, Ctr Hlth, Dept Microbiol, 1650 Cedar Ave,Rm D16-168, Montreal, PQ H3G 1A4, Canada.	vivian.loo@muhc.mcgill.ca	Brassard, Paul/F-4079-2018	Hudson, Thomas/0000-0002-1376-4849				Allen S.D., 2003, MANUAL CLIN MICROBIO, P835; Barbut F, 1996, ARCH INTERN MED, V156, P1449, DOI 10.1001/archinte.156.13.1449; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; *CLIN LAB STAND I, 2004, M11A6 CLIN LAB STAND; Cohen SH, 2000, J INFECT DIS, V181, P659, DOI 10.1086/315248; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Fawley WN, 2002, J CLIN MICROBIOL, V40, P3546, DOI 10.1128/JCM.40.9.3546-3547.2002; Gaynes R, 2004, CLIN INFECT DIS, V38, P640, DOI 10.1086/381551; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; Hyland M, 2001, Can J Infect Dis, V12, P81; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; Lai KK, 1997, INFECT CONT HOSP EP, V18, P628, DOI 10.2307/30141489; McCusker ME, 2003, EMERG INFECT DIS, V9, P730; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; Morris AM, 2002, ARCH SURG-CHICAGO, V137, P1096, DOI 10.1001/archsurg.137.10.1096; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; RUBIN MS, 1995, DIS COLON RECTUM, V38, P350, DOI 10.1007/BF02054220; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	32	1504	1590	0	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2442	2449		10.1056/NEJMoa051639	http://dx.doi.org/10.1056/NEJMoa051639			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16322602				2022-12-01	WOS:000233754400006
J	Timpson, NJ; Lawlor, DA; Harbord, RM; Gaunt, TR; Day, INM; Palmer, LJ; Hattersley, AT; Ebrahim, S; Lowe, GDO; Rumley, A; Smith, GD				Timpson, NJ; Lawlor, DA; Harbord, RM; Gaunt, TR; Day, INM; Palmer, LJ; Hattersley, AT; Ebrahim, S; Lowe, GDO; Rumley, A; Smith, GD			C-reactive protein and its role in metabolic syndrome: mendelian randomisation study	LANCET			English	Article							CORONARY-HEART-DISEASE; INSTRUMENTAL VARIABLES; GENETIC EPIDEMIOLOGY; INSULIN-RESISTANCE; WEAK INSTRUMENTS; STATIN THERAPY; PUBLIC-HEALTH; CRP GENE; INFLAMMATION; ASSOCIATION	Background Circulating C-reactive protein (CRP) is associated with the metabolic syndrome and might be causally linked to it. Our aim was to generate estimates of the association between plasma CRP and metabolic syndrome phenotypes that were free from confounding and reverse causation, to assess the causal role of this protein. Methods We examined associations between serum CRP concentration and metabolic syndrome phenotypes in the British Women's Heart and Health Study. We then compared these estimates with those derived from a mendelian randomised framework with common CRP gene haplotypes to generate unconfounded and unbiased estimates of any causal associations. Findings In a sample of British women, body-mass index (BMI), systolic blood pressure, waist-to-hip ratio, serum concentrations of HDL cholesterol and triglycerides, and insulin resistance were all associated with plasma CRP concentration. CRP haplotypes were associated with plasma CRP concentration (p<0.0001). With instrumental variable analyses, there was no association between plasma CRP concentration and any of the metabolic syndrome phenotypes analysed. There was strong evidence that linear regression and mendelian randomisation based estimation gave conflicting results for the CRP-BMI association (p=0.0002), and some evidence of conflicting results for the association of CRP with the score for insulin resistance (p=0.0139), triglycerides (p=0.0313), and HDL cholesterol (p=0.0688). Interpretation Disparity between estimates of the association between plasma CRP and phenotypes comprising the metabolic syndrome derived from conventional analyses and those from a mendelian randomisation approach suggests that there is no causal association between CRP and the metabolic syndrome phenotypes.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England; Western Australian Inst Med Res, Lab Genet Epidemiol, Perth, WA, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; Univ Exeter, Peninsular Med Sch, Exeter, Devon, England; Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Bristol; University of Southampton; University of Western Australia; University of Western Australia; University of Exeter; University of Glasgow	Timpson, NJ (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.	n.j.timpson@bristol.ac.uk	Gaunt, Tom R/O-3918-2014; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013; Harbord, Roger M/A-8699-2008; Palmer, Lyle John/N-1948-2019; Attrill, Lauren/V-1688-2018; Palmer, Lyle John/K-3196-2014	Gaunt, Tom R/0000-0003-0924-3247; Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Harbord, Roger M/0000-0002-2257-8271; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Hattersley, Andrew/0000-0001-5620-473X; Lawlor, Debbie A/0000-0002-6793-2262				Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Durbin J., 1954, REV INT STAT I, V22, P23, DOI DOI 10.2307/1401917; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; LOWE GD, 2005, J THROMB HAEMOST, V3, P1076; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/00004872-200310000-00002; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Sjoholm A, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	33	258	264	0	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1954	1959		10.1016/S0140-6736(05)67786-0	http://dx.doi.org/10.1016/S0140-6736(05)67786-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325697				2022-12-01	WOS:000233777900023
J	Maecker, H; Varfolomeev, E; Kischkel, F; Lawrence, D; LeBlanc, H; Lee, W; Hurst, S; Danilenko, D; Li, J; Filvaroff, E; Yang, B; Daniel, D; Ashkenazi, A				Maecker, H; Varfolomeev, E; Kischkel, F; Lawrence, D; LeBlanc, H; Lee, W; Hurst, S; Danilenko, D; Li, J; Filvaroff, E; Yang, B; Daniel, D; Ashkenazi, A			TWEAK attenuates the transition from innate to adaptive immunity	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; DENDRITIC CELLS; INTERFERON-GAMMA; T-CELLS; PERITONEAL-MACROPHAGES; FACTOR FAMILY; IN-VIVO	Innate immunity is the first line of defense against infection, protecting the host during the development of adaptive immunity and critically affecting the nature of the adaptive response. We show that, in contrast to tumor necrosis factor alpha (TNF-alpha), the related protein TWEAK attenuates the transition from innate to adaptive mechanisms. TWEAK(-/-) mice had overabundant natural killer (NK) cells and displayed hypersensitivity to bacterial endotoxin, with their innate immune cells producing excess interferon (IFN)-gamma and interleukin (IL)-12. TWEAK inhibited stimulation of the transcriptional activator STAT-1 and induced p65 nuclear factor (NF)-kappa B association with histone deacetylase 1, repressing cytokine production. TWEAK(-/-) mice developed oversized spleens with expanded memory and T helper 1 (T(H)1) subtype cells upon aging and mounted stronger innate and adaptive T(H)1-based responses against tumor challenge. Thus, TWEAK suppresses production of IFN-gamma and IL-12, curtailing the innate response and its transition to adaptive T(H)1 immunity.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Danilenko, Dimitry/0000-0002-8326-1921; Maecker, Heather/0000-0002-5378-1141				Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Araujo LM, 2000, INT IMMUNOL, V12, P1613, DOI 10.1093/intimm/12.11.1613; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Castriconi R, 2004, CR BIOL, V327, P533, DOI 10.1016/j.crvi.2003.12.001; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen NJ, 2001, J IMMUNOL, V166, P270, DOI 10.4049/jimmunol.166.1.270; Chen QY, 2002, IMMUNOLOGY, V107, P199, DOI 10.1046/j.1365-2567.2002.01485.x; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Coudert RD, 2002, J IMMUNOL, V169, P2979, DOI 10.4049/jimmunol.169.6.2979; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Diefenbach A, 2002, IMMUNOL REV, V188, P9, DOI 10.1034/j.1600-065X.2002.18802.x; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Emoto M, 2002, J IMMUNOL, V169, P1426, DOI 10.4049/jimmunol.169.3.1426; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Greene Warner C, 2004, Novartis Found Symp, V259, P208; HEREMANS H, 1994, EUR J IMMUNOL, V24, P1155, DOI 10.1002/eji.1830240522; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jakubowski A, 2002, J CELL SCI, V115, P267; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Leite-De-Moraes MC, 2001, J IMMUNOL, V166, P945, DOI 10.4049/jimmunol.166.2.945; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2002, MANUAL CLIN LAB IMMU, P338; Maecker HL, 2002, CANCER CELL, V2, P139, DOI 10.1016/S1535-6108(02)00095-8; Marodi L, 2001, CLIN EXP IMMUNOL, V126, P456, DOI 10.1046/j.1365-2249.2001.01693.x; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Nelson N, 1996, J IMMUNOL, V156, P3711; Oswald IP, 1999, EUR CYTOKINE NETW, V10, P533; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Palucka K, 1999, NAT MED, V5, P868, DOI 10.1038/11303; Pan JP, 2004, IMMUNOL LETT, V94, P141, DOI 10.1016/j.imlet.2004.05.003; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perez Omar D, 2004, Methods Mol Biol, V263, P67; Prevost-Blondel A, 2000, EUR J IMMUNOL, V30, P2507, DOI 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rothke, 1994, Assessment, V1, P1, DOI 10.1177/1073191194001001002; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Yang Q, 2003, INT J CANCER, V105, P512, DOI 10.1002/ijc.11119; Yang SX, 1997, CELL IMMUNOL, V179, P84, DOI 10.1006/cimm.1997.1151; Yei S, 2002, GENE THER, V9, P1302, DOI 10.1038/sj.gt.3301803; Zhan YF, 1998, J IMMUNOL, V161, P1447; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	63	190	200	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					931	944		10.1016/j.cell.2005.09.022	http://dx.doi.org/10.1016/j.cell.2005.09.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325585	Bronze			2022-12-01	WOS:000233814100024
J	Baroch, T				Baroch, T			Profile - Alex Galvez - Transitions of fortune	LANCET			English	Biographical-Item									Transit Fdn Guatemala, Miami Springs, FL 33266 USA		Baroch, T (corresponding author), Transit Fdn Guatemala, POB 669004,A1-46, Miami Springs, FL 33266 USA.	transitionsdevelop@conexion.com.gt						GALVEZ A, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S7	S7		10.1016/S0140-6736(05)67822-1	http://dx.doi.org/10.1016/S0140-6736(05)67822-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360764	Bronze			2022-12-01	WOS:000234374400005
J	Brebner, K; Wong, TP; Liu, LD; Liu, YT; Campsall, P; Gray, S; Phelps, L; Phillips, AG; Wang, YT				Brebner, K; Wong, TP; Liu, LD; Liu, YT; Campsall, P; Gray, S; Phelps, L; Phillips, AG; Wang, YT			Nucleus accumbens long-term depression and the expression of behavioral sensitization	SCIENCE			English	Article							AMPA RECEPTOR ENDOCYTOSIS; VENTRAL TEGMENTAL AREA; COCAINE SENSITIZATION; SYNAPTIC PLASTICITY; DOPAMINE; RATS; LTD; AMPHETAMINE; ADDICTION; GLUTAMATE	Drug-dependent neural plasticity related to drug addiction and schizophrenia can be modeled in animals as behavioral sensitization, which is induced by repeated noncontingent or self-administration of many drugs of abuse. Molecular mechanisms that are critical for behavioral sensitization have yet to be specified. Long-term depression (LTD) of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor (AMPAR)-mediated synaptic transmission in the brain has been proposed as a cellular substrate for learning and memory. The expression of LTD in the nucleus accumbens (NAc) required clathrin-dependent endocytosis of postsynaptic AMPARs. NAc LTD was blocked by a dynamin-derived peptide that inhibited clathrin-mediated endocytosis or by a GluR2-derived peptide that blocked regulated AMPAR endocytosis. Systemic or intra-NAc infusion of the membrane-permeable GluR2 peptide prevented the expression of amphetamine-induced behavioral sensitization in the rat.	Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Phillips, AG (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.	aphillips@psych.ubc.ca; ytwang@interchange.ubc.ca	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Wong, Tak Pan/0000-0001-8611-4911; Liu, Lidong/0000-0002-7026-690X				Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; FERRARIO CR, 2005, BIOL PSYCHIAT; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; PERUGINI M, 1994, J PHARMACOL EXP THER, V270, P690; Phillips AG, 1996, PSYCHOPHARMACOLOGY, V124, P279, DOI 10.1007/BF02246669; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; VEZINA P, 1990, BRAIN RES, V516, P99, DOI 10.1016/0006-8993(90)90902-N; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	30	225	235	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1340	1343		10.1126/science.1116894	http://dx.doi.org/10.1126/science.1116894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311338				2022-12-01	WOS:000233600200045
J	Wing, SL; Harrington, GJ; Smith, FA; Bloch, JI; Boyer, DM; Freeman, KH				Wing, SL; Harrington, GJ; Smith, FA; Bloch, JI; Boyer, DM; Freeman, KH			Transient floral change and rapid global warming at the Paleocene-Eocene boundary	SCIENCE			English	Article							CARBON-ISOTOPE EXCURSION; THERMAL MAXIMUM; NORTH-AMERICA; BIGHORN BASIN; OXYGEN-ISOTOPE; CLIMATE-CHANGE; FOSSIL LEAVES; TEMPERATURE; PLANT; VEGETATION	Rapid global warming of 5 degrees to 10 degrees C during the Paleocene-Eocene Thermal Maximum (PETM) coincided with major turnover in vertebrate faunas, but previous studies have found little floral change. Plant fossils discovered in Wyoming, United States, show that PETM floras were a mixture of native and migrant lineages and that plant range shifts were large and rapid (occurring within 10,000 years). Floral composition and leaf shape and size suggest that climate warmed by similar to 5 degrees C during the PETM and that precipitation was low early in the event and increased later. Floral response to warming and/or increased atmospheric CO2 during the PETM was comparable in rate and magnitude to that seen in postglaciat floras and to the predicted effects of anthropogenic carbon release and climate change on future vegetation.	Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Univ Birmingham, Dept Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Florida Museum Nat Hist, Div Vertebrate Paleontol, Gainesville, FL 32611 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Wing, SL (corresponding author), Smithsonian Museum Nat Hist, Dept Paleobiol, 10th St & Constitut Ave NW, Washington, DC 20560 USA.	wings@si.edu	McInerney, Francesca/B-7894-2009; McInerney, Francesca A/ABE-3639-2020; Freeman, Katherine H/H-5140-2011	McInerney, Francesca/0000-0002-2020-6650; McInerney, Francesca A/0000-0002-2020-6650; Freeman, Katherine H/0000-0002-3350-7671; Boyer, Douglas/0000-0002-8697-2999; Bloch, Jonathan/0000-0003-1484-6931; Wing, Scott/0000-0002-2954-8905				Bains R.M., 2001, U MICHIGAN PAPERS PA, V33, P73; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; BOWN TM, 1993, PALAIOS, V8, P68, DOI 10.2307/3515222; Brown RW., 1962, US GEOL SURV PROF PA, V375, P1; Burnham RJ, 2001, AM J BOT, V88, P1096, DOI 10.2307/2657093; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Collinson M. E., CAUSES CONSEQUENCES, V369, P333; Crouch EM, 2003, PALAEOGEOGR PALAEOCL, V194, P387, DOI 10.1016/S0031-0182(03)00334-1; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; CROUCH EM, 2003, GEOL SOC AM SPEC PAP, V369, P333; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Fricke HC, 1998, EARTH PLANET SC LETT, V160, P193, DOI 10.1016/S0012-821X(98)00088-0; Gingerich P.D., 1989, U MICH PAP PALEONT, V28, P1; GINGERICH PD, 2001, U MICHIGAN PAPERS PA, V33, P37; GRADSTEIN F.M., 2005, GEOLOGIC TIME SCALE; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Harrington G. J., 2003, GEOLOGICAL SOC AM SP, P381, DOI DOI 10.1130/0-8137-2369-8.381; Harrington GJ, 2004, J GEOL SOC LONDON, V161, P173, DOI 10.1144/0016-764903-100; Harrington GJ, 2001, PALAEOGEOGR PALAEOCL, V167, P1, DOI 10.1016/S0031-0182(00)00228-5; Harrington GJ, 2001, PALAIOS, V16, P266, DOI 10.2307/3515604; Harrington GJ., 2001, U MICHIGAN PAPERS PA, V33, P89; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jacobs BF, 2004, PALAEOGEOGR PALAEOCL, V213, P115, DOI 10.1016/j.palaeo.2004.07.007; Kelly DC, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000761; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; Kowalski EA, 2003, P NATL ACAD SCI USA, V100, P167, DOI 10.1073/pnas.232693599; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Magioncalda R, 2004, GEOLOGY, V32, P553, DOI 10.1130/G20476.1; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; ROSE KD, 1981, U MICHIGAN MUSEUM PA, V26, P1; Schmitz B, 2003, GEOLOGY, V31, P689, DOI 10.1130/G19527.1; Strait S.G., 2001, U MICHIGAN PAPERS PA, V33, P127; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; Wing SL, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P380; WING SL, 1995, PALAEOGEOGR PALAEOCL, V115, P117, DOI 10.1016/0031-0182(94)00109-L; Wing SL, 2001, PALEOBIOLOGY, V27, P539, DOI 10.1666/0094-8373(2001)027<0539:FRTRWI>2.0.CO;2; WING SL, 2000, WARM CLIMATES EARTH, P197; Wing SL., 2003, CAUSES CONSEQUENCES, V369, P425, DOI DOI 10.1130/0-8137-2369-8.425; Wolfe J. A, 1979, US GEOLOGICAL SURVEY, V1106, P1, DOI DOI 10.3133/PP1106; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	48	410	429	9	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					993	996		10.1126/science.1116913	http://dx.doi.org/10.1126/science.1116913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284173				2022-12-01	WOS:000233343400036
J	Obenauer, JC; Denson, J; Mehta, PK; Su, XP; Mukatira, S; Finkelstein, DB; Xu, XQ; Wang, JH; Ma, J; Fan, YP; Rakestraw, KM; Webster, RG; Hoffmann, E; Krauss, S; Zheng, J; Zhang, ZW; Naeve, CW				Obenauer, JC; Denson, J; Mehta, PK; Su, XP; Mukatira, S; Finkelstein, DB; Xu, XQ; Wang, JH; Ma, J; Fan, YP; Rakestraw, KM; Webster, RG; Hoffmann, E; Krauss, S; Zheng, J; Zhang, ZW; Naeve, CW			Large-scale sequence analysis of avian influenza isolates	SCIENCE			English	Article							NS1 PROTEIN; PDZ DOMAINS; GENE; VIRUSES; CELLS; RECOGNITION; RESPONSES	The spread of H5N1 avian influenza viruses (AIVs) from China to Europe has raised global concern about their potential to infect humans and cause a pandemic. In spite of their substantial threat to human health, remarkably little AIV whole-genome information is available. We report here a preliminary analysis of the first large-scale sequencing of AIVs, including 2196 AIV genes and 169 complete genomes. We combine this new information with public AIV data to identify new gene alleles, persistent genotypes, compensatory mutations, and a potential virulence determinant.	St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Naeve, CW (corresponding author), St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA.	clayton.naeve@stjude.org		Zheng, Jie/0000-0001-6524-6800	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061739, R01GM069916] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIAID NIH HHS [AI95357] Funding Source: Medline; NIGMS NIH HHS [R01 GM069916, R01 GM061739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Enserink M, 2005, SCIENCE, V310, P209, DOI 10.1126/science.310.5746.209; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; MAHY BWJ, 1983, GENETICS INFLUENZA V, P192; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Schultz-Cherry S, 2001, J VIROL, V75, P7875, DOI 10.1128/JVI.75.17.7875-7881.2001; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wuthrich K, 2000, NAT STRUCT BIOL, V7, P188, DOI 10.1038/73278; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	19	474	728	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1576	1580		10.1126/science.1121586	http://dx.doi.org/10.1126/science.1121586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16439620				2022-12-01	WOS:000236029500036
J	Jha, P; Kumar, R; Vasa, P; Dhingra, N; Thiruchelvam, D; Moineddin, R				Jha, P; Kumar, R; Vasa, P; Dhingra, N; Thiruchelvam, D; Moineddin, R			Low male-to-female sex ratio of children born in India: national survey of 1.1 million households	LANCET			English	Article							MISSING WOMEN; INFANTS; TIME	Background Fewer girls than boys are born in India. Various hypotheses have been proposed to explain this low sex ratio. Our aim was to ascertain the contribution of prenatal sex determination and selective abortion as measured by previous birth sex. Methods We analysed data obtained for the Special Fertility and Mortality Survey undertaken in 1998. Ever-married women living in 1.1 million households in 6671 nationally-representative units were asked questions about their fertility history and children born in 1997. Findings For the 133 738 births studied for 1997, the adjusted sex ratio for the second birth when the preceding child was a girl was 759 per 1000 males (99% Cl 731-787). The adjusted sex ratio for the third child was 719 (675-762) if the previous two children were girls. By contrast, adjusted sex ratios for second or third births if the previous children were boys were about equal (1102 and 1176, respectively). Mothers with grade 10 or higher education had a significantly lower adjusted sex ratio (683, 610-756) than did illiterate mothers (869, 820-917). Stillbirths and neonatal deaths were more commonly male, and the numbers of stillbirths were fewer than the numbers of missing births, suggesting that female infanticide does not account for the difference. Interpretation Prenatal sex determination followed by selective abortion of female fetuses is the most plausible explanation for the low sex ratio at birth in India. Women most clearly at risk are those who already have one or two female children. Based on conservative assumptions, the practice accounts for about 0.5 million missing female births yearly, translating over the past 2 decades into the abortion of some 10 million female fetuses.	Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5C 1N8, Canada; Univ Toronto, Fac Med, Dept Publ Hlth Sci, Toronto, ON M5C 1N8, Canada; Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, 70 Richmond St E,2nd Floor, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca			FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW05991-01] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2019, NATL FAMILY HLTH SUR; [Anonymous], 2005, SPEC FERT MORT SURV; Babu NP, 1998, J FAM WELFARE, V44, P45; BOOTH BE, 1994, BRIT MED J, V309, P1259, DOI 10.1136/bmj.309.6964.1259; Census of India, 2001, PROV POP TOT; Chan CLW, 2002, J ASSIST REPROD GEN, V19, P426, DOI 10.1023/A:1016815807703; Chaturvedi S, 2001, TROP DOCT, V31, P204, DOI 10.1177/004947550103100407; Dickinson HO, 1997, OCCUP ENVIRON MED, V54, P868, DOI 10.1136/oem.54.12.868; DREW JS, 1986, HUM BIOL, V58, P115; Fukuda M, 2002, LANCET, V359, P1407, DOI 10.1016/S0140-6736(02)08362-9; Ganatra B.R., 2001, ASIA PACIFIC POPULAT, V16, P109; GEORGE S, 1998, SEARCH B, V12, P18; George SM, 2002, REPROD HEALTH MATTER, V10, P190, DOI 10.1016/S0968-8080(02)00034-4; Grant VJ, 2003, HUM BIOL, V75, P917, DOI 10.1353/hub.2004.0005; HATTI N, 2004, 93 LUND PAP EC HIST; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Khanna SK, 1997, SOC SCI MED, V44, P171, DOI 10.1016/S0277-9536(96)00144-X; Klasen S, 2003, FEM ECON, V9, P263, DOI 10.1080/1354570022000077999; MCCURRY J, 2004, GUARDIAN        0903; Miller R. G., 1981, SURVIVAL ANAL; MUTHARYAPPA R, 1997, 3 NAT FAM HLTH SURV; NORBERG K, DADS CADS PARENTAL C; *REG GEN IND, 2002, SAMPL REG SYST STAT; Rodgers JL., 2001, CHANCE MAG, V14, P8, DOI DOI 10.1080/09332480.2001.10542293; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Smits LJM, 2005, BRIT MED J, V331, P1437, DOI 10.1136/bmj.331.7530.1437; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; *UN POP DIV, 2003, DEM YB SYST; *UNFPA, 2001, SEX SEL AB FERT DECL; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; Zeng Y, 1992, China Popul Today, V9, P3; 2005, TIMES INDIA     0715, P1	33	230	233	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2006	367	9506					211	218		10.1016/S0140-6736(06)67930-0	http://dx.doi.org/10.1016/S0140-6736(06)67930-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	005GM	16427489				2022-12-01	WOS:000234810600025
J	Keppler, F; Hamilton, JTG; Brass, M; Rockmann, T				Keppler, F; Hamilton, JTG; Brass, M; Rockmann, T			Methane emissions from terrestrial plants under aerobic conditions	NATURE			English	Article							ATMOSPHERIC METHANE; ECOSYSTEM; BUDGET	Methane is an important greenhouse gas and its atmospheric concentration has almost tripled since pre-industrial times(1,2). It plays a central role in atmospheric oxidation chemistry and affects stratospheric ozone and water vapour levels. Most of the methane from natural sources in Earth's atmosphere is thought to originate from biological processes in anoxic environments(2). Here we demonstrate using stable carbon isotopes that methane is readily formed in situ in terrestrial plants under oxic conditions by a hitherto unrecognized process. Significant methane emissions from both intact plants and detached leaves were observed during incubation experiments in the laboratory and in the field. If our measurements are typical for short-lived biomass and scaled on a global basis, we estimate a methane source strength of 62 - 236 Tg yr(-1) for living plants and 1 - 7 Tg yr(-1) for plant litter (1 Tg = 10(12) g). We suggest that this newly identified source may have important implications for the global methane budget and may call for a reconsideration of the role of natural methane sources in past climate change.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; Dept Agr & Rural Dev No Ireland, Agr Food & Environm Sci Div, Belfast BT9 5PX, Antrim, North Ireland; Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TA Utrecht, Netherlands	Max Planck Society; Utrecht University	Keppler, F (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	frank.keppler@mpi-hd.mpg.de	Keppler, Frank/F-4401-2012; Röckmann, Thomas/F-4479-2015	Keppler, Frank/0000-0003-2766-8812; Röckmann, Thomas/0000-0002-6688-8968				BARTLETT KB, 1993, CHEMOSPHERE, V26, P261, DOI 10.1016/0045-6535(93)90427-7; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; FAO, 2001, 140 FAO UN; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Gogoi N, 2005, CHEMOSPHERE, V59, P1677, DOI 10.1016/j.chemosphere.2004.11.047; Hamilton JTG, 2003, SCIENCE, V301, P206, DOI 10.1126/science.1085036; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P8981, DOI 10.1029/1999JD901149; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P17243, DOI 10.1029/2000JD900193; Keppler F, 2004, BIOGEOSCIENCES, V1, P123, DOI 10.5194/bg-1-123-2004; Keppler F, 2005, ATMOS CHEM PHYS, V5, P2403, DOI 10.5194/acp-5-2403-2005; Lassey KR, 2000, GLOBAL BIOGEOCHEM CY, V14, P41, DOI 10.1029/1999GB900094; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; LOWE DC, 1994, J GEOPHYS RES-ATMOS, V99, P16913, DOI 10.1029/94JD00908; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Sass RL, 2002, P NATL ACAD SCI USA, V99, P11993, DOI 10.1073/pnas.202483599; SAUGIER B, 2001, GLOBAL TERRESTRIAL P, P541; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164	23	615	709	10	333	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					187	191		10.1038/nature04420	http://dx.doi.org/10.1038/nature04420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407949				2022-12-01	WOS:000234538400036
J	Oganesyan, G; Saha, SK; Guo, BC; He, JQ; Shahangian, A; Zarnegar, B; Perry, A; Cheng, GH				Oganesyan, G; Saha, SK; Guo, BC; He, JQ; Shahangian, A; Zarnegar, B; Perry, A; Cheng, GH			Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response	NATURE			English	Article							NF-KAPPA-B; INTERFERON-ALPHA INDUCTION; DOUBLE-STRANDED-RNA; SIGNALING PATHWAY; VIRAL-INFECTION; ESSENTIAL COMPONENTS; IMMUNE-RESPONSES; ACTIVATION; KINASE; CELLS	Type I interferon (IFN) production is a critical component of the innate defence against viral infections(1). Viral products induce strong type I IFN responses through the activation of Toll-like receptors (TLRs) and intracellular cytoplasmic receptors such as protein kinase R (PKR)(2-12). Here we demonstrate that cells lacking TRAF3, a member of the TNF receptor-associated factor family, are defective in type I IFN responses activated by several different TLRs. Furthermore, we show that TRAF3 associates with the TLR adaptors TRIF and IRAK1, as well as downstream IRF3/7 kinases TBK1 and IKK-epsilon, suggesting that TRAF3 serves as a critical link between TLR adaptors and downstream regulatory kinases important for IRF activation. In addition to TLR stimulation, we also show that TRAF3-deficient fibroblasts are defective in their type I IFN response to direct infection with vesicular stomatitis virus, indicating that TRAF3 is also an important component of TLR-independent viral recognition pathways. Our data demonstrate that TRAF3 is a major regulator of type I IFN production and the innate antiviral response.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Med Sci Training Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, 609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	genhongc@microbio.ucla.edu	Saha, Supriya/AAC-5365-2019	Miyahira, Andrea/0000-0003-4976-002X; Saha, Supriya/0000-0003-3029-7995				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	30	672	721	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					208	211		10.1038/nature04374	http://dx.doi.org/10.1038/nature04374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16306936				2022-12-01	WOS:000234538400041
J	Schmitt, AM; Shi, J; Wolf, AM; Lu, CC; King, LA; Zou, YM				Schmitt, AM; Shi, J; Wolf, AM; Lu, CC; King, LA; Zou, YM			Wnt-Ryk signalling mediates medial-lateral retinotectal topographic mapping	NATURE			English	Article							RECEPTOR TYROSINE KINASES; VISUAL-SYSTEM; AXON GUIDANCE; CELL-SURFACE; GROWTH; REQUIREMENT; CONNECTIONS; PROJECTION; PROTEINS; MOLECULE	Computational modelling has suggested that at least two counteracting forces are required for establishing topographic maps. Ephrin-family proteins are required for both anterior - posterior and medial - lateral topographic mapping, but the opposing forces have not been well characterized. Wnt-family proteins are recently discovered axon guidance cues. We find that Wnt3 is expressed in a medial - lateral decreasing gradient in chick optic tectum and mouse superior colliculus. Retinal ganglion cell (RGC) axons from different dorsal - ventral positions showed graded and biphasic response to Wnt3 in a concentration-dependent manner. Wnt3 repulsion is mediated by Ryk, expressed in a ventral-to-dorsal decreasing gradient, whereas attraction of dorsal axons at lower Wnt3 concentrations is mediated by Frizzled(s). Overexpression of Wnt3 in the lateral tectum repelled the termination zones of dorsal RGC axons in vivo. Expression of a dominant-negative Ryk in dorsal RGC axons caused a medial shift of the termination zones, promoting medially directed interstitial branches and eliminating laterally directed branches. Therefore, a classical morphogen, Wnt3, acting as an axon guidance molecule, plays a role in retinotectal mapping along the medial - lateral axis, counterbalancing the medial-directed EphrinB1-EphB activity.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu	shi, jun/C-2389-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	28	215	222	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					31	37		10.1038/nature04334	http://dx.doi.org/10.1038/nature04334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16280981				2022-12-01	WOS:000234378700027
J	Stucki, M; Clapperton, JA; Mohammad, D; Yaffe, MB; Smerdon, SJ; Jackson, SP				Stucki, M; Clapperton, JA; Mohammad, D; Yaffe, MB; Smerdon, SJ; Jackson, SP			MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks	CELL			English	Article							IONIZING-RADIATION; BRCT REPEATS; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; GENOMIC INSTABILITY; DAMAGE CHECKPOINT; EARLY PARTICIPANT; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FOCUS FORMATION	Histone variant H2AX phosphorylation in response to DNA damage is the major signal for recruitment of DNA-damage-response proteins to regions of damaged chromatin. Loss of H2AX causes radiosensitivity, genome instability, and DNA double-strand-break repair defects, yet the mechanisms underlying these phenotypes remain obscure. Here, we demonstrate that mammalian MDC1/NFBD1 directly binds to phospho-H2AX (gamma H2AX) by specifically interacting with the phosphoepitope at the gamma H2AX carboxyl terminus. Moreover, through a combination of biochemical, cell-biological, and X-ray crystallographic approaches, we reveal the molecular details of the MDC1/NFBD1-gammaH2AX complex. These data provide compelling evidence that the MDC1/NFBD1 BRCT repeat domain is the major mediator of gamma H2AX recognition following DNA damage. We further show that MDC1/NFBD1-gamma H2AX complex formation regulates H2AX phosphorylation and is required for normal radioresistance and efficient accumulation of DNA-damage-response proteins on damaged chromatin. Thus, binding of MDCl/NFBD1 to gamma H2AX plays a central role in the mammalian response to DNA damage.	Univ Cambridge, Wellcome Trust Canc Res UK Gordon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Natl Inst Med Res, MRC, Div Prot Struct, London NW7 1AA, England; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	University of Cambridge; University of Cambridge; MRC National Institute for Medical Research; Massachusetts Institute of Technology (MIT)	Smerdon, SJ (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gordon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ssmerdo@nimr.mrc.ac.uk; s.jackson@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019; Stucki, Manuel/H-4739-2017	Jackson, Stephen Philip/0000-0001-9317-7937; Smerdon, Stephen/0000-0001-5688-8465	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mochan TA, 2003, CANCER RES, V63, P8586; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	51	787	819	1	41	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1213	1226		10.1016/j.cell.2005.09.038	http://dx.doi.org/10.1016/j.cell.2005.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377563	Bronze			2022-12-01	WOS:000234584500011
J	Casarett, D; Kapo, J; Caplan, A				Casarett, D; Kapo, J; Caplan, A			Appropriate use of artificial nutrition and hydration - Fundamental principles and recommendations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ADJUVANT PARENTERAL-NUTRITION; NURSING-HOME RESIDENTS; ENTERAL NUTRITION; ADVANCED DEMENTIA; CARE; PREFERENCES; END; MANAGEMENT; PHYSICIANS											AHRONHEIM JC, 1990, LANCET, V335, P278, DOI 10.1016/0140-6736(90)90084-I; *AM AC HOSP PALL M, STAT US NUTR HYDR; *AM NURS ASS, 1992, ANA NURSING WOR 0402; [Anonymous], COMMUNICATION; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; BONE RC, 1990, CHEST, V97, P949, DOI 10.1378/chest.97.4.949; BRENNAN MF, 1994, ANN SURG, V220, P436, DOI 10.1097/00000658-199410000-00003; Brett AS, 2001, ARCH INTERN MED, V161, P745, DOI 10.1001/archinte.161.5.745; Buchanan AE., 1989, DECIDING OTHERS ETHI; Callahan CM, 2000, J AM GERIATR SOC, V48, P1048, DOI 10.1111/j.1532-5415.2000.tb04779.x; CALLAHAN D, 1983, HASTINGS CENT REP, V13, P22, DOI 10.2307/3560573; Casarett David J, 2002, J Palliat Med, V5, P3, DOI 10.1089/10966210252784962; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; Centers for Medicare and Medicaid Services, NURS HOM COMP; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; *COMM UN STAT LAWS, 1993, NAT C COMM UN STAT L; *CTR MED MED SERV, DESCR RUG3 CLASS SYS; DALY JM, 1995, ANN SURG, V221, P327, DOI 10.1097/00000658-199504000-00002; DALY JM, 1984, AM J SURG, V148, P514, DOI 10.1016/0002-9610(84)90379-9; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Happ MB, 2002, J AM GERIATR SOC, V50, P829, DOI 10.1046/j.1532-5415.2002.50207.x; Helman C. G, 2000, CULTURE HLTH ILLNESS; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; *HOSP PALL NURS AS, POS STAT ART NUTR HY; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Lee JH, 1998, ARCH OTOLARYNGOL, V124, P871, DOI 10.1001/archotol.124.8.871; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; MAZZINI L, 1995, J NEUROL, V242, P695, DOI 10.1007/BF00866922; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Meisel A, 1995, AM J LAW MED, V21, P335; Meisel A, 2004, RIGHT DIE LAW END OF; MEISEL A, 1995, RIGHT TO DIE; Miller RG, 2001, AMYOTROPH LATERAL SC, V2, P3, DOI 10.1080/146608201300079355; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2003, J AM GERIATR SOC, V51, P129, DOI 10.1034/j.1601-5215.2002.51021.x; Mitchell SL, 2001, J AM GERIATR SOC, V49, P313, DOI 10.1046/j.1532-5415.2001.4930313.x; Mitchell SL, 1998, J GERONTOL A-BIOL, V53, pM207, DOI 10.1093/gerona/53A.3.M207; Mitchell Susan L, 2004, J Am Med Dir Assoc, V5, pS22, DOI 10.1097/00130535-200403001-00010; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; Morrison RS, 1998, ARCH INTERN MED, V158, P2493, DOI 10.1001/archinte.158.22.2493; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; National Consensus Project for Quality Palliative Care, CLIN PRACT GUID QUAL, V4th; Odom SR, 2003, SURG ENDOSC, V17, P651, DOI 10.1007/s00464-002-8599-y; Pasman HRW, 2005, ARCH INTERN MED, V165, P1729, DOI 10.1001/archinte.165.15.1729; PATRICK DL, 1994, MED DECIS MAKING, V14, P9, DOI 10.1177/0272989X9401400102; POPP MB, 1981, SURGERY, V90, P195; Post SG, 2001, HASTINGS CENT REP, V31, P36, DOI 10.2307/3528732; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAK HLTH CAR DEC REP; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Scolapio JS, 1999, MAYO CLIN PROC, V74, P217, DOI 10.4065/74.3.217; Senkal M, 1999, ARCH SURG-CHICAGO, V134, P1309, DOI 10.1001/archsurg.134.12.1309; SHAMBERGER RC, 1984, SURGERY, V96, P1; Shannon TA, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3528689; Sieger CE, 2002, J AM GERIATR SOC, V50, P544, DOI 10.1046/j.1532-5415.2002.50124.x; *SOC CRIT CAR MED, 1990, CRIT CARE MED, V18, P1435; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Teno JM, 1997, J AM GERIATR SOC, V45, P939, DOI 10.1111/j.1532-5415.1997.tb02963.x; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Viola RA, 1997, J PALLIATIVE CARE, V13, P41, DOI 10.1177/082585979701300407; WANKLYN P, 1995, AGE AGEING, V24, P510, DOI 10.1093/ageing/24.6.510; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; WHO, WHO DEF PALL CAR; YAMADA N, 1983, BRIT J SURG, V70, P267, DOI 10.1002/bjs.1800700508; 2005, PHYS ORDERS LIFE SUS	78	124	127	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2607	2612		10.1056/NEJMsb052907	http://dx.doi.org/10.1056/NEJMsb052907			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354899				2022-12-01	WOS:000233926500013
J	Ortiz-Barrientos, D; Noor, MAF				Ortiz-Barrientos, D; Noor, MAF			Evidence for a one-allele assortative mating locus	SCIENCE			English	Article							SPECIATION		Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ortiz-Barrientos, D (corresponding author), Indiana Univ, Dept Biol, 1001 E 3rd St, Bloomington, IN 47405 USA.	dortizba@indiana.edu	Ortiz-Barrientos, Daniel/B-2274-2010; Ortiz-Barrientos, Daniel/N-3294-2019	Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Noor, Mohamed/0000-0002-5400-4408				COYNE J, 2004, SPECIATION, P20601; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412	5	66	68	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1467	1467		10.1126/science.1121260	http://dx.doi.org/10.1126/science.1121260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322450				2022-12-01	WOS:000233756500036
J	Rosenberg, OS; Deindl, S; Sung, RJ; Nairn, AC; Kuriyan, J				Rosenberg, OS; Deindl, S; Sung, RJ; Nairn, AC; Kuriyan, J			Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CALMODULIN; AUTOPHOSPHORYLATION; SUBSTRATE; ALPHA; SUBUNIT; SITE	Ca2+/calmodulin-dependent protein kinase-II (CaMKII) is unique among protein kinases for its dodecameric assembly and its complex response to Ca2+. The crystal structure of the autoinhibited kinase domain of CaMKII, determined at 1.8 angstrom resolution, reveals an unexpected dimeric organization in which the calmodulin-responsive regulatory segments form a coiled-coil strut that blocks peptide and ATP binding to the otherwise intrinsically active kinase domains. A threonine residue in the regulatory segment, which when phosphorylated renders CaMKII calmodulin independent, is held apart from the catalytic sites by the organization of the dimer. This ensures a strict Ca2+ dependence for initial activation. The structure of the kinase dimer, when combined with small-angle X-ray scattering data for the holoenzyme, suggests that inactive CaMKII forms tightly packed autoinhibited assemblies that convert upon activation into clusters of loosely tethered and independent kinase domains.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06508 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Yale University; Yale University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		Deindl, Sebastian/0000-0001-6807-8654; Nairn, Angus/0000-0002-7075-0195				Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case D., 2004, AMBER; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DAVIESJM, 2005, STRUCTURE CAMB, V13, P183; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; HUANG CYF, 1995, J BIOL CHEM, V270, P7183, DOI 10.1074/jbc.270.13.7183; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; KING MM, 1988, ARCH BIOCHEM BIOPHYS, V267, P467, DOI 10.1016/0003-9861(88)90052-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KOVNAREV PV, 2003, J APPL CRYSTALLOGR, V36, P1277; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1989, J NEUROSCI, V9, P2020; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SHIELDS SM, 1984, J NEUROCHEM, V43, P1599, DOI 10.1111/j.1471-4159.1984.tb06084.x; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	54	221	230	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					849	860		10.1016/j.cell.2005.10.029	http://dx.doi.org/10.1016/j.cell.2005.10.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325579	Bronze			2022-12-01	WOS:000233814100018
J	Fogelman, I; Blake, GM				Fogelman, I; Blake, GM			Bone densitometry: an update	LANCET			English	Editorial Material							FRACTURE RISK; POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURES; MINERAL DENSITY; REDUCTION; TRIAL; BMD		Guys Kings & St Thomas Sch Med, London SE1 9RT, England	University of London; King's College London	Fogelman, I (corresponding author), Guys Kings & St Thomas Sch Med, London SE1 9RT, England.	ignac.fogelman@kcl.ac.uk						Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; De Laet C, 2005, OSTEOPOROSIS INT, V16, P313, DOI 10.1007/s00198-004-1689-z; Eastell R, 2003, J BONE MINER RES, V18, P1051, DOI 10.1359/jbmr.2003.18.6.1051; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Genant HK, 1996, J BONE MINER RES, V11, P707; Gluer CC, 1999, J BONE MINER RES, V14, P1952, DOI 10.1359/jbmr.1999.14.11.1952; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Lu Y, 2001, J BONE MINER RES, V16, P901, DOI 10.1359/jbmr.2001.16.5.901; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; National Osteoporosis Society, 2004, POS STAT US PER XRAY; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Royal College of Physicians, 1999, OST CLIN GUID PREV T; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; *UK NAT I HLTH CLI, 2005, OST SEC PREV; World Health Organization, 1994, WHO TECHN REP SER, V843	20	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2068	2070		10.1016/S0140-6736(05)67867-1	http://dx.doi.org/10.1016/S0140-6736(05)67867-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360773				2022-12-01	WOS:000234146000006
J	Smith, GCS; Wood, AM; Pell, JP; Dobbie, R				Smith, GCS; Wood, AM; Pell, JP; Dobbie, R			Sudden infant death syndrome and complications in other pregnancies	LANCET			English	Article							SYNDROME SIDS BABIES; RECURRENCE RISK; BIRTH-WEIGHT; SCOTLAND; AGE	Background The likelihood of recurrence of sudden infant death syndrome (SIDS) is an issue of biological, clinical, and legal interest. Obstetric complications are associated with an increased risk of SIDS and are likely to recur in subsequent pregnancies. We postulated that women whose infants died from SIDS would be more likely to have had obstetric complications in their other pregnancies. Methods We linked national UK databases of maternity-hospital discharges, perinatal deaths, and death certifications. We studied 258 096 women who had consecutive births in Scotland between 1985 and 2001. Findings Women who had an infant who died from SIDS were at increased risk in their next pregnancy of delivering an infant small for gestational age (odds ratio 2.27, 95% CI 1.54-3.34, p<0.0001) and of preterm birth (2.53, 1.82-3.53, p<0.0001). The risk of SIDS was higher for the children of women whose previous infant had been small for gestational age (1.87, 1.19-2.94, p=0.007) or preterm (1.93, 1.24-3.00, p=0.004). Multivariate analysis showed that all associations were explained by common maternal risk factors for SIDS and obstetric complications and by the likelihood of recurrence of fetal growth restriction and preterm birth. Interpretation Women whose infants die from SIDS are more likely to have complications in their other pregnancies. Recurrence of pregnancy complications predisposing to SIDS could partly explain why some women have recurrent SIDS.	Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CBR 2SW, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Robinson Way, Cambridge CBR 2SW, England.	gcss2@cam.ac.uk	Wood, Angela/GZA-5762-2022; Smith, Gordon/A-8070-2008	Wood, Angela/0000-0002-7937-304X; Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				BEAL SM, 1988, ARCH DIS CHILD, V63, P924, DOI 10.1136/adc.63.8.924; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; CAMPBELL S, 1993, ULTRASOUND OBST GYN, P1431; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; COLE S, 1980, 8 STUD GROUP ROYAL C, P39; *CROWN OFF, 1998, DEATH PROC FISC; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; EVANS E, 1990, CLIN APPL ULTRASONIC; GUNTHEROTH WG, 1990, J PEDIATR-US, V116, P520, DOI 10.1016/S0022-3476(05)81596-3; IRGENS LM, 1984, J PEDIATR-US, V104, P349, DOI 10.1016/S0022-3476(84)81093-8; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; *NHS SCOTL INF STA, 2001, SCOTT PER INF MORT R; OYEN N, 1995, AM J EPIDEMIOL, V142, P84, DOI 10.1093/oxfordjournals.aje.a117549; Oyen N, 1997, PAEDIATR PERINAT EP, V11, P84, DOI 10.1046/j.1365-3016.11.s1.17.x; Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Smith GCS, 2004, NEW ENGL J MED, V351, P978, DOI 10.1056/NEJMoa040963; Smith GCS, 2003, PEDIATRICS, V111, P1367, DOI 10.1542/peds.111.6.1367; SPIERS PS, 1983, GROWTH, V47, P104; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; VANBELLE G, 1988, SUDDEN INFANT DEATH, P203; Watkins SJ, 2000, BRIT MED J, V320, P2, DOI 10.1136/bmj.320.7226.2	25	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2107	2111		10.1016/S0140-6736(05)67888-9	http://dx.doi.org/10.1016/S0140-6736(05)67888-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360787				2022-12-01	WOS:000234146000025
J	Rothwell, PM; Coull, AJ; Silver, LE; Fairhead, JF; Giles, MF; Lovelock, CE; Redgrave, JNE; Bull, LM; Welch, SJV; Cuthbertson, FC; Binney, LE; Gutnikov, SA; Anslow, P; Banning, AP; Mant, D; Mehta, Z				Rothwell, PM; Coull, AJ; Silver, LE; Fairhead, JF; Giles, MF; Lovelock, CE; Redgrave, JNE; Bull, LM; Welch, SJV; Cuthbertson, FC; Binney, LE; Gutnikov, SA; Anslow, P; Banning, AP; Mant, D; Mehta, Z		Oxford Vasc Study	Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)	LANCET			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; MONICA PROJECT; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR-DISEASE; EUROPEAN-SOCIETY; STROKE INCIDENCE; GLOBAL BURDEN; RISK-FACTORS	Background Acute coronary, cerebrovascular, and peripheral vascular events have common underlying arterial pathology, risk factors, and preventive treatments, but they are rarely studied concurrently. In the Oxford Vascular Study, we determined the comparative epidemiology of different acute vascular syndromes, their current burdens, and the potential effect of the ageing population on future rates. Methods We prospectively assessed all individuals presenting with an acute vascular event of any type in any arterial territory irrespective of age in a population of 91106 in Oxfordshire, UK, in 2002-05. Findings 2024 acute vascular events occurred in 1657 individuals: 918 (45%) cerebrovascular (618 stroke, 300 transient ischaernic attacks [TIA]); 856 (42%) coronary vascular (159 ST-elevation myocardial infarction, 316 non-ST-elevation myocardial infarction, 218 unstable angina, 163 sudden cardiac death); 188 (9%) peripheral vascular (43 aortic, 53 embolic visceral or limb ischaemia, 92 critical limb ischaemia); and 62 unclassifiable deaths. Relative incidence of cerebrovascular events compared with coronary events was 1.19 (95% CI 1.06-1.33) overall; 1.40 (1.23-1.59) for non-fatal events; and 1.21 (1.04-1.41) if TIA and unstable angina were further excluded. Event and incidence rates rose steeply with age in all arterial territories, with 735 (80%) cerebrovascular, 623 (73%) coronary, and 147 (78%) peripheral vascular events in 12 886 (14%) individuals aged 65 years or older; and 503 (54%), 402 (47%), and 105 (56%), respectively, in the 5919 (6%) aged 75 years or older. Although case-fatality rates increased with age, 736 (47%) of 1561 non-fatal events occurred at age 75 years or older. Interpretation The high rates of acute vascular events outside the coronary arterial territory and the steep rise in event rates with age in all territories have implications for prevention strategies, clinical trial design, and the targeting of funds for service provision and research.	Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Dept Neuroradiol, Oxford OX2 6HE, England; John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; Univ Oxford, Inst Hlth Sci, Dept Publ Hlth & Primary Care, Oxford, England	University of Oxford; Radcliffe Infirmary; University of Oxford; University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Mant, David CA/C-7763-2009; banning, adrian p/AAF-7229-2021; Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211; Banning, Adrian/0000-0002-2842-7861	Medical Research Council [G0500987] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Shahi R, 2005, BRIT MED J, V331, P942, DOI 10.1136/bmj.38624.397569.68; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Asplund K, 2005, LANCET NEUROL, V4, P64, DOI 10.1016/S1474-4422(04)00967-6; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BONITA R, 1993, LANCET, V341, P1510, DOI 10.1016/0140-6736(93)90640-3; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Department of the Environment, 2000, IND DEPR; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferguson JL, 2002, HEART, V88, P343, DOI 10.1136/heart.88.4.343; Findlay IN, 2005, HEART, V91, P857, DOI 10.1136/hrt.2004.052795; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuster V, 1999, CIRCULATION, V99, P1132, DOI 10.1161/01.CIR.99.9.1132; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MELTON LJ, 1980, DIABETES CARE, V3, P650, DOI 10.2337/diacare.3.6.650; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarti C, 2003, STROKE, V34, P1833, DOI 10.1161/01.STR.0000081224.15480.52; *STAT OFF, 2001, 2001 CENS AR STAT; Thom T J, 1993, Ann Epidemiol, V3, P509; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	34	713	735	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1773	1783		10.1016/S0140-6736(05)67702-1	http://dx.doi.org/10.1016/S0140-6736(05)67702-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298214				2022-12-01	WOS:000233517200021
J	Zhang, Y; Lu, H; Bargmann, CI				Zhang, Y; Lu, H; Bargmann, CI			Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; TRYPTOPHAN-HYDROXYLASE; SIGNALING PATHWAY; NEURONS; GENE; ADAPTATION; PLASTICITY; CHANNEL; MEMORY; FOOD	Food can be hazardous, either through toxicity or through bacterial infections that follow the ingestion of a tainted food source. Because learning about food quality enhances survival, one of the most robust forms of olfactory learning is conditioned avoidance of tastes associated with visceral malaise. The nematode Caenorhabditis elegans feeds on bacteria but is susceptible to infection by pathogenic bacteria in its natural environment. Here we show that C. elegans modifies its olfactory preferences after exposure to pathogenic bacteria, avoiding odours from the pathogen and increasing its attraction to odours from familiar nonpathogenic bacteria. Particular bacteria elicit specific changes in olfactory preferences that are suggestive of associative learning. Exposure to pathogenic bacteria increases serotonin in ADF chemosensory neurons by transcriptional and post-transcriptional mechanisms. Serotonin functions through MOD-1, a serotonin-gated chloride channel expressed in sensory interneurons, to promote aversive learning. An increase in serotonin may represent the negative reinforcing stimulus in pathogenic infection.	Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618; Lu, Hang/0000-0002-6881-660X				Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; Bernstein IL, 1999, NUTRITION, V15, P229, DOI 10.1016/S0899-9007(98)00192-0; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chou JH, 2001, GENETICS, V157, P211; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Darmaillacq AS, 2004, ANIM BEHAV, V68, P1291, DOI 10.1016/j.anbehav.2004.01.015; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Estevez M, 2004, J NEUROCHEM, V88, P102, DOI 10.1046/j.1471-4159.2003.02140.x; Gershon MD, 2003, CURR OPIN PHARMACOL, V3, P600, DOI 10.1016/j.coph.2003.07.005; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lints R, 1999, DEVELOPMENT, V126, P5819; Mockus SM, 1998, J MOL NEUROSCI, V10, P163, DOI 10.1007/BF02761772; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047	32	554	580	3	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					179	184		10.1038/nature04216	http://dx.doi.org/10.1038/nature04216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281027				2022-12-01	WOS:000233133500039
J	Brockmann, D; Hufnagel, L; Geisel, T				Brockmann, D; Hufnagel, L; Geisel, T			The scaling laws of human travel	NATURE			English	Article							RANDOM-WALKS; DISPERSAL; EPIDEMICS; DYNAMICS; PATTERNS	The dynamic spatial redistribution of individuals is a key driving force of various spatiotemporal phenomena on geographical scales. It can synchronize populations of interacting species, stabilize them, and diversify gene pools(1-3). Human travel, for example, is responsible for the geographical spread of human infectious disease(4-9). In the light of increasing international trade, intensified human mobility and the imminent threat of an influenza A epidemic(10), the knowledge of dynamical and statistical properties of human travel is of fundamental importance. Despite its crucial role, a quantitative assessment of these properties on geographical scales remains elusive, and the assumption that humans disperse diffusively still prevails in models. Here we report on a solid and quantitative assessment of human travelling statistics by analysing the circulation of bank notes in the United States. Using a comprehensive data set of over a million individual displacements, we find that dispersal is anomalous in two ways. First, the distribution of travelling distances decays as a power law, indicating that trajectories of bank notes are reminiscent of scale-free random walks known as Levy flights. Second, the probability of remaining in a small, spatially confined region for a time T is dominated by algebraically long tails that attenuate the superdiffusive spread. We show that human travelling behaviour can be described mathematically on many spatiotemporal scales by a two-parameter continuous-time random walk model to a surprising accuracy, and conclude that human travel on geographical scales is an ambivalent and effectively superdiffusive process.	Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; Univ Gottingen, Dept Phys, D-37073 Gottingen, Germany; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen; University of California System; University of California Santa Barbara	Brockmann, D (corresponding author), Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	brockmann@ds.mpg.de	Brockmann, Dirk A/B-7342-2009; Brockmann, Dirk/A-1931-2014	Geisel, Theo/0000-0002-5681-2708				Brockmann D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.170601; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Clobert J, 2001, DISPERSAL; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hudson PJ., 2002, ECOLOGY WILDLIFE DIS; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Klafter J, 1996, PHYS TODAY, V49, P33, DOI 10.1063/1.881487; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Murray JD, 1993, MATH BIOL, DOI [DOI 10.1007/978-3-662-08542-4, 10.1007/b98869, DOI 10.1007/B98869]; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; Nicholson KG, 1998, TXB INFLUENZA, P219; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; SHLESINGER MF, 1982, J STAT PHYS, V27, P499, DOI 10.1007/BF01011089; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350	23	1401	1455	21	355	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					462	465		10.1038/nature04292	http://dx.doi.org/10.1038/nature04292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437114	Green Submitted			2022-12-01	WOS:000234859200044
J	Noda, T; Sagara, H; Yen, A; Takada, A; Kida, H; Cheng, RH; Kawaoka, Y				Noda, T; Sagara, H; Yen, A; Takada, A; Kida, H; Cheng, RH; Kawaoka, Y			Architecture of ribonucleoprotein complexes in influenza A virus particles	NATURE			English	Article							RNA SEGMENTS; PACKAGING SIGNALS; NONCODING REGIONS; VIRIONS; PB2	In viruses, as in eukaryotes, elaborate mechanisms have evolved to protect the genome and to ensure its timely replication and reliable transmission to progeny. Influenza A viruses are enveloped, spherical or filamentous structures, ranging from 80 to 120 nm in diameter(1). Inside each envelope is a viral genome consisting of eight single-stranded negative- sense RNA segments of 890 to 2,341 nucleotides each(1). These segments are associated with nucleoprotein and three polymerase subunits, designated PA, PB1 and PB2; the resultant ribonucleoprotein complexes (RNPs) resemble a twisted rod ( 10 - 15 nm in width and 30 - 120 nm in length) that is folded back and coiled on itself(2-4). Late in viral infection, newly synthesized RNPs are transported from the nucleus to the plasma membrane, where they are incorporated into progeny virions capable of infecting other cells. Here we show, by transmission electron microscopy of serially sectioned virions, that the RNPs of influenza A virus are organized in a distinct pattern ( seven segments of different lengths surrounding a central segment). The individual RNPs are suspended from the interior of the viral envelope at the distal end of the budding virion and are oriented perpendicular to the budding tip. This finding argues against random incorporation of RNPs into virions(5), supporting instead a model in which each segment contains specific incorporation signals that enable the RNPs to be recruited and packaged as a complete set(6-12). A selective mechanism of RNP incorporation into virions and the unique organization of the eight RNP segments may be crucial to maintaining the integrity of the viral genome during repeated cycles of replication.	Univ Tokyo, Inst Med Sci, Internal Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab,Kita Ku, Sapporo, Hokkaido 0600818, Japan; Japan SCi & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Med Sci, Div Virol, Tokyo 1088639, Japan; Univ Tokyo, Dept Basic Med Sci, Fine Morphol Lab, Minato Ku, Tokyo 1088639, Japan; Karolinska Inst, Dept Biosci, S-14157 Huddinge, Sweden; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Calif Davis, Davis, CA 95616 USA; Univ Wisconsin, Sch Vet Med, Dept Pathol Sci, Madison, WI 53706 USA	University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Karolinska Institutet; University of Tokyo; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Internal Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan.	Kawaoka@ims.u-tokyo.ac.jp	Kida, Hiroshi/F-7244-2012; Sagara, Hiroshi/GRX-7740-2022; Takada, Ayato/A-6679-2012; Cheng, Holland/A-8973-2008	Sagara, Hiroshi/0000-0001-8456-8362; 				Afonso EDS, 2005, VIROLOGY, V341, P34, DOI 10.1016/j.virol.2005.06.040; BENDAYAN M, 1984, BIOL CELL, V52, P129; BENDAYAN M, 1983, J HISTOCHEM CYTOCHEM, V31, P101, DOI 10.1177/31.1.6187796; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; ENAMI M, 1991, VIROLOGY, V185, P291, DOI 10.1016/0042-6822(91)90776-8; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; HEGGENESS MH, 1982, VIROLOGY, V118, P466, DOI 10.1016/0042-6822(82)90367-1; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Odagiri T, 1997, J VIROL, V71, P2138, DOI 10.1128/JVI.71.3.2138-2145.1997; Oxford J. S., 1987, ORTHOMYXOVIRIDAE ANI, P213; SCHULZE IT, 1970, VIROLOGY, V42, P890, DOI 10.1016/0042-6822(70)90338-7; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003	18	294	324	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					490	492		10.1038/nature04378	http://dx.doi.org/10.1038/nature04378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437116				2022-12-01	WOS:000234859200050
J	Reich, PB; Tjoelker, MG; Machado, JL; Oleksyn, J				Reich, PB; Tjoelker, MG; Machado, JL; Oleksyn, J			Universal scaling of respiratory metabolism, size and nitrogen in plants	NATURE			English	Article							CYPRESS CHAMAECYPARIS-OBTUSA; TREE SIZE; ABOVEGROUND RESPIRATION; GENERAL-MODEL; BIOLOGY; TEMPERATURE; ECOSYSTEMS; ORGANISMS; ALLOMETRY; PATTERNS	The scaling of respiratory metabolism to body size in animals is considered to be a fundamental law of nature(1-11), and there is substantial evidence for an approximate 3/4-power relation. Studies suggest that plant respiratory metabolism also scales as the 3/4-power of mass(12-14), and that higher plant and animal scaling follow similar rules owing to the predominance of fractal-like transport networks and associated allometric scaling(8-14). Here, however, using data obtained from about 500 laboratory and field-grown plants from 43 species and four experiments, we show that whole-plant respiration rate scales approximately isometrically ( scaling exponent approximate to 1) with total plant mass in individual experiments and has no common relation across all data. Moreover, consistent with theories about biochemically based physiological scaling(15-18), isometric scaling of whole-plant respiration rate to total nitrogen content is observed within and across all data sets, with a single relation common to all data. This isometric scaling is unaffected by growth conditions including variation in light, nitrogen availability, temperature and atmospheric CO2 concentration, and is similar within or among species or functional groups. These findings suggest that plants and animals follow different metabolic scaling relations, driven by distinct mechanisms.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Texas A&M Univ, Dept Forest Sci, College Stn, TX 77843 USA; Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Swarthmore College; Polish Academy of Sciences	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	preich@umn.edu	Oleksyn, Jacek/AAR-2351-2020; Tjoelker, Mark G/M-2413-2016; Machado, Jose-Luis/W-1229-2019; Oleksyn, Jacek/I-4539-2012	Tjoelker, Mark G/0000-0003-4607-5238; Machado, Jose-Luis/0000-0002-6047-3665; Reich, Peter/0000-0003-4424-662X; Oleksyn, Jacek/0000-0002-6576-3258				Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Calder W. A, 1984, SIZE FUNCTION LIFE H; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; McCulloh KA, 2005, TREE PHYSIOL, V25, P257, DOI 10.1093/treephys/25.3.257; Meinzer FC, 2005, FUNCT ECOL, V19, P558, DOI 10.1111/j.1365-2435.2005.01017.x; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reich PB, 1998, OECOLOGIA, V114, P471, DOI 10.1007/s004420050471; Reich PB, 2001, TRENDS ECOL EVOL, V16, P674, DOI 10.1016/S0169-5347(01)02306-0; Riisgard HU, 1998, ECOL LETT, V1, P71; RYAN MG, 1995, PLANT CELL ENVIRON, V18, P765, DOI 10.1111/j.1365-3040.1995.tb00579.x; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yokota T, 1998, TREE PHYSIOL, V18, P37; YOKOTA T, 1994, TREE PHYSIOL, V14, P467, DOI 10.1093/treephys/14.5.467	30	364	444	2	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					457	461		10.1038/nature04282	http://dx.doi.org/10.1038/nature04282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437113	Green Published			2022-12-01	WOS:000234859200043
J	Alder, MN; Rogozin, IB; Iyer, LM; Glazko, GV; Cooper, MD; Pancer, Z				Alder, MN; Rogozin, IB; Iyer, LM; Glazko, GV; Cooper, MD; Pancer, Z			Diversity and function of adaptive immune receptors in a jawless vertebrate	SCIENCE			English	Article							AMINO-ACID SITES; VARIABLE LYMPHOCYTE RECEPTORS; SOMATIC DIVERSIFICATION; CRYSTAL-STRUCTURE; PROTEIN; SELECTION; COMPLEX; GENE; SUBSTITUTION; INHIBITION	Instead of the immunoglobulin-type antigen receptors of jawed vertebrates, jawless fish have variable lymphocyte receptors (VLRs), which consist of leucine-rich repeat (LRR) modules. Somatic diversification of the VLR gene is shown here to occur through a multistep assembly of LRR modules randomly selected from a large bank of flanking cassettes. The predicted concave surface of the VLR is lined with hypervariable positively selected residues, and computational analysis suggests a repertoire of about 1014 unique receptors. Lamprey immunized with anthrax spores responded with the production of soluble antigen-specific VLRs. These findings reveal that two strikingly different modes of antigen recognition through rearranged lymphocyte receptors have evolved in the jawless and jawed vertebrates.	Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Dept Pathol, Birmingham, AL 35294 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stowers Institute for Medical Research	Pancer, Z (corresponding author), Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, 600 E Lombard St, Baltimore, MD 21202 USA.	pancer@comb.umbi.umd.edu	Iyer, Lakshminarayan M./H-2996-2019	Alder, Matthew/0000-0003-2879-6576; Rogozin, Igor/0000-0003-0802-4851	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; GOJOBORI T, 1986, MOL BIOL EVOL, V3, P156; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kreitman M, 1999, CURR OPIN GENET DEV, V9, P637, DOI 10.1016/S0959-437X(99)00034-9; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Nielsen R, 1998, GENETICS, V148, P929; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Papadopoulos NG, 1997, CLIN RHEUMATOL, V16, P162, DOI 10.1007/BF02247845; Rogozin IB, 2001, HUM MUTAT, V17, P83, DOI 10.1002/1098-1004(200102)17:2<83::AID-HUMU1>3.0.CO;2-E; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tang H, 1999, GENETICS, V153, P485; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Yang ZH, 2000, GENETICS, V155, P431; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	23	233	254	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1970	1973		10.1126/science.1119420	http://dx.doi.org/10.1126/science.1119420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373579				2022-12-01	WOS:000234275400047
J	Paterick, TE; Paterick, TJ; Fletcher, GF; Maron, BJ				Paterick, TE; Paterick, TJ; Fletcher, GF; Maron, BJ			Medical and legal issues in the cardiovascular evaluation of competitive athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR HYPERTROPHY; SUDDEN CARDIAC DEATH; YOUNG-ADULTS; CARDIOMYOPATHY; DISEASE; PREVENTION; RECOMMENDATIONS; PARTICIPATION; CARDIOLOGY; ANOMALIES	Healthy-appearing competitive athletes may harbor unsuspected cardiovascular disease with the potential to cause sudden death. This fact raises issues of physician responsibility in preparticipation screening and eligibility/ disqualification decisions. A number of medical-legal cases now represent a framework for screening and eligibility decision making in high school and college athletes. Physicians screening competitive athletes should strictly adhere to recommendations from the American Heart Association. Precedent exists for disqualifying athletes with heart disease from competition to prevent unnecessary exposure to risk of injury or death. By virtue of the court decision in Larkin v Archdiocese of Cincinnati, high school students with heart disease have no compelling right to participate in interscholastic sports without medical clearance. In Knapp v Northwestern University, an appellate court ruled that college athletes can be medically disqualified from sports and supported the use of national association medical guidelines by team physicians in formulating eligibility/disqualification decisions. This medical-legal analysis provides guidelines for physicians participating in medical evaluations of competitive athletes by clarifying the standard of care, potential pitfalls, and the evolving liability associated with this clinical practice.	Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; Mayo Clin, Div Cardiovasc Med, Jacksonville, FL 32224 USA; Univ Richmond, Richmond, VA 23173 USA	Minneapolis Heart Institute Foundation; Mayo Clinic; University of Richmond	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org						ANDERSON D, 1993, NY TIMES        0729, pB1; BAKER WH, 1993, DICK L REV, V97, P656; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; COHEN AJ, 1989, ANN THORAC SURG, V47, P630, DOI 10.1016/0003-4975(89)90454-2; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; Harris KM, 2005, J AM COLL CARDIOL, V45, p180A; Jones CJ, 1992, BUFF L REV, V113, P114; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; MARON BJ, 1994, J AM COLL CARDIOL, V24, P848, DOI 10.1016/0735-1097(94)90837-0; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; Maron BJ, 2005, EUR HEART J, V26, P428, DOI 10.1093/eurheartj/ehi154; Maron BJ, 1998, NEW ENGL J MED, V339, P1632, DOI 10.1056/NEJM199811263392211; Maron BJ, 1998, ANN INTERN MED, V129, P379, DOI 10.7326/0003-4819-129-5-199809010-00006; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; MARON BJ, 1985, J AM COLL CARDIOL, V6, P1189; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1995, CIRCULATION, V91, P1596, DOI 10.1161/01.CIR.91.5.1596; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Mitten MJ, 2005, J AM COLL CARDIOL, V45, P1373, DOI 10.1016/j.jacc.2005.02.019; MITTEN MJ, 1993, U PITT LAW REV, V55, P129; Movahed MR, 2002, CIRCULATION, V106, P352; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; POST JC, 1995, CIRCULATION, V92, P3163, DOI 10.1161/01.CIR.92.11.3163; *PROF DIV, 2005, PREP PHYS EX, P1; ULMER RA, 1996, MED MALPRACTICE LIB, P89; Vinereanu D, 2001, AM J CARDIOL, V88, P53, DOI 10.1016/S0002-9149(01)01585-5; 1993, NY TIMES        0728, pB7; 1992, NY TIMES        0331, pB13	36	47	48	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					3011	3018		10.1001/jama.294.23.3011	http://dx.doi.org/10.1001/jama.294.23.3011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414949				2022-12-01	WOS:000234087700028
J	Golding, I; Paulsson, J; Zawilski, SM; Cox, EC				Golding, I; Paulsson, J; Zawilski, SM; Cox, EC			Real-time kinetics of gene activity in individual bacteria	CELL			English	Article							RNA-POLYMERASE MOLECULES; ESCHERICHIA-COLI; MESSENGER-RNA; TRANSCRIPTION ELONGATION; TRYPTOPHAN OPERON; STOCHASTIC-MODEL; LACTOSE OPERON; SINGLE-CELL; EXPRESSION; PROTEIN	Protein levels have been shown to vary substantially between individual cells in clonal populations. In prokaryotes, the contribution to such fluctuations from the inherent randomness of gene expression has largely been attributed to having just a few transcripts of the corresponding mRNAs. By contrast, eukaryotic studies tend to emphasize chromatin remodeling and burst-like transcription. Here, we study single-cell transcription in Escherichia coli by measuring mRNA levels in individual living cells. The results directly demonstrate transcriptional bursting, similar to that indirectly inferred foreukaryotes. We also measure mRNA partitioning at cell division and correlate mRNA and protein levels in single cells. Partitioning is approximately binomial, and mRNA protein correlations are weaker earlier in the cell cycle, where cell division has recently randomized the relative concentrations. Our methods further extend protein-based approaches by counting the integer-valued number of transcript with single-molecule resolution. This greatly facilitates kinetic interpretations in terms of the integer-valued random processes that produce the fluctuations.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Princeton University; University of Cambridge	Golding, I (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	igolding@princeton.edu; ecox@princeton.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001506] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 001506] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BAKER RF, 1968, P NATL ACAD SCI USA, V60, P313, DOI 10.1073/pnas.60.1.313; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Beckwith J. R., 1970, LACTOSE OPERON; BENZER S, 1953, BIOCHIM BIOPHYS ACTA, V11, P383, DOI 10.1016/0006-3002(53)90057-2; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BREMER H, 1995, BBA-GENE STRUCT EXPR, V1262, P15, DOI 10.1016/0167-4781(95)00042-F; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CONTESSE G, 1969, B SOC CHIM BIOL, V51, P1445; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [DOI 10.1063/1.1750549, 10.1063/1.1750549]; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; Gardiner C. W., 2004, HDB STOCHASTIC METHO, V3rd; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; Hendrix R.W., 1983, LAMBDA, VII; IMAMOTO F, 1968, P NATL ACAD SCI USA, V60, P305, DOI 10.1073/pnas.60.1.305; Johansson HE, 1998, P NATL ACAD SCI USA, V95, P9244, DOI 10.1073/pnas.95.16.9244; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Li Y, 2004, J MOL BIOL, V339, P31, DOI 10.1016/j.jmb.2004.03.041; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathews C.K., 2000, BIOCHEMISTRY; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RIGNEY DR, 1979, J THEOR BIOL, V79, P247, DOI 10.1016/0022-5193(79)90250-9; RIGNEY DR, 1979, J THEOR BIOL, V76, P453, DOI 10.1016/0022-5193(79)90013-4; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RYALS J, 1982, J BACTERIOL, V151, P879, DOI 10.1128/JB.151.2.879-887.1982; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; TAPASWI PK, 1987, SANKHYA SER B, V49, P51; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tolker-Nielsen T, 1998, MOL MICROBIOL, V27, P1099, DOI 10.1046/j.1365-2958.1998.00760.x; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; van Kampen N. G., 1992, STOCHASTIC PROCESSES; YANOFSKY C, 1966, J MOL BIOL, V21, P313, DOI 10.1016/0022-2836(66)90102-1	59	1023	1039	6	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1025	1036		10.1016/j.cell.2005.09.031	http://dx.doi.org/10.1016/j.cell.2005.09.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360033	Bronze			2022-12-01	WOS:000234177200012
J	Hill, R; Song, YR; Cardiff, RD; Van Dyke, T				Hill, R; Song, YR; Cardiff, RD; Van Dyke, T			Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis	CELL			English	Article							GENETIC ALTERATIONS; TUMOR-SUPPRESSOR; MICRODISSECTED STROMA; TARGETED DISRUPTION; UROGENITAL SINUS; G(1) CONTROL; CELLS; CARCINOGENESIS; FIBROBLASTS; MUTATIONS	Our understanding of cancer has largely come from the analysis of aberrations within the tumor cell population. Yet it is increasingly clear that the tumor microenvironment can significantly influence tumorigenesis. For example, the mesenchyme can support the growth of tumorigenic epithelium. However, whether fibroblasts are subject to genetic/epigenetic changes as a result of selective pressures conferred by oncogenic stress in the epithelium has not been experimentally assessed. Recent analyses of some human carcinomas have shown tumor-suppressor gene mutations within the stroma, suggesting that the interplay among multiple cell types can select for aberrations nonautonomously during tumor progression. We demonstrate that this indeed occurs in a mouse model of prostate cancer where epithelial cell cycle disruption via cell-specific inhibition of pRb function induces a paracrine p53 response that suppresses fibroblast proliferation in associated stroma. This interaction imposes strong selective pressure yielding a highly proliferative mesenchyme that has undergone p53 loss.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis	Hill, R (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	tvdlab@med.unc.edu	Hill, Reginald/D-2270-2016; Song, Yurong/GRX-9328-2022		NATIONAL CANCER INSTITUTE [R01CA046283, U01CA084294] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA046283, U01-CA84294] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Cunha GR, 1996, ACTA ANAT, V155, P63; CUNHA GR, 1980, ENDOCRINOLOGY, V107, P1767, DOI 10.1210/endo-107-6-1767; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; DAMERON KM, 1994, COLD SPRING HARB SYM, V59, P483, DOI 10.1101/SQB.1994.059.01.053; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gatalica Z, 2001, PATHOL RES PRACT, V197, P183, DOI 10.1078/0344-0338-00031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ittmann M, 1996, CANCER RES, V56, P2143; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kleihues P, 1997, AM J PATHOL, V150, P1; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Matsumoto N, 2003, BRIT J CANCER, V89, P707, DOI 10.1038/sj.bjc.6601141; McCarthy RP, 2004, AM J PATHOL, V165, P1395, DOI 10.1016/S0002-9440(10)63397-4; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Moinfar F, 2000, CANCER RES, V60, P2562; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; SAKAKURA T, 1991, INT REV CYTOL, V125, P165, DOI 10.1016/S0074-7696(08)61219-X; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wernert N, 2001, ANTICANCER RES, V21, P2259; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Yu EY, 1997, PROSTATE CANCER P D, V1, P39, DOI 10.1038/sj.pcan.4500205	50	263	278	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1001	1011		10.1016/j.cell.2005.09.030	http://dx.doi.org/10.1016/j.cell.2005.09.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360031	Bronze, Green Submitted			2022-12-01	WOS:000234177200010
J	Scarborough, CL; Ferrari, J; Godfray, HCJ				Scarborough, CL; Ferrari, J; Godfray, HCJ			Aphid protected from pathogen by endosymbiont	SCIENCE			English	Editorial Material							HOST-PLANT SPECIALIZATION; RESISTANCE; SYMBIONTS		Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Ferrari, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	julia.ferrari@imperial.ac.uk	Ferrari, Julia/B-2376-2009	Ferrari, Julia/0000-0001-6519-4254	Biotechnology and Biological Sciences Research Council [D19263] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Ferrari J, 2003, ECOL LETT, V6, P111, DOI 10.1046/j.1461-0248.2003.00399.x; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	6	522	555	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1781	1781		10.1126/science.1120180	http://dx.doi.org/10.1126/science.1120180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357252				2022-12-01	WOS:000234093600036
J	Yue, ZC; Jiang, TX; Widelitz, RB; Chuong, CM				Yue, ZC; Jiang, TX; Widelitz, RB; Chuong, CM			Mapping stem cell activities in the feather follicle	NATURE			English	Article							EVOLUTIONARY ORIGIN; EMBRYONIC INDUCTION; ADHESION MOLECULES; HAIR-FOLLICLES; MORPHOGENESIS; SKIN; EXPRESSION; GROWTH; NICHE	It is important to know how different organs 'manage' their stem cells. Both hair and feather follicles show robust regenerative powers that episodically renew the epithelial organ. However, the evolution of feathers ( from reptiles to birds) and hairs ( from reptiles to mammals) are independent events and their follicular structures result from convergent evolution. Because feathers do not have the anatomical equivalent of a hair follicle bulge, we are interested in determining where their stem cells are localized. By applying long-term label retention(1), transplantation(2) and DiI tracing to map stem cell activities, here we show that feather follicles contain slow-cycling long-term label-retaining cells (LRCs), transient amplifying cells and differentiating keratinocytes. Each population, located in anatomically distinct regions, undergoes dynamic homeostasis during the feather cycle. In the growing follicle, LRCs are enriched in a 'collar bulge' niche. In the moulting follicle, LRCs shift to populate a papillar ectoderm niche near the dermal papilla. On transplantation, LRCs show multipotentiality. In a three-dimensional view, LRCs are configured as a ring that is horizontally placed in radially symmetric feathers but tilted in bilaterally symmetric feathers. The changing topology of stem cell activities may contribute to the construction of complex feather forms.	Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA.	chuong@pathfinder.usc.edu	yue, zhicao/AAJ-4636-2020; Yue, ZhiCao/A-5075-2016	Yue, ZhiCao/0000-0001-5729-3842	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047364-03, R01 AR047364-01A2, R01 AR042177-08S1, R01 AR042177-09, R01 AR047364-02, R01 AR042177-08, R01 AR042177-11, R01 AR042177-10, R01 AR042177, R01 AR047364, R01 AR047364-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BronnerFraser M, 1996, METHOD CELL BIOL, V51, P61, DOI 10.1016/S0091-679X(08)60622-6; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; CHUONG CM, 1985, J CELL BIOL, V101, P1027, DOI 10.1083/jcb.101.3.1027; CHUONG CM, 1985, J CELL BIOL, V101, P1009, DOI 10.1083/jcb.101.3.1009; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P223; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dupin E, 1998, CURR TOP DEV BIOL, V36, P1; FIALA JC, 2002, MICROSC ANAL, V52, P5; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Koster MI, 2002, J INVEST DERM SYMP P, V7, P41, DOI 10.1046/j.1523-1747.2002.19639.x; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; Lillie Frank R., 1944, PHYSIOL ZOOL, V17, P1; Lucas A. M., 1972, AGR HDB, V362; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Potten CS, 2002, J CELL SCI, V115, P2381; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2001, J EXP ZOOL, V291, P30, DOI 10.1002/jez.4; TingBerreth SA, 1996, DEV DYNAM, V207, P157, DOI 10.1002/(SICI)1097-0177(199610)207:2<157::AID-AJA4>3.0.CO;2-G; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang Hsi, 1943, PHYSIOL ZOOL, V16, P325; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196	29	98	102	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1026	1029		10.1038/nature04222	http://dx.doi.org/10.1038/nature04222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355227	Green Accepted			2022-12-01	WOS:000233934600069
J	Feddema, JJ; Oleson, KW; Bonan, GB; Mearns, LO; Buja, LE; Meehl, GA; Washington, WM				Feddema, JJ; Oleson, KW; Bonan, GB; Mearns, LO; Buja, LE; Meehl, GA; Washington, WM			The importance of land-cover change in simulating future climates	SCIENCE			English	Article							GLOBAL CLIMATE; TROPICAL DEFORESTATION; UNITED-STATES; VEGETATION; SENSITIVITY; LANDSCAPE; DYNAMICS; IMPACTS	Adding the effects of changes in land cover to the A2 and B1 transient climate simulations described in the Special Report on Emissions Scenarios (SRES) by the Intergovernmental Panel on Climate Change leads to significantly different regional climates in 2100 as compared with climates resulting from atmospheric SRES forcings alone. Agricultural expansion in the A2 scenario results in significant additional warming over the Amazon and cooling of the upper air column and nearby oceans. These and other influences on the Hadley and monsoon circulations affect extratropical climates. Agricultural expansion in the mid-latitudes produces cooling and decreases in the mean daily temperature range over many areas. The A2 scenario results in more significant change, often of opposite sign, than does the B1 scenario.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Kansas, Dept Geog, Lawrence, KS 66045 USA	National Center Atmospheric Research (NCAR) - USA; University of Kansas	Feddema, JJ (corresponding author), Univ Kansas, Dept Geog, Lawrence, KS 66045 USA.	feddema@ku.edu	Oleson, Keith/A-9328-2008; Feddema, Johannes/J-4400-2012	Oleson, Keith/0000-0002-0057-9900; Feddema, Johannes/0000-0002-0800-0908				Alcamo J, 1998, GLOBAL CHANGE SCENAR; [Anonymous], 2000, SPECIAL REPORT EMISS; Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Betts RA, 2001, ATMOS SCI LETT, V2, P39, DOI 10.1006/asle.2001.0023; Bonan GB, 1999, ECOL APPL, V9, P1305, DOI 10.1890/1051-0761(1999)009[1305:FFTPIO]2.0.CO;2; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2001, J CLIMATE, V14, P2430, DOI 10.1175/1520-0442(2001)014&lt;2430:OEFROD&gt;2.0.CO;2; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Chase TN, 2000, CLIM DYNAM, V16, P93, DOI 10.1007/s003820050007; Costa MH, 2000, J CLIMATE, V13, P18, DOI 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2; DeFries RS, 2002, GLOBAL CHANGE BIOL, V8, P438, DOI 10.1046/j.1365-2486.2002.00483.x; Feddema J, 2005, CLIM DYNAM, V25, P581, DOI 10.1007/s00382-005-0038-z; Gedney N, 2000, GEOPHYS RES LETT, V27, P3053, DOI 10.1029/2000GL011794; Hansen JE, 1998, P NATL ACAD SCI USA, V95, P12753, DOI 10.1073/pnas.95.22.12753; Hoerling MP, 2004, CLIM DYNAM, V23, P391, DOI 10.1007/s00382-004-0433-x; Houghton J, 2001, CLIMATE CHANGE 2000; Kabat P., 2002, VEGETATION WATER HUM; Karl TR, 1997, B AM METEOROL SOC, V78, P1107, DOI 10.1175/1520-0477(1997)078<1107:TCHWHL>2.0.CO;2; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; MCGUFFIE K, 1995, GLOBAL PLANET CHANGE, V10, P97, DOI 10.1016/0921-8181(94)00022-6; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; *RIJKS I VOLKSG MI, 2002, IMAGE 2 2 IMPL SRES; SITCH S, 2004, GLOBAL BIOGEOCHEM CY, V19, DOI UNSP GB2013; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Steffen W., 2004, GLOBAL CHANGE EARTH, DOI DOI 10.1029/2004EO350005; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079	28	754	820	14	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2005	310	5754					1674	1678		10.1126/science.1118160	http://dx.doi.org/10.1126/science.1118160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339443				2022-12-01	WOS:000233961700043
J	Ruotolo, BT; Giles, K; Campuzano, I; Sandercock, AM; Bateman, RH; Robinson, CV				Ruotolo, BT; Giles, K; Campuzano, I; Sandercock, AM; Bateman, RH; Robinson, CV			Evidence for macromolecular protein rings in the absence of bulk water	SCIENCE			English	Article							IONIZATION MASS-SPECTROMETRY; BINDING ATTENUATION PROTEIN; ELECTROSPRAY-IONIZATION; GAS-PHASE; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; ION-TRAP; COMPLEXES; CHROMATOGRAPHY; TRANSITIONS	We have examined the architecture of a protein complex in the absence of bulk water. By determining collision cross sections of assemblies of the trp RNA binding protein, TRAP, we established that the 11-membered ring topology of the complex can be maintained within a mass spectrometer. We also found that the binding of tryptophan enhances the stability of the ring structure and that addition of a specific RNA molecule increases the size of the complex and prevents structural collapse. These results provide definitive evidence that protein quaternary structure can be maintained in the absence of bulk water and highlight the potential of ion mobility separation for defining shapes of heterogeneous macromolecular assemblies.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Waters MS Technol Ctr, Manchester M55 5PP, Lancs, England	University of Cambridge; Waters UK	Robinson, CV (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk	Ruotolo, Brandon/F-2669-2013	Ruotolo, Brandon/0000-0002-6084-2328; robinson, carol/0000-0001-7829-5505	Engineering and Physical Sciences Research Council [GR/R87703/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Anchordoquy TJ, 2001, ARCH BIOCHEM BIOPHYS, V390, P35, DOI 10.1006/abbi.2001.2351; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Badman ER, 2001, ANAL CHEM, V73, P6000, DOI 10.1021/ac010744a; Bell JA, 1999, PROTEIN SCI, V8, P2033, DOI 10.1110/ps.8.10.2033; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Hanson CL, 2004, J BIOL CHEM, V279, P24907, DOI 10.1074/jbc.R300037200; Jarrold MF, 2000, ANNU REV PHYS CHEM, V51, P179, DOI 10.1146/annurev.physchem.51.1.179; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATTA V, 1991, J AM CHEM SOC, V113, P8534, DOI 10.1021/ja00022a058; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; LIGHTWAHL KJ, 1994, J AM CHEM SOC, V116, P5271, DOI 10.1021/ja00091a035; Loo JA, 2005, J AM SOC MASS SPECTR, V16, P998, DOI 10.1016/j.jasms.2005.02.017; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mason E.A., 1988, TRANSPORT PROPERTIES; McCammon MG, 2004, J AM CHEM SOC, V126, P5950, DOI 10.1021/ja0317170; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Myung S, 2002, J PHYS CHEM A, V106, P9976, DOI 10.1021/jp0206368; Nagendra HG, 1998, PROTEINS, V32, P229, DOI 10.1002/(SICI)1097-0134(19980801)32:2<229::AID-PROT9>3.0.CO;2-F; Oomens J, 2005, PHYS CHEM CHEM PHYS, V7, P1345, DOI 10.1039/b502322j; Pace CN, 2004, PHILOS T ROY SOC B, V359, P1225, DOI 10.1098/rstb.2004.1500; Rostom AA, 1999, J AM CHEM SOC, V121, P4718, DOI 10.1021/ja990238r; Sobott F, 2002, CURR OPIN STRUC BIOL, V12, P729, DOI 10.1016/S0959-440X(02)00400-1; Sobott F, 2003, INT J MASS SPECTROM, V230, P193, DOI 10.1016/j.ijms.2003.09.008; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; VON HELDEN G, 1995, SCIENCE, V267, P1483, DOI 10.1126/science.267.5203.1483; WOOD TD, 1995, P NATL ACAD SCI USA, V92, P2451, DOI 10.1073/pnas.92.7.2451; Wyttenbach T, 2003, TOP CURR CHEM, V225, P207, DOI 10.1007/b10470	32	483	486	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1658	1661		10.1126/science.1120177	http://dx.doi.org/10.1126/science.1120177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16293722				2022-12-01	WOS:000233961700038
J	Niemann, HB; Atreya, SK; Bauer, SJ; Carignan, GR; Demick, JE; Frost, RL; Gautier, D; Haberman, JA; Harpold, DN; Hunten, DM; Israel, G; Lunine, JI; Kasprzak, WT; Owen, TC; Paulkovich, M; Raulin, F; Raaen, E; Way, SH				Niemann, HB; Atreya, SK; Bauer, SJ; Carignan, GR; Demick, JE; Frost, RL; Gautier, D; Haberman, JA; Harpold, DN; Hunten, DM; Israel, G; Lunine, JI; Kasprzak, WT; Owen, TC; Paulkovich, M; Raulin, F; Raaen, E; Way, SH			The abundances of constituents of Titan's atmosphere from the GCMS instrument on the Huygens probe	NATURE			English	Article							HETERODYNE OBSERVATIONS; MASS-SPECTROMETER; ORIGIN; EVOLUTION; NITROGEN; METHANE; PHOTOCHEMISTRY; HYDROCARBONS; TEMPERATURES; MILLIMETER	Saturn's largest moon, Titan, remains an enigma, explored only by remote sensing from Earth, and by the Voyager and Cassini spacecraft. The most puzzling aspects include the origin of the molecular nitrogen and methane in its atmosphere, and the mechanism(s) by which methane is maintained in the face of rapid destruction by photolysis. The Huygens probe, launched from the Cassini spacecraft, has made the first direct observations of the satellite's surface and lower atmosphere. Here we report direct atmospheric measurements from the Gas Chromatograph Mass Spectrometer (GCMS), including altitude profiles of the constituents, isotopic ratios and trace species ( including organic compounds). The primary constituents were confirmed to be nitrogen and methane. Noble gases other than argon were not detected. The argon includes primordial Ar-36, and the radiogenic isotope Ar-40, providing an important constraint on the outgassing history of Titan. Trace organic species, including cyanogen and ethane, were found in surface measurements.	NASA, Greenbelt, MD 20771 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Graz Univ, Inst Meteorol & Geophys, A-8010 Graz, Austria; Observ Paris, LESIA, F-92195 Meudon, France; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85716 USA; CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Alabama Birmingham, CMC, Birmingham, AL 35205 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Paris 12, Lab Interuniv Syst Atmospher, F-94010 Creteil, France; Univ Paris 07, F-94010 Creteil, France	National Aeronautics & Space Administration (NASA); University of Michigan System; University of Michigan; University of Graz; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Arizona; Centre National de la Recherche Scientifique (CNRS); University of Alabama System; University of Alabama Birmingham; University of Hawaii System; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Niemann, HB (corresponding author), NASA, Greenbelt, MD 20771 USA.	Hasso.B.Niemann@nasa.gov	Harpold, Dan/I-3345-2013	Lunine, Jonathan/0000-0003-2279-4131; Bauer, Siegfried/0000-0003-4213-2047				ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Boetius A, 2005, SCIENCE, V307, P1420, DOI 10.1126/science.1109849; Chiodini G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019480; COUSTENIS A, 1989, ICARUS, V82, P67, DOI 10.1016/0019-1035(89)90024-9; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; DEBERGH C, 1986, ASTROPHYS J, V311, P501, DOI 10.1086/164790; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; ENGEL S, 1994, J GEOPHYS RES-PLANET, V99, P3745, DOI 10.1029/93JE03433; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Foustoukos DI, 2004, SCIENCE, V304, P1002, DOI 10.1126/science.1096033; Hersant F, 2004, PLANET SPACE SCI, V52, P623, DOI 10.1016/j.pss.2003.12.011; Hidayat T, 1997, ICARUS, V126, P170, DOI 10.1006/icar.1996.5640; HOLLAND H, 1984, CHEM EVOLUTION ATMOS, V39; Hunten D.M, 1984, SATURN, P671; Israel G, 2002, SPACE SCI REV, V104, P433, DOI 10.1023/A:1023640723915; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; KOUVARIS LC, 1991, ICARUS, V91, P112, DOI 10.1016/0019-1035(91)90131-C; KUNDE VG, 1981, NATURE, V292, P686, DOI 10.1038/292686a0; KURAMOTO K, 1994, J GEOPHYS RES-PLANET, V99, P21183, DOI 10.1029/94JE01864; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; Lorenz RD, 1997, SCIENCE, V275, P642, DOI 10.1126/science.275.5300.642; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; Lunine JI, 1999, PLANET SPACE SCI, V47, P1291, DOI 10.1016/S0032-0633(99)00052-5; Marten A, 2002, ICARUS, V158, P532, DOI 10.1006/icar.2002.6897; MCKAY CP, 1988, NATURE, V332, P520, DOI 10.1038/332520a0; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Niemann HB, 1998, ADV SPACE RES, V21, P1455, DOI 10.1016/S0273-1177(98)00019-2; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; ORTON G, 1992, ESA SP, V338; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; Owen T, 2002, SPACE SCI REV, V104, P347, DOI 10.1023/A:1023684406168; OWEN T, 1982, PLANET SPACE SCI, V30, P833, DOI 10.1016/0032-0633(82)90115-5; Owen T., 1999, IAU CIRC, V7306, P3; SAGAN C, 1992, ACCOUNTS CHEM RES, V25, P286, DOI 10.1021/ar00019a003; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; STROBEL DF, 1974, ICARUS, V21, P466, DOI 10.1016/0019-1035(74)90149-3; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; Wilson EH, 2003, PLANET SPACE SCI, V51, P1017, DOI 10.1016/j.pss.2003.06.003; Wong AS, 2002, ICARUS, V155, P382, DOI 10.1006/icar.2001.6720; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	46	699	705	5	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					779	784		10.1038/nature04122	http://dx.doi.org/10.1038/nature04122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319830	Green Published			2022-12-01	WOS:000233777800038
J	Danaei, G; Vander Hoorn, S; Lopez, AD; Murray, CJL; Ezzati, M				Danaei, G; Vander Hoorn, S; Lopez, AD; Murray, CJL; Ezzati, M		Comparative Risk Assessment Collab	Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors	LANCET			English	Article							COLORECTAL-CANCER; PARTICLE VACCINE; CERVICAL-CANCER; BREAST-CANCER; YOUNG-WOMEN; MORTALITY; EFFICACY; TRENDS; PREVENTION; INFECTION	Introduction With respect to reducing mortality, advances in cancer treatment have not been as effective as those for other chronic diseases; effective screening methods are available for only a few cancers. Primary prevention through lifestyle and environmental interventions remains the main way to reduce the burden of cancers. In this report, we estimate mortality from 12 types of cancer attributable to nine risk factors in seven World Bank regions for 2001. Methods We analysed data from the Comparative Risk Assessment project and from new sources to assess exposure to risk factors and relative risk by age, sex, and region. We applied population attributable fractions for individual and multiple risk factors to site-specific cancer mortality from WHO. Findings of the 7 million deaths from cancer worldwide in 2001, an estimated 2.43 million (35%) were attributable to nine potentially modifiable risk factors. Of these, 0.76 million deaths were in high-income countries and 1.67 million in low-and-middle-income nations. Among low-and-middle-income regions, Europe and Central Asia had the highest proportion (39%) of deaths from cancer attributable to the risk factors studied. 1.6 million of the deaths attributable to these risk factors were in men and 0.83 million in women. Smoking, alcohol use, and low fruit and vegetable intake were the leading risk factors for death from cancer worldwide and in low-and-middle-income countries. In high-income countries, smoking, alcohol use, and overweight and obesity were the most important causes of cancer. Sexual transmission of human papilloma virus is a leading risk factor for cervical cancer in women in low-and-middle-income countries. interpretation Reduction of exposure to key behavioural and environmental risk factors would prevent a substantial proportion of deaths from cancer.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Auckland; University of Queensland	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu	Danaei, Goodarz/B-6085-2008; Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512	NIA NIH HHS [P01-AG17625] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANNIE YHJ, 2003, CANC TREAT REV, V29, P461; [Anonymous], 2002, WORLD HLTH REP 2002; BULL FC, 2004, COMP QUANTIFICATION, P729; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; Cohen A. J., 2004, COMP QUANTIFICATION, V2, P1353; Concha-Barrientos M, 2004, COMP QUANTIFICATION, P1651; Dikshit RP, 2000, INT J EPIDEMIOL, V29, P609, DOI 10.1093/ije/29.4.609; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1990, EUR J CANCER, V26, P500; Early Breast Cancer Trialists' Collaborative Group, 2001, COCHRANE DB SYST REV; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M., 2004, COMP QUANTIFICATION; Ezzati M., 2004, COMP QUANTIFICATION; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Freedman DA, 2004, INT J EPIDEMIOL, V33, P43, DOI 10.1093/ije/dyg275; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Hackshaw A, 2003, ANN ONCOL, V14, P1193, DOI 10.1093/annonc/mdg321; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; HAURI AM, 2004, COMP QUANTIFICATION, P1803; Hirayama T, 1990, LIFE STYLE MORTALITY; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; James WPT, 2004, COMP QUANTIFICATION, P497; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LAARA E, 1987, LANCET, V1, P1247; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; LOCK K, 2004, COMP QUANTIFICATION, P597; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Manser RL, 2004, COCHRANE DB SYST REV, V1; Mathers CD, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-36; Mezzetti M, 1998, J NATL CANCER I, V90, P389, DOI 10.1093/jnci/90.5.389; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; PRESTON SH, 2005, DEMOGRAPHY MEASURING; Rehm J, 2004, COMP QUANTIFICATION, P959; Ries LAG., SEER CANC STAT REV 1; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Slaymaker E., 2004, COMP QUANTIFICATION, P1177; Smith KR, 2004, COMP QUANTIFICATION, V2, P1435; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; STEWART B, 2003, WORLD CANC REP; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040	49	844	885	3	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1784	1793		10.1016/S0140-6736(05)67725-2	http://dx.doi.org/10.1016/S0140-6736(05)67725-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298215				2022-12-01	WOS:000233517200022
J	Kukura, P; McCamant, DW; Yoon, S; Wandschneider, DB; Mathies, RA				Kukura, P; McCamant, DW; Yoon, S; Wandschneider, DB; Mathies, RA			Structural observation of the primary isomerization in vision with femtosecond-stimulated Raman	SCIENCE			English	Article							INFRARED-SPECTROSCOPY; ENERGY-STORAGE; 1ST STEP; DYNAMICS; RHODOPSIN; CHROMOPHORE; MECHANISM; PROTEIN; HEME	The primary event that initiates vision is the light-induced 11-cis to all-trans isomerization of retinal in the visual pigment rhodopsin. Despite decades of study with the traditional tools of chemical reaction dynamics, both the timing and nature of the atomic motions that lead to photoproduct production remain unknown. We used femtosecond-stimulated Raman spectroscopy to obtain time-resolved vibrational spectra of the molecular structures formed along the reaction coordinate. The spectral evolution of the vibrational features from 200 femtoseconds to 1 picosecond after photon absorption reveals the temporal sequencing of the geometric changes in the retinal backbone that activate this receptor.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mathies, RA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rich@zinc.cchem.berkeley.edu		Kukura, Philipp/0000-0003-0136-7704; Yoon, Sangwoon/0000-0001-5705-4569; McCamant, David/0000-0002-9095-040X	NATIONAL EYE INSTITUTE [R01EY002051, R37EY002051] Funding Source: NIH RePORTER; NEI NIH HHS [EY-02051] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andruniow T, 2004, P NATL ACAD SCI USA, V101, P17908, DOI 10.1073/pnas.0407997101; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; Blomgren F, 2003, CHEM PHYS LETT, V376, P704, DOI 10.1016/S0009-2614(03)01062-5; Bromberg SE, 1997, SCIENCE, V278, P260, DOI 10.1126/science.278.5336.260; FAYER MD, 2001, ULTRAFAST INFRARED R; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Fleming GR, 1997, CURR OPIN STRUC BIOL, V7, P738, DOI 10.1016/S0959-440X(97)80086-3; FRISCH MJ, 2001, GAUSSIAN 03; HAMAGUCHI H, 1994, ANNU REV PHYS CHEM, V45, P593, DOI 10.1146/annurev.physchem.45.1.593; Kochendoerfer GG, 1996, J PHYS CHEM-US, V100, P14526, DOI 10.1021/jp960509+; Lee SY, 2004, J CHEM PHYS, V121, P3632, DOI 10.1063/1.1777214; Liu RSH, 2001, ACCOUNTS CHEM RES, V34, P555, DOI 10.1021/ar000165c; LOPPNOW GR, 1988, BIOPHYS J, V54, P35, DOI 10.1016/S0006-3495(88)82928-X; Mahet M, 2004, FEMTOCHEMISTRY AND FEMTOBIOLOGY: ULTRAFAST EVENTS IN MOLECULAR SCIENCE, P441, DOI 10.1016/B978-044451656-5/50086-4; Mathies R. A., 2000, HDB BIOL PHYSICS, P55, DOI DOI 10.1016/S1383-8121(00)80005-6; McCamant DW, 2003, J PHYS CHEM A, V107, P8208, DOI 10.1021/jp030147n; Mizutani Y, 1997, SCIENCE, V278, P443, DOI 10.1126/science.278.5337.443; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; POLLARD WT, 1990, J CHEM PHYS, V92, P4012, DOI 10.1063/1.457815; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SHANK CV, 1986, SCIENCE, V233, P1276, DOI 10.1126/science.233.4770.1276; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Yan ECY, 2004, BIOCHEMISTRY-US, V43, P10867, DOI 10.1021/bi0400148; ZEWAIL AH, 1994, FEMTOCHEMISTRY; ZHU LY, 1994, SCIENCE, V266, P629, DOI 10.1126/science.7939716	26	527	531	5	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1006	1009		10.1126/science.1118379	http://dx.doi.org/10.1126/science.1118379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284176				2022-12-01	WOS:000233343400040
J	Mellinghoff, IK; Wang, MY; Vivanco, I; Haas-Kogan, DA; Zhu, SJ; Dia, EQ; Lu, KV; Yoshimoto, K; Huang, JHY; Chute, DJ; Riggs, BL; Horvath, S; Liau, LM; Cavenee, WK; Rao, PN; Beroukhim, R; Peck, TC; Lee, JC; Sellers, WR; Stokoe, D; Prados, M; Cloughesy, TF; Sawyers, CL; Mischel, PS				Mellinghoff, IK; Wang, MY; Vivanco, I; Haas-Kogan, DA; Zhu, SJ; Dia, EQ; Lu, KV; Yoshimoto, K; Huang, JHY; Chute, DJ; Riggs, BL; Horvath, S; Liau, LM; Cavenee, WK; Rao, PN; Beroukhim, R; Peck, TC; Lee, JC; Sellers, WR; Stokoe, D; Prados, M; Cloughesy, TF; Sawyers, CL; Mischel, PS			Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMAL-GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; ABL TYROSINE KINASE; CELL LUNG-CANCER; PHASE-II TRIAL; FACTOR-RECEPTOR; ANAPLASTIC ASTROCYTOMA; GLIOMA-CELLS; MUTATIONS; GEFITINIB	BACKGROUND: The epidermal growth factor receptor (EGFR) is frequently amplified, overexpressed, or mutated in glioblastomas, but only 10 to 20 percent of patients have a response to EGFR kinase inhibitors. The mechanism of responsiveness of glioblastomas to these inhibitors is unknown. METHODS: We sequenced kinase domains in the EGFR and human EGFR type 2 (Her2/neu) genes and analyzed the expression of EGFR, EGFR deletion mutant variant III (EGFRvIII), and the tumor-suppressor protein PTEN in recurrent malignant gliomas from patients who had received EGFR kinase inhibitors. We determined the molecular correlates of clinical response, validated them in an independent data set, and identified effects of the molecular abnormalities in vitro. RESULTS: Of 49 patients with recurrent malignant glioma who were treated with EGFR kinase inhibitors, 9 had tumor shrinkage of at least 25 percent. Pretreatment tissue was available for molecular analysis from 26 patients, 7 of whom had had a response and 19 of whom had rapid progression during therapy. No mutations in EGFR or Her2/neu kinase domains were detected in the tumors. Coexpression of EGFRvIII and PTEN was significantly associated with a clinical response (P<0.001; odds ratio, 51; 95 percent confidence interval, 4 to 669). These findings were validated in 33 patients who received similar treatment for glioblastoma at a different institution (P=0.001; odds ratio, 40; 95 percent confidence interval, 3 to 468). In vitro, coexpression of EGFRvIII and PTEN sensitized glioblastoma cells to erlotinib. CONCLUSIONS: Coexpression of EGFRvIII and PTEN by glioblastoma cells is associated with responsiveness to EGFR kinase inhibitors.	Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Ctr Hlth Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurosurg, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Henry E Singleton Brain Tumor Program, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Broad Inst, Boston, MA 02115 USA; MIT, Boston, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mischel, PS (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Ctr Hlth Sci, 10833 Le Conte Ave,Room 13-321, Los Angeles, CA 90095 USA.	pmischel@mednet.ucla.edu	Vivanco, Igor/GZH-2045-2022; Sawyers, Charles/G-5327-2016; Prados, Michael/N-5220-2019; Cloughesy, Timothy Francis/AGV-1013-2022	Vivanco, Igor/0000-0001-6347-9416; Liau, Linda/0000-0002-4053-0052	NATIONAL CANCER INSTITUTE [T32CA009172, P50CA097257, R01CA108633, U01CA062399, P01CA095616, T32CA009056, U01CA105695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM067600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS043147, R01NS050151] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09056, CA95616, CA097257, CA62399, T32 CA009172, CA108633, CA105695] Funding Source: Medline; NIGMS NIH HHS [5F31GM067600] Funding Source: Medline; NINDS NIH HHS [NS43147, NS050151] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choe G, 2003, CANCER RES, V63, P2742; Dancey JE, 2003, LANCET, V362, P62, DOI 10.1016/S0140-6736(03)13810-X; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Frederick L, 2000, CANCER RES, V60, P1383; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Furnari FB, 1998, CANCER RES, V58, P5002; Goudar RK, 2005, MOL CANCER THER, V4, P101; Han YC, 1996, CANCER RES, V56, P3859; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MANNING BD, 2002, SCI STKE; Marie Y, 2005, NEUROLOGY, V64, P1444, DOI 10.1212/01.WNL.0000158654.07080.B0; Mellinghoff IK, 2002, CANCER RES, V62, P5254; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Mishima K, 2001, CANCER RES, V61, P5349; Mishima K, 2001, CANCER RES, V61, P7703; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PRADOS M, 2003, P AN M AM SOC CLIN, V22, P99; Rich JN, 2004, NEW ENGL J MED, V351, P1260; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Sonoda Y, 2001, CANCER RES, V61, P6674; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965	51	1124	1188	1	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2005	353	19					2012	2024		10.1056/NEJMoa051918	http://dx.doi.org/10.1056/NEJMoa051918			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981WV	16282176				2022-12-01	WOS:000233119600006
J	Toda, M; Takagaki, A; Okamura, M; Kondo, JN; Hayashi, S; Domen, K; Hara, M				Toda, M; Takagaki, A; Okamura, M; Kondo, JN; Hayashi, S; Domen, K; Hara, M			Green chemistry - Biodiesel made with sugar catalyst	NATURE			English	Editorial Material							SOLID ACID CATALYSTS		Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Tsukuba, Ibaraki 3058565, Japan; Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Tokyo Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Toda, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan.	mhara@res.titech.ac.jp	Hara, Masayuki/AAH-4361-2019; KONDO, Junko N./E-8648-2014; Hara, Michikazu/E-6418-2014; Takagaki, Atsushi/E-6788-2010	KONDO, Junko N./0000-0002-7940-1266; Hara, Michikazu/0000-0003-3450-5704; Takagaki, Atsushi/0000-0002-7829-3451				Clark JH, 2002, ACCOUNTS CHEM RES, V35, P791, DOI 10.1021/ar010072a; Hara M, 2004, ANGEW CHEM INT EDIT, V43, P2955, DOI 10.1002/anie.200453947; Misono M, 2000, CR ACAD SCI II C, V3, P471, DOI 10.1016/S1387-1609(00)01165-8; Okuhara T, 2002, CHEM REV, V102, P3641, DOI 10.1021/cr0103569; Silverstien R. M., 1991, SPECTROMETRIC IDENTI, P218; Smith K, 2003, ORG BIOMOL CHEM, V1, P1560, DOI 10.1039/b301260c; Tsubouchi N, 2003, ENERG FUEL, V17, P1119, DOI 10.1021/ef020265u; Zhang XQ, 1999, CHEM MATER, V11, P384, DOI 10.1021/cm980605i	8	698	779	10	408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					178	178		10.1038/438178a	http://dx.doi.org/10.1038/438178a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281026	Bronze			2022-12-01	WOS:000233133500036
J	Xu, N; Tsai, CL; Lee, JT				Xu, N; Tsai, CL; Lee, JT			Transient homologous chromosome pairing marks the onset of X inactivation	SCIENCE			English	Article							XIST GENE; TSIX; MICE; CHOICE; XITE	Mammalian X inactivation turns off one female X chromosome to enact dosage compensation between XX and XY individuals. X inactivation is known to be regulated in cis by Xite, Tsix, and Xist, but in principle the two Xs must also be regulated in trans to ensure mutually exclusive silencing. Here, we demonstrate that interchromosomal pairing mediates this communication. Pairing occurs transiently at the onset of X inactivation and is specific to the X-inactivation center. Deleting Xite and Tsix perturbs pairing and counting/choice, whereas their autosomal insertion induces de novo X-autosome pairing. Ectopic X-autosome interactions inhibit endogenous X-X pairing and block the initiation of X-chromosome inactivation. Thus, Tsix and Xite function both in cis and in trans. We propose that Tsix and Xite regulate counting and mutually exclusive choice through X-X pairing.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst,Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst,Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu						Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brown S W, 1992, Seizure, V1, P71, DOI 10.1016/1059-1311(92)90002-I; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Sado T, 2001, DEVELOPMENT, V128, P1275; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	21	312	327	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1149	1152		10.1126/science.1122984	http://dx.doi.org/10.1126/science.1122984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16424298				2022-12-01	WOS:000235688100048
J	Fogg, DK; Sibon, C; Miled, C; Jung, S; Aucouturier, P; Littman, DR; Cumano, A; Geissmann, F				Fogg, DK; Sibon, C; Miled, C; Jung, S; Aucouturier, P; Littman, DR; Cumano, A; Geissmann, F			A clonogenic bone marrow progenitor specific for macrophages and dendritic cells	SCIENCE			English	Article							COMMON MYELOID PROGENITOR; COLONY-STIMULATING FACTOR; BLOOD MONOCYTES; HEMATOPOIETIC PRECURSORS; IN-VIVO; MOUSE; DIFFERENTIATION; IDENTIFICATION; INTERLEUKIN-4; RECOGNITION	Macrophages and dendritic cells (DCs) are crucial for immune and inflammatory responses and belong to a network of cells that has been termed the mononuclear phagocyte system (MPS). However, the origin and lineage of these cells remain poorly understood. Here, we describe the isolation and clonal analysis of a mouse bone marrow progenitor that is specific for monocytes, several macrophage subsets, and resident spleen DCs in vivo. It was also possible to recapitulate this differentiation in vitro by using treatment with the cytokines macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Thus, macrophages and DCs appear to renew from a common progenitor, providing a cellular and molecular basis for the concept of the MPS.	Necker Enfants Malad Inst, Avenir Team, Lab Mononucl Phagocyte Biol, INSERM, F-75015 Paris, France; INSERM, U712, F-75012 Paris, France; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA; INSERM, U668, F-75015 Paris, France; Inst Pasteur, Lymphocyte Dev Unit, F-75015 Paris, France; Univ Paris, Descartes Fac Med, Hop Necker Enfants Malad, Dept Pathol, F-75015 Paris, France; Assistance Publ Hop Paris, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Geissmann, F (corresponding author), Necker Enfants Malad Inst, Avenir Team, Lab Mononucl Phagocyte Biol, INSERM, F-75015 Paris, France.	geissman@necker.fr	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline; PHS HHS [A133856] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; COLLINS LS, 1987, J IMMUNOL, V138, P1082; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; McKenna HJ, 2001, CURR OPIN HEMATOL, V8, P149, DOI 10.1097/00062752-200105000-00004; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	28	740	758	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					83	87		10.1126/science.1117729	http://dx.doi.org/10.1126/science.1117729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16322423				2022-12-01	WOS:000234546300038
J	Shackleton, M; Vaillant, F; Simpson, KJ; Stingl, J; Smyth, GK; Asselin-Labat, ML; Wu, L; Lindeman, GJ; Visvader, JE				Shackleton, M; Vaillant, F; Simpson, KJ; Stingl, J; Smyth, GK; Asselin-Labat, ML; Wu, L; Lindeman, GJ; Visvader, JE			Generation of a functional mammary gland from a single stem cell	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; MORPHOGENESIS; MODEL; MICE; INDUCE	The existence of mammary stem cells (MaSCs) has been postulated from evidence that the mammary gland can be regenerated by transplantation of epithelial fragments in mice(1-3). Interest in MaSCs has been further stimulated by their potential role in breast tumorigenesis(4). However, the identity and purification of MaSCs has proved elusive owing to the lack of defined markers. We isolated discrete populations of mouse mammary cells on the basis of cell-surface markers and identified a subpopulation (Lin(-) CD29(hi) CD24(+)) that is highly enriched for MaSCs by transplantation. Here we show that a single cell, marked with a LacZ transgene, can reconstitute a complete mammary gland in vivo. The transplanted cell contributed to both the luminal and myoepithelial lineages and generated functional lobuloalveolar units during pregnancy. The self-renewing capacity of these cells was demonstrated by serial transplantation of clonal outgrowths. In support of a potential role for MaSCs in breast cancer, the stem-cell-enriched subpopulation was expanded in premalignant mammary tissue from MMTV-wnt-1 mice and contained a higher number of MaSCs. Our data establish that single cells within the Lin(-) CD29(hi) CD24(+) population are multipotent and self-renewing, properties that define them as MaSCs.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Royal Melbourne Hosp, Bone Marrow Res Labs, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Stem Cell Technol Inc, Vancouver, BC V5Z 1B3, Canada	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Melbourne; British Columbia Cancer Agency	Visvader, JE (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	lindeman@wehi.edu.au; visvader@wehi.edu.au	Smyth, Gordon/B-5276-2008	Smyth, Gordon/0000-0001-9221-2892; Simpson, Kaylene/0000-0001-9136-1781; Lindeman, Geoffrey/0000-0001-9386-2416				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI [10.1186/bcr563, 10.1186/bcr547]; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2003, NATURE, V423, P231, DOI 10.1038/423231a; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kenney Nicholas J., 2001, Journal of Biomedicine and Biotechnology, V1, P133, DOI 10.1155/S1110724301000304; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; STINGL J, 2006, NATURE          0104; Sum EYM, 2005, J HISTOCHEM CYTOCHEM, V53, P475, DOI 10.1369/jhc.4A6553.2005; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6	30	1497	1593	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					84	88		10.1038/nature04372	http://dx.doi.org/10.1038/nature04372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397499				2022-12-01	WOS:000234378700039
J	Farh, KKH; Grimson, A; Jan, C; Lewis, BP; Johnston, WK; Lim, LP; Burge, CB; Bartel, DP				Farh, KKH; Grimson, A; Jan, C; Lewis, BP; Johnston, WK; Lim, LP; Burge, CB; Bartel, DP			The widespread impact of mammalian microRNAs on mRNA repression and evolution	SCIENCE			English	Article							TARGET; EXPRESSION; GENES; IDENTIFICATION; PREDICTION	Thousands of mammalian messenger RNAs are under selective pressure to maintain 7-nucleotide sites matching microRNAs (miRNAs). We found that these conserved targets are often highly expressed at developmental stages before miRNA expression and that their levels tend to fall as the miRNA that targets them begins to accumulate. Nonconserved sites, which outnumber the conserved sites 10 to 1, also mediate repression. As a consequence, genes preferentially expressed at the same time and place as a miRNA have evolved to selectively avoid sites matching the miRNA. This phenomenon of selective avoidance extends to thousands of genes and enables spatial and temporal specificities of miRNAs to be revealed by finding tissues and developmental stages in which messages with, corresponding sites are expressed at lower levels.	MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Rosetta Inpharmat, Seattle, WA 98109 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Merck & Company	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	23	1224	1317	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1817	1821		10.1126/science.1121158	http://dx.doi.org/10.1126/science.1121158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16308420				2022-12-01	WOS:000234093600047
J	Seibel, BA; Robison, BH; Haddock, SHD				Seibel, BA; Robison, BH; Haddock, SHD			Post-spawning egg care by a squid	NATURE			English	Article							GONATUS-ONYX CEPHALOPODA; LIFE-HISTORY; TEUTHOIDEA		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Seibel, BA (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	seibel@uri.edu						Arkhipkin AI, 1999, POLAR BIOL, V22, P357, DOI 10.1007/s003000050429; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139, DOI 10.1017/S0954102094000210; Childress JJ, 1998, J EXP BIOL, V201, P1223; CHILDRESS JJ, 1983, MAR BIOL, V76, P165, DOI 10.1007/BF00392733; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P979, DOI 10.1098/rstb.1996.0088; HOCHACHKA PW, 1992, EXPERIENTIA, V48, P570, DOI 10.1007/BF01920241; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Hunt JC, 2000, MAR BIOL, V136, P543, DOI 10.1007/s002270050714; Nesis KN., 1999, RUSS J MAR BIOL+, V25, P499; Okutani T., 1988, Bulletin of the Ocean Research Institute University of Tokyo, V26, P159; ROBISON BH, 1992, MAR TECHNOL SOC J, V26, P32; Seibel BA, 2000, MAR BIOL, V137, P519, DOI 10.1007/s002270000359; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270	13	57	57	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					929	929		10.1038/438929a	http://dx.doi.org/10.1038/438929a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355206	Bronze			2022-12-01	WOS:000233934600045
J	Usherwood, JR; Wilson, AM				Usherwood, JR; Wilson, AM			No force limit on greyhound sprint speed	NATURE			English	Editorial Material							HORSE EQUUS-CABALLUS; DOGS		Univ London Royal Vet Coll, Struct & Mot Lab, N Mymms AL9 7TA, Herts, England; UCL, Ctr Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Usherwood, JR (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, N Mymms AL9 7TA, Herts, England.	jusherwood@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455				ALEXANDER RM, 1974, J ZOOL, V173, P549, DOI 10.1111/j.1469-7998.1974.tb04134.x; ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Gray J., 1968, ANIMAL LOCOMOTION; GREENE PR, 1987, J BIOMECH, V20, P667, DOI 10.1016/0021-9290(87)90033-9; Gregersen CS, 1998, J EXP BIOL, V201, P3197; Lee DV, 1999, J EXP BIOL, V202, P3565; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Witte TH, 2004, J EXP BIOL, V207, P3639, DOI 10.1242/jeb.01182	9	78	80	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2005	438	7069					753	754		10.1038/438753a	http://dx.doi.org/10.1038/438753a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341003				2022-12-01	WOS:000233777800030
J	Castellone, MD; Teramoto, H; Williams, BO; Druey, KM; Gutkind, JS				Castellone, MD; Teramoto, H; Williams, BO; Druey, KM; Gutkind, JS			Prostaglandin E-2 promotes colon cancer cell growth through a G(s)-axin-beta-catenin signaling axis	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; BETA-CATENIN; ALPHA-SUBUNITS; PHOSPHORYLATION; RECEPTOR; MECHANISM; COMPLEX; INACTIVATION; CARCINOMA; TRANSCRIPTION	How cyclooxygenase-2 (COX-2) and its proinflammatory metabolite prostaglandin E2 (PGE2) enhance colon cancer progression remains poorly understood. We show that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein beta gamma subunits and the direct association of the G protein a. subunit with the regulator of G protein signaling (RGS) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3 beta from its complex with axin, thereby relieving the inhibitory phosphorytation of beta-catenin and activating its signaling pathway. These findings may provide a molecular framework for the future evaluation of chemopreventive strategies for colorectal cancer.	Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; Kojin Hosp, Nagoya, Aichi 4638530, Japan; Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA; NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Williams, Bart/A-3539-2013	Gutkind, J. Silvio/0000-0002-5150-4482; Williams, Bart/0000-0002-5261-5301; CASTELLONE, MARIADOMENICA/0000-0003-0507-8037	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000939, ZIAAI000939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Cong F, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-10; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; DAY RN, 1989, J BIOL CHEM, V264, P431; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Hansen-Petrik MB, 2002, CANCER RES, V62, P403; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ingi T, 1998, J NEUROSCI, V18, P7178; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEVY DB, 1994, CANCER RES, V54, P5953; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; QIAO L, 1995, BBA-LIPID LIPID MET, V1258, P215, DOI 10.1016/0005-2760(95)00100-Q; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603	40	726	765	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1504	1510		10.1126/science.1116221	http://dx.doi.org/10.1126/science.1116221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16293724				2022-12-01	WOS:000233756500047
J	Loucks, AB; Nattiv, A				Loucks, AB; Nattiv, A			Essay - The female athlete triad	LANCET			English	Article							DISORDERS		Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; Univ Calif Los Angeles, Dept Family Med, Div Sports Med, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA	Ohio University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Loucks, AB (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	loucks@ohio.edu						Beals KA, 2002, INT J SPORT NUTR EXE, V12, P281, DOI 10.1123/ijsnem.12.3.281; Bennell K, 1999, SPORTS MED, V28, P91, DOI 10.2165/00007256-199928020-00004; De Souza MJ, 1998, J CLIN ENDOCR METAB, V83, P4220, DOI 10.1210/jc.83.12.4220; Dusek T, 2001, CROAT MED J, V42, P79	4	16	17	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S49	S50		10.1016/S0140-6736(05)67848-8	http://dx.doi.org/10.1016/S0140-6736(05)67848-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360753				2022-12-01	WOS:000234374400031
J	Muthukumar, T; Dadhania, D; Ding, RC; Snopkowski, C; Naqvi, R; Lee, JB; Hartono, C; Li, BG; Sharma, VK; Seshan, SV; Kapur, S; Hancock, WW; Schwartz, JE; Suthanthiran, M				Muthukumar, T; Dadhania, D; Ding, RC; Snopkowski, C; Naqvi, R; Lee, JB; Hartono, C; Li, BG; Sharma, VK; Seshan, SV; Kapur, S; Hancock, WW; Schwartz, JE; Suthanthiran, M			Messenger RNA for FOXP3 in the urine of renal-allograft recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; REJECTION EPISODES; KIDNEY-TRANSPLANTS; TOLERANCE; EXPRESSION; BIOPSY; COMPLICATIONS; ENTEROPATHY; PATHOLOGY; SCURFIN	Background: The outcome of renal transplantation after an episode of acute rejection is difficult to predict, even with an allograft biopsy. Methods: We studied urine specimens from 36 subjects with acute rejection, 18 subjects with chronic allograft nephropathy, and 29 subjects with normal biopsy results. Levels of messenger RNA (mRNA) for FOXP3, a specification and functional factor for regulatory T lymphocytes, and mRNA for CD25, CD3(epsilon), perforin, and 18S ribosomal RNA (rRNA) were measured with a kinetic, quantitative polymerase-chain-reaction assay. We examined associations of mRNA levels with acute rejection, rejection reversal, and graft failure. Results: The log-transformed mean (+/-SE) ratio of FOXP3 mRNA copies to 18S ribosomal RNA copies was higher in urine from the group with acute rejection (3.8+/-0.5) than in the group with chronic allograft nephropathy (1.3+/-0.7) or the group with normal biopsy results (1.6+/-0.4) (P<0.001 by the Kruskal-Wallis test). FOXP3 mRNA levels were inversely correlated with serum creatinine levels measured at the time of biopsy in the acute-rejection group (Spearman's correlation coefficient =-0.38, P=0.02) but not in the group with chronic allograft nephropathy or the group with normal biopsy results. Analyses of receiver-operating-characteristic curves demonstrated that reversal of acute rejection can be predicted with 90 percent sensitivity and 73 percent specificity with use of the optimal identified cutoff for FOXP3 mRNA of 3.46 (P=0.001). FOXP3 mRNA levels identified subjects at risk for graft failure within six months after the incident episode of acute rejection (relative risk for the lowest third of FOXP3 mRNA levels, 6; P=0.02). None of the other mRNA levels were predictive of reversal of acute rejection or graft failure. Conclusions: Measurement of FOXP3 mRNA in urine may offer a noninvasive means of improving the prediction of outcome of acute rejection of renal transplants.	Cornell Univ, Weill Med Coll, Dept Med, Div Nephrol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Surg, New York, NY 10021 USA; New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA; Rogosin Inst, New York, NY USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Suthanthiran, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Nephrol, 525 E 68th St,Box 3, New York, NY 10021 USA.	msuthan@med.cornell.edu	Suthanthiran, Manikkam/AAL-9104-2020; Dadhania, Darshana/L-4651-2019	Schwartz, Joseph/0000-0002-8944-3566	NIAID NIH HHS [R01 AI054720, AI51652, AI54720, AI60706] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051652, R01AI054720, R01AI060706, R01AI051652] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agodoa L, 1997, KIDNEY INT, pS144; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; BECKINGHAM IJ, 1994, BRIT J UROL, V73, P13, DOI 10.1111/j.1464-410X.1994.tb07449.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BURDICK JF, 1984, TRANSPLANTATION, V38, P679, DOI 10.1097/00007890-198412000-00026; CHEIGH JS, 1983, NEPHRON, V35, P6, DOI 10.1159/000183036; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ding RC, 2003, TRANSPLANTATION, V75, P1307, DOI 10.1097/01.TP.0000064210.92444.B5; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gonzalez A, 2001, NAT IMMUNOL, V2, P1117, DOI 10.1038/ni738; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; GULANIKAR AC, 1992, TRANSPLANTATION, V53, P323, DOI 10.1097/00007890-199202010-00013; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hayry P, 2000, TRANSPLANTATION, V69, P1038; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; HURAIB S, 1989, AM J KIDNEY DIS, V14, P13, DOI 10.1016/S0272-6386(89)80087-3; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Langone AJ, 2003, NEW ENGL J MED, V349, P704, DOI 10.1056/NEJMe038117; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Luo ZR, 2005, TRANSPLANTATION, V79, P1091, DOI 10.1097/01.TP.0000161223.54452.A2; Maluccio M, 2003, TRANSPLANTATION, V76, P597, DOI 10.1097/01.TP.0000081399.75231.3B; MATAS AJ, 1983, ANN SURG, V197, P226, DOI 10.1097/00000658-198302000-00017; Opelz G, 1997, TRANSPL P, V29, P73, DOI 10.1016/S0041-1345(96)00013-9; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Siddiqi N, 2004, KIDNEY INT, V65, P1906, DOI 10.1111/j.1523-1755.2004.00589.x; Sijpkens YWJ, 2003, TRANSPLANTATION, V75, P204, DOI 10.1097/01.TP.0000041722.34000.21; STROM TB, 1975, NEW ENGL J MED, V292, P1257, DOI 10.1056/NEJM197506122922402; Tatapudi RR, 2004, KIDNEY INT, V65, P2390, DOI 10.1111/j.1523-1755.2004.00663.x; Tejani A H, 1998, Pediatr Transplant, V2, P318; Vasconcellos LM, 1998, TRANSPLANTATION, V66, P562, DOI 10.1097/00007890-199809150-00002; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0	40	432	467	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2342	2351		10.1056/NEJMoa051907	http://dx.doi.org/10.1056/NEJMoa051907			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319383				2022-12-01	WOS:000233574600006
J	de la Salle, H; Mariotti, S; Angenieux, C; Gilleron, M; Garcia-Alles, LF; Malm, D; Berg, T; Paoletti, S; Maitre, B; Mourey, L; Salamero, J; Cazenave, JP; Hanau, D; Mori, L; Puzo, G; De Libero, G				de la Salle, H; Mariotti, S; Angenieux, C; Gilleron, M; Garcia-Alles, LF; Malm, D; Berg, T; Paoletti, S; Maitre, B; Mourey, L; Salamero, J; Cazenave, JP; Hanau, D; Mori, L; Puzo, G; De Libero, G			Assistance of microbial glycolipid antigen processing by CD1e	SCIENCE			English	Article							T-CELL RECOGNITION; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-TUBERCULOSIS; PHOSPHATIDYLINOSITOL MANNOSIDES; SELF-GLYCOLIPIDS; ACYLATION STATE; MOLECULES; INFECTION	Complexes between CD1 molecules and self or microbial glycolipids represent important immunogenic ligands for specific subsets of T cells. However, the function of one of the CD1 family members, CD1e, has yet to be determined. Here, we show that the mycobacterial antigens hexamannosylated phosphatidyl-myo-inositols (PIM6) stimulate CD1b-restricted T cells only after partial digestion of the oligomannose moiety by lysosomal a-mannosidase and that soluble CD1e is required for this processing. Furthermore, recombinant CD1e was able to bind glycolipids and assist in the digestion of PIM6. We propose that, through this form of glycolipid editing, CD1e helps expand the repertoire of glycolipidic T cell antigens to optimize antimicrobial immune responses.	CNRS, UMR 5089, F-31077 Toulouse, France; Etab Francais Sang Alsace, INSERM, U725, F-67065 Strasbourg, France; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Inst Pharmacol & Biol Struct, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; Univ Hosp No Norway, Dept Med, N-9038 Tromso, Norway; Univ Hosp No Norway, Dept Pathol, N-9038 Tromso, Norway; Inst Curie, CNRS, UMR 144, F-75005 Paris, France; Etab Francais Sang Alsace, INSERM, U311, F-67065 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Puzo, G (corresponding author), CNRS, UMR 5089, F-31077 Toulouse, France.	germain.puzo@ipbs.fr; gennaro.delibero@unibas.ch	De La Salle, Henri/H-9353-2016; Cazenave, Jean-Pierre/AAE-2935-2019; MARIOTTI, SABRINA/M-4361-2015; Mourey, Lionel/B-5662-2009; De Libero, Gennaro/P-2694-2017	De La Salle, Henri/0000-0001-5136-0776; MARIOTTI, SABRINA/0000-0002-7009-7616; Mourey, Lionel/0000-0002-8259-1259; maitre, blandine/0000-0002-3264-7330; De Libero, Gennaro/0000-0003-0853-7868; salamero, jean/0000-0002-2610-5826; Garcia-Alles, Luis/0000-0002-1141-0393; GILLERON, Martine/0000-0002-2581-3302				Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Malm Dag, 1995, Tidsskrift for den Norske Laegeforening, V115, P594; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Sakai T, 1999, J MED CHEM, V42, P1836, DOI 10.1021/jm990054n; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; TULSIANI DRP, 1983, ARCH BIOCHEM BIOPHYS, V224, P594, DOI 10.1016/0003-9861(83)90247-3	24	203	207	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1321	1324		10.1126/science.1115301	http://dx.doi.org/10.1126/science.1115301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311334				2022-12-01	WOS:000233600200039
J	Zhang, JV; Ren, PG; Avsian-Kretchmer, O; Luo, CW; Rauch, R; Klein, C; Hsueh, AJW				Zhang, JV; Ren, PG; Avsian-Kretchmer, O; Luo, CW; Rauch, R; Klein, C; Hsueh, AJW			Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake	SCIENCE			English	Article							RECEPTOR; FAMILY; OBESITY; DELETION; NEURONS; PROTEIN; MEMBER; RATS	Ghrelin, a circulating appetite-inducing hormone, is derived from a prohormone by posttranslational processing. On the basis of the bioinformatic prediction that another peptide also derived from proghrelin exists, we isolated a hormone from rat stomach and named it obestatin-a contraction of obese, from the Latin "obedere," meaning to devour, and "statin," denoting suppression. Contrary to the appetite-stimulating effects of ghrelin, treatment of rats with obestatin suppressed food intake, inhibited jejunal contraction, and decreased body-weight gain. Obestatin bound to the orphan G protein-coupled receptor GPR39. Thus, two peptide hormones with opposing action in weight regulation are derived from the same ghrelin gene. After differential modification, these hormones activate distinct receptors.	Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA	Stanford University	Hsueh, AJW (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu	ZHANG, Jian/B-5157-2009; Ren, Pei-Gen/A-4099-2009					Ariyasu H, 2005, ENDOCRINOLOGY, V146, P355, DOI 10.1210/en.2004-0629; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; BOWERS CY, 1980, ENDOCRINOLOGY, V106, P663, DOI 10.1210/endo-106-3-663; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Edholm T, 2004, REGUL PEPTIDES, V121, P25, DOI 10.1016/j.regpep.2004.04.001; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pemberton C, 2003, BIOCHEM BIOPH RES CO, V310, P567, DOI 10.1016/j.bbrc.2003.09.045; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Smith RG, 1999, HORM RES, V51, P1; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540	26	892	953	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					996	999		10.1126/science.1117255	http://dx.doi.org/10.1126/science.1117255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284174				2022-12-01	WOS:000233343400037
J	Lee, WY; Sine, SM				Lee, WY; Sine, SM			Principal pathway coupling agonist binding to channel gating in nicotinic receptors	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR DOMAIN; CONFORMATIONAL-CHANGES; CHARGED RESIDUES; GLYCINE RECEPTOR; GABA(A) RECEPTOR; ASPARTIC-ACID; ACH-BINDING; ACTIVATION; SUBUNIT	Synaptic receptors respond to neurotransmitters by opening an intrinsic ion channel in the final step in synaptic transmission. How binding of the neurotransmitter is conveyed over the long distance to the channel remains a central question in neurobiology. Here we delineate a principal pathway that links neurotransmitter binding to channel gating by using a structural model of the Torpedo acetylcholine receptor at 4-angstrom resolution(1), recordings of currents through single receptor channels and determinations of energetic coupling between pairs of residues. We show that a pair of invariant arginine and glutamate residues in each receptor alpha-subunit electrostatically links peripheral and inner beta-sheets from the binding domain and positions them to engage with the channel. The key glutamate and flanking valine residues energetically couple to conserved proline and serine residues emerging from the top of the channel-forming alpha-helix, suggesting that this is the point at which the binding domain triggers opening of the channel. The series of interresidue couplings identified here constitutes a primary allosteric pathway that links neurotransmitter binding to channel gating.	Mayo Clin & Mayo Fdn, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Mol Neurosci Grad Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sine, SM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, 200 1st St SW, Rochester, MN 55905 USA.	sine@mayo.edu		Lee, Won Yong/0000-0001-7915-1829	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Lee WY, 2004, J GEN PHYSIOL, V124, P555, DOI 10.1085/jgp.200409077; Lyford LK, 2003, MOL PHARMACOL, V64, P650, DOI 10.1124/mol.64.3.650; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Vaughan CK, 2002, ACTA CRYSTALLOGR D, V58, P591, DOI 10.1107/S0907444902001567; Vicente-Agullo F, 2001, BIOCHEMISTRY-US, V40, P8300, DOI 10.1021/bi010087g; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	30	235	236	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					243	247		10.1038/nature04156	http://dx.doi.org/10.1038/nature04156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281039				2022-12-01	WOS:000233133500053
J	Winkelmayer, WC; Stampfer, MJ; Willett, WC; Curhan, GC				Winkelmayer, WC; Stampfer, MJ; Willett, WC; Curhan, GC			Habitual caffeine intake and the risk of hypertension in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ANALGESIC USE; QUESTIONNAIRE; FREQUENCY; COFFEE; REPRODUCIBILITY; VALIDATION; RESPONSES; VALIDITY	Context Caffeine acutely increases blood pressure, but the association between habitual consumption of caffeinated beverages and incident hypertension is uncertain. Objective To examine the association between caffeine intake and incident hypertension in women. Design, Setting, and Participants Prospective cohort study conducted in the Nurses' Health Studies (NHSs) I and II of 155 594 US women free from physician-diagnosed hypertension followed up over 12 years (1990-1991 to 2002-2003 questionnaires). Caffeine intake and possible confounders were ascertained from regularly administered questionnaires. We also tested the associations with types of caffeinated beverages. Main Outcome Measure Incident physician-diagnosed hypertension. Results During follow-up, 19 541 incident cases of physician-diagnosed hypertension were reported in NHS I and 13 536 in NHS II. In both cohorts, no linear association between caffeine consumption and risk of incident hypertension was observed after multivariate adjustment (NHS I, P for trend=.29; NHS II, P for trend =.53). Using categorical analysis, an inverse U-shaped association between caffeine consumption and incident hypertension was found. Compared with participants in the lowest quintile of caffeine consumption, those in the third quintile had a 13% and 12% increased risk of hypertension, respectively (95% confidence interval in NHS I, 8%-18%; in NHS II, 6%-18%). When studying individual classes of caffeinated beverages, habitual coffee consumption was not associated with increased risk of hypertension. By contrast, consumption of cola beverages was associated with an increased risk of hypertension, independent of whether it was sugared or diet cola (P for trend <.001). Conclusion No linear association between caffeine consumption and incident hypertension was found. Even though habitual coffee consumption was not associated with an increased risk of hypertension, consumption of sugared or diet cola was associated with it. Further research to elucidate the role of cola beverages in hypertension is warranted.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, Boston, MA 02120 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02120 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Winkelmayer, WC (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	wwinkelmayer@partners.org			NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052866, R01DK066574] Funding Source: NIH RePORTER; NCI NIH HHS [CA050385, CA87969] Funding Source: Medline; NIDDK NIH HHS [DK66574, DK52866] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM HEART ASS, 2001, 2002 HEART STROK STA; Choi SB, 2002, J NUTR BIOCHEM, V13, P727, DOI 10.1016/S0955-2863(02)00216-4; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Dedier J, 2002, HYPERTENSION, V40, P604, DOI 10.1161/01.HYP.0000035856.77718.DA; FIEBACH NH, 1989, AM J EPIDEMIOL, V130, P646; Forman JP, 2005, JAMA-J AM MED ASSOC, V293, P320, DOI 10.1001/jama.293.3.320; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647; JEE SH, 1997, CAN J CARDIOL SB, V13, pB36; Klag MJ, 2002, ARCH INTERN MED, V162, P657, DOI 10.1001/archinte.162.6.657; LANE JD, 1990, PSYCHOSOM MED, V52, P320, DOI 10.1097/00006842-199005000-00006; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; LOVALLO WR, 1989, HYPERTENSION, V14, P170, DOI 10.1161/01.HYP.14.2.170; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534	23	203	212	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 9	2005	294	18					2330	2335		10.1001/jama.294.18.2330	http://dx.doi.org/10.1001/jama.294.18.2330			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981LI	16278361	Bronze			2022-12-01	WOS:000233089700025
J	Lee, G; Abdi, K; Jiang, Y; Michaely, P; Bennett, V; Marszalek, PE				Lee, G; Abdi, K; Jiang, Y; Michaely, P; Bennett, V; Marszalek, PE			Nanospring behaviour of ankyrin repeats	NATURE			English	Article							PROTEIN; SPECTROSCOPY; MICROSCOPY; SPECTRIN; HEARING; CHANNEL	Ankyrin repeats are an amino-acid motif believed to function in protein recognition; they are present in tandem copies in diverse proteins in nearly all phyla(1). Ankyrin repeats contain antiparallel alpha-helices that can stack to form a superhelical spiral(2). Visual inspection of the extrapolated structure of 24 ankyrin-R repeats(2) indicates the possibility of spring-like behaviour of the putative superhelix. Moreover, stacks of 17-29 ankyrin repeats in the cytoplasmic domains of transient receptor potential (TRP) channels have been identified as candidates for a spring that gates mechanoreceptors in hair cells as well as in Drosophila bristles(3-5). Here we report that tandem ankyrin repeats exhibit tertiary-structure-based elasticity and behave as a linear and fully reversible spring in single-molecule measurements by atomic force microscopy. We also observe an unexpected ability of unfolded repeats to generate force during refolding, and report the first direct measurement of the refolding force of a protein domain. Thus, we show that one of the most common amino-acid motifs has spring properties that could be important in mechanotransduction and in the design of nanodevices.	Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27708 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bennett, V (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.	benne012@mc.duke.edu; pemar@duke.edu	Jiang, Yong/A-4173-2008	Jiang, Yong/0000-0002-5815-1480; Lee, Gwangrog/0000-0002-1720-8524				Ashmore J, 2004, NATURE, V432, P685, DOI 10.1038/432685a; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Schmid EL, 1997, ANAL CHEM, V69, P1979, DOI 10.1021/ac9700033; Schmitt L, 2000, BIOPHYS J, V78, P3275, DOI 10.1016/S0006-3495(00)76863-9; Schwaiger I, 2005, EMBO REP, V6, P46, DOI 10.1038/sj.embor.7400317; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	28	282	298	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					246	249		10.1038/nature04437	http://dx.doi.org/10.1038/nature04437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16415852	Bronze			2022-12-01	WOS:000235839500054
J	Rodriguez-Viciana, P; Tetsu, O; Tidyman, WE; Estep, AL; Conger, BA; Cruz, MS; McCormick, F; Rauen, KA				Rodriguez-Viciana, P; Tetsu, O; Tidyman, WE; Estep, AL; Conger, BA; Cruz, MS; McCormick, F; Rauen, KA			Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome	SCIENCE			English	Article							SIGNALING PATHWAY; COSTELLO-SYNDROME; KINASE KINASE; MICE; CELLS; MEK1; RAF; DIFFERENTIATION; PROTOONCOGENES; TRANSFORMATION	Cardio-facio-cutaneous (CFC) syndrome is a sporadic developmental disorder involving characteristic craniofacial features, cardiac defects, ectodermal abnormalities, and developmental delay. We demonstrate that heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid substitutions that occur in tumors, but most are unique and suggest previously unknown mechanisms of B-Raf activation. Furthermore, three of five individuals without BRAF mutations had missense mutations in either MEK1 or MEK2, downstream effectors of B-Raf. Our findings highlight the involvement of the MAPK pathway in human development and will provide a molecular diagnosis of CFC syndrome.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94115 USA; CFC Int, Vestal, NY 13850 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rauen, KA (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.	rauen@cc.ucsf.edu		Tetsu, Osamu/0000-0003-1820-7539	NICHD NIH HHS [HD048502] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD048502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bansal A, 1997, ONCOGENE, V14, P1231, DOI 10.1038/sj.onc.1200947; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Estep AL, 2006, AM J MED GENET A, V140A, P8, DOI 10.1002/ajmg.a.31078; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gong XH, 2001, INVEST OPHTH VIS SCI, V42, P539; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; REYNOLDS JF, 1986, AM J MED GENET, V25, P413, DOI 10.1002/ajmg.1320250303; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; SOLIT DB, 2005, NATURE          1106; STORM SM, 1990, ONCOGENE, V5, P345; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2	20	420	452	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2006	311	5765					1287	1290		10.1126/science.1124642	http://dx.doi.org/10.1126/science.1124642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019XB	16439621				2022-12-01	WOS:000235870400042
J	Park, HS; Nam, SH; Lee, JK; Yoon, CN; Mannervik, B; Benkovic, SJ; Kim, HS				Park, HS; Nam, SH; Lee, JK; Yoon, CN; Mannervik, B; Benkovic, SJ; Kim, HS			Design and evolution of new catalytic activity with an existing protein scaffold	SCIENCE			English	Article							METALLO-BETA-LACTAMASE; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; GLYOXALASE-II; BINDING; SITE; INHIBITOR; MECHANISM; COMPLEX; ENZYME	The design of enzymes with new functions and properties has long been a goal in protein engineering. Here, we report a strategy to change the catalytic activity of an existing protein scaffold. This was achieved by simultaneous incorporation and adjustment of functional elements through insertion, deletion, and substitution of several active site loops, followed by point mutations to fine-tune the activity. Using this approach, we were able to introduce beta-lactamase activity into the alpha beta/beta alpha metallohydrolase scaffold of glyoxalase II. The resulting enzyme, evMBL8 (evolved metallo beta-lactamase 8), completely lost its original activity and, instead, catalyzed the hydrolysis of cefotaxime with a (k(cat)/K-m)(app) of 1.8 x 10(2) (mole/titer)(-1) second(-1), thus increasing resistance to Escherichia coli growth on cefotaxime by a factor of about 100.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Seoul 130650, South Korea; Uppsala Univ, Biomed Ctr, Dept Biochem, SE-75123 Uppsala, Sweden; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Institute of Science & Technology (KIST); Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kim, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Kusung Dong, Taejon 305701, South Korea.	hskim76@kaist.ac.kr	Kim, Hak-Sung/C-1929-2011; Park, Hee-Sung/C-2042-2011					Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Cheon YH, 2004, BIOCHEMISTRY-US, V43, P7413, DOI 10.1021/bi036330o; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Joerger AC, 2003, P NATL ACAD SCI USA, V100, P5694, DOI 10.1073/pnas.0531477100; Leopoldseder S, 2004, J MOL BIOL, V337, P871, DOI 10.1016/j.jmb.2004.01.062; Park HS, 2004, METHOD ENZYMOL, V388, P187; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Tang LX, 2005, BIOCHEMISTRY-US, V44, P6609, DOI 10.1021/bi047613z; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524; Zang TM, 2001, J BIOL CHEM, V276, P4788, DOI 10.1074/jbc.M005090200	18	194	211	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					535	538		10.1126/science.1118953	http://dx.doi.org/10.1126/science.1118953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439663				2022-12-01	WOS:000235071400049
J	Ferres-Marco, D; Gutierrez-Garcia, I; Vallejo, DM; Bolivar, J; Gutierrez-Avino, FJ; Dominguez, M				Ferres-Marco, D; Gutierrez-Garcia, I; Vallejo, DM; Bolivar, J; Gutierrez-Avino, FJ; Dominguez, M			Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing	NATURE			English	Article							DROSOPHILA EYE; METHYLTRANSFERASE ACTIVITY; PIPSQUEAK PROTEIN; LOLA ENCODES; BTB-DOMAIN; HISTONE H3; METHYLATION; CANCER; DNA; POLYCOMB	Cancer is both a genetic and an epigenetic disease. Inactivation of tumour-suppressor genes by epigenetic changes is frequently observed in human cancers, particularly as a result of the modifications of histones and DNA methylation. It is therefore important to understand how these damaging changes might come about. By studying tumorigenesis in the Drosophila eye, here we identify two Polycomb group epigenetic silencers, Pipsqueak and Lola, that participate in this process. When coupled with overexpression of Delta, deregulation of the expression of Pipsqueak and Lola induces the formation of metastatic tumours. This phenotype depends on the histone-modifying enzymes Rpd3 ( a histone deacetylase), Su(var)3-9 and E(z), as well as on the chromodomain protein Polycomb. Expression of the gene Retinoblastoma-family protein (Rbf) is downregulated in these tumours and, indeed, this downregulation is associated with DNA hypermethylation. Together, these results establish a mechanism that links the Notch - Delta pathway, epigenetic silencing pathways and cell-cycle control in the process of tumorigenesis.	CSIC, UMH, Inst Neurosci, Alicante, Spain; Univ Cadiz, Fac Ciencias, Dept Bioquim & Biol Mol, Puerto Real 11510, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Universidad de Cadiz	Dominguez, M (corresponding author), CSIC, UMH, Inst Neurosci, Campus San Juan,Apartado 18, Alicante, Spain.	m.dominguez@umh.es	Dominguez, Maria/G-2171-2014; Martínez, Diana Marcela Vallejo/AAE-8516-2019; BOLIVAR, JORGE/G-4322-2015; Ferres-Marco, Maria/G-8364-2015; Martínez, Diana Marcela Vallejo/AAE-7604-2019	Dominguez, Maria/0000-0002-3329-7862; BOLIVAR, JORGE/0000-0002-2645-9528; Ferres-Marco, Maria/0000-0002-0596-4891; Martínez, Diana Marcela Vallejo/0000-0003-0447-4265; Gutierrez Avino, Francisco Jose/0000-0002-9428-0765				Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Horowitz H, 1996, DEVELOPMENT, V122, P1859; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Janody F, 2004, GENETICS, V166, P187, DOI 10.1534/genetics.166.1.187; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Madden K, 1999, DEV BIOL, V213, P301, DOI 10.1006/dbio.1999.9399; Marhold J, 2004, DEVELOPMENT, V131, P6033, DOI 10.1242/dev.01531; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nguyen CT, 2002, CANCER RES, V62, P6456; Ohsako T, 2003, GENE, V311, P59, DOI 10.1016/S0378-1119(03)00554-7; Reddy MN, 2003, ONCOGENE, V22, P6301, DOI 10.1038/sj.onc.1206650; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rorth P, 1998, DEVELOPMENT, V125, P1049; Salzberg A, 2004, BIOCHEM BIOPH RES CO, V322, P465, DOI 10.1016/j.bbrc.2004.07.134; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; SIEGEL V, 1993, DEVELOPMENT, V119, P1187; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tie F, 2001, DEVELOPMENT, V128, P275; Toba G, 1999, GENETICS, V151, P725; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Weber U, 1995, EMBO J, V14, P6247, DOI 10.1002/j.1460-2075.1995.tb00315.x; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woodhouse EC, 2004, CELL CYCLE, V3, P38	50	165	168	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					430	436		10.1038/nature04376	http://dx.doi.org/10.1038/nature04376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437107				2022-12-01	WOS:000234859200037
J	Devine, JA; Baker, KD; Haedrich, RL				Devine, JA; Baker, KD; Haedrich, RL			Deep-sea fishes qualify as endangered	NATURE			English	Editorial Material							ATLANTIC		Mem Univ Newfoundland, Dept Biol, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Devine, JA (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF A1C 5S7, Canada.	jdevine@mun.ca						Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Haedrich RL, 2001, FISH RES, V51, P113, DOI 10.1016/S0165-7836(01)00239-9; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Moore JA, 1999, FISHERIES, V24, P22; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; *WORLD CONS UN, 2001, IUCN RED LIST CAT CR	9	180	188	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 5	2006	439	7072					29	29		10.1038/439029a	http://dx.doi.org/10.1038/439029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397489	Bronze			2022-12-01	WOS:000234378700024
J	Yin, HS; Wen, XL; Paterson, RG; Lamb, RA; Jardetzky, TS				Yin, HS; Wen, XL; Paterson, RG; Lamb, RA; Jardetzky, TS			Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation	NATURE			English	Article							PARAMYXOVIRUS FUSION PROTEIN; VIRAL MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; INFLUENZA-VIRUS; NIPAH VIRUS; HEMAGGLUTININ; RECEPTOR; ACTIVATION; BINDING; DOMAIN	Enveloped viruses have evolved complex glycoprotein machinery that drives the fusion of viral and cellular membranes, permitting entry of the viral genome into the cell. For the paramyxoviruses, the fusion ( F) protein catalyses this membrane merger and entry step, and it has been postulated that the F protein undergoes complex refolding during this process. Here we report the crystal structure of the parainfluenza virus 5 F protein in its prefusion conformation, stabilized by the addition of a carboxy-terminal trimerization domain. The structure of the F protein shows that there are profound conformational differences between the pre- and postfusion states, involving transformations in secondary and tertiary structure. The positions and structural transitions of key parts of the fusion machinery, including the hydrophobic fusion peptide and two helical heptad repeat regions, clarify the mechanism of membrane fusion mediated by the F protein.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Jardetzky, TS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	tedj@northwestern.edu						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Calder LJ, 2000, VIROLOGY, V271, P122, DOI 10.1006/viro.2000.0279; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen B, 2004, J VIROL, V78, P4508, DOI 10.1128/JVI.78.9.4508-4516.2004; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Ito M, 2000, J GEN VIROL, V81, P719, DOI 10.1099/0022-1317-81-3-719; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi SB, 1998, VIROLOGY, V248, P20, DOI 10.1006/viro.1998.9242; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Paterson RG, 2000, VIROLOGY, V270, P17, DOI 10.1006/viro.2000.0267; PATERSON RG, 1989, J VIROL, V63, P1293, DOI 10.1128/JVI.63.3.1293-1301.1989; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Strokopytov BV, 2005, ACTA CRYSTALLOGR D, V61, P285, DOI 10.1107/S0907444904033037; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsurudome M, 2001, J VIROL, V75, P8999, DOI 10.1128/JVI.75.19.8999-9009.2001; Waning DL, 2004, P NATL ACAD SCI USA, V101, P9217, DOI 10.1073/pnas.0403339101; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yanagi Y, 2002, VIROLOGY, V299, P155, DOI 10.1006/viro.2002.1471; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102	49	337	378	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					38	44		10.1038/nature04322	http://dx.doi.org/10.1038/nature04322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397490	Green Published			2022-12-01	WOS:000234378700028
J	Polyn, SM; Natu, VS; Cohen, JD; Norman, KA				Polyn, SM; Natu, VS; Cohen, JD; Norman, KA			Category-specific cortical activity precedes retrieval during memory search	SCIENCE			English	Article							REPRESENTATION; RECOGNITION	Here we describe a functional magnetic resonance imaging study of humans engaged in memory search during a free recall task. Patterns of cortical activity associated with the study of three categories of pictures (faces, locations, and objects) were identified by a pattern-classification algorithm. The algorithm was used to track the reappearance of these activity patterns during the recall period. The reappearance of a given category's activity pattern correlates with verbal recalls made from that category and precedes the recall event by several seconds. This result is consistent with the hypothesis that category-specific activity is cueing the memory system to retrieve studied items.	Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University; Princeton University	Polyn, SM (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	polyn@psych.upenn.edu		Natu, Vaidehi/0000-0001-8012-2822	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052864, R01MH069456] Funding Source: NIH RePORTER; NIMH NIH HHS [MH070177-01, R01MH052864, R01MH069456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1993, CURR DIR PSYCHOL SCI, V2, P67, DOI [DOI 10.1111/1467-8721.EP10770899, 10.1111/1467-8721.ep10770899]; Bartlett F.C., 1995, REMEMBERING STUDY EX, DOI 10.1017/CBO9780511759185; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McClelland J. L., 1986, PARALLEL DISTRIBUTED, P170; McClelland JL, 1995, MEMORY DISTORTION, P69; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; NORMAN KA, 1996, IMPLICIT MEMORY META; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; SHIFFRIN RM, 1990, J EXP PSYCHOL LEARN, V16, P179, DOI 10.1037/0278-7393.16.2.179; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Smith S.M., 1988, MEMORY CONTEXT CONTE, P13; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125	24	445	456	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1963	1966		10.1126/science.1117645	http://dx.doi.org/10.1126/science.1117645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373577				2022-12-01	WOS:000234275400045
J	Nierman, WC; Pain, A; Anderson, MJ; Wortman, JR; Kim, HS; Arroyo, J; Berriman, M; Abe, K; Archer, DB; Bermejo, C; Bennett, J; Bowyer, P; Chen, D; Collins, M; Coulsen, R; Davies, R; Dyer, PS; Farman, M; Fedorova, N; Fedorova, N; Feldblyum, TV; Fischer, R; Fosker, N; Fraser, A; Garcia, JL; Garcia, MJ; Goble, A; Goldman, GH; Gomi, K; Griffith-Jones, S; Gwilliam, R; Haas, B; Haas, H; Harris, D; Horiuchi, H; Huang, J; Humphray, S; Jimenez, J; Keller, N; Khouri, H; Kitamoto, K; Kobayashi, T; Konzack, S; Kulkarni, R; Kumagai, T; Lafton, A; Latge, JP; Li, WX; Lord, A; Majoros, WH; May, GS; Miller, BL; Mohamoud, Y; Molina, M; Monod, M; Mouyna, I; Mulligan, S; Murphy, L; O'Neil, S; Paulsen, I; Penalva, MA; Pertea, M; Price, C; Pritchard, BL; Quail, MA; Rabbinowitsch, E; Rawlins, N; Rajandream, MA; Reichard, U; Renauld, H; Robson, GD; de Cordoba, SR; Rodriguez-Pena, JM; Ronning, CM; Rutter, S; Salzberg, SL; Sanchez, M; Sanchez-Ferrero, JC; Saunders, D; Seeger, K; Squares, R; Squares, S; Takeuchi, M; Tekaia, F; Turner, G; de Aldana, CRV; Weidman, J; White, O; Woodward, J; Yu, JH; Fraser, C; Galagan, JE; Asai, K; Machida, M; Hall, N; Barrell, B; Denning, DW				Nierman, WC; Pain, A; Anderson, MJ; Wortman, JR; Kim, HS; Arroyo, J; Berriman, M; Abe, K; Archer, DB; Bermejo, C; Bennett, J; Bowyer, P; Chen, D; Collins, M; Coulsen, R; Davies, R; Dyer, PS; Farman, M; Fedorova, N; Fedorova, N; Feldblyum, TV; Fischer, R; Fosker, N; Fraser, A; Garcia, JL; Garcia, MJ; Goble, A; Goldman, GH; Gomi, K; Griffith-Jones, S; Gwilliam, R; Haas, B; Haas, H; Harris, D; Horiuchi, H; Huang, J; Humphray, S; Jimenez, J; Keller, N; Khouri, H; Kitamoto, K; Kobayashi, T; Konzack, S; Kulkarni, R; Kumagai, T; Lafton, A; Latge, JP; Li, WX; Lord, A; Majoros, WH; May, GS; Miller, BL; Mohamoud, Y; Molina, M; Monod, M; Mouyna, I; Mulligan, S; Murphy, L; O'Neil, S; Paulsen, I; Penalva, MA; Pertea, M; Price, C; Pritchard, BL; Quail, MA; Rabbinowitsch, E; Rawlins, N; Rajandream, MA; Reichard, U; Renauld, H; Robson, GD; de Cordoba, SR; Rodriguez-Pena, JM; Ronning, CM; Rutter, S; Salzberg, SL; Sanchez, M; Sanchez-Ferrero, JC; Saunders, D; Seeger, K; Squares, R; Squares, S; Takeuchi, M; Tekaia, F; Turner, G; de Aldana, CRV; Weidman, J; White, O; Woodward, J; Yu, JH; Fraser, C; Galagan, JE; Asai, K; Machida, M; Hall, N; Barrell, B; Denning, DW			Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus	NATURE			English	Article							CELL-WALL; SACCHAROMYCES-CEREVISIAE; GENE-CLUSTER; SENSITIZATION; ARSENITE; COMPOST	Aspergillus fumigatus is exceptional among microorganisms in being both a primary and opportunistic pathogen as well as a major allergen(1-3). Its conidia production is prolific, and so human respiratory tract exposure is almost constant(4). A. fumigatus is isolated from human habitats(5) and vegetable compost heaps(6,7). In immunocompromised individuals, the incidence of invasive infection can be as high as 50% and the mortality rate is often about 50% (ref. 2). The interaction of A. fumigatus and other airborne fungi with the immune system is increasingly linked to severe asthma and sinusitis(8). Although the burden of invasive disease caused by A. fumigatus is substantial, the basic biology of the organism is mostly obscure. Here we show the complete 29.4-megabase genome sequence of the clinical isolate Af293, which consists of eight chromosomes containing 9,926 predicted genes. Microarray analysis revealed temperature-dependent expression of distinct sets of genes, as well as 700 A. fumigatus genes not present or significantly diverged in the closely related sexual species Neosartorya fischeri, many of which may have roles in the pathogenicity phenotype. The Af293 genome sequence provides an unparalleled resource for the future understanding of this remarkable fungus.	Inst Genom Res, Rockville, MD 20850 USA; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Manchester M13 9PT, Lancs, England; Univ Complutense Madrid, Dept Microbiol 2, E-28040 Madrid, Spain; Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808555, Japan; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; European Bioinformat Inst, Hinxton CB10 1SD, England; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; CSIC, Ctr Invest Biol, Madrid 28040, Spain; Univ Salamanca, Dept Genet & Microbiol, Salamanca 37007, Spain; Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-05508 Sao Paulo, Brazil; Innsbruck Med Univ, Dept Mol Biol, A-6020 Innsbruck, Austria; Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi 4648601, Japan; Natl Inst Adv Ind Sci 7 Technol AIST, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; Inst Pasteur, INRA USC 2019, Unite Postulante Biol & Pathogen Fong, F-75015 Paris, France; Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Univ Idaho, Ctr Reprod Biol, Dept Microbiol, Moscow, ID 83844 USA; Univ Idaho, Ctr Reprod Biol, Dept Mol Biol & Biochem, Moscow, ID 83844 USA; CHU Vaudois, Dept Dermatol, CH-1011 Lausanne, Switzerland; Univ Gottingen, Dept Bacteriol, D-37077 Gottingen, Germany; Tokyo Univ Agr & Technol, Tokyo 1830054, Japan; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan	J. Craig Venter Institute; George Washington University; Wellcome Trust Sanger Institute; University of Manchester; University of Manchester; Complutense University of Madrid; Tohoku University; University of Nottingham; Tulane University; European Molecular Biology Laboratory (EMBL); University of Kentucky; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Salamanca; Universidade de Sao Paulo; Medical University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Nagoya University; National Institute of Advanced Industrial Science & Technology (AIST); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Texas System; UTMD Anderson Cancer Center; Idaho; University of Idaho; Idaho; University of Idaho; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Gottingen; Tokyo University of Agriculture & Technology; University of Sheffield; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; National Institute of Advanced Industrial Science & Technology (AIST)	Nierman, WC (corresponding author), Inst Genom Res, Rockville, MD 20850 USA.	wnierman@tigr.org	Denning, David/AAC-6931-2019; Arroyo, Javier/E-9308-2016; de Aldana, Carlos Vazquez/B-7772-2008; Molina, Maria/F-7939-2015; Pertea, Mihaela/AAT-2705-2021; Tekaia, Fredj/H-4553-2012; Berriman, Matthew/A-7618-2011; Salzberg, Steven/Q-6514-2019; Goldman, Gustavo Henrique/F-1848-2013; Paulsen, Ian T/K-3832-2012; Molina, Maria/ABE-7186-2021; Salzberg, Steven L/F-6162-2011; Kobayashi, Tetsuo/I-6901-2014; Kim, Heenam Stanley/L-2279-2016; Quail, michael/ABE-6131-2020; Penalva, Miguel A/G-2295-2015; Rodriguez-Peña, Jose M/E-9624-2016; Abrams, Natalie/AAM-5468-2021; Jiménez, Javier/ABE-1795-2020; mouyna, isabelle/F-3578-2011; Asai, Kiyoshi/AAT-8344-2020; Pain, Arnab/L-5766-2015; Latge, Jean Paul/C-9846-2014; Mouyna, Isabelle/O-7697-2018; Abrams, Natalie/F-4845-2011; Hall, Neil/A-8717-2013; TAKEUCHI, Michio/H-6592-2013; de Cordoba, Santiago Rodriguez/K-6727-2014; Rawlings, Neil/M-5566-2013; Griffiths-Jones, Sam/H-2998-2014; Garcia Lopez, Jose Luis/G-9139-2015	Denning, David/0000-0001-5626-2251; Arroyo, Javier/0000-0002-1971-1721; de Aldana, Carlos Vazquez/0000-0002-4513-3654; Molina, Maria/0000-0003-0074-3309; Pertea, Mihaela/0000-0003-0762-8637; Berriman, Matthew/0000-0002-9581-0377; Salzberg, Steven/0000-0002-8859-7432; Goldman, Gustavo Henrique/0000-0002-2986-350X; Paulsen, Ian T/0000-0001-9015-9418; Molina, Maria/0000-0003-0074-3309; Salzberg, Steven L/0000-0002-8859-7432; Kobayashi, Tetsuo/0000-0002-4008-454X; Kim, Heenam Stanley/0000-0003-4856-3518; Penalva, Miguel A/0000-0002-3102-2806; Rodriguez-Peña, Jose M/0000-0002-8792-362X; Abrams, Natalie/0000-0001-9698-2819; Jiménez, Javier/0000-0002-0402-4427; Asai, Kiyoshi/0000-0003-0909-4982; Pain, Arnab/0000-0002-1755-2819; Mouyna, Isabelle/0000-0003-3140-5927; Abrams, Natalie/0000-0001-9698-2819; Hall, Neil/0000-0002-7995-3810; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Murphy, Lee/0000-0001-6467-7449; GARCIA SALGADO, MARIA JESUS/0000-0001-6921-8938; Rawlings, Neil/0000-0001-5557-7665; Fraser, Claire/0000-0003-1462-2428; Griffiths-Jones, Sam/0000-0001-6043-807X; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Yates, Bethan/0000-0003-1658-1762; Wortman, Jennifer/0000-0002-8713-1227; Dyer, Paul/0000-0003-0237-026X; Galagan, James/0000-0003-0542-3291; Yu, Jae-Hyuk/0000-0002-6530-8407; Robson, Geoff/0000-0003-4959-042X; bowyer, paul/0000-0002-1083-9286; Tekaia, Fredj/0000-0003-1934-2396; Hall, Neil/0000-0003-2808-0009	Biotechnology and Biological Sciences Research Council [CFB17726] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amin S, 2004, MICROBIOL-SGM, V150, P1937, DOI 10.1099/mic.0.26830-0; Beffa T, 1998, MED MYCOL, V36, P137; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; BLYTH W, 1977, CLIN ALLERGY, V7, P549, DOI 10.1111/j.1365-2222.1977.tb01485.x; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Hirsch T, 2000, ALLERGY, V55, P79, DOI 10.1034/j.1398-9995.2000.00250.x; Kim H, 2002, BIOTECHNIQUES, V33, P924, DOI 10.2144/02334mt06; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kodzius R, 2003, COMB CHEM HIGH T SCR, V6, P147, DOI 10.2174/1386207033329751; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Thrane C, 2004, FUNGAL GENET BIOL, V41, P361, DOI 10.1016/j.fgb.2003.11.003; Weichel M, 2003, CLIN EXP ALLERGY, V33, P72, DOI 10.1046/j.1365-2222.2003.01574.x; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhou SG, 2003, GENOME RES, V13, P2142, DOI 10.1101/gr.1128803; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	28	1025	2007	2	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1151	1156		10.1038/nature04332	http://dx.doi.org/10.1038/nature04332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372009	Green Submitted, Bronze			2022-12-01	WOS:000234111500050
J	Salter, MG; Fern, R				Salter, MG; Fern, R			NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; RAT OPTIC-NERVE; MULTIPLE-SCLEROSIS; WHITE-MATTER; GLUTAMATE RELEASE; CELL-DEATH; LINEAGE; EXCITOTOXICITY; VULNERABILITY; ASTROCYTES	Injury to oligodendrocyte processes, the structures responsible for myelination, is implicated in many forms of brain disorder(1-4). Here we show NMDA (N-methyl-D-aspartate) receptor subunit expression on oligodendrocyte processes, and the presence of NMDA receptor subunit messenger RNA in isolated white matter. NR1, NR2A, NR2B, NR2C, NR2D and NR3A subunits showed clustered expression in cell processes, but NR3B was absent. During modelled ischaemia, NMDA receptor activation resulted in rapid Ca2+-dependent detachment and disintegration of oligodendroglial processes in the white matter of mice expressing green fluorescent protein (GFP) specifically in oligodendrocytes (CNP-GFP mice). This effect occurred at mouse ages corresponding to both the initiation and the conclusion of myelination. NR1 subunits were found mainly in oligodendrocyte processes, whereas AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptor subunits were mainly found in the somata. Consistent with this observation, injury to the somata was prevented by blocking AMPA/kainate receptors, and preventing injury to oligodendroglial processes required the blocking of NMDA receptors. The presence of NMDA receptors in oligodendrocyte processes explains why previous studies that have focused on the somata have not detected a role for NMDA receptors in oligodendrocyte injury. These NMDA receptors bestow a high sensitivity to acute injury and represent an important new target for drug development in a variety of brain disorders.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Fern, R (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rf34@le.ac.uk		fern, robert/0000-0002-0625-3434				Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; BUTT AM, 1993, J COMP NEUROL, V338, P141, DOI 10.1002/cne.903380110; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Ludwin S K, 1981, Adv Neurol, V31, P123; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; RODRIGUEZ M, 1993, MAYO CLIN PROC, V68, P627, DOI 10.1016/S0025-6196(12)60597-7; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wilke SR, 2004, J NEUROPATH EXP NEUR, V63, P872, DOI 10.1093/jnen/63.8.872; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Ziak D, 1998, PHYSIOL RES, V47, P365	28	406	426	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1167	1171		10.1038/nature04301	http://dx.doi.org/10.1038/nature04301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372012				2022-12-01	WOS:000234111500053
J	Bhat, N; Wright, JG; Broder, KR; Murray, EL; Greenberg, ME; Glover, MJ; Likos, AM; Posey, DL; Klimov, A; Lindstrom, SE; Balish, A; Medina, MJ; Wallis, TR; Guarner, J; Paddock, CD; Shieh, WJ; Zaki, SR; Sejvar, JJ; Shay, DK; Harper, SA; Cox, NJ; Fukuda, K; Uyeki, TM				Bhat, N; Wright, JG; Broder, KR; Murray, EL; Greenberg, ME; Glover, MJ; Likos, AM; Posey, DL; Klimov, A; Lindstrom, SE; Balish, A; Medina, MJ; Wallis, TR; Guarner, J; Paddock, CD; Shieh, WJ; Zaki, SR; Sejvar, JJ; Shay, DK; Harper, SA; Cox, NJ; Fukuda, K; Uyeki, TM		Influenza Special Investigations T	Influenza-associated deaths among children in the United States, 2003-2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; OUTPATIENT VISITS; HOSPITALIZATIONS; MORTALITY; INFANTS; INFECTION; ILLNESS; BURDEN	BACKGROUND: Although influenza is common among children, pediatric mortality related to laboratory-confirmed influenza has not been assessed nationally. METHODS: During the 2003-2004 influenza season, we requested that state health departments report any death associated with laboratory-confirmed influenza in a U.S. resident younger than 18 years of age. Case reports, medical records, and autopsy reports were reviewed, and available influenza-virus isolates were analyzed at the Centers for Disease Control and Prevention. RESULTS: One hundred fifty-three influenza-associated deaths among children were reported by 40 state health departments. The median age of the children was three years, and 96 of them (63 percent) were younger than five years old. Forty-seven of the children (31 percent) died outside a hospital setting, and 45 (29 percent) died within three days after the onset of illness. Bacterial coinfections were identified in 24 of the 102 children tested (24 percent). Thirty-three percent of the children had an underlying condition recognized to increase the risk of influenza-related complications, and 20 percent had other chronic conditions; 47 percent had previously been healthy. Chronic neurologic or neuromuscular conditions were present in one third. The mortality rate was highest among children younger than six months of age (0.88 per 100,000 children; 95 percent confidence interval, 0.52 to 1.39 per 100,000). CONCLUSIONS: A substantial number of influenza-associated deaths occurred among U.S. children during the 2003-2004 influenza season. High priority should be given to improvements in influenza-vaccine coverage and improvements in the diagnosis and treatment of influenza to reduce childhood mortality from influenza.	CDC, Epidem Intelligence Serv,Career Dev Div, Off Workforce & Career Dev, Div Viral & Rickettsial Div,Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDC, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDC, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bhat, N (corresponding author), CDC, Epidem Intelligence Serv,Career Dev Div, Off Workforce & Career Dev, Div Viral & Rickettsial Div,Natl Ctr Infect Dis, Mailstop A-32,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	nbhat@cdc.gov	Greenberg, Michael E/AGZ-9651-2022; Guarner, Jeannette/B-8273-2013; Fischer, Thea K/AAH-9892-2019	Guarner, Jeannette/0000-0001-5610-3541; Fischer, Thea K/0000-0003-4812-980X; Shay, David/0000-0001-9619-4820; Fukuda, Keiji/0000-0002-9598-9565				BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; BRIDGES CB, 2003, MMWR-MORBID MORTAL W, V52, P526; BROCKLEBANK JT, 1972, LANCET, V2, P497; *CDCP, 2005, 2004 05 US INFL SEAS; *CENS BUR, 2003, ANN EST POP SEX RAC; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P837; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Council of State and Territorial Epidemiologists, 2004, INFL ASS PED MORT; *EM INF PROGR NETW, 2004, STREPT PNEUM 2003 AC; Erhart LM, 2004, J PEDIATR-US, V144, P191, DOI 10.1016/j.jpeds.2003.11.007; Gindler J, 2004, J INFECT DIS, V189, pS69, DOI 10.1086/378565; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; HAMILTON BE, 2004, DHHS PUBLICATION; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kappagoda C, 2000, J PAEDIATR CHILD H, V36, P318, DOI 10.1046/j.1440-1754.2000.00507.x; Kendal AP, 1982, CONCEPTS PROCEDURES; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shui I., 2004, Morbidity and Mortality Weekly Report, V52, P1286; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; VARGOSKO AJ, 1959, NEW ENGL J MED, V261, P1, DOI 10.1056/NEJM195907022610101; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; 2004, MMWR MORB MORTAL WKL, V52, P1254	36	475	508	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2559	2567		10.1056/NEJMoa051721	http://dx.doi.org/10.1056/NEJMoa051721			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993BA	16354892				2022-12-01	WOS:000233926500005
J	Laumon, B; Gadegbeku, B; Martin, JL; Biecheler, MB				Laumon, B; Gadegbeku, B; Martin, JL; Biecheler, MB		SAM Grp	Cannabis intoxication and fatal road crashes in France: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							MOTOR-VEHICLE CRASHES; RESPONSIBILITY ANALYSIS; DRIVER CULPABILITY; ATTRIBUTABLE RISK; TRAFFIC CRASHES; INJURED DRIVERS; ALCOHOL; DRUGS; BENZODIAZEPINES; STIMULANTS	Objectives To evaluate the relative risk of being responsible for a fatal crash while driving under die influence of cannabis, the prevalence of such drivers within the driving population, and the corresponding share of fatal crashes. Design Population based case-control study. Participants 10 748 drivers, with known drug and alcohol concentrations, who were involved in fatal crashes in France from October 2001 to September 2003. Main outcome measures The cases were the 6766 drivers considered at fault in their crash; the controls were 3006 drivers selected from the 3982 other drivers. Positive detection of cannabis was defined as a blood concentration of Delta(9) tetrahydrocannabinol of over 1 ng/ml. The prevalence of positive drivers in the driving population was estimated by standardising controls off drivers not at fault who were involved in crashes resulting in slight injuries. Results 681 drivers were positive for cannabis (cases 8.8%, controls 2.8% including 285 with an illegal blood alcohol concentration (>= 0.5 g/l). Positive cannabis detection was associated with increased risk of responsibility (odds ratio 3.32, 95% confidence interval 2.63 to 4.18). A significant dose effect was identified; the odds ratio increased from 2.18 (1.22 to 3.89) if 0 < Delta(9) tetrahydrocarmabinol < 1 ng/ml to 4.72 (3.04 to 7.33) if Delta(9) tetrahydrocarniabinol >= 5 ng/ml. The effect of cannabis remains significant after adjustment for different cofactors, including alcohol, with which no statistical interaction was observed. The prevalence of cannabis (2.9%) estimated for the driving population is similar to that for alcohol (2.7%). At least 2.5% (1.5% to 3.5%) of fatal crashes were estimated as being attributable to cannabis, compared with 28.6% for alcohol (26.8% to 30.5%). Conclusions Driving under the influence of cannabis increases the risk of involvement in a crash. However, in France its share in fatal crashes is significantly lower than that associated with positive blood alcohol concentration.	French Natl Inst Transport & Safety Res INRETS, Epidemiol Res & Surveillance Unit Transport Occup, F-69675 Bron, France; Univ Lyon 1, INRETS, Inst Veille Sanitaire InVS UMRESTTE, F-69622 Villeurbanne, France	Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS); Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS)	Laumon, B (corresponding author), French Natl Inst Transport & Safety Res INRETS, Epidemiol Res & Surveillance Unit Transport Occup, 25 Ave Francois Mitterrand, F-69675 Bron, France.	bernard.laumon@inrets.fr	Gadegbeku, Blandine/AAE-3618-2019; Martin, Jean-Louis/X-6588-2019	Gadegbeku, Blandine/0000-0001-6720-206X; Martin, Jean-Louis/0000-0002-3426-9601				ASSAILLY JP, 2002, CONDUITE AUTOMOBILE, P87; Bates MN, 1999, EPIDEMIOL REV, V21, P222, DOI 10.1093/oxfordjournals.epirev.a017998; Berghaus G., 1995, P 13 INT C ALC DRUGS, P403; Breslow NE, 1980, STAT METHODS CANC RE; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; Davis G. A., 1993, TRANSPORT RES REC, V1401, P43; DiCiccio TJ, 1996, STAT SCI, V11, P189; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Drummer OH, 2003, FORENSIC SCI INT, V134, P154, DOI 10.1016/S0379-0738(03)00134-8; DUSSAULT C, 2002, ALCOHOL DRUGS TRAFFI, P423; Evans Leonard, 1991, TRAFFIC SAFETY DRIVE; Everett SA, 1999, ACCIDENT ANAL PREV, V31, P667, DOI 10.1016/S0001-4575(99)00027-5; HUESTIS MA, 1992, J ANAL TOXICOL, V16, P276, DOI 10.1093/jat/16.5.276; *INSERM, 2001, CANN QUELS EFF COMP, P165; LATNERS C, 2000, 809020 US DOT HS NAT; LAUMON B, 2005, STUPEFIANTS ACCIDE 3; Liguori A, 1998, BEHAV PHARMACOL, V9, P599, DOI 10.1097/00008877-199811000-00015; Llorca J, 2000, STAT MED, V19, P1089, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1089::AID-SIM411>3.0.CO;2-0; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P623, DOI 10.1016/S0001-4575(99)00110-4; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P613, DOI 10.1016/S0001-4575(99)00111-6; Mann RE, 2003, IMPACTS CANNABIS DRI; MOSKOWITZ H, 1985, ACCIDENT ANAL PREV, V17, P323, DOI 10.1016/0001-4575(85)90034-X; *ONISR, 2003, SEC ROUL FRANC BIL A, P137; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; ROBBE H, 1999, 808939 US DOT HS NAT; Roberts RG, 1994, AUSTR ABORIGINAL STU, V2, P2; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SEXTON B, 2000, 477 TRL, P106; SMILEY A, 1998, MARIJUANA ON ROAD DR, P526; TERHUNE KW, 1983, ACCIDENT ANAL PREV, V15, P237, DOI 10.1016/0001-4575(83)90024-6; VERSTRAETE A, 2004, ROAD TRAFFIC PSYCHOA, P155	32	199	207	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1371	1374		10.1136/bmj.38648.617986.1F	http://dx.doi.org/10.1136/bmj.38648.617986.1F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993ZO	16321993	Green Published, Bronze			2022-12-01	WOS:000233999300018
J	Sall, M; Sylla, J				Sall, M; Sylla, J			African Prime Ministers take lead in child survival	LANCET			English	Editorial Material												bndiaye@clm.sn						Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; *MIN SANT PREV MED, 2005, SEN ENQ DEM SANT 200; 2005, LANCET, V365, P2152	3	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					1988	1989		10.1016/S0140-6736(05)67796-3	http://dx.doi.org/10.1016/S0140-6736(05)67796-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991PW	16338438				2022-12-01	WOS:000233826900005
J	Rustichini, A				Rustichini, A			Emotion and reason in making decisions	SCIENCE			English	Editorial Material							MODEL UNCERTAINTY; AMBIGUITY; CHOICE		Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Rustichini, A (corresponding author), Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA.	arust@econ.umn.edu						Chamberlain G, 2001, AM ECON REV, V91, P55, DOI 10.1257/aer.91.2.55; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Epstein LG, 2001, AM ECON REV, V91, P45, DOI 10.1257/aer.91.2.45; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Hansen LP, 2001, AM ECON REV, V91, P60, DOI 10.1257/aer.91.2.60; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Sims CA, 2001, AM ECON REV, V91, P51, DOI 10.1257/aer.91.2.51; SNELL J, 2005, SOC NEUR M WASH DC 1	10	31	32	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1624	1625		10.1126/science.1122179	http://dx.doi.org/10.1126/science.1122179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993NV	16339434				2022-12-01	WOS:000233961700029
J	Ojha, A; Anand, M; Bhatt, A; Kremer, L; Jacobs, WR; Hatfull, GF				Ojha, A; Anand, M; Bhatt, A; Kremer, L; Jacobs, WR; Hatfull, GF			GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria	CELL			English	Article							KETOACYL-ACP SYNTHASE; HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; ISONIAZID RESISTANCE; CRYSTAL-STRUCTURE; TUBERCULOSIS; KASA; GENE; VIRULENCE; SMEGMATIS	Mycobacteria are unusual in encoding two GroEL paralogs, GroEL1 and GroEL2. GroEL2 is essential-presumably providing the housekeeping chaperone functions-while groEL1 is nonessential, contains the attB site for phage Bxb1 integration, and encodes a putative chaperone with unusual structural features. Inactivation of the Mycobacterium smegmatis groEL1 gene by phage Bxb1 integration allows normal planktonic growth but prevents the formation of mature biofilms. GroEL1 modulates synthesis of mycolates-long-chain fatty acid components of the mycobacterial cell wall-specifically during biofilm formation and physically associates with KasA, a key component of the type II Fatty Acid Synthase involved in mycolic acid synthesis. Biofilm formation is associated with elevated synthesis of short-chain (C-56-C-68) fatty acids, and strains with altered mycolate profiles-including an InhA mutant resistant to the antituberculosis drug isoniazid and a strain overexpressing KasA-are defective in biofilm formation.	UIiv Pittsburgh, Dept Biol Sci, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; Univ Montpellier 2, CNRS, UMR 5539, Lab Dynam Mol Interact Membranires, F-34095 Montpellier, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hatfull, GF (corresponding author), UIiv Pittsburgh, Dept Biol Sci, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Jacobs, William/0000-0003-3321-3080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI028927, R22AI026170, R01AI028927, R01AI026170, R37AI026170] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28927, AI26170] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barreiro C, 2005, J BACTERIOL, V187, P884, DOI 10.1128/JB.187.3.884-889.2005; Beloin C, 2005, TRENDS MICROBIOL, V13, P16, DOI 10.1016/j.tim.2004.11.008; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Coates Anthony R. M., 1996, P267, DOI 10.1016/B978-012237455-5/50011-7; Dosanjh NS, 2005, FEMS MICROBIOL LETT, V249, P87, DOI 10.1016/j.femsle.2005.06.004; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fisher MT, 1998, BIOCHEMISTRY-MOSCOW+, V63, P382; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grimaud R, 1998, J BACTERIOL, V180, P1148, DOI 10.1128/JB.180.5.1148-1153.1998; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; HARTL DL, 1992, GENETICA, V86, P47, DOI 10.1007/BF00133710; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P136, DOI 10.1073/pnas.75.1.136; HERMAN C, 2000, ENCY MICROBIOLOGY, P598; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; HUSSON RN, 1987, P NATL ACAD SCI USA, V84, P1679, DOI 10.1073/pnas.84.6.1679; Karlin S, 2000, P NATL ACAD SCI USA, V97, P11348, DOI 10.1073/pnas.97.21.11348; Kim AI, 2003, MOL MICROBIOL, V50, P463, DOI 10.1046/j.1365-2958.2003.03723.x; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; KONG TH, 1993, P NATL ACAD SCI USA, V90, P2608, DOI 10.1073/pnas.90.7.2608; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kressel AB, 2001, INFECT CONT HOSP EP, V22, P414, DOI 10.1086/501926; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lewis William M. Jr., 2000, Lakes Reservoirs Research and Management, V5, P35, DOI 10.1046/j.1440-1770.2000.00091.x; Lewthwaite JC, 2001, INFECT IMMUN, V69, P7349, DOI 10.1128/IAI.69.12.7349-7355.2001; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; OGAWA J, 1995, GENE DEV, V9, P714, DOI 10.1101/gad.9.6.714; ORME IM, 1993, J IMMUNOL, V151, P518; PRIMM TP, 2004, J BACTERIOL, V183, P5718; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Reguera G, 2005, J BACTERIOL, V187, P3551, DOI 10.1128/JB.187.10.3551-3555.2005; Rose L, 2004, MICROBES INFECT, V6, P965, DOI 10.1016/j.micinf.2004.05.011; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; SCHULZEROBBECKE R, 1992, TUBERCLE LUNG DIS, V73, P141, DOI 10.1016/0962-8479(92)90147-C; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Taneja B, 2001, PROTEIN ENG, V14, P391, DOI 10.1093/protein/14.6.391; Teng R, 2003, FEMS MICROBIOL LETT, V227, P171, DOI 10.1016/S0378-1097(03)00584-6; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x	70	269	275	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					861	873		10.1016/j.cell.2005.09.012	http://dx.doi.org/10.1016/j.cell.2005.09.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325580	Bronze			2022-12-01	WOS:000233814100019
J	Solter, D				Solter, D			Politically correct human embryonic stemm cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLASTOMERES		Max Planck Inst Immunbiol, Dept Dev Biol, D-7800 Freiburg, Germany	Max Planck Society	Solter, D (corresponding author), Max Planck Inst Immunbiol, Dept Dev Biol, Stubeweg 51, D-7800 Freiburg, Germany.		Solter, Davor/Q-5476-2019					CHUNG Y, IN PRESS NATURE; MEISSNER A, IN PRESS NATURE; MOORE NW, 1968, J REPROD FERTIL, V17, P527, DOI 10.1530/jrf.0.0170527; Wade Nicholas, 2005, NY TIMES        1017; WILLADSEN SM, 1981, J EMBRYOL EXP MORPH, V65, P165	5	21	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2321	2323		10.1056/NEJMp058283	http://dx.doi.org/10.1056/NEJMp058283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988EO	16319380				2022-12-01	WOS:000233574600003
J	Lin, JP; Balabin, IA; Beratan, DN				Lin, JP; Balabin, IA; Beratan, DN			The nature of aqueous tunneling pathways between electron-transfer proteins	SCIENCE			English	Article							TRANSFER SELF-EXCHANGE; CYTOCHROME-C; DYNAMICS; ELEMENT; WATER; B(5)	Structured water molecules near redox cofactors were found recently to accelerate electron-transfer (ET) kinetics in several systems. Theoretical study of interprotein electron transfer across an aqueous interface reveals three distinctive electronic coupling mechanisms that we describe here: (i) a protein-mediated regime when the two proteins are in van der Waals contact; (ii) a structured water-mediated regime featuring anomalously weak distance decay at relatively close protein-protein contact distances; and (iii) a bulk water-mediated regime at large distances. Our analysis explains a range of otherwise puzzling biological ET kinetic data and provides a framework for including explicit water-mediated tunneling effects on ET kinetics.	Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Dept Biochem, Durham, NC 27708 USA	Duke University; Duke University	Beratan, DN (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	david.beratan@duke.edu	Beratan, David N/C-5098-2011; Balabin, Ilya/P-2421-2019; Balabin, Ilya/B-3967-2013	Beratan, David N/0000-0003-4758-8676; Balabin, Ilya/0000-0001-6245-3855; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-048043, R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW SM, 1993, J AM CHEM SOC, V115, P5516, DOI 10.1021/ja00066a020; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; Barnett RN, 2001, SCIENCE, V294, P567, DOI 10.1126/science.1062864; Benjamin I, 1997, J CHEM PHYS, V106, P6647, DOI 10.1063/1.474079; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Berg J., 2002, BIOCHEMISTRY-US, V2002, P5; Blankenship RE, 2001, NAT STRUCT BIOL, V8, P94, DOI 10.1038/84191; DIXON DW, 1990, J AM CHEM SOC, V112, P1082, DOI 10.1021/ja00159a030; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HEGESH E, 1986, NEW ENGL J MED, V314, P757, DOI 10.1056/NEJM198603203141206; Jones ML, 2002, J PHYS CHEM A, V106, P2002, DOI 10.1021/jp0133743; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kawatsu T, 2002, J PHYS CHEM B, V106, P5068, DOI 10.1021/jp013975u; LARSSON S, 1984, J PHYS CHEM-US, V88, P1321, DOI 10.1021/j150651a016; Liang ZX, 2004, J AM CHEM SOC, V126, P2785, DOI 10.1021/ja038163l; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCLENDON G, 1992, CHEM REV, V92, P481, DOI 10.1021/cr00011a007; Miller NE, 1999, J PHYS CHEM A, V103, P1084, DOI 10.1021/jp983171n; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Newton MD, 1997, J ELECTROANAL CHEM, V438, P3, DOI 10.1016/S0022-0728(96)05025-5; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Onda K, 2005, SCIENCE, V308, P1154, DOI 10.1126/science.1109366; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Ponce A, 2000, J AM CHEM SOC, V122, P8187, DOI 10.1021/ja000017h; SIDDARTH P, 1993, J PHYS CHEM-US, V97, P13078, DOI 10.1021/j100152a008; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898; UTECHT RE, 1988, BIOCHIM BIOPHYS ACTA, V953, P164, DOI 10.1016/0167-4838(88)90021-0; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Verlet JRR, 2005, SCIENCE, V307, P93, DOI 10.1126/science.1106719; Wenger OS, 2005, SCIENCE, V307, P99, DOI 10.1126/science.1103818	38	201	207	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1311	1313		10.1126/science.1118316	http://dx.doi.org/10.1126/science.1118316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311331	Green Accepted			2022-12-01	WOS:000233600200036
J	Hayashi, K; Yoshida, K; Matsui, Y				Hayashi, K; Yoshida, K; Matsui, Y			A histone H3 methyltransferase controls epigenetic events required for meiotic prophase	NATURE			English	Article							CHROMOSOME SYNAPSIS; METHYLATION PATTERNS; ACTIVE GENES; MOUSE; MICE; HETEROCHROMATIN; PROTEINS; COMPLEX; TRANSCRIPTION; CHROMATIN	Epigenetic modifications of histones regulate gene expression and chromatin structure(1,2). Here we show that Meisetz (meiosis-induced factor containing a PR/SET domain and zinc-finger motif) is a histone methyltransferase that is important for the progression of early meiotic prophase. Meisetz transcripts are detected only in germ cells entering meiotic prophase in female fetal gonads and in postnatal testis. Notably, Meisetz has catalytic activity for trimethylation, but not mono- or dimethylation, of lysine 4 of histone H3, and a transactivation activity that depends on its methylation activity. Mice in which the Meisetz gene is disrupted show sterility in both sexes due to severe impairment of the double-stranded break repair pathway, deficient pairing of homologous chromosomes and impaired sex body formation. In Meisetz-deficient testis, trimethylation of lysine 4 of histone H3 is attenuated and meiotic gene transcription is altered. These findings indicate that meiosis-specific epigenetic events in mammals are crucial for proper meiotic progression.	Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Mol Embryol, Osaka 5941101, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Genet, Abeno Ku, Osaka 5458585, Japan; Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Sendai, Miyagi 9808575, Japan	Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tohoku University	Matsui, Y (corresponding author), Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Mol Embryol, Murodo Cho 840, Osaka 5941101, Japan.	ymatsui@idac.tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355				Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	28	353	372	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					374	378		10.1038/nature04112	http://dx.doi.org/10.1038/nature04112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292313				2022-12-01	WOS:000233300200052
J	Wu, WS; Heinrichs, S; Xu, D; Garrison, SP; Zambetti, GP; Adams, JM; Look, AT				Wu, WS; Heinrichs, S; Xu, D; Garrison, SP; Zambetti, GP; Adams, JM; Look, AT			Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma	CELL			English	Article							TRANSCRIPTION FACTORS SNAIL; RADIATION-THERAPY; BCL-2 FAMILY; CELL-DEATH; C-ELEGANS; P53; EXPRESSION; GENE; SURVIVAL; PROTEIN	In response to DNA damage, the p53 tumor suppressor can elicit either apoptosis or cell-cycle arrest and repair, but how this critical decision is made in specific cell types remains largely undefined. We investigated the mechanism by which the transcriptional repressor Slug specifically rescues hematopoietic progenitor cells from lethal doses of gamma radiation. We show that Slug is transcriptionally induced by p53 upon irradiation and then protects the damaged cell from apoptosis by directly repressing p53-mediated transcription of puma, a key BH3-only antagonist of the antiapoptotic Bcl-2 proteins. We established the physiologic significance of Slug-mediated repression of puma by demonstrating that mice deficient in both genes survive doses of total-body irradiation that lethally deplete hematopoietic progenitor populations in mice lacking only slug. Thus, Slug functions downstream of p53 in developing blood cells as a critical switch that prevents their apoptosis by antagonizing the trans-activation of puma by p53.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; St Jude Children's Research Hospital; Walter & Eliza Hall Institute	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Adams, Jerry M/E-1199-2013; Zambetti, Gerard/N-8093-2018; Wu, Wen-Shu/I-1258-2014	Zambetti, Gerard/0000-0002-0929-5007; Wu, Wen-Shu/0000-0002-0225-2522; Adams, Jerry/0000-0002-4360-8628	NATIONAL CANCER INSTITUTE [R01CA059571, F32CA103726] Funding Source: NIH RePORTER; NCI NIH HHS [CA-059571, CA103726] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; LEDOUARIN NM, 1994, CURR OPIN GENET DEV, V4, P685, DOI 10.1016/0959-437X(94)90135-P; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Werner-Wasik M, 2004, HEMATOL ONCOL CLIN N, V18, P131, DOI 10.1016/S0889-8588(03)00150-3; Yoshizawa H, 2003, BRIT J CANCER, V89, P803, DOI 10.1038/sj.bjc.6601227; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	40	334	362	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					641	653		10.1016/j.cell.2005.09.029	http://dx.doi.org/10.1016/j.cell.2005.09.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286009	Bronze			2022-12-01	WOS:000233497400013
J	Watanabe, M; Houten, SM; Mataki, C; Christoffolete, MA; Kim, BW; Sato, H; Messaddeq, N; Harney, JW; Ezaki, O; Kodama, T; Schoonjans, K; Bianco, AC; Auwerx, J				Watanabe, M; Houten, SM; Mataki, C; Christoffolete, MA; Kim, BW; Sato, H; Messaddeq, N; Harney, JW; Ezaki, O; Kodama, T; Schoonjans, K; Bianco, AC; Auwerx, J			Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation	NATURE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; NUCLEAR RECEPTOR; ADAPTIVE THERMOGENESIS; INSULIN-RESISTANCE; BROWN FAT; GENE; FXR; IDENTIFICATION; BIOSYNTHESIS; HEPATOCYTES	While bile acids (BAs) have long been known to be essential in dietary lipid absorption and cholesterol catabolism, in recent years an important role for BAs as signalling molecules has emerged. BAs activate mitogen-activated protein kinase pathways(1,2), are ligands for the G-protein-coupled receptor ( GPCR) TGR5(3,4) and activate nuclear hormone receptors such as farnesoid X receptor alpha ( FXR-alpha; NR1H4)(5-7). FXR-alpha regulates the enterohepatic recycling and biosynthesis of BAs by controlling the expression of genes such as the short heterodimer partner (SHP; NR0B2)(8,9) that inhibits the activity of other nuclear receptors. The FXR-alpha-mediated SHP induction also underlies the downregulation of the hepatic fatty acid and triglyceride biosynthesis and very-low-density lipoprotein production mediated by sterol-regulatory-element-binding protein 1c(10). This indicates that BAs might be able to function beyond the control of BA homeostasis as general metabolic integrators. Here we show that the administration of BAs to mice increases energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This novel metabolic effect of BAs is critically dependent on induction of the cyclic-AMP-dependent thyroid hormone activating enzyme type 2 iodothyronine deiodinase (D2) because it is lost in D2(-/-) mice. Treatment of brown adipocytes and human skeletal myocytes with BA increases D2 activity and oxygen consumption. These effects are independent of FXR-alpha, and instead are mediated by increased cAMP production that stems from the binding of BAs with the G-protein-coupled receptor TGR5. In both rodents and humans, the most thermogenically important tissues are specifically targeted by this mechanism because they coexpress D2 and TGR5. The BA - TGR5 - cAMP - D2 signalling pathway is therefore a crucial mechanism for fine-tuning energy homeostasis that can be targeted to improve metabolic control.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Brigham & Womens Hosp, Dept Med, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Natl Inst Hlth & Nutr, Div Clin Nutr, Shinjuku Ku, Tokyo 1628636, Japan; Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo 1538904, Japan; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institute of Health & Nutrition - Japan; University of Tokyo	Auwerx, J (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Bianco, Antonio C/A-4965-2008; Auwerx, Johan/ABE-9307-2021; Bianco, Antonio/AAK-6336-2020; Houten, Sander/Y-3599-2019	Bianco, Antonio C/0000-0001-7737-6813; Bianco, Antonio/0000-0001-7737-6813; Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393; Christoffolete, Marcelo/0000-0003-0374-0795; Schoonjans, Kristina/0000-0003-1247-4265				Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Branco M, 1999, AM J PHYSIOL-ENDOC M, V276, pE179, DOI 10.1152/ajpendo.1999.276.1.E179; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Cohen DE, 2003, HEPATOLOGY TXB LIVER, P1713; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; EVERSON GT, 1987, J LIPID RES, V28, P238; FAIN JN, 1967, J BIOL CHEM, V242, P1887; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HINUMA S, 2005, Patent No. 2003380574; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; IKEMOTO S, 1997, AM J PHYSIOL, V273, P37; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025	25	1476	1603	10	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					484	489		10.1038/nature04330	http://dx.doi.org/10.1038/nature04330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16400329				2022-12-01	WOS:000234859200049
J	Badano, JL; Leitch, CC; Ansley, SJ; May-Simera, H; Lawson, S; Lewis, RA; Beales, PL; Dietz, HC; Fisher, S; Katsanis, N				Badano, JL; Leitch, CC; Ansley, SJ; May-Simera, H; Lawson, S; Lewis, RA; Beales, PL; Dietz, HC; Fisher, S; Katsanis, N			Dissection of epistasis in oligogenic Bardet-Biedl syndrome	NATURE			English	Article							HUMAN OBESITY SYNDROME; HUMAN GENETIC-DISEASE; TRIALLELIC INHERITANCE; PROTEIN; MUTATIONS; BBS1; IDENTIFICATION; DISORDER	Epistatic interactions have an important role in phenotypic variability, yet the genetic dissection of such phenomena remains challenging(1). Here we report the identification of a novel locus, MGC1203, that contributes epistatic alleles to Bardet-Biedl syndrome (BBS), a pleiotropic, oligogenic disorder(2-9). MGC1203 encodes a pericentriolar protein that interacts and colocalizes with the BBS proteins. Sequencing of two independent BBS cohorts revealed a significant enrichment of a heterozygous C430T mutation in patients, and a transmission disequilibrium test (TDT) showed strong over-transmission of this variant. Further analyses showed that the 430T allele enhances the use of a cryptic splice acceptor site, causing the introduction of a premature termination codon (PTC) and the reduction of steady-state MGC1203 messenger RNA levels. Finally, recapitulation of the human genotypes in zebrafish shows that modest suppression of mgc1203 exerts an epistatic effect on the developmental phenotype of BBS morphants. Our data demonstrate how the combined use of biochemical, genetic and in vivo tools can facilitate the dissection of epistatic phenomena, and enhance our appreciation of the genetic basis of phenotypic variability.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21205 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Fisher, Shannon/K-7351-2012; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	May-Simera, Helen/0000-0002-9477-4036; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fauser S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e104; FU X, 1992, SCIENCE, V256, P533; Gabut M, 2005, MOL CELL BIOL, V25, P3286, DOI 10.1128/MCB.25.8.3286-3294.2005; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; KACSER H, 1981, GENETICS, V97, P639; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Lele Z, 2002, DEVELOPMENT, V129, P3281; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	30	202	212	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2006	439	7074					326	330		10.1038/nature04370	http://dx.doi.org/10.1038/nature04370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16327777				2022-12-01	WOS:000234682100043
J	Gibson, CS; MacLennan, AH; Goldwater, PN; Haan, EA; Priest, K; Dekker, GA				Gibson, CS; MacLennan, AH; Goldwater, PN; Haan, EA; Priest, K; Dekker, GA		S Australian Cerebral Palsy Res Gr	Neurotropic viruses and cerebral palsy: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							POLYMERASE-CHAIN-REACTION; AMNIOTIC-FLUID; PRETERM LABOR; CYTOMEGALOVIRUS-INFECTION; INHERITED THROMBOPHILIAS; INTRAUTERINE INFECTION; BRAIN-BARRIER; BIRTH; VARICELLA; PREGNANCY	Objective To investigate the association between cerebral palsy and direct evidence for perinatal exposure to neurotropic viruses. Design Population based case-control study. Setting Adelaide Women's and Children's Hospital Research Laboratory. Participants and main outcome measures Newborn screening cards of 443 white case patients with cerebral palsy and 883 white controls were tested for viral nucleic acids from enteroviruses and herpes viruses by using polymerase chain reaction. Herpes group A viruses included herpes simplex viruses I and 2 (HSV-1 and HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus 8 (HHV-8); herpes group B viruses included varicella zoster virus (VZV) and human herpes viruses 6 and 7 (HHV-6 and HHV-7). Results The prevalence of viral nucleic acids in the control population was high: 39.8% of controls tested positive, and the prevalence was highest in preterm babies. The detection of herpes group B viral nucleic acids increased the risk of developing cerebral palsy (odds ratio 1.68, 95% confidence interval 1.09 to 2.59). Conclusions Perinatal exposure to neurotropic viruses is associated with preterm delivery and cerebral palsy.	Univ Adelaide, Dept Obstet Gynaecol, Womens Childrens Hosp, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Microbiol & Infect Dis, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; Dept Hlth, Epidemiol Branch, Adelaide, SA 5000, Australia	University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide; Womens & Childrens Hospital Australia	Gibson, CS (corresponding author), Univ Adelaide, Dept Obstet Gynaecol, Womens Childrens Hosp, 1st Floor Queen Victoria Bldg,72 King William Rd, Adelaide, SA 5006, Australia.	catherine.s.gibson@adelaide.edu.au						ADINOLFI M, 1985, DEV MED CHILD NEUROL, V27, P532; Brown HL, 1998, SEMIN PERINATOL, V22, P260, DOI 10.1016/S0146-0005(98)80014-1; Corey RP, 2000, ARCH OPHTHALMOL-CHIC, V118, P837, DOI 10.1001/archopht.118.6.837; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; FOROUZAN I, 1992, OBSTET GYNECOL, V80, P535; Friese K, 2003, BJOG-INT J OBSTET GY, V110, P52, DOI 10.1016/S1470-0328(03)00025-9; Gibson CS, 2005, AM J OBSTET GYNECOL, V193, P1437, DOI 10.1016/j.ajog.2005.02.107; Gibson CS, 2005, PATHOLOGY, V37, P160, DOI 10.1080/00313020500058250; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HAMMAD E, 1989, ACTA PAEDIATR SCAND, V78, P963, DOI 10.1111/j.1651-2227.1989.tb11186.x; HUANG YC, 1996, J FORMOS MED ASSOC, V93, P393; Jacobsson B, 2004, EUR J OBSTET GYN R B, V115, P159, DOI 10.1016/j.ejogrb.2003.11.014; Johnson G, 2000, J CLIN MICROBIOL, V38, P3274, DOI 10.1128/JCM.38.9.3274-3279.2000; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; MCLEAN LK, 1995, AM J OBSTET GYNECOL, V173, P1282, DOI 10.1016/0002-9378(95)91371-8; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Mouly F, 1997, AM J OBSTET GYNECOL, V177, P894, DOI 10.1016/S0002-9378(97)70291-6; Nelson KB, 2002, MENT RETARD DEV D R, V8, P1, DOI 10.1002/mrdd.10010; O'Neill J F, 1998, Trans Am Ophthalmol Soc, V96, P813; Palmer AL, 1997, J INFECT DIS, V176, P1437, DOI 10.1086/514139; REMINGTON JS, 1995, INFECT DIS FETUS UNB; Rogers CDG, 2000, BIOTECHNOL APPL BIOC, V31, P219, DOI 10.1042/BA19990113; Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S; Takami T, 2000, J HOSP INFECT, V45, P283, DOI 10.1053/jhin.2000.0788; Vigneswaran Rasiah, 2004, BMC Pregnancy Childbirth, V4, P1, DOI 10.1186/1471-2393-4-1; Wenstrom KD, 1998, OBSTET GYNECOL, V92, P420, DOI 10.1016/S0029-7844(98)00210-5; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yost NP, 2000, CLIN OBSTET GYNECOL, V43, P759, DOI 10.1097/00003081-200012000-00006	28	56	61	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					76	79		10.1136/bmj.38668.616806.3A	http://dx.doi.org/10.1136/bmj.38668.616806.3A			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16399770	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000234777000016
J	Smith, C				Smith, C			Two geometric solutions to a transporting problem	SCIENCE			English	Editorial Material							COPII VESICLE COAT; ELECTRON CRYOMICROSCOPY; CLATHRIN		Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Smith, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	corinne.smith@warwick.ac.uk	Smith, Corinne J/A-3170-2009	Smith, Corinne J/0000-0003-3364-7946				BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003	15	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					182	183		10.1126/science.1123754	http://dx.doi.org/10.1126/science.1123754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410510				2022-12-01	WOS:000234722200025
J	Flannery, B; Heffernan, RT; Harrison, LH; Ray, SM; Reingold, AL; Hadler, J; Schaffner, W; Lynfield, R; Thomas, AR; Li, JM; Campsmith, M; Whitney, CG; Schuchat, A				Flannery, B; Heffernan, RT; Harrison, LH; Ray, SM; Reingold, AL; Hadler, J; Schaffner, W; Lynfield, R; Thomas, AR; Li, JM; Campsmith, M; Whitney, CG; Schuchat, A			Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization	ANNALS OF INTERNAL MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SURVEILLANCE; CHILDREN; AIDS	Background: Adults infected with HIV have high rates of invasive pneumococcal disease. Introduction of pneumococcal conjugate vaccine for children could affect disease among HIV-infected adults. Objective: To compare invasive pneumococcal disease among HIV-infected adults before and after the introduction of a pediatric conjugate vaccine. Design: Active laboratory-based surveillance in an adult population of 10.8 million, including 38 314 living with AIDS. Setting: 7 Active Bacterial Core surveillance areas in the United States. Patients: All surveillance-area residents 18 to 64 years of age with Streptococcus pneumoniae isolated from a sterile site between 1998 and 2003. Measurements: Ratio of the number of cases of invasive pneumococcal disease among HIV-infected adults to the estimated number of adults 18 to 64 years of age living with AIDS; serotype-specific subset analyses; and comparison of periods before and after introduction of conjugate vaccine by using exact tests. Results: Of 8582 cases of invasive pneumococcal disease in adults, 2013 (24%) occurred among persons infected with HIV. Between baseline (1998 to 1999) and 2003, the ratio of invasive pneumococcal disease in HIV-infected adults to the number of adults living with AIDS in the surveillance areas decreased from 1127 to 919 cases per 100000 AIDS population, a reduction of 19% (P= 0.002). Among HIV-infected adults, the ratio for disease caused by pneumococcal serotypes included in the conjugate vaccine decreased 62% (P < 0.001), although the ratio for disease caused by nonvaccine serotypes increased 44% (P < 0.001). Limitations: Ratios are proxy measures of incidence rates. The denominator of surveillance-area residents living with HIV infection was not available. Conclusions: Introduction of the pediatric conjugate vaccine was associated with an overall decrease in invasive pneumococcal disease among HIV-infected adults, despite increased disease caused by nonvaccine serotypes.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Flannery, B (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, 1600 Clifton Rd NE,MS C-23, Atlanta, GA 30333 USA.	bflannery@cdc.gov		Ray, Susan/0000-0002-6327-088X				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Breiman RF, 2000, ARCH INTERN MED, V160, P2633, DOI 10.1001/archinte.160.17.2633; *CDCP\, NAT IMM SURV; *CDCP, 2004, HIV AIDS SURV REP 20, V15; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; *NAT COMM CLIN LAB, 2004, METH DIL ANT SUSC TE; National Committee for Clinical Laboratory Standards, 2004, PERF STAND ANT SUS S, V24; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; *US BUR CENS, POP EST; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 1989, MMWR MORB MORTAL WKL, V38, P73; 1989, MMWR MORB MORTAL WKL, V38, P64	23	122	127	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					1	9		10.7326/0003-4819-144-1-200601030-00004	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389249				2022-12-01	WOS:000234474200001
J	Laird, DJ; De Tomaso, AW; Weissman, IL				Laird, DJ; De Tomaso, AW; Weissman, IL			Stem cells are units of natural selection in a colonial ascidian	CELL			English	Article							PROTOCHORDATE HISTOCOMPATIBILITY LOCUS; BOTRYLLUS-SCHLOSSERI; BONE-MARROW; ALDEHYDE DEHYDROGENASE; HEMATOPOIETIC-CELLS; TELOMERASE ACTIVITY; BUDDING TUNICATES; PERIPHERAL-BLOOD; EVOLUTION; ALLORECOGNITION	Stem cells are highly conserved biological units of development and regeneration. Here we formally demonstrate that stem cell lineages are also legitimate units of natural selection. In a colonial ascidian, Botryllus schlosseri, vascular fusion between genetically distinct individuals results in cellular parasitism of somatic tissues, gametes, or both. We show that genetic hierarchies of somatic and gametic parasitism following fusion can be replicated by transplanting cells between colonies. We prospectively isolate a population of multipotent, self-renewing stem cells that retain their competitive phenotype upon transplantation. Their single-cell contribution to either somatic or germline fates, but not to both, is consistent with separate lineages of somatic and germline stem cells or pluripotent stem cells that differentiate according to the niche in which they land. Since fusion is restricted to individuals that share a fusion/histocompatibility allele, these data suggest that histocompatibility genes in Botryllus evolved to protect the body from parasitic stem cells usurping asexual or sexual inheritance.	Stanford Univ, Med Ctr, Dept Biol Sci, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Laird, DJ (corresponding author), Stanford Univ, Med Ctr, Dept Biol Sci, Dept Pathol, Stanford, CA 94305 USA.	diana@stanfordalumni.org	Laird, Diana/Y-4387-2019		NIAID NIH HHS [R01 AI041588] Funding Source: Medline; NIDDK NIH HHS [DK54762, R01 DK054762] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054762] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Berrill NJ, 1941, BIOL BULL-US, V80, P169, DOI 10.2307/1537595; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BOYD H, 1986, BIOL B, V170; BUSS LW, 1985, DEV COMP IMMUNOL, V9, P191, DOI 10.1016/0145-305X(85)90110-7; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Chadwick-Furman NE, 2003, BIOL BULL-US, V205, P133, DOI 10.2307/1543234; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fallon P, 2003, BRIT J HAEMATOL, V122, P99, DOI 10.1046/j.1365-2141.2003.04357.x; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARA K, 1992, DEV GROWTH DIFFER, V34, P437; HENRY C, 1980, SELECTED METHODS CEL; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hou M, 2001, CLIN CHEM, V47, P519; IZZARD CS, 1973, J MORPHOL, V139, P1, DOI 10.1002/jmor.1051390102; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; KAWAMURA K, 1995, SEMIN CELL BIOL, V6, P117, DOI 10.1006/scel.1995.0017; Laird DJ, 2004, DEV BIOL, V273, P185, DOI 10.1016/j.ydbio.2004.05.029; Laird DJ, 2004, DEV COMP IMMUNOL, V28, P201, DOI 10.1016/j.dci.2003.08.007; LAUZON RJ, 1992, DEV DYNAM, V194, P71, DOI 10.1002/aja.1001940109; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; MUKAI H, 1976, J MORPHOL, V148, P337, DOI 10.1002/jmor.1051480306; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; OKA H, 1959, BIOL BULL, V117, P340, DOI 10.2307/1538913; OKA H, 1959, BIOL BULL, V1112, P225; Paz G, 2002, DEV COMP IMMUNOL, V26, P615, DOI 10.1016/S0145-305X(02)00022-8; RINKEVICH B, 1991, INT IMMUNOL, V3, P1265, DOI 10.1093/intimm/3.12.1265; RINKEVICH B, 1987, J ZOOL, V213, P717, DOI 10.1111/j.1469-7998.1987.tb03736.x; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Stoner DS, 1997, MOL MAR BIOL BIOTECH, V6, P163; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455	52	143	146	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1351	1360		10.1016/j.cell.2005.10.026	http://dx.doi.org/10.1016/j.cell.2005.10.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377573	Bronze			2022-12-01	WOS:000234584500021
J	Li, X; Carthew, RW				Li, X; Carthew, RW			A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye	CELL			English	Article							GENE REGULATORY NETWORKS; TYROSINE KINASE; FEEDBACK LOOP; CELL; ACTIVATION; EXPRESSION; TRANSCRIPTION; TARGETS; PROTEIN; LIN-14	A critical question about signal transduction is how weak or transient activation of signaling pathways achieves a robust and long-term switch in gene expression. We report that a microRNA is part of a mechanism that makes cells sensitive to signals in the Drosophila eye. Expression of miR-7 is activated in cells as they begin differentiating into photoreceptors. This is dependent on EGF receptor (EGFR) signaling that triggers ERK-mediated degradation of the transcription factor Yan. In nonstimulated cells, Yan represses miR-7 transcription, whereas miR-7 RNA represses Yan protein expression in photoreceptors, by binding to sequences within its mRNA 3'UTR. We propose that reciprocal negative feedback between Yan and miR-7 ensures mutually exclusive expression, with Yan in progenitor cells and miR-7 in photoreceptor cells. Expression is switched when EGFR signaling transiently triggers Yan degradation. This two-tiered mechanism explains how signal transduction activity can robustly generate a stable change in gene-expression patterns.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Gabay L, 1996, DEVELOPMENT, V122, P3355; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pichaud F, 2001, CELL, V105, P9, DOI 10.1016/S0092-8674(01)00292-6; Queenan AM, 1997, DEVELOPMENT, V124, P3871; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	45	270	313	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1267	1277		10.1016/j.cell.2005.10.040	http://dx.doi.org/10.1016/j.cell.2005.10.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377567	Bronze			2022-12-01	WOS:000234584500015
J	Boisvert, CA				Boisvert, CA			The pelvic fin and girdle of Panderichthys and the origin of tetrapod locomotion	NATURE			English	Article								One of the most marked transformations in the vertebrate transition to land was that of fins to limbs. This transformation involved not only the generation of morphological novelties ( digits, sacrum) but also a shift in locomotory dominance from the pectoral to the pelvic appendage(1). Despite its importance, the transformation from pelvic fin to hindlimb is the least studied and least well-documented part of this transformation, which is bracketed by the osteolepiform Eusthenopteron and the early tetrapods Ichthyostega and Acanthostega, but is not directly illuminated by any intermediate form. Panderichthys is the closest tetrapod relative currently represented by complete fossils(2), but its pelvic fin skeleton has not been described. Here, I present the only known articulated pelvic fin endoskeleton and associated partial pelvis of Panderichthys. The pelvic girdle is even less tetrapod-like than that of the osteolepiform Eusthenopteron(3), but the pelvic fin endoskeleton shares derived characteristics with basal tetrapods despite being more primitive than the pectoral fin of Panderichthys(4,5). The evolution of tetrapod locomotion appears to have passed through a stage of body-flexion propulsion, in which the pelvic fins played a relatively minor anchoring part, before the emergence of hindlimb-powered propulsion in the interval between Panderichthys and Acanthostega.	Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden	Uppsala University	Boisvert, CA (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	catherine.boisvert@ebc.uu.se	Boisvert, Catherine A/A-9782-2019	Boisvert, Catherine A/0000-0002-0618-7270				Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Carroll RL, 2005, ZOOL J LINN SOC-LOND, V143, P345, DOI 10.1111/j.1096-3642.2005.00151.x; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Jarvik E., 1980, BASIC STRUCTURE EVOL; Mark-Kurik E., 1992, FOSSIL FISHES LIVING, P131; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1992, ZH OBSHCH BIOL, V53, P149; Vorobyeva EI, 1998, PALEONTOL ZH, P3; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285	14	73	77	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1145	1147		10.1038/nature04119	http://dx.doi.org/10.1038/nature04119			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372007				2022-12-01	WOS:000234111500048
J	Sun, QH; Wang, AX; Jin, XM; Natanzon, A; Duquaine, D; Brook, RD; Aguinaldo, JGS; Fayad, ZA; Fuster, V; Lippmann, M; Chen, LC; Rajagopalan, S				Sun, QH; Wang, AX; Jin, XM; Natanzon, A; Duquaine, D; Brook, RD; Aguinaldo, JGS; Fayad, ZA; Fuster, V; Lippmann, M; Chen, LC; Rajagopalan, S			Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIESEL EXHAUST PARTICLES; IN-VIVO; PEROXYNITRITE FORMATION; RADICAL GENERATION; AMBIENT PARTICLES; MORTALITY; HEART; LUNG; HEALTH; OZONE	Context Recent studies have suggested a link between inhaled particulate matter exposure in urban areas and susceptibility to cardiovascular events; however, the precise mechanisms remain to be determined. Objective To test the hypothesis that subchronic exposure to environmentally relevant particulate matter, even at low concentrations, potentiates atherosclerosis and alters vasomotor tone in a susceptible disease model. Design, Setting, and Participants Between July 21, 2004, and January 12, 2005, 28 apolipoprotein E-/- (apoE(-/-)) mice were, based on randomized assignments, fed with normal chow or high-fat chow and exposed to concentrated ambient particles of less than 2.5 mu m (PM2.5) or filtered air (FA) in Tuxedo, NY, for 6 hours per day, 5 days per week for a total of 6 months. Main Outcome Measures Composite atherosclerotic plaque in the thoracic and abdominal aorta and vasomotor tone changes. Results In the high-fat chow group, the mean (SD) composite plaque area of PM2.5 vs FA was 41.5% (9.8%) vs 26.2% (8.6%), respectively (P<.001); and in the normal chow group, the composite plaque area was 19.2% (13.1 %) vs 13.2% (8.1%), respectively (P=.15). Lipid content in the aortic arch measured by oil red-O staining revealed a 1.5-fold increase in mice fed the high-fat chow and exposed to PM2.5 vs FA (30.0 (8.2] vs 20.0 [7.0]; 95% confidence interval [CI], 1.21-1.83; P=.02). Vasoconstrictor responses to phenylephrine and serotonin challenge in the thoracic aorta of mice fed high-fat chow and exposed to PM2.5 were exaggerated compared with exposure to FA (mean [SE], 134.2% [5.2 %) vs 100.9% [2.9%], for phenylephrine, and 156.0% [5.6%] vs 125.1% [7.5%], for serotonin; both P=.03); relaxation to the endothelium-dependent agonist acetylcholine was attenuated (mean [SE] of half-maximal dose for dilation, 8.9 [0.2] X 10(-8) vs 4.3 [0.1] X 10(-8), respectively; P=.04). Mice fed high-fat chow and exposed to PM2.5 demonstrated marked increases in macrophage infiltration, expression of the inducible isoform of nitric oxide synthase, increased generation of reactive oxygen species, and greater immunostaining for the protein nitration product 3-nitrotyrosine (all P<.001). Conclusion In an apoE(-/-) mouse model, long-term exposure to low concentration of PM2.5 altered vasomotor tone, induced vascular inflammation, and potentiated atherosclerosis.	Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Icahn School of Medicine at Mount Sinai; New York University; New York University; University of Michigan System; University of Michigan	Rajagopalan, S (corresponding author), Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.		Fuster, Valentin/H-4319-2015; Cjem, Lung-Chi/H-5030-2012; Fayad, Zahi/Z-3272-2019	Fuster, Valentin/0000-0002-9043-9986; Fayad, Zahi/0000-0002-3439-7347; Chen, Lung Chi/0000-0003-1154-2107	NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES013406] Funding Source: NIH RePORTER; NCI NIH HHS [1 R24 CA095823-01] Funding Source: Medline; NIEHS NIH HHS [R01ES013406-01, ES00260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bai YS, 2001, FREE RADICAL BIO MED, V30, P555, DOI 10.1016/S0891-5849(00)00499-8; Bouthillier L, 1998, AM J PATHOL, V153, P1873, DOI 10.1016/S0002-9440(10)65701-X; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Chen LC, 2005, INHAL TOXICOL, V17, P217, DOI 10.1080/08958370590912815; Choudhury RP, 2002, ATHEROSCLEROSIS, V162, P315, DOI 10.1016/S0021-9150(01)00730-4; Dellinger B, 2001, CHEM RES TOXICOL, V14, P1371, DOI 10.1021/tx010050x; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dvonch JT, 2004, INHAL TOXICOL, V16, P473, DOI 10.1080/08958370490439678; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Han JY, 2001, FREE RADICAL BIO MED, V30, P516, DOI 10.1016/S0891-5849(00)00501-3; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kwon HJ, 2001, EPIDEMIOLOGY, V12, P413, DOI 10.1097/00001648-200107000-00011; Li XY, 1996, THORAX, V51, P1216, DOI 10.1136/thx.51.12.1216; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Nemmar A, 2002, AM J RESP CRIT CARE, V166, P998, DOI 10.1164/rccm.200110-026OC; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Prahalad AK, 1999, TOXICOL APPL PHARM, V158, P81, DOI 10.1006/taap.1999.8701; Quay JL, 1998, AM J RESP CELL MOL, V19, P98, DOI 10.1165/ajrcmb.19.1.3132; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rossi G, 1999, ARCH ENVIRON HEALTH, V54, P158, DOI 10.1080/00039899909602254; Shukla A, 2000, AM J RESP CELL MOL, V23, P182, DOI 10.1165/ajrcmb.23.2.4035; SIOUTAS C, 1995, ENVIRON HEALTH PERSP, V103, P172, DOI 10.2307/3432274; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Tan WC, 2000, AM J RESP CRIT CARE, V161, P1213, DOI 10.1164/ajrccm.161.4.9904084; Trogan E, 2004, ARTERIOSCL THROM VAS, V24, P1714, DOI 10.1161/01.ATV.0000139313.69015.1c; United States Environmental Protection Agency (US EPA), NAT AMB AIR QUAL STA; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160	33	589	620	4	111	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					3003	3010		10.1001/jama.294.23.3003	http://dx.doi.org/10.1001/jama.294.23.3003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414948	Bronze			2022-12-01	WOS:000234087700027
J	Fry, AM; Shay, DK; Holman, RC; Curns, AT; Anderson, LJ				Fry, AM; Shay, DK; Holman, RC; Curns, AT; Anderson, LJ			Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZA VACCINATION; RISK-FACTORS; ANTIBODY-RESPONSE; INFECTION; DISEASE; POPULATION; STROKE; MORTALITY	Context Pneumonia causes significant mortality and morbidity among persons aged 65 years or older. However, few studies have explored trends according to age groups, which may affect intervention strategies. Objectives To examine trends in hospitalizations for pneumonia among persons aged 65 years or older and to compare characteristics, outcomes, and comorbid diagnoses. Design, Setting, and Patients Data from 1988 through 2002 on pneumonia and comorbid diagnoses among patients aged 65 to 74 years, 75 to 84 years, and 85 years or older from the National Hospital Discharge Survey. Main Outcome Measures Hospitalization rates by first-listed and any-listed discharge codes for pneumonia; proportions of hospitalizations reporting comorbid diagnoses for the 3 age groups (65-74 years, 75-84 years, >= 85 years). Results Hospitalization rates by both first-listed and any-listed discharge codes for pneumonia increased by 20% from 1988-1990 to 2000-2002 for patients aged 65 to 74 years (P=.01) and for patients aged 75 to 84 years (P<.001). Rates of hospitalization for pneumonia were 2-fold higher for patients aged 85 years or older (51 per 1000 population for first-listed discharge code of pneumonia; 95% confidence interval [CI], 46-55 per 1000 population) than among patients aged 75 to 84 years (26 per 1000 population; 95% Cl, 24-28 per 1000 population), but did not significantly increase from 1988-1990 to 2000-2002. The proportion of patients aged 65 years or older diagnosed with pneumonia and a chronic cardiac disease, chronic pulmonary disease, or diabetes mellitus increased from 66% (SE, 1.0%) in 1988-1990 to 77% (SE, 0.8%) in 2000-2002. The risk of death during a hospitalization for pneumonia compared with the risk of death during a hospital stay for the 10 other most frequent causes of hospitalization was 1.5 (95% Cl, 1.4-1.7) and remained constant from 19881990 to 2000-2002. Conclusions Hospitalization rates for pneumonia have increased among US adults aged 64 to 74 years and aged 75 to 84 years during the past 15 years. Among those aged 85 years or older, at least 1 in 20 patients were hospitalized each year due to pneumonia. Concomitantly, the proportion of comorbid chronic diseases has increased. Efforts to prevent pneumonia should include reducing preventable comorbid conditions and improving vaccine effectiveness and vaccination programs in elderly persons.	Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-34, Atlanta, GA 30333 USA.	afry@cdc.gov		Shay, David/0000-0001-9619-4820				[Anonymous], 1979, HLTH PEOPL SURG GEN; [Anonymous], 1996, US BUREAU CENSUS CUR; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; Barker WH, 1997, STROKE, V28, P284, DOI 10.1161/01.STR.28.2.284; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Dennison C, 2000, Vital Health Stat 1, P1; Dorrell L, 1997, INT J STD AIDS, V8, P776, DOI 10.1258/0956462971919264; Falsey AR, 1998, VACCINE, V16, P1775, DOI 10.1016/S0264-410X(98)00142-X; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Farr BM, 2000, RESP MED, V94, P954, DOI 10.1053/rmed.2000.0865; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GILLIUM BS, 1996, TRENDS HOSP UTILIZAT; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; KOIVULA I, 1994, AM J MED, V96, P313, DOI 10.1016/0002-9343(94)90060-4; KOZAK LJ, 2005, VITAL HLTH STAT, V13, P1729; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; MCBEAN AM, 1993, ARCH INTERN MED, V153, P2105, DOI 10.1001/archinte.153.18.2105; MCELHANEY JE, 1990, J AM GERIATR SOC, V38, P652, DOI 10.1111/j.1532-5415.1990.tb01424.x; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Muder RR, 1998, AM J MED, V105, P319, DOI 10.1016/S0002-9343(98)00262-9; *NAT CTR HLTH STAT, 2004, NAT HOSP DISCH SURV; *NAT HLTH INT SURV, INFL VACC DAT; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Remarque EJ, 1999, EXP GERONTOL, V34, P109, DOI 10.1016/S0531-5565(98)00060-6; Shah BV, 1996, SUDAAN USERS MANUAL; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Simonsen L, 1998, ARCH INTERN MED, V158, P1923, DOI 10.1001/archinte.158.17.1923; Thompson WW, 2005, ARCH INTERN MED, V165, P2038, DOI 10.1001/archinte.165.17.2038-b; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US BUR CENS, 2003, INT EST POP AG SEX R; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; *US EPA, 1991, NAT AIR QUAL EM TREN; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907	52	313	328	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2712	2719		10.1001/jama.294.21.2712	http://dx.doi.org/10.1001/jama.294.21.2712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333006	Bronze			2022-12-01	WOS:000233726900019
J	Harris, RA; de Ibarra, NH; Graham, P; Collett, TS				Harris, RA; de Ibarra, NH; Graham, P; Collett, TS			Ant navigation - Priming of visual route memories	NATURE			English	Editorial Material							DESERT ANTS; HONEY-BEES; VECTORS; INFORMATION; LANDMARKS; INSECTS		Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Harris, RA (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	t.s.collett@sussex.ac.uk	de Ibarra, Natalie Hempel/A-1962-2013; Graham, Paul/C-6420-2009	de Ibarra, Natalie Hempel/0000-0002-0859-8217; Graham, Paul/0000-0002-3745-0940				Beugnon G, 2005, J INSECT BEHAV, V18, P415, DOI 10.1007/s10905-005-3700-8; Bisch-Knaden S, 2003, J COMP PHYSIOL A, V189, P181, DOI 10.1007/s00359-003-0389-z; Collett M, 1998, NATURE, V394, P269, DOI 10.1038/28378; COLLETT TS, 1992, J COMP PHYSIOL A, V170, P435; Dyer FC, 2002, NATURWISSENSCHAFTEN, V89, P262, DOI 10.1007/s00114-002-0311-5; Graham P, 2002, J EXP BIOL, V205, P2499; Kohler M, 2005, NEUROBIOL LEARN MEM, V83, P1, DOI 10.1016/j.nlm.2004.05.011; KOLTERMANN R, 1971, Z VERGL PHYSIOL, V75, P49, DOI 10.1007/BF00335137; Menzel R, 1998, ANIM BEHAV, V55, P139, DOI 10.1006/anbe.1997.0574; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Santschi F., 1913, Revue Suisse de Zoologie, V21; Wahl O., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P529; Wehner R, 1996, J EXP BIOL, V199, P129	13	52	55	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					302	302		10.1038/438302a	http://dx.doi.org/10.1038/438302a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292300	Bronze			2022-12-01	WOS:000233300200034
J	Rifkin, SA; Houle, D; Kim, J; White, KP				Rifkin, SA; Houle, D; Kim, J; White, KP			A mutation accumulation assay reveals a broad capacity for rapid evolution of gene expression	NATURE			English	Article							SELECTION; PROFILES; TISSUE	Mutation is the ultimate source of biological diversity because it generates the variation that fuels evolution(1). Gene expression is the first step by which an organism translates genetic information into developmental change. Here we estimate the rate at which mutation produces new variation in gene expression by measuring transcript abundances across the genome during the onset of metamorphosis in 12 initially identical Drosophila melanogaster lines that independently accumulated mutations for 200 generations(2). We find statistically significant mutational variation for 39% of the genome and a wide range of variability across corresponding genes. As genes are upregulated in development their variability decreases, and as they are downregulated it increases, indicating that developmental context affects the evolution of gene expression. A strong correlation between mutational variance and environmental variance shows that there is the potential for widespread canalization(3). By comparing the evolutionary rates that we report here with differences between species(4,5), we conclude that gene expression does not evolve according to strictly neutral models. Although spontaneous mutations have the potential to generate abundant variation in gene expression, natural variation is relatively constrained.	Univ Penn, Dept Biol, Goddard Labs 203, Philadelphia, PA 19104 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Pennsylvania; Yale University; Yale University; State University System of Florida; Florida State University	Kim, J (corresponding author), Univ Penn, Dept Biol, Goddard Labs 203, 415 S Univ Ave, Philadelphia, PA 19104 USA.	junhyong@sas.upenn.edu; kevin.white@yale.edu		Houle, David/0000-0002-8095-3156; Rifkin, Scott/0000-0001-8476-3256				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Fry JD, 2004, GENETIC ANAL COMPLEX, P11; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; HARTL DL, 1985, GENETICS, V111, P655; Houle D, 1996, GENETICS, V143, P1467; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; Houle D, 2004, GENET RES, V83, P7, DOI 10.1017/S0016672303006505; Hsieh WP, 2003, GENETICS, V165, P747; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Lemos B, 2005, EVOLUTION, V59, P126; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; Lynch Michael, 1998; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Sokal RR, 2012, BIOMETRY, V4th; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yang HP, 2001, GENETICS, V157, P1285	30	154	154	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					220	223		10.1038/nature04114	http://dx.doi.org/10.1038/nature04114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281035				2022-12-01	WOS:000233133500048
J	Mariathasan, S; Weiss, DS; Newton, K; McBride, J; O'Rourke, K; Roose-Girma, M; Lee, WP; Weinrauch, Y; Monack, DM; Dixit, VM				Mariathasan, S; Weiss, DS; Newton, K; McBride, J; O'Rourke, K; Roose-Girma, M; Lee, WP; Weinrauch, Y; Monack, DM; Dixit, VM			Cryopyrin activates the inflammasome in response to toxins and ATP	NATURE			English	Article							NF-KAPPA-B; INTERLEUKIN-1-BETA SECRETION; MURAMYL DIPEPTIDE; GENE; PROTEIN; ASC; MUTATIONS; MICE; MAITOTOXIN; CASPASE-1	A crucial part of the innate immune response is the assembly of the inflammasome, a cytosolic complex of proteins that activates caspase-1 to process the proinflammatory cytokines interleukin (IL)-1 beta and IL-18. The adaptor protein ASC is essential for inflammasome function(1,2), binding directly to caspase-1 (refs 3, 4), but the triggers of this interaction are less clear. ASC also interacts with the adaptor cryopyrin (also known as NALP3 or CIAS1)(5,6). Activating mutations in cryopyrin are associated with familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal onset multisystem inflammatory disease, diseases that are characterized by excessive production of IL-1 beta(5,7). Here we show that cryopyrin-deficient macrophages cannot activate caspase-1 in response to Toll-like receptor agonists plus ATP, the latter activating the P2X(7) receptor to decrease intracellular K+ levels(8,9). The release of IL-1 beta in response to nigericin, a potassium ionophore, and maitotoxin, a potent marine toxin, was also found to be dependent on cryopyrin. In contrast to Asc(-/-) macrophages, cells deficient in the gene encoding cryopyrin (Cias1(-/-)) activated caspase-1 and secreted normal levels of IL-1 beta and IL-18 when infected with Gram-negative Salmonella typhimurium or Francisella tularensis. Macrophages exposed to Gram-positive Staphylococcus aureus or Listeria monocytogenes, however, required both ASC and cryopyrin to activate caspase-1 and secrete IL-1 beta. Therefore, cryopyrin is essential for inflammasome activation in response to signalling pathways triggered specifically by ATP, nigericin, maitotoxin, S. aureus or L. monocytogenes.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University; Stanford University; New York University	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com		Monack, Denise/0000-0003-3804-2209				Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Damiano JS, 2004, J IMMUNOL, V173, P6338, DOI 10.4049/jimmunol.173.10.6338; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDermott MF, 2002, TRENDS MOL MED, V8, P550, DOI 10.1016/S1471-4914(02)02425-5; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Verhoef PA, 2004, MOL PHARMACOL, V66, P909, DOI 10.1124/mol.66.4.909; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	25	2241	2322	4	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					228	232		10.1038/nature04515	http://dx.doi.org/10.1038/nature04515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407890	Bronze			2022-12-01	WOS:000235839500050
J	Kendall, MJ; Mehta, DK				Kendall, MJ; Mehta, DK			Sick children deserve a better deal	LANCET			English	Editorial Material									Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Royal Pharmaceut Soc Great Britain, London, England	University of Birmingham	Kendall, MJ (corresponding author), Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.	m.j.kendall@bham.ac.uk						Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Choonara I, 2002, DRUG SAFETY, V25, P1, DOI 10.2165/00002018-200225010-00001; COPE L, 1996, A HEY BOOK CHILDRENS; *EUR MED AG, 2004, MED CHILDR EUR PAED; HEY E, 2003, NEONATAL FORMULARY; *PAED FORM COMM, 2005, BNF CHILDR; TOMLIN S, 2005, PAEDIAT FORMULARY	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 28	2006	367	9507					281	283		10.1016/S0140-6736(06)68048-3	http://dx.doi.org/10.1016/S0140-6736(06)68048-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	009AX	16443023				2022-12-01	WOS:000235084600007
J	Cowen, RK; Paris, CB; Srinivasan, A				Cowen, RK; Paris, CB; Srinivasan, A			Scaling of connectivity in marine populations	SCIENCE			English	Article							LARVAL DISPERSAL; CARIBBEAN CORAL; LOCAL RETENTION; RECRUITMENT	Defining the scale of connectivity, or exchange, among marine populations and determining the factors driving this-exchange are pivotal to our understanding of the population dynamics, genetic structure, and biogeography of many coastal species. Using a high-resolution biophysical model for the Caribbean region, we report that typical larval dispersal distances of ecologically relevant magnitudes are on the scale of only 10 to 100 kilometers for a variety of reef fish species. We also show the importance of the early onset of active larval movement mediating the dispersal potential. In addition to self -recruitment, larval import from outside the local area is required to sustain most populations, although these population subsidies are very limited in particular systems. The results reveal distinct regions of population isolation based on larval dispersal that also correspond to genetic and morphological clines observed across a range of marine organisms.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami	Cowen, RK (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	rcowen@rsmas.miami.edu		Paris, Claire B./0000-0002-0637-1334				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Botsford LW, 2001, ECOL LETT, V4, P144; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; COE WR, 1953, ECOLOGY, V34, P225, DOI 10.2307/1930330; Colin P., 1975, COLIN; COWEN RK, 1985, J MAR RES, V43, P719, DOI 10.1357/002224085788440376; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; EFFORD I E, 1970, Crustaceana (Leiden), V18, P293, DOI 10.1163/156854070X00248; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; HILL AE, 1990, MAR ECOL PROG SER, V64, P217, DOI 10.3354/meps064217; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Largier JL, 2003, ECOL APPL, V13, pS71; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; SAMMARCO PW, 1989, LIMNOL OCEANOGR, V34, P896, DOI 10.4319/lo.1989.34.5.0896; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Shanks AL, 2003, ECOL APPL, V13, pS159; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; THORSON G, 1950, MEDD DOMM DAN FISK P, V4, P1; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Warner RR, 2002, B MAR SCI, V70, P245; Werner FE, 2001, SARSIA, V86, P411, DOI 10.1080/00364827.2001.10420483; Wolanski E, 1997, NATURWISSENSCHAFTEN, V84, P262, DOI 10.1007/s001140050394	34	1016	1042	5	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					522	527		10.1126/science.1122039	http://dx.doi.org/10.1126/science.1122039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16357224				2022-12-01	WOS:000235071400046
J	Bomback, A				Bomback, A			Becoming a physician - The physical exam and the sense of smell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina Hosp, Chapel Hill, NC 27514 USA	University North Carolina Hospital	Bomback, A (corresponding author), Univ N Carolina Hosp, Chapel Hill, NC 27514 USA.		Bomback, Andrew/A-8063-2009						0	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2006	354	4					327	329		10.1056/NEJMp048244	http://dx.doi.org/10.1056/NEJMp048244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005VY	16436763				2022-12-01	WOS:000234854000003
J	Flack, JC; Girvan, M; de Waal, FBM; Krakauer, DC				Flack, JC; Girvan, M; de Waal, FBM; Krakauer, DC			Policing stabilizes construction of social niches in primates	NATURE			English	Article							RECIPROCITY; CENTRALITY; ROBUSTNESS; MECHANISMS; EVOLUTION	All organisms interact with their environment, and in doing so shape it, modifying resource availability. Termed niche construction, this process has been studied primarily at the ecological level with an emphasis on the consequences of construction across generations(1). We focus on the behavioural process of construction within a single generation, identifying the role a robustness mechanism(2) - conflict management - has in promoting interactions that build social resource networks or social niches. Using 'knockout' experiments on a large, captive group of pigtailed macaques ( Macaca nemestrina), we show that a policing function, performed infrequently by a small subset of individuals(3), significantly contributes to maintaining stable resource networks in the face of chronic perturbations that arise through conflict. When policing is absent, social niches destabilize, with group members building smaller, less diverse, and less integrated grooming, play, proximity and contact-sitting networks. Instability is quantified in terms of reduced mean degree, increased clustering, reduced reach, and increased assortativity. Policing not only controls conflict(3-5), we find it significantly influences the structure of networks that constitute essential social resources in gregarious primate societies. The structure of such networks plays a critical role in infant survivorship(6), emergence and spread of cooperative behaviour(7), social learning and cultural traditions(8).	Santa Fe Inst, Santa Fe, NM 87501 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Living Links Ctr, Atlanta, GA 30322 USA; Emory Univ, Neurosci & Anim Behav Program, Atlanta, GA 30322 USA	The Santa Fe Institute; Emory University; Emory University	Flack, JC (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	jflack@santafe.edu	Girvan, Michelle/E-3982-2016	Girvan, Michelle/0000-0003-0299-0784; Girvan, Michelle/0000-0001-7519-2842				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2013, NICHE CONSTRUCTION N; Boehm C., 1981, PRIMATE BEHAV SOCIOB, P161; CALDECOTT JO, 1986, CONTRIBUTIONS PRIMAT; de Waal F. B. M., 1977, Zeitschrift Tierpsychol, V44, P225; De Waal FBM, 2000, ANIM BEHAV, V60, P253, DOI 10.1006/anbe.2000.1471; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1985, AM J PRIMATOL, V9, P73, DOI 10.1002/ajp.1350090202; Flack J.C., 2004, MACAQUE SOC, P157; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Frank SA, 2003, EVOLUTION, V57, P693; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KEPPEL G, 1991, DESIGN ANAL RESEARCH, P329; KRAKAUER DC, 2003, ENCY HUMAN GENOME, V2, P892; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Thierry Bernard, 2000, P106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WASSERMAN S, 1994, SOCIAL NETWORK ANAL, P107; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WATTS DJ, 1999, SMALL WORLDS DYNAMIC, P199; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047	29	426	440	0	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					426	429		10.1038/nature04326	http://dx.doi.org/10.1038/nature04326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437106				2022-12-01	WOS:000234859200036
J	Goll, MG; Kirpekar, F; Maggert, KA; Yoder, JA; Hsieh, CL; Zhang, XY; Golic, KG; Jacobsen, SE; Bestor, TH				Goll, MG; Kirpekar, F; Maggert, KA; Yoder, JA; Hsieh, CL; Zhang, XY; Golic, KG; Jacobsen, SE; Bestor, TH			Methylation of tRNA(AsP) by the DNA methyltransferase homolog Dnmt2	SCIENCE			English	Article							TRANSFER-RNA; CYTOSINE METHYLTRANSFERASES; NUCLEOTIDE-SEQUENCE; FISSION YEAST; MECHANISM; SUBSTRATE; BINDING; LIVER	The sequence and the structure of DNA methyltransferase-2 (Dnmt2) bear close affinities to authentic DNA cytosine methyltransferases. A combined genetic and biochemical approach revealed that human DNMT2 did not methylate DNA but instead methylated a small RNA; mass spectrometry showed that this RNA is aspartic acid transfer RNA (tRNA(Asp)) and that DNMT2 specifically methylated cytosine 38 in the anticodon loop. The function of DNMT2 is highly conserved, and human DNMT2 protein restored methylation in vitro to tRNA(Asp) from Dnmt2-deficient strains of mouse, Arabidopsis thaliana, and Drosophila melanogaster in a manner that was dependent on preexisting patterns of modified nucleosides. indirect sequence recognition is also a feature of eukaryotic DNA methyltransferases, which may have arisen from a Dnmt2-like RNA methyltransferase.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; Univ So Calif, Dept Urol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Columbia University; University of Southern Denmark; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; University of Southern California; University of Southern California; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	THB12@Columbia.edu	Yoder, Jeffrey A./I-5329-2019	Yoder, Jeffrey A./0000-0002-6083-1311; Maggert, Keith/0000-0002-9291-9481; Kirpekar, Finn/0000-0003-1901-2266				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Foster PG, 2003, STRUCTURE, V11, P1609, DOI 10.1016/j.str.2003.10.014; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GOLL MG, UNPUB; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; HAUMONT E, 1984, BIOCHIMIE, V66, P579, DOI 10.1016/0300-9084(84)90154-8; JOHNSON GD, 1985, ARCH BIOCHEM BIOPHYS, V236, P448, DOI 10.1016/0003-9861(85)90647-2; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; KUCHINO Y, 1981, J BIOL CHEM, V256, P9059; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; MANGROO D, 1995, J BACTERIOL, V177, P2858, DOI 10.1128/jb.177.10.2858-2862.1995; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Taniguchi H, 1998, NUCLEIC ACIDS RES, V26, P1481, DOI 10.1093/nar/26.6.1481; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	22	719	771	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					395	398		10.1126/science.1120976	http://dx.doi.org/10.1126/science.1120976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424344				2022-12-01	WOS:000234938500049
J	Vignuzzi, M; Stone, JK; Arnold, JJ; Cameron, CE; Andino, R				Vignuzzi, M; Stone, JK; Arnold, JJ; Cameron, CE; Andino, R			Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population	NATURE			English	Article							DEPENDENT RNA-POLYMERASE; ERROR CATASTROPHE; VIRUS; POLIOVIRUS; MUTATIONS; EXTINCTION; RIBAVIRIN; EVOLUTION; FIDELITY; MUTANTS	An RNA virus population does not consist of a single genotype; rather, it is an ensemble of related sequences, termed quasispecies(1-4). Quasispecies arise from rapid genomic evolution powered by the high mutation rate of RNA viral replication(5-8). Although a high mutation rate is dangerous for a virus because it results in nonviable individuals, it has been hypothesized that high mutation rates create a 'cloud' of potentially beneficial mutations at the population level, which afford the viral quasispecies a greater probability to evolve and adapt to new environments and challenges during infection(4,9-11). Mathematical models predict that viral quasispecies are not simply a collection of diverse mutants but a group of interactive variants, which together contribute to the characteristics of the population(4,12). According to this view, viral populations, rather than individual variants, are the target of evolutionary selection(4,12). Here we test this hypothesis by examining the consequences of limiting genomic diversity on viral populations. We find that poliovirus carrying a high-fidelity polymerase replicates at wild-type levels but generates less genomic diversity and is unable to adapt to adverse growth conditions. In infected animals, the reduced viral diversity leads to loss of neurotropism and an attenuated pathogenic phenotype. Notably, using chemical mutagenesis to expand quasispecies diversity of the high-fidelity virus before infection restores neurotropism and pathogenesis. Analysis of viruses isolated from brain provides direct evidence for complementation between members in the quasispecies, indicating that selection indeed occurs at the population level rather than on individual variants. Our study provides direct evidence for a fundamental prediction of the quasispecies theory and establishes a link between mutation rate, population dynamics and pathogenesis.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	andino@itsa.ucsf.edu		Vignuzzi, Marco/0000-0002-4400-771X	NIAID NIH HHS [U01 AI054776, R01 AI040085, R01 AI045818-08, R01 AI045818, N01AI40085, R01 AI036178, R01 AI045818-07] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040085, R01AI040085, R01AI036178, U01AI054776, R01AI045818] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; BALTERA RF, 1989, J VIROL, V63, P4441, DOI 10.1128/JVI.63.10.4441-4444.1989; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; DOMINGO E, 1994, MUTATION RATES RAPID, P161; Domingo E., 1988, RNA GENETICS; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Eigen M., 1988, RNA GENETICS, V3, P211; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; PINCUS SE, 1986, J VIROL, V57, P638, DOI 10.1128/JVI.57.2.638-646.1986; REN RB, 1992, J INFECT DIS, V166, P747, DOI 10.1093/infdis/166.4.747; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357	24	770	797	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					344	348		10.1038/nature04388	http://dx.doi.org/10.1038/nature04388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16327776	Green Accepted			2022-12-01	WOS:000234682100047
J	Winkowski, DE; Knudsen, EI				Winkowski, DE; Knudsen, EI			Top-down gain control of the auditory space map by gaze control circuitry in the barn owl	NATURE			English	Article							FRONTAL EYE FIELD; ATTENTIONAL MODULATION; OPTIC TECTUM; MICROSTIMULATION; MONKEY; NEURONS; ARCHISTRIATUM; INACTIVATION; MEMORY	High-level circuits in the brain that control the direction of gaze are intimately linked with the control of visual spatial attention(1-5). Immediately before an animal directs its gaze towards a stimulus, both psychophysical sensitivity to that visual stimulus and the responsiveness of high-order neurons in the cerebral cortex that represent the stimulus increase dramatically(3,6,7). Equivalent effects on behavioural sensitivity and neuronal responsiveness to visual stimuli result from focal electrical microstimulation of gaze control centres in monkeys(8-11). Whether the gaze control system modulates neuronal responsiveness in sensory modalities other than vision is unknown. Here we show that electrical microstimulation applied to gaze control circuitry in the forebrain of barn owls regulates the gain of midbrain auditory responses in an attention-like manner. When the forebrain circuit was activated, midbrain responses to auditory stimuli at the location encoded by the forebrain site were enhanced and spatial selectivity was sharpened. The same stimulation suppressed responses to auditory stimuli represented at other locations in the midbrain map. Such space-specific, top-down regulation of auditory responses by gaze control circuitry in the barn owl suggests that the central nervous system uses a common strategy for dynamically regulating sensory gain that applies across modalities, brain areas and classes of vertebrate species. This approach provides a path for discovering mechanisms that underlie top-down gain control in the central nervous system.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Winkowski, DE (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	dwinkows@stanford.edu			NIDCD NIH HHS [R01 DC000155-28, R01 DC000155, F32 DC006569-01A2, F32 DC006569-02, F32 DC006569] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC006569, R01DC000155] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; COHEN YE, 1995, J NEUROSCI, V15, P5152; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; FISCHER B, 1981, EXP BRAIN RES, V44, P129; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 1996, EXP BRAIN RES, V108, P23; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Miller GL, 1999, J NEUROSCI, V19, P2326; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; OLSEN JF, 1989, J NEUROSCI, V9, P2591; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rorden C, 1999, NEUROPSYCHOLOGIA, V37, P357, DOI 10.1016/S0028-3932(98)00072-4; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; STANTON GB, 1988, J COMP NEUROL, V271, P493, DOI 10.1002/cne.902710403; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0	30	78	78	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					336	339		10.1038/nature04411	http://dx.doi.org/10.1038/nature04411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421572	Green Accepted			2022-12-01	WOS:000234682100045
J	Freedman, DO; Weld, LH; Kozarsky, PE; Fisk, T; Robins, R; von Sonnenburg, F; Keystone, JS; Pandey, P; Cetron, MS				Freedman, DO; Weld, LH; Kozarsky, PE; Fisk, T; Robins, R; von Sonnenburg, F; Keystone, JS; Pandey, P; Cetron, MS		GeoSentinel Surveillance Network	Spectrum of disease and relation to place of exposure among ill returned travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEVELOPING-COUNTRIES; TROPICAL COUNTRIES; HEALTH-PROBLEMS; FEVER; EPIDEMIOLOGY; DIARRHEA; AFRICA; RESIDENTS; ETIOLOGY; ILLNESS	BACKGROUND: Approximately 8 percent of travelers to the developing world require medical care during or after travel. Current understanding of morbidity profiles among ill returned travelers is based on limited data from the 1980s. METHODS: Thirty GeoSentinel sites, which are specialized travel or tropical-medicine clinics on six continents, contributed clinician-based sentinel surveillance data for 17,353 ill returned travelers. We compared the frequency of occurrence of each diagnosis among travelers returning from six developing regions of the world. RESULTS: Significant regional differences in proportionate morbidity were detected in 16 of 21 broad syndromic categories. Among travelers presenting to GeoSentinel sites, systemic febrile illness without localizing findings occurred disproportionately among those returning from sub-Saharan Africa or Southeast Asia, acute diarrhea among those returning from south central Asia, and dermatologic problems among those returning from the Caribbean or Central or South America. With respect to specific diagnoses, malaria was one of the three most frequent causes of systemic febrile illness among travelers from every region, although travelers from every region except sub-Saharan Africa and Central America had confirmed or probable dengue more frequently than malaria. Among travelers returning from sub-Saharan Africa, rickettsial infection, primarily tick-borne spotted fever, occurred more frequently than typhoid or dengue. Travelers from all regions except Southeast Asia presented with parasite-induced diarrhea more often than with bacterial diarrhea. CONCLUSIONS: When patients present to specialized clinics after travel to the developing world, travel destinations are associated with the probability of the diagnosis of certain diseases. Diagnostic approaches and empiric therapies can be guided by these destination-specific differences.	Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; Univ Munich, Dept Trop & Infect Dis, Munich, Germany; Univ Toronto, Div Infect Dis, Toronto, ON, Canada; CIWEC Clin, Kathmandu, Nepal	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Emory University; University of Munich; University of Toronto	Freedman, DO (corresponding author), Univ Alabama, Div Geog Med, 1530 3rd Ave S,BBRB 203, Birmingham, AL 35294 USA.	freedman@uab.edu	Freedman, David O./AAV-2999-2020	Freedman, David O./0000-0002-5642-5257; Weld, Leisa/0000-0001-6550-0135	ODCDC CDC HHS [U50/CCU412347] Funding Source: Medline	ODCDC CDC HHS		CAUMES E, 1995, CLIN INFECT DIS, V20, P542, DOI 10.1093/clinids/20.3.542; Caumes E, 2001, J TRAVEL MED, V8, P293, DOI 10.2310/7060.2001.22378; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; DUPONT HL, 1993, NEW ENGL J MED, V328, P1821, DOI 10.1056/NEJM199306243282507; Freedman DO, 1999, J TRAVEL MED, V6, P94, DOI 10.1111/j.1708-8305.1999.tb00839.x; Herwaldt BL, 2000, ANN INTERN MED, V132, P982, DOI 10.7326/0003-4819-132-12-200006200-00009; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Hoge CW, 1996, JAMA-J AM MED ASSOC, V275, P533, DOI 10.1001/jama.275.7.533; Humar A, 1996, BMJ-BRIT MED J, V312, P953, DOI 10.1136/bmj.312.7036.953; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Jensenius M, 2003, CLIN INFECT DIS, V36, P1411, DOI 10.1086/375083; Liese B, 1997, OCCUP ENVIRON MED, V54, P499, DOI 10.1136/oem.54.7.499; Patel D, 2000, J TRAVEL MED, V7, P64; Raoult D, 2001, NEW ENGL J MED, V344, P1504, DOI 10.1056/NEJM200105173442003; REID D, 1993, BRIT MED BULL, V49, P257, DOI 10.1093/oxfordjournals.bmb.a072609; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Shah Snehal, 2004, Morbidity and Mortality Weekly Report, V53, P21; Steffen R, 2003, INT J ANTIMICROB AG, V21, P89, DOI 10.1016/S0924-8579(02)00293-5; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; TAYLOR DN, 1988, JAMA-J AM MED ASSOC, V260, P1245, DOI 10.1001/jama.260.9.1245; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4	22	666	693	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					119	130		10.1056/NEJMoa051331	http://dx.doi.org/10.1056/NEJMoa051331			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407507				2022-12-01	WOS:000234528600004
J	Palliser, D; Chowdhury, D; Wang, QY; Lee, SJ; Bronson, RT; Knipe, DM; Lieberman, J				Palliser, D; Chowdhury, D; Wang, QY; Lee, SJ; Bronson, RT; Knipe, DM; Lieberman, J			An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SHORT INTERFERING RNA; REPLICATION-DEFECTIVE MUTANT; DNA-BINDING PROTEIN; HERPES; INHIBITION; ESCAPE; CHALLENGE; CELLS	Herpes simplex virus 2 (HSV-2) infection causes significant morbidity(1) and is an important cofactor for the transmission of HIV infection(2). A microbicide to prevent sexual transmission of HSV-2 would contribute substantially to controlling the spread of HIV and other infections(3,4). Because RNA interference (RNAi) provides effective antiviral defence in plants and other organisms, several studies have focused on harnessing RNAi to inhibit viral infection(5). Here we show that vaginal instillation of small interfering RNAs (siRNAs) targeting HSV-2 protects mice from lethal infection. siRNAs mixed with lipid are efficiently taken up by epithelial and lamina propria cells and silence gene expression in the mouse vagina and ectocervix for at least nine days. Intravaginal application of siRNAs targeting the HSV-2 UL27 and UL29 genes ( which encode an envelope glycoprotein and a DNA binding protein(6), respectively) was well tolerated, did not induce interferon-responsive genes or cause inflammation, and protected mice when administered before and/or after lethal HSV-2 challenge. These results suggest that siRNAs are attractive candidates for the active component of a microbicide designed to prevent viral infection or transmission.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015					[Anonymous], FIELDS VIROLOGY FIEL; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; GAO M, 1989, J VIROL, V63, P5258, DOI 10.1128/JVI.63.12.5258-5267.1989; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Pilcher H, 2004, NATURE, V430, P138, DOI 10.1038/430138a; Roizman B., 2001, FIELDS VIROLOGY, V4th ed., P2399; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SPANG AE, 1983, J VIROL, V45, P332, DOI 10.1128/JVI.45.1.332-342.1983; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	29	332	374	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					89	94		10.1038/nature04263	http://dx.doi.org/10.1038/nature04263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16306938				2022-12-01	WOS:000234378700040
J	McDermott, MM; Liu, K; Ferrucci, L; Criqui, MH; Greenland, P; Guralnik, JM; Tian, L; Schneider, JR; Pearce, WH; Tan, J; Martin, GJ				McDermott, MM; Liu, K; Ferrucci, L; Criqui, MH; Greenland, P; Guralnik, JM; Tian, L; Schneider, JR; Pearce, WH; Tan, J; Martin, GJ			Physical performance in peripheral arterial disease: A slower rate of decline in patients who walk more	ANNALS OF INTERNAL MEDICINE			English	Article							ANKLE BRACHIAL INDEX; LEG SYMPTOMS; CLINICAL CHARACTERISTICS; EXERCISE REHABILITATION; CALTRAC ACCELEROMETER; OCCLUSIVE DISEASE; LONGITUDINAL DATA; 6-MINUTE WALK; RISK-FACTORS; PREVALENCE	Background: Exercise rehabilitation programs increase treadmill walking performance in patients with peripheral arterial disease (PAD) and intermittent claudication. However, it is unknown whether patients with PAD who walk for exercise regularly have less functional decline than those with less walking activity. Objective: To determine whether patients with PAD who report that they walk for exercise 3 or more times per week have less annual functional decline than those who walk for exercise less frequently. Design: Prospective cohort study with a median follow-up of 36 months (interquartile range, 24 to 36 months). Setting: Academic medical center. Participants: 417 men and women with PAID. Measurements: Participants were classified at baseline and annually according to the number of times they reportedly walked for exercise each week. Functional assessments (6-minute walk distance, 4-meter walking speed, summary performance score) were measured at baseline and annually. Results were adjusted for age, sex, ethnicity, comorbid conditions, body mass index, ankle-brachial index, education, leg symptoms, cigarette use, geriatric depression score, previous year's level of functioning, and patterns of missing data. Results: Compared with those who exercised less frequently, patients who walked for exercise 3 or more times per week had a significantly smaller average annual decline in 6-minute walking distance (-48.0 feet per year compared with - 56.6 feet per year for those who walked 1 to 2 times per week and - 79.4 feet per year for nonexercisers; P for trend = 0.037). Patients who walked for exercise at least 3 times per week experienced a smaller average annual decline in the usual-paced 4-meter walking velocity (-0.014 m/s per year compared with - 0.022 m/s per year for those who walked 1 to 2 times per week and - 0.045 m/s per year for nonexercisers; P = 0.005). Similar findings were observed for the fast-paced 4-meter walk. The subset of asymptomatic patients who walked for exercise 3 or more times per week had annual declines in 6-minute walking performance (P = 0.107), normal-paced walking velocity (P = 0.065), and the summary performance score (P = 0.115); however, these declines were smaller than those observed in asymptomatic participants who walked fewer than 3 times per week. Limitations: Because this was an observational study, associations reported here cannot be construed as causal relationships. Sample sizes for subgroup analyses were small, which limited statistical power. Conclusion: Among patients with PAD, self-directed walking exercise performed at least 3 times weekly is associated with significantly less functional decline during the subsequent year. Similar trends were observed in the subset of asymptomatic patients with PAD. These findings may be particularly important for the numerous patients with PAD who do not have access to supervised walking exercise programs.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Evanston NW Hosp, Evanston, IL USA; NIA, Baltimore, MD 21224 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Northwestern University; Feinberg School of Medicine; NorthShore University Health System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Greenland, Philip/ABD-5528-2021		NCRR NIH HHS [RR-00048] Funding Source: Medline; NHLBI NIH HHS [R01-HL58099, R01-HL64739] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064739, R01HL058099] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; Criqui M H, 1996, Vasc Med, V1, P65; Falcone Rita A, 2003, J Cardiopulm Rehabil, V23, P170, DOI 10.1097/00008483-200305000-00002; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; GURALNIK JM, 1995, N IH PUBL; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1177/1358836X0100600204; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LENG GC, 2000, COCHRANE DB SYST REV, V2; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2002, J GEN INTERN MED, V17, P895, DOI 10.1046/j.1525-1497.2002.20307.x; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; McDermott MM, 1997, J GEN INTERN MED, V12, P209, DOI 10.1046/j.1525-1497.1997.012004209.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; Regensteiner Judith G., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P233, DOI 10.2174/1568006043336195; Richardson M T, 1995, J Cardiopulm Rehabil, V15, P107, DOI 10.1097/00008483-199503000-00003; Rucker-Whitaker C, 2004, J AM GERIATR SOC, V52, P922, DOI 10.1111/j.1532-5415.2004.52259.x; SALLIS JF, 1990, MED SCI SPORT EXER, V22, P698, DOI 10.1249/00005768-199010000-00023; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Stewart KJ, 2002, NEW ENGL J MED, V347, P1941, DOI 10.1056/NEJMra021135; Swan PD, 1997, BRIT J SPORT MED, V31, P235, DOI 10.1136/bjsm.31.3.235; *TASC, 2000, J VASC SURG, V31, pS118; *TASC, 2000, J VASC SURG 2, V31, pS83	40	88	96	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					10	20		10.7326/0003-4819-144-1-200601030-00005	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389250				2022-12-01	WOS:000234474200002
J	Siegrist, SE; Doe, CQ				Siegrist, SE; Doe, CQ			Microtubule-induced Pins/G alpha i cortical polarity in Drosophila neuroblasts	CELL			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEINS; LARGE TUMOR-SUPPRESSOR; C-ELEGANS; NERVOUS-SYSTEM; DAUGHTER CELL; HUMAN HOMOLOG; 2 DISTINCT; LOCALIZATION; COMPLEX	Cortical polarity regulates cell division, migration, and differentiation. Microtubules induce cortical polarity in yeast, but few examples are known in metazoans. We show that astral microtubules, kinesin Khc-73, and Discs large (Dig) induce cortical polarization of Pins/G alpha i in Drosophila neuroblasts; this cortical domain is functional for generating spindle asymmetry, daughtercell-size asymmetry, and distinct sibling fates. Khc-73 localizes to astral microtubule plus ends, and Dlg/Khc-73 and Dig/Pins co-immunoprecipitate, suggesting that microtubules induce Pins/G alpha i cortical polarity through Dlg/Khc-73 interactions. The microtubule/Khc-73/Dlg pathway acts in parallel to the well-characterized Inscuteable/ Par pathway, but each provides unique spatial and temporal information: The Inscuteable/Par pathway initiates at prophase to coordinate neuroblast cortical polarity with CNS tissue polarity, whereas the microtubule/Khc-73/Dlg pathway functions at metaphase to coordinate neuroblast cortical polarity with the mitotic spindle axis. These results identify a role for microtubules in polarizing the neuroblast cortex, a fundamental step for generating cell diversity through asymmetric cell division.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu						Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Asaba N, 2003, J BIOL CHEM, V278, P8395, DOI 10.1074/jbc.M210362200; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Chou TB, 1996, GENETICS, V144, P1673; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Harlow, 1999, USING ANTIBODIES LAB; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; KIEHART DP, 1994, METHOD CELL BIOL, V44, P507, DOI 10.1016/S0091-679X(08)60929-2; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Mok H, 2002, J NEUROSCI, V22, P5253; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; SIEGRIST SE, 2006, IN PRESS DEVELOPMENT; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002	55	197	205	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1323	1335		10.1016/j.cell.2005.09.043	http://dx.doi.org/10.1016/j.cell.2005.09.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377571	Bronze			2022-12-01	WOS:000234584500019
J	van Leeuwen, R; Boekhoorn, S; Vingerling, JR; Witteman, JCM; Klaver, CCW; Hofman, A; de Jong, PTVM				van Leeuwen, R; Boekhoorn, S; Vingerling, JR; Witteman, JCM; Klaver, CCW; Hofman, A; de Jong, PTVM			Dietary intake of antioxidants and risk of age-related macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-E SUPPLEMENTATION; BEAVER DAM EYE; 5-YEAR INCIDENCE; ZINC INTAKE; MACULOPATHY; ROTTERDAM; QUESTIONNAIRE; PATHOGENESIS; VALIDATION; TRIAL	Context Age-related macular degeneration (AMD) is the most prevalent cause of irreversible blindness in developed countries. Recently, high-dose supplementation with beta carotene, vitamins C and E, and zinc was shown to slow the progression of AMD. Objective To investigate whether regular dietary intake of antioxidants is associated with a lower risk of incident AMD. Design Dietary intake was assessed at baseline in the Rotterdam Study (19901993) using a semiquantitative food frequency questionnaire. Incident AMD until final follow-up in 2004 was determined by grading fundus color transparencies in a masked way according to the International Classification and Grading System. Setting Population-based cohort of all inhabitants aged 55 years or older in a middle-class suburb of Rotterdam, the Netherlands. Participants Of 5836 persons at risk of AMD at baseline, 4765 had reliable dietary data and 4170 participated in the follow-up. Main Outcome Measure Incident AMD, defined as soft distinct drusen with pigment alterations, indistinct or reticular drusen, geographic atrophy, or choroidal neovascularization. Results Incident AMD occurred in 560 participants after a mean follow-up of 8.0 years (range, 0.3-13.9 years). Dietary intake of both vitamin E and zinc was inversely associated with incident AMD. The hazard ratio (H R) per standard deviation increase of intake for vitamin E was 0.92 (95% confidence interval [CI], 0.84-1.00) and for zinc was 0.91 (95% Cl, 0.83-0.98). An above-median intake of all 4 nutrients, beta carotene, vitamin C, vitamin E, and zinc, was associated with a 35% reduced risk (HR, 0.65; 95% Cl, 0.46-0.92) of AMD. Exclusion of supplement users did not affect the results. Conclusion In this study, a high dietary intake of beta carotene, vitamins C and E, and zinc was associated with a substantially reduced risk of AMD in elderly persons.	Royal Netherlands Acad Arts & Sci, Netherlands Ophthalm Res Inst, KNAW, NL-1105 BA Amsterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	de Jong, PTVM (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Ophthalm Res Inst, KNAW, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.dejong@ioi.knaw.nl	Klaver, Caroline C.W./A-2013-2016	Klaver, Caroline/0000-0002-2355-5258				Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cho EY, 2001, ANN EPIDEMIOL, V11, P328, DOI 10.1016/S1047-2797(01)00217-4; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Flood V, 2002, OPHTHALMOLOGY, V109, P2272, DOI 10.1016/S0161-6420(02)01263-0; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Ott A, 1998, AM J EPIDEMIOL, V147, P574; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Smith W, 1999, OPHTHALMOLOGY, V106, P761, DOI 10.1016/S0161-6420(99)90164-1; Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; *VOORL VOED, 2001, DUTCH FOOD COMP TABL; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	27	244	254	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3101	3107		10.1001/jama.294.24.3101	http://dx.doi.org/10.1001/jama.294.24.3101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380590				2022-12-01	WOS:000234274200026
J	Ogilvie, D; Hamlet, N				Ogilvie, D; Hamlet, N			Obesity: the elephant in the corner	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Forth Valley NHS Board, Stirling FK8 1DX, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Ogilvie, D (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	d.ogilvie@msoc.mrc.gla.ac.uk	Ogilvie, David/B-2444-2012	Ogilvie, David/0000-0002-0270-4672				[Anonymous], 2002, DIET NUTR PREV CHRON; ASP NG, 2002, OBESITY PROBLEMS INT; Day B.P.F., 2000, POSTHARV NEWS INFORM, V11, P27; *DEP TRANSP, ITS NO JOK; Department of Health, 2004, CHOOS HLTH MAK HLTH; Department of Transport, 2004, TRANSP STAT B NAT TR; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Ellaway A, 2003, J Epidemiol Community Health, V57, P315, DOI 10.1136/jech.57.5.315; ELLAWAY A, 2004, J EPIDEMIOLOGY COMMU, V58, P892; Hamilton Clive, 2004, GROWTH FETISH; Lean MEJ, 2005, BMJ-BRIT MED J, V330, P1339, DOI 10.1136/bmj.330.7504.1339; Neroth P, 2004, LANCET, V364, P651, DOI 10.1016/S0140-6736(04)16914-6; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; *ROYAL COLL PHYS L, 2004, STOR PROBL MED CAS S; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	17	17	17	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1545	1548		10.1136/bmj.331.7531.1545	http://dx.doi.org/10.1136/bmj.331.7531.1545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373747	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000234351300028
J	Pittermann, J; Sperry, JS; Hacke, UG; Wheeler, JK; Sikkema, EH				Pittermann, J; Sperry, JS; Hacke, UG; Wheeler, JK; Sikkema, EH			Torus-margo pits help conifers compete with angiosperms	SCIENCE			English	Article									Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sperry, JS (corresponding author), Univ Utah, Dept Biol, 257S 1400E, Salt Lake City, UT 84112 USA.	sperry@biology.utah.edu	Hacke, Uwe/M-7719-2015	Hacke, Uwe/0000-0001-5983-3582				HACKE UG, IN PRESS TREE PHYSL; SIAU JF, 1984, TRANSPORT PROCESSES, P49	2	139	150	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1924	1924		10.1126/science.1120479	http://dx.doi.org/10.1126/science.1120479			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373568				2022-12-01	WOS:000234275400033
J	Napolitano, C; Priori, SG; Schwartz, PJ; Bloise, R; Ronchetti, E; Nastoli, J; Bottelli, G; Cerrone, M; Leonardi, S				Napolitano, C; Priori, SG; Schwartz, PJ; Bloise, R; Ronchetti, E; Nastoli, J; Bottelli, G; Cerrone, M; Leonardi, S			Genetic testing in the long QT syndrome - Development and validation of an efficient approach to genotyping in clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPOUND MUTATIONS; CHANNEL; ARRHYTHMIA; DISEASE; EVENTS; DEATH; RISK	Context In long QT syndrome (LQTS), disease severity and response to therapy vary according to the genetic loci. There exists a critical need to devise strategies to expedite genetic analysis. Objective To perform genetic screening inpatients with LQTS to determine the yield of genetic testing, as well as the type and the prevalence of mutations. Design, Patients, and Setting We investigated whether the detection of a set of frequently mutated codons in the KCNQ1, KCNH2, and SCN5A genes may translate in a novel strategy for rapid efficient genetic testing of 430 consecutive patients referred to our center between June 1996 and June 2004. The entire coding regions of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 were screened by denaturing high-performance liquid chromatography and DNA sequencing. The frequency and the type of mutations were defined to identify a set of recurring mutations. A separate cohort of 75 consecutive probands was used as a validation group to quantify prospectively the prevalence of the recurring mutations identified in the primary LQTS population. Main Outcome Measures Development of a novel approach to LQTS genotyping. Results We identified 235 different mutations, 138 of which were novel, in 310 (72%) of 430 probands (49% KCNQ1, 39% KCNH2, 10% SCN5A, 1.7% KCNE1, and 0.7% KCNE2). Fifty-eight percent of probands carried nonprivate mutations in 64 codons of KCNQ1, KCNH2, and SCN5A genes. A similar occurrence of mutations at these codons (52%) was confirmed in the prospective cohort of 75 probands and in previously published LQTS cohorts. Conclusions We have developed an approach to improve the efficiency of genetic screening for LQTS. This novel method may facilitate wider access to genotyping resulting in better risk stratification and treatment of LQTS patients.	Univ Pavia, Maugeri Fdn, I-27100 Pavia, Italy; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; IRCCS Policlin S Matteo, Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo	Priori, SG (corresponding author), Univ Pavia, Maugeri Fdn, Via Ferrata 8, I-27100 Pavia, Italy.	spriori@fsm.it	Napolitano, Carlo/K-4760-2016; Leonardi, Sergio/AAK-1490-2020; Priori, Silvia G/ABH-6894-2020; napolitano, carlo/ABI-4608-2020; Leonardi, Sergio/K-4334-2018; bloise, raffaella/AAC-2922-2020; Schwartz, Peter J/J-4267-2016; Priori, Silvia G G/A-6116-2014	Napolitano, Carlo/0000-0002-7643-4628; Leonardi, Sergio/0000-0002-4800-6132; Priori, Silvia G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; Leonardi, Sergio/0000-0002-4800-6132; bloise, raffaella/0000-0003-3485-9596; Schwartz, Peter J/0000-0003-0367-1048; Priori, Silvia G G/0000-0001-6877-0288; Cerrone, Marina/0000-0002-6122-9939; ronchetti, elena/0000-0002-9185-7848; Nastoli, janni/0000-0002-5888-5951	NHLBI NIH HHS [HL68880] Funding Source: Medline; Telethon [GP0227Y01, GGP04066] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068880] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 1998, CIRCULATION, V97, P2420, DOI 10.1161/01.CIR.97.24.2420; PRIORI SG, 2003, CARDIAC ELECTROPHYSI, P462; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2003, J CARDIOVASC ELECTR, V14, P1120, DOI 10.1046/j.1540-8167.2003.03339.x; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; WARD O C, 1964, J Ir Med Assoc, V54, P103; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zareba W, 2003, J CARDIOVASC ELECTR, V14, P1149, DOI 10.1046/j.1540-8167.2003.03177.x	21	328	343	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					2975	2980		10.1001/jama.294.23.2975	http://dx.doi.org/10.1001/jama.294.23.2975			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414944	Bronze			2022-12-01	WOS:000234087700023
J	Hnasko, TS; Sotak, BN; Palmiter, RD				Hnasko, TS; Sotak, BN; Palmiter, RD			Morphine reward in dopamine-deficient mice	NATURE			English	Article							VENTRAL TEGMENTAL AREA; KNOCK-OUT MICE; NUCLEUS-ACCUMBENS; LOCOMOTOR-ACTIVITY; PLACE PREFERENCE; RECEPTOR; RATS; ANALGESIA; SYSTEM; AMPHETAMINE	Dopamine has been widely implicated as a mediator of many of the behavioural responses to drugs of abuse(1). To test the hypothesis that dopamine is an essential mediator of various opiate-induced responses, we administered morphine to mice unable to synthesize dopamine. We found that dopamine-deficient mice are unable to mount a normal locomotor response to morphine, but a small dopamine-independent increase in locomotion remains. Dopamine-deficient mice have a rightward shift in the dose - response curve to morphine on the tail-flick test ( a pain sensitivity assay), suggesting either a decreased sensitivity to the analgesic effects of morphine and/or basal hyperalgesia. In contrast, dopamine-deficient mice display a robust conditioned place preference for morphine when given either caffeine or L-dihydroxyphenylalanine ( a dopamine precursor that restores dopamine throughout the brain) during the testing phases. Together, these data demonstrate that dopamine is a crucial component of morphine-induced locomotion, dopamine may contribute to morphine analgesia, but that dopamine is not required for morphine-induced reward as measured by conditioned place preference.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@u.washington.edu		Hnasko, Thomas/0000-0001-6176-8513				Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; BECHARA A, 1989, J NEUROSCI, V9, P3400; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; BOZARTH MA, 1987, BRAIN RES, V414, P77, DOI 10.1016/0006-8993(87)91327-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; Elmer GI, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0004.2002; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Franklin KBJ, 1998, PHARMACOL BIOCHEM BE, V59, P993, DOI 10.1016/S0091-3057(97)00535-2; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kim DS, 2003, P NATL ACAD SCI USA, V100, P1346, DOI 10.1073/pnas.252753799; King MA, 2001, J NEUROSCI, V21, P7788, DOI 10.1523/JNEUROSCI.21-19-07788.2001; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Manzanedo C, 2001, BEHAV BRAIN RES, V121, P189, DOI 10.1016/S0166-4328(01)00164-4; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; OLDS ME, 1982, BRAIN RES, V237, P429, DOI 10.1016/0006-8993(82)90454-1; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; SHIPPENBERG TS, 1993, J PHARMACOL EXP THER, V265, P53; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	29	182	196	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					854	857		10.1038/nature04172	http://dx.doi.org/10.1038/nature04172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341013				2022-12-01	WOS:000233777800051
J	Kaplan, RN; Riba, RD; Zacharoulis, S; Bramley, AH; Vincent, L; Costa, C; MacDonald, DD; Jin, DK; Shido, K; Kerns, SA; Zhu, ZP; Hicklin, D; Wu, Y; Port, JL; Altorki, N; Port, ER; Ruggero, D; Shmelkov, SV; Jensen, KK; Rafii, S; Lyden, D				Kaplan, RN; Riba, RD; Zacharoulis, S; Bramley, AH; Vincent, L; Costa, C; MacDonald, DD; Jin, DK; Shido, K; Kerns, SA; Zhu, ZP; Hicklin, D; Wu, Y; Port, JL; Altorki, N; Port, ER; Ruggero, D; Shmelkov, SV; Jensen, KK; Rafii, S; Lyden, D			VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-1; ENDOTHELIAL-CELLS; CHEMOKINE RECEPTORS; TUMOR ANGIOGENESIS; STEM; ADHESION; INTEGRINS; MMP-9; RECRUITMENT; PROGRESSION	The cellular and molecular mechanisms by which a tumour cell undergoes metastasis to a predetermined location are largely unknown. Here we demonstrate that bone marrow-derived haematopoietic progenitor cells that express vascular endothelial growth factor receptor 1 (VEGFR1; also known as Flt1) home to tumour-specific pre-metastatic sites and form cellular clusters before the arrival of tumour cells. Preventing VEGFR1 function using antibodies or by the removal of VEGFR1(+) cells from the bone marrow of wild-type mice abrogates the formation of these pre-metastatic clusters and prevents tumour metastasis, whereas reconstitution with selected Id3 ( inhibitor of differentiation 3)-competent VEGFR1(+) cells establishes cluster formation and tumour metastasis in Id3 knockout mice. We also show that VEGFR1(+) cells express VLA-4 ( also known as integrin alpha(4)beta(1)), and that tumour-specific growth factors upregulate fibronectin - a VLA-4 ligand - in resident fibroblasts, providing a permissive niche for incoming tumour cells. Conditioned media obtained from distinct tumour types with unique patterns of metastatic spread redirected fibronectin expression and cluster formation, thereby transforming the metastatic profile. These findings demonstrate a requirement for VEGFR1(+) haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1(+)VLA-4(+) clusters dictate organ-specific tumour spread.	Cornell Univ, Weill Cornell Med Coll, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Cornell Med Coll, Childrens Blood Fdn Labs, New York, NY 10021 USA; Cornell Univ, Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Imclone Syst Inc, New York, NY 10014 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Eli Lilly; Fox Chase Cancer Center	Lyden, D (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pediat, 1300 York Ave, New York, NY 10021 USA.	srafii@med.cornell.edu; dcl2001@med.cornell.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Costa, Carla/0000-0001-5977-6207	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL067839-050004, R01 HL061849, R01 HL061849-03, P01 HL067839-040004, R01 HL061849-02, P01 HL067839-010004, R01 HL061849-05, R01 HL061849-03S1, R01 HL058707-03, P01 HL067839, R01 HL058707-04, R01 HL061849-04, P01 HL067839-020004, P01 HL067839-030004] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067839, R01HL058707, R01HL061849] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Burger JA, 2003, BRIT J HAEMATOL, V122, P579, DOI 10.1046/j.1365-2141.2003.04466.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; JONJIC N, 1992, J IMMUNOL, V148, P2080; Kessinger A, 2001, EXP HEMATOL, V29, P775, DOI 10.1016/S0301-472X(01)00642-7; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neeson PJ, 2003, PATHOLOGY, V35, P50, DOI 10.1080/003130202201478; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian F, 2001, P NATL ACAD SCI USA, V98, P3976, DOI 10.1073/pnas.061633698; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; TAM PP, 1999, DEVELOPMENT, V124, P1631; Yakubenko VP, 2000, EXP CELL RES, V260, P73, DOI 10.1006/excr.2000.5002	36	2252	2373	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					820	827		10.1038/nature04186	http://dx.doi.org/10.1038/nature04186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341007	Green Accepted			2022-12-01	WOS:000233777800044
J	Pacheco, G; Cavallasca, JA				Pacheco, G; Cavallasca, JA			Deforming gout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital de Clinicas Jose de San Martin	Pacheco, G (corresponding author), Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina.			Cavallasca, Javier/0000-0003-4621-519X					0	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					E20	E20		10.1056/NEJMicm040861	http://dx.doi.org/10.1056/NEJMicm040861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339089				2022-12-01	WOS:000233754400011
J	Johnston, DT; Wing, BA; Farquhar, J; Kaufman, AJ; Strauss, H; Lyons, TW; Kah, LC; Canfield, DE				Johnston, DT; Wing, BA; Farquhar, J; Kaufman, AJ; Strauss, H; Lyons, TW; Kah, LC; Canfield, DE			Active microbial sulfur disproportionation in the Mesoproterozoic	SCIENCE			English	Article							ELEMENTAL SULFUR; ATMOSPHERIC OXYGEN; ISOTOPE; SULFATE; EVOLUTION; OCEAN; REDUCTION; CYCLES; CARBON	The environmental expression of sulfur compound disproportionation has been placed between 640 and 1050 million years ago (Ma) and linked to increases in atmospheric oxygen. These arguments have their basis in temporal changes in the magnitude of S-34/S-32 fractionations between sulfate and sulfide. Here, we present a Proterozoic seawater sulfate isotope record that includes the less abundant sulfur isotope S-33. These measurements imply that sulfur compound disproportionation was an active part of the sulfur cycle by 1300 Ma and that progressive Earth surface oxygenation may have characterized the Mesoproterozoic.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Univ Munster, Inst Geol Palaontol, D-48149 Munster, Germany; Univ Munster, Geol Palaontol Museum, D-48149 Munster, Germany; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; So Denmark Univ, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; So Denmark Univ, Inst Biol, DK-5230 Odense, Denmark	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Munster; University of Munster; University of California System; University of California Riverside; University of Tennessee System; University of Tennessee Knoxville; University of Southern Denmark; University of Southern Denmark	Johnston, DT (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	dtj@geol.umd.edu; wing@essic.umd.edu	Canfield, Don/C-1735-2012; Kah, Linda C/J-3754-2019; Johnston, David/A-9796-2010	Canfield, Don/0000-0001-7602-8366; Kah, Linda C/0000-0001-7172-2033; Johnston, David/0000-0002-2487-1084				BAK F, 1987, ARCH MICROBIOL, V147, P184, DOI 10.1007/BF00415282; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 1998, LIMNOL OCEANOGR, V43, P253, DOI 10.4319/lo.1998.43.2.0253; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Frank TD, 2003, GEOL MAG, V140, P397, DOI 10.1017/S0016756803007830; GARRELS RM, 1981, P NATL ACAD SCI USA, V78, P4652, DOI 10.1073/pnas.78.8.4652; Gellatly AM, 2005, GEOCHIM COSMOCHIM AC, V69, P3813, DOI 10.1016/j.gca.2005.01.019; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HATTORI K, 1983, NATURE, V302, P323, DOI 10.1038/302323a0; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Johnston DT, 2005, AM J SCI, V305, P645, DOI 10.2475/ajs.305.6-8.645; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; PERRY EC, 1971, SCIENCE, V171, P1015, DOI 10.1126/science.171.3975.1015; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2	27	173	177	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1477	1479		10.1126/science.1117824	http://dx.doi.org/10.1126/science.1117824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322453	Green Submitted			2022-12-01	WOS:000233756500039
J	Reddien, PW; Oviedo, NJ; Jennings, JR; Jenkin, JC; Alvarado, AS				Reddien, PW; Oviedo, NJ; Jennings, JR; Jenkin, JC; Alvarado, AS			SMEDWI-2 is a PIWI-like protein that regulates planarian stem cells	SCIENCE			English	Article							REGENERATION; GENE; SPERMATOGENESIS; IDENTIFICATION; ARGONAUTE2; HOMOLOG; FAMILY; RNAI	We have identified two genes, smedwi-1 and smedwi-2, expressed in the dividing adult stem cells (neoblasts) of the planarian Schmidtea mediterranea. Both genes encode proteins that belong to the Argonaute/PIWI protein family and that share highest homology with those proteins defined by Drosophila PIWI. RNA interference (RNAi) of smedwi-2 blocks regeneration, even though neoblasts are present, irradiation-sensitive, and capable of proliferating in response to wounding; smedwi-2(RNAi) neoblast progeny migrate to sites of cell turnover but, unlike normal cells, fail at replacing aged tissue. We suggest that SMEDWI-2 functions within dividing neoblasts to support the generation of cells that promote regeneration and homeostasis.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.	sanchez@neuro.utah.edu		/0000-0002-5569-333X	NIGMS NIH HHS [R0-1 GM57260] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057260] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Asami M, 2002, ZOOL SCI, V19, P1257, DOI 10.2108/zsj.19.1257; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004	19	434	455	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1327	1330		10.1126/science.1116110	http://dx.doi.org/10.1126/science.1116110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311336				2022-12-01	WOS:000233600200041
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Control of B-cell responses by Toll-like receptors	NATURE			English	Article							GERMINAL CENTER FORMATION; T-CELL; IMMUNE-RESPONSES; PLASMA-CELLS; BLIMP-1; LYMPHOCYTES; ACTIVATION; EXPRESSION; DIFFERENTIATION; MEMORY	Toll-like receptors (TLRs) detect microbial infection and have an essential role in the induction of immune responses(1-3). TLRs can directly induce innate host defence responses, but the mechanisms of TLR-mediated control of adaptive immunity are not fully understood. Although TLR-induced dendritic cell maturation is required for activation of T-helper (T-H) cells(4), the role of TLRs in B-cell activation and antibody production in vivo is not yet known. Here we show that activation and differentiation of TH cells is not sufficient for the induction of T-dependent B-cell responses. We find that, in addition to CD4(+) T-cell help, generation of T-dependent antigen-specific antibody responses requires activation of TLRs in B cells.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu	Eckhardt, Erik/G-1567-2010					Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barton GM, 2002, CURR OPIN IMMUNOL, V14, P380, DOI 10.1016/S0952-7915(02)00343-6; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bondada S, 2000, VACCINE, V19, P557, DOI 10.1016/S0264-410X(00)00161-4; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LASZLO G, 1993, J IMMUNOL, V150, P5252; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MOLLER G, 1972, CELL IMMUNOL, V4, P416, DOI 10.1016/0008-8749(72)90043-3; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Soro PG, 1999, J IMMUNOL, V163, P611; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vos Q, 2000, IMMUNOL REV, V176, P154	30	579	601	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					364	368		10.1038/nature04267	http://dx.doi.org/10.1038/nature04267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292312				2022-12-01	WOS:000233300200050
J	Haumann, M; Liebisch, P; Muller, C; Barra, M; Grabolle, M; Dau, H				Haumann, M; Liebisch, P; Muller, C; Barra, M; Grabolle, M; Dau, H			Photosynthetic O-2 formation tracked by time-resolved X-ray experiments	SCIENCE			English	Article							BIOLOGICAL METAL CENTERS; II-MANGANESE COMPLEX; PHOTOSYSTEM-II; WATER OXIDATION; ABSORPTION SPECTROSCOPY; ROOM-TEMPERATURE; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; PROTON RELEASE; OXYGEN	Plants and cyanobacteria produce atmospheric dioxygen from water, powered by sunlight and catalyzed by a manganese complex in photosystem II. A classic S-cycle model for oxygen evolution involves five states, but only four have been identified. The missing S-4 state is particularly important because it is directly involved in dioxygen formation. Now progress comes from an x-ray technique that can monitor redox and structural changes in metal centers in real time with 10-microsecond resolution. We show that in the O-2-formation step, an intermediate is formed-the enigmatic S-4 state. Its creation is identified with a deprotonation process rather than the expected electron-transfer mechanism. Subsequent electron transfer would give an additional S-4' state, thus extending the fundamental S-state cycle of dioxygen formation.	Free Univ Berlin, FB Phys, D-14195 Berlin, Germany	Free University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, FB Phys, Arnimallee 14, D-14195 Berlin, Germany.	haumann@physik.fu-berlin.de; holger.dau@physik.fu-berlin.de	MIchael, Haumann/A-7087-2013	Dau, Holger/0000-0001-6482-7494				Ahlbrink R, 1998, BIOCHEMISTRY-US, V37, P1131, DOI 10.1021/bi9719152; BABCOCK GT, 1976, FEBS LETT, V61, P286; Barber J, 2004, BBA-BIOENERGETICS, V1655, P123, DOI 10.1016/j.bbabio.2003.10.011; Clausen J, 2004, NATURE, V430, P480, DOI 10.1038/nature02676; Dau H, 2005, PHOTOSYNTH RES, V84, P325, DOI 10.1007/s11120-004-7080-2; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 2005, J SYNCHROTRON RADIAT, V12, P35, DOI 10.1107/S0909049504027803; Haumann M, 2002, FEBS LETT, V512, P116, DOI 10.1016/S0014-5793(02)02237-8; HAUMANN M, 1994, BIOCHEMISTRY-US, V33, P864, DOI 10.1021/bi00170a003; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; JOLIOT P, 1968, BIOCHIM BIOPHYS ACTA, V153, P625, DOI 10.1016/0005-2728(68)90190-4; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Mamedov F, 1998, BIOCHEMISTRY-US, V37, P14245, DOI 10.1021/bi980194j; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; McEvoy JP, 2004, PHYS CHEM CHEM PHYS, V6, P4754, DOI 10.1039/b407500e; Meinke C, 2000, BIOCHEMISTRY-US, V39, P7033, DOI 10.1021/bi9924258; ONO T, 1992, SCIENCE, V258, P1335, DOI 10.1126/science.258.5086.1335; Penner-Hahn JE, 2003, NAT STRUCT BIOL, V10, P75, DOI 10.1038/nsb0203-75; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Razeghifard MR, 1997, BIOCHEMISTRY-US, V36, P86, DOI 10.1021/bi9614287; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P341, DOI 10.1016/S0968-0004(01)01874-6; YACHANDRA VK, 1995, METHOD ENZYMOL, V246, P638; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589; 2001, BIOCH BIOPHYS ACTA, V1503	30	375	381	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1019	1021		10.1126/science.1117551	http://dx.doi.org/10.1126/science.1117551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284178				2022-12-01	WOS:000233343400044
J	He, MM; Smith, AS; Oslob, JD; Flanagan, WM; Braisted, AC; Whitty, A; Cancilla, MT; Wang, J; Lugovskoy, AA; Yoburn, JC; Fung, AD; Farrington, G; Eldredge, JK; Day, ES; Cruz, LA; Cachero, TG; Miller, SK; Friedman, JE; Choong, IC; Cunningham, BC				He, MM; Smith, AS; Oslob, JD; Flanagan, WM; Braisted, AC; Whitty, A; Cancilla, MT; Wang, J; Lugovskoy, AA; Yoburn, JC; Fung, AD; Farrington, G; Eldredge, JK; Day, ES; Cruz, LA; Cachero, TG; Miller, SK; Friedman, JE; Choong, IC; Cunningham, BC			Small-molecule inhibition of TNF-alpha	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; DIMERIZATION; DERIVATIVES; DISCOVERY; RECEPTOR	We have identified a small-molecule inhibitor of tumor necrosis factor a (TNF-alpha) that promotes subunit disassembly of this trimeric cytokine family member. The compound inhibits TNF-alpha activity in biochemical and cell-based assays with median inhibitory concentrations of 22 and 4.6 micromolar, respectively. Formation of an intermediate complex between the compound and the intact trimer results in a 600-fold accelerated subunit dissociation rate that leads to trimer dissociation. A structure solved by x-ray crystallography reveals that a single compound molecule displaces a subunit of the trimer to form a complex with a dimer of TNF-alpha subunits.	Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA; CUNY Mt Sinai Sch Med, Kravis Childrens Hosp, New York, NY 10029 USA; Biogenldec, Dept Drug Discovery, Cambridge, MA 02142 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94143 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Cunningham, BC (corresponding author), Sunesis Pharmaceut Inc, 341 Oyster Point Blvd, San Francisco, CA 94080 USA.	bcc@sunesis.com	Stroustrup, Annemarie/ABB-5846-2020; Day, Eric S/C-5020-2009	Stroustrup, Annemarie/0000-0002-5667-6195; 				Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Blasko E, 2002, J BIOL CHEM, V277, P295, DOI 10.1074/jbc.M105691200; Capps KJ, 2005, BIOORG MED CHEM LETT, V15, P2840, DOI 10.1016/j.bmcl.2005.03.094; Cheng JF, 2003, BIOORG MED CHEM LETT, V13, P3647, DOI 10.1016/j.bmcl.2003.08.025; Clark MP, 2004, J MED CHEM, V47, P2724, DOI 10.1021/jm049968m; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DELANO WL, 2004, PRACTICAL APPROACH S, V266, P85; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Jackson RW, 2003, BIOORG MED CHEM LETT, V13, P205, DOI 10.1016/S0960-894X(02)00877-6; Jackson RW, 2002, BIOORG MED CHEM LETT, V12, P1093, DOI 10.1016/S0960-894X(02)00098-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P2189, DOI 10.1016/S0960-894X(01)00419-X; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Niwayama S, 1996, J MED CHEM, V39, P3044, DOI 10.1021/jm960284r; Niwayama S, 1998, BIOORG MED CHEM LETT, V8, P1071, DOI 10.1016/S0960-894X(98)00171-1; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Toogood PL, 2002, J MED CHEM, V45, P1543, DOI 10.1021/jm010468s	19	338	387	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1022	1025		10.1126/science.1116304	http://dx.doi.org/10.1126/science.1116304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	984YN	16284179				2022-12-01	WOS:000233343400045
J	Huang, CC; Tang, M; Zhang, MY; Majeed, S; Montabana, E; Stanfield, RL; Dimitrov, DS; Korber, B; Sodroski, J; Wilson, IA; Wyatt, R; Kwong, PD				Huang, CC; Tang, M; Zhang, MY; Majeed, S; Montabana, E; Stanfield, RL; Dimitrov, DS; Korber, B; Sodroski, J; Wilson, IA; Wyatt, R; Kwong, PD			Structure of a V3-containing HIV-1 gp120 core	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; SOLUBLE CD4; V3 LOOP; CRYSTAL-STRUCTURE; TYPE-1; RECEPTOR; ANTIBODY; BINDING; NEUTRALIZATION	The third variable region (V3) of the HIV-1 gp120 envelope glycoprotein is immunodominant and contains features essential for coreceptor binding. We determined the structure of V3 in the context of an HIV-1 gp120 core complexed to the CD4 receptor and to the X5 antibody at 3.5 angstrom resolution. Binding of gp120 to cell-surface CD4 would position V3 so that its coreceptor-binding tip protrudes 30 angstroms from the core toward the target cell membrane. The extended nature and antibody accessibility of V3 explain its immunodominance. Together, the results provide a structural rationale for the role of V3 in HIV entry and neutralization.	NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; SAIC Frederick, Basic Res Program, Frederick, MD USA; NCI, Prot Interact Grp, Ctr Canc Res, Nanobiol Program, Frederick, MD 21702 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Wyatt, R (corresponding author), NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA.	richw@mail.nih.gov; pdkwong@nih.gov	Abrams, William R/A-5782-2008; Stanfield, Robyn/AAH-3190-2019	Korber, Bette/0000-0002-2026-5757	Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NIAID NIH HHS [AI24755, AI40895, AI39429, AI31783] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005050, R01AI031783, R37AI024755, Z01AI005022, R01AI024755, R01AI040895] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; KUIKEN CL, 2002, SEQUENCE COMPENDIUM; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LIN G, 2005, 12 C RETR OPP INF BO; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; Stevens RC, 2001, SCIENCE, V293, P519, DOI 10.1126/science.293.5529.519; Sullivan N, 1998, J VIROL, V72, P6332, DOI 10.1128/JVI.72.8.6332-6338.1998; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WERNER A, 1993, J VIROL, V67, P2566, DOI 10.1128/JVI.67.5.2566-2574.1993; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	35	609	640	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1025	1028		10.1126/science.1118398	http://dx.doi.org/10.1126/science.1118398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284180	Green Accepted			2022-12-01	WOS:000233343400046
J	Kanneganti, TD; Ozoren, N; Body-Malapel, M; Amer, A; Park, JH; Franchi, L; Whitfield, J; Barchet, W; Colonna, M; Vandenabeele, P; Bertin, J; Coyle, A; Grant, EP; Akira, S; Nunez, G				Kanneganti, TD; Ozoren, N; Body-Malapel, M; Amer, A; Park, JH; Franchi, L; Whitfield, J; Barchet, W; Colonna, M; Vandenabeele, P; Bertin, J; Coyle, A; Grant, EP; Akira, S; Nunez, G			Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3	NATURE			English	Article							TOLL-LIKE RECEPTORS; CUTTING EDGE; INTERLEUKIN-1-BETA; CELLS; INFLAMMASOME; SECRETION; IMIQUIMOD; DISEASE; INNATE; RECOGNITION	Missense mutations in the CIAS1 gene cause three autoinflammatory disorders: familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multiple-system inflammatory disease(1). Cryopyrin (also called Nalp3), the product of CIAS1, is a member of the NOD-LRR protein family that has been linked to the activation of intracellular host defence signalling pathways(2,3). Cryopyrin forms a multi-protein complex termed 'the inflammasome', which contains the apoptosis-associated speck-like protein (ASC) and caspase-1, and promotes caspase-1 activation and processing of pro-interleukin (IL)-1 beta (ref. 4). Here we show the effect of cryopyrin deficiency on inflammasome function and immune responses. Cryopyrin and ASC are essential for caspase-1 activation and IL-1 beta and IL-18 production in response to bacterial RNA and the imidazoquinoline compounds R837 and R848. In contrast, secretion of tumour-necrosis factor-alpha and IL-6, as well as activation of NF-kappa B and mitogen-activated protein kinases (MAPKs) were unaffected by cryopyrin deficiency. Furthermore, we show that Toll-like receptors and cryopyrin control the secretion of IL-1 beta and IL-18 through different intracellular pathways. These results reveal a critical role for cryopyrin in host defence through bacterial RNA-mediated activation of caspase-1, and provide insights regarding the pathogenesis of autoinflammatory syndromes.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Ghent, Dept Mol Biomed Res, B-9052 Zwijnaarde, Belgium; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	University of Michigan System; University of Michigan; Washington University (WUSTL); Ghent University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Osaka University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@med.umich.edu	Amer, Amal/E-2643-2011; Kanneganti, Thirumala-Devi/Y-2503-2019; Grant, Ethan/GQP-2720-2022; Vandenabeele, Peter/AAD-5793-2022; Akira, Shizuo/C-3134-2009; Kanneganti, Thirumala-Devi/M-9435-2018; Vandenabeele, Peter/C-8597-2009; Nuñez, Gabriel/A-7160-2014; Ozoren, Nesrin/AAS-3279-2020; Body-Malapel, Mathilde/K-9981-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vandenabeele, Peter/0000-0002-6669-8822; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Body-Malapel, Mathilde/0000-0003-3392-4229; Colonna, Marco/0000-0001-5222-4987; Barchet, Winfried/0000-0002-6745-6606; OZOREN, NESRIN/0000-0002-8580-618X				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Athman R, 2004, CURR OPIN MICROBIOL, V7, P25, DOI 10.1016/j.mib.2003.12.013; Craft N, 2005, J IMMUNOL, V175, P1983, DOI 10.4049/jimmunol.175.3.1983; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dockrell DH, 2001, J ANTIMICROB CHEMOTH, V48, P751, DOI 10.1093/jac/48.6.751; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; HARRISON CJ, 1988, ANTIVIR RES, V10, P209, DOI 10.1016/0166-3542(88)90032-0; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Janssen R, 2004, ARTHRITIS RHEUM, V50, P3329, DOI 10.1002/art.20494; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marks R, 2001, J AM ACAD DERMATOL, V44, P807, DOI 10.1067/mjd.2001.113689; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; OZOREN N, UNPUB J IMMUNOL; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; TOMAI MA, 1995, ANTIVIR RES, V28, P253, DOI 10.1016/0166-3542(95)00054-P	27	860	898	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					233	236		10.1038/nature04517	http://dx.doi.org/10.1038/nature04517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407888	Green Published, Bronze			2022-12-01	WOS:000235839500051
J	Stingl, J; Eirew, P; Ricketson, I; Shackleton, M; Vaillant, F; Choi, D; Li, HYI; Eaves, CJ				Stingl, J; Eirew, P; Ricketson, I; Shackleton, M; Vaillant, F; Choi, D; Li, HYI; Eaves, CJ			Purification and unique properties of mammary epithelial stem cells	NATURE			English	Article							IDENTIFICATION; GLAND; PROGENITORS; ENRICHMENT	Elucidation of the cellular and molecular mechanisms that maintain mammary epithelial tissue integrity is of broad interest and paramount to the design of more effective treatments for breast cancer(1). Evidence from both in vitro and in vivo experiments suggests that mammary cell differentiation is a hierarchical process originating in an uncommitted stem cell with self-renewal potential(2-4). However, analysis of the properties and regulation of mammary stem cells has been limited by a lack of methods for their prospective isolation. Here we report the use of multiparameter cell sorting and limiting dilution transplant analysis to demonstrate the purification of a rare subset of adult mouse mammary cells that are able individually to regenerate an entire mammary gland within 6 weeks in vivo while simultaneously executing up to ten symmetrical self-renewal divisions. These mammary stem cells are phenotypically distinct from and give rise to mammary epithelial progenitor cells that produce adherent colonies in vitro. The mammary stem cells are also a rapidly cycling population in the normal adult and have molecular features indicative of a basal position in the mammary epithelium.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; StemCell Technol Inc, Vancouver, BC V5Z 1B3, Canada; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, WEHI Biotechnol Ctr, Parkville, Vic 3050, Australia; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; STEMCELL Technologies Canada Inc.; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of British Columbia; University of British Columbia; University of British Columbia	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca						Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI [10.1186/bcr563, 10.1186/bcr547]; Bhattacharya S, 2003, INVEST OPHTH VIS SCI, V44, P2764, DOI 10.1167/iovs.02-0899; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Sakakura T., 1987, The mammary gland. Development, regulation, and function., P37; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; STINGL J, 2005, METHODS MOL BIOL BAS, P249; SZILVASSY SJ, 2002, METHODS MOL MED HEMA, P167; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Uchida N, 2004, BLOOD, V103, P4487, DOI 10.1182/blood-2003-11-3989; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Young SR, 2000, AM J HUM GENET, V67, P74; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	29	1175	1238	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					993	997		10.1038/nature04496	http://dx.doi.org/10.1038/nature04496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16395311				2022-12-01	WOS:000235486100051
J	Aaskov, J; Buzacott, K; Thu, HM; Lowry, K; Holmes, EC				Aaskov, J; Buzacott, K; Thu, HM; Lowry, K; Holmes, EC			Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes	SCIENCE			English	Article							SELECTION; GENETICS; HOST	In 2001, dengue virus type 1 (DENV-1) populations in humans and mosquitoes from Myanmar acquired a stop-codon mutation in the surface envelope (E) protein gene. Within a year, this stop-codon strain had spread to all individuals sampled. The presence of truncated E protein species within individual vital populations, along with a general relaxation in selective constraint, indicated that the stop-codon strain represents a defective lineage of DENV-1. We propose that such tong-term transmission of defective RNA viruses in nature was achieved through complementation by coinfection of host cells with functional viruses.	Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia; Dept Med Res, Yangon 11191, Myanmar; Australian Army Malaria Inst, Brisbane, Qld 4051, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute	Holmes, EC (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	ech15@psu.edu	Lowry, Kym/AAK-2711-2021; Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022	Holmes, Edward/0000-0001-9596-3552; Lowry, Kym/0000-0002-9666-149X				Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Craig S, 2003, J VIROL, V77, P4463, DOI 10.1128/JVI.77.7.4463-4467.2003; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Froissart R, 2004, GENETICS, V168, P9, DOI 10.1534/genetics.104.030205; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; KASSANIS B, 1960, NATURE, V336, P435; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lopez-Ferber M, 2003, P ROY SOC B-BIOL SCI, V270, P2249, DOI 10.1098/rspb.2003.2498; Maddison, 2000, MACCLADE ANAL PHYLOG; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Novella IS, 2004, J VIROL, V78, P5799, DOI 10.1128/JVI.78.11.5799-5804.2004; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STRAUSS EG, 1988, VIROLOGY, V164, P265, DOI 10.1016/0042-6822(88)90644-7; Swofford DL, 2002, PAUP VERSION 40 B10; Taylor DR, 1998, AM NAT, V151, P343, DOI 10.1086/286123; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549	20	191	193	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					236	238		10.1126/science.1115030	http://dx.doi.org/10.1126/science.1115030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410525				2022-12-01	WOS:000234722200044
J	Alto, NM; Shao, F; Lazar, CS; Brost, RL; Chua, G; Mattoo, S; McMahon, SA; Ghosh, P; Hughes, TR; Boone, C; Dixon, JE				Alto, NM; Shao, F; Lazar, CS; Brost, RL; Chua, G; Mattoo, S; McMahon, SA; Ghosh, P; Hughes, TR; Boone, C; Dixon, JE			Identification of a bacterial type III effector family with G protein mimicry functions	CELL			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ACTIN STRESS FIBERS; GENOME-WIDE ANALYSIS; SALMONELLA-TYPHIMURIUM; FOCAL ADHESIONS; RHO; EXPRESSION; INTEGRITY; CYTOSKELETON; PATHWAYS	Many bacterial pathogens use the type III secretion system to inject "effector" proteins into host cells. Here, we report the identification of a 24 member effector protein family found in pathogens including Salmonella, Shigella, and entero pathogenic E. coli. Members of this family subvert host cell function by mimicking the signaling properties of Ras-like GTPases. The effector IpgB2 stimulates cellular responses analogous to GTP-active RhoA, whereas IpgB1 and Map function as the active forms of Rac1 and Cdc42, respectively. These effectors do not bind guanine nucleotides or have sequences corresponding the conserved GTPase domain, suggesting that they are functional but not structural mimics. However, several of these effectors harbor intracellular targeting sequences that contribute to their signaling specificities. The activities of IpgB2, IpgB1, and Map are dependent on an invariant WxxxE motif found in numerous effectors leading to the speculation that they all function by a similar molecular mechanism.	Univ Calif San Diego, Dept Pharmacol Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institute of Biological Sciences, Beijing; University of Toronto; University of Toronto; University of St Andrews	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol Cellular & Mol Med, La Jolla, CA 92093 USA.	jedixon@ucsd.edu	Mattoo, Seema/ABD-5624-2021	Mattoo, Seema/0000-0003-3260-0046				Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217	36	219	229	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					133	145		10.1016/j.cell.2005.10.031	http://dx.doi.org/10.1016/j.cell.2005.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413487	Bronze			2022-12-01	WOS:000234969600015
J	Coyne, CB; Bergelson, JM				Coyne, CB; Bergelson, JM			Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions	CELL			English	Article							DECAY-ACCELERATING FACTOR; TYROSINE KINASE; ADENOVIRUS RECEPTOR; ACTIN CYTOSKELETON; ADHESION MOLECULE; DYNAMIN; PHOSPHORYLATION; PROTEIN; INTERNALIZATION; INHIBITION	Group B coxsackieviruses (CVBs) must cross the epithelium as they initiate infection, but the mechanism by which this occurs remains uncertain. The coxsackievirus and adenovirus receptor (CAR) is a component of the tight junction and is inaccessible to virus approaching from the apical surface. Many CVBs also interact with the GPI-anchored protein decay-accelerating factor (DAF). Here, we report that virus attachment to DAF on the apical cell surface activates Abl kinase, triggering Rac-dependent actin rearrangements that permit virus movement to the tight junction. Within the junction, interaction with CAR promotes conformational changes in the virus capsid that are essential for virus entry and release of viral RNA. Interaction with DAF also activates Fyn kinase, an event that is required for the phosphorylation of caveolin and transport of virus into the cell within caveolar vesicles. CVBs thus exploit DAF-mediated signaling pathways to surmount the epithelial barrier.	Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Bergelson, JM (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.	bergelson@email.chop.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI07324, R01AI5228] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bergelson Jeffrey M., 2002, P107; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen YZ, 1999, EXP CELL RES, V246, P83, DOI 10.1006/excr.1998.4301; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Milstone AM, 2005, J VIROL, V79, P655, DOI 10.1128/JVI.79.1.655-660.2005; Nusrat A, 2000, J CELL SCI, V113, P1771; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Pallansch MA, 2001, ENTEROVIRUSES POLIOV; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; REAGAN KJ, 1984, J VIROL, V49, P635, DOI 10.1128/JVI.49.3.635-640.1984; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; Rueckert R., 1996, FIELDS VIROLOGY, P609; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Shieh JTC, 2002, J VIROL, V76, P9474, DOI 10.1128/JVI.76.18.9474-9480.2002; Skorski T, 1998, BLOOD, V91, P406, DOI 10.1182/blood.V91.2.406.406_406_418; STUTTS MJ, 1981, TOXICOL APPL PHARM, V60, P91, DOI 10.1016/0041-008X(81)90139-3; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tosteson MT, 1997, J VIROL, V71, P507, DOI 10.1128/JVI.71.1.507-511.1997; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	55	401	423	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					119	131		10.1016/j.cell.2005.10.035	http://dx.doi.org/10.1016/j.cell.2005.10.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413486	Bronze			2022-12-01	WOS:000234969600014
J	Komeili, A; Li, Z; Newman, DK; Jensen, GJ				Komeili, A; Li, Z; Newman, DK; Jensen, GJ			Magnetosomes are cell membrane invaginations organized by the actin-like protein MamK	SCIENCE			English	Article							CRYOELECTRON TOMOGRAPHY; SEGREGATION; BACTERIA; GRYPHISWALDENSE; CYTOSKELETON; FILAMENTS; REVEALS; GENE	Magnetosomes are membranous bacterial organelles sharing many features of eukaryotic organelles. Using electron cryotomography, we found that magnetosomes are invaginations of the cell membrane flanked by a network of cytoskeletal filaments. The filaments appeared to be composed of MamK, a homolog of the bacterial actin-like protein MreB, which formed filaments in vivo. In a mamK deletion strain, the magnetosome-associated cytoskeleton was absent and individual magnetosomes were no longer organized into chains. Thus, it seems that prokaryotes can use cytoskeletal filaments to position organelles within the cell.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Mail Code 3102, Berkeley, CA 94720 USA.	komeili@nature.berkeley.edu			NIGMS NIH HHS [P01 GM66521] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066521] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; FUERST JA, 2005, ANN REV MICROBIOL ON; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Kurner J, 2004, EXP CELL RES, V301, P38, DOI 10.1016/j.yexcr.2004.08.005; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; OFER S, 1984, BIOPHYS J, V46, P57, DOI 10.1016/S0006-3495(84)83998-3; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	22	475	504	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 13	2006	311	5758					242	245		10.1126/science.1123231	http://dx.doi.org/10.1126/science.1123231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16373532				2022-12-01	WOS:000234722200046
J	Jones, RB; Gordus, A; Krall, JA; MacBeath, G				Jones, RB; Gordus, A; Krall, JA; MacBeath, G			A quantitative protein interaction network for the ErbB receptors using protein microarrays	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASES; SH2 DOMAINS; SACCHAROMYCES-CEREVISIAE; WIDE PREDICTION; BREAST-CANCER; IDENTIFICATION; TRANSFORMATION; CARCINOMAS; EXPRESSION	Although epidermal growth factor receptor ( EGFR; also called ErbB1) and its relatives initiate one of the most well-studied signalling networks, there is not yet a genome-wide view of even the earliest step in this pathway: recruitment of proteins to the activated receptors. Here we use protein microarrays comprising virtually every Src homology 2 (SH2) and phosphotyrosine binding (PTB) domain encoded in the human genome to measure the equilibrium dissociation constant of each domain for 61 peptides representing physiological sites of tyrosine phosphorylation on the four ErbB receptors. This involved 77,592 independent biochemical measurements and provided a quantitative protein interaction network that reveals many new interactions, including ones that fall outside of our current view of domain selectivity. By slicing through the network at different affinity thresholds, we found surprising differences between the receptors. Most notably, EGFR and ErbB2 become markedly more promiscuous as the threshold is lowered, whereas ErbB3 does not. Because EGFR and ErbB2 are overexpressed in many human cancers, our results suggest that the extent to which promiscuity changes with protein concentration may contribute to the oncogenic potential of receptor tyrosine kinases, and perhaps other signalling proteins as well.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	macbeath@chemistry.harvard.edu		MacBeath, Gavin/0000-0003-2585-6772				ALIMANDI M, 1995, ONCOGENE, V10, P1813; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; FELDER S, 1993, MOL CELL BIOL, V13, P1449, DOI 10.1128/MCB.13.3.1449; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GORGOULIS V, 1992, ANTICANCER RES, V12, P1183; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Haugh Jason M, 2002, Mol Interv, V2, P292, DOI 10.1124/mi.2.5.292; Hendriks BS, 2005, J BIOL CHEM, V280, P6157, DOI 10.1074/jbc.M410491200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; IRISH JC, 1993, LARYNGOSCOPE, V103, P42; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; MacBeath G, 2000, SCIENCE, V289, P1760; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	36	558	593	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					168	174		10.1038/nature04177	http://dx.doi.org/10.1038/nature04177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16273093				2022-12-01	WOS:000234538400032
J	McCollom, TM; Hynek, BM				McCollom, TM; Hynek, BM			A volcanic environment for bedrock diagenesis at Meridiani Planum on Mars	NATURE			English	Article							TERRA-MERIDIANI; HEMATITE; CHEMISTRY; JAROSITE; REGION; CRATER; ROCKS; SOILS; WATER	Exposed bedrocks at Meridiani Planum on Mars display chemical and mineralogical evidence suggesting interaction with liquid water(1-6). On the basis of morphological observations as well as high abundances of haematite and sulphate minerals, the rocks have been interpreted as sediments that were deposited in a shallow body of briny water with subsequent evaporation leaving behind the sulphate minerals(1,2). The iron-sulphur mineralization at Meridiani has also been inferred to be analogous to that produced during oxidative weathering of metal sulphide minerals, such as occurs at acid mine drainage sites(7). Neither of these interpretations, however, is consistent with the chemical composition of the rocks. Here we propose an alternative model for diagenesis of Meridiani bedrock that involves deposition of volcanic ash followed by reaction with condensed sulphur dioxide- and water-bearing vapours emitted from fumaroles. This scenario does not require prolonged interaction with a standing body of surface water and may have occurred at high temperatures. Consequently, the model invokes an environment considerably less favourable for biological activity on Mars than previously proposed interpretations.	Univ Colorado, Ctr Astrobiol, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McCollom, TM (corresponding author), Univ Colorado, Ctr Astrobiol, Campus Box 392, Boulder, CO 80309 USA.	mccollom@lasp.colorado.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Coradossi N, 1996, B VOLCANOL, V58, P310, DOI 10.1007/s004450050142; CROWN DA, 1993, J GEOPHYS RES-PLANET, V98, P3431, DOI 10.1029/92JE02804; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Glamoclija M, 2004, GEOMICROBIOL J, V21, P529, DOI 10.1080/01490450490888235; Herkenhoff KE, 2004, SCIENCE, V306, P1727, DOI 10.1126/science.1105286; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; LAUL JC, 1986, GEOCHIM COSMOCHIM AC, V50, P909, DOI 10.1016/0016-7037(86)90373-X; Lodders K, 1998, METEORIT PLANET SCI, V33, pA183, DOI 10.1111/j.1945-5100.1998.tb01331.x; Madden MEE, 2004, NATURE, V431, P821, DOI 10.1038/nature02971; Owen T., 1992, MARS, P818; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Ross CS, 1961, GEOLOGICAL SURVEY PR, V366, P1; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Villemant B, 1999, EARTH PLANET SC LETT, V168, P271, DOI 10.1016/S0012-821X(99)00058-8; WAHRENBERGER CM, 1997, THESIS SWISS FEDERAL; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113; Wohletz K.H., 1979, ASH FLOW TUFFS, P177, DOI [10.1130/SPE180-p177, DOI 10.1130/SPE180-P177]	28	121	121	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1129	1131		10.1038/nature04390	http://dx.doi.org/10.1038/nature04390			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372002				2022-12-01	WOS:000234111500043
J	Kelly, DF; Pollard, AJ; Moxon, ER				Kelly, DF; Pollard, AJ; Moxon, ER			Immunological memory - The role of B cells in long-term protection against invasive bacterial pathogens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZAE TYPE-B; C CONJUGATE VACCINE; ACELLULAR PERTUSSIS; ANTIBODY; HIB; IMMUNIZATION; DISEASE; INFANTS; MARKER; POLYSACCHARIDE	Protein-polysaccharide conjugate vaccines that protect against Haemophilus influenzae type b (Hib), serogroup C Neisseria meningitidis, and multiple capsular serotypes of Streptococcus pneumoniae have had a major impact on invasive bacterial disease in childhood when incorporated into routine infant immunization schedules. However, effectiveness data from the United Kingdom suggest that primary infant immunization alone may not be associated with long-term protection. Both immunological priming and antibody persistence are important aspects of long-term protection induced by these vaccines. An improved understanding of the immunobiology of the B-cell response to these vaccines may direct development of immunization strategies that provide sustained protection.	Univ Oxford, Dept Paediat, Oxford, England	University of Oxford	Kelly, DF (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Level 4, Oxford OX3 9DU, England.	dominic.kelly@paediatrics.ox.ac.uk	Kelly, Dominic F/C-5498-2011	Kelly, Dominic/0000-0002-6063-8896				ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Ala'Aldeen DAA, 2000, J CLIN MICROBIOL, V38, P2311; Anderson P, 2000, PEDIATR INFECT DIS J, V19, P589, DOI 10.1097/00006454-200007000-00001; ANDERSON P, 1987, J PEDIATR-US, V111, P644, DOI 10.1016/S0022-3476(87)80237-8; ANDERSON PW, 1986, J IMMUNOL, V137, P1181; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Borrow R, 2001, VACCINE, V19, P3043, DOI 10.1016/S0264-410X(01)00050-0; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; EDWARDS EA, 1977, SCAND J INFECT DIS, V9, P105, DOI 10.3109/inf.1977.9.issue-2.09; Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; Heath PT, 2003, BMJ-BRIT MED J, V326, P1158, DOI 10.1136/bmj.326.7400.1158; Hougs L, 1999, J IMMUNOL, V162, P224; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Lucas AH, 2001, INFECT IMMUN, V69, P853, DOI 10.1128/IAI.69.2.853-864.2001; Lucas AH, 2001, PEDIATR INFECT DIS J, V20, P235, DOI 10.1097/00006454-200103000-00002; MacLennan I C, 1997, Semin Immunol, V9, P229, DOI 10.1006/smim.1997.0078; MacLennan JM, 2000, JAMA-J AM MED ASSOC, V283, P2795, DOI 10.1001/jama.283.21.2795; Makela PH, 2003, VACCINE, V22, P287, DOI 10.1016/S0264-410X(03)00524-3; McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6; McVernon J, 2003, ARCH DIS CHILD, V88, P379, DOI 10.1136/adc.88.5.379; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; Pichichero ME, 1999, J INFECT DIS, V180, P1390, DOI 10.1086/314989; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8	34	68	76	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					3019	3023		10.1001/jama.294.23.3019	http://dx.doi.org/10.1001/jama.294.23.3019			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414950				2022-12-01	WOS:000234087700029
J	Meibom, KL; Blokesch, M; Dolganov, NA; Wu, CY; Schoolnik, GK				Meibom, KL; Blokesch, M; Dolganov, NA; Wu, CY; Schoolnik, GK			Chitin induces natural competence in Vibrio cholerae	SCIENCE			English	Article							GENETIC-TRANSFORMATION; HAEMOPHILUS-INFLUENZAE; DNA; EXPRESSION; IDENTIFICATION; POPULATION; INDUCTION; VIRULENCE; LYSIS	The mosaic-structured Vibrio cholerae genome points to the importance of horizontal gene transfer (HGT) in the evolution of this human pathogen. We showed that V. cholerae can acquire new genetic material by natural transformation during growth on chitin, a biopolymer that is abundant in aquatic habitats (e.g., from crustacean exoskeletons), where it lives as an autochthonous microbe. Transformation competence was found to require a type IV pilus assembly complex, a putative DNA binding protein, and three convergent regulatory cascades, which are activated by chitin, increasing cell density, and nutrient limitation, a decline in growth rate, or stress.	Stanford Univ, Div Infect Dis & Geog Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Stanford Inst Environm, Stanford, CA 94305 USA	Stanford University; Stanford University	Meibom, KL (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	kmeibom@necker.fr; schoolni@cmgm.stanford.edu	Blokesch, Melanie/A-4057-2013	Blokesch, Melanie/0000-0002-7024-1489; Meibom, Karin/0000-0002-2612-6424	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053706] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053706] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; HAHN J, 1993, MOL MICROBIOL, V10, P99, DOI 10.1111/j.1365-2958.1993.tb00907.x; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; PALMEN R, 1995, CURR MICROBIOL, V30, P7, DOI 10.1007/BF00294516; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Silva AJ, 2004, J BACTERIOL, V186, P6374, DOI 10.1128/JB.186.19.6374-6382.2004; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; ZULTY JJ, 1995, P NATL ACAD SCI USA, V92, P3616, DOI 10.1073/pnas.92.8.3616	20	440	463	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1824	1827		10.1126/science.1120096	http://dx.doi.org/10.1126/science.1120096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357262				2022-12-01	WOS:000234093600049
J	Vassylyev, DG; Artsimovitch, I				Vassylyev, DG; Artsimovitch, I			Tracking RNA polymerase, one step at a time	CELL			English	Editorial Material							STRUCTURAL BASIS; TRANSCRIPTION; MECHANISM; TRANSLOCATION; ELONGATION; NTP	Although the structural analysis of transcription has attained atomic resolution, techniques to manipulate single molecules involved in transcription have lagged behind. A recent paper in Nature by Abbondanzieri et al. (2005) closes this gap. This study finds that individual molecules of bacterial RNA polymerase move in single base-pair steps and concludes that RNA polymerase acts as a Brownian ratchet that is driven forward by the binding of incoming nucleoside triphosphates.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham	Vassylyev, DG (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu	Artsimovitch, Irina/L-3467-2019; Vassylyev, Dmitry/A-9005-2008					Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; VASSYLYEV DG, 2005, NAT STRUCT MOL BIOL; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	10	12	12	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					977	979		10.1016/j.cell.2005.11.030	http://dx.doi.org/10.1016/j.cell.2005.11.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360025	Bronze			2022-12-01	WOS:000234177200004
J	Kraft, S				Kraft, S			Fourth floor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												skraft@optonline.net							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2821	2822		10.1001/jama.294.22.2821	http://dx.doi.org/10.1001/jama.294.22.2821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352781				2022-12-01	WOS:000233826700001
J	Yokobayashi, S; Watanabe, Y				Yokobayashi, S; Watanabe, Y			The kinetochore protein Moa1 enables cohesion-mediated monopolar attachment at meiosis I	CELL			English	Article							SISTER-CHROMATID COHESION; REDUCTIONAL CHROMOSOME SEGREGATION; 1ST MEIOTIC DIVISION; FISSION YEAST; CENTROMERIC COHESION; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR-BIOLOGY; DNA-REPLICATION; AXIAL ELEMENTS; REC8	Meiosis resembles mitosis but employs a unique "reductional" nuclear division to allow the production of haploid gametes from diploid cells. The crucial ploidy reduction step requires that sister kinetochores attach to microtubules emanating from the same spindle pole, achieving "monopolar attachment," which ensures that maternal and paternal chromosomes are segregated. Here we screened for factors required to establish monopolar attachment in fission yeast and identified a novel protein, Moa1. Moa1 is meiosis specific and localizes exclusively to the central core of the centromere, a region that binds meiotic Rec8-containing cohesin complexes but not mitotic Rad21/Scc1-containing complexes. Enforced cleavage of Rec8 in the central core region led to the disruption of monopolar attachment, as in moa1 Delta cells, without diminishing Moa1 localization. Moa1 physically interacts with Rec8, implying that Moa1 functions only through Rec8, presumably to facilitate central core cohesion. These results prove that monoorientation of kinetochores is established in a cohesion-mediated manner.	Univ Tokyo, Grad Sch Sci, Lab Chromosome Dynam,SORST,Japan Sci & Technol Ag, Inst Mol & Cellular Biosci,Grad Sch Biophys & Bio, Tokyo 1130032, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Lab Chromosome Dynam,SORST,Japan Sci & Technol Ag, Inst Mol & Cellular Biosci,Grad Sch Biophys & Bio, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812				Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Chua G, 2000, Nucleic Acids Res, V28, pE53, DOI 10.1093/nar/28.11.e53; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1980, GENETICS, V96, P589; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee Y, 2000, MEAS SCI TECHNOL, V11, P51, DOI 10.1088/0957-0233/11/1/308; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; MOLNAR M, 1995, GENETICS, V141, P61; NAKASEKO Y, 1984, J BACTERIOL, V157, P334, DOI 10.1128/JB.157.1.334-336.1984; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; OSTERGREN G, 1951, HEREDITAS, V37, P85; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003	48	120	126	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					803	817		10.1016/j.cell.2005.09.013	http://dx.doi.org/10.1016/j.cell.2005.09.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325576	Bronze			2022-12-01	WOS:000233814100015
J	McConnell, J; Horton, R				McConnell, J; Horton, R			Preparing for pandemic influenza	LANCET			English	Editorial Material									Lancet Infect Dis, London NW1 7BY, England; Lancet, London NW1 7BY, England		McConnell, J (corresponding author), Lancet Infect Dis, London NW1 7BY, England.			McConnell, John/0000-0002-9928-6568				Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; *WHO, 2005, CUM NUMB CONF HUM CA; 1933, LANCET, V2, P83	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2072	2072		10.1016/S0140-6736(05)67869-5	http://dx.doi.org/10.1016/S0140-6736(05)67869-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360775	Green Published, Bronze			2022-12-01	WOS:000234146000008
J	Poulet, F; Bibring, JP; Mustard, JF; Gendrin, A; Mangold, N; Langevin, Y; Arvidson, RE; Gondet, B; Gomez, C				Poulet, F; Bibring, JP; Mustard, JF; Gendrin, A; Mangold, N; Langevin, Y; Arvidson, RE; Gondet, B; Gomez, C		Omega Team	Phyllosilicates on Mars and implications for early martian climate	NATURE			English	Article							REFLECTANCE SPECTROSCOPY; SURFACE; REGION; WATER; DIVERSITY; MINERALS; OLIVINE; SPECTRA; ANALOG	The recent identification of large deposits of sulphates by remote sensing and in situ observations has been considered evidence of the past presence of liquid water on Mars. Here we report the unambiguous detection of diverse phyllosilicates, a family of aqueous alteration products, on the basis of observations by the OMEGA imaging spectrometer on board the Mars Express spacecraft. These minerals are mainly associated with Noachian outcrops, which is consistent with an early active hydrological system, sustaining the long- term contact of igneous minerals with liquid water. We infer that the two main families of hydrated alteration products detected - phyllosilicates and sulphates - result from different formation processes. These occurred during two distinct climatic episodes: an early Noachian Mars, resulting in the formation of hydrated silicates, followed by a more acidic environment, in which sulphates formed.	Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; CNRS, UMR 8617, F-91405 Orsay, France; Brown Univ, Providence, RI 02912 USA; Interact & Dynam Environm Surface, F-91405 Orsay, France; Washington Univ, St Louis, MO 63130 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Brown University; Washington University (WUSTL)	Poulet, F (corresponding author), Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France.	francois.poulet@ias.fr	Hauber, Ernst/U-2521-2018; Korablev, Oleg/L-5083-2013; Gomez, Cécile/B-8473-2012; Fouchet, Thierry/C-6374-2017; Gomez, cecile/Q-2526-2019	Hauber, Ernst/0000-0002-1375-304X; Korablev, Oleg/0000-0003-1115-0656; Gomez, Cécile/0000-0002-2986-430X; Fouchet, Thierry/0000-0001-9040-8285; Gomez, cecile/0000-0002-2986-430X; Altieri, Francesca/0000-0002-6338-8300; Erard, Stephane/0000-0002-9099-8366				ALLEN PA, 1997, EARTH SURFACE PROCES; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bishop J, 2002, CLAY MINER, V37, P607, DOI 10.1180/0009855023740063; Bishop J, 2002, CLAY MINER, V37, P617, DOI 10.1180/0009855023740064; BISHOP JL, 1995, J GEOPHYS RES-PLANET, V100, P5369, DOI 10.1029/94JE03331; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P14463, DOI 10.1029/JB095iB09p14463; Dickinson WW, 2003, GEOLOGY, V31, P199, DOI 10.1130/0091-7613(2003)031<0199:APAAFW>2.0.CO;2; Edgett KS, 1997, GEOPHYS RES LETT, V24, P2897, DOI 10.1029/97GL02840; Frost RL, 2002, SPECTROCHIM ACTA A, V58, P1657, DOI 10.1016/S1386-1425(01)00637-0; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; HAMILTON VE, 2005, IN PRESS GEOLOGY; Hiesinger H, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002143; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Ivanov MA, 2001, J GEOPHYS RES-PLANET, V106, P3275, DOI 10.1029/2000JE001257; Keeling J. L., 2004, REGOLITH 2004, P166; Kraft MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018848; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Righi D., 1995, Origin and mineralogy of clays: clays and the environment., P43; Schiffman P, 2000, GEOCHEM GEOPHY GEOSY, V1; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; Velde B., 1995, Origin and mineralogy of clays: clays and the environment., P8; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a	32	710	719	3	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					623	627		10.1038/nature04274	http://dx.doi.org/10.1038/nature04274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319882				2022-12-01	WOS:000233593100040
J	Talkington, MWT; Siuzdak, G; Williamson, JR				Talkington, MWT; Siuzdak, G; Williamson, JR			An assembly landscape for the 30S ribosomal subunit	NATURE			English	Article							LASER-DESORPTION IONIZATION; DNAK CHAPERONE SYSTEM; ESCHERICHIA-COLI; MASS-SPECTROMETRY; BACTERIAL RIBOSOMES; PROTEIN EXPRESSION; CENTRAL DOMAIN; 16-S RNA; 30-S; RECONSTITUTION	Self- assembling macromolecular machines drive fundamental cellular processes, including transcription, messenger RNA processing, translation, DNA replication and cellular transport. The ribosome, which carries out protein synthesis, is one such machine, and the 30S subunit of the bacterial ribosome is the preeminent model system for biophysical analysis of large RNA - protein complexes. Our understanding of 30S assembly is incomplete, owing to the challenges of monitoring the association of many components simultaneously. Here we have developed a method involving pulse - chase monitored by quantitative mass spectrometry ( PC/ QMS) to follow the assembly of the 20 ribosomal proteins with 16S ribosomal RNA during formation of the functional particle. These data represent a detailed and quantitative kinetic characterization of the assembly of a large multicomponent macromolecular complex. By measuring the protein binding rates at a range of temperatures, we find that local transformations throughout the assembling subunit have similar but distinct activation energies. Thus, the prevailing view of 30S assembly as a pathway proceeding through a global rate-limiting conformational change must give way to one in which the assembly of the complex traverses a landscape dotted with various local conformational transitions.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009	Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Siuzdak, Gary/0000-0002-4749-0014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053757] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053757] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalarov SC, 2000, RNA, V6, P402, DOI 10.1017/S1355838200991945; ALIX JH, 1993, P NATL ACAD SCI USA, V90, P9725, DOI 10.1073/pnas.90.20.9725; Beavis RC, 1996, METHOD ENZYMOL, V270, P519; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HELD WA, 1974, J BIOL CHEM, V249, P3103; HELD WA, 1973, BIOCHEMISTRY-US, V12, P3273, DOI 10.1021/bi00741a020; HILLENKAMP F, 1990, METHOD ENZYMOL, V193, P280, DOI 10.1016/0076-6879(90)93420-P; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; JENNINGS KR, 1990, METHOD ENZYMOL, V193, P37, DOI 10.1016/0076-6879(90)93410-M; Maki JA, 2003, RNA, V9, P1418, DOI 10.1261/rna.5139703; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; MANGIARO.G, 1968, BIOCHEMISTRY-US, V7, P456, DOI 10.1021/bi00841a058; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Pasa-Tolic L, 1999, J AM CHEM SOC, V121, P7949, DOI 10.1021/ja991063o; PICHON J, 1975, J MOL BIOL, V96, P125, DOI 10.1016/0022-2836(75)90186-2; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; Recht MI, 2001, COLD SPRING HARB SYM, V66, P591, DOI 10.1101/sqb.2001.66.591; Rook MS, 1998, J MOL BIOL, V281, P609, DOI 10.1006/jmbi.1998.1960; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sechi S, 2003, CURR OPIN CHEM BIOL, V7, P70, DOI 10.1016/S1367-5931(02)00010-8; SERDYUK IN, 1983, J MOL BIOL, V169, P409, DOI 10.1016/S0022-2836(83)80058-8; SRIVASTAVA AK, 1990, RIBOSOME, P426; Stagg SM, 2003, J MOL BIOL, V328, P49, DOI 10.1016/S0022-2836(03)00174-8; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Thirumalai D, 1996, ACCOUNTS CHEM RES, V29, P433, DOI 10.1021/ar9500933; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	36	208	214	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					628	632		10.1038/nature04261	http://dx.doi.org/10.1038/nature04261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319883	Green Accepted			2022-12-01	WOS:000233593100041
J	Abraham, C; Cho, JH				Abraham, C; Cho, JH			Inducing intestinal growth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EPITHELIUM		Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Abraham, C (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521	3	4	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2297	2299		10.1056/NEJMcibr053367	http://dx.doi.org/10.1056/NEJMcibr053367			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FC	16306530				2022-12-01	WOS:000233434500017
J	Levskaya, A; Chevalier, AA; Tabor, JJ; Simpson, ZB; Lavery, LA; Levy, M; Davidson, EA; Scouras, A; Ellington, AD; Marcotte, EM; Voigt, CA				Levskaya, A; Chevalier, AA; Tabor, JJ; Simpson, ZB; Lavery, LA; Levy, M; Davidson, EA; Scouras, A; Ellington, AD; Marcotte, EM; Voigt, CA			Engineering Escherichia coli to see light - These smart bacteria 'photograph' a light pattern as a high-definition chemical image.	NATURE			English	Editorial Material							SYSTEM		Univ Calif San Francisco, Biophys Program, San Francisco, CA 94143 USA; Univ Texas, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Synthet Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Levskaya, A (corresponding author), Univ Calif San Francisco, Biophys Program, San Francisco, CA 94143 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008	Tabor, Jeffrey/0000-0001-7316-0361; Marcotte, Edward/0000-0001-8808-180X				Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	8	428	473	4	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					441	442		10.1038/nature04405	http://dx.doi.org/10.1038/nature04405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306980				2022-12-01	WOS:000233458200034
J	Rolfs, A; Bottcher, T; Zschiesche, M; Morris, P; Winchester, B; Bauer, P; Walter, U; Mix, E; Lohr, M; Harzer, K; Strauss, U; Pahnke, J; Grossmann, A; Benecke, R				Rolfs, A; Bottcher, T; Zschiesche, M; Morris, P; Winchester, B; Bauer, P; Walter, U; Mix, E; Lohr, M; Harzer, K; Strauss, U; Pahnke, J; Grossmann, A; Benecke, R			Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study	LANCET			English	Article							ISCHEMIC STROKE	Background Strokes are an important cause of morbidity and mortality in young adults. However, in most cases the cause of the stroke remains unclear. Anderson-Fabry disease is an X-linked recessive lysosomal storage disease resulting from the deficient alpha-galactosidase and causes an endothelial vasculopathy followed by cerebral ischaemia. To determine the importance of Fabry disease in young people with stroke, we measured the frequency of unrecognised Fabry disease in a cohort of acute stroke patients. Methods Between February, 2110, and December, 2004 721 German adults aged 18 to 55 years suffering from acute cryptogenic stroke were screened for Fabry disease. The plasma alpha-galactosidase activity in men was measured followed by sequencing of the entire alpha-GAL gene in those with low enzyme activity. By contrast, the entire alpha-GAL gene was genetically screened for mutations in women even if enzyme activity was normal. Findings 21 of 432 (4.9%) male stroke patients and seven of 2879 (2.4%) women had a biologically significant mutation within the alpha-GAL gene. The mean age of onset of symptomatic cerebrovascular disease was 38.4 years (SD 13.0) in the male stroke patients and 40.3 years (13.1) in the female group. The higher frequency of infarctions in the vertebrobasilar area correlated with more pronounced changes in the vertebrobasilar vessels like dolichoectatic pathology (42.9% vs 6.8%). Interpretation We have shown a high frequency of Fabry disease in a cohort of patients with cryptogenic stroke, which corresponds to about 1.2% in young stroke patients. Fabry disease must be considered in all cases of unexplained stroke in young patients, especially in those with the combination of infarction in the vertebrobasilar artery system and proteinuria.	Univ Rostock, Dept Neurol, D-18055 Rostock, Germany; Univ Rostock, Inst Diagnost & Intervent Radiol, Rostock, Germany; Univ Tubingen, Dept Med Genet, Tubingen, Germany; Univ Tubingen, Neurochem Lab, Tubingen, Germany; Inst Child Hlth, London, England; UCL, Great Ormond St Hosp Children NHS Trust, London, England; Univ Mannheim Heidelberg, Dept Gastroenterol, Mannheim, Germany; Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Rostock; University of Rostock; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Mannheim; University of Zurich; University Zurich Hospital	Rolfs, A (corresponding author), Univ Rostock, Dept Neurol, POB 100 888, D-18055 Rostock, Germany.	arndt.rolfs@med.uni-rostock.cle	Löhr, Matthias/A-3692-2012; Walter, Uwe/O-4591-2017; Pahnke, Jens/G-1757-2010; Strauss, Ulf/I-4146-2012	Löhr, Matthias/0000-0002-7647-198X; Walter, Uwe/0000-0002-6280-785X; Pahnke, Jens/0000-0001-7355-4213; Strauss, Ulf/0000-0002-1534-6624				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bauer P, 2002, HUM MUTAT, V19, P30, DOI 10.1002/humu.10016; BOGOUSSLAVSKY J, 1992, NEUROL CLIN, V10, P113, DOI 10.1016/S0733-8619(18)30236-6; Brady RO, 2000, JAMA-J AM MED ASSOC, V284, P2771, DOI 10.1001/jama.284.21.2771; Kittner SJ, 1998, NEUROLOGY, V50, P890, DOI 10.1212/WNL.50.4.890; Mills K, 2002, FEBS LETT, V515, P171, DOI 10.1016/S0014-5793(02)02491-2; Mogensen J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e59; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352	8	323	344	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1794	1796		10.1016/S0140-6736(05)67635-0	http://dx.doi.org/10.1016/S0140-6736(05)67635-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298216				2022-12-01	WOS:000233517200023
J	Heit, JA; Kobbervig, CE; James, AH; Petterson, TM; Bailey, KR; Melton, LJ				Heit, JA; Kobbervig, CE; James, AH; Petterson, TM; Bailey, KR; Melton, LJ			Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; RISK-FACTORS; PULMONARY-EMBOLISM; CUMULATIVE INCIDENCE; MATERNAL MORTALITY; UNITED-STATES; PUERPERIUM; DISEASE; PREVENTION; WOMEN	Background: The risk for venous thromboembolism during pregnancy or postpartum is uncertain. Objectives: To estimate the relative and absolute risk for deep venous thrombosis and pulmonary embolism during pregnancy and postpartum and to describe trends in incidence. Design: Population-based inception cohort study using the resources of the Rochester Epidemiology Project. Setting: Olmsted County, Minnesota. Patients: women with deep venous thrombosis or pulmonary embolism first diagnosed between 1966 and 1995, including women with venous thromboembolism during pregnancy or the postpartum period (defined as delivery of a newborn no more than 3 months before the deep venous thrombosis or pulmonary embolism event date, including delivery of a stillborn infant after the first trimester). Measurements: The authors obtained yearly counts of live births in Olmsted County between 1966 and 1995 from the Minnesota Department of Health. Results: The relative risk (standardized incidence ratio) for venous thromboembolism among pregnant or postpartum women was 4.29 (95% Cl, 3.49 to 5.22; P < 0.001), and the overall incidence of venous thromboembolism (absolute risk) was 199.7 per 100 000 woman-years. The annual incidence was 5 times higher among postpartum women than pregnant women (511.2 vs. 95.8 per 100 000), and the incidence of deep venous thrombosis was 3 times higher than that of pulmonary embolism (151.8 vs. 47.9 per 100 000). Pulmonary embolism was relatively uncommon during pregnancy versus the postpartum period (10.6 vs. 159.7 per 100 000). Over the 30-year study period, the incidence of venous thromboembolism during pregnancy remained relatively constant whereas the postpartum incidence of pulmonary embolism decreased more than 2-fold. Limitations: Because the Olmsted County population was 98% white and of non-Hispanic ethnicity, the results may not be generalizable to other ethnicities. Conclusions: Among pregnant women, the highest risk period for venous thromboembolism and pulmonary embolism in particular is during the postpartum period. Any prophylaxis against these events should be particularly targeted to postpartum women. Although the incidence of pulmonary embolism has decreased over time, the incidence of deep venous thrombosis remains unchanged, indicating the need to better identify pregnant women at increased risk.	Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Heit, JA (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW,Stabile 660, Rochester, MN 55905 USA.			James, Andra/0000-0003-4570-6595	NHLBI NIH HHS [HL-66216, HL-60279] Funding Source: Medline; NIAMS NIH HHS [AR-30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060279, R01HL066216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; Armour R, 2001, AM SURGEON, V67, P641; ATRASH HK, 1990, OBSTET GYNECOL, V76, P1055; Berg CJ, 1996, OBSTET GYNECOL, V88, P161, DOI 10.1016/0029-7844(96)00135-4; BERGQVIST A, 1983, ACTA OBSTET GYN SCAN, V62, P443, DOI 10.3109/00016348309154217; BERGQVIST D, 1983, ACTA OBSTET GYN SCAN, V62, P449, DOI 10.3109/00016348309154218; Bonnar J, 1999, AM J OBSTET GYNECOL, V180, P784, DOI 10.1016/S0002-9378(99)70648-4; Chan LY, 2001, OBSTET GYNECOL, V98, P471, DOI 10.1016/S0029-7844(01)01476-4; Danilenko-Dixon DR, 2001, AM J OBSTET GYNECOL, V184, P104, DOI 10.1067/mob.2001.107919; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; GINSBERG JS, 1992, THROMB HAEMOSTASIS, V67, P519; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; HULL RD, 1990, ANN INTERN MED, V112, P663, DOI 10.7326/0003-4819-112-9-663; HUSNI EA, 1967, AM J OBSTET GYNECOL, V97, P901, DOI 10.1016/0002-9378(67)90514-5; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; James K V, 1996, Cardiovasc Surg, V4, P777, DOI 10.1016/S0967-2109(96)00042-7; KIERKEGAARD A, 1983, ACTA OBSTET GYN SCAN, V62, P239, DOI 10.3109/00016348309155799; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Macklon NS, 1996, SCOT MED J, V41, P83, DOI 10.1177/003693309604100305; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Res HS, 2001, EPIDEMIOLOGY, V12, P456, DOI 10.1097/00001648-200107000-00016; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; RUTHERFORD S, 1991, American Journal of Obstetrics and Gynecology, V164, P286; SACHS BP, 1987, NEW ENGL J MED, V316, P667, DOI 10.1056/NEJM198703123161105; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Soomro RM, 2002, ANGIOLOGY, V53, P429, DOI 10.1177/000331970205300409; TREFFERS PE, 1983, INT J GYNECOL OBSTET, V21, P327, DOI 10.1016/0020-7292(83)90024-3; Weiss N, 2000, AM J OBSTET GYNECOL, V182, P1073, DOI 10.1067/mob.2000.105441	34	808	865	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2005	143	10					697	706		10.7326/0003-4819-143-10-200511150-00006	http://dx.doi.org/10.7326/0003-4819-143-10-200511150-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986YY	16287790				2022-12-01	WOS:000233486800001
J	Fabrizio, P; Gattazzo, C; Battistella, L; Wei, M; Cheng, C; McGrew, K; Longo, VD				Fabrizio, P; Gattazzo, C; Battistella, L; Wei, M; Cheng, C; McGrew, K; Longo, VD			Sir2 blocks extreme life-span extension	CELL			English	Article							POSITION-EFFECT VARIEGATION; FACTOR-BINDING PROTEIN-1; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; FORKHEAD TRANSCRIPTION; STRESS RESISTANCE; YEAST; GROWTH; GENE; LONGEVITY	Sir2 is a conserved deacetylase that modulates life span in yeast, worms, and files and stress response in mammals. In yeast, Sir2 is required for maintaining replicative life span, and increasing Sir2 dosage can delay replicative aging. We address the role of Sir2 in regulating chronological life span in yeast. Lack of Sir2 along with calorie restriction and/or mutations in the yeast AKT homolog, Sch9, or Ras pathways causes a dramatic chronological life-span extension. Inactivation of Sir2 causes uptake and catabolism of ethanol and upregulation of many stress-resistance and sporulation genes. These changes while sufficient to extend chronological life span in wild-type yeast require severe calorie restriction or additional mutations to extend life span of sir2 Delta mutants. Our results demonstrate that effects of SIR2 on chronological life span are opposite to replicatve life span and suggest that the relevant activities of Sir2-like deacetylases may also be complex in higher eukaryotes.	Univ So Calif, Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Mol & Computat Biol Dept, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Longo, VD (corresponding author), Univ So Calif, Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	vlongo@usc.edu	Wei, Min/GSI-8510-2022	Wei, Min/0000-0002-2649-9271; fabrizio, paola/0000-0002-1144-7727	NATIONAL INSTITUTE ON AGING [R01AG020642] Funding Source: NIH RePORTER; NIA NIH HHS [AG20642, AG01028] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Astrom SU, 2003, GENETICS, V163, P931; Brachmann CB, 1998, YEAST, V14, P115; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937; Geyskens I, 2000, NATO SCI S A LIF SCI, V316, P117; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Harris N, 2001, MOL GENET GENOMICS, V265, P258, DOI 10.1007/s004380000409; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; Jazwinski SM, 2004, FEMS YEAST RES, V5, P119, DOI 10.1016/j.femsyr.2004.04.005; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; KAISER C, 1994, METHODS YEAST GENETI, V234; Karathanasis E, 2002, GENETICS, V161, P1015; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Newman BL, 2002, GENETICS, V162, P1675; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WILLIAMSON VM, 1980, NATURE, V283, P214, DOI 10.1038/283214a0; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570	46	315	332	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 8	2005	123	4					655	667		10.1016/j.cell.2005.08.042	http://dx.doi.org/10.1016/j.cell.2005.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286010	Bronze			2022-12-01	WOS:000233497400014
J	Xu, YD; Chun, MM				Xu, YD; Chun, MM			Dissociable neural mechanisms supporting visual short-term memory for objects	NATURE			English	Article							WORKING-MEMORY; ACTIVATION; CAPACITY; ATTENTION; DYNAMICS; STORAGE; CORTEX; AREAS	Using visual information to guide behaviour requires storage in a temporary buffer, known as visual short-term memory (VSTM)(1), that sustains attended information across saccades and other visual interruptions. There is growing debate on whether VSTM capacity is limited to a fixed number of objects(2,3) or whether it is variable(4,5). Here we report four experiments using functional magnetic resonance imaging that resolve this controversy by dissociating the representation capacities of the parietal and occipital cortices. Whereas representations in the inferior intraparietal sulcus (IPS) are fixed to about four objects at different spatial locations regardless of object complexity, those in the superior IPS and the lateral occipital complex are variable, tracking the number of objects held in VSTM, and representing fewer than four objects as their complexity increases. These neural response patterns were observed during both VSTM encoding and maintenance. Thus, multiple systems act together to support VSTM: whereas the inferior IPS maintains spatial attention over a fixed number of objects at different spatial locations, the superior IPS and the lateral occipital complex encode and maintain a variable subset of the attended objects, depending on their complexity. VSTM capacity is therefore determined both by a fixed number of objects and by object complexity.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Xu, YD (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	yaoda.xu@yale.edu		Chun, Marvin/0000-0003-1070-7993				Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; FUSTER JM, 1982, J NEUROSCI, V2, P361; Goldman-Rakic P. S., 1987, HDB PHYSL, V5, P373, DOI DOI 10.1002/CPHY.CP010509; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Miller EK, 1996, J NEUROSCI, V16, P5154; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; TALAIRACH J, 1988, COPLANAR STEREOAXIS; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770	30	708	730	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					91	95		10.1038/nature04262	http://dx.doi.org/10.1038/nature04262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16382240				2022-12-01	WOS:000235685700046
J	Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK				Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK			NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia	NATURE			English	Article							WHITE-MATTER; GLIAL-CELLS; GLUTAMATE; EXCITOTOXICITY; OLIGODENDROCYTES; MECHANISMS; DISORDERS; GLYCINE; INJURY	Central nervous system myelin is a specialized structure produced by oligodendrocytes that ensheaths axons, allowing rapid and efficient saltatory conduction of action potentials(1). Many disorders promote damage to and eventual loss of the myelin sheath, which often results in significant neurological morbidity. However, little is known about the fundamental mechanisms that initiate myelin damage, with the assumption being that its fate follows that of the parent oligodendrocyte. Here we show that NMDA (N-methyl-D-aspartate) glutamate receptors mediate Ca2+ accumulation in central myelin in response to chemical ischaemia in vitro. Using two-photon microscopy, we imaged fluorescence of the Ca2+ indicator X-rhod-1 loaded into oligodendrocytes and the cytoplasmic compartment of the myelin sheath in adult rat optic nerves. The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptor antagonist NBQX(2) completely blocked the ischaemic Ca2+ increase in oligodendroglial cell bodies, but only modestly reduced the Ca2+ increase in myelin. In contrast, the Ca2+ increase in myelin was abolished by broad-spectrum NMDA receptor antagonists (MK-801, 7-chlorokynurenic acid, D-AP5(3,4)), but not by more selective blockers of NR2A and NR2B subunit-containing receptors (NVP-AAM077(5) and ifenprodil(2,4)). In vitro ischaemia causes ultrastructural damage to both axon cylinders and myelin(6). NMDA receptor antagonism greatly reduced the damage to myelin. NR1, NR2 and NR3 subunits were detected in myelin by immunohistochemistry and immunoprecipitation, indicating that all necessary subunits are present for the formation of functional NMDA receptors. Our data show that the mature myelin sheath can respond independently to injurious stimuli. Given that axons are known to release glutamate(7-9), our finding that the Ca2+ increase was mediated in large part by activation of myelinic NMDA receptors suggests a new mechanism of axo-myelinic signalling. Such a mechanism may represent a potentially important therapeutic target in disorders in which demyelination is a prominent feature, such as multiple sclerosis, neurotrauma, infections (for example, HIV encephalomyelopathy) and aspects of ischaemic brain injury.	Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4K9, Canada; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA; Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Cleveland Clinic Foundation; University of Calgary	Stys, PK (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada.	pstys@ohri.ca	Micu, Ileana/M-9468-2016	Micu, Ileana/0000-0001-7112-0075; Zamponi, Gerald W./0000-0002-0644-9066				Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dingledine R, 1999, PHARMACOL REV, V51, P7; Hinman JD, 2004, J NEUROCHEM, V89, P430, DOI 10.1046/j.1471-4159.2004.02348.x; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; Li S, 1999, J Neurosci, V19, pRC16; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MRSULJA BJ, 1985, BRAIN RES, V343, P154, DOI 10.1016/0006-8993(85)91170-9; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; QUARLES RH, IN PRESS BASIC NEURO, P51; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Wallstrom E, 1996, J NEUROL SCI, V137, P89, DOI 10.1016/0022-510X(95)00339-4; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; Waxman SG, 1995, AXON STRUCTURE FUNCT; Ziak D, 1998, PHYSIOL RES, V47, P365	30	382	398	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					988	992		10.1038/nature04474	http://dx.doi.org/10.1038/nature04474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014NE	16372019				2022-12-01	WOS:000235486100050
J	Tornroth-Horsefield, S; Wang, Y; Hedfalk, K; Johanson, U; Karlsson, M; Tajkhorshid, E; Neutze, R; Kjellbom, P				Tornroth-Horsefield, S; Wang, Y; Hedfalk, K; Johanson, U; Karlsson, M; Tajkhorshid, E; Neutze, R; Kjellbom, P			Structural mechanism of plant aquaporin gating	NATURE			English	Article							WATER CHANNEL; PROTON EXCLUSION; MOLECULAR-MECHANISMS; GLYCEROL CONDUCTION; MEMBRANE AQUAPORIN; PERMEATION; TRANSPORT; PERMEABILITY; DYNAMICS; SELECTIVITY	Plants counteract fluctuations in water supply by regulating all aquaporins in the cell plasma membrane. Channel closure results either from the dephosphorylation of two conserved serine residues under conditions of drought stress, or from the protonation of a conserved histidine residue following a drop in cytoplasmic pH due to anoxia during flooding. Here we report the X-ray structure of the spinach plasma membrane aquaporin SoPIP2; 1 in its closed conformation at 2.1 angstrom resolution and in its open conformation at 3.9 angstrom resolution, and molecular dynamics simulations of the initial events governing gating. In the closed conformation loop D caps the channel from the cytoplasm and thereby occludes the pore. In the open conformation loop D is displaced up to 16 angstrom and this movement opens a hydrophobic gate blocking the channel entrance from the cytoplasm. These results reveal a molecular gating mechanism which appears conserved throughout all plant plasma membrane aquaporins.	Chalmers Univ Technol, Dept Chem & Biosci, SE-40530 Gothenburg, Sweden; Univ Illinois, Beckman Inst, Theoret & Computat Biophys Grp, Urbana, IL 61801 USA; Lund Univ, Dept Plant Biochem, SE-22100 Lund, Sweden	Chalmers University of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Lund University	Neutze, R (corresponding author), Chalmers Univ Technol, Dept Chem & Biosci, POB 462, SE-40530 Gothenburg, Sweden.	emad@ks.uiuc.edu; richard.neutze@chembio.chalmers.se; per.kjellbom@plantbio.lu.se	Johanson, Urban/AHE-8231-2022; Törnroth-Horsefield, Susanna/B-2702-2010; Tajkhorshid, Emad/A-1249-2010; Johanson, Urban/D-4344-2015; Wang, Yi/P-9069-2017; Hedfalk, Kristina/A-8244-2010; Tajkhorshid, Emad/AAN-8323-2021; Neutze, Richard/A-7573-2010	Johanson, Urban/0000-0001-8862-128X; Johanson, Urban/0000-0001-8862-128X; Wang, Yi/0000-0002-4174-8790; Neutze, Richard/0000-0003-0986-6153; Tajkhorshid, Emad/0000-0001-8434-1010; Tornroth-Horsefield, Susanna/0000-0002-9435-8243				Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borstlap AC, 2002, TRENDS PLANT SCI, V7, P529, DOI 10.1016/S1360-1385(02)02365-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilan B, 2004, PROTEINS, V55, P223, DOI 10.1002/prot.20038; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jensen MO, 2003, BIOPHYS J, V85, P2884, DOI 10.1016/S0006-3495(03)74711-0; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madsen D, 2002, J APPL CRYSTALLOGR, V35, P137, DOI 10.1107/S0021889802000602; Morishita Y, 2004, J PHARMACOL SCI, V96, P276, DOI 10.1254/jphs.FMJ04004X7; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schlenkrich Michael, 1996, P31; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200	47	601	647	11	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					688	694		10.1038/nature04316	http://dx.doi.org/10.1038/nature04316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16340961				2022-12-01	WOS:000235193100036
J	Deville, S; Saiz, E; Nalla, RK; Tomsia, AP				Deville, S; Saiz, E; Nalla, RK; Tomsia, AP			Freezing as a path to build complex composites	SCIENCE			English	Article							HYDROXYAPATITE SCAFFOLDS; COMPRESSIVE STRENGTH; POROUS CERAMICS; FABRICATION; DESIGN; FIBERS	Materials that are strong, ultralightweight, and tough are in demand for a range of applications, requiring architectures and components carefully designed from the micrometer down to the nanometer scale. Nacre, a structure found in many molluscan shells, and bone are frequently used as examples for how nature achieves this through hybrid organic-inorganic composites. Unfortunately, it has proven extremely difficult to transcribe nacre-like clever designs into synthetic materials, partly because their intricate structures need to be replicated at several length scales. We demonstrate how the physics of ice formation can be used to develop sophisticated porous and layered-hybrid materials, including artificial bone, ceramic-metal composites, and porous scaffolds for osseous tissue regeneration with strengths up to four times higher than those of materials currently used for implantation.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Deville, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	sdeville@lbl.gov	Deville, Sylvain/H-5515-2019	Deville, Sylvain/0000-0002-3363-3184	NIDCR NIH HHS [5R01 DE015633] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015633] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066; An Y. H., 2000, MECH TESTING BONE BO, P41; BIGNON A, 2002, THESIS NATL I APPL S; Clegg WJ, 1999, SCIENCE, V286, P1097, DOI 10.1126/science.286.5442.1097; del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Gay G, 2002, CRYST GROWTH DES, V2, P135, DOI 10.1021/cg0100383; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Karlsson JOM, 2002, SCIENCE, V296, P655; Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa; Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Milosevski M, 1999, CERAM INT, V25, P693, DOI 10.1016/S0272-8842(99)00003-6; Ota Y, 1997, J AM CERAM SOC, V80, P225, DOI 10.1111/j.1151-2916.1997.tb02814.x; Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6; Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582; Saiz E, 2000, ACTA MATER, V48, P4449, DOI 10.1016/S1359-6454(00)00231-7; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sofie SW, 2001, J AM CERAM SOC, V84, P1459; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Worster MG, 1997, J PHYS CHEM B, V101, P6132, DOI 10.1021/jp9632448	30	1451	1508	48	1261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					515	518		10.1126/science.1120937	http://dx.doi.org/10.1126/science.1120937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439659	Green Submitted			2022-12-01	WOS:000235071400044
J	Eldridge, AG; Loktev, AV; Hansen, DV; Verschuren, EW; Reimann, JDR; Jackson, PK				Eldridge, AG; Loktev, AV; Hansen, DV; Verschuren, EW; Reimann, JDR; Jackson, PK			The Evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor Emi1	CELL			English	Article							POLO-LIKE KINASE; CELL-CYCLE; CENTROSOME DUPLICATION; UBIQUITIN LIGASES; REQUIRES E2F; PROTEIN; PLK1; PHOSPHORYLATION; DESTRUCTION; IDENTIFICATION	The anaphase-promoting complex/cyclosome (APC/C) inhibitor Emi1 controls progression to S phase and mitosis by stabilizing key APC/C ubiquitination substrates, including cyclin A. Examining Emi1 binding proteins, we identified the Evi5 oncogene as a regulator of Emi1 accumulation. Evi5 antagonizes SCF beta TrCP-dependent Emi1 ubiquitination and destruction by binding to a site adjacent to Emi1's DSGxxS degron and blocking both degron phosphorylation by Polo-like kinases and subsequent beta TrCP binding. Thus, Evi5 functions as a stabilizing factor maintaining Emi1 levels in S/G2 phase. Evi5 protein accumulates in early G1 following Plk1 destruction and is degraded in a Plk1 - and ubiquitin-dependent manner in early mitosis. Ablation of Evi5 induces precocious degradation of Emi1 by the Plk/SCF beta TrCP pathway, causing premature APC/C activation; cyclin destruction; cell-cycle arrest; centrosome overduplication; and, finally, mitotic catastrophe. We propose that the balance of Evi5 and Pololike kinase activities determines the timely accumulation of Emi1 and cyclin, ensuring mitotic fidelity.	Stanford Univ, Sch Med, Dept Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Dept Canc Biol, 300 Pasteur Dr, Stanford, CA 94305 USA.	pjackson@stanford.edu		Jackson, Peter/0000-0002-1742-2539; Hansen, David/0000-0001-9679-7189	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060439, R01GM054811, R01GM073023] Funding Source: NIH RePORTER; NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [R01 GM73023, R01 GM060439, R01 GM54811] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang X. L., 2004, SCI STKE, V242, ppe31; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Faitar SL, 2005, GENOMICS, V86, P594, DOI 10.1016/j.ygeno.2005.06.002; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Liao XB, 1997, ONCOGENE, V14, P1023, DOI 10.1038/sj.onc.1200929; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Roberts T, 1998, HUM MOL GENET, V7, P1169, DOI 10.1093/hmg/7.7.1169; Wakefield JG, 2000, CURR BIOL, V10, P1367, DOI 10.1016/S0960-9822(00)00776-4; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	31	81	85	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 27	2006	124	2					367	380		10.1016/j.cell.2005.10.038	http://dx.doi.org/10.1016/j.cell.2005.10.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439210	Bronze			2022-12-01	WOS:000235068500024
J	Robinson, GV				Robinson, GV			Pulmonary embolism in hospital practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; RISK-FACTORS; PREVENTION; THERAPY		Royal Berkshire & Battle Hosp, Dept Resp Med, Reading RG1 5AN, Berks, England		Robinson, GV (corresponding author), Royal Berkshire & Battle Hosp, Dept Resp Med, Reading RG1 5AN, Berks, England.	gracevrobinson@yahoo.co.uk						Anderson AF, 2003, CIRCULATION S1, V107, P9, DOI [10.1161/01.CIR.0000078469.07362.E6, DOI 10.1161/01.CIR.0000078469.07362.E6]; Aurangzeb M, 2004, CRIT CARE CLIN, V20, P643, DOI 10.1016/j.ccc.2004.06.002; BARRITT DW, 1960, LANCET, V1, P1309; Campbell IA, 2003, THORAX, V58, P470; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; FABIAN TC, 1990, CRIT CARE MED, V18, P42; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Greaves M, 2001, CLIN MED, V1, P432; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; HUISMAN MV, 1989, CHEST, V95, P498, DOI 10.1378/chest.95.3.498; Hull RD, 2000, ARCH INTERN MED, V160, P229, DOI 10.1001/archinte.160.2.229; Kakkar VV, 1998, BAILLIERE CLIN HAEM, V11, P605, DOI 10.1016/S0950-3536(98)80085-1; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; MOSER KM, 1994, JAMA-J AM MED ASSOC, V271, P223, DOI 10.1001/jama.271.3.223; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; PALMBERG S, 1979, GERONTOLOGY, V25, P103, DOI 10.1159/000212327; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piccioli A, 2003, J THROMB HAEMOST, V1, P2271, DOI 10.1046/j.1538-7836.2003.00505.x; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Wahlander K, 2002, THROMB RES, V107, P93, DOI 10.1016/S0049-3848(02)00259-1; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	34	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					156	160F		10.1136/bmj.332.7534.156	http://dx.doi.org/10.1136/bmj.332.7534.156			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16424493	Green Published			2022-12-01	WOS:000234905800026
J	D'Costa, VM; McGrann, KM; Hughes, DW; Wright, GD				D'Costa, VM; McGrann, KM; Hughes, DW; Wright, GD			Sampling the antibiotic resistome	SCIENCE			English	Article							GRAM-POSITIVE PATHOGENS; IN-VITRO ACTIVITIES; RESISTANCE GENES; STREPTOCOCCUS-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; UNITED-STATES; DAPTOMYCIN; VANCOMYCIN; DETERMINANTS	Microbial resistance to antibiotics currently spans all known classes of natural and synthetic compounds. It has not only hindered our treatment of infections but also dramatically reshaped drug discovery, yet its origins have not been systematically studied. Soil-dwelling bacteria produce and encounter a myriad of antibiotics, evolving corresponding sensing and evading strategies. They are a reservoir of resistance determinants that can be mobilized into the microbial community. Study of this reservoir could provide an early warning system for future clinically relevant antibiotic resistance mechanisms.	McMaster Univ, Dept Biochem & Biomed Sci, Antimicrobial Res Ctr, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Chem, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Wright, GD (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Antimicrobial Res Ctr, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Garcia-Armisen, Tamara/A-6173-2008; Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131				ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Critchley IA, 2003, ANTIMICROB AGENTS CH, V47, P1689, DOI 10.1128/AAC.47.5.1689-1693.2003; CUNDLIFFE E, 1992, ANTIMICROB AGENTS CH, V36, P348, DOI 10.1128/AAC.36.2.348; Cundliffe E, 2001, ANTON LEEUW INT J G, V79, P229, DOI 10.1023/A:1012065300116; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; DEBONO M, 1988, J ANTIBIOT, V41, P1093, DOI 10.7164/antibiotics.41.1093; Descheemaeker P, 2000, J ANTIMICROB CHEMOTH, V45, P167, DOI 10.1093/jac/45.2.167; Doern GV, 2001, ANTIMICROB AGENTS CH, V45, P1721, DOI 10.1128/AAC.45.6.1721-1729.2001; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Guardabassi L, 2004, APPL ENVIRON MICROB, V70, P984, DOI 10.1128/AEM.70.2.984-990.2004; Hong HJ, 2002, MOL MICROBIOL, V44, P1199, DOI 10.1046/j.1365-2958.2002.02960.x; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020; Kieser T, 2000, PRACTICAL STREPTOMYC; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; NOGUCHI N, 1995, ANTIMICROB AGENTS CH, V39, P2359, DOI 10.1128/AAC.39.10.2359; PENG H, 1993, J BIOL CHEM, V268, P24481; Piddock LJV, 1999, DRUGS, V58, P11, DOI 10.2165/00003495-199958002-00003; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Snydman DR, 2000, ANTIMICROB AGENTS CH, V44, P3447, DOI 10.1128/AAC.44.12.3447-3450.2000; THOMPSON CJ, 1983, P NATL ACAD SCI-BIOL, V80, P5190, DOI 10.1073/pnas.80.17.5190; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Walsh C., 2003, ANTIBIOTICS ACTIONS; Waters B, 1997, ANTIMICROB AGENTS CH, V41, P2766, DOI 10.1128/AAC.41.12.2766	26	997	1054	9	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					374	377		10.1126/science.1120800	http://dx.doi.org/10.1126/science.1120800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424339				2022-12-01	WOS:000234938500043
J	Donato, DC; Fontaine, JB; Campbell, JL; Robinson, WD; Kauffman, JB; Law, BE				Donato, DC; Fontaine, JB; Campbell, JL; Robinson, WD; Kauffman, JB; Law, BE			Post-wildfire logging hinders regeneration and increases fire risk	SCIENCE			English	Article									Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; Forest Serv, Inst Pacific Isl Forestry, USDA, Pacific SW Res Stn, Hilo, HI 96720 USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Donato, DC (corresponding author), Oregon State Univ, Dept Forest Sci, Peavy Hall 154, Corvallis, OR 97331 USA.	dan.donato@oregonstate.edu	Law, Beverly/G-3882-2010; Fontaine, Joseph B/M-9186-2013; Fontaine, Joseph/O-2758-2019	Law, Beverly/0000-0002-1605-1203; Fontaine, Joseph B/0000-0002-6515-7864; Fontaine, Joseph/0000-0002-6515-7864				Agee J.K., 1993, FIRE ECOLOGY PACIFIC; GORTE RW, 1996, C RES SERVICE PUBLIC; Lindenmayer DB, 2004, SCIENCE, V303, P1303, DOI 10.1126/science.1093438; Sessions J, 2004, J FOREST, V102, P38; Tesch S. D., 1989, Western Journal of Applied Forestry, V4, P89	5	225	234	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 20	2006	311	5759					352	352		10.1126/science.1122855	http://dx.doi.org/10.1126/science.1122855			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16400111	Green Submitted			2022-12-01	WOS:000234938500035
J	Xu, J; Hofhuis, H; Heidstra, R; Sauer, M; Friml, J; Scheres, B				Xu, J; Hofhuis, H; Heidstra, R; Sauer, M; Friml, J; Scheres, B			A molecular framework for plant regeneration	SCIENCE			English	Article							ARABIDOPSIS ROOT-MERISTEM; DEPENDENT AUXIN GRADIENTS; ASYMMETRIC CELL-DIVISION; GNOM ARF-GEF; EFFLUX; TRANSPORT; SCARECROW; EXPRESSION; PATTERNS; POLARITY	Plants and some animals have a profound capacity to regenerate organs from adult tissues. Molecular mechanisms for regeneration have, however, been largely unexplored. Here we investigate a local regeneration response in Arabidopsis roots. Laser-induced wounding disrupts the flow of auxin-a cell-fate-instructive plant hormone-in root tips, and we demonstrate that resulting cell-fate changes require the PLETHORA, SHORTROOT, and SCARECROW transcription factors. These transcription factors regulate the expression and polar position of PIN auxin efflux-facilitating membrane proteins to reconstitute auxin transport in renewed root tips. Thus, a regeneration mechanism using embryonic root stem-cell patterning factors first responds to and subsequently stabilizes a new hormone distribution.	Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Utrecht University; Eberhard Karls University of Tubingen	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Genet, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Sauer, Michael/F-6519-2014; Xu, Jian/I-2921-2012; Sauer, Michael/G-3424-2011; Friml, Jiri/D-9511-2012	Sauer, Michael/0000-0002-4014-9825; Xu, Jian/0000-0001-6194-6316; Friml, Jiri/0000-0002-8302-7596; Scheres, Ben/0000-0001-5400-9578; hofhuis, hugo/0000-0001-7882-7380				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; MITCHISON GJ, 1981, PHILOS T ROY SOC B, V295, P461, DOI 10.1098/rstb.1981.0154; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; SACHS T, 1991, DEVELOPMENT S, V1, P83; SACHS T, 1981, ADV BOT RES, V9, P152; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	25	249	271	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					385	388		10.1126/science.1121790	http://dx.doi.org/10.1126/science.1121790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424342	Green Submitted			2022-12-01	WOS:000234938500046
J	Albanese, V; Yam, AYW; Baughman, J; Parnot, C; Frydman, J				Albanese, V; Yam, AYW; Baughman, J; Parnot, C; Frydman, J			Systems analyses reveal two chaperone networks with distinct functions in eukaryotic cells	CELL			English	Article							HEAT-SHOCK RESPONSE; RIBOSOME-ASSOCIATED CHAPERONE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MOLECULAR CHAPERONES; TRIGGER FACTOR; POLYPEPTIDE FLUX; BINDING PROTEIN; CYTOSOLIC HSP70; NASCENT CHAINS	Molecular chaperones assist the folding of newly translated and stress-denatured proteins. In prokaryotes, overlapping sets of chaperones mediate both processes. In contrast, we find that eukaryotes evolved distinct chaperone networks to carry out these functions. Genomic and functional analyses indicate that in addition to stress-inducible chaperones that protect the cellular proteome from stress, eukaryotes contain a stress-repressed chaperone network that is dedicated to protein biogenesis. These stress-repressed chaperones are transcriptionally, functionally, and physically linked to the translational apparatus and associate with nascent polypeptides emerging from the ribosome. Consistent with a function in de novo protein folding, impairment of the translation-linked chaperone network renders cells sensitive to misfolding in the context of protein synthesis but not in the context of environmental stress. The emergence of a translation-linked chaperone network likely underlies the elaborate cotranslational folding process necessary for the evolution of larger multidomain proteins characteristic of eukaryotic cells.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, BioX Program, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Gimenez, Luis E Diaz/D-9291-2011	, judith/0000-0003-2302-6943; Parnot, Charles/0000-0002-7346-5883; Albanese, Veronique/0000-0002-5947-7415	NIGMS NIH HHS [GM56433] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ashburner M, 2001, GENOME RES, V11, P1425; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bukau B, 1996, TRENDS CELL BIOL, V6, P480, DOI 10.1016/0962-8924(96)84946-4; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; HALLADAY JT, 1995, MOL CELL BIOL, V15, P4890; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu Xiao-Dong, 1996, Genes and Development, V10, P592, DOI 10.1101/gad.10.5.592; Lopez N, 1999, J BACTERIOL, V181, P3136, DOI 10.1128/JB.181.10.3136-3143.1999; MAGER WH, 1991, MOL CELL BIOCHEM, V104, P181; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; MIKLOS D, 1994, P NATL ACAD SCI USA, V91, P2743, DOI 10.1073/pnas.91.7.2743; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200	58	190	195	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					75	88		10.1016/j.cell.2005.11.039	http://dx.doi.org/10.1016/j.cell.2005.11.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413483	Bronze			2022-12-01	WOS:000234969600011
J	Zhai, WG; Jeong, H; Cui, LB; Krainc, D; Tjian, R				Zhai, WG; Jeong, H; Cui, LB; Krainc, D; Tjian, R			In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets	CELL			English	Article							INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE DISEASE; GENE-EXPRESSION; CAG REPEAT; PROTEIN; SP1; ACTIVATION; BRAIN; TFIIF; DYSREGULATION	Transcriptional dysregulation has emerged as a potentially important pathogenic mechanism in Huntington's disease, a neurodegenerative disorder associated with polyglutamine expansion in the huntingtin (htt) protein. Here, we report the development of a biochemically defined in vitro transcription assay that is responsive to mutant htt. We demonstrate that both gene-specific activator protein Sp1 and selective components of the core transcription apparatus, including TRID and TFIIF, are direct targets inhibited by mutant htt in a polyglutamine-dependent manner. The RAP30 subunit of TRIF specifically interacts with mutant htt both in vitro and in vivo to interfere with formation of the RAP30-RAP74 native complex. Importantly, overexpression of RAP30 in cultured primary striatal cells protects neurons from mutant htt-induced cellular toxicity and alleviates the transcriptional inhibition of the dopamine D2 receptor gene by mutant htt. Our results suggest a mutant htt-directed repression mechanism involving multiple specific components of the basal transcription apparatus.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodenerat Dis, Charlestown, MA 02129 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodenerat Dis, 114 16th St, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu; jmlim@uclink4.berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA025417, R37CA025417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050352, P01NS045242] Funding Source: NIH RePORTER; NCI NIH HHS [CA025417] Funding Source: Medline; NINDS NIH HHS [R01NS050352, P01NS045242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Frejtag W, 2001, J BIOL CHEM, V276, P14685, DOI 10.1074/jbc.M009224200; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GARRETT KP, 1992, J BIOL CHEM, V267, P23942; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Hoshino M, 2004, BIOCHEM BIOPH RES CO, V313, P110, DOI 10.1016/j.bbrc.2003.11.086; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Okazawa H, 2003, CELL MOL LIFE SCI, V60, P1427, DOI 10.1007/s00018-003-3013-z; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sipione S, 2001, MOL NEUROBIOL, V23, P21; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212	34	139	140	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1241	1253		10.1016/j.cell.2005.10.030	http://dx.doi.org/10.1016/j.cell.2005.10.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377565	Bronze			2022-12-01	WOS:000234584500013
J	Jackson, T				Jackson, T			The emergence of ringing vertigo	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Jackson, T (corresponding author), BMJ, London WC1H 9JR, England.	tjackson@bmj.com						BENNETT R, 2005, RINGING WORLD   0701, P618; Bunyan John, 1998, GRACE ABOUNDING CHIE; CAMP J, 2005, RINGING WORLD   0520, P473; MAJOR H, 2005, RINGING WORLD   1202, P1162; MAYOU R, 2005, RINGING WORLD   0715, P666; MORRIS M, 2005, GUARDIAN        0704; MOTTERSHEAD J, 2005, RINGING WORLD   0506, P426; SHERLAWJOHNSON R, 2005, RINGING WORLD   0610, P548; WILD J, 2005, RINGING WORLD   0729, P717	9	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1502	1503		10.1136/bmj.331.7531.1502	http://dx.doi.org/10.1136/bmj.331.7531.1502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998WT	16373729	Green Published, Bronze			2022-12-01	WOS:000234351300009
J	Schoener, TW; Losos, JB; Spiller, DA				Schoener, TW; Losos, JB; Spiller, DA			Island biogeography of populations: An introduced species transforms survival patterns	SCIENCE			English	Article							PREDATION; BEHAVIOR; HABITAT; BIRDS; RISK	Population phenomena; which provide much of the underlying basis for the theoretical structure of island biogeography, have received little direct study. We determined a key population trait-survival-in the Bahamian lizard Anolis sagrei on islands with an experimentally introduced predatory lizard and on neighboring unmanipulated islands. On unmanipulated islands, survival declined with several variables, most notably vegetation height: The island with the shortest vegetation had nearly the highest survival recorded for any lizard. On islands with, the introduced predator, which forages mostly on the ground, A. sagrei shifted to taller vegetation; unlike on unmanipulated islands, its survival was very low on islands with the shortest vegetation but was higher on the others. Thus, species introduction radically changed a resident species' relation of survival to a key island-biogeogriphical variable.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Davis; Washington University (WUSTL)	Schoener, TW (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	twschoener@ucdavis.edu						BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Castilla AM, 1998, ACTA OECOL, V19, P107, DOI 10.1016/S1146-609X(98)80014-3; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P262, DOI 10.1073/pnas.73.1.262; HOLT RD, 1966, FOOD WEBS INTEGRATIO, P313; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lomolino M.V., 2005, BIOGEOGRAPHY; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.1890/0012-9658(1998)079[2143:PPPIEP]2.0.CO;2; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; MAC ARTHUR ROBERT H., 1967; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Peterson AT, 2003, ECOL LETT, V6, P774, DOI 10.1046/j.1461-0248.2003.00502.x; Philippi Thomas E., 1993, P183; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schoener A., 1988, P483; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; SCHOENER TW, 1982, OECOLOGIA, V53, P160, DOI 10.1007/BF00545659; SCHOENER TW, 1983, J ANIM ECOL, V52, P237, DOI 10.2307/4598; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stephens D.W., 1986, pi	23	30	31	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1807	1809		10.1126/science.1120165	http://dx.doi.org/10.1126/science.1120165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357259				2022-12-01	WOS:000234093600044
J	Coull, JAM; Beggs, S; Boudreau, D; Boivin, D; Tsuda, M; Inoue, K; Gravel, C; Salter, MW; De Koninck, Y				Coull, JAM; Beggs, S; Boudreau, D; Boivin, D; Tsuda, M; Inoue, K; Gravel, C; Salter, MW; De Koninck, Y			BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain	NATURE			English	Article							NEUROTROPHIC FACTOR; TACTILE ALLODYNIA; DORSAL-HORN; LAMINA-I; PLASTICITY; RELEASE	Neuropathic pain that occurs after peripheral nerve injury depends on the hyperexcitability of neurons in the dorsal horn of the spinal cord(1-3). Spinal microglia stimulated by ATP contribute to tactile allodynia, a highly debilitating symptom of pain induced by nerve injury(4). Signalling between microglia and neurons is therefore an essential link in neuropathic pain transmission, but how this signalling occurs is unknown. Here we show that ATP-stimulated microglia cause a depolarizing shift in the anion reversal potential (E-anion) in spinal lamina I neurons. This shift inverts the polarity of currents activated by GABA (gamma-amino butyric acid), as has been shown to occur after peripheral nerve injury(5). Applying brain-derived neurotrophic factor ( BDNF) mimics the alteration in Eanion. Blocking signalling between BDNF and the receptor TrkB reverses the allodynia and the E-anion shift that follows both nerve injury and administration of ATP-stimulated microglia. ATP stimulation evokes the release of BDNF from microglia. Preventing BDNF release from microglia by pretreating them with interfering RNA directed against BDNF before ATP stimulation also inhibits the effects of these cells on the withdrawal threshold and E-anion. Our results show that ATP-stimulated microglia signal to lamina I neurons, causing a collapse of their transmembrane anion gradient, and that BDNF is a crucial signalling molecule between microglia and neurons. Blocking this microglia-neuron signalling pathway may represent a therapeutic strategy for treating neuropathic pain.	Univ Laval, Ctr Rech, Div Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; Univ Laval, Ctr Rech, Div Neurobiol Syst, Quebec City, PQ G1J 2G3, Canada; Univ Laval, Dept Psychiat, Quebec City, PQ G1K 7P4, Canada	Laval University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kyushu University; Laval University; Laval University	De Koninck, Y (corresponding author), Univ Laval, Ctr Rech, Div Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada.	mike.salter@utoronto.ca; Yves.DeKoninck@crulrg.ulaval.ca	Boudreau, Dominic/I-8144-2012; Tsuda, Makoto/AAE-7256-2020; Beggs, Simon/AAI-4438-2021; Bourinet, Emmanuel/S-4396-2017; De Koninck, Yves/C-2659-2008	Beggs, Simon/0000-0002-1582-8391; Bourinet, Emmanuel/0000-0001-8021-0419; De Koninck, Yves/0000-0002-5779-9330				Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chery N, 2000, J NEUROSCI METH, V96, P133, DOI 10.1016/S0165-0270(99)00195-8; CODERRE TJ, 1994, PAIN, V59, P345, DOI 10.1016/0304-3959(94)90020-5; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Jiang B, 2003, J NEUROSCI, V23, P3761; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; Lewin GR, 2004, CURR OPIN NEUROBIOL, V14, P443, DOI 10.1016/j.conb.2004.07.009; Malcangio M, 2003, TRENDS PHARMACOL SCI, V24, P116, DOI 10.1016/S0165-6147(03)00025-7; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nakajima K, 2002, J NEUROCHEM, V80, P697, DOI 10.1046/j.0022-3042.2001.00752.x; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Thompson SWN, 1999, P NATL ACAD SCI USA, V96, P7714, DOI 10.1073/pnas.96.14.7714; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0	29	1360	1436	6	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1017	1021		10.1038/nature04223	http://dx.doi.org/10.1038/nature04223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355225				2022-12-01	WOS:000233934600067
J	Jeganathan, KB; Malureanu, L; van Deursen, JM				Jeganathan, KB; Malureanu, L; van Deursen, JM			The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation	NATURE			English	Article							RNA EXPORT FACTOR; SPINDLE-CHECKPOINT; HUMAN-CELLS; CDC20; PROTEINS; BUB3; CDH1; PROTEOLYSIS; APC/C; RAE1	Cdc20 and Cdh1 are the activating subunits of the anaphase-promoting complex (APC), an E3 ubiquitin ligase that drives cells into anaphase by inducing degradation of cyclin B and the anaphase inhibitor securin(1). To prevent chromosome missegregation, APC activity directed against these mitotic regulators must be inhibited until all chromosomes are properly attached to the mitotic spindle(2). Here we show that in mitosis timely destruction of securin by APC is regulated by the nucleocytoplasmic transport factors Rae1 and Nup98. We show that combined Rae1 and Nup98 haploinsufficiency in mice results in premature separation of sister chromatids, severe aneuploidy and untimely degradation of securin. We find that Rae1 and Nup98 form a complex with Cdh1-activated APC (APC(Cdh1)) in early mitosis and specifically inhibit APC(Cdh1)-mediated ubiquitination of securin. Dissociation of Rae1 and Nup98 from APC(Cdh1) coincides with the release of the mitotic checkpoint protein BubR1 from Cdc20-activated APC (APC(Cdc20)) at the metaphase to anaphase transition. Together, our results suggest that Rae1 and Nup98 are temporal regulators of APC(Cdh1) that maintain euploidy by preventing unscheduled degradation of securin.	Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu	Holt, Janet E/B-2415-2013	Jeganathan, KARTHIK/0000-0001-5587-1266				Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Matsuoka Y, 1999, BIOCHEM BIOPH RES CO, V254, P417, DOI 10.1006/bbrc.1998.9953; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	22	147	149	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1036	1039		10.1038/nature04221	http://dx.doi.org/10.1038/nature04221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355229				2022-12-01	WOS:000233934600071
J	McDonald, LC; Killgore, GE; Thompson, A; Owens, RC; Kazakova, SV; Sambol, SP; Johnson, S; Gerding, DN				McDonald, LC; Killgore, GE; Thompson, A; Owens, RC; Kazakova, SV; Sambol, SP; Johnson, S; Gerding, DN			An epidemic, toxin gene-variant strain of Clostridium difficile	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			BINARY TOXIN; ADP-RIBOSYLTRANSFERASE; OUTBREAK; DIARRHEA; DISEASE; TOXINOTYPES; COLITIS	BACKGROUND: Recent reports suggest that the rate and severity of Clostridium difficile-associated disease in the United States are increasing and that the increase may be associated with the emergence of a new strain of C. difficile with increased virulence, resistance, or both. METHODS: A total of 187 C. difficile isolates were collected from eight health care facilities in six states (Georgia, Illinois, Maine, New Jersey, Oregon, and Pennsylvania) in which outbreaks of C. difficile-associated disease had occurred between 2000 and 2003. The isolates were characterized by restriction-endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE), and toxinotyping, and the results were compared with those from a database of more than 6000 isolates obtained before 2001. The polymerase chain reaction was used to detect the recently described binary toxin CDT and a deletion in the pathogenicity locus gene, tcdC, that might result in increased production of toxins A and B. RESULTS: Isolates that belonged to one REA group (BI) and had the same PFGE type (NAP1) were identified in specimens collected from patients at all eight facilities and accounted for at least half of the isolates from five facilities. REA group BI, which was first identified in 1984, was uncommon among isolates from the historic database (14 cases). Both historic and current (obtained since 2001) BI/NAP1 isolates were of toxinotype III, were positive for the binary toxin CDT, and contained an 18-bp tcdC deletion. Resistance to gatifloxacin and moxifloxacin was more common in current BI/NAP1 isolates than in non-BI/NAP1 isolates (100 percent vs. 42 percent, P<0.001), whereas the rate of resistance to clindamycin was the same in the two groups (79 percent). All of the current but none of the historic BI/NAP1 isolates were resistant to gatifloxacin and moxifloxacin (P<0.001). CONCLUSIONS: A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geographically dispersed outbreaks of C. difficile-associated disease.	Ctr Dis Control & Prevent, Epidemiol & Lab Branch, Div Healthcare Qual Promot, Atlanta, GA USA; Maine Med Ctr, Dept Pharm, Portland, ME 04102 USA; Maine Med Ctr, Dept Infect Dis, Portland, ME 04102 USA; Univ Vermont, Coll Med, Burlington, VT USA; Vet Affairs Edward Hines Jr Hosp, Infect Dis Sect, Hines, IL USA; Vet Affairs Edward Hines Jr Hosp, Res Serv, Hines, IL USA; Loyola Univ, Stritch Sch Med, Hines, IL USA	Centers for Disease Control & Prevention - USA; Maine Medical Center; Maine Medical Center; University of Vermont; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	McDonald, LC (corresponding author), 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	cmcdonald1@cdc.gov		Johnson, Stuart/0000-0001-9548-229X; McDonald, L. Clifford/0000-0003-3044-5572				Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BARTLETT JG, 1979, REV INFECT DIS, V1, P370; BILLER P, 2005, P 2005 ANN C ASS PRO; BOYCE JM, 2005, P 15 ANN SCI M SOC H; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gaynes R, 2004, CLIN INFECT DIS, V38, P640, DOI 10.1086/381551; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Johal SS, 2004, GUT, V53, P673, DOI 10.1136/gut.2003.028803; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Klaassen CHW, 2002, J CLIN MICROBIOL, V40, P101, DOI 10.1128/JCM.40.1.101-104.2002; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; LAYTON BA, 2005, P 15 ANN SCI M SOC H; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MCDONALD LC, 2004, P 14 ANN SCI M SOC H; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; *NAT COMM CLIN LAB, 2004, M11A6 NCCLS; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PATEL S, 2005, P 15 ANN SCI M SOC H; RUBIN MS, 1995, DIS COLON RECTUM, V38, P350, DOI 10.1007/BF02054220; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Samore M, 1997, J INFECT DIS, V176, P1233, DOI 10.1086/514117; SEHULSTER L, 2003, MMWR RECOMM REP, V55, P1; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; TAYLOR NS, 1979, REV INFECT DIS, V1, P379; TAYLOR NS, 1981, INFECT IMMUN, V34, P1036, DOI 10.1128/IAI.34.3.1036-1043.1981; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	36	1546	1630	2	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2433	2441		10.1056/NEJMoa051590	http://dx.doi.org/10.1056/NEJMoa051590			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	990OZ	16322603	Bronze			2022-12-01	WOS:000233754400005
J	Mason, BR; Portus, M				Mason, BR; Portus, M			Essay - Biomechanical support in sport	LANCET			English	Article									Australian Inst Sport, Biomech Dept, Belconnen, ACT 2616, Australia	Australian Institute of Sport	Mason, BR (corresponding author), Australian Inst Sport, Biomech Dept, POB 176, Belconnen, ACT 2616, Australia.	bmason@ausport.gov.au							0	3	3	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S25	S26		10.1016/S0140-6736(05)67834-8	http://dx.doi.org/10.1016/S0140-6736(05)67834-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360738				2022-12-01	WOS:000234374400017
J	Stuebe, AM; Rich-Edwards, JW; Willett, WC; Manson, JE; Michels, KB				Stuebe, AM; Rich-Edwards, JW; Willett, WC; Manson, JE; Michels, KB			Duration of lactation and incidence of type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL OBESITY; PHYSICAL-ACTIVITY; BODY-COMPOSITION; DELAYED-ONSET; RISK-FACTORS; WEIGHT; WOMEN; METABOLISM; PREGNANCY; MELLITUS	Context Lactation is associated with improved glucose and insulin homeostasis, independent of weight change. Objective To evaluate the association between lactation history and incidence of type 2 diabetes. Design, Setting, and Participants Prospective observational cohort study of 83 585 parous women in the Nurses' Health Study (NHS) and retrospective observational cohort study of 73 418 parous women in the Nurses' Health Study II (NHS II). Main Outcome Measure Incident cases of type 2 diabetes mellitus. Results In the NHS, 5145 cases of type 2 diabetes were diagnosed during 1239709 person-years of follow-up between 1986 and 2002, and in the NHS II, 1132 cases were diagnosed during 778876 person-years of follow-up between 1989 and 2001. Among parous women, increasing duration of lactation was associated with a reduced risk of type 2 diabetes. For each additional year of lactation, women with a birth in the prior 15 years had a decrease in the risk of diabetes of 15% (95% confidence interval, 1%-27%) among NHS participants and of 14% (95% confidence interval, 7%-21%) among NHS II participants, controlling for current body mass index and other relevant risk factors for type 2 diabetes. Conclusions Longer duration of breastfeeding was associated with reduced incidence of type 2 diabetes in 2 large US cohorts of women. Lactation may reduce risk of type 2 diabetes in young and middle-aged women by improving glucose homeostasis.	Harvard Univ, Sch Med,Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Wellesley, MA USA; Harvard Univ, Sch Publ Hlth, Channing Lab, Dept Nutr, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Channing Lab, Dept Epidemiol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Michels, KB (corresponding author), Harvard Univ, Sch Med,Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, 221 Longwood Ave, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu			NCI NIH HHS [CA87969, CA50385] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM DIAB ASS, 2002, NAT DIAB FACT SHEET; American Diabetes Association, 1998, DIABETES CARE S1, V12, pS20, DOI DOI 10.2337/DIACARE.21.1.S20; BREWER MM, 1989, AM J CLIN NUTR, V49, P259, DOI 10.1093/ajcn/49.2.259; BURNOL AF, 1986, AM J PHYSIOL, V251, pE537, DOI 10.1152/ajpendo.1986.251.5.E537; Butte NF, 1999, AM J CLIN NUTR, V69, P299; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; Butte NF, 2001, J NUTR, V131, P53, DOI 10.1093/jn/131.1.53; *CDCP, 2003 NAT IMM SURV AN; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; de Zegher F, 1998, J CLIN ENDOCR METAB, V83, P103, DOI 10.1210/jc.83.1.103; Denis RGP, 2003, J ENDOCRINOL, V176, P193, DOI 10.1677/joe.0.1760193; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; DEWEY KG, 1993, AM J CLIN NUTR, V58, P162, DOI 10.1093/ajcn/58.2.162; Donath SM, 2000, J PAEDIATR CHILD H, V36, P482, DOI 10.1046/j.1440-1754.2000.00562.x; DUGDALE AE, 1989, BRIT J NUTR, V61, P149, DOI 10.1079/BJN19890105; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Gigante DP, 2001, J NUTR, V131, P78, DOI 10.1093/jn/131.1.78; HARRIS M, 1979, DIABETES, V28, P1039; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; JONES RG, 1984, BIOCHEM J, V220, P455, DOI 10.1042/bj2200455; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; Lankarani-Fard A, 2001, J WOMEN HEALTH GEN-B, V10, P681, DOI 10.1089/15246090152563560; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McManus RM, 2001, METABOLISM, V50, P715, DOI 10.1053/meta.2001.23304; National Center for Health Statistics, 2004, HLTH US 2004 CHARTB; Neville MC, 2001, J NUTR, V131, p3005S, DOI 10.1093/jn/131.11.3005S; Petersen M, 2003, DIABETES CARE, V26, P917; Rasmussen KM, 2001, J NUTR, V131, p3009S, DOI 10.1093/jn/131.11.3009S; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sichieri R, 2003, INT J OBESITY, V27, P815, DOI 10.1038/sj.ijo.0802285; Solomon CG, 1996, DIABETES CARE, V19, P12, DOI 10.2337/diacare.19.1.12; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	36	299	303	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2601	2610		10.1001/jama.294.20.2601	http://dx.doi.org/10.1001/jama.294.20.2601			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304074	Bronze			2022-12-01	WOS:000233436200025
J	Aylin, P; Williams, S; Bottle, A				Aylin, P; Williams, S; Bottle, A			Dr Foster's case notes - Obesity and type 2 diabetes in children, 1996-7 to 2003-4	BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS						Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743				Ehtisham S, 2004, ARCH DIS CHILD, V89, P526, DOI 10.1136/adc.2003.027821; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; JOTANGIA D, 2005, OBESITY CHILDREN 11; *NHS HLTH SOC CAR, CLIN COD DEC IMPR; *OFF NAT STAT, 2004, POP EST CURR REL; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Skidmore PML, 2004, QJM-INT J MED, V97, P817, DOI 10.1093/qjmed/hch136	7	10	11	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1167	+						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293839				2022-12-01	WOS:000233571000015
J	Miller, N; Estoup, A; Toepfer, S; Bourguet, D; Lapchin, L; Derridj, S; Kim, KS; Reynaud, P; Furlan, L; Guillemaud, T				Miller, N; Estoup, A; Toepfer, S; Bourguet, D; Lapchin, L; Derridj, S; Kim, KS; Reynaud, P; Furlan, L; Guillemaud, T			Multiple transatlantic introductions of the western corn rootworm	SCIENCE			English	Article						invasion; introduced species; Approximate Bayesian Computation; colonization; Diabrotica virgifera virgifera; microsatellites; pest species; biological invasion; bioinvasion; multiple introductions; bayesian analysis; ABC; diabrotica virgifera virgifera	INVASIONS		Univ Nice, INRA, UMR 1112, F-06903 Sophia Antipolis, France; Ctr Biol & Gest Populat, F-34988 Montferrier Sur Lez, France; Plant Hlth Serv, CABI Biosci, Switzerland Ctr Field Labs, H-6800 Hodmezovasarhely, Hungary; INRA, UMR 1272, F-78026 Versailles, France; Iowa State Univ, Agr Res Serv, USDA, Corn Insects & Crop Genet Res Unit,Genet Lab, Ames, IA 50011 USA; Lab Natl Protect Vegetaux, F-34060 Montpellier, France; Agripolis, Dipartimento Agron Ambientale & Prod Vegetali, I-35020 Padua, Italy	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Institut de Recherche pour le Developpement (IRD); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Iowa State University; United States Department of Agriculture (USDA)	Guillemaud, T (corresponding author), Univ Nice, INRA, UMR 1112, 400 Route Chappes, F-06903 Sophia Antipolis, France.	guillem@antibes.inra.fr	Miller, Nicholas/I-4119-2012; guillemaud, thomas/B-4899-2012	Miller, Nicholas/0000-0001-9827-8286; guillemaud, thomas/0000-0003-0451-1644; Furlan, Lorenzo/0000-0003-4021-4532; Bourguet, Denis/0000-0002-2109-5323				Beaumont MA, 2002, GENETICS, V162, P2025; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Kim KS, 2005, MOL ECOL NOTES, V5, P115, DOI 10.1111/j.1471-8286.2004.00853.x; Kiss J, 2005, Western Corn Rootworm: Ecology and Management, P29, DOI 10.1079/9780851998176.0029; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2	5	254	270	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2005	310	5750					992	992		10.1126/science.1115871	http://dx.doi.org/10.1126/science.1115871			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284172	Green Submitted			2022-12-01	WOS:000233343400035
J	Stoleru, D; Peng, Y; Nawathean, P; Rosbash, M				Stoleru, D; Peng, Y; Nawathean, P; Rosbash, M			A resetting signal between Drosophila pacemakers synchronizes morning and evening activity	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; NERVOUS-SYSTEM; TIMELESS GENES; NEURONS; RHYTHMS; BRAIN; CELLS	The biochemical machinery that underlies circadian rhythms is conserved among animal species and drives self-sustained molecular oscillations and functions, even within individual asynchronous tissue-culture cells(1-3). Yet the rhythm- generating neural centres of higher eukaryotes are usually composed of interconnected cellular networks, which contribute to robustness and synchrony as well as other complex features of rhythmic behaviour(4-7). In mammals, little is known about how individual brain oscillators are organized to orchestrate a complex behavioural pattern. Drosophila is arguably more advanced from this point of view: we and others have recently shown that a group of adult brain clock neurons expresses the neuropeptide PDF8 and controls morning activity ( small LNv cells; M-cells), whereas another group of clock neurons controls evening activity (CRY+, PDF- cells; E-cells)(6,9). We have generated transgenic mosaic animals with different circadian periods in morning and evening cells. Here we show, by behavioural and molecular assays, that the six canonical groups of clock neurons(10) are organized into two separate neuronal circuits. One has no apparent effect on locomotor rhythmicity in darkness, but within the second circuit the molecular and behavioural timing of the evening cells is determined by morning-cell properties. This is due to a daily resetting signal from the morning to the evening cells, which run at their genetically programmed pace between consecutive signals. This neural circuit and oscillator-coupling mechanism ensures a proper relationship between the timing of morning and evening locomotor activity.	Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Petri B, 1997, J NEUROSCI, V17, P4087; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	24	231	233	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2005	438	7065					238	242		10.1038/nature04192	http://dx.doi.org/10.1038/nature04192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281038				2022-12-01	WOS:000233133500052
J	Lee, CY; Robinson, KJ; Doe, CQ				Lee, CY; Robinson, KJ; Doe, CQ			lgl, pins and aPKC regulate neuroblast self-renewal versus differentiation	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA NEUROBLASTS; POLARITY; LOCALIZATION; PROLIFERATION; LINEAGES; REVEALS; COMPLEX; GROWTH	How a cell chooses to proliferate or to differentiate is an important issue in stem cell and cancer biology. Drosophila neuroblasts undergo self-renewal with every cell division, producing another neuroblast and a differentiating daughter cell, but the mechanisms controlling the self-renewal/differentiation decision are poorly understood. Here we tested whether cell polarity genes, known to regulate embryonic neuroblast asymmetric cell division(1), also regulate neuroblast self-renewal. Clonal analysis in larval brains showed that pins mutant neuroblasts rapidly fail to self-renew, whereas lethal giant larvae (lgl) mutant neuroblasts generate multiple neuroblasts. Notably, lgl pins double mutant neuroblasts all divide symmetrically to self-renew, filling the brain with neuroblasts at the expense of neurons. The lgl pins neuroblasts show ectopic cortical localization of atypical protein kinase C ( aPKC), and a decrease in aPKC expression reduces neuroblast numbers, suggesting that aPKC promotes neuroblast self-renewal. In support of this hypothesis, neuroblast-specific overexpression of membrane-targeted aPKC, but not a kinase-dead version, induces ectopic neuroblast self-renewal. We conclude that cortical aPKC kinase activity is a potent inducer of neuroblast self-renewal.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoregon.edu						Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BUENZOW DE, 1995, DEV BIOL, V170, P338, DOI 10.1006/dbio.1995.1219; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; DATTA S, 1995, DEVELOPMENT, V121, P1173; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Freeman MR, 2001, DEVELOPMENT, V128, P4103; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	27	246	256	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					594	598		10.1038/nature04299	http://dx.doi.org/10.1038/nature04299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16357871				2022-12-01	WOS:000235033900042
J	Hsu, HJ; Liang, MR; Chen, CT; Chung, BC				Hsu, HJ; Liang, MR; Chen, CT; Chung, BC			Pregnenolone stabilizes microtubules and promotes zebrafish embryonic cell movement	NATURE			English	Article							YOLK SYNCYTIAL LAYER; EXPRESSION; VERTEBRATE; GENES; ORGANIZATION; DYNAMICS; MICE	Embryonic cell movement is essential for morphogenesis and the establishment of body shapes(1,2), but little is known about its mechanism. Here we report that pregnenolone, which is produced from cholesterol by the steroidogenic enzyme Cyp11a1 ( cholesterol side-chain cleavage enzyme, P450scc)(3), functions in promoting cell migration during epiboly. Epiboly is a process in which embryonic cells spread from the animal pole to cover the underlying yolk. During epiboly, cyp11a1 is expressed in an extra-embryonic yolk syncytial layer(4). Reducing cyp11a1 expression in zebrafish using antisense morpholino oligonucleotides did not perturb cell fates, but caused epibolic delay. This epibolic defect was partially rescued by the injection of cyp11a1 RNA or the supplementation of pregnenolone. We show that the epibolic delay is accompanied by a decrease in the level of polymerized microtubules, and that pregnenolone can rescue this microtubule defect. Our results indicate that pregnenolone preserves microtubule abundance and promotes cell movement during epiboly.	Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	mbchung@sinica.edu.tw	Hsu, Hwei-Jan/AAD-1518-2022	Hsu, Hwei-Jan/0000-0001-7892-2310; Chung, Bon-chu/0000-0002-8612-0219				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Arensburg J, 1999, ENDOCRINOLOGY, V140, P5220, DOI 10.1210/en.140.11.5220; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Cato AC, 2002, SCI STKE, V138, pre9, DOI [10.1126/stke.2002.138.re9, DOI 10.1126/STKE.2002.138.RE9]; Chen SR, 2000, DEVELOPMENT, V127, P4681; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; D'Amico LA, 2001, DEV DYNAM, V222, P611, DOI 10.1002/dvdy.1216; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; Grigoryev DN, 1999, ANAL BIOCHEM, V267, P319, DOI 10.1006/abio.1998.2993; Hsu Hwei-Jan, 2002, Gene Expression Patterns, V2, P219, DOI 10.1016/S1567-133X(02)00059-5; Hu MC, 2002, MOL ENDOCRINOL, V16, P1943, DOI 10.1210/me.2002-0055; Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Murakami K, 2000, P NATL ACAD SCI USA, V97, P3579, DOI 10.1073/pnas.97.7.3579; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; Sharma MK, 2004, COMP BIOCHEM PHYS B, V138, P391, DOI 10.1016/j.cbpc.2004.05.009; SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443; STRAHLE U, 1993, DEVELOPMENT, V119, P909; Venihaki M, 2000, P NATL ACAD SCI USA, V97, P7336, DOI 10.1073/pnas.97.13.7336; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	28	75	80	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					480	483		10.1038/nature04436	http://dx.doi.org/10.1038/nature04436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437115	Green Published			2022-12-01	WOS:000234859200048
J	Ohlstein, B; Spradling, A				Ohlstein, B; Spradling, A			The adult Drosophila posterior midgut is maintained by pluripotent stem cells	NATURE			English	Article							MELANOGASTER; GUT; DIFFERENTIATION; EXPRESSION; OOGENESIS; NICHE	Vertebrate and invertebrate digestive systems show extensive similarities in their development, cellular makeup and genetic control(1). The Drosophila midgut is typical: enterocytes make up the majority of the intestinal epithelial monolayer, but are interspersed with hormone-producing enteroendocrine cells(2-4). Human ( and mouse) intestinal cells are continuously replenished by stem cells, the misregulation of which may underlie some common digestive diseases and cancer(5). In contrast, stem cells have not been described in the intestines of flies, and Drosophila intestinal cells have been thought to be relatively stable(6-7). Here we use lineage labelling to show that adult Drosophila posterior midgut cells are continuously replenished by a distinctive population of intestinal stem cells (ISCs). As in vertebrates, ISCs are multipotent, and Notch signalling is required to produce an appropriate fraction of enteroendocrine cells(8). Notch is also required for the differentiation of ISC daughter cells, a role that has not been addressed in vertebrates. Unlike previously characterized stem cells, which reside in niches containing a specific partner stromal cell(9,10), ISCs adjoin only the basement membrane, differentiated enterocytes and their most recent daughters. The identification of Drosophila intestinal stem cells with striking similarities to their vertebrate counterparts will facilitate the genetic analysis of normal and abnormal intestinal function.	Carnegie Inst Sci, Howard Hughes Med Inst Res Labs, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, A (corresponding author), Carnegie Inst Sci, Howard Hughes Med Inst Res Labs, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 BC010738-01] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Baumann O, 2001, EXP CELL RES, V270, P176, DOI 10.1006/excr.2001.5343; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DAY MF, 1949, AUST J SCI RES SER B, V2, P175, DOI 10.1071/BI9490175; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gartner L P, 1970, J Baltimore Coll Dent Surg, V25, P64; GARTNER LP, 1973, INT J RADIAT BIOL, V23, P23, DOI 10.1080/09553007314550031; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; MICCHELLI CA, 2005, NATURE          1207, DOI DOI 10.1038/NATURE04371; Miller A., 1950, BIOL DROSOPHILA, P420; Nassel DR, 1999, PEPTIDES, V20, P141, DOI 10.1016/S0196-9781(98)00142-9; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709; Yoon JG, 1995, J COMP NEUROL, V363, P475, DOI 10.1002/cne.903630310	29	727	751	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					470	474		10.1038/nature04333	http://dx.doi.org/10.1038/nature04333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16340960				2022-12-01	WOS:000234859200046
J	Alter, DA; Chong, A; Austin, PC; Mustard, C; Iron, K; Williams, JI; Morgan, CD; Tu, JV; Irvine, J; Naylor, CD				Alter, DA; Chong, A; Austin, PC; Mustard, C; Iron, K; Williams, JI; Morgan, CD; Tu, JV; Irvine, J; Naylor, CD		SESAMI Study Grp	Socioeconomic status and mortality after acute myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							DISEASE RISK-FACTORS; CARDIOVASCULAR-DISEASE; REGIONAL-VARIATIONS; CARDIAC PROCEDURES; FACTORS EXPLAIN; HEART-DISEASE; SOCIAL-CLASS; HEALTH; CARE; INCOME	Background: Gradients that link socioeconomic status and cardiovascular mortality have been observed in many populations, including those of countries that provide publicly funded comprehensive medical coverage. The intermediary causes of such gradients remain poorly elucidated. Objective: To examine the relationships among socioeconomic status, other health factors, and 2-year mortality rates after acute myocardial infarction (MI). Design: Prospective cohort study. Setting: Ontario, Canada. Patients: 3407 patients who were hospitalized for acute MI in 53 large-volume hospitals in Canada from December 1999 to February 2003. Measurements: The authors obtained self-reported measures of income and education and developed profiles of the patients' pre-hospitalization cardiac risks and comorbid conditions. To create these profiles, the authors used the patients' self-reports and retrospectively linked no less than 12 years' worth of previous hospitalization data. Mortality rates 2 years after acute MI were examined with and without sequential risk adjustment for age, sex, ethnicity, social support, cardiovascular history and risk, comorbid conditions, and selected in-hospital process factors. Results: Income was strongly and inversely correlated with 2-year mortality rate (crude hazard ratio for high-income vs. low-income tertile, 0.45 [95% Cl, 0.35 to 0.57); P < 0.001). However, after adjustment for age and preexisting cardiovascular events or conventional vascular risk factors, the effect of income was greatly attenuated (adjusted hazard ratio for high-income vs. low-income tertile, 0.77 [CI, 0.54 to 1.10]; P = 0.150). Noncardiovascular comorbid conditions and in-hospital process factors had negligible explanatory effect. Limitations: Previous cardiovascular risks were ascertained through self-report or retrospectively through the longitudinal tracking of the hospitals' administrative databases. The study began with a cohort of patients who had an index cardiac event rather than with asymptomatic individuals. Conclusions: Age, past cardiovascular events, and current vascular risk factors accounted for most of the income-mortality gradient after acute MI. This observation suggests that the "wealth-health gradient" in cardiovascular mortality may be partially ameliorated by more rigorous management of known risk factors among less affluent persons.	York Univ, Inst Clin Evaluat Sci, Sunnybrook Womens Coll Hlth Sci Ctr, Inst Work & Hlth, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada	Institute for Work & Health; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; York University - Canada; University of Toronto	Alter, DA (corresponding author), York Univ, Inst Clin Evaluat Sci, Sunnybrook Womens Coll Hlth Sci Ctr, Inst Work & Hlth, 2075 Bayview Ave,G106, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca	Irvine, M. Jane/F-5442-2011	Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X				Abubakar Ibrahim, 2004, BMC Cardiovasc Disord, V4, P14, DOI 10.1186/1471-2261-4-14; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Alter DA, 2004, CAN J CARDIOL, V20, P1219; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Capewell S, 2001, LANCET, V358, P1213, DOI 10.1016/S0140-6736(01)06343-7; Chang CL, 2002, J CLIN EPIDEMIOL, V55, P749, DOI 10.1016/S0895-4356(02)00414-6; Choiniere R, 2000, CAN MED ASSOC J, V162, pS13; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Evans R. G., 1994, WHY ARE SOME PEOPLE, P3; Filate WA, 2003, CAN J CARDIOL, V19, P1241; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fox J., 2019, REGRESSION DIAGNOSTI; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; Goldman N, 2001, ANN NY ACAD SCI, V954, P118; GUADAGNOLI E, 1995, SOC SCI MED, V40, P1399, DOI 10.1016/0277-9536(94)00266-V; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HERLITZ J, 1994, CORONARY ARTERY DIS, V5, P51; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; MARMOT M, 1996, HLTH SOCIAL ORG, P42; MARMOT MG, 1983, J PSYCHOSOM RES, V27, P377, DOI 10.1016/0022-3999(83)90069-7; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Millar W J, 1993, Health Rep, V5, P143; Mookadam F, 2004, ARCH INTERN MED, V164, P1514, DOI 10.1001/archinte.164.14.1514; Mulatu MS, 2002, J HEALTH SOC BEHAV, V43, P22, DOI 10.2307/3090243; Mustard CA, 1997, SOC SCI MED, V45, P383, DOI 10.1016/S0277-9536(96)00354-1; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; POCOCK SJ, 1987, LANCET, V2, P197; Rao S, 2003, J AM COLL CARDIOL, V41, P1948, DOI 10.1016/S0735-1097(03)00402-9; Roos NP, 1997, MILBANK Q, V75, P89, DOI 10.1111/1468-0009.00045; ROSE G, 1981, BRIT HEART J, V45, P13, DOI 10.1136/hrt.45.1.13; Shen JJ, 2001, HEALTH SERV RES, V36, P711; *STAT CAN, 1996, NAT POP HLTH SURV DO; Stronks K, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1177/14034948020300032101; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Tu JV, 2001, JAMA-J AM MED ASSOC, V285, P3116, DOI 10.1001/jama.285.24.3116; Wolfson M, 1999, BRIT MED J, V319, P953, DOI 10.1136/bmj.319.7215.953; WOLFSON M, 1993, J GERONTOL, V48, pS167, DOI 10.1093/geronj/48.4.S167; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	47	132	141	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2006	144	2					82	93		10.7326/0003-4819-144-2-200601170-00005	http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	004AX	16418407				2022-12-01	WOS:000234725500004
J	Hanisch, LJ; Mao, JJ; Kodransky, M; Coyne, JC				Hanisch, LJ; Mao, JJ; Kodransky, M; Coyne, JC			Endogenous opioids and hot flushes still hypothetical	LANCET			English	Editorial Material							MENOPAUSAL FLUSHES; POSTMENOPAUSAL WOMEN; BETA-ENDORPHIN; NALOXONE; SECRETION; FLASHES		Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Dept Family Practice & Community Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hanisch, LJ (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	hanisch@mail.med.upenn.edu	Hanisch, Laura/A-2222-2008					CAGNACCI A, 1991, MATURITAS, V13, P283, DOI 10.1016/0378-5122(91)90237-K; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; COHEN MR, 1983, ARCH GEN PSYCHIAT, V40, P613; DEFAZIO J, 1984, J CLIN ENDOCR METAB, V58, P578, DOI 10.1210/jcem-58-3-578; Freeman EW, 2005, MENOPAUSE, V12, P258, DOI 10.1097/01.GME.0000142440.49698.B7; GENAZZANI AR, 1984, AM J OBSTET GYNECOL, V149, P775, DOI 10.1016/0002-9378(84)90121-2; GUILLEMIN R, 1977, SCIENCE, V197, P1367, DOI 10.1126/science.197601; JEFFCOATE WJ, 1978, LANCET, V2, P119; LESLIE RDG, 1979, LANCET, V1, P341; LIGHTMAN SL, 1981, BRIT J OBSTET GYNAEC, V88, P919, DOI 10.1111/j.1471-0528.1981.tb02229.x; Nedstrand E, 2005, CLIMACTERIC, V8, P243, DOI 10.1080/13697130500118050; SIMPKINS JW, 1983, LIFE SCI, V32, P1957, DOI 10.1016/0024-3205(83)90047-4; TEPPER R, 1987, OBSTET GYNECOL, V70, P150; TULANDI T, 1985, AM J OBSTET GYNECOL, V151, P277, DOI 10.1016/0002-9378(85)90026-2	14	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 14	2006	367	9505					92	93		10.1016/S0140-6736(06)67940-3	http://dx.doi.org/10.1016/S0140-6736(06)67940-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003BB	16413859				2022-12-01	WOS:000234655500007
J	Ciruna, B; Jenny, A; Lee, D; Mlodzik, M; Schier, AF				Ciruna, B; Jenny, A; Lee, D; Mlodzik, M; Schier, AF			Planar cell polarity signalling couples cell division and morphogenesis during neurulation	NATURE			English	Article							NEURAL-TUBE DEFECTS; CONVERGENT EXTENSION; LOOP-TAIL; ZEBRAFISH GASTRULATION; FLOOR PLATE; MOUSE; MOVEMENTS; STRABISMUS; ORIENTATION; MIGRATION	Environmental and genetic aberrations lead to neural tube closure defects (NTDs) in 1 out of every 1,000 births(1). Mouse and frog models for these birth defects have indicated that Van Gogh-like 2 (Vangl2, also known as Strabismus) and other components of planar cell polarity (PCP) signalling might control neurulation by promoting the convergence of neural progenitors to the midline(2-8). Here we show a novel role for PCP signalling during neurulation in zebrafish. We demonstrate that non-canonical Wnt/PCP signalling polarizes neural progenitors along the anteroposterior axis. This polarity is transiently lost during cell division in the neural keel but is re-established as daughter cells reintegrate into the neuroepithelium. Loss of zebrafish Vangl2 ( in trilobite mutants) abolishes the polarization of neural keel cells, disrupts re-intercalation of daughter cells into the neuroepithelium, and results in ectopic neural progenitor accumulations and NTDs. Remarkably, blocking cell division leads to rescue of trilobite neural tube morphogenesis despite persistent defects in convergence and extension. These results reveal a function for PCP signalling in coupling cell division and morphogenesis at neurulation and indicate a previously unrecognized mechanism that might underlie NTDs.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Mt Sinai Sch Med, Brookdale Dept Mol Cellular & Dev Biol, New York, NY 10029 USA	New York University; New York University; Icahn School of Medicine at Mount Sinai	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev Biol, Toronto Med Discovery Tower, Toronto, ON M5G 1L7, Canada.	ciruna@sickkids.ca; schier@fas.harvard.edu		Schier, Alexander Franz/0000-0001-7645-5325	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056211] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Concha ML, 1998, DEVELOPMENT, V125, P983; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Thisse C, 1999, DEVELOPMENT, V126, P229; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581	30	300	310	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					220	224		10.1038/nature04375	http://dx.doi.org/10.1038/nature04375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407953	Green Accepted			2022-12-01	WOS:000234538400044
J	Gartley, C				Gartley, C			Life with incontinence	LANCET			English	Editorial Material									Simon Fdn Continence, Wilmette, IL 60091 USA		Gartley, C (corresponding author), Simon Fdn Continence, POB 815, Wilmette, IL 60091 USA.	cbgartley@simonfoundation.org							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					68	68		10.1016/S0140-6736(06)67926-9	http://dx.doi.org/10.1016/S0140-6736(06)67926-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399155				2022-12-01	WOS:000234443100032
J	Chen, CJ; Yang, HI; Su, J; Jen, CL; You, SL; Lu, SN; Huang, GT; Iloeje, UH				Chen, CJ; Yang, HI; Su, J; Jen, CL; You, SL; Lu, SN; Huang, GT; Iloeje, UH		REVEAL-HBV Study Grp	Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E-ANTIGEN; HBV-DNA; AMINOTRANSFERASE LEVELS; INFECTION; ETIOLOGY; EFFICACY; THERAPY	Context Serum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy of antiviral treatment in individuals with chronic hepatitis B. Objective To evaluate the relationship between serum HBV DNA level and risk of hepatocellular carcinoma. Design, Setting, and Participants Prospective cohort study of 3653 participants (aged 30-65 years), who were seropositive for the hepatitis B surface antigen and seronegative for antibodies against the hepatitis C virus, recruited to a community-based cancer screening program in Taiwan between 1991 and 1992. Main Outcome Measure Incidence of hepatocellular carcinoma during follow-up examination and by data linkage with the national cancer registry and the death certification systems. Results There were 164 incident cases of hepatocellular carcinoma and 346 deaths during a mean follow-up of 11.4 years and 41779 person-years of follow-up. The incidence of hepatocellular carcinoma increased with serum HBV DNA level at study entry, in a dose-response relationship ranging from 108 per 100 000 person-years for an HBV DNA level of less than 300 copies/mL to 1152 per 100000 person-years for an HBV DNA level of 1 million copies/mL or greater. The corresponding cumulative incidence rates of hepatocellular carcinoma were 1.3% and 14.9%, respectively. The biological gradient of hepatocellular carcinoma by serum HBV DNA levels remained significant (P<.001) after adjustment for sex, age, cigarette smoking, alcohol consumption, serostatus for the hepatitis Be antigen (HBeAg), serum alanine aminotransferase level, and liver cirrhosis at study entry. The dose-response relationship was most prominent for participants who were seronegative for HBeAg with normal serum alanine aminotransferase levels and no liver cirrhosis at study entry. Participants with persistent elevation of serum HBV DNA level during follow-up had the highest hepatocellular carcinoma risk. Conclusion Elevated serum HBV DNA level (>= 10 000 copies/mL) is a strong risk predictor of hepatocellular carcinoma independent of HBeAg, serum alanine aminotransferase level, and liver cirrhosis.	Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10018, Taiwan; Bristol Myers Squibb Co, Global Epidemiol & Outcomes Res, Wallingford, CT 06492 USA; Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol, Kaohsiung, Taiwan	National Taiwan University; Bristol-Myers Squibb; Chang Gung Memorial Hospital	Chen, CJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Room 1547,1,Jen Ai Rd Sec 1, Taipei 10018, Taiwan.	cjchen@ha.mc.ntu.edu.tw	Chen, Chien-Jen/C-6976-2008; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/N-4723-2019; Ibrahim, Essam Hassan/G-1960-2018; ting, huang/V-6326-2017	Yang, Hwai-I/0000-0002-3433-942X; Ibrahim, Essam Hassan/0000-0003-0130-2257; Huang, Guan-Tarn/0000-0001-7004-826X				AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Alberti A, 2003, HEPATOLOGY, V38, P18, DOI 10.1053/jhep.2003.50280; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BRESLOW N, 1974, ANN STAT, V2, P437, DOI 10.1214/aos/1176342705; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chen CJ, 2002, NEW ENGL J MED, V347, P1722; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Geier A, 2003, HEPATOLOGY, V37, P712, DOI 10.1053/jhep.2003.50099; LEE PI, 1990, HEPATOLOGY, V12, P657, DOI 10.1002/hep.1840120406; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Lok ASF, 2003, HEPATOLOGY, V37, P713, DOI 10.1053/jhep.2003.50111; MCMAHON BJ, 1997, VIRAL HEPATITIS, P315; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; PENA E, 1993, J STAT PLAN INFER, V37, P192; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; You SL, 2004, ANN MED, V36, P215, DOI 10.1080/07853890310021580; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043	22	2273	2445	1	201	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					65	73		10.1001/jama.295.1.65	http://dx.doi.org/10.1001/jama.295.1.65			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391218	Bronze			2022-12-01	WOS:000234381100022
J	Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA				Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA			Epidemiology and prognosis of coma in daytime television dramas	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOAP-OPERA; VEGETATIVE STATE; HEAD-INJURY; BREAST-CANCER; BRAIN-INJURY; EDUCATION; ATTITUDES; BEHAVIOR; PROGRAM; AIDS	Objective To determine how soap operas Portray, and possibly misrepresent, the likelihood of recovery for patients in coma. Design Retrospective cohort study Setting Nine soap operas in the United States reviewed between 1 January 1995 and 15 May 2005. Subjects 64 characters who experienced a period of unconsciousness lasting at least 24 hours. Their final status at the end of the follow-up period was compared with pooled data from a meta-analysis. Results Comas lasted a median of 13 days (interquartile range 7-25 days). Fifty seven (89%) patients recovered fully, five (8%) died, and two (3%) remained in a vegetative state. Mortality for non-traumatic and traumatic coma was significantly lower than would be predicted from the meta-analysis data (non-traumatic 4% v 53%; traumatic 6% v 67%; Fisher's exact test both P < 0.001). On the day that patients regained consciousness, most (49/57; 86%) had no evidence of limited function, cognitive deficit, or residual disability needing rehabilitation. Compared with meta-analysis data, patients in this sample had a much better than expected chance of returning to normal function (non-traumatic 91% v 1%; traumatic 89% 7%; both P < 0.001). Conclusions The portrayal of coma in soap operas is overly optimistic. Although these programmes are presented as fiction, they may contribute to unrealistic expectations of recovery.	Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Div Geriatr Med, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Casarett, D (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, 9 E,3900 Woodland Ave, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X				Ang I, 1991, DESPERATELY SEEKING; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BANJA JD, 1990, PHYS MED REHABIL, V4, P579; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; Borrayo EA, 2004, PREV MED, V39, P99, DOI 10.1016/j.ypmed.2004.03.024; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Brodie M, 2001, HEALTH AFFAIR, V20, P192, DOI 10.1377/hlthaff.20.1.192; Campbell MK, 2004, J NUTR EDUC BEHAV, V36, P58, DOI 10.1016/S1499-4046(06)60134-6; *COUNC SCI AFF COU, 1990, JAMA-J AM MED ASSOC, P426; Cranford R E, 1991, Law Med Health Care, V19, P13; Crayford T, 1997, BRIT MED J, V315, P1649, DOI 10.1136/bmj.315.7123.1649; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hamel Mary Beth, 1995, JAMA (Journal of the American Medical Association), V273, P1842, DOI 10.1001/jama.273.23.1842; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Howe A, 2002, J PUBLIC HEALTH MED, V24, P299, DOI 10.1093/pubmed/24.4.299; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jibaja ML, 2000, J CANCER EDUC, V15, P237; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kennedy MG, 2004, J COMMUN, V54, P287, DOI 10.1093/joc/54.2.287; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; *MULT SOC TASK FOR, 1995, NEW ENGL J MED, V330, P1572; *NIELS MED RES, 2000, REP TEL; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shapiro D, 2003, AIDS CARE, V15, P303, DOI 10.1080/0954012031000105360; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Walker WC, 1996, BRAIN INJURY, V10, P65	38	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1537	1539		10.1136/bmj.331.7531.1537	http://dx.doi.org/10.1136/bmj.331.7531.1537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373744	Green Published, Bronze			2022-12-01	WOS:000234351300025
J	Jackson, RB; Jobbagy, EG; Avissar, R; Roy, SB; Barrett, DJ; Cook, CW; Farley, KA; le Maitre, DC; McCarl, BA; Murray, BC				Jackson, RB; Jobbagy, EG; Avissar, R; Roy, SB; Barrett, DJ; Cook, CW; Farley, KA; le Maitre, DC; McCarl, BA; Murray, BC			Trading water for carbon with biological sequestration	SCIENCE			English	Article							GREENHOUSE-GAS MITIGATION; REGIONAL CLIMATE; US AGRICULTURE; LAND-USE; AFFORESTATION; VEGETATION; IMPACTS; TREES; GROUNDWATER; GRASSLAND	Carbon sequestration strategies highlight tree plantations without considering their full environmental consequences. We combined field research, synthesis of more than 600 observations, and climate and economic modeling to document substantial losses in stream flow, and increased soil salinization and acidification, with afforestation. Plantations decreased stream flow by 227 millimeters per year globally (52%), with 13% of streams drying completely for at least 1 year. Regional modeling of U.S. plantation scenarios suggests that climate feedbacks, are unlikely to offset such water losses and could exacerbate them. Plantations can help control groundwater recharge and upwelling but reduce stream flow and salinize and acidify some soils.	Duke Univ, Nicholas Sch Environm & Earth Sci, Dept Biol, Durham, NC 27708 USA; Duke Univ, Ctr Global Change, Durham, NC 27708 USA; Univ Nacl San Luis, IMASL, Grp Estudios Ambientales, RA-5700 San Luis, Argentina; Consejo Nacl Invest Cient & Tecn, RA-5700 San Luis, Argentina; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; CSIRO Land & Water, Canberra, ACT 2601, Australia; CSIR, ZA-7599 Stellenbosch, South Africa; Texas A&M Univ, Dept Agr Econ, College Stn, TX 77843 USA; Res Triangle Inst, Ctr Regulatory Econ & Policy Res, Res Triangle Pk, NC 27709 USA	Duke University; Duke University; Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Council for Scientific & Industrial Research (CSIR) - South Africa; Texas A&M University System; Texas A&M University College Station; Research Triangle Institute	Jackson, RB (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Dept Biol, Durham, NC 27708 USA.	jackson@duke.edu	Barrett, Damian J/C-7972-2009; Le Maitre, David/M-8791-2015; McCarl, Bruce A/E-9445-2011; Jobbágy, Esteban Gabriel/A-6293-2010	Barrett, Damian J/0000-0002-8215-4892; Le Maitre, David/0000-0003-1037-6637; Jobbágy, Esteban Gabriel/0000-0002-4214-6011; Baidya Roy, Somnath/0000-0002-7677-4972; Jackson, Robert/0000-0001-8846-7147				Adams DM, 1996, PNWRP495 USDA FOR SE; Cannell MGR, 1999, NEW FOREST, V17, P239, DOI 10.1023/A:1006551018221; Cotton WR, 2003, METEOROL ATMOS PHYS, V82, P5, DOI 10.1007/s00703-001-0584-9; DICKINSON RE, 1992, GEOPHYS RES LETT, V19, P1947, DOI 10.1029/92GL01905; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; George RJ, 1999, AGR WATER MANAGE, V39, P91, DOI 10.1016/S0378-3774(98)00073-0; Heuperman A, 1999, AGR WATER MANAGE, V39, P153, DOI 10.1016/S0378-3774(98)00076-6; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jobbagy EG, 2004, GLOBAL CHANGE BIOL, V10, P1299, DOI 10.1111/j.1365-2486.2004.00806.x; Le Maitre DC, 1999, WATER SA, V25, P137; McCarl BA, 2001, SCIENCE, V294, P2481, DOI 10.1126/science.1064193; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pattanayak SK, 2005, CLIMATIC CHANGE, V71, P341, DOI 10.1007/s10584-005-5925-0; Pearce A. J., 1979, J HYDROLOGY NZ, V18, P73; PIELKE RA, 1990, LANDSCAPE ECOL, V4, P133, DOI 10.1007/BF00132857; Plantinga AJ, 2003, LAND ECON, V79, P74, DOI 10.2307/3147106; Roy SB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000266; Sapanov MK, 2000, EURASIAN SOIL SCI+, V33, P1157; Scott DF, 1997, J HYDROL, V199, P360, DOI 10.1016/S0022-1694(96)03336-7; VITOUSEK PM, 1991, J ENVIRON QUAL, V20, P348, DOI 10.2134/jeq1991.00472425002000020003x; Walker GR, 2002, HYDROGEOL J, V10, P68, DOI 10.1007/s10040-001-0181-5; Wright JA, 2000, J FOREST, V98, P20; Xue YK, 1996, J GEOPHYS RES-ATMOS, V101, P7419, DOI 10.1029/95JD02169; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	28	831	893	33	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1944	1947		10.1126/science.1119282	http://dx.doi.org/10.1126/science.1119282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373572				2022-12-01	WOS:000234275400039
J	van Oort, BEH; Tyler, NJC; Gerkema, MP; Folkow, L; Blix, AS; Stokkan, KA				van Oort, BEH; Tyler, NJC; Gerkema, MP; Folkow, L; Blix, AS; Stokkan, KA			Circadian organization in reindeer	NATURE			English	Editorial Material							MELATONIN		Univ Tromso, Dept Arctic Biol, N-9037 Tromso, Norway; Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; Univ Tromso, Ctr Sami Studies, N-9037 Tromso, Norway; Univ Groningen, Dept Chronobiol, NL-9750 AA Haren, Netherlands	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Groningen	van Oort, BEH (corresponding author), Univ Tromso, Dept Arctic Biol, N-9037 Tromso, Norway.	karlarne@fagmed.uit.no	Jansen, Heiko T./A-5770-2008; gerkema, menno/GLN-3200-2022; van Oort, Bob/J-8617-2016	Jansen, Heiko T./0000-0003-0178-396X; van Oort, Bob/0000-0001-9508-1162				Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; de Mairian J. J., 1729, HIST ACADEMIE ROYALE, P35; Gerkema M. P., 2002, P207; HAU M, 1995, PHYSIOL BEHAV, V58, P89, DOI 10.1016/0031-9384(95)00002-Z; Hut RA, 2002, J COMP PHYSIOL B, V172, P59; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; STOKKAN KA, 1994, CAN J ZOOL, V72, P904, DOI 10.1139/z94-123; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264	9	122	125	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1095	1096		10.1038/4381095a	http://dx.doi.org/10.1038/4381095a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371996				2022-12-01	WOS:000234111500033
J	Okie, S				Okie, S			Glimpses of Guantanamo - Medical ethics and the war on terror	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*DEP JUST IMM NAT, 1992, IMM ACT 1990 REP CRI, P3; Lewis Neil A, 2004, N Y Times Web, pA14; RUMSFELD D, 2003, COMMUNICATION   0416; WHITE J, 2005, WASHINGTON POST 0902, pA1	4	30	31	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2005	353	24					2529	2534		10.1056/NEJMp058296	http://dx.doi.org/10.1056/NEJMp058296			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	993BA	16354888				2022-12-01	WOS:000233926500001
J	Wu, HJ; Chen, YP; Liang, J; Shi, B; Wu, G; Zhang, Y; Wang, D; Li, RF; Yi, X; Zhang, H; Sun, LY; Shang, YF				Wu, HJ; Chen, YP; Liang, J; Shi, B; Wu, G; Zhang, Y; Wang, D; Li, RF; Yi, X; Zhang, H; Sun, LY; Shang, YF			Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis	NATURE			English	Article							ESTROGEN-RECEPTOR MODULATORS; CANCER-CELLS; BREAST-CANCER; GENE-EXPRESSION; ABERRANT EXPRESSION; PROMOTER CONTEXT; BINDING PROTEIN; TARGET GENES; ER-ALPHA; IN-VIVO	Tamoxifen, a selective oestrogen receptor modulator, has been used in the treatment of all stages of hormone-responsive breast cancer. However, tamoxifen shows partial oestrogenic activity in the uterus and its use has been associated with an increased incidence of endometrial cancer. The molecular explanation for these observations is not known. Here we show that tamoxifen and oestrogen have distinct but overlapping target gene profiles. Among the overlapping target genes, we identify a paired-box gene, PAX2, that is crucially involved in cell proliferation and carcinogenesis in the endometrium. Our experiments show that PAX2 is activated by oestrogen and tamoxifen in endometrial carcinomas but not in normal endometrium, and that this activation is associated with cancer-linked hypomethylation of the PAX2 promoter.	Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China.	jason@bjmu.edu.cn	Chen, Yupeng/T-5275-2019	Chen, Yupeng/0000-0001-8887-9547				Akhmedkhanov A, 2001, ANN NY ACAD SCI, V943, P296, DOI 10.1111/j.1749-6632.2001.tb03811.x; Bramlett KS, 2003, J STEROID BIOCHEM, V86, P27, DOI 10.1016/S0960-0760(03)00258-9; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro-Rivera E, 2003, J STEROID BIOCHEM, V84, P23, DOI 10.1016/S0960-0760(03)00010-4; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Dardes RC, 2002, GYNECOL ONCOL, V85, P498, DOI 10.1006/gyno.2002.6659; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Galien R, 1996, MOL ENDOCRINOL, V10, P713, DOI 10.1210/me.10.6.713; Ghosh MG, 2000, CANCER RES, V60, P6367; Gupta A, 2003, CANCER RES, V63, P664; Hague S, 2002, BRIT J CANCER, V86, P761, DOI 10.1038/sj.bjc.6600157; Hernandez E, 2001, OBSTET GYN CLIN N AM, V28, P743, DOI 10.1016/S0889-8545(05)70233-3; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jones PS, 1999, J BIOL CHEM, V274, P32008, DOI 10.1074/jbc.274.45.32008; Jordan VC, 2001, J NATL CANCER I, V93, P1449, DOI 10.1093/jnci/93.19.1449; KATZENELLENBOGEN BS, 1995, J STEROID BIOCHEM, V53, P387, DOI 10.1016/0960-0760(95)00084-D; Khoubehi B, 2001, J UROLOGY, V165, P2115, DOI 10.1016/S0022-5347(05)66304-5; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MONTANO MM, 1995, MOL ENDOCRINOL, V9, P814, DOI 10.1210/me.9.7.814; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; Robertson JA, 1998, J STEROID BIOCHEM, V67, P285, DOI 10.1016/S0960-0760(98)00121-6; Russo LA, 2001, J BIOL CHEM, V276, P686, DOI 10.1074/jbc.M004106200; Sakamoto T, 2002, MOL CELL ENDOCRINOL, V192, P93, DOI 10.1016/S0303-7207(02)00086-2; Sato N, 2003, CANCER RES, V63, P4158; Seth P, 2002, ONCOGENE, V21, P836, DOI 10.1038/sj.onc.1205113; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SHYAMALA G, 1992, P NATL ACAD SCI USA, V89, P10628, DOI 10.1073/pnas.89.22.10628; Silberstein GB, 2002, ONCOGENE, V21, P1009, DOI 10.1038/sj.onc.1205172; Stayner CK, 1998, J BIOL CHEM, V273, P25472, DOI 10.1074/jbc.273.39.25472; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Wang ZO, 2002, ONCOGENE, V21, P3517, DOI 10.1038/sj.onc.1205463; Watanabe T, 1997, BIOCHEM BIOPH RES CO, V236, P140, DOI 10.1006/bbrc.1997.6915; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704	47	212	234	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					981	987		10.1038/nature04225	http://dx.doi.org/10.1038/nature04225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355216				2022-12-01	WOS:000233934600058
J	Tomasko, MG; Archinal, B; Becker, T; Bezard, B; Bushroe, M; Combes, M; Cook, D; Coustenis, A; de Bergh, C; Dafoe, LE; Doose, L; Doute, S; Eibl, A; Engel, S; Gliem, F; Grieger, B; Holso, K; Howington-Kraus, E; Karkoschka, E; Keller, HU; Kirk, R; Kramm, R; Kuppers, M; Lanagan, P; Lellouch, E; Lemmon, M; Lunine, J; McFarlane, E; Moores, J; Prout, GM; Rizk, B; Rosiek, M; Rueffer, P; Schroder, SE; Schmitt, B; See, C; Smith, P; Soderblom, L; Thomas, N; West, R				Tomasko, MG; Archinal, B; Becker, T; Bezard, B; Bushroe, M; Combes, M; Cook, D; Coustenis, A; de Bergh, C; Dafoe, LE; Doose, L; Doute, S; Eibl, A; Engel, S; Gliem, F; Grieger, B; Holso, K; Howington-Kraus, E; Karkoschka, E; Keller, HU; Kirk, R; Kramm, R; Kuppers, M; Lanagan, P; Lellouch, E; Lemmon, M; Lunine, J; McFarlane, E; Moores, J; Prout, GM; Rizk, B; Rosiek, M; Rueffer, P; Schroder, SE; Schmitt, B; See, C; Smith, P; Soderblom, L; Thomas, N; West, R			Rain, winds and haze during the Huygens probe's descent to Titan's surface	NATURE			English	Article							AGGREGATE PARTICLES; ATMOSPHERE; AEROSOLS; SIMULATION; AMMONIA; ENTRY; MODEL; ICE	The irreversible conversion of methane into higher hydrocarbons in Titan's stratosphere implies a surface or subsurface methane reservoir. Recent measurements from the cameras aboard the Cassini orbiter fail to see a global reservoir, but the methane and smog in Titan's atmosphere impedes the search for hydrocarbons on the surface. Here we report spectra and high-resolution images obtained by the Huygens Probe Descent Imager/Spectral Radiometer instrument in Titan's atmosphere. Although these images do not show liquid hydrocarbon pools on the surface, they do reveal the traces of once flowing liquid. Surprisingly like Earth, the brighter highland regions show complex systems draining into flat, dark lowlands. Images taken after landing are of a dry riverbed. The infrared reflectance spectrum measured for the surface is unlike any other in the Solar System; there is a red slope in the optical range that is consistent with an organic material such as tholins, and absorption from water ice is seen. However, a blue slope in the near-infrared suggests another, unknown constituent. The number density of haze particles increases by a factor of just a few from an altitude of 150 km to the surface, with no clear space below the tropopause. The methane relative humidity near the surface is 50 per cent.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Observ Paris, LESIA, F-92195 Meudon, France; Univ Grenoble 1, CNRS, Lab Planetol Grenoble, F-38041 Grenoble, France; Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; Ist Fis Spazio Interplanetario, Ist Nazl Astrofis, ARTOV, I-00133 Rome, Italy; Univ Bern, Dept Phys, CH-3012 Bern, Switzerland; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; United States Department of the Interior; United States Geological Survey; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Braunschweig University of Technology; Max Planck Society; Texas A&M University System; Texas A&M University College Station; Istituto Nazionale Astrofisica (INAF); University of Bern; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	See, C (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	csee@lpl.arizona.edu	Moores, John E./AAO-6622-2021; Schröder, Stefan/D-9709-2013; Schmitt, Bernard/A-1064-2009; Lemmon, Mark/X-2333-2019; Lemmon, Mark T/E-9983-2010; Thomas, Nicolas/G-4693-2015	Moores, John E./0000-0001-9435-1095; Schröder, Stefan/0000-0003-0323-8324; Schmitt, Bernard/0000-0002-1230-6627; Lemmon, Mark/0000-0002-4504-5136; Lemmon, Mark T/0000-0002-4504-5136; Lunine, Jonathan/0000-0003-2279-4131; Bezard, Bruno/0000-0002-5433-5661; Thomas, Nicolas/0000-0002-0146-0071				Bernard JM, 2003, PLANET SPACE SCI, V51, P1003, DOI 10.1016/j.pss.2003.05.009; BERNARD JM, UNPUB ICARUS; BOND NA, 1992, J CLIMATE, V5, P699, DOI 10.1175/1520-0442(1992)005<0699:OOPBLS>2.0.CO;2; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CABANE M, 1993, PLANET SPACE SCI, V41, P257, DOI 10.1016/0032-0633(93)90021-S; CABANE M, 1992, ICARUS, V96, P176, DOI 10.1016/0019-1035(92)90071-E; Coll P, 1999, PLANET SPACE SCI, V47, P1331, DOI 10.1016/S0032-0633(99)00054-9; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; Coustenis A, 2005, ICARUS, V177, P89, DOI 10.1016/j.icarus.2005.03.012; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; FLASAR FM, 1997, ESA SP PUBL, V1177, P287; Griffith CA, 2003, SCIENCE, V300, P628, DOI 10.1126/science.1081897; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Ivanov BA, 1997, PLANET SPACE SCI, V45, P993, DOI 10.1016/S0032-0633(97)00044-5; Karkoschka E, 1998, ICARUS, V133, P134, DOI 10.1006/icar.1998.5913; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Lellouch E, 2004, ICARUS, V168, P209, DOI 10.1016/j.icarus.2003.12.001; LEMMON MT, 1994, THESIS U ARIZONA; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tomasko MG, 2002, SPACE SCI REV, V104, P469, DOI 10.1023/A:1023632422098; TOON OB, 1992, ICARUS, V95, P24, DOI 10.1016/0019-1035(92)90188-D; WEST RA, 1991, APPL OPTICS, V30, P5316, DOI 10.1364/AO.30.005316; WEST RA, 1991, ICARUS, V90, P330, DOI 10.1016/0019-1035(91)90113-8	31	415	420	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					765	778		10.1038/nature04126	http://dx.doi.org/10.1038/nature04126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319829				2022-12-01	WOS:000233777800037
J	Yamada, S; Pokutta, S; Drees, F; Weis, WI; Nelson, WJ				Yamada, S; Pokutta, S; Drees, F; Weis, WI; Nelson, WJ			Deconstructing the cadherin-catenin-actin complex	CELL			English	Article							CELL-CELL ADHESION; ALPHA-CATENIN; EPITHELIAL-CELLS; BETA-CATENIN; INTERCELLULAR-ADHESION; JUNCTIONAL COMPLEX; F-ACTIN; PROTEIN; MEMBRANE; BINDING	Spatial and functional organization of cells in tissues is determined by cell-cell adhesion, thought to be initiated through trans-interactions between extracellular domains of the cadherin family of adhesion proteins, and strengthened by linkage to the actin cytoskeleton. Prevailing dogma is that cadherins are linked to the actin cytoskeleton through beta-catenin and alpha-catenin, although the quaternary complex has never been demonstrated. We test this hypothesis and find that alpha-catenin does not interact with actin filaments and the E-cadherin-beta-catenin complex simultaneously, even in the presence of the actin binding proteins vinculin and alpha-actinin, either in solution or on isolated cadherin-containing membranes. Direct analysis in polarized cells shows that mobilities of E-cadherin, beta-catenin, and alpha-catenin are similar, regardless of the dynamic state of actin assembly, whereas actin and several actin binding proteins have higher mobilities. These results suggest that the linkage between the cadherin-catenin complex and actin filaments is more dynamic than previously appreciated.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	bill.weis@stanford.edu; wjnelson@stanford.edu	Weis, William I/G-1437-2011; Yamada, Soichiro/B-7360-2019	Weis, William I/0000-0002-5583-6150; Yamada, Soichiro/0000-0001-6413-0814	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM035527] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM35527, R01 GM035527, R01 GM56169, R01 GM056169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERLE H, 1994, J CELL SCI, V107, P3655; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Drees Frauke, 2004, V294, P303; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	46	760	783	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					889	901		10.1016/j.cell.2005.09.020	http://dx.doi.org/10.1016/j.cell.2005.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325582	Bronze, Green Accepted			2022-12-01	WOS:000233814100021
J	Kollmann, M; Lovdok, L; Bartholome, K; Timmer, J; Sourjik, V				Kollmann, M; Lovdok, L; Bartholome, K; Timmer, J; Sourjik, V			Design principles of a bacterial signalling network	NATURE			English	Article							GENE-EXPRESSION; CHEMOTAXIS; ROBUSTNESS; STOCHASTICITY; SENSITIVITY; PROTEIN; NOISE	Cellular biochemical networks have to function in a noisy environment using imperfect components. In particular, networks involved in gene regulation or signal transduction allow only for small output tolerances, and the underlying network structures can be expected to have undergone evolution for inherent robustness against perturbations(1). Here we combine theoretical and experimental analyses to investigate an optimal design for the signalling network of bacterial chemotaxis, one of the most thoroughly studied signalling networks in biology. We experimentally determine the extent of intercellular variations in the expression levels of chemotaxis proteins and use computer simulations to quantify the robustness of several hypothetical chemotaxis pathway topologies to such gene expression noise. We demonstrate that among these topologies the experimentally established chemotaxis network of Escherichia coli has the smallest sufficiently robust network structure, allowing accurate chemotactic response for almost all individuals within a population. Our results suggest that this pathway has evolved to show an optimal chemotactic performance while minimizing the cost of resources associated with high levels of protein expression. Moreover, the underlying topological design principles compensating for intercellular variations seem to be highly conserved among bacterial chemosensory systems(2).	Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany; Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany; Univ Freiburg, FDM, D-79104 Freiburg, Germany	University of Freiburg; Ruprecht Karls University Heidelberg; University of Freiburg	Kollmann, M (corresponding author), Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.	markus.kollmann@fdm.uni-freiburg.de; v.sourjik@zmbh.uni-heidelberg.de	Bartholome, Kilian/A-9593-2013; Bartholome, Kilian/F-1691-2011	Bartholome, Kilian/0000-0001-6525-777X; Bartholome, Kilian/0000-0001-6525-777X				Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Almogy G, 2001, BIOPHYS J, V81, P3016, DOI 10.1016/S0006-3495(01)75942-5; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; ROSENFELD N, 2005, NATURE, V307, P1962; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Webre DJ, 2003, CURR BIOL, V13, pR47, DOI 10.1016/S0960-9822(02)01424-0	30	229	243	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					504	507		10.1038/nature04228	http://dx.doi.org/10.1038/nature04228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306993				2022-12-01	WOS:000233458200051
J	Filardi, CE; Moyle, RG				Filardi, CE; Moyle, RG			Single origin of a pan-Pacific bird group and upstream colonization of Australasia	NATURE			English	Article							BIOGEOGRAPHY; ISLANDS; EVOLUTION; MODEL	Oceanic islands have long served as natural laboratories for understanding the diversification of life(1-4). In particular, the many thousands of islands spanning the tropical Pacific support an unparalleled array of terrestrial communities whose patterns of diversity contributed fundamental insights to the development of classical speciation and biogeographic theory(4-8). Much of this work is founded on an assumption derived from traditional taxonomic approaches, namely that faunas on these widely separated archipelagos stem from a simple one-way, downstream flow of colonists from continents to islands(2,4). Here we show, with the use of molecular phylogenetic data from one of the original bird families used to justify this assumption, that a diverse array of endemic island genera and species are the product of a single radiation that diversified across all major Pacific archipelagos in a non-stepping-stone fashion, and recently recolonized continental areas. The geographic scope and lineage-specific approach of this study reveal evolutionary patterns long obscured by traditional taxonomic surveys and indicate thatwidely dispersed archipelagos can be sources of biological diversity.	Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Filardi, CE (corresponding author), Amer Museum Nat Hist, Ctr Biodivers & Conservat, Cent Pk W & 79th St, New York, NY 10024 USA.	filardi@amnh.org						Cibois A, 2004, CONDOR, V106, P837, DOI 10.1650/7491; DIAMOND JM, 1974, SCIENCE, V184, P803, DOI 10.1126/science.184.4138.803; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Filardi CE, 2005, MOL PHYLOGENET EVOL, V37, P776, DOI 10.1016/j.ympev.2005.02.007; FJELDSA J, 2002, TRENDS ECOL EVOL, V17, P292; Gillespie RG, 2002, J BIOGEOGR, V29, P655, DOI 10.1046/j.1365-2699.2002.00714.x; Grant PR, 2001, OIKOS, V92, P385, DOI 10.1034/j.1600-0706.2001.920301.x; Hall Robert, 1998, P99; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lack D., 1947, DARWINS FINCHES; LOMOLINO MV, 1986, BIOL J LINN SOC, V28, P1, DOI 10.1111/j.1095-8312.1986.tb01746.x; MAC ARTHUR ROBERT H., 1967; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E., 1942, SYSTEMATICS ORIGIN S, DOI 10.2307/1790142; MAYR ERNST, 1939, PROC 6TH PACIFIC SCI CONGR, V4, P197; OLSON S L, 1980, Notornis, V27, P7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ricklefs RE, 2001, SCIENCE, V294, P1522, DOI 10.1126/science.1065005; Slikas B, 2000, AUK, V117, P355, DOI 10.1642/0004-8038(2000)117[0355:PROMWE]2.0.CO;2; Spironello M, 2003, J BIOGEOGR, V30, P1563, DOI 10.1046/j.1365-2699.2003.00945.x; STEADMAN DW, 1993, P NATL ACAD SCI USA, V90, P818, DOI 10.1073/pnas.90.3.818; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; TARR CL, 1993, AUK, V110, P825, DOI 10.2307/4088636; Wallace A. R., 1855, J NAT HIST, V16, P184, DOI DOI 10.1080/037454809495509; Ward SA, 2000, GLOBAL ECOL BIOGEOGR, V9, P7, DOI 10.1046/j.1365-2699.2000.00196.x; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.2307/2405948; Wright SD, 2000, P NATL ACAD SCI USA, V97, P4118, DOI 10.1073/pnas.050351197	30	165	173	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					216	219		10.1038/nature04057	http://dx.doi.org/10.1038/nature04057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281034				2022-12-01	WOS:000233133500047
J	Gallo, RC				Gallo, RC			The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years	LANCET			English	Editorial Material							REACTIVE NEUTRALIZING ANTIBODIES; GENOMIC DIVERSITY; INTERFERON-ALPHA; BETA-CHEMOKINES; PUBLIC-HEALTH; ELICIT; AIDS; IMMUNIZATION; COMPLEXES; MACAQUES		Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Gallo, RC (corresponding author), Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA.	gallo@umbi.umd.edu						AIDS Vaccine Advocacy Coalition, 2004, SCIENCE, V305, P177; Barouch DH, 2002, VACCINE, V20, pA66, DOI 10.1016/S0264-410X(02)00390-0; Belshe R, 2004, SCIENCE, V305, P177; Bower JF, 2004, VIROLOGY, V328, P292, DOI 10.1016/j.virol.2004.07.031; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen J, 2003, SCIENCE, V299, P1290, DOI 10.1126/science.299.5611.1290; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Devico A, 1996, VIROLOGY, V218, P258, DOI 10.1006/viro.1996.0188; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; Gallo RC, 2004, SCIENCE, V305, P179; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gringeri A, 1996, J ACQ IMMUN DEF SYND, V13, P55, DOI 10.1097/00042560-199609000-00009; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Hilleman MR, 2002, INTERVIROLOGY, V45, P199, DOI 10.1159/000067911; Hilleman MR, 2001, VACCINE, V19, P1837, DOI 10.1016/S0264-410X(00)00364-9; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Horton R, 2004, NEW YORK REV BOOKS, V51, P14; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KAHN JO, 1990, ANN INTERN MED, V112, P254, DOI 10.7326/0003-4819-112-4; KOUP R, 2004, 13 INT S HIV EM INF; Kuhmann SE, 2004, TRENDS PHARMACOL SCI, V25, P117, DOI 10.1016/j.tips.2004.01.005; Lehner T, 2000, IMMUNOLOGY, V99, P569, DOI 10.1046/j.1365-2567.2000.00993.x; Lockey TD, 2000, IMMUNOL RES, V21, P7, DOI 10.1385/IR:21:1:7; McCutchan FE, 2000, AIDS, V14, pS31; McNeil JG, 2004, SCIENCE, V303, P961, DOI 10.1126/science.1096161; Pauza CD, 2000, P NATL ACAD SCI USA, V97, P3515, DOI 10.1073/pnas.070049797; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Srivastava Indresh K, 2004, Expert Rev Vaccines, V3, pS33, DOI 10.1586/14760584.3.4.S33; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; WONGSTAAL F, 1985, SCIENCE, V229, P759, DOI 10.1126/science.2992084; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; 2001, AIDSCIENCE, V1, P1	42	30	103	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2005	366	9500					1894	1898		10.1016/S0140-6736(05)67395-3	http://dx.doi.org/10.1016/S0140-6736(05)67395-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ZR	16310557				2022-12-01	WOS:000233643200029
J	Poulet, JFA; Hedwig, B				Poulet, JFA; Hedwig, B			The cellular basis of a corollary discharge	SCIENCE			English	Article							PRESYNAPTIC INHIBITION; STRIDULATING CRICKET; GRYLLUS-BIMACULATUS; MOTOR CONTROL; NEURONS; VERTEBRATE; PATHWAYS; INTERNEURONS; LOCOMOTION; MECHANISM	How do animals discriminate self-generated from external stimuli during behavior and prevent desensitization of their sensory pathways? A fundamental concept in neuroscience states that neural signals, termed corollary discharges or efference copies, are forwarded from motor to sensory areas. Neurons mediating these signals have proved difficult to identify. We show that a single, multisegmental interneuron is responsible for the pre- and postsynaptic inhibition of auditory neurons in singing crickets (Gryllus bimaculatus). Therefore, this neuron represents a corollary discharge interneuron that provides a neuronal basis for the central control of sensory responses.	Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cambridge	Poulet, JFA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	james.poulet@epfl.ch		Poulet, James/0000-0003-0296-5415	Biotechnology and Biological Sciences Research Council [S19133] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BELL C, 1995, J COMP PHYSIOL A, V177, P449, DOI 10.1007/BF00187481; BELL CC, 1989, J NEUROSCI, V9, P1029; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Clarac F, 1996, EXP BRAIN RES, V112, P163; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; DAMBACH M, 1983, NATURWISSENSCHAFTEN, V70, P417, DOI 10.1007/BF01047183; HENNIG RM, 1990, J COMP PHYSIOL A, V167, P629; KIRK MD, 1984, SCIENCE, V225, P854, DOI 10.1126/science.6474158; Li WC, 2002, J NEUROSCI, V22, P10924; MICHEL K, 1974, Z MORPHOL TIERE, V77, P285, DOI 10.1007/BF00298805; NOLEN TG, 1984, SCIENCE, V226, P992, DOI 10.1126/science.6505681; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Poulet JFA, 2003, J NEUROSCI, V23, P4717; Poulet JFA, 2003, J NEUROPHYSIOL, V89, P1528, DOI 10.1152/jn.0846.2002; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Poulet JFA, 2001, J EXP BIOL, V204, P1281; Rosen SC, 2000, J NEUROPHYSIOL, V83, P1621, DOI 10.1152/jn.2000.83.3.1621; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Schildberger K., 1989, P423; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; SILLAR KT, 1986, J NEUROPHYSIOL, V55, P678, DOI 10.1152/jn.1986.55.4.678; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Weeg MS, 2005, J NEUROSCI, V25, P5967, DOI 10.1523/JNEUROSCI.0019-05.2005; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0	28	119	123	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2006	311	5760					518	522		10.1126/science.1120847	http://dx.doi.org/10.1126/science.1120847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439660				2022-12-01	WOS:000235071400045
J	Burroughs, AK; Sabin, CA; Rolles, K; Delvart, V; Karam, V; Buckels, J; O'Grady, JG; Castaing, D; Klempnauer, J; Jamieson, N; Neuhaus, P; Lerut, J; de Goyet, JD; Pollard, S; Salizzoni, M; Rogiers, X; Muhlbacher, F; Valdecasas, JCG; Broelsch, C; Jaeck, D; Berenguer, J; Gonzalez, EM; Adam, R				Burroughs, AK; Sabin, CA; Rolles, K; Delvart, V; Karam, V; Buckels, J; O'Grady, JG; Castaing, D; Klempnauer, J; Jamieson, N; Neuhaus, P; Lerut, J; de Goyet, JD; Pollard, S; Salizzoni, M; Rogiers, X; Muhlbacher, F; Valdecasas, JCG; Broelsch, C; Jaeck, D; Berenguer, J; Gonzalez, EM; Adam, R		European Liver Transplant Assoc	3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome	LANCET			English	Article							FULMINANT HEPATIC-FAILURE; MELD SCORE; SURVIVAL; EXPERIENCE; REGISTRY; GRAFT	Background Mortality after liver transplantation depends on heterogeneous recipient and donor factors. Our aim was to assess risk of death and to develop models to help predict mortality after liver transplantation. Methods We analysed data from 34 664 first adult liver transplants from the European Liver Transplant Registry to identify factors associated with mortality at 3-months (n=21 605 in training dataset) and 12-months (n=18 852 in training dataset) after transplantation. We used multivariable logistic regression models to generate mortality scores for each individual, and assessed model discrimination and calibration on an independent validation dataset (n=9489 for 3-month model and n=8313 for 12-month model). Findings 2540 of 21 605 (12%) individuals in the 3-month training sample had died by 3 months. Compared with those transplanted in 2000-03, those transplanted earlier had a higher risk of death. increased mortality at 3-months post- transplantation was associated with acute liver failure (adjusted odds ratio 1.61), donor age older than 60 years (1.16), compatible (1.22) or incompatible (2.07) donor-recipient blood group, older recipient age (1.12 per 5 years), split or reduced graft (1.96), total ischaemia time of longer than 13 h (1.38), and low United Network for Organ Sharing score (score 1: 2.43; score 2: 1.67). However, cirrhosis with hepatocellular carcinoma, alcohol cirrhosis, hepatitis C or primary biliary cirrhosis, donor age 40 years or younger, or less, hepatitis B, and larger size of transplant Centre (>= 70 transplants per year) were associated with improved early outcomes. The 3-month mortality score discriminated well between those who did and did not die in the validation sample (C statistic=0.688). We noted similar findings for 12-month mortality, although deaths were generally underestimated at this timepoint. Interpretation The 3-month and 12-month mortality models can be effectively used to assess outcomes both within and between centres. Furthermore, the models provide a means of assessing the risk of post-transplantation mortality, giving clinicians important data on which to base strategic decisions about transplant policy in particular individuals or groups.	UCL Royal Free Hampstead NHS Trust, London NW3 2QG, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England; Hop Paul Brousse, Villejuif, France; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; Kings Coll Hosp London, London, England; Hannover Med Sch, Hannover, Germany; Addenbrookes Hosp, Cambridge, England; Charite Univ Klinikum Berlin, Berlin, Germany; Clin Univ St Luc, B-1200 Brussels, Belgium; St James & Seacroft Univ Hosp, Leeds, W Yorkshire, England; Ctr Trapianti Fegato, Turin, Italy; Univ Krankenhaus Eppendorf, Hamburg, Germany; Klin Abt Transplantat, Vienna, Austria; Hosp Clin Barcelona, Barcelona, Spain; CUK GHs Essen, Essen, Germany; Hop Hautepierre, Strasbourg, France; Hosp Univ L Fe, Valencia, Spain; Hosp 12 Octubre, E-28041 Madrid, Spain	University of London; University College London; University of London; University College London; UCL Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; University of Birmingham; King's College Hospital NHS Foundation Trust; King's College Hospital; Hannover Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Saint James's University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Barcelona; Hospital Clinic de Barcelona; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hospital Universitario 12 de Octubre	Burroughs, AK (corresponding author), UCL Royal Free Hampstead NHS Trust, London NW3 2QG, England.	andrew.burroughs@royalfree.nhs.uk	Goyet, Jean de Ville de/I-6913-2019; Goyet, Jean de Ville de/A-1708-2014; Burroughs, Andrew K/C-5645-2009; Lerut, Jan PM/B-9571-2016; Sabin, Caroline/C-2464-2008	Goyet, Jean de Ville de/0000-0001-7681-6178; Goyet, Jean de Ville de/0000-0001-7681-6178; Burroughs, Andrew K/0000-0001-6527-457X; Lerut, Jan PM/0000-0002-4718-9950; Sabin, Caroline/0000-0001-5173-2760; Karam, Vincent/0000-0002-7391-0190; Salizzoni, Mauro/0000-0002-5480-8705				Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Adam R, 2005, J HEPATOL, V42, P33, DOI 10.1016/j.jhep.2004.11.006; ADAM R, 1992, LANCET, V340, P1373, DOI 10.1016/0140-6736(92)92559-X; Adam R, 2000, LANCET, V356, P621, DOI 10.1016/S0140-6736(00)02603-9; ASCHER NL, 1993, ARCH SURG-CHICAGO, V128, P677; Belle S H, 1995, Liver Transpl Surg, V1, P347, DOI 10.1002/lt.500010602; Bilbao I, 2003, CLIN TRANSPLANT, V17, P401, DOI 10.1034/j.1399-0012.2003.00068.x; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; CLAVIEN PA, 1994, ANN SURG, V220, P109, DOI 10.1097/00000658-199408000-00002; Farmer DG, 2003, ANN SURG, V237, P666, DOI 10.1097/00000658-200305000-00009; Ghobrial RM, 2002, ANN SURG, V236, P315, DOI 10.1097/00000658-200209000-00008; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hosmer DW, 1997, STAT MED, V16, P965; Jacob M, 2004, LIVER TRANSPLANT, V10, P903, DOI 10.1002/lt.20169; KALAYOGLU M, 1988, LANCET, V1, P617; Karam V, 2003, TRANSPLANTATION, V75, P2167, DOI 10.1097/01.TP.0000080271.20145.07; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; Marino IR, 1998, LIVER TRANSPLANT SUR, V4, pS115; Northup PG, 2004, AM J TRANSPLANT, V4, P1643, DOI 10.1111/j.1600-6143.2004.00593.x; Rela M, 1998, ANN SURG, V227, P282, DOI 10.1097/00000658-199802000-00019; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Thuluvath PJ, 2003, LIVER TRANSPLANT, V9, P527, DOI 10.1053/jlts.2003.50089	22	260	265	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2006	367	9506					225	232		10.1016/S0140-6736(06)68033-1	http://dx.doi.org/10.1016/S0140-6736(06)68033-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005GM	16427491	Green Submitted			2022-12-01	WOS:000234810600027
J	Wallace, C; Leask, J; Trevena, LJ				Wallace, C; Leask, J; Trevena, LJ			Effects of a web based decision aid on parental attitudes to MMR vaccination: a before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZE	Objective To determine whether an evidence based decision aid on the measles, mumps, and rubella (MMR) vaccine changed parents' attitudes towards vaccination. Design Before and after study. Setting Website promoted through search engines and online parenting and health websites. Participants 158 people completing offline questions out of 1277 who accessed the website. Intervention Evidence based decision aid with text and graphical representation of the possible outcomes of measles, mumps, and rubella diseases compared with MMR vaccination. Main outcome measures Attitudes towards MMR vaccination. Results Significantly more participants indicated they were "leaning towards" vaccination after using the decision aid (39% before v 55% after, P<0.001). Compared with those who were undecided or "leaning away from" vaccination after using the decision aid, participants "leaning towards" it were more likely to strongly value its potential to protect their children from the serious side effects of disease (98% v 84%) and other children who could not be vaccinated for medical reasons (68% v 25%). Participants with an unfavourable attitude to vaccination were more likely to be very concerned about die rare side effects of vaccination (78% v 57%), have residual concerns about autism and bowel disease (78% v 27%), and anticipate guilt should their child have an adverse reaction (77% v 50%). Those with a positive attitude to vaccination after using the decision aid were also more likely to feel well informed (83% v 48%). Conclusions A web based decision aid significantly improved parental attitudes to MMR vaccination. Residual concerns about autism and bowel disease and the rare chance of serious complications remained as attitudinal barriers to some parents.	Univ Sydney, Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW 2145, Australia; Univ Sydney, Sch Publ Hlth, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney	Leask, J (corresponding author), Univ Sydney, Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Locked Bag 4001, Westmead, NSW 2145, Australia.	JulieL3@chw.edu.au	Leask, Julie/ABE-2077-2020	Leask, Julie/0000-0001-5095-1443; Trevena, Lyndal/0000-0003-1419-1832				Davies P, 2002, ARCH DIS CHILD, V87, P22, DOI 10.1136/adc.87.1.22; Guillaume L., 2004, HEALTH INFORM J, V10, P522, DOI DOI 10.1177/1460458204040664; Hall S., 1980, CULTURE MEDIA LANGUA; McMurray R, 2004, BRIT J GEN PRACT, V54, P520; O'Connor AM, 2003, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; OConnor AM, 1996, J CLIN EPIDEMIOL, V49, P1271, DOI 10.1016/S0895-4356(96)00177-1; Payne D, 2000, BRIT MED J, V321, P197; Petts J, 2004, HEALTH RISK SOC, V6, P7, DOI 10.1080/13698570410001678284; Raithatha N, 2003, J PUBLIC HEALTH MED, V25, P161, DOI 10.1093/pubmed/fdg034; RITOV I, 1995, ORGAN BEHAV HUM DEC, V64, P119, DOI 10.1006/obhd.1995.1094; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Sporton RK, 2001, FAM PRACT, V18, P181, DOI 10.1093/fampra/18.2.181; STACEY D, 2001, MED DECIS MAKING, V21, P527; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245; Wroe AL, 2004, HEALTH PSYCHOL, V23, P33, DOI 10.1037/0278-6133.23.1.33; 2004, COMMUN DIS REP CDR W, V14	16	74	74	2	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					146	+		10.1136/bmj.38678.681840.68	http://dx.doi.org/10.1136/bmj.38678.681840.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	006OC	16352657	Green Published, Bronze			2022-12-01	WOS:000234905800016
J	McKee, MG; Layman, JM; Cashion, MP; Long, TE				McKee, MG; Layman, JM; Cashion, MP; Long, TE			Phospholipid nonwoven electrospun membranes	SCIENCE			English	Article							FIBER FORMATION; SURFACE-MORPHOLOGY; MOLECULAR-WEIGHT; POLYMER; NANOFIBERS; MONOLAYER; MICELLES; BEHAVIOR	Nonwoven fibrous membranes were formed from electrospinning lecithin solutions in a single processing step. As the concentration of lecithin increased, the micellar morphology evolved from spherical to cylindrical, and at higher concentrations the cylindrical micelles overlapped and entangled in a fashion similar to polymers in semi-dilute or concentrated solutions. At concentrations above the onset of entanglements of the wormlike micelles, electrospun fibers were fabricated with diameters on the order of 1 to 5 micrometers. The electrospun phospholipid fibers offer the potential for direct fabrication of biologically based, high-surface-area membranes without the use of multiple synthetic steps, complicated electrospinning designs, or postprocessing surface treatments.	Virginia Tech, Dept Chem, MII, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Long, TE (corresponding author), Virginia Tech, Dept Chem, MII, Blacksburg, VA 24061 USA.	telong@vt.edu						Bai SJ, 2002, J POLYM SCI POL PHYS, V40, P1760, DOI 10.1002/polb.10229; CAPPELAERE E, 1995, COLLOID SURFACE A, V104, P353, DOI 10.1016/0927-7757(95)03332-2; Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975; CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012; Cirkel PA, 1998, LANGMUIR, V14, P7095, DOI 10.1021/la971326x; Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(01)00336-6; FENDLER JH, 1984, SCIENCE, V223, P888, DOI 10.1126/science.223.4639.888; Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3; Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502; Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021; He P, 2005, BIOMACROMOLECULES, V6, P2455, DOI 10.1021/bm050338r; Kanamaru M, 2002, POLYMER, V43, P3925, DOI 10.1016/S0032-3861(02)00218-5; Kim HK, 2005, BIOMATERIALS, V26, P3435, DOI 10.1016/j.biomaterials.2004.09.066; Kim K, 2004, LANGMUIR, V20, P5396, DOI 10.1021/la049959g; Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1; Lee KH, 2003, POLYMER, V44, P4029, DOI 10.1016/S0032-3861(03)00345-8; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Magid LJ, 1998, J PHYS CHEM B, V102, P4064, DOI 10.1021/jp9730961; McKee MG, 2004, POLYMER, V45, P8705, DOI 10.1016/j.polymer.2004.10.049; McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h; McKee MG, 2005, MACROMOLECULES, V38, P6015, DOI 10.1021/ma050667b; Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a; Mezzasalma SA, 2000, LANGMUIR, V16, P10564, DOI 10.1021/la000860t; Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6; NAKAI S, 1978, MAKROMOL CHEM, V179, P2349; Pratt C.W., 2015, ESSENTIAL BIOCH, V3rd; Regalado EJ, 1999, MACROMOLECULES, V32, P8580, DOI 10.1021/ma990999e; Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009; Rubinstein M, 2001, MACROMOLECULES, V34, P1058, DOI 10.1021/ma0013049; SCHURTENBERGER P, 1990, J PHYS CHEM-US, V94, P3695, DOI 10.1021/j100372a062; SHCHIPUNOV YA, 1995, MAT SCI ENG C-BIOMIM, V3, P43, DOI 10.1016/0928-4931(95)00102-6; Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011; Ye SH, 2003, BIOMATERIALS, V24, P4143, DOI 10.1016/S0142-9612(03)00296-5	33	239	254	4	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					353	355		10.1126/science.1119790	http://dx.doi.org/10.1126/science.1119790			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424332				2022-12-01	WOS:000234938500036
J	Schmeler, KM; Lynch, HT; Chen, LM; Munsell, MF; Soliman, PT; Clark, MB; Daniels, MS; White, KG; Boyd-Rogers, SG; Conrad, PG; Yang, KY; Rubin, MM; Sun, CC; Slomovitz, BM; Gershenson, DM; Lu, KH				Schmeler, KM; Lynch, HT; Chen, LM; Munsell, MF; Soliman, PT; Clark, MB; Daniels, MS; White, KG; Boyd-Rogers, SG; Conrad, PG; Yang, KY; Rubin, MM; Sun, CC; Slomovitz, BM; Gershenson, DM; Lu, KH			Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; COLON-CANCER; MUTATION CARRIERS; WOMEN; HYSTERECTOMY; CARCINOMA; HOMOLOG; OOPHORECTOMY; ESTROGEN; TRIAL	BACKGROUND: Women with the Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a 40 to 60 percent lifetime risk of endometrial cancer and a 10 to 12 percent lifetime risk of ovarian cancer. The benefit of prophylactic gynecologic surgery for women with this syndrome has been uncertain. We designed this study to determine the reduction in the risk of gynecologic cancers associated with prophylactic hysterectomy and bilateral salpingo-oophorectomy in women with the Lynch syndrome. METHODS: Three hundred fifteen women with documented germ-line mutations associated with the Lynch syndrome were identified. Women who had undergone prophylactic hysterectomy (61 women) and women who had undergone prophylactic bilateral salpingo-oophorectomy (47 women) were matched with mutation-positive women who had not undergone the procedure in question (210 women for the analysis of endometrial cancer and 223 for the analysis of ovarian cancer). Women who had undergone prophylactic surgery and their matched controls were followed from the date of the surgery until the occurrence of cancer or until the data were censored at the time of the last follow-up visit. RESULTS: There were no occurrences of endometrial, ovarian, or primary peritoneal cancer among the women who had undergone prophylactic surgery. Endometrial cancer was diagnosed in 69 women in the control group (33 percent), for an incidence density of 0.045 per woman-year, yielding a prevented fraction (the proportion of potential new cancers prevented) of 100 percent (95 percent confidence interval, 90 to 100 percent). Ovarian cancer was diagnosed in 12 women in the control group (5 percent), for an incidence density of 0.005 per woman-year, yielding a prevented fraction of 100 percent (95 percent confidence interval, -62 to 100 percent). CONCLUSIONS: These findings suggest that prophylactic hysterectomy with bilateral salpingo-oophorectomy is an effective strategy for preventing endometrial and ovarian cancer in women with the Lynch syndrome.	Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77230 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77230 USA; Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Genet, Houston, TX 77230 USA; Creighton Univ, Dept Prevent Med, Omaha, NE 68178 USA; Univ Calif San Francisco, Dept Gynecol Oncol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Creighton University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lu, KH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, POB 301439,Unit 1362, Houston, TX 77230 USA.	khlu@mdanderson.org	Slomovitz, Brian/AAB-3247-2022; Slomoivtz, Brian/AAB-3226-2022	Daniels, Molly/0000-0002-5093-5539	NCI NIH HHS [N01-CN-05127] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN005127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 1982, EPIDEMIOLOGIC RES; Bertagnolli MM, 2005, J CLIN ONCOL, V23, P324, DOI 10.1200/JCO.2005.08.096; Boks DES, 2002, INT J CANCER, V102, P198, DOI 10.1002/ijc.10667; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Chung L, 2003, OBSTET GYNECOL, V102, P1152, DOI 10.1016/S0029-7844(03)00699-9; Dove-Edwin I, 2002, CANCER, V94, P1708, DOI 10.1002/cncr.10380; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1994, CELL, V77, P167; GOODNO JA, 1995, AM J OBSTET GYNECOL, V172, P1817, DOI 10.1016/0002-9378(95)91417-X; Graziottin A, 2004, MENOPAUSE, V11, P766, DOI 10.1097/01.GME.0000139926.02689.A1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kolodner RD, 1999, CANCER RES, V59, P5068; Kovac SR, 2000, OBSTET GYNECOL, V95, P787, DOI 10.1016/S0029-7844(99)00641-9; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lu KH, 2005, OBSTET GYNECOL, V105, P569, DOI 10.1097/01.AOG.0000154885.44002.ae; Lynch HT, 1999, CANCER, V86, P2457, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2457::AID-CNCR2>3.0.CO;2-I; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Prior JC, 1997, J BONE MINER RES, V12, P1851, DOI 10.1359/jbmr.1997.12.11.1851; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rijcken FEM, 2003, GYNECOL ONCOL, V91, P74, DOI 10.1016/S0090-8258(03)00371-8; Scully R. E., 1998, ATLAS TUMOR PATHOL, P125; SPEROFF L, 1999, CLIN GYNECOLOGIC END, P662; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Watson P, 2001, GYNECOL ONCOL, V82, P223, DOI 10.1006/gyno.2001.6279; Weber AM, 1996, NEW ENGL J MED, V335, P1406	29	515	533	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2006	354	3					261	269		10.1056/NEJMoa052627	http://dx.doi.org/10.1056/NEJMoa052627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003DF	16421367				2022-12-01	WOS:000234661100006
J	Hacker, H; Redecke, V; Blagoev, B; Kratchmarova, I; Hsu, LC; Wang, GG; Kamps, MP; Raz, E; Wagner, H; Hacker, G; Mann, M; Karin, M				Hacker, H; Redecke, V; Blagoev, B; Kratchmarova, I; Hsu, LC; Wang, GG; Kamps, MP; Raz, E; Wagner, H; Hacker, G; Mann, M; Karin, M			Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6	NATURE			English	Article							INTERFERON-ALPHA INDUCTION; KAPPA-B ACTIVATION; PATHWAY; KINASE; INTERLEUKIN-1; COMPLEX; CASCADE; CELLS; TANK; TBK1	Toll-like receptors (TLRs) are activated by pathogen-associated molecular patterns to induce innate immune responses and production of pro-inflammatory cytokines, interferons and anti-inflammatory cytokines(1). TLRs activate downstream effectors through adaptors that contain Toll/interleukin-1 receptor (TIR) domains(2), but the mechanisms accounting for diversification of TLR effector functions are unclear. To dissect biochemically TLR signalling, we established a system for isolating signalling complexes assembled by dimerized adaptors. Using MyD88 as a prototypical adaptor, we identified TNF receptor-associated factor 3 (TRAF3) as a new component of TIR signalling complexes that is recruited along with TRAF6. Using myeloid cells from TRAF3- and TRAF6-deficient mice, we show that TRAF3 is essential for the induction of type I interferons (IFN) and the anti-inflammatory cytokine interleukin-10 (IL-10), but is dispensable for expression of pro-inflammatory cytokines. In fact, TRAF3- deficient cells overproduce pro-inflammatory cytokines owing to defective IL-10 production. Despite their structural similarity, the functions of TRAF3 and TRAF6 are largely distinct. TRAF3 is also recruited to the adaptor TRIF (Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta) and is required for marshalling the protein kinase TBK1 ( also called NAK) into TIR signalling complexes, thereby explaining its unique role in activation of the IFN response.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense M, Denmark; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Southern Denmark; Technical University of Munich	Hacker, H (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	Hans.Haecker@stjude.org	Li, Chia Cheng/D-9906-2015; Mann, Matthias/A-3454-2013; Haecker, Hans/F-6826-2013; Wang, G Greg/L-6666-2014	Mann, Matthias/0000-0003-1292-4799; Haecker, Hans/0000-0001-5971-0451; Wang, G Greg/0000-0002-7210-9940; Kratchmarova, Irina/0000-0001-6613-7315; Blagoev, Blagoy/0000-0002-3596-0066; Hsu, Li-Chung/0000-0001-7206-5231				Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Knoepfler PS, 2001, ONCOGENE, V20, P5440, DOI 10.1038/sj.onc.1204710; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	25	699	760	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					204	207		10.1038/nature04369	http://dx.doi.org/10.1038/nature04369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16306937	Bronze			2022-12-01	WOS:000234538400040
J	Svenningsson, P; Chergui, K; Rachleff, I; Flajolet, M; Zhang, XQ; El Yacoubi, M; Vaugeois, JM; Nomikos, GG; Greengard, P				Svenningsson, P; Chergui, K; Rachleff, I; Flajolet, M; Zhang, XQ; El Yacoubi, M; Vaugeois, JM; Nomikos, GG; Greengard, P			Alterations in 5-HT1B receptor function by p11 in depression-like states	SCIENCE			English	Article							EXPRESSION; DISORDERS; PROTEINS; CHANNEL; MICE	The pathophysiology of depression remains enigmatic, although abnormalities in serotonin signaling have been implicated. We have found that the serotonin 113 receptor [5-hydroxytryptamine (5-HT1B) receptor] interacts with p11. p11 increases localization of 5-HT1B receptors at the cell surface. p11 is increased in rodent brains by antidepressants or electroconvulsive therapy, but decreased in an animal model of depression and in brain tissue from depressed patients. Overexpression of p11 increases 5-HT1B receptor function in cells and recapitulates certain behaviors seen after antidepressant treatment in mice. p11 knockout mice exhibit a depression-like phenotype and have reduced responsiveness to 5-HT1B receptor agonists and reduced behavioral reactions to an antidepressant.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; European Inst Peptide Res, IFRMP 23, Fac Med & Pharm, CNRS FRE2735,Unite Neuropsychopharmacol Expt, F-76183 Rouen, France; Eli Lilly & Co, Lilly Corp Ctr, Neurosci Discovery Res, Indianapolis, IN 46285 USA	Rockefeller University; Karolinska Institutet; Eli Lilly	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	greengard@rockefeller.edu	Svenningsson, Per JL/K-5210-2014	Vaugeois, Jean-Marie/0000-0001-8296-672X; EL YACOUBI, Malika/0000-0002-1010-9179; Chergui, Karima/0000-0001-5702-0422	NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; Moret C, 2000, EUR J PHARMACOL, V404, P1, DOI 10.1016/S0014-2999(00)00581-1; Morikawa H, 2000, MOL PHARMACOL, V58, P1271, DOI 10.1124/mol.58.6.1271; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SCHLICKER E, 1992, BRIT J PHARMACOL, V105, P732, DOI 10.1111/j.1476-5381.1992.tb09047.x; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162	16	430	447	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					77	80		10.1126/science.1117571	http://dx.doi.org/10.1126/science.1117571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400147				2022-12-01	WOS:000234546300036
J	Dupont, E; Hanganu, IL; Kilb, W; Hirsch, S; Luhmann, HJ				Dupont, E; Hanganu, IL; Kilb, W; Hirsch, S; Luhmann, HJ			Rapid developmental switch in the mechanisms driving early cortical columnar networks	NATURE			English	Article							RAT SOMATOSENSORY CORTEX; OCULAR DOMINANCE COLUMNS; SUBPLATE NEURONS; DEVELOPING NEOCORTEX; CEREBRAL-CORTEX; VISUAL-CORTEX; OSCILLATIONS; RECEPTORS; CIRCUITS; MOUSE	The immature cerebral cortex self-organizes into local neuronal clusters long before it is activated by patterned sensory inputs1. In the cortical anlage of newborn mammals, neurons coassemble through electrical or chemical synapses either spontaneously(2-4) or by activation of transmitter-gated receptors(5,6). The neuronal network and the cellular mechanisms underlying this cortical self-organization process during early development are not completely understood. Here we show in an intact in vitro preparation of the immature mouse cerebral cortex that neurons are functionally coupled in local clusters by means of propagating network oscillations in the beta frequency range. In the newborn mouse, this activity requires an intact subplate and is strongly synchronized within a cortical column by gap junctions. With the developmental disappearance of the subplate at the end of the first postnatal week(7), activation of NMDA (N-methyl-D-aspartate) receptors in the immature cortical network is essential to generate this columnar activity pattern. Our findings show that during a brief developmental period the cortical network switches from a subplate-driven, gap-junction-coupled syncytium to a synaptic network acting through NMDA receptors to generate synchronized oscillatory activity, which may function as an early functional template for the development of the cortical columnar architecture.	Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Luhmann, HJ (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Duesbergweg 6, D-55128 Mainz, Germany.	luhmann@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; Kilb, Werner/F-6675-2010	Luhmann, Heiko J./0000-0002-7934-8661; Dupont, Erwan/0000-0003-0777-9734				Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CONNORS BW, 1983, J NEUROSCI, V3, P773; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FRIAUF E, 1990, J NEUROSCI, V10, P2601; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Hanganu IL, 2004, J NEUROPHYSIOL, V92, P189, DOI 10.1152/jn.00010.2004; Hanganu IL, 2002, J NEUROSCI, V22, P7165; Hanganu IL, 2001, CEREB CORTEX, V11, P400, DOI 10.1093/cercor/11.5.400; Kandler K, 1998, J NEUROSCI, V18, P1419; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kilb W, 2003, CEREB CORTEX, V13, P409, DOI 10.1093/cercor/13.4.409; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Mechawar N, 2001, NEUROSCIENCE, V108, P555, DOI 10.1016/S0306-4522(01)00389-X; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; Peinado A, 2000, J NEUROSCI, V20; Price DJ, 1997, J COMP NEUROL, V377, P414; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	30	230	231	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					79	83		10.1038/nature04264	http://dx.doi.org/10.1038/nature04264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16327778				2022-12-01	WOS:000234378700038
J	Bienko, M; Green, CM; Crosetto, N; Rudolf, F; Zapart, G; Coull, B; Kannouche, P; Wider, G; Peter, M; Lehmann, AR; Hofmann, K; Dikic, I				Bienko, M; Green, CM; Crosetto, N; Rudolf, F; Zapart, G; Coull, B; Kannouche, P; Wider, G; Peter, M; Lehmann, AR; Hofmann, K; Dikic, I			Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis	SCIENCE			English	Article							DNA-POLYMERASES; PCNA; ETA; LOCALIZATION; COMPONENTS; SWITCH; DAMAGE; CELLS; IOTA; SUMO	Translesion synthesis (TLS) is the major pathway by which mammalian cells replicate across DNA lesions. Upon DNA damage, ubiquitination of proliferating cell nuclear antigen (PCNA) induces bypass of the lesion by directing the replication machinery into the TLS pathway. Yet, how this modification is recognized and interpreted in the cell remains unclear. Here we describe the identification of two ubiquitin (Ub)-binding domains (UBM and UBZ), which are evolutionarily conserved in all Y-family TLS polymerases (pols). These domains are required for binding of pol eta and pol iota to ubiquitin, their accumulation in replication factories, and their interaction with monoubiquitinated PCNA. Moreover, the UBZ domain of poll) is essential to efficiently restore a normal response to ultraviolet irradiation in xeroderma pigmentosum variant (XP-V) fibroblasts. Our results indicate that Ub-binding domains of Y-family polymerases play crucial regulatory roles in TLS.	Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Univ Sussex, Brighton BN1 9RQ, E Sussex, England; ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Miltenyi Biotec GmbH, Bioinformat Grp, D-50829 Cologne, Germany	Goethe University Frankfurt; University of Sussex; Swiss Federal Institutes of Technology Domain; ETH Zurich; Miltenyi Biotec	Dikic, I (corresponding author), Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Green, Catherine/B-4235-2009; Green, Catherine/D-7528-2014; Bienko, Magda/AAM-8867-2020; Dikic, Ivan/O-4650-2015; Hofmann, Kay/D-6714-2011	Bienko, Magda/0000-0002-6499-9082; Dikic, Ivan/0000-0001-8156-9511; Hofmann, Kay/0000-0002-2289-9083; Green, Catherine/0000-0002-7068-7106; Wider, Gerhard/0000-0001-9366-7645; Coull, Barry/0000-0001-5438-7085				Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HOELLER D, IN PRESS NAT CELL BI; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche P, 2003, EMBO J, V22, P1223, DOI 10.1093/emboj/7595006; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lehmann A, 2003, CURR BIOL, V13, pR585, DOI 10.1016/S0960-9822(03)00518-9; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	18	557	568	7	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1821	1824		10.1126/science.1120615	http://dx.doi.org/10.1126/science.1120615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357261				2022-12-01	WOS:000234093600048
J	Moumen, A; Masterson, P; O'Connor, MJ; Jackson, SP				Moumen, A; Masterson, P; O'Connor, MJ; Jackson, SP			hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage	CELL			English	Article							NUCLEAR RIBONUCLEOPROTEIN-K; CELL-CYCLE CHECKPOINTS; BOX-BINDING-PROTEIN; SINGLE-STRANDED-DNA; ATAXIA-TELANGIECTASIA; GEL-ELECTROPHORESIS; GENE-EXPRESSION; IN-VIVO; CANCER; RNA	In response to DNA damage, mammalian cells trigger the p53-dependent transcriptional induction of factors that regulate DNA repair, cell-cycle progression, or cell survival. Through differential proteomics, we identify heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR. Induction of hnRNP K ensues through the inhibition of its ubiquitin-dependent proteasomal degradation mediated by the ubiquitin E3 ligase HDM2/MDM2. Strikingly, hnRNP K depletion abrogates transcriptional induction of p53 target genes and causes defects in DNA-damage induced cell-cycle-checkpoint arrests. Furthermore, in response to DNA damage, p53 and hnRNP K are recruited to the promoters of p53-responsive genes in a mutually dependent manner. These findings establish hnRNP K as a new HDM2 target and show that, by serving as a cofactor for p53, hnRNP K plays key roles in coordinating transcriptional responses to DNA damage.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England	University of Cambridge; University of Cambridge; AstraZeneca	Moumen, A (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	mjoconnor@kudospharma.co.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Elkon R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r43; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farmer G, 1996, MOL CELL BIOL, V16, P4295; GAILLARD C, 1994, NUCLEIC ACIDS RES, V22, P4183, DOI 10.1093/nar/22.20.4183; Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ichikawa M, 2000, MUTAT RES-DNA REPAIR, V459, P285, DOI 10.1016/S0921-8777(00)00005-7; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee MH, 1996, J BIOL CHEM, V271, P3420; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LUNA RMD, 1995, NATURE, V378, P203; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Perry ME, 2004, MOL CANCER RES, V2, P9; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Prives C, 1999, J PATHOL, V187, P112; Ramos YFM, 2001, CANCER RES, V61, P1839; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shiloh Y, 2004, SEMIN CANCER BIOL, V14, P295, DOI 10.1016/j.semcancer.2004.04.009; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Urbani A, 2005, PROTEOMICS, V5, P796, DOI 10.1002/pmic.200401147; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	56	247	261	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1065	1078		10.1016/j.cell.2005.09.032	http://dx.doi.org/10.1016/j.cell.2005.09.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360036	Bronze			2022-12-01	WOS:000234177200015
J	Cymes, GD; Ni, Y; Grosman, C				Cymes, GD; Ni, Y; Grosman, C			Probing ion-channel pores one proton at a time	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR CHANNEL; SHAKER K+ CHANNEL; ELECTROSTATIC BASIS; CHARGE SELECTIVITY; TRANSITION-STATE; SODIUM-CHANNEL; M2 SEGMENT; PROTEINS; DYNAMICS; SUBUNIT	Although membrane proteins often rely on ionizable residues for structure and function, their ionization states under physiological conditions largely elude experimental estimation. To gain insight into the effect of the local microenvironment on the proton affinity of ionizable residues, we have engineered individual lysines, histidines and arginines along the alpha-helical lining of the transmembrane pore of the nicotinic acetylcholine receptor. We can detect individual proton binding - unbinding reactions electrophysiologically at the level of a single proton on a single side chain as brief blocking - unblocking events of the passing cation current. Kinetic analysis of these fluctuations yields the position-dependent rates of proton transfer, from which the corresponding pK(a) values and shifts in pK(a) can be calculated. Here we present a self-consistent, residue-by-residue description of the microenvironment around the pore-lining transmembrane alpha-helices (M2) in the open-channel conformation, in terms of the excess free energy that is required to keep the engineered basic side chains protonated relative to bulk water. A comparison with closed-channel data leads us to propose that the rotation of M2, which is frequently invoked as a hallmark of the gating mechanism of Cys-loop receptors, is minimal, if any.	Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	grosman@life.uiuc.edu		Cymes, Gisela/0000-0002-4155-585X; Grosman, Claudio/0000-0001-8093-8362	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042169] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adcock C, 1998, BIOPHYS J, V75, P1211, DOI 10.1016/S0006-3495(98)74040-8; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Corry B, 2005, BBA-BIOMEMBRANES, V1711, P72, DOI 10.1016/j.bbamem.2005.03.002; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DAVIS ME, 1990, CHEM REV, V90, P509, DOI 10.1021/cr00101a005; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grosman C, 2003, BIOCHEMISTRY-US, V42, P14977, DOI 10.1021/bi0354334; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Kim S, 2004, BIOPHYS J, V87, P792, DOI 10.1579/biophysj.103.039396; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Parzefall F, 1998, J PHYSIOL-LONDON, V512, P181, DOI 10.1111/j.1469-7793.1998.181bf.x; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Stopar D, 1996, BIOCHEMISTRY-US, V35, P15467, DOI 10.1021/bi961770j; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	43	134	136	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					975	980		10.1038/nature04293	http://dx.doi.org/10.1038/nature04293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355215	Green Accepted			2022-12-01	WOS:000233934600057
J	Loll, B; Kern, J; Saenger, W; Zouni, A; Biesiadka, J				Loll, B; Kern, J; Saenger, W; Zouni, A; Biesiadka, J			Towards complete cofactor arrangement in the 3.0 angstrom resolution structure of photosystem II	NATURE			English	Article							FTIR DIFFERENCE SPECTROSCOPY; CYTOCHROME B(6)F COMPLEX; AMINO-ACID-RESIDUES; MANGANESE CLUSTER; CRYSTAL-STRUCTURE; WATER-OXIDATION; D1 POLYPEPTIDE; MN-CLUSTER; ANGSTROM RESOLUTION; COORDINATION	Oxygenic photosynthesis in plants, algae and cyanobacteria is initiated at photosystem II, a homodimeric multisubunit protein cofactor complex embedded in the thylakoid membrane(1). Photosystem II captures sunlight and powers the unique photo-induced oxidation of water to atmospheric oxygen(1,2). Crystallographic investigations of cyanobacterial photosystem II have provided several medium-resolution structures (3.8 to 3.2 angstrom)(3-6) that explain the general arrangement of the protein matrix and cofactors, but do not give a full picture of the complex. Here we describe the most complete cyanobacterial photosystem II structure obtained so far, showing locations of and interactions between 20 protein subunits and 77 cofactors per monomer. Assignment of 11 beta-carotenes yields insights into electron and energy transfer and photoprotection mechanisms in the reaction centre and antenna subunits. The high number of 14 integrally bound lipids reflects the structural and functional importance of these molecules for flexibility within and assembly of photosystem II. A lipophilic pathway is proposed for the diffusion of secondary plastoquinone that transfers redox equivalents from photosystem II to the photosynthetic chain. The structure provides information about the Mn4Ca cluster, where oxidation of water takes place. Our study uncovers near-atomic details necessary to understand the processes that convert light to chemical energy.	Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Kristallog, Takustr 6, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; zouni@phosis1.chem.tu-berlin.de	Loll, Bernhard/J-4815-2019; Kern, Jan/G-2586-2013	Loll, Bernhard/0000-0001-7928-4488; Kern, Jan/0000-0002-7272-1603				Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Debus RJ, 2001, BBA-BIOENERGETICS, V1503, P164, DOI 10.1016/S0005-2728(00)00221-8; Diner BA, 2001, BBA-BIOENERGETICS, V1503, P147, DOI 10.1016/S0005-2728(00)00220-6; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Gombos Z, 2002, BIOCHEMISTRY-US, V41, P3796, DOI 10.1021/bi011884h; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Ke B., 2001, PHOTOSYNTHESIS PHOTO; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P7613, DOI 10.1021/bi048203d; Kimura Y, 2005, J BIOL CHEM, V280, P2078, DOI 10.1074/jbc.M410627200; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1099, P193; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Roelofs TA, 1996, P NATL ACAD SCI USA, V93, P3335, DOI 10.1073/pnas.93.8.3335; Sauer K, 2005, PHOTOSYNTH RES, V85, P73, DOI 10.1007/s11120-005-0638-9; Steffen R, 2005, BIOCHEMISTRY-US, V44, P3134, DOI 10.1021/bi048465f; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Telfer A, 2002, PHILOS T R SOC B, V357, P1431, DOI 10.1098/rstb.2002.1139; Wada H, 1998, LIPIDS PHOTOSYNTHESI, P65, DOI [10.1007/0-306-48087-5_4, DOI 10.1007/0-306-48087-5_4]; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	1547	1607	6	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1040	1044		10.1038/nature04224	http://dx.doi.org/10.1038/nature04224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355230				2022-12-01	WOS:000233934600072
J	Roche, JJW; Wenn, RT; Sahota, O; Moran, CG				Roche, JJW; Wenn, RT; Sahota, O; Moran, CG			Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGERY; NECK; FEMUR; CARE; POPULATION; PREDICTORS; MORBIDITY; TIME; AGE	Objectives To evaluate postoperative medical complications and the association between these complications and mortality at 30 days mid one year after surgery for hip fracture and to examine the association between preoperative comorbidity and the risk of postoperative complications and mortality Design Prospective observational cohort study Setting University teaching hospital. Participants 2448 consecutive patients admitted With an acute hip fracture over a four year period. We excluded 358 patients: all those aged < 60; those With periprosthetic fractures, pathological fractures, and fractures treated without surgery; and patients who died before surgery. Interventions Routine care for hip fractures. Main outcome measures Postoperative complications and mortality at 30 days and one year. Results Mortality Was 9.6% at 30 days and 33% at one year. The most common postoperative complications were chest infection (9%) and heart failure (5%). In patients Who developed postoperative heart failure mortality Was 65% at 30 days (hazard ratio 16.1, 95% confidence interval 12.2 to 21.3). Of these patients, 92% were dead by one year (11.3, 9.1 to 14.0). In patients Who developed a postoperative chest infection mortality at 30 days Was 43% (8.5, 6.6 to 11.1). Significant preoperative variables for increased mortality at 30 days included die presence of three or more comorbidities (2.5, 1.6 to 3.9), respiratory disease (1.8,1.3 to 2.5), and malignancy (1.5, 1.01 to 9.3). Conclusions In elderly people with hip fracture, the presence of three or more comorbidities is die strongest preoperative risk factor. Chest infection and heart failure are the most common postoperative complications and lead to increased mortality. These groups offer a clear target for specialist medical assessment.	Univ Nottingham Hosp, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Dept Care Elderly, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Moran, CG (corresponding author), Univ Nottingham Hosp, Dept Trauma & Orthopaed, Nottingham NG7 2UH, England.	anne.hay@qmc.nhs.uk		Sahota, Opinder/0000-0003-0055-7637				[Anonymous], 1989, J R Coll Physicians Lond, V23, P8; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; *BRIT ORTH ASS, 2003, CAR FRAG FRACT PAT; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; *DEP HLTH, 2005, HOSP EP STAT; DIRKSEN A, 1988, BRIT MED J, V297, P1011, DOI 10.1136/bmj.297.6655.1011; DYSON A, 1988, ANAESTH INTENS CARE, V16, P405, DOI 10.1177/0310057X8801600404; EISKJAER S, 1991, CLIN ORTHOP RELAT R, P295; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; HEMPSALL VJ, 1990, J ROY COLL PHYS LOND, V24, P47; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Juelsgaard P, 1998, EUR J ANAESTH, V15, P656, DOI 10.1097/00003643-199811000-00006; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Khan R, 2002, ANN ROY COLL SURG, V84, P122; *LUND U HOSP, 1997, SAHFE STAND AUD HIP; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; Nettleman MD, 1996, J GEN INTERN MED, V11, P765, DOI 10.1007/BF02598997; PRICE JD, 2005, COCHRANE DB SYST REV; Roberts SE, 2003, BRIT MED J, V327, P771, DOI 10.1136/bmj.327.7418.771; Royal College of Physicians, 1999, OST CLIN GUID PREV T; *SCOTT INT GUID NE, 2002, PREV MAN HIP FRACT O; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904	24	844	894	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1374	1376A		10.1136/bmj.38643.663843.55	http://dx.doi.org/10.1136/bmj.38643.663843.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16299013	Green Published, Bronze			2022-12-01	WOS:000233999300019
J	Sejvar, JJ; Labutta, RJ; Chapman, LE; Grabenstein, JD; Iskander, J; Lane, JM				Sejvar, JJ; Labutta, RJ; Chapman, LE; Grabenstein, JD; Iskander, J; Lane, JM			Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; VACCINIA VIRUS; BELLS-PALSY; COMPLICATIONS; IMMUNIZATION; SURVEILLANCE; ENCEPHALITIS; CHILDREN; RISK	Context Neurologic illness is an infrequent but severe adverse event associated with smallpox vaccination. The reinstatement of smallpox vaccination in the United States in response to possible bioterrorism renewed concerns about vaccine-related adverse neurologic events. Objective To determine rates and describe the clinical features of neurologic events associated with smallpox vaccination. Design and Setting We assessed reports of adverse events obtained through active case reporting and review of data reported to the Vaccine Adverse Event Reporting System among 665 000 persons vaccinated against smallpox by the Departments of Defense (n = 590 400) and Health and Human Services (n =64 600) during the 20022004 US Smallpox Vaccination Program. Main Outcome Measure Adverse neurologic events temporally associated with smallpox vaccination. Results Between December 16, 2002, and March 11, 2004, 214 neurologic adverse events temporally associated with smallpox vaccination were reported; 111 reports involved Department of Health and Human Services and 103 involved Department of Defense vaccinees. Fifty-four percent of these events occurred within 1 week of vaccination, and 53% were among primary vaccinees. The most common neurologic adverse event was headache (95 cases), followed by nonserious limb paresthesias (n = 17) or pain (n = 13) and dizziness or vertigo (n = 13). Serious neurologic adverse events included 13 cases of suspected meningitis, 3 cases of suspected encephalitis or myelitis, 11 cases of Bell palsy, 8 seizures (including 1 death), and 3 cases of Guillain-Barre syndrome. Among these 39 events, 27 (69%) occurred in primary vaccinees and all but 2 occurred within 12 days of vaccination. Conclusions During the 2002-2004 smallpox vaccination campaign, reported neurologic events were generally mild and self-limited, and no neurologic syndrome was identified at a rate above baseline estimates. Serious neurologic adverse events, such as postvaccinal encephalitis, Bell palsy, and Guillain-Barre syndrome, occurred in accordance with expected ranges.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Walter Reed Army Med Ctr, Dept Neurol, Washington, DC 20307 USA; USA Med Command, Mil Vaccine Agcy, Falls Church, VA USA; Ctr Dis Control & Prevent, Smallpox Eradicat Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Centers for Disease Control & Prevention - USA	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-39, Atlanta, GA 30333 USA.	zea3@cdc.gov	Grabenstein, John/Y-7322-2019					[Anonymous], 1989, PEDIATRICS, V84, P1110; BERGER K, 1973, S SERIES IMMUNOBIOLO, P199; BOE E, 1980, SCAND J INFECT DIS, V12, P231, DOI 10.3109/inf.1980.12.issue-3.12; BRANDENBURG NA, 1993, NEUROEPIDEMIOLOGY, V12, P313, DOI 10.1159/000110333; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; CHAPMAN LE, 2005, US SMALLPOX VACCINE; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; De Wals P, 2004, JAMA-J AM MED ASSOC, V292, P2491, DOI 10.1001/jama.292.20.2491; DEVRIES E, 1959, POSTVACCINIAL PERIVE; Fenichel GM, 1999, NEUROLOGY, V52, P1546, DOI 10.1212/WNL.52.8.1546; FENICHEL GM, 1989, PEDIATR NEUROL, V5, P287, DOI 10.1016/0887-8994(89)90019-2; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; GURVICH EB, 1975, ACTA VIROL, V19, P92; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; HERRLICH A, 1954, Munch Med Wochenschr, V96, P529; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; KHLIABICH G, 1977, ZH MIKROBIOL EPIDEMI, V10, P77; KIMFARLEY RJ, 1984, LANCET, V2, P1315; KISCH AL, 1958, NEW ENGL J MED, V258, P83, DOI 10.1056/NEJM195801092580207; KURATA T, 1977, JPN J MED SCI BIOL, V30, P137, DOI 10.7883/yoken1952.30.137; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; MARRENIKOVA SS, 1969, P S SMALLP ZAGR YUG, P65; MILLER H, 1957, BRIT MED J, V23, P668; MILLER HG, 1953, AMA ARCH NEUROL PSY, V69, P695, DOI 10.1001/archneurpsyc.1953.02320300028003; Naruse Hiroshi, 1993, Acta Paediatrica Japonica, V35, P345; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; Orovcanec K, 1974, Med Pregl, V27, P25; Plesner AM, 1998, EUR J NEUROL, V5, P479, DOI 10.1046/j.1468-1331.1998.550479.x; POLACK MF, 1973, S SERIES IMMUNOLOBIO, P235; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; RUBEN FL, 1970, ARCH OPHTHALMOL-CHIC, V84, P45, DOI 10.1001/archopht.1970.00990040047012; SEELEMANN K, 1960, DEUT MED WOCHENSCHR, V85, P1081, DOI 10.1055/s-0028-1112546; Sejvar J, 2005, HEADACHE, V45, P87, DOI 10.1111/j.1526-4610.2005.t01-5-05013.x; SHAW FE, 1988, AM J EPIDEMIOL, V127, P337, DOI 10.1093/oxfordjournals.aje.a114808; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; SPILLANE JD, 1964, BRAIN, V87, P1, DOI 10.1093/brain/87.1.1; Stratton K.R., 1994, ADVERSE EVENTS ASS C; Stuart G, 1948, Bull World Health Organ, V1, P36; THALASSI.NC, 1973, LANCET, V1, P1130; THOMPSON R., 1931, Arch. Pathol., V12, P601; Turnbull HM, 1926, BRIT J EXP PATHOL, V7, P181; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; 2003, MMWR MORB MORTAL WKL, V52, P99	49	49	53	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2744	2750		10.1001/jama.294.21.2744	http://dx.doi.org/10.1001/jama.294.21.2744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333010	Bronze			2022-12-01	WOS:000233726900023
J	Larkin, M				Larkin, M			Feature - Can nutrition improve athletic performance?	LANCET			English	Article												Mleditor@aol.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S27	S28		10.1016/S0140-6736(05)67835-X	http://dx.doi.org/10.1016/S0140-6736(05)67835-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360739				2022-12-01	WOS:000234374400018
J	Abbondanzieri, EA; Greenleaf, WJ; Shaevitz, JW; Landick, R; Block, SM				Abbondanzieri, EA; Greenleaf, WJ; Shaevitz, JW; Landick, R; Block, SM			Direct observation of base-pair stepping by RNA polymerase	NATURE			English	Article							OPTICAL FORCE CLAMP; HAND-OVER-HAND; SINGLE-MOLECULE; TRANSCRIPTION ELONGATION; STRUCTURAL BASIS; MECHANISM; DNA; TRANSLOCATION; BACKTRACKING; KINETICS	During transcription, RNA polymerase ( RNAP) moves processively along a DNA template, creating a complementary RNA. Here we present the development of an ultra-stable optical trapping system with angstrom-level resolution, which we used to monitor transcriptional elongation by single molecules of Escherichia coli RNAP. Records showed discrete steps averaging 3.7 +/- 0.6 angstrom, a distance equivalent to the mean rise per base found in B-DNA. By combining our results with quantitative gel analysis, we conclude that RNAP advances along DNA by a single base pair per nucleotide addition to the nascent RNA. We also determined the force-velocity relationship for transcription at both saturating and sub-saturating nucleotide concentrations; fits to these data returned a characteristic distance parameter equivalent to one base pair. Global fits were inconsistent with a model for movement incorporating a power stroke tightly coupled to pyrophosphate release, but consistent with a brownian ratchet model incorporating a secondary NTP binding site.	Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu			NIGMS NIH HHS [R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1995, BIOPHYS J, V68, pS230; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; GREENLEAF WJ, IN PRESS PHYS REV LE; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Mukherjee S, 2003, EMBO J, V22, P6483, DOI 10.1093/emboj/cdg618; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; RHODES G, 1974, J BIOL CHEM, V249, P6675; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Thomen P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128102; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	50	628	662	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					460	465		10.1038/nature04268	http://dx.doi.org/10.1038/nature04268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16284617	Green Accepted			2022-12-01	WOS:000233458200041
J	Mossman, KD; Campi, G; Groves, JT; Dustin, ML				Mossman, KD; Campi, G; Groves, JT; Dustin, ML			Altered TCR signaling from geometrically repatterned immunological synapses	SCIENCE			English	Article							T-CELL-ACTIVATION; LIPID RAFTS; CYTOSKELETON; TRANSDUCTION; RECOGNITION; MEMBRANES; MOLECULES; BILAYERS; ACTIN	The immunological synapse is a specialized cell-cell junction that is defined by large-scale spatial patterns of receptors and signaling molecules yet remains largely enigmatic in terms of formation and function. We used supported bilayer membranes and nanometer-scale structures fabricated onto the underlying substrate to impose geometric constraints on immunological synapse formation. Analysis of the resulting alternatively patterned synapses revealed a causal relation between the radial position of T cell receptors (TCRs) and signaling activity, with prolonged signaling from TCR microclusters that had been mechanically trapped in the peripheral regions of the synapse. These results are consistent with a model of the synapse in which spatial translocation of TCRs represents a direct mechanism of signal regulation.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; New York University	Dustin, ML (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	JTGroves@lbl.gov; Dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064900] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64900] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Friedl P, 2004, TRENDS CELL BIOL, V14, P557, DOI 10.1016/j.tcb.2004.09.005; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jackson BL, 2004, J AM CHEM SOC, V126, P13878, DOI 10.1021/ja046040a; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; TSENG SY, IN PRESS J IMMUNOL; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	22	416	429	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1191	1193		10.1126/science.1119238	http://dx.doi.org/10.1126/science.1119238			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293763				2022-12-01	WOS:000233437300047
J	Wagner, JR; Brunzelle, JS; Forest, KT; Vierstra, RD				Wagner, JR; Brunzelle, JS; Forest, KT; Vierstra, RD			A light-sensing knot revealed by the structure of the chromophore-binding domain of phytochrome	NATURE			English	Article							CRYSTAL-STRUCTURE ANALYSIS; DEEP TREFOIL KNOT; BILIVERDIN CHROMOPHORE; PROTEIN; REFINEMENT; MODEL; CRYSTALLIZATION; AGP1; PR; BACTERIOPHYTOCHROMES	Phytochromes are red/far-red light photoreceptors that direct photosensory responses across the bacterial, fungal and plant kingdoms. These include photosynthetic potential and pigmentation in bacteria as well as chloroplast development and photomorphogenesis in plants. Phytochromes consist of an amino-terminal region that covalently binds a single bilin chromophore, followed by a carboxy-terminal dimerization domain that often transmits the light signal through a histidine kinase relay. Here we describe the three-dimensional structure of the chromophore-binding domain of Deinococcus radiodurans phytochrome assembled with its chromophore biliverdin in the Pr ground state. Our model, refined to 2.5 angstrom resolution, reaffirms Cys 24 as the chromophore attachment site, locates key amino acids that form a solvent-shielded bilin-binding pocket, and reveals an unusually formed deep trefoil knot that stabilizes this region. The structure provides the first three-dimensional glimpse into the photochromic behaviour of these photoreceptors and helps to explain the evolution of higher plant phytochromes from prokaryotic precursors.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Northwestern Univ, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University	Forest, KT (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	forest@bact.wisc.edu						Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Bhoo SH, 1997, J AM CHEM SOC, V119, P11717, DOI 10.1021/ja972875s; Braslavsky SE, 2003, PHOTOCHROMISM: MOLECULES AND SYSTEMS, P738, DOI 10.1016/B978-044451322-9/50023-3; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Gartner W., 2004, PHOTORECEPTORS LIGHT, P136; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1974, DOI 10.1107/S0907444903021206; Hanzawa H, 2001, P NATL ACAD SCI USA, V98, P3612, DOI 10.1073/pnas.051629698; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mallam AL, 2005, J MOL BIOL, V346, P1409, DOI 10.1016/j.jmb.2004.12.055; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Taylor WR, 2003, NATURE, V421, P25, DOI 10.1038/421025a; Terauchi K, 2004, MOL MICROBIOL, V51, P567, DOI 10.1046/j.1365-2958.2003.03853.x; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tu SL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P121, DOI 10.1002/352760510X.ch6; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311	48	421	446	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					325	331		10.1038/nature04118	http://dx.doi.org/10.1038/nature04118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292304				2022-12-01	WOS:000233300200041
J	Vire, E; Brenner, C; Deplus, R; Blanchon, L; Fraga, M; Didelot, C; Morey, L; Van Eynde, A; Bernard, D; Vanderwinden, JM; Bollen, M; Esteller, M; Di Croce, L; de Launoit, Y; Fuks, F				Vire, E; Brenner, C; Deplus, R; Blanchon, L; Fraga, M; Didelot, C; Morey, L; Van Eynde, A; Bernard, D; Vanderwinden, JM; Bollen, M; Esteller, M; Di Croce, L; de Launoit, Y; Fuks, F			The Polycomb group protein EZH2 directly controls DNA methylation	NATURE			English	Article							HISTONE H3 METHYLTRANSFERASE; LYSINE-27 METHYLATION; GROUP-COMPLEXES; X-INACTIVATION; RECRUITMENT; DNMT1; ESTABLISHMENT; TRANSCRIPTION; REPRESSOR; PATTERNS	The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function(1). The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins(2,3) and the DNA methylation(4,5) systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 ( Enhancer of Zeste homolog 2) interacts within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3) - with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.	Free Univ Brussels, Fac Med, Mol Virol Lab, B-1070 Brussels, Belgium; CNIO, Canc Epigenet Grp, Madrid 28029, Spain; ICREA, E-08003 Barcelona, Spain; CRG, E-08003 Barcelona, Spain; Katholieke Univ Leuven, Fac Geneeskunde, Div Biochem, B-3000 Louvain, Belgium; Free Univ Brussels, Fac Med, Neurophysiol Lab, B-1070 Brussels, Belgium; Univ Lille 1, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8117, F-59021 Lille, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centro Nacional de Investigaciones Oncologicas (CNIO); ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Fuks, F (corresponding author), Free Univ Brussels, Fac Med, Mol Virol Lab, 808 Route Lennik, B-1070 Brussels, Belgium.	ffuks@ulb.ac.be	Esteller, Manel/L-5956-2014; Hu, Ruogu/B-2203-2008; Di Croce, Luciano/E-7759-2015; jia, xu/A-8386-2016; Fraga, Mario F/H-7824-2017; Bernard, David/D-6265-2018	Esteller, Manel/0000-0003-4490-6093; Di Croce, Luciano/0000-0003-3488-6228; Fraga, Mario F/0000-0001-8450-2603; Mirjolet Didelot, Celine/0000-0003-0047-9421; Bernard, David/0000-0002-1557-2074; Morey, Lluis/0000-0001-9851-4066; BLANCHON, LOIC/0000-0001-8842-0162; Vire, Emmanuelle/0000-0002-7868-9923	ICREA Funding Source: Custom	ICREA(ICREA)		Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	27	1594	1681	4	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					871	874		10.1038/nature04431	http://dx.doi.org/10.1038/nature04431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16357870				2022-12-01	WOS:000235333600055
J	Keogh, MC; Kim, JA; Downey, M; Fillingham, J; Chowdhury, D; Harrison, JC; Onishi, M; Datta, N; Galicia, S; Emili, A; Lieberman, J; Shen, XT; Buratowski, S; Haber, JE; Durocher, D; Greenblatt, JF; Krogan, NJ				Keogh, MC; Kim, JA; Downey, M; Fillingham, J; Chowdhury, D; Harrison, JC; Onishi, M; Datta, N; Galicia, S; Emili, A; Lieberman, J; Shen, XT; Buratowski, S; Haber, JE; Durocher, D; Greenblatt, JF; Krogan, NJ			A phosphatase complex that dephosphorylates gamma H2AX regulates DNA damage checkpoint recovery	NATURE			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HISTONE H2AX; G2/M ARREST; CELL-CYCLE; REPAIR; PROTEIN; PHOSPHORYLATION; RECOMBINATION	One of the earliest marks of a double-strand break (DSB) in eukaryotes is serine phosphorylation of the histone variant H2AX at the carboxy-terminal SQE motif to create gamma H2AX-containing nucleosomes(1). Budding-yeast histone H2A is phosphorylated in a similar manner by the checkpoint kinases Tel1 and Mec1 (ref. 2; orthologous to mammalian ATM and ATR, respectively) over a 50-kilobase region surrounding the DSB3. This modification is important for recruiting numerous DSB-recognition and repair factors to the break site, including DNA damage checkpoint proteins(4,5), chromatin remodellers(6) and cohesins(7,8). Multiple mechanisms for eliminating gamma H2AX as DNA repair completes are possible, including removal by histone exchange followed potentially by degradation, or, alternatively, dephosphorylation. Here we describe a three-protein complex (HTP-C, for histone H2A phosphatase complex) containing the phosphatase Pph3 that regulates the phosphorylation status of gamma H2AX in vivo and efficiently dephosphorylates gamma H2AX in vitro. gamma H2AX is lost from chromatin surrounding a DSB independently of the HTP-C, indicating that the phosphatase targets gamma H2AX after its displacement from DNA. The dephosphorylation of gamma H2AX by the HTP-C is necessary for efficient recovery from the DNA damage checkpoint.	Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Microbiol, Toronto, ON M5G 1L6, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; CBR Inst Biomed Res, Boston, MA 02115 USA; MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA	University of Toronto; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brandeis University; Brandeis University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Texas System; UTMD Anderson Cancer Center	Durocher, D (corresponding author), Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L6, Canada.	durocher@mshri.on.ca; jack.greenblatt@utoronto.ca	Durocher, Daniel/A-7733-2010; Lieberman, Judy/A-2717-2015	Durocher, Daniel/0000-0003-3863-8635; Haber, James/0000-0002-1878-0610; Shen, Xuetong/0000-0002-4267-5298				Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; CHOWDHURY D, IN PRESS MOL CELL; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113	30	359	377	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					497	501		10.1038/nature04384	http://dx.doi.org/10.1038/nature04384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16299494				2022-12-01	WOS:000234859200052
J	McVary, KT				McVary, KT			Non-steroidal anti-inflammatory drugs and urinary retention	LANCET			English	Editorial Material							BENIGN PROSTATIC HYPERPLASIA; CLINICAL PROGRESSION; IMPACT; RISK; MEN		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	McVary, KT (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	k-mcvary@northwestern.edu						Araki T, 2004, ACTA MED OKAYAMA, V58, P45; Gannon K, 2004, J HEALTH PSYCHOL, V9, P411, DOI 10.1177/1359105304042350; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Pickard R, 1998, BRIT J UROL, V81, P712; Roehrborn CG, 2005, J UROLOGY, V173, P346, DOI 10.1016/S0022-5347(18)35422-3; Thomas K, 2005, BJU INT, V95, P72, DOI 10.1111/j.1464-410X.2004.05254.x; Verhamme KMC, 2005, ARCH INTERN MED, V165, P1547, DOI 10.1001/archinte.165.13.1547	7	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 21	2006	367	9506					195	196		10.1016/S0140-6736(06)68013-6	http://dx.doi.org/10.1016/S0140-6736(06)68013-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005GM	16427476				2022-12-01	WOS:000234810600009
J	O'Connell, KA; Wood, JJ; Wise, RP; Lozier, JN; Braun, MM				O'Connell, KA; Wood, JJ; Wise, RP; Lozier, JN; Braun, MM			Thromboembolic adverse events after use of recombinant human coagulation factor VIIa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVATED FACTOR-VII; DOSE FACTOR VIIA; DEPENDENT COAGULATION; HEMOPHILIA BLOOD; MECHANISM	Context The US Food and Drug Administration (FDA) licensed recombinant human coagulation factor VIIa (rFVIIa) on March 25, 1999, for bleeding in patients with hemophilia A or B and inhibitors to factors VIII or IX Use in patients without hemophilia has been increasing since licensure. Objective To review serious thromboembolic adverse events (AEs) reported to the FDA's Adverse Event Reporting System (AERS). Design, Setting, and Patients The AERS database was reviewed from March 25, 1999, through December 31, 2004, for thromboembolic AE reports with rFVIIa. The AERS database includes US and non-US spontaneous AE reports from both approved (specific indications for patients with hemophilia) and unlabeled uses. It also includes serious AEs in patients enrolled in postlicensure clinical trials who received rFVIIa. Manufacturer reporting to FDA is mandatory, but primary notification from clinicians and others to FDA or manufacturers is voluntary for spontaneous reports; therefore, AERS underrepresents actual event occurrences. Main Outcome Measure Reported thromboembolic events occurring in patients administered rFVIIa. Results A total of 431 AE reports for rFVIIa were found, of which 168 reports described 185 thromboembolic events. Seventeen events occurred in patients with hemophilia and 59 occurred in patients enrolled in postlicensure trials. Unlabeled indications accounted for 151 of the reports, most with active bleeding (n=115). Reported AEs were thromboembolic cerebrovascular accident (n=39), acute myocardial infarction (n=34), other arterial thromboses (n=26), pulmonary embolism (n=32), other venous thromboses (including deep vein thrombosis) (n=42), and clotted devices (n=10). In 36 (72%) of 50 reported deaths, the probable cause of death was the thromboembolic event. In 144 patients with timing information, 73 events (52%) occurred in, the first 24 hours after the last dose (30 events within 2 hours). Sixty-four reports (38%) noted concomitant use of hemostatic agents. Most reports lacked sufficient information to evaluate potential dosage associations. Conclusions Most reported thromboembolic AEs followed the use of rFVIIa for unlabeled indications and occurred in arterial and venous systems, often resulting in serious morbidity and mortality. Analysis of the relationship between AEs and rFVIIa is hindered by concomitant medications, preexisting medical conditions, confounding by indication, and inherent limitations of passive surveillance. Randomized controlled trials are needed to establish the safety and efficacy of rFVIIa in patients without hemophilia.	US FDA, Div Epidemiol, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; US FDA, Div Hematol, Off Blood Res & Review, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	O'Connell, KA (corresponding author), US FDA, Div Epidemiol HFM224, Ctr Biol Evaluat & Res, 1401 Rockville Pike, Rockville, MD 20852 USA.	oconnellk@cber.fda.gov						[Anonymous], 2005, NOVOSEVEN PACK INS; Butenas S, 2002, BLOOD, V99, P923, DOI 10.1182/blood.V99.3.923; Ghorashian S, 2004, BLOOD REV, V18, P245, DOI 10.1016/j.blre.2003.12.003; Hoffman M, 1998, BLOOD COAGUL FIBRIN, V9, pS61; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 2002, BLOOD, V100, P364, DOI 10.1182/blood-2002-03-0736; Mann KG, 2002, BLOOD, V100, P365; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; *US FDA, CLIN IMP ADV EV REP; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; World Health Organization, 1977, INT CLASS DIS	12	493	510	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2006	295	3					293	298		10.1001/jama.295.3.293	http://dx.doi.org/10.1001/jama.295.3.293			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003LU	16418464	Bronze			2022-12-01	WOS:000234684500022
J	Davenport, RJ				Davenport, RJ			Drumming up dollars for stem cell research	CELL			English	Article																			0	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1169	1171		10.1016/j.cell.2005.12.012	http://dx.doi.org/10.1016/j.cell.2005.12.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377553	Bronze			2022-12-01	WOS:000234584500001
J	Kumar, S; Hedges, SB				Kumar, S; Hedges, SB			Pushing back the expansion of introns in animal genomes	CELL			English	Article							GENES		Arizona State Univ, Ctr Evolut Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, NASA, Astrobiol Inst, University Pk, PA 16802 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kumar, S (corresponding author), Arizona State Univ, Ctr Evolut Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA.	s.kumar@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212				Blair JE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-53; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; LUNCH M, 2005, MOL BIOL EVOL; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0	8	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1182	1184		10.1016/j.cell.2005.12.007	http://dx.doi.org/10.1016/j.cell.2005.12.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377558	Bronze			2022-12-01	WOS:000234584500006
J	Macqueen, AJ; Phillips, CM; Bhalla, N; Weiser, P; Villeneuve, AM; Dernburg, AF				Macqueen, AJ; Phillips, CM; Bhalla, N; Weiser, P; Villeneuve, AM; Dernburg, AF			Chromosome sites play dual roles to establish homologous synapsis during meiosis in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; NUCLEAR REORGANIZATION; GENETIC-ANALYSIS; CROSSING-OVER; X-CHROMOSOME; PROPHASE; TRANSLOCATION; MECHANISM; COMPONENT	We have investigated the role of pairing centers (PCs), cis-acting sites required for accurate segregation of homologous chromosomes during meiosis in C. elegans. We find that these sites play two distinct roles that contribute to proper segregation. Chromosomes lacking PCs usually fail to synapse and also lack a synapsis-independent stabilization activity. The presence of a PC on just one copy of a chromosome pair promotes synapsis but does not support synapsis independent pairing stabilization, indicating that these functions are separable. Once initiated, synapsis is highly processive, even between nonhomologous chromosomes of disparate lengths, elucidating how translocations suppress meiotic recombination in C. elegans. These findings suggest a multistep pathway for chromosome synapsis in which PCs impart selectivity and efficiency through a "kinetic proofreading" mechanism. We speculate that concentration of these activities at one region per chromosome may have coevolved with the loss of a point centromere to safeguard karyotype stability.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Lawrence Berkeley Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Macqueen, AJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011	Phillips, Carolyn/0000-0002-6228-6468; Dernburg, Abby/0000-0001-8037-1079	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065591, F32GM067408, R01GM053804] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM067408-01A1, R01 GM655591, R01 GM53804, GM067408, R01 GM053804, F32 GM067408-02, F32 GM067408, R01 GM065591] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBAZUK WB, 1994, GENETICS, V136, P129; CARLTON PM, 2005, IN PRESS PLOS GENET; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; Edgley ML, 1995, METHOD CELL BIOL, V48, P147; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GOLDSTEIN P, 1986, CHROMOSOMA, V93, P256, DOI 10.1007/BF00292746; HAWLEY RS, 1980, GENETICS, V94, P625; HERMAN RK, 1982, GENETICS, V102, P379; HERMAN RK, 1989, GENETICS, V121, P723; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Koh K, 2004, DEV BIOL, V267, P252, DOI 10.1016/j.ydbio.2003.11.014; Loidl J, 2004, CHROMOSOM T, V14, P93; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; MCKIM KS, 1988, GENETICS, V120, P987; MCKIM KS, 1993, GENETICS, V134, P749; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; Riddle D. L, 1997, C ELEGANS, P47; Rinaldo C, 2002, GENETICS, V160, P471; ROSENBLUTH RE, 1981, GENETICS, V99, P415; Sherizen D, 2005, GENETICS, V169, P767, DOI 10.1534/genetics.104.035824; SIGURDSON DC, 1986, MOL GEN GENET, V202, P212, DOI 10.1007/BF00331639; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; VILLENEUVE AM, 1994, GENETICS, V136, P887; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	37	196	204	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1037	1050		10.1016/j.cell.2005.09.034	http://dx.doi.org/10.1016/j.cell.2005.09.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360034	Green Accepted, Bronze			2022-12-01	WOS:000234177200013
J	Andrews, NC				Andrews, NC			Understanding heme transport	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IDENTIFICATION		Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Andrews, NC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.			Andrews, Nancy/0000-0003-0243-4462				Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAFFIN SB, 1974, J CLIN INVEST, V54, P1344, DOI 10.1172/JCI107881; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025	5	39	41	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2005	353	23					2508	2509		10.1056/NEJMcibr053987	http://dx.doi.org/10.1056/NEJMcibr053987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990OZ	16339100				2022-12-01	WOS:000233754400015
J	Israel, G; Szopa, C; Raulin, F; Cabane, M; Niemann, HB; Atreya, SK; Bauer, SJ; Brun, JF; Chassefiere, E; Coll, P; Conde, E; Coscia, D; Hauchecorne, A; Millian, P; Nguyen, MJ; Owen, T; Riedler, W; Samuelson, RE; Siguier, JM; Steller, M; Sternberg, R; Vidal-Madjar, C				Israel, G; Szopa, C; Raulin, F; Cabane, M; Niemann, HB; Atreya, SK; Bauer, SJ; Brun, JF; Chassefiere, E; Coll, P; Conde, E; Coscia, D; Hauchecorne, A; Millian, P; Nguyen, MJ; Owen, T; Riedler, W; Samuelson, RE; Siguier, JM; Steller, M; Sternberg, R; Vidal-Madjar, C			Complex organic matter in Titan's atmospheric aerosols from in situ pyrolysis and analysis	NATURE			English	Article							OPTICAL-PROPERTIES; ACETYLENE; PLASMA; CLOUDS	Aerosols in Titan's atmosphere play an important role in determining its thermal structure(1-3). They also serve as sinks for organic vapours(4) and can act as condensation nuclei for the formation of clouds(5,6), where the condensation efficiency will depend on the chemical composition of the aerosols(5,7). So far, however, no direct information has been available on the chemical composition of these particles. Here we report an in situ chemical analysis of Titan's aerosols by pyrolysis at 600 degrees C. Ammonia (NH3) and hydrogen cyanide (HCN) have been identified as the main pyrolysis products. This clearly shows that the aerosol particles include a solid organic refractory core. NH3 and HCN are gaseous chemical fingerprints of the complex organics that constitute this core, and their presence demonstrates that carbon and nitrogen are in the aerosols.	Univ Paris 06, CNRS, UMR 7620, Serv Aeron, F-91371 Verrieres Le Buisson, France; Univ Versailles St Quentin, F-91371 Verrieres Le Buisson, France; Univ Paris 12, CNRS, UMR 7583, Lab Interuniv Syst Atmospher, F-94010 Creteil, France; Univ Paris 07, F-94010 Creteil, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Graz Univ, Inst Meteorol & Geophys, A-8010 Graz, Austria; Ctr Natl Etud Spatiales, F-31401 Toulouse, France; Off Natl Etud & Rech Aerosp, F-31055 Toulouse, France; Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; Austrian Acad Sci, Space Res Inst, A-8010 Graz, Austria; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Austrian Acad Sci, Inst Weltraumforsch, A-8042 Graz, Austria; CNRS, UMR 7581, Lab Rech Polymeres, F-94320 Thiais, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; University of Graz; National Office for Aerospace Studies & Research (ONERA); University of Hawaii System; University of Hawaii Manoa; Austrian Academy of Sciences; University System of Maryland; University of Maryland College Park; Austrian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS)	Israel, G (corresponding author), Univ Paris 06, CNRS, UMR 7620, Serv Aeron, F-91371 Verrieres Le Buisson, France.	Guy.israel@aerov.jussieu.fr	Hauchecorne, Alain/A-8489-2013; szopa, cyril/C-6865-2015	szopa, cyril/0000-0002-0090-4056; Bauer, Siegfried/0000-0003-4213-2047; Siguier, Jean-Michel/0000-0003-3568-9816; Hauchecorne, Alain/0000-0001-9888-6994				BARNUN A, 1988, J GEOPHYS RES-ATMOS, V93, P8383, DOI 10.1029/JD093iD07p08383; Barth EL, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019825; Chang S., 1982, EARTHS EARLIEST BIOS, P53; Clarke DW, 1997, ICARUS, V127, P158, DOI 10.1006/icar.1996.5667; Coll P, 1998, ORIGINS LIFE EVOL B, V28, P195, DOI 10.1023/A:1006521601133; Coll P, 1999, PLANET SPACE SCI, V47, P1331, DOI 10.1016/S0032-0633(99)00054-9; DELGENIO AD, 1993, ICARUS, V101, P1, DOI 10.1006/icar.1993.1001; EHRENFREUND P, 1994, ADV SPACE RES, V15, P335; Imanaka H, 2004, ICARUS, V168, P344, DOI 10.1016/j.icarus.2003.12.014; ISRAEL G, 1991, ANN GEOPHYS, V9, P1; Israel G, 2002, SPACE SCI REV, V104, P433, DOI 10.1023/A:1023640723915; Khare B N, 1984, Adv Space Res, V4, P59, DOI 10.1016/0273-1177(84)90545-3; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Lebonnois S, 2002, ICARUS, V159, P505, DOI 10.1006/icar.2002.6943; Mayo LA, 2005, ICARUS, V176, P316, DOI 10.1016/j.icarus.2005.01.020; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; McKay CP, 1996, PLANET SPACE SCI, V44, P741, DOI 10.1016/0032-0633(96)00009-8; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Minard RD, 1998, ORIGINS LIFE EVOL B, V28, P461, DOI 10.1023/A:1006566125815; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; Rannou P, 2004, ICARUS, V170, P443, DOI 10.1016/j.icarus.2004.03.007; Somogyi A, 2005, J AM SOC MASS SPECTR, V16, P850, DOI 10.1016/j.jasms.2005.01.027; THOMPSON WR, 1991, ICARUS, V90, P57, DOI 10.1016/0019-1035(91)90068-5; Wilson EH, 2003, PLANET SPACE SCI, V51, P1017, DOI 10.1016/j.pss.2003.06.003	24	166	167	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					796	799		10.1038/nature04349	http://dx.doi.org/10.1038/nature04349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16319825				2022-12-01	WOS:000233777800041
J	Lipka, V; Dittgen, J; Bednarek, P; Bhat, R; Wiermer, M; Stein, M; Landtag, J; Brandt, W; Rosahl, S; Scheel, D; Llorente, F; Molina, A; Parker, J; Somerville, S; Schulze-Lefert, P				Lipka, V; Dittgen, J; Bednarek, P; Bhat, R; Wiermer, M; Stein, M; Landtag, J; Brandt, W; Rosahl, S; Scheel, D; Llorente, F; Molina, A; Parker, J; Somerville, S; Schulze-Lefert, P			Pre- and postinvasion defenses both contribute to nonhost resistance in Arabidopsis	SCIENCE			English	Article							DISEASE RESISTANCE; POWDERY MILDEW; HOST; MICROBES; PROTEINS; ANIMALS; SIGNALS; PLANTS	Nonhost resistance describes the immunity of an entire plant species against nonadapted pathogen species. We report that Arabidopsis PEN2 restricts pathogen entry of two ascomycete powdery mildew fungi that in nature colonize grass and pea species. The PEN2 glycosyl hydrolase localizes to peroxisomes and acts as a component of an inducible preinvasion resistance mechanism. Postinvasion fungal growth is blocked by a separate resistance layer requiring the EDS1-PAD4-SAG101 signaling complex, which is known to function in basal and resistance (R) gene-triggered immunity. Concurrent impairment of pre- and postinvasion resistance renders Arabidopsis a host for both nonadapted fungi.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle Saale, Germany; Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle Saale, Germany; Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Lab Bioquim & Biol Mol, E-28040 Madrid, Spain	Max Planck Society; Carnegie Institution for Science; Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Universidad Politecnica de Madrid	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/A-7746-2008; Schulze-Lefert, Paul/B-6707-2011; Bednarek, Pawel/D-2561-2009; Wiermer, Marcel/F-4791-2018; de Gracia, Francisco Llorente/G-1760-2010; Bruening, Stefan/B-8505-2011; Lipka, Volker/C-5874-2009; Molina, Antonio/G-9789-2015	Bednarek, Pawel/0000-0002-3064-7775; Wiermer, Marcel/0000-0002-1232-2707; de Gracia, Francisco Llorente/0000-0003-1566-0266; Molina, Antonio/0000-0003-3137-7938; Stein, Monica/0000-0002-1926-4212				Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; JOHNSON LEB, 1982, CAN J BOT, V60, P1068, DOI 10.1139/b82-137; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Panstruga R, 2003, MICROBES INFECT, V5, P429, DOI 10.1016/S1286-4579(03)00053-4; Saenz GS, 1999, CAN J BOT, V77, P150, DOI 10.1139/cjb-77-1-150; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	18	578	595	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1180	1183		10.1126/science.1119409	http://dx.doi.org/10.1126/science.1119409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293760	Green Published			2022-12-01	WOS:000233437300044
J	Millar, JK; Pickard, BS; Mackie, S; James, R; Christie, S; Buchanan, SR; Malloy, MP; Chubb, JE; Huston, E; Baillie, GS; Thomson, PA; Hill, EV; Brandon, NJ; Rain, JC; Camargo, LM; Whiting, PJ; Houslay, MD; Blackwood, DHR; Muir, WJ; Porteous, DJ				Millar, JK; Pickard, BS; Mackie, S; James, R; Christie, S; Buchanan, SR; Malloy, MP; Chubb, JE; Huston, E; Baillie, GS; Thomson, PA; Hill, EV; Brandon, NJ; Rain, JC; Camargo, LM; Whiting, PJ; Houslay, MD; Blackwood, DHR; Muir, WJ; Porteous, DJ			DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling	SCIENCE			English	Article							PROTEIN-KINASE; PHOSPHODIESTERASE; PHOSPHORYLATION; TRANSLOCATION; ACTIVATION; FORM	The disrupted in schizophrenia 1 (DISC1) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B (PDE4B) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3',5'-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.	Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; Merck Sharp & Dohme Ltd MSD, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England; Hybrigen SA, F-75014 Paris, France; Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	University of Edinburgh; University of Glasgow; Merck & Company; Royal Infirmary of Edinburgh; University of Edinburgh	Millar, JK (corresponding author), Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland.	Kirsty.Millar@ed.ac.uk	Pickard, Benjamin S/K-3923-2014; Houslay, Miles/AAM-5281-2020; Porteous, David/AAA-3446-2021; Houslay, Miles D/A-6825-2011; Porteous, David J/C-7289-2013; blackwood, douglas/AIB-8874-2022	Pickard, Benjamin S/0000-0002-2374-6329; Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; RAIN, Jean-Christophe/0000-0001-8110-0641; Baillie, George/0000-0003-2469-6316; Whiting, Paul/0000-0002-4121-1379; James, Rachel/0000-0002-6529-5335; Houslay, Miles/0000-0002-3826-8091; Brandon, Nicholas/0000-0002-3917-0096	Medical Research Council [G8604010] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G8604010] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hayashi MAF, 2005, P NATL ACAD SCI USA, V102, P3828, DOI 10.1073/pnas.0500330102; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Lamprecht R, 1999, CELL MOL LIFE SCI, V55, P554, DOI 10.1007/s000180050314; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	20	512	539	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1187	1191		10.1126/science.1112915	http://dx.doi.org/10.1126/science.1112915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293762				2022-12-01	WOS:000233437300046
J	Lee, N; Maurange, C; Ringrose, L; Paro, R				Lee, N; Maurange, C; Ringrose, L; Paro, R			Suppression of Polycomb group proteins by JNK signalling induces transdetermination in Drosophila imaginal discs	NATURE			English	Article							METHYLTRANSFERASE ACTIVITY; PATHWAY; COMPLEX; WINGLESS; ENHANCER; ENCODES; CLOSURE; KINASE; DJUN; EYE	During the regeneration of Drosophila imaginal discs, cellular identities can switch fate in a process known as transdetermination(1). For leg-to-wing transdetermination, the underlying mechanism involves morphogens such as Wingless that, when activated outside their normal context, induce ectopic expression of the wing-specific selector gene vestigial(2,3). Polycomb group (PcG) proteins maintain cellular fates by controlling the expression patterns of homeotic genes and other developmental regulators(4). Here we report that transdetermination events are coupled to PcG regulation. We show that the frequency of transdetermination is enhanced in PcG mutant flies. Downregulation of PcG function, as monitored by the reactivation of a silent PcG-regulated reporter gene, is observed in transdetermined cells. This downregulation is directly controlled by the Jun amino-terminal kinase (JNK) signalling pathway, which is activated in cells undergoing regeneration. Accordingly, transdetermination frequency is reduced in a JNK mutant background. This regulatory interaction also occurs in mammalian cells, indicating that the role of this signalling cascade in remodelling cellular fates may be conserved.	Univ Heidelberg, Ctr Mol Biol Heidelberg ZMBH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Paro, R (corresponding author), Univ Heidelberg, Ctr Mol Biol Heidelberg ZMBH, D-69120 Heidelberg, Germany.	paro@zmbh.uni-heidelberg.de	Ringrose, Leonie/AAV-4734-2021	Maurange, Cedric/0000-0001-8931-1419				Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gibson MC, 1999, DEVELOPMENT, V126, P1591; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hadorn E., 1978, P556; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Maves L, 1998, DEVELOPMENT, V125, P115; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; PERKINS KK, 1988, EMBO J, V7, P4265, DOI 10.1002/j.1460-2075.1988.tb03324.x; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Sustar A, 2005, CELL, V120, P383, DOI 10.1016/j.cell.2004.12.008; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Weber U, 2000, DEVELOPMENT, V127, P3619; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	28	170	174	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2005	438	7065					234	237		10.1038/nature04120	http://dx.doi.org/10.1038/nature04120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281037				2022-12-01	WOS:000233133500051
J	Thomas, SE; Soltani-Bejnood, M; Roth, P; Dorn, R; Logsdon, JM; McKee, BD				Thomas, SE; Soltani-Bejnood, M; Roth, P; Dorn, R; Logsdon, JM; McKee, BD			Identification of two proteins required for conjunction and regular segregation of achiasmate homologs in Drosophila male Meiosis	CELL			English	Article							POSITION-EFFECT VARIEGATION; SYNAPTONEMAL COMPLEX; CHROMATIN INSULATOR; DNA-BINDING; GENE; MOD(MDG4); MELANOGASTER; LOCUS; DYNAMICS; ENHANCER	In Drosophila males, homologous chromosomes segregate by an unusual process involving physical connections not dependent on recombination. We have identified two meiotic proteins specifically required for this process. Stromalin in Melosis (SNM) is a divergent member of the SCC3/SA/STAG family of cohesin proteins, and Modifier of Mdg4 in Melosis (MNM) is one of many BTB-domain proteins expressed from the mod(mdg4) locus. SNM and MNM colocalize along with a repetitive rDNA sequence known to function as an X-Y pairing site to nucleolar foci during meiotic prophase and to a compact structure associated with the X-Y bivalent during prometaphase I and metaphase 1. Additionally, MNM localizes to autosomal foci throughout meiosis 1. These proteins are mutually dependent for their colocalization, and at least MNM requires the function of teflon, another meiotic gene. SNM and MNM do not colocalize with SMC1, suggesting that the homolog conjunction mechanism is independent of cohesin.	Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA; Univ Halle Wittenberg, Inst Genet, Halle An Der Saale, Germany; Univ Iowa, Roy J Carver Ctr Comparat Genom, Dept Biol Sci, Iowa City, IA 52242 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Martin Luther University Halle Wittenberg; University of Iowa	McKee, BD (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	bdmckee@utk.edu	Logsdon, John M/B-7812-2009		NIGMS NIH HHS [R01 GM40489] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040489] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balicky EM, 2002, MOL BIOL CELL, V13, P3890, DOI 10.1091/mbc.E02-06-0332; BONACCORSI S, 2000, DROSOPHILA PROTOCOLS; Buchner K, 2000, GENETICS, V155, P141; CARPENTER ATC, 1994, CELL, V77, P959, DOI 10.1016/0092-8674(94)90434-0; CENCI G, 1994, J CELL SCI, V107, P3521; Cooper KW, 1950, BIOL DROSOPHILA, P1; Dorn R, 2003, GENETICA, V117, P165, DOI 10.1023/A:1022983810016; DORN R, 1993, P NATL ACAD SCI USA, V90, P11376, DOI 10.1073/pnas.90.23.11376; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Gorczyca M, 1999, J NEUROBIOL, V39, P447, DOI 10.1002/(SICI)1097-4695(19990605)39:3<447::AID-NEU10>3.0.CO;2-Q; GOULDSOMERO M, 1974, ROUX ARCH DEV BIOL, V174, P133, DOI 10.1007/BF00573626; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; Hime GR, 1996, J CELL SCI, V109, P2779; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; MADDISON WP, 2003, MACCLADE; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; MEYER GF, 1960, P EUROPEAN REGIONAL, P951; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; RASMUSSEN SW, 1977, CHROMOSOMA, V60, P205, DOI 10.1007/BF00329771; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomkiel JE, 2001, GENETICS, V157, P273; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Valdeolmillos A, 1998, DNA CELL BIOL, V17, P699, DOI 10.1089/dna.1998.17.699; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Vazquez J, 2002, CURR BIOL, V12, P1473, DOI 10.1016/S0960-9822(02)01090-4; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; WANDALL A, 1985, CHROMOSOMA, V92, P254, DOI 10.1007/BF00329808; WOLF KW, 1994, BIOESSAYS, V16, P107, DOI 10.1002/bies.950160207	49	65	69	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					555	568		10.1016/j.cell.2005.08.043	http://dx.doi.org/10.1016/j.cell.2005.08.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286005	Bronze			2022-12-01	WOS:000233497400006
J	Barber, DL; Wherry, EJ; Masopust, D; Zhu, BG; Allison, JP; Sharpe, AH; Freeman, GJ; Ahmed, R				Barber, DL; Wherry, EJ; Masopust, D; Zhu, BG; Allison, JP; Sharpe, AH; Freeman, GJ; Ahmed, R			Restoring function in exhausted CD8 T cells during chronic viral infection	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IN-VIVO; B7 FAMILY; PD-1; PERSISTENCE; TOLERANCE; RESPONSES; MEMORY; MEMBER; IMMUNOTHERAPY	Functional impairment of antigen-specific T cells is a defining characteristic of many chronic infections, but the underlying mechanisms of T-cell dysfunction are not well understood. To address this question, we analysed genes expressed in functionally impaired virus-specific CD8 T cells present in mice chronically infected with lymphocytic choriomeningitis virus ( LCMV), and compared these with the gene profile of functional memory CD8 T cells. Here we report that PD-1 ( programmed death 1; also known as Pdcd1) was selectively upregulated by the exhausted T cells, and that in vivo administration of antibodies that blocked the interaction of this inhibitory receptor with its ligand, PD-L1 ( also known as B7-H1), enhanced T-cell responses. Notably, we found that even in persistently infected mice that were lacking CD4 T-cell help, blockade of the PD-1/PD-L1 inhibitory pathway had a beneficial effect on the 'helpless' CD8 T cells, restoring their ability to undergo proliferation, secrete cytokines, kill infected cells and decrease viral load. Blockade of the CTLA-4 ( cytotoxic T-lymphocyte-associated protein 4) inhibitory pathway had no effect on either T-cell function or viral control. These studies identify a specific mechanism of T-cell exhaustion and define a potentially effective immunological strategy for the treatment of chronic viral infections.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Dept Med, New York, NY 10021 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Emory University; Emory University; The Wistar Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ra@microbio.emory.edu	masopust, david/B-5027-2008; Wherry, John/ABI-1280-2020; Yang, Chen/G-1379-2010; Barber, Daniel L./V-1190-2019; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Allison, James/0000-0001-8980-5697				Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Dong HD, 1999, NAT MED, V5, P1365; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	2851	3159	8	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					682	687		10.1038/nature04444	http://dx.doi.org/10.1038/nature04444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16382236				2022-12-01	WOS:000235193100035
J	Adams, GB; Chabner, KT; Alley, IR; Olson, DP; Szczepiorkowski, ZM; Poznansky, MC; Kos, CH; Pollak, MR; Brown, EM; Scadden, DT				Adams, GB; Chabner, KT; Alley, IR; Olson, DP; Szczepiorkowski, ZM; Poznansky, MC; Kos, CH; Pollak, MR; Brown, EM; Scadden, DT			Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor	NATURE			English	Article							BONE-MARROW; IN-VIVO; HEMATOPOIETIC MICROENVIRONMENT; MICE; EXPRESSION	During mammalian ontogeny, haematopoietic stem cells (HSCs) translocate from the fetal liver to the bone marrow, where haematopoiesis occurs throughout adulthood(1). Unique features of bone that contribute to a microenvironmental niche for stem cells might include the known high concentration of calcium ions at the HSC-enriched endosteal surface. Cells respond to extracellular ionic calcium concentrations through the seven-transmembrane-spanning calcium-sensing receptor (CaR), which we identified as being expressed on HSCs. Here we show that, through the CaR, the simple ionic mineral content of the niche may dictate the preferential localization of adult mammalian haematopoiesis in bone. Antenatal mice deficient in CaR had primitive haematopoietic cells in the circulation and spleen, whereas few were found in bone marrow. CaR-/- HSCs from fetal liver were normal in number, in proliferative and differentiative function, and in migration and homing to the bone marrow. Yet they were highly defective in localizing anatomically to the endosteal niche, behaviour that correlated with defective adhesion to the extracellular matrix protein, collagen I. CaR has a function in retaining HSCs in close physical proximity to the endosteal surface and the regulatory niche components associated with it.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Blood Transfus Serv, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Membrane Biol Program,Endocrine Hypertens Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu	Poznansky, Mark C/M-4996-2015; Szczepiorkowski, Zbigniew M./A-1359-2007	Poznansky, Mark C/0000-0003-1344-7103; Szczepiorkowski, Zbigniew M./0000-0003-2357-9564				An J, 1996, EXP HEMATOL, V24, P768; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Garner SC, 2001, ENDOCRINOLOGY, V142, P3996, DOI 10.1210/en.142.9.3996; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; KAWAI M, 1994, BLOOD CELLS, V20, P191; LORD BI, 1975, BLOOD, V46, P65; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Olszak IT, 2000, J CLIN INVEST, V105, P1299, DOI 10.1172/JCI9799; Orschell-Traycoff CM, 2000, BLOOD, V96, P1380, DOI 10.1182/blood.V96.4.1380.h8001380_1380_1387; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; TAVASSOLI M, 1991, BLOOD CELLS, V17, P269; WOLF NS, 1974, CELL TISSUE KINET, V7, P89, DOI 10.1111/j.1365-2184.1974.tb00402.x; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZHOU H, 1995, BONE, V17, P407, DOI 10.1016/S8756-3282(95)00264-2	25	526	555	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					599	603		10.1038/nature04247	http://dx.doi.org/10.1038/nature04247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16382241				2022-12-01	WOS:000235033900043
J	Bild, AH; Yao, G; Chang, JT; Wang, QL; Potti, A; Chasse, D; Joshi, MB; Harpole, D; Lancaster, JM; Berchuck, A; Olson, JA; Marks, JR; Dressman, HK; West, M; Nevins, JR				Bild, AH; Yao, G; Chang, JT; Wang, QL; Potti, A; Chasse, D; Joshi, MB; Harpole, D; Lancaster, JM; Berchuck, A; Olson, JA; Marks, JR; Dressman, HK; West, M; Nevins, JR			Oncogenic pathway signatures in human cancers as a guide to targeted therapies	NATURE			English	Article							GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; MUTATIONS; PROFILES; PATTERNS; ASSAYS	The development of an oncogenic state is a complex process involving the accumulation of multiple independent mutations that lead to deregulation of cell signalling pathways central to the control of cell growth and cell fate(1-3). The ability to define cancer subtypes, recurrence of disease and response to specific therapies using DNA microarray-based gene expression signatures has been demonstrated in multiple studies(4). Various studies have also demonstrated the potential for using gene expression profiles for the analysis of oncogenic pathways(5-11). Here we show that gene expression signatures can be identified that reflect the activation status of several oncogenic pathways. When evaluated in several large collections of human cancers, these gene expression signatures identify patterns of pathway deregulation in tumours and clinically relevant associations with disease outcomes. Combining signature-based predictions across several pathways identifies coordinated patterns of pathway deregulation that distinguish between specific cancers and tumour subtypes. Clustering tumours based on pathway signatures further defines prognosis in respective patient subsets, demonstrating that patterns of oncogenic pathway deregulation underlie the development of the oncogenic phenotype and reflect the biology and outcome of specific cancers. Predictions of pathway deregulation in cancer cell lines are also shown to predict the sensitivity to therapeutic agents that target components of the pathway. Linking pathway deregulation with sensitivity to therapeutics that target components of the pathway provides an opportunity to make use of these oncogenic pathway signatures to guide the use of targeted therapeutics.	Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Nevins, JR (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	j.nevins@duke.edu		, Guang/0000-0003-0167-777X	NCI NIH HHS [R21 CA108707, K23 CA106595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K23CA106595, R21CA108707] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black EP, 2003, CANCER RES, V63, P3716; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fearon E., 1990, CELL, V17, P671; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; IRIZARRY RA, IN PRESS BIOSTATISTI; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2002, J CLIN ONCOL, V20, P1932, DOI 10.1200/JCO.2002.20.7.1932; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; RISS TL, 1992, MOL BIOL CELL, V3, pA184; Rodenhuis S, 1997, J CLIN ONCOL, V15, P285, DOI 10.1200/JCO.1997.15.1.285; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; STAMPFER MR, 1993, CANCER SURV, V18, P7; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	24	1536	1625	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					353	357		10.1038/nature04296	http://dx.doi.org/10.1038/nature04296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16273092				2022-12-01	WOS:000234682100049
J	Vento, S; Cainelli, F; Temesgen, Z				Vento, S; Cainelli, F; Temesgen, Z			Interleukin-2 therapy and CD4+T cells in HIV-1 infection	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; T-CELLS; EXPANSION; TRIAL		Univ Verona, Dept Pathol, Infect Dis Sect, I-37138 Verona, Italy; Mayo Clin & Mayo Fdn, Div Infect Dis, Rochester, MN 55905 USA	University of Verona; Mayo Clinic	Vento, S (corresponding author), Univ Verona, Dept Pathol, Infect Dis Sect, I-37138 Verona, Italy.	ventosandro@yahoo.it	Vento, Sandro/I-1662-2017	Vento, Sandro/0000-0003-0084-4062; Cainelli, Francesca/0000-0003-1838-3946				De Paoli P, 2001, CLIN EXP IMMUNOL, V125, P440, DOI 10.1046/j.1365-2249.2001.01615.x; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Emery S, 2000, J INFECT DIS, V182, P428, DOI 10.1086/315736; Hengge UR, 1998, AIDS, V12, pF225, DOI 10.1097/00002030-199817000-00003; Kovacs JA, 2005, J CLIN INVEST, V115, P2139, DOI 10.1172/JCI23196; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; Levy Y, 1999, LANCET, V353, P1923, DOI 10.1016/S0140-6736(98)07345-0; Sereti I, 2004, BLOOD, V104, P775, DOI 10.1182/blood-2003-12-4355; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sousa AE, 2001, J INFECT DIS, V184, P552, DOI 10.1086/322804	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2006	367	9505					93	95		10.1016/S0140-6736(06)67941-5	http://dx.doi.org/10.1016/S0140-6736(06)67941-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003BB	16413860				2022-12-01	WOS:000234655500008
J	Sander, PM; Klein, N				Sander, PM; Klein, N			Developmental plasticity in the life history of a prosauropod dinosaur	SCIENCE			English	Article							GROWTH-PATTERNS; BONE-HISTOLOGY; RATES; EVOLUTION	Long-bone histology indicates that the most common early dinosaur, the prosauropod Plateosaurus engelhardti from the Upper Triassic of Central Europe, had variable life histories. Although Plateosaurus grew at the fast rates typical for dinosaurs, as indicated by fibrolamellar bone, qualitative (growth stop) and quantitative (growth-mark counts) features of its histology are poorly correlated with body size. Individual life histories of P. engelhardti were influenced by environmental factors, as in modern ectothermic reptiles, but not in mammals, birds, or other dinosaurs.	Univ Bonn, Inst Palaontol, D-53115 Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Inst Palaontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de						Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; LEGLER JOHN M., 1960, UNIV KANSAS PUBL MUS NAT HIST, V11, P527; Moser M, 2003, ZITTELIANA B, VB24, P1; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Ricqlesde A, 2000, ZOOL J LINN SOC-LOND, V129, P271; SANDER PM, 1992, PALAEOGEOGR PALAEOCL, V93, P255; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SMITHGILL SJ, 1983, AM ZOOL, V23, P47; Starck J.M., 1998, AVIAN GROWTH DEV; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Weishampel D.B., 1990, P43, DOI 10.1017/CBO9780511608377.006; Yates Adam M., 2004, Postilla, V230, P1; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; ZUG G R, 1987, Amphibia-Reptilia, V8, P237, DOI 10.1163/156853887X00289; Zug G.R., 2001, HERPETOLOGY; Zug GR, 1986, SMITHSONIAN CONTRIBU, V427, P1, DOI DOI 10.5479/SI.00810282.427; [No title captured]	32	119	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1800	1802		10.1126/science.1120125	http://dx.doi.org/10.1126/science.1120125			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357257				2022-12-01	WOS:000234093600042
J	Jambou, R; Legrand, E; Niang, M; Khim, N; Lim, P; Volney, B; Ekala, MT; Bouchier, C; Esterre, P; Fandeur, T; Mercereau-Puijalon, O				Jambou, R; Legrand, E; Niang, M; Khim, N; Lim, P; Volney, B; Ekala, MT; Bouchier, C; Esterre, P; Fandeur, T; Mercereau-Puijalon, O			Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6	LANCET			English	Article							SUSCEPTIBILITY; CHLOROQUINE; ARTESUNATE; GENE	Artemisinin derivatives are an essential component of treatment against multidrug-resistant Plasmodium falciparum malaria. We aimed to investigate in-vitro resistance to arternisinin derivatives in field isolates. In-vitro susceptibility of 530 P faliciparum isolates from three countries (Cambodia, French Guiana, and Senegal) with different arternisinin use was assessed with an isotopic microtest. Artemether IC50 up to 117 and 45 nmol/L was seen in French Guiana and Senegal, respectively. DNA sequencing in a subsample of 60 isolates lends support to SERCA-PfATPase6 as the target for artemisinins. The S769N PfATPase6 mutation, noted exclusively in French Guiana, was associated with raised (>30 nmol/L) artemether IC(50)s (p<0.0001, Mann-Whitney). All resistant isolates came from areas with uncontrolled use of arternisinin derivatives. This rise in resistance indicates the need for increased vigilance and a coordinated and rapid deployment of drug combinations.	Inst Pasteur, Unite Immunol, Dakar, Senegal; Inst Pasteur, Ctr Natl Reference Chimioresistance Paludisme Ant, Cayenne, French Guiana; Inst Pasteur Cambodge, Lab Epidemiol Mol, Phnom Penh, Cambodia; Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France; Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jambou, R (corresponding author), Inst Pasteur, Unite Immunol, 36 Ave Pasteur,POB 220, Dakar, Senegal.	rjambou@pasteur.sn	JAMBOU, RONAN/CAG-3718-2022; Mercereau-Puijalon, Odile/AAA-2242-2020; Lim, Pharath/AAF-6699-2020	Lim, Pharath/0000-0002-1012-2461; Legrand, Eric/0000-0003-4725-0712				Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Ferrer-Rodriguez I, 2004, J PARASITOL, V90, P152, DOI 10.1645/GE-3225; KIMURA M, 1993, J CELL SCI, V104, P1129; Lim P, 2005, ACTA TROP, V93, P31, DOI 10.1016/j.actatropica.2004.09.002; Ringwald P, 1999, AM J TROP MED HYG, V61, P187, DOI 10.4269/ajtmh.1999.61.187; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200	9	372	388	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2005	366	9501					1960	1963		10.1016/S0140-6736(05)67787-2	http://dx.doi.org/10.1016/S0140-6736(05)67787-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325698				2022-12-01	WOS:000233777900024
J	Morel, CM; Lauer, JA; Evans, DB				Morel, CM; Lauer, JA; Evans, DB			Achieving the millennium development goals for health - Cost effectiveness analysis of strategies to combat malaria in developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INSECTICIDE-TREATED NETS; KWAZULU; DRUG	Objective To determine the cost effectiveness of selected malaria control interventions in the context of reaching the millennium development goals for malaria. Design Generalised cost effectiveness analysis. Data sources Efficacy data came from the literature and authors' calculations supported by expert opinion. Quantities for resource inputs came from the literature and from expert opinion; prices came from the WHO-CHOICE database. Methods Costs were assessed in year 2000 international dollars, and effects were assessed as disability adjusted life years averted by a 10 year implementation programme. Analysis was restricted to sub-Saharan regions where the most deadly form of malaria, Plasmodium falciparum, is most prevalent. The impact on population health for various interventions, and their combinations, was evaluated at selected coverage levels by using a state-transition model. Sensitivity analysis was done for age weights and discounting. Results High coverage with artemisinin based combination treatments was found to be the most cost effective strategy for control of malaria in most countries in sub-Saharan Africa. Conclusions A much larger infusion of resources than those currently available is needed to make headway in the fight to roll back malaria. On cost effectiveness grounds, in most areas in sub-Saharan Africa greater coverage with highly effective combination treatments should be the cornerstone of malaria control. However, treatment alone can achieve less than half the total benefit obtainable through a combination of interventions-and scaling up the use of impregnated mosquito nets or indoor spraying with insecticides is also critical. Intermittent presumptive treatment of pregnant women can bring a small but important additional health gain at relatively low cost.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; WHO, Costs Effectiveness Expenditure & Prior Setting T, Hlth Syst Financing Dept, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Morel, CM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.	Chantal.Morel@lshtm.ac.uk	Morel, Chantal M/R-8243-2017	Morel, Chantal M/0000-0003-3984-9741; Lauer, Jeremy A/0000-0003-0652-0691				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Bakyaita N, 2005, AM J TROP MED HYG, V72, P573; BALRUSSEN R, 2003, METHODS GEN COST EFF; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Coleman PG, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.196; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Goodman CA, 2001, HEALTH ECON, V10, P731, DOI 10.1002/hec.621; Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x; Guyatt HL, 2002, HEALTH POLICY PLANN, V17, P144, DOI 10.1093/heapol/17.2.144; HANSON K, 2004, EC MALARIA CONTROL I; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; United Nations, 2005, MILL DEV GOALS REP; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; WHITFIELD D, 1999, ED SOCIAL JUSTICE, V1, P1; *WHO, 2002, GLOB BURD DIS EST; *WHO UNICEF, 2003, AFR MAL REP 2003, P120; *WHO UNICEF ROLL B, 2005, WORLD MAL REP 2005	28	86	86	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2005	331	7528					1299	1302B		10.1136/bmj.38639.702384.AE	http://dx.doi.org/10.1136/bmj.38639.702384.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	990YE	16282381	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000233778500015
J	Vong, QP; Cao, K; Li, HY; Iglesias, PA; Zheng, YX				Vong, QP; Cao, K; Li, HY; Iglesias, PA; Zheng, YX			Chromosome alignment and segregation regulated by ubiquitination of survivin	SCIENCE			English	Article							DROSOPHILA-FAT-FACETS; AURORA-B; DEUBIQUITINATING ENZYME; GENE; SUBSTRATE; SEQUENCES; CDC48/P97; DYNAMICS; MCAK; EYE	Proper chromosome segregation requires the attachment of sister kinetochores to microtubules from opposite spindle poles to form bi-oriented chromosomes on the metaphase spindle. The chromosome passenger complex containing Survivin and the kinase Aurora B regulates this process from the centromeres. We report that a de-ubiquitinating enzyme, hFAM, regulates chromosome alignment and segregation by controlling both the dynamic association of Survivin with centromeres and the proper targeting of Survivin and Aurora B to centromeres. Survivin is ubiquitinated in mitosis through both Lys(48) and LyS(63) ubiquitin linkages. LyS(63) de-ubiquitination mediated by hFAM is required for the dissociation of Survivin from centromeres, whereas LyS(63) ubiquitination mediated by the ubiquitin binding protein Ufd1 is required for the association of Survivin with centromeres. Thus, ubiquitinaton regulates dynamic protein-protein interactions and chromosome segregation independently of protein degradation.	Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Iglesias, PA (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	pi@jhu.edu; zheng@ciwemb.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X; Li, Hoi Yeung/0000-0002-8603-1953	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Delacour-Larose M, 2004, CELL CYCLE, V3, P1418, DOI 10.4161/cc.3.11.1203; EARNSHAW W, 1986, J CLIN INVEST, V77, P426, DOI 10.1172/JCI112320; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang YZ, 1996, DEVELOPMENT, V122, P3207; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Noma T, 2002, MECH DEVELOP, V119, pS91, DOI 10.1016/S0925-4773(03)00098-4; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhao J, 2000, J CELL SCI, V113, P4363	30	197	214	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1499	1504		10.1126/science.1120160	http://dx.doi.org/10.1126/science.1120160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322459				2022-12-01	WOS:000233756500046
J	Baumgartner, C; Aull-Watschinger, S				Baumgartner, C; Aull-Watschinger, S			The pre-ictal state in focal epilepsy	LANCET			English	Editorial Material							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE EPILEPSY; FUNCTIONAL MRI; PREDICTION; SEIZURES		Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria	Medical University of Vienna	Baumgartner, C (corresponding author), Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria.	christoph.baumgartner@meduniwien.ac.at						Baumgartner C, 1998, J NUCL MED, V39, P978; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; JACKSON GD, 1994, NEUROLOGY, V44, P850, DOI 10.1212/WNL.44.5.850; Krings T, 2000, NEUROLOGY, V54, P524, DOI 10.1212/WNL.54.2.524; Lehnertz K, 2003, IEEE ENG MED BIOL, V22, P57, DOI 10.1109/MEMB.2003.1191451; Lindenberg CS, 1999, INT J NURS STUD, V36, P3, DOI 10.1016/S0020-7489(98)00046-7; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; WALLSTEDT L, 1996, EPILEPSIA S4, V37, P163; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; WEINAND ME, 1994, NEUROSURGERY, V35, P657, DOI 10.1227/00006123-199410000-00011	11	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2065	2066		10.1016/S0140-6736(05)67865-8	http://dx.doi.org/10.1016/S0140-6736(05)67865-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360771				2022-12-01	WOS:000234146000004
J	Sanders, CJG				Sanders, CJG			The road	LANCET			English	Article									Univ Med Ctr, Dept Dermatol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Sanders, CJG (corresponding author), Univ Med Ctr, Dept Dermatol, G02-124,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	c.sanders@umcutrecht.nl							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2135	2136		10.1016/S0140-6736(05)67892-0	http://dx.doi.org/10.1016/S0140-6736(05)67892-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360792				2022-12-01	WOS:000234146000030
J	Attiyeh, EF; London, WB; Mosse, YP; Wang, Q; Winter, C; Khazi, D; McGrady, PW; Seeger, RC; Look, AT; Shimada, H; Brodeur, GM; Cohn, SL; Matthay, KK; Maris, JM				Attiyeh, EF; London, WB; Mosse, YP; Wang, Q; Winter, C; Khazi, D; McGrady, PW; Seeger, RC; Look, AT; Shimada, H; Brodeur, GM; Cohn, SL; Matthay, KK; Maris, JM		Children's Oncology Grp	Chromosome 1p and 11q deletions and outcome in neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 13-17, 2005	Orlando, FL	Amer Soc Clin Oncol			TUMOR-CELL PLOIDY; GENE AMPLIFICATION; ALLELIC DELETION; STAGE; PROGRESSION; DEFINITION; ONCOGENE; THERAPY; BIOLOGY; COMMON	BACKGROUND Neuroblastoma is a childhood cancer with considerable morbidity and mortality. Tumor-derived biomarkers may improve risk stratification. METHODS We screened 915 samples of neuroblastoma for loss of heterozygosity (LOH) at chromosome bands 1p36 and 11q23. Additional analyses identified a subgroup of cases of 11q23 LOH with unbalanced 11q LOH (unb11q LOH; defined as loss of 11q with retention of 11p). The associations of LOH with relapse and survival were determined. RESULTS LOH at 1p36 was identified in 209 of 898 tumors (23 percent) and LOH at 11q23 in 307 of 913 (34 percent). Unb11q LOH was found in 151 of 307 tumors with 11q23 LOH (17 percent of the total cohort). There was a strong association of 1p36 LOH, 11q23 LOH, and unb11q LOH with most high-risk disease features (P<0.001). LOH at 1p36 was associated with amplification of the MYCN oncogene (P<0.001), but 11q23 LOH and unb11q LOH were not (P<0.001 and P=0.002, respectively). Cases with unb11q LOH were associated with three-year event-free and overall survival rates (+/-SE) of 50+/-5 percent and 66+/-5 percent, respectively, as compared with 74+/-2 percent and 83+/-2 percent among cases without unb11q LOH (P<0.001 for both comparisons). In a multivariate model, unb11q LOH was independently associated with decreased event-free survival (P=0.009) in the entire cohort, and both 1p36 LOH and unb11q LOH were independently associated with decreased progression-free survival in the subgroup of patients with features of low-risk and intermediate-risk disease (P=0.002 and P=0.02, respectively). CONCLUSIONS Unb11q LOH and 1p36 LOH are independently associated with a worse outcome in patients with neuroblastoma.	Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst, Philadelphia, PA USA; Childrens Oncol Grp, Arcadia, CA USA; Univ Florida, Dept Stat, Gainesville, FL 32611 USA; Childrens Oncol Grp, Gainesville, FL USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Children's Oncology Group (COG); State University System of Florida; University of Florida; Children's Oncology Group (COG); Children's Hospital Los Angeles; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Abramson Pediat Res Ctr 902A, Div Oncol, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	maris@email.chop.edu	Cohn, Susan/AAB-6010-2021; London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021	London, Wendy Beth/0000-0003-3571-6538; Cohn, Susan/0000-0001-5749-7650	NATIONAL CANCER INSTITUTE [U10CA098543, R01CA087847, R01CA039771, U10CA078966] Funding Source: NIH RePORTER; NCI NIH HHS [U10-CA98543, R01-CA87847, U10-CA78966, R01-CA39771] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alvarado CS, 2000, J PEDIAT HEMATOL ONC, V22, P197, DOI 10.1097/00043426-200005000-00003; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brodeur GM, 2002, PRINCIPLES PRACTICE, P895; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; COX DR, 1972, J R STAT SOC B, V34, P187; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzenstein HM, 1998, J CLIN ONCOL, V16, P2007, DOI 10.1200/JCO.1998.16.6.2007; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Luttikhuis MEMO, 2001, BRIT J CANCER, V85, P531, DOI 10.1054/bjoc.2001.1960; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2001, MED PEDIATR ONCOL, V36, P24, DOI 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Matthay KK, 1998, J CLIN ONCOL, V16, P1256, DOI 10.1200/JCO.1998.16.4.1256; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nickerson HJ, 2000, J CLIN ONCOL, V18, P477, DOI 10.1200/JCO.2000.18.3.477; Perez CA, 2000, J CLIN ONCOL, V18, P18, DOI 10.1200/JCO.2000.18.1.18; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Plantaz D, 1997, AM J PATHOL, V150, P81; Pritchard J, 2005, PEDIATR BLOOD CANCER, V44, P348, DOI 10.1002/pbc.20219; Seeger R C, 1988, Prog Clin Biol Res, V271, P41; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; Simon T, 2004, J CLIN ONCOL, V22, P3549, DOI 10.1200/JCO.2004.08.143; Spitz R, 2003, CLIN CANCER RES, V9, P52; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306	30	381	394	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2005	353	21					2243	2253		10.1056/NEJMoa052399	http://dx.doi.org/10.1056/NEJMoa052399			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	986FC	16306521				2022-12-01	WOS:000233434500007
J	De Tomaso, AW; Nyholm, SV; Palmeri, KJ; Ishizuka, KJ; Ludington, WB; Mitchel, K; Weissman, IL				De Tomaso, AW; Nyholm, SV; Palmeri, KJ; Ishizuka, KJ; Ludington, WB; Mitchel, K; Weissman, IL			Isolation and characterization of a protochordate histocompatibility locus	NATURE			English	Article							KILLER-CELL RECEPTORS; BOTRYLLUS-SCHLOSSERI; IMMUNOGLOBULIN SUPERFAMILY; GERM CELLS; RECOGNITION; EVOLUTION; ALLORECOGNITION; UROCHORDATE; PROTEINS; LIGANDS	Histocompatibility - the ability of an organism to distinguish its own cells and tissue from those of another - is a universal phenomenon in the Metazoa. In vertebrates, histocompatibility is a function of the immune system controlled by a highly polymorphic major histocompatibility complex (MHC), which encodes proteins that target foreign molecules for immune cell recognition. The association of the MHC and immune function suggests an evolutionary relationship between metazoan histocompatibility and the origins of vertebrate immunity. However, the MHC of vertebrates is the only functionally characterized histocompatibility system; the mechanisms underlying this process in non-vertebrates are unknown. A primitive chordate, the ascidian Botryllus schlosseri, also undergoes a histocompatibility reaction controlled by a highly polymorphic locus. Here we describe the isolation of a candidate gene encoding an immunoglobulin superfamily member that, by itself, predicts the outcome of histocompatibility reactions. This is the first non-vertebrate histocompatibility gene described, and may provide insights into the evolution of vertebrate adaptive immunity.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA; Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA	Stanford University; Stanford University; Stanford University	De Tomaso, AW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	tdet@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041588] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BOYD HC, 1986, BIOL BULL, V170, P91, DOI 10.2307/1541383; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Buss L. W., 1987, EVOLUTION INDIVIDUAL; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Davidson B, 2002, DEVELOPMENT, V129, P4739; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Flajnik M.F., 2003, FUNDAMENTAL IMMUNOLO, V5th, P519; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Grosberg RK, 2000, SCIENCE, V289, P2111, DOI 10.1126/science.289.5487.2111; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; IZZARD CS, 1968, BIOL BULL, V135, P424; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	33	155	160	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					454	459		10.1038/nature04150	http://dx.doi.org/10.1038/nature04150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306984	Green Accepted			2022-12-01	WOS:000233458200040
J	Vukusic, P; Hooper, I				Vukusic, P; Hooper, I			Directionally controlled fluorescence emission in butterflies	SCIENCE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	p.vukusic@ex.ac.uk		Hooper, Ian/0000-0002-5736-8610	Biotechnology and Biological Sciences Research Council [JF16983] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Erchak AA, 2001, APPL PHYS LETT, V78, P563, DOI 10.1063/1.1342048; Kelber A, 2001, J EXP BIOL, V204, P2469; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Vos WL, 2001, MRS BULL, V26, P642, DOI 10.1557/mrs2001.160	5	122	128	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2005	310	5751					1151	1151		10.1126/science.1116612	http://dx.doi.org/10.1126/science.1116612			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293753				2022-12-01	WOS:000233437300036
J	Keogh, MC; Kurdistani, SK; Morris, SA; Ahn, SH; Podolny, V; Collins, SR; Schuldiner, M; Chin, KY; Punna, T; Thompson, NJ; Boone, C; Emili, A; Weissman, JS; Hughes, TR; Strahl, BD; Grunstein, M; Greenblatt, JF; Buratowski, S; Krogan, NJ				Keogh, MC; Kurdistani, SK; Morris, SA; Ahn, SH; Podolny, V; Collins, SR; Schuldiner, M; Chin, KY; Punna, T; Thompson, NJ; Boone, C; Emili, A; Weissman, JS; Hughes, TR; Strahl, BD; Grunstein, M; Greenblatt, JF; Buratowski, S; Krogan, NJ			Cotranscriptional Set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex	CELL			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTORS; CHROMATIN REMODELING COMPLEX; REGULATES H3 METHYLATION; H2A VARIANT HTZ1; SACCHAROMYCES-CEREVISIAE; DEACETYLASE COMPLEX; GENE-EXPRESSION; IN-VIVO; TARGETED RECRUITMENT	The yeast histone deacetylase Rpd3 can be recruited to promoters to repress transcription initiation. Biochemical, genetic, and gene-expression analyses show that Rpd3 exists in two distinct complexes. The smaller complex, Rpd3C(S), shares Sin3 and Ume1 with Rpd3C(L) but contains the unique subunits Rco1 and Eaf3. Rpd3C(S) mutants exhibit phenotypes remarkably similar to those of Set2, a histone methyltransferase associated with elongating RNA polymerase II. Chromatin immunoprecipitation and biochemical experiments indicate that the chromodomain of Eaf3 recruits Rpd3C(S) to nucleosomes methylated by Set2 on histone H3 lysine 36, leading to deacetylation of transcribed regions. This pathway apparently acts to negatively regulate transcription because deleting the genes for Set2 or Rpd3C(S) bypasses the requirement for the positive elongation factor Bur1/ Bur2.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; University of Toronto	Greenblatt, JF (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	jack.greenblatt@utoronto.ca; steveb@hms.harvard.edu	Strahl, Brian/C-7601-2012; Schuldiner, Maya/C-9488-2009	Strahl, Brian/0000-0002-4947-6259; Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840; Ahn, Seong-Hoon/0000-0002-9174-4966; Schuldiner, Maya/0000-0001-9947-115X; Kurdistani, Siavash/0000-0003-3295-3511				ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hochstrasser M, 1999, PHILOS T ROY SOC B, V354, P1513, DOI 10.1098/rstb.1999.0495; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; KEOGH MC, 2005, IN PRESS NATURE; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lennon JC, 1998, MOL CELL BIOL, V18, P5771, DOI 10.1128/MCB.18.10.5771; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moris G, 2003, NEUROLOGIA, V18, P723; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun ZW, 1999, GENETICS, V152, P921; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	84	600	619	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					593	605		10.1016/j.cell.2005.10.025	http://dx.doi.org/10.1016/j.cell.2005.10.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286008	Green Published, Bronze			2022-12-01	WOS:000233497400009
J	Scheffel, A; Gruska, M; Faivre, D; Linaroudis, A; Plitzko, JM; Schuler, D				Scheffel, A; Gruska, M; Faivre, D; Linaroudis, A; Plitzko, JM; Schuler, D			An acidic protein aligns magnetosomes along a filamentous structure in magnetotactic bacteria	NATURE			English	Article							MAGNETOSPIRILLUM; MAGNETITE; MEMBRANE; VESICLES; REVEALS; ICE	Magnetotactic bacteria are widespread aquatic microorganisms that use unique intracellular organelles to navigate along the Earth's magnetic field. These organelles, called magnetosomes, consist of membrane-enclosed magnetite crystals that are thought to help to direct bacterial swimming towards growth-favouring microoxic zones at the bottom of natural waters(1). Questions in the study of magnetosome formation include understanding the factors governing the size and redox-controlled synthesis of the nano-sized magnetosomes and their assembly into a regular chain in order to achieve the maximum possible magnetic moment, against the physical tendency of magnetosome agglomeration. A deeper understanding of these mechanisms is expected from studying the genes present in the identified chromosomal 'magnetosome island', for which the connection with magnetosome synthesis has become evident(2). Here we use gene deletion in Magnetospirillum gryphiswaldense to show that magnetosome alignment is coupled to the presence of the mamJ gene product. MamJ is an acidic protein associated with a novel filamentous structure, as revealed by fluorescence microscopy and cryoelectron tomography. We suggest a mechanism in which MamJ interacts with the magnetosome surface as well as with a cytoskeleton-like structure. According to our hypothesis, magnetosome architecture represents one of the highest structural levels achieved in prokaryotic cells.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Schuler, D (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	dschuele@mpi-bremen.de	faivre, damien/D-3713-2009; Plitzko, Juergen M/H-9576-2014	faivre, damien/0000-0001-6191-3389; Plitzko, Juergen M/0000-0002-6402-8315; Schuler, Dirk/0000-0002-2327-0762				Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1994, MICROSC RES TECHNIQ, V27, P389, DOI 10.1002/jemt.1070270505; BAZYLINSKI DA, 1995, ASM NEWS, V61, P337; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; Evans JS, 2003, CURR OPIN COLLOID IN, V8, P48, DOI 10.1016/S1359-0294(03)00009-8; Grimm R, 1996, ULTRAMICROSCOPY, V63, P169, DOI 10.1016/0304-3991(96)00035-6; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; KIRSCHVINK JL, 1982, EARTH PLANET SC LETT, V59, P388, DOI 10.1016/0012-821X(82)90140-6; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Philipse AP, 2002, LANGMUIR, V18, P9977, DOI 10.1021/la0205811; Sambrook JF., 2001, MOL CLONING LAB MANU; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; Schultheiss D, 2004, APPL ENVIRON MICROB, V70, P3624, DOI 10.1128/aem.70.6.3624-3631.2004; Schultheiss D, 2003, ARCH MICROBIOL, V179, P89, DOI 10.1007/s00203-002-0498-z; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; VALI H, 1991, IRON BIOMINERALS, P97	23	391	417	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					110	114		10.1038/nature04382	http://dx.doi.org/10.1038/nature04382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16299495				2022-12-01	WOS:000235685700050
J	Bhattacharyya, RP; Remenyi, A; Good, MC; Bashor, CJ; Falick, AM; Lim, WA				Bhattacharyya, RP; Remenyi, A; Good, MC; Bashor, CJ; Falick, AM; Lim, WA			The Ste5 scaffold allosterically modulates signaling output of the yeast mating pathway	SCIENCE			English	Article							PHEROMONE RESPONSE PATHWAY; MAP KINASE CASCADE; PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; FEEDBACK PHOSPHORYLATION; CATALYTIC SUBUNIT; DOCKING MOTIF; ACTIVATION; REGULATORS; FUS3	Scaffold proteins organize signaling proteins into pathways and are often viewed as passive assembly platforms. We found that the Ste5 scaffold has a more active role in the yeast mating pathway: A fragment of Ste5 allosterically activated autophosphorylation of the mitogen-activated protein kinase Fus3. The resulting form of Fus3 is partially active-it is phosphorylated on only one of two key residues in the activation loop. Unexpectedly, at a systems level, autoactivated Fus3 appears to have a negative regulatory rote, promoting Ste5 phosphorylation and a decrease in pathway transcriptional output. Thus, scaffolds not only direct basic pathway connectivity but can precisely tune quantitative pathway input-output properties.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	lim@cmp.ucsf.edu	Bhattacharyya, Roby/AAF-7670-2019; Remenyi, Attila/N-1345-2016; Good, Matthew C/GLS-0964-2022	Bhattacharyya, Roby/0000-0001-6955-5088; Remenyi, Attila/0000-0002-8345-1311; Good, Matthew/0000-0002-6367-1034				Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BHATTACHARYYA RP, UNPUB; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; CHOI KY, 1994, CELL, V78, P499; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Elion EA, 2001, J CELL SCI, V114, P3967; Errede B, 1996, PHILOS T ROY SOC B, V351, P143, DOI 10.1098/rstb.1996.0010; FERRELL JE, 2000, SCI STKE, pPE1; Flotho A, 2004, J BIOL CHEM, V279, P47391, DOI 10.1074/jbc.M405681200; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inouye C, 1997, GENETICS, V147, P479; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; PRINTEN JA, 1994, GENETICS, V138, P609; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	38	216	222	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2006	311	5762					822	826		10.1126/science.1120941	http://dx.doi.org/10.1126/science.1120941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012XT	16424299				2022-12-01	WOS:000235374900040
J	Krause, J; Dear, PH; Pollack, JL; Slatkin, M; Spriggs, H; Barnes, I; Lister, AM; Ebersberger, I; Paabo, S; Hofreiter, M				Krause, J; Dear, PH; Pollack, JL; Slatkin, M; Spriggs, H; Barnes, I; Lister, AM; Ebersberger, I; Paabo, S; Hofreiter, M			Multiplex amplification of the mammoth mitochondrial genome and the evolution of Elephantidae	NATURE			English	Article							DNA-SEQUENCES; PHYLOGENETIC INFERENCE; CYTOCHROME-B; ANCIENT DNA; CLOCK	In studying the genomes of extinct species, two principal limitations are typically the small quantities of endogenous ancient DNA and its degraded condition(1), even though products of up to 1,600 base pairs ( bp) have been amplified in rare cases(2). Using small overlapping polymerase chain reaction products, longer stretches of sequences or even whole mitochondrial genomes(3,4) can be reconstructed, but this approach is limited by the number of amplifications that can be performed from rare samples. Thus, even from well-studied Pleistocene species such as mammoths, ground sloths and cave bears, no DNA sequences of more than about 1,000 bp have been reconstructed(5-7). Here we report the complete mitochondrial genome sequence of the Pleistocene woolly mammoth Mammuthus primigenius. We used about 200 mg of bone and a new approach that allows the simultaneous retrieval of multiple sequences from small amounts of degraded DNA. Our phylogenetic analyses show that the mammoth was more closely related to the Asian than to the African elephant. However, the divergence of mammoth, African and Asian elephants occurred over a short time, corresponding to only about 7% of the total length of the phylogenetic tree for the three evolutionary lineages.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; UCL, Dept Biol, London WC1E 6BT, England; Univ Dusseldorf, WE Informat, D-40225 Dusseldorf, Germany	Max Planck Society; MRC Laboratory Molecular Biology; University of California System; University of California Berkeley; University of London; University College London; Heinrich Heine University Dusseldorf	Hofreiter, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.	hofreiter@eva.mpg.de	Barnes, Ian C/B-8081-2008; Krause, Johannes/AFP-2642-2022; Dear, Paul H/A-1162-2012; Krause, Johannes/E-6640-2015; Hofreiter, Michael/A-3996-2017	Barnes, Ian C/0000-0001-8322-6918; Krause, Johannes/0000-0001-9144-3920; Krause, Johannes/0000-0001-5475-4690; Lister, Adrian/0000-0002-7985-138X; Hofreiter, Michael/0000-0003-0441-4705	MRC [MC_U105131672] Funding Source: UKRI; Medical Research Council [MC_U105131672] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Debruyne R, 2003, MOL PHYLOGENET EVOL, V26, P421, DOI 10.1016/S1055-7903(02)00292-0; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Felsenstein J., 2004, INFERRING PHYLOGENIE, P196; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Haddrath O, 2001, P ROY SOC B-BIOL SCI, V268, P939, DOI 10.1098/rspb.2001.1587; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Nei M., 1986, Progress in Clinical and Biological Research, V218, P133; Noro M, 1998, J MOL EVOL, V46, P314, DOI 10.1007/PL00006308; Ozawa T, 1997, J MOL EVOL, V44, P406, DOI 10.1007/PL00006160; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1993, GENETICS, V135, P599; TAJIMA F, 1983, GENETICS, V105, P437; Tassy Pascal, 2003, P331; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Yang H, 1996, P NATL ACAD SCI USA, V93, P1190, DOI 10.1073/pnas.93.3.1190	29	161	185	2	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					724	727		10.1038/nature04432	http://dx.doi.org/10.1038/nature04432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16362058				2022-12-01	WOS:000235193100044
J	Li, XT; Lonard, DM; Jung, SY; Malovannaya, A; Feng, G; Qin, J; Tsai, SY; Tsai, MJ; O'Malley, BW				Li, XT; Lonard, DM; Jung, SY; Malovannaya, A; Feng, G; Qin, J; Tsai, SY; Tsai, MJ; O'Malley, BW			The SRC-3/AIB1 coactivator is degraded 14 in a ubiquitin- and ATP-independent manner by the REG gamma proteasome	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; STEROID-RECEPTOR; NUCLEAR RECEPTORS; GENE-EXPRESSION; ACTIVATOR PA28; MICE LACKING; AIB1; GROWTH; IDENTIFICATION	Steroid receptor coactivator-3 (SRC-3/AIB1) is an oncogene frequently amplified and overexpressed in breast cancers. Here we report that SRC-3 interacts with REG gamma, a proteasome activator known to stimulate the trypsin-like activity of the 20S proteasome. RNAi knockdown and gain-of-function experiments suggest that REG gamma promotes SRC-3 protein degradation. Cellular levels of REG gamma expression affect estrogen-receptor target-gene expression and cell growth as a result of its ability to promote degradation of the SRC-3 protein. In vitro proteasome proteolysis assays using purified REGy, SRC-3, and the 20S proteasome reinforce these conclusions and demonstrate that REG gamma promotes the degradation of SRC-3 in a ubiquitin- and ATP-independent manner. This work demonstrates the first example of a physiologically relevant endogenous cellular target for the REG gamma-proteasome complex. It also highlights the fact that an alternative mode of proteasome-mediated protein degradation, independent of the 19S proteasome regulatory cap, targets the SRC-3 protein for degradation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Chongqing Univ Med Sci, Affiliated Hosp 1, Chongqing 400016, Peoples R China	Baylor College of Medicine; Chongqing Medical University	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	Qin, Jun/A-1148-2010	Jung, Sung Yun/0000-0003-1521-7977	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK063802] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK063802-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Bouras T, 2001, CANCER RES, V61, P903; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; JUGN SY, 2005, J MOL ENDOCRINOL, V19, P2451; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lonard DM, 2004, MOL CELL BIOL, V24, P14, DOI 10.1128/MCB.24.1.14-24.2004; MA CP, 1992, J BIOL CHEM, V267, P10515; Masson P, 2001, J BIOL CHEM, V276, P1383, DOI 10.1074/jbc.M007379200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Murphy LC, 2000, CANCER RES, V60, P6266; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; ONATE SA, 1995, SCIENCE, V270, P1354; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wojcik C, 1998, EUR J CELL BIOL, V77, P151, DOI 10.1016/S0171-9335(98)80083-6; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yan F, 2003, MOL ENDOCRINOL, V17, P1315, DOI 10.1210/me.2002-0209; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003	44	209	228	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 27	2006	124	2					381	392		10.1016/j.cell.2005.11.037	http://dx.doi.org/10.1016/j.cell.2005.11.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439211	Bronze			2022-12-01	WOS:000235068500025
J	Solit, DB; Garraway, LA; Pratilas, CA; Sawai, A; Getz, G; Basso, A; Ye, Q; Lobo, JM; She, YH; Osman, I; Golub, TR; Sebolt-Leopold, J; Sellers, WR; Rosen, N				Solit, DB; Garraway, LA; Pratilas, CA; Sawai, A; Getz, G; Basso, A; Ye, Q; Lobo, JM; She, YH; Osman, I; Golub, TR; Sebolt-Leopold, J; Sellers, WR; Rosen, N			BRAF mutation predicts sensitivity to MEK inhibition	NATURE			English	Article							CYCLIN D1; PROTEIN-KINASE; RAS MUTATIONS; IN-VIVO; MELANOMA; CANCER; EXPRESSION; PATHWAY; GENE; PROTEOLYSIS	The kinase pathway comprising RAS, RAF, mitogen-activated protein kinase kinase (MEK) and extracellular signal regulated kinase (ERK) is activated in most human tumours, often through gain-of-function mutations of RAS and RAF family members(1). Using small-molecule inhibitors of MEK and an integrated genetic and pharmacologic analysis, we find that mutation of BRAF is associated with enhanced and selective sensitivity to MEK inhibition when compared to either 'wild-type' cells or cells harbouring a RAS mutation. This MEK dependency was observed in BRAF mutant cells regardless of tissue lineage, and correlated with both downregulation of cyclin D1 protein expression and the induction of G1 arrest. Pharmacological MEK inhibition completely abrogated tumour growth in BRAF mutant xenografts, whereas RAS mutant tumours were only partially inhibited. These data suggest an exquisite dependency on MEK activity in BRAF mutant tumours, and offer a rational therapeutic strategy for this genetically defined tumour subtype.	Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; NYU Med Ctr, Dept Med, New York, NY 10016 USA; NYU Med Ctr, Dept Urol, New York, NY 10016 USA; Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); New York University; New York University; Pfizer	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	rosenn@mskcc.org	Solit, David B./AAC-5309-2019; Rosen, Neal/ABF-2677-2020		NCI NIH HHS [P01 CA094060, P01 CA094060-01A1, T32 CA009172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA094060, T32CA009172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Brose MS, 2002, CANCER RES, V62, P6997; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dombrowski A, 1999, J ANTIBIOT, V52, P1077, DOI 10.7164/antibiotics.52.1077; FILMUS J, 1994, ONCOGENE, V9, P3627; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gorden A, 2003, CANCER RES, V63, P3955; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Zhao A, 1999, J ANTIBIOT, V52, P1086, DOI 10.7164/antibiotics.52.1086	28	1066	1115	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					358	362		10.1038/nature04304	http://dx.doi.org/10.1038/nature04304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16273091	Green Accepted			2022-12-01	WOS:000234682100050
J	MacRae, IJ; Zhou, KH; Li, F; Repic, A; Brooks, AN; Cande, WZ; Adams, PD; Doudna, JA				MacRae, IJ; Zhou, KH; Li, F; Repic, A; Brooks, AN; Cande, WZ; Adams, PD; Doudna, JA			Structural basis for double-stranded RNA processing by dicer	SCIENCE			English	Article							COLI RIBONUCLEASE-III; CRYSTAL-STRUCTURE; INTERFERENCE; INITIATION; BINDING; MECHANISM; SUBSTRATE; MICRORNA; DOMAIN; IONS	The specialized ribonuclease Dicer initiates RNA interference by cleaving double-stranded RNA (dsRNA) substrates into small fragments about 25 nucleotides in length. In the crystal structure of an intact Dicer enzyme, the PAZ domain, a module that binds the end of dsRNA, is separated from the two catalytic ribonuclease III (RNase III) domains by a flat, positively charged surface. The 65 angstrom distance between the PAZ and RNase III domains matches the length spanned by 25 base pairs of RNA. Thus, Dicer itself is a molecular ruler that recognizes dsRNA and cleaves a specified distance from the helical end.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Brooks, Angela/B-6173-2011; Adams, Paul David/A-1977-2013	Adams, Paul David/0000-0001-9333-8219; Li, Fei/0000-0002-1206-9684				AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Akey DL, 2005, PROTEIN SCI, V14, P2744, DOI 10.1110/ps.051665905; Baulcombe D, 2002, TRENDS MICROBIOL, V10, P306, DOI 10.1016/S0966-842X(02)02387-9; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chang JH, 2003, J VIROL, V77, P11910, DOI 10.1128/JVI.77.22.11910-11917.2003; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MACRAE IJ, UNPUB; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; REPIC A, UNPUB; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Sun W, 2005, NUCLEIC ACIDS RES, V33, P807, DOI 10.1093/nar/gki197; Sun WM, 2001, BIOCHEMISTRY-US, V40, P14976, DOI 10.1021/bi011570u; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Zamore PD, 2001, MOL CELL, V8, P1158, DOI 10.1016/S1097-2765(01)00418-X; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	38	656	731	4	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					195	198		10.1126/science.1121638	http://dx.doi.org/10.1126/science.1121638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410517				2022-12-01	WOS:000234722200032
J	Meyer, P; Saez, L; Young, MW				Meyer, P; Saez, L; Young, MW			PER-TIM interactions in living Drosophila cells: An interval timer for the circadian clock	SCIENCE			English	Article							TIMELESS PROTEIN; NUCLEAR ENTRY; MELANOGASTER; TRANSCRIPTION; DOUBLETIME; GENETICS; KINASES; LOOP	In contrast to current models, fluorescence resonance energy transfer measurements using a single-cell imaging assay with fluorescent forms of PER and TIM showed that these proteins bind rapidly and persist in the cytoplasm while gradually accumulating in discrete foci. After similar to 6 hours, complexes abruptly dissociated, as PER and TIM independently moved to the nucleus in a narrow time frame. The per(L) mutation delayed nuclear accumulation in vivo and in our cultured cell system, but without affecting rates of PER/TIM assembly or dissociation. This finding points to a previously unrecognized form of temporal regulation that underlies the periodicity of the circadian clock.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIGMS NIH HHS [GM54339] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chang DC, 2003, CURR BIOL, V13, P758, DOI 10.1016/S0960-9822(03)00286-0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 2004, DEV CELL, V6, P160, DOI 10.1016/S1534-5807(04)00030-9; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Hall JC, 2005, METHOD ENZYMOL, V393, P61, DOI 10.1016/S0076-6879(05)93004-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	22	133	138	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					226	229		10.1126/science.1118126	http://dx.doi.org/10.1126/science.1118126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410523				2022-12-01	WOS:000234722200041
J	Szabadics, J; Varga, C; Molnar, G; Olah, S; Barzo, P; Tamas, G				Szabadics, J; Varga, C; Molnar, G; Olah, S; Barzo, P; Tamas, G			Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits	SCIENCE			English	Article							ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; IN-VIVO; CORTEX; GABA; HIPPOCAMPUS; RESPONSES; RAT; INTERNEURONS; INHIBITION	Axons in the cerebral cortex receive synaptic input at the axon initial segment almost exclusively from gamma-aminobutyric acid-releasing (GABAergic) axo-axonic cells (AACs). The axon has the lowest threshold for action potential generation in neurons; thus, AACs are considered to be strategically placed inhibitory neurons controlling neuronal output. However, we found that AACs can depolarize pyramidal cells and can initiate stereotyped series of synaptic events in rat and human cortical networks because of a depolarized reversal potential for axonal relative to perisomatic GABAergic inputs. Excitation and signal propagation initiated by AACs is supported by the absence of the potassium chloride cotransporter 2 in the axon.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Univ Szeged, Dept Neurosurg, H-6726 Szeged, Hungary	Szeged University; Szeged University	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozep Fasor 52, H-6726 Szeged, Hungary.	gtamas@bio.u-szeged.hu	Molnar, Gabor/L-8415-2018; Tamas, Gabor/AAG-9305-2020	Molnar, Gabor/0000-0001-7959-139X; Tamas, Gabor/0000-0002-7905-6001; Varga, Csaba/0000-0002-9188-1282; Szabadics, Janos/0000-0002-4968-2562	PHS HHS [N535915] Funding Source: Medline; Wellcome Trust Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Abeles M., 1991, CORTICONICS; ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; Chavas J, 2003, J NEUROSCI, V23, P2019; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gulacsi A, 2003, J NEUROSCI, V23, P8237; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	28	415	421	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					233	235		10.1126/science.1121325	http://dx.doi.org/10.1126/science.1121325			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16410524				2022-12-01	WOS:000234722200043
J	Netuveli, G; Wiggins, RD; Hildon, Z; Montgomery, SM; Blane, D				Netuveli, G; Wiggins, RD; Hildon, Z; Montgomery, SM; Blane, D			Functional limitation in long standing illness and quality of life: evidence from a national survey	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England; Karolinska Inst, Karolinska Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; City Univ London, Dept Sociol, London EC1V OHB, England	Imperial College London; Karolinska Institutet; Karolinska University Hospital; City University London	Netuveli, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England.	g.netuveli@ic.ac.uk	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494	Economic and Social Research Council [RES-544-28-5001, RES-337-25-0001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Department of Health, 2002, NAT SERV FRAM OLD PE; Leplege A, 1997, JAMA-J AM MED ASSOC, V278, P47, DOI 10.1001/jama.278.1.47; Marmot M., 2003, HLTH WEALTH LIFESTYL; Steffick DE., 2000, DOCUMENTATION AFFECT; Wiggins RD, 2004, AGEING SOC, V24, P693, DOI 10.1017/S0144686X04002284	5	34	34	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1382	+		10.1136/bmj.331.7529.1382	http://dx.doi.org/10.1136/bmj.331.7529.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339249	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000233999300022
J	Tegmark, M; Bostrom, N				Tegmark, M; Bostrom, N			Is a doomsday catastrophe likely?	NATURE			English	Editorial Material									MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Oxford, Fac Philosophy, Future Human Inst, Oxford OX1 4JJ, England	Massachusetts Institute of Technology (MIT); University of Oxford	Tegmark, M (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	tegmark@mit.edu						Bostrom N., 2002, ANTHROPIC BIAS OBSER; Carter B., 1974, IAU Symposium no.63 on Confrontation of Cosmological Theories with Observational Data, P291; Dar A, 1999, PHYS LETT B, V470, P142, DOI 10.1016/S0370-2693(99)01307-6; HUT P, 1983, NATURE, V302, P508, DOI 10.1038/302508a0; Jaffe RL, 2000, REV MOD PHYS, V72, P1125, DOI 10.1103/RevModPhys.72.1125; Lineweaver CH, 2004, SCIENCE, V303, P59, DOI 10.1126/science.1092322	6	18	18	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					754	754		10.1038/438754a	http://dx.doi.org/10.1038/438754a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341005				2022-12-01	WOS:000233777800031
J	Fazi, F; Rosa, A; Fatica, A; Gelmetti, V; De Marchis, ML; Nervi, C; Bozzoni, I				Fazi, F; Rosa, A; Fatica, A; Gelmetti, V; De Marchis, ML; Nervi, C; Bozzoni, I			A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBP alpha regulates human granulopoiesis	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-ALPHA; RETINOIC ACID; GRANULOCYTIC DIFFERENTIATION; IN-VITRO; RAR-ALPHA; GENE; EXPRESSION; PROMOTER; EPSILON	MicroRNAs play important roles in cell differentiation by acting as translational inhibitors of specific target genes. Here we show that human granulocytic differentiation is controlled by a regulatory circuitry involving miR-223 and two transcriptional factors, NFI-A and C/EBP alpha. The two factors compete for binding to the miR-223 promoter: NFI-A maintains miR-223 at low levels, whereas its replacement by C/EBP alpha, following retinoic acid (RA)-induced differentiation, upregulates miR-223 expression. The competition by C/EBP alpha and the granulocytic differentiation are favored by a negative-feedback loop in which miR-223 represses NFI-A translation. In line with this, both RNAi against NFI-A and ectopic expression of miR-223 in acute promyelocytic leukemia (APL) cells enhance differentiation, whereas miR-223 knockdown inhibits the differentiation response to RA. Altogether, our data indicate that miR-223 plays a crucial role during granulopoiesis and point to the NFI-A repression as an important molecular pathway mediating gene reprogramming in this cell lineage.	Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00128 Rome, Italy; Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy; Univ Roma La Sapienza, IBPM, I-00185 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Nervi, C (corresponding author), Univ Roma La Sapienza, Dept Histol & Med Embryol, Via Castel Romano 100, I-00128 Rome, Italy.	clara.nervi@uniroma1.it; irene.bozzoni@uniroma1.it	Fatica, Alessandro/L-2866-2019; Fazi, Francesco/K-5304-2018; Alessandro, Rosa/A-3860-2012; De Marchis, Maria Laura/O-6315-2019; De Marchis, Maria Laura/J-8803-2016	Fazi, Francesco/0000-0003-2910-7912; Alessandro, Rosa/0000-0001-9999-7223; De Marchis, Maria Laura/0000-0002-3720-6550; De Marchis, Maria Laura/0000-0002-3720-6550; NERVI, Clara/0000-0001-9341-0188; Fatica, Alessandro/0000-0002-0743-7905; bozzoni, irene/0000-0002-3485-8537				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bachurski CJ, 1997, J BIOL CHEM, V272, P32759, DOI 10.1074/jbc.272.52.32759; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamin D, 1996, J IMMUNOL, V156, P1626; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; GARLATTI M, 1993, J BIOL CHEM, V268, P6567; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Khanna-Gupta A, 2001, P NATL ACAD SCI USA, V98, P8000, DOI 10.1073/pnas.141229598; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LANOTTE M, 1991, BLOOD, V77, P1080; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lo Coco F, 2002, CANCER RES, V62, P5618; LOCOCO F, 1992, LANCET, V340, P1437, DOI 10.1016/0140-6736(92)92625-P; Lodie TA, 1999, BLOOD, V94, p692A; Mandelli F, 1997, BLOOD, V90, P1014; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tenen DG, 2001, LEUKEMIA, V15, P688, DOI 10.1038/sj.leu.2402088; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571	43	789	863	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					819	831		10.1016/j.cell.2005.09.023	http://dx.doi.org/10.1016/j.cell.2005.09.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325577	Bronze			2022-12-01	WOS:000233814100016
J	Armstrong, N; Welsman, J				Armstrong, N; Welsman, J			Essay - Physiology of the child athlete	LANCET			English	Article									Univ Exeter, Childrens Hlth & Exercise Res Ctr, Exeter EX1 2LU, Devon, England	University of Exeter	Armstrong, N (corresponding author), Univ Exeter, Childrens Hlth & Exercise Res Ctr, Exeter EX1 2LU, Devon, England.	N.Armstrong@exeter.ac.uk						Armstrong N, 2000, PAEDIAT EXERCISE SCI; Armstrong N, 1997, YOUNG PEOPLE PHYS AC; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003	3	11	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S44	S45		10.1016/S0140-6736(05)67845-2	http://dx.doi.org/10.1016/S0140-6736(05)67845-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360750				2022-12-01	WOS:000234374400028
J	Ptacek, J; Devgan, G; Michaud, G; Zhu, H; Zhu, XW; Fasolo, J; Guo, H; Jona, G; Breitkreutz, A; Sopko, R; McCartney, RR; Schmidt, MC; Rachidi, N; Lee, SJ; Mah, AS; Meng, L; Stark, MJR; Stern, DF; De Virgilio, C; Tyers, M; Andrews, B; Gerstein, M; Schweitzer, B; Predki, PF; Snyder, M				Ptacek, J; Devgan, G; Michaud, G; Zhu, H; Zhu, XW; Fasolo, J; Guo, H; Jona, G; Breitkreutz, A; Sopko, R; McCartney, RR; Schmidt, MC; Rachidi, N; Lee, SJ; Mah, AS; Meng, L; Stark, MJR; Stern, DF; De Virgilio, C; Tyers, M; Andrews, B; Gerstein, M; Schweitzer, B; Predki, PF; Snyder, M			Global analysis of protein phosphorylation in yeast	NATURE			English	Article							DATABASE; GENOME	Protein phosphorylation is estimated to affect 30% of the proteome and is a major regulatory mechanism that controls many basic cellular processes(1-3). Until recently, our biochemical understanding of protein phosphorylation on a global scale has been extremely limited; only one half of the yeast kinases have known in vivo substrates and the phosphorylating kinase is known for less than 160 phosphoproteins. Here we describe, with the use of proteome chip technology(4), the in vitro substrates recognized by most yeast protein kinases(5): we identified over 4,000 phosphorylation events involving 1,325 different proteins. These substrates represent a broad spectrum of different biochemical functions and cellular roles. Distinct sets of substrates were recognized by each protein kinase, including closely related kinases of the protein kinase A family and four cyclin- dependent kinases that vary only in their cyclin subunits. Although many substrates reside in the same cellular compartment or belong to the same functional category as their phosphorylating kinase, many others do not, indicating possible new roles for several kinases. Furthermore, integration of the phosphorylation results with protein - protein interaction(6-10) and transcription factor binding data(11,12) revealed novel regulatory modules. Our phosphorylation results have been assembled into a first- generation phosphorylation map for yeast. Because many yeast proteins and pathways are conserved, these results will provide insights into the mechanisms and roles of protein phosphorylation in many eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Invitrogen Corp, Carlsbad, CA 92008 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Univ Dundee, Sch Life Sci, Divb Gene Regulat & Express, Dundee DD1 5EH, Scotland; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Geneva, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M55 1A8, Canada	Yale University; Yale University; Thermo Fisher Scientific; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Dundee; Yale University; California Institute of Technology; University of Geneva; University of Toronto	Snyder, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	michael.snyder@yale.edu	Yang, Chen/G-1379-2010; Stark, Michael J. R./B-2815-2014; De Virgilio, Claudio/B-4707-2012; Tyers, Michael/ABE-3194-2021	Stark, Michael J. R./0000-0001-9086-191X; Jona, Ghil/0000-0002-4526-6182; Rachidi, Najma/0000-0002-1247-7768; De Virgilio, Claudio/0000-0001-8826-4323; Zhu, Xiaowei/0000-0002-5731-3177; Snyder, Michael/0000-0003-0784-7987	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; BREITKREUTZ BJ, 2003, GENOME BIOL, V4; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Pan XW, 1999, MOL CELL BIOL, V19, P4874; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	27	762	795	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					679	684		10.1038/nature04187	http://dx.doi.org/10.1038/nature04187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319894				2022-12-01	WOS:000233593100053
J	Severe, P; Leger, P; Charles, M; Noel, F; Bonhomme, G; Bois, G; George, E; Kenel-Pierre, S; Wright, PF; Gulick, R; Johnson, WD; Pape, JW; Fitzgerald, DW				Severe, P; Leger, P; Charles, M; Noel, F; Bonhomme, G; Bois, G; George, E; Kenel-Pierre, S; Wright, PF; Gulick, R; Johnson, WD; Pape, JW; Fitzgerald, DW			Antiretroviral therapy in a thousand patients with AIDS in Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; COMBINATION THERAPY; RANDOMIZED-TRIAL; NATURAL-HISTORY; HIV TREATMENT; EXPERIENCE; EFAVIRENZ; MORTALITY; INDINAVIR	Background: The one-year survival rate of adults and children with the acquired immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 percent in Haiti. Antiretroviral therapy has recently become available in Haiti and in other developing countries. Data on the efficacy of antiretroviral therapy in developing countries are limited. High rates of coinfection with tropical diseases and tuberculosis, along with malnutrition and limited laboratory monitoring of therapy, may decrease the efficacy of antiretroviral therapy in these countries. Methods: We studied the efficacy of antiretroviral therapy in the first 1004 consecutive patients with AIDS and without previous antiretroviral therapy who were treated beginning in March 2003 in Port-au-Prince, Haiti. Results: During a 14-month period, three-drug antiretroviral therapy was initiated in 1004 patients, including 94 children under 13 years of age. At enrollment, the median CD4 T-cell count in adults and adolescents was 131 per cubic millimeter (interquartile range, 55 to 211 per cubic millimeter); in children, a median of 13 percent of T cells were CD4-positive (interquartile range, 8 to 20 percent). According to a Kaplan-Meier survival analysis, 87 percent of adults and adolescents and 98 percent of children were alive one year after beginning treatment. In a subgroup of 100 adult and adolescent patients who were followed for 48 to 56 weeks, 76 patients had fewer than 400 copies of human immunodeficiency virus RNA per milliliter. In adults and adolescents, the median increase in the CD4 T-cell count from baseline to 12 months was 163 per cubic millimeter (interquartile range, 77 to 251 per cubic millimeter). In children, the median percentage of CD4 T cells rose from 13 percent at baseline to 26 percent (interquartile range, 22 to 36 percent) at 12 months. Treatment-limiting toxic effects occurred in 102 of the 910 adults and adolescents (11 percent) and 5 of the 94 children (5 percent). Conclusions: This report documents the feasibility of effective antiretroviral therapy in a large number of patients in an impoverished country. Overall, the outcomes are similar to those in the United States. These results provide evidence in support of international efforts to make antiretroviral therapy available to patients with AIDS in developing countries.	Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA; Grp Haitien Etud Sarcome Kaposi & Infect Opportun, Port Au Prince, Haiti; Vanderbilt Univ, Div Pediat Infect Dis, Nashville, TN USA	Cornell University; Vanderbilt University	Fitzgerald, DW (corresponding author), Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Room A-421,1300 York Ave, New York, NY 10021 USA.	dfitzgerald@gheskio.org		Kenel-Pierre, Stefan/0000-0003-0011-8511	FIC NIH HHS [TW006901, TW006896, TW00018, TW00002] Funding Source: Medline; NIAID NIH HHS [AI64021, AI58257, AI 07613, AI38858, AI51966] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [U2RTW006896, U2RTW006901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058257, K24AI051966, U01AI038858, R21AI064021] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adje-Toure C, 2003, AIDS, V17, pS23, DOI 10.1097/00002030-200317003-00004; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; BARTLETT JA, 2005, 12 C RETR OPP INF BO; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fawzi W, 2005, J NUTR, V135, P938, DOI 10.1093/jn/135.4.938; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Haas DW, 2004, AIDS, V18, P2391; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hofer CB, 2004, JAIDS-J ACQ IMM DEF, V36, P967, DOI 10.1097/00126334-200408010-00011; *I HAIT ENF CTR GH, 2001, ET SER METH SENT PRE; *I MED, 2005, SCAL TREATM GLOB AID, P75; Jean SS, 1999, PEDIATR INFECT DIS J, V18, P58, DOI 10.1097/00006454-199901000-00014; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Lucas GM, 2003, JAIDS-J ACQ IMM DEF, V33, P321, DOI 10.1097/00126334-200307010-00005; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Mouton Y, 1997, AIDS, V11, pF101, DOI 10.1097/00002030-199712000-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN CLIN PRACT TR, 2005, GUID US ANT AG HIV I; PAPE J, 1993, CLIN INFECT DIS, V17, pS341, DOI 10.1093/clinids/17.Supplement_2.S341; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; SCHNEIDER M, NATURAL HIST MORTALI; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WORLD BANK, HAIT AT GLANC; World Bank, EC GROWTH GLOSS; World Health Organization, 2004, SCAL ANT THER RES LT; 2005, MMWR MORB MORTAL WKL, V53, P1203; 1994, WKLY EPIDEMIOL REC, V37, P273	35	205	209	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2005	353	22					2325	2334		10.1056/NEJMoa051908	http://dx.doi.org/10.1056/NEJMoa051908			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988EO	16319381	Bronze			2022-12-01	WOS:000233574600004
J	van Mechelen, W; Verhagen, E				van Mechelen, W; Verhagen, E			Essay - Injury prevention in young people - time to accept responsibility	LANCET			English	Article									VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Dept Publ & Occupat Hlth, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Mechelen, W (corresponding author), VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	w.vanmechelen@vumc.nl	van Mechelen, Willem/C-8463-2013; Verhagen, Evert/A-1502-2013	Verhagen, Evert/0000-0001-9227-8234; van Mechelen, Willem/0000-0001-7136-6382					0	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S46	S46		10.1016/S0140-6736(05)67846-4	http://dx.doi.org/10.1016/S0140-6736(05)67846-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360751				2022-12-01	WOS:000234374400029
J	Zinsstag, J; Schelling, E; Wyss, K; Mahamat, MB				Zinsstag, J; Schelling, E; Wyss, K; Mahamat, MB			Potential of cooperation between human and animal health to strengthen health systems	LANCET			English	Editorial Material							Q-FEVER; BRUCELLOSIS; LIVESTOCK; INFLUENZA; MEDICINE; DISEASE		Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; Swiss Trop Inst, Swiss Ctr Int Hlth, CH-4002 Basel, Switzerland; Ctr Support Sante Int, NDjamena, Chad	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Zinsstag, J (corresponding author), Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland.	jakob.zinsstag@unibas.ch	Schelling, Esther/K-7990-2015; Zinsstag, Jakob/A-8317-2008	Schelling, Esther/0000-0001-6444-0898; Zinsstag, Jakob/0000-0002-8899-6097; Wyss, Kaspar/0000-0003-0156-5989				*AFR UN INT BUR AF, 2003, COMM BAS AN HLTH WOR; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2004, STRENGTHENING HLTH S; [Anonymous], [No title captured]; Bechir M, 2004, Med Trop (Mars), V64, P497; Bertollini R, 2004, B WORLD HEALTH ORGAN, V82, P322; Braine T, 2005, B WORLD HEALTH ORGAN, V83, P7; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Digoutte JP, 1999, B SOC PATHOL EXOT, V92, P343; DRIESCH A, 2003, GESCH TIERMEDIZIN; Karesh WB, 2005, FOREIGN AFF, V84, P38, DOI 10.2307/20034419; Karesh WB, 2002, CONSERV BIOL, V16, P1432, DOI 10.1046/j.1523-1739.2002.01443.x; Klempner MS, 2004, NEW ENGL J MED, V350, P1171, DOI 10.1056/NEJMp048039; Lebel J., 2002, HLTH ECOSYSTEM APPRO; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; *NAT LIB MED, FIND AID CW SCHWAB P; Osofsky S. A., 2005, CONSERVATION DEV INT; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Ruegg W, 2004, HIST U EUROPE; Saunders LZ, 2000, VET PATHOL, V37, P199, DOI 10.1354/vp.37-3-199; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Schwabe CW., 1984, VET MED HUMAN HLTH, V3rd; SILKIN T, 2005, VET SERVICES HORN AF; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Tan-Torres ET, 2003, MAKING CHOICES HLTH; Tanner M, 2005, B WORLD HEALTH ORGAN, V83, P403; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Weiss M.G., 2001, ANTHROPOL MED, V8, P5, DOI [10.1080/13648470120070980, DOI 10.1080/13648470120070980]; *WHO, MIN SUMM HLTH RES; *WHO REG OFF EUR, EC INF DIS; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017; Zinsstag J, 2001, SCIENCE, V294, P477, DOI 10.1126/science.294.5542.477; 1994, LIVING UNCERTAINTY N; WORLD REPORT KNOWLED	37	169	176	1	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC-JAN	2005	366	9503					2142	2145		10.1016/S0140-6736(05)67731-8	http://dx.doi.org/10.1016/S0140-6736(05)67731-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996AE	16360795				2022-12-01	WOS:000234146000033
J	Baum, DA; Smith, SD; Donovan, SSS				Baum, DA; Smith, SD; Donovan, SSS			Evolution - The tree-thinking challenge	SCIENCE			English	Editorial Material							SCIENCE		Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; Univ Pittsburgh, Dept Instruct & Learning, Pittsburgh, PA 15260 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baum, DA (corresponding author), Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA.	dbaum@wisc.edu; sdsmith4@wisc.edu; sdonovan@pitt.edu	Baum, David/D-6804-2015	Baum, David/0000-0001-8334-6311; Donovan, Sam/0000-0003-4021-9878				Cracraft J., 2004, ASSEMBLING TREE LIFE; Crandall KA, 1999, EVOLUTION OF HIV, P153; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; DAWKINS R, 2004, ANCESTORS TALE PILMG; Gilbert SF, 2003, NAT REV GENET, V4, P735, DOI 10.1038/nrg1159; Goldsmith DW, 2003, AM BIOL TEACH, V65, P679, DOI 10.1662/0002-7685(2003)065[0679:TGCR]2.0.CO;2; HERRON J, 2005, EVOBEAKER 1 0; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Nee S, 2005, NATURE, V435, P429, DOI 10.1038/435429a; O'Hara RJ, 1997, ZOOL SCR, V26, P323, DOI 10.1111/j.1463-6409.1997.tb00422.x; OHARA RJ, 1988, SYST ZOOL, V37, P142, DOI 10.2307/2992272; PENNY D, 1982, NATURE, V297, P197, DOI 10.1038/297197a0; Rudolph JL, 1998, J RES SCI TEACH, V35, P1069, DOI 10.1002/(SICI)1098-2736(199812)35:10<1069::AID-TEA2>3.0.CO;2-A; Sober E, 2002, J THEOR BIOL, V218, P395, DOI 10.1006/jtbi.2002.3086	14	156	159	2	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					979	980		10.1126/science.1117727	http://dx.doi.org/10.1126/science.1117727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284166				2022-12-01	WOS:000233343400029
J	Bloodgood, BL; Sabatini, BL				Bloodgood, BL; Sabatini, BL			Neuronal activity regulates diffusion across the neck of dendritic spines	SCIENCE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; PROTEIN-KINASE-II; LTP; ACTIN; CELLS; INDUCTION; STRENGTH; CAMKII	In mammalian excitatory neurons, dendritic spines are separated from dendrites by thin necks. Diffusion across the neck limits the chemical and electrical isolation of each spine. We found that 'spine/dendrite diffusional coupling is heterogeneous and uncovered a class of diffusionally isolated spines. The barrier to diffusion posed by the neck and the number of diffusionally isolated spines is bidirectionally regulated by neuronal activity. Furthermore, coincident synaptic activation and postsynaptic action potentials rapidly restrict diffusion across the neck. The regulation of diffusional. coupling provides a possible mechanism for determining the amplitude of postsynaptic potentials and the accumulation of plasticity-inducing molecules within the spine head.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu		Bloodgood, Brenda/0000-0002-4797-9119				Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Kiskin NI, 2002, EUR BIOPHYS J BIOPHY, V30, P588, DOI 10.1007/s00249-001-0187-x; KOCH C, 1993, J NEUROSCI, V13, P413; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Post JN, 2005, FEBS LETT, V579, P325, DOI 10.1016/j.febslet.2004.11.092; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	26	251	257	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					866	869		10.1126/science.1114816	http://dx.doi.org/10.1126/science.1114816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272125				2022-12-01	WOS:000233121800049
J	Martinon, F; Petrilli, V; Mayor, A; Tardivel, A; Tschopp, J				Martinon, F; Petrilli, V; Mayor, A; Tardivel, A; Tschopp, J			Gout-associated uric acid crystals activate the NALP3 inflammasome	NATURE			English	Article							COLD AUTOINFLAMMATORY SYNDROME; NECROSIS-FACTOR-ALPHA; MONOSODIUM URATE; IMMUNE-SYSTEM; PROTEIN; PYRIN; IDENTIFICATION; INTERLEUKIN-1; ANTAGONIST; COLCHICINE	Development of the acute and chronic inflammatory responses known as gout and pseudogout are associated with the deposition of monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals, respectively, in joints and periarticular tissues. Although MSU crystals were first identified as the aetiological agent of gout in the eighteenth century(1) and more recently as a 'danger signal' released from dying cells(2), little is known about the molecular mechanisms underlying MSU- or CPPD-induced inflammation. Here we show that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the production of active interleukin (IL)-1 beta and IL-18. Macrophages from mice deficient in various components of the inflammasome such as caspase-1, ASC and NALP3 are defective in crystal-induced IL-1 beta activation. Moreover, an impaired neutrophil influx is found in an in vivo model of crystal-induced peritonitis in inflammasome-deficient mice or mice deficient in the IL-1 beta receptor (IL-1R). These findings provide insight into the molecular processes underlying the inflammatory conditions of gout and pseudogout, and further support a pivotal role of the inflammasome in several autoinflammatory diseases.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Martinon, Fabio/A-5575-2009; Petrilli, Virginie/ABI-8199-2020	Martinon, Fabio/0000-0002-6969-822X; Petrilli, Virginie/0000-0001-8502-6979				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI [10.1093/rheumatology/keh640, 10.1186/ar2952]; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; FAIRES JS, 1962, LANCET, V2, P682; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Getting SJ, 1997, J PHARMACOL EXP THER, V283, P123; GOLDFINGER SE, 1965, ARTHRITIS RHEUM-US, V8, P1112, DOI 10.1002/art.1780080610; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; MALAWIST.SE, 1965, ANN INTERN MED, V62, P648, DOI 10.7326/0003-4819-62-4-648; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meng ZH, 1997, J RHEUMATOL, V24, P2385; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; WOLLASTON HW, 1797, PHIL T, V87, P386; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	30	3516	3704	28	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					237	241		10.1038/nature04516	http://dx.doi.org/10.1038/nature04516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16407889	Bronze			2022-12-01	WOS:000235839500052
J	Ramiro, AR; Jankovic, M; Callen, E; Difilippantonio, S; Chen, HT; McBride, KM; Eisenreich, TR; Chen, JJ; Dickins, RA; Lowe, SW; Nussenzweig, A; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Callen, E; Difilippantonio, S; Chen, HT; McBride, KM; Eisenreich, TR; Chen, JJ; Dickins, RA; Lowe, SW; Nussenzweig, A; Nussenzweig, MC			Role of genomic instability and p53 in AID-induced c-myc-Igh translocations	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; URACIL-DNA GLYCOSYLASE; CHROMOSOMAL TRANSLOCATIONS; SOMATIC HYPERMUTATION; DEFICIENT MICE; B-CELLS; ACTIVATION; REGIONS; 53BP1	Chromosomal translocations involving the immunoglobulin switch region are a hallmark feature of B-cell malignancies(1). However, little is known about the molecular mechanism by which primary B cells acquire or guard against these lesions. Here we find that translocations between c-myc and the IgH locus (Igh) are induced in primary B cells within hours of expression of the catalytically active form of activation-induced cytidine deaminase (AID), an enzyme that deaminates cytosine to produce uracil in DNA(2,3). Translocation also requires uracil DNA glycosylase (UNG), which removes uracil from DNA to create abasic sites that are then processed to double-strand breaks(4,5). The pathway that mediates aberrant joining of c-myc and Igh differs from intrachromosomal repair during immunoglobulin class switch recombination in that it does not require histone H2AX(6), p53 binding protein 1 ( 53BP1)(7,8) or the non-homologous end-joining protein Ku80(9). In addition, translocations are inhibited by the tumour suppressors ATM, Nbs1, p19 (Arf) and p53, which is consistent with activation of DNA damage- and oncogenic stress-induced checkpoints during physiological class switching. Finally, we demonstrate that accumulation of AID-dependent, IgH-associated chromosomal lesions is not sufficient to enhance c-myc-Igh translocations. Our findings reveal a pathway for surveillance and protection against AID-dependent DNA damage, leading to chromosomal translocations.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Mayo Clin, Div Oncol, Rochester, MN 55905 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Mayo Clinic; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov; nussen@mail.rockefeller.edu	mcbride, kevin/E-8230-2011; Dickins, Ross A/K-2852-2012; Nussenzweig, Michel/AAE-7292-2019; Ramiro, Almudena R/H-6037-2015	Dickins, Ross A/0000-0003-4112-5304; Ramiro, Almudena R/0000-0002-7539-3844	NATIONAL CANCER INSTITUTE [P30CA008748, Z01BC010283, P01CA013106] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [P30 CA008748, P01 CA013106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Endres M, 2004, J CLIN INVEST, V113, P1711, DOI 10.1172/JCI200420926; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021	30	258	264	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2006	440	7080					105	109		10.1038/nature04495	http://dx.doi.org/10.1038/nature04495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HW	16400328	Green Accepted			2022-12-01	WOS:000235685700049
J	DeLong, EF; Preston, CM; Mincer, T; Rich, V; Hallam, SJ; Frigaard, NU; Martinez, A; Sullivan, MB; Edwards, R; Brito, BR; Chisholm, SW; Karl, DM				DeLong, EF; Preston, CM; Mincer, T; Rich, V; Hallam, SJ; Frigaard, NU; Martinez, A; Sullivan, MB; Edwards, R; Brito, BR; Chisholm, SW; Karl, DM			Community genomics among stratified microbial assemblages in the ocean's interior	SCIENCE			English	Article							PACIFIC SUBTROPICAL GYRE; IN-SITU HYBRIDIZATION; MESOPELAGIC ZONE; MARINE; PROCHLOROCOCCUS; METAGENOMICS; DIVERSITY; SEQUENCES; ARCHAEA; DEEP	Microbial life predominates in the ocean, yet little is known about its genomic variability, especially along the depth continuum. We report here genomic analyses of planktonic microbial communities in the North Pacific Subtropical Gyre, from the ocean's surface to near-sea floor depths. Sequence variation in microbial community genes reflected vertical zonation of taxonomic groups, functional gene repertoires, and metabolic potential. The distributional patterns of microbial genes suggested depth-variable community trends in carbon and energy metabolism, attachment and motility, gene mobility, and host-viral interactions. Comparative genomic analyses of stratified microbial communities have the potential to provide significant insight into higher-order community organization and dynamics.	MIT, Cambridge, MA 02139 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95064 USA; San Diego State Univ, San Diego, CA 92182 USA; Univ Hawaii, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); Monterey Bay Aquarium Research Institute; California State University System; San Diego State University; University of Hawaii System	DeLong, EF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu	Sullivan, Matthew B/H-3256-2011; Edwards, Robert/Q-1691-2019; Frigaard, Niels-Ulrik/H-1277-2011; Karl, David/AFP-3837-2022	Sullivan, Matthew B/0000-0003-4040-9831; Edwards, Robert/0000-0001-8383-8949; Frigaard, Niels-Ulrik/0000-0002-9389-8109; Karl, David/0000-0002-6660-6721; Chisholm, Sallie/0000-0003-1480-2445; Mincer, Tracy/0000-0002-4644-5609				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 2005, NAT REV MICROBIOL; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filee J, 2005, P NATL ACAD SCI USA, V102, P12471, DOI 10.1073/pnas.0503404102; Forbes E., 1856, PHYS ATLAS NATURAL P; FRIGAARD NU, IN PRESS NATURE; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HOCHACHKA PW, 1984, BIOCH ADAPTATION, P450; JOHNSON Z, UNPUB; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Morris RM, 2004, APPL ENVIRON MICROB, V70, P2836, DOI 10.1128/AEM.70.5.2836-2842.2004; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUZUKI MT, 2005, MICROB ECOL; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021	47	993	1031	8	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2006	311	5760					496	503		10.1126/science.1120250	http://dx.doi.org/10.1126/science.1120250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439655				2022-12-01	WOS:000235071400039
J	Mostoslavsky, R; Chua, KF; Lombard, DB; Pang, WW; Fischer, MR; Gellon, L; Liu, PF; Mostoslavsky, G; Franco, S; Murphy, MM; Mills, KD; Patel, P; Hsu, JT; Hong, AL; Ford, E; Cheng, HL; Kennedy, C; Nunez, N; Bronson, R; Frendewey, D; Auerbach, W; Valenzuela, D; Karow, M; Hottiger, MO; Hursting, S; Barrett, JC; Guarente, L; Mulligan, R; Demple, B; Yancopoulos, GD; Alt, FW				Mostoslavsky, R; Chua, KF; Lombard, DB; Pang, WW; Fischer, MR; Gellon, L; Liu, PF; Mostoslavsky, G; Franco, S; Murphy, MM; Mills, KD; Patel, P; Hsu, JT; Hong, AL; Ford, E; Cheng, HL; Kennedy, C; Nunez, N; Bronson, R; Frendewey, D; Auerbach, W; Valenzuela, D; Karow, M; Hottiger, MO; Hursting, S; Barrett, JC; Guarente, L; Mulligan, R; Demple, B; Yancopoulos, GD; Alt, FW			Genomic instability and aging-like phenotype in the absence of mammalian SIRT6	CELL			English	Article							BASE-EXCISION-REPAIR; DNA-REPAIR; CALORIE RESTRICTION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; ADP-RIBOSYLTRANSFERASE; PROTEIN DEACETYLASES; IONIZING-RADIATION; OXIDATIVE STRESS; B-CELLS	The Sir2 histone deacetylase functions as a chromatin silencer to regulate recombination, genomic stability, and aging in budding yeast. Seven mammalian Sir2 homologs have been identified (SIRT1-SIRT7), and it has been speculated that some may have similar functions to Sir2. Here, we demonstrate that SIRT6 is a nuclear, chromatin-associated protein that promotes resistance to DNA damage and suppresses genomic instability in mouse cells, in association with a role in base excision repair (BER). SIRT6-deficient mice are small and at 2-3 weeks of age develop abnormalities that include profound lymphopenia, loss of subcutaneous fat, lordokyphosis, and severe metabolic defects, eventually dying at about 4 weeks. We conclude that one function of SIRT6 is to promote normal DNA repair, and that SIRT6 loss leads to abnormalities in mice that overlap with aging-associated degenerative processes.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CB Inst Biomed Res, Boston, MA 02115 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; NCI, Canc Res Ctr, Bethesda, MD 20892 USA; Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Regeneron; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Zurich	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,CB Inst Biomed Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Hottiger, Michael O./J-7747-2013	Hottiger, Michael O./0000-0002-7323-2270; Hsu, Joyce/0000-0002-1825-4733; Gellon, Lionel/0000-0003-4981-581X; Frendewey, David/0000-0003-2305-3490; Lombard, David/0000-0002-4292-0185; Mostoslavsky, Gustavo/0000-0002-0784-2169; Hong, Andrew/0000-0003-0374-1667	PHS HHS [K08] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allman D, 2005, IMMUNOL REV, V205, P18, DOI 10.1111/j.0105-2896.2005.00269.x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7; Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dorshkind K, 2003, CLIN IMMUNOL, V109, P197, DOI 10.1016/S1521-6616(03)00181-5; Dutnall RN, 2001, CELL, V105, P161, DOI 10.1016/S0092-8674(01)00305-1; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KLAR AJS, 1981, NATURE, V289, P239, DOI 10.1038/289239a0; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mori K, 2000, BIOCHEM BIOPH RES CO, V278, P665, DOI 10.1006/bbrc.2000.3864; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Peretz S, 2001, P NATL ACAD SCI USA, V98, P1676, DOI 10.1073/pnas.041416598; Pifer J, 2003, MECH AGEING DEV, V124, P207, DOI 10.1016/S0047-6374(02)00141-0; RINE J, 1987, GENETICS, V116, P9; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Stephan RP, 1997, J IMMUNOL, V158, P1598; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	76	1135	1194	3	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 27	2006	124	2					315	329		10.1016/j.cell.2005.11.044	http://dx.doi.org/10.1016/j.cell.2005.11.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439206	Bronze			2022-12-01	WOS:000235068500020
J	Fuyuno, I				Fuyuno, I			Hwang scandal hits Korean biotech hard	NATURE			English	News Item																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2006	439	7074					265	265		10.1038/439265a	http://dx.doi.org/10.1038/439265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421542				2022-12-01	WOS:000234682100016
J	Huisman, J; Thi, NNP; Karl, DM; Sommeijer, B				Huisman, J; Thi, NNP; Karl, DM; Sommeijer, B			Reduced mixing generates oscillations and chaos in the oceanic deep chlorophyll maximum	NATURE			English	Article							CENTRAL NORTH PACIFIC; SINKING PHYTOPLANKTON; LIGHT; VARIABILITY; NITRATE; MODELS	Deep chlorophyll maxima (DCMs) are widespread in large parts of the world's oceans(1-7). These deep layers of high chlorophyll concentration reflect a compromise of phytoplankton growth exposed to two opposing resource gradients: light supplied from above and nutrients supplied from below. It is often argued that DCMs are stable features. Here we show, however, that reduced vertical mixing can generate oscillations and chaos in phytoplankton biomass and species composition of DCMs. These fluctuations are caused by a difference in the timescales of two processes: (1) rapid export of sinking plankton, withdrawing nutrients from the euphotic zone and (2) a slow upward flux of nutrients fuelling new phytoplankton production. Climate models predict that global warming will reduce vertical mixing in the oceans(8-11). Our model indicates that reduced mixing will generate more variability in DCMs, thereby enhancing variability in oceanic primary production and in carbon export into the ocean interior.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; CWI, NL-1090 GB Amsterdam, Netherlands; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of Amsterdam; University of Hawaii System	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Nieuwe Achtergracht 127, NL-1018 WS Amsterdam, Netherlands.	jef.huisman@science.uva.nl	Karl, David/AFP-3837-2022; Huisman, Jef/A-1089-2013	Huisman, Jef/0000-0001-9598-3211				Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Finnigan TD, 2002, J PHYS OCEANOGR, V32, P2988, DOI 10.1175/1520-0485(2002)032<2988:OOEDMN>2.0.CO;2; Hodges BA, 2004, DEEP-SEA RES PT I, V51, P999, DOI 10.1016/j.dsr.2004.02.009; Holm-Hansen O, 2004, POLAR BIOL, V27, P699, DOI 10.1007/s00300-004-0641-1; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2002, AM NAT, V159, P245, DOI 10.1086/338511; Huisman J, 2002, J SEA RES, V48, P83, DOI 10.1016/S1385-1101(02)00137-5; Karl DM, 1996, DEEP-SEA RES PT II, V43, P539, DOI 10.1016/0967-0645(96)00002-1; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Mann K.H., 1996, DYNAMICS MARINE ECOS, DOI 10.2307/2960585; Okubo A., 2001, DIFFUSION ECOLOGICAL; RINALDI S, 1993, B MATH BIOL, V55, P15, DOI 10.1007/BF02460293; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Schmittner A, 2005, NATURE, V434, P628, DOI 10.1038/nature03476; Smyth WD, 2001, J PHYS OCEANOGR, V31, P1969, DOI 10.1175/1520-0485(2001)031<1969:TEOMIT>2.0.CO;2; Vandermeer J, 2001, CHAOS SOLITON FRACT, V12, P265, DOI 10.1016/S0960-0779(00)00111-9; Venrick EL, 1999, J PLANKTON RES, V21, P1029, DOI 10.1093/plankt/21.6.1029; VENRICK EL, 1993, LIMNOL OCEANOGR, V38, P1135, DOI 10.4319/lo.1993.38.6.1135; VENRICK EL, 1973, FISH B-NOAA, V71, P41	26	266	280	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 19	2006	439	7074					322	325		10.1038/nature04245	http://dx.doi.org/10.1038/nature04245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421570	Green Submitted			2022-12-01	WOS:000234682100042
J	Tectonidis, M				Tectonidis, M			Crisis in Niger - Outpatient care for severe acute malnutrition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Frontieres, Dept Med, Paris, France	Sanofi-Aventis; Sanofi France	Tectonidis, M (corresponding author), Med Frontieres, Dept Med, Paris, France.							Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6	2	21	21	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2006	354	3					224	227		10.1056/NEJMp058240	http://dx.doi.org/10.1056/NEJMp058240			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003DF	16421363				2022-12-01	WOS:000234661100002
J	Grunewald, M; Avraham, I; Dor, Y; Bachar-Lustig, E; Itin, A; Yung, S; Chimenti, S; Landsman, L; Abramovitch, R; Keshet, E				Grunewald, M; Avraham, I; Dor, Y; Bachar-Lustig, E; Itin, A; Yung, S; Chimenti, S; Landsman, L; Abramovitch, R; Keshet, E			VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARROW-DERIVED CELLS; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; TUMOR ANGIOGENESIS; STEM; TRANSPLANTATION; VASCULARIZATION; EXPRESSION; INDUCTION	Adult neovascularization relies on the recruitment of circulating cells, but their angiogenic roles and recruitment mechanisms are unclear. We show that the endothelial growth factor VEGF is sufficient for organ homing of circulating mononuclear myeloid cells and is required for their perivascular positioning and retention. Recruited bone marrow-derived circulating cells (RBCCs) summoned by VEGF serve a function distinct from endothelial progenitor cells. Retention of RBCCs in close proximity to angiogenic vessels is mediated by SDF1, a chemokine induced by VEGF in activated perivascular myofibroblasts. RBCCs enhance in situ proliferation of endothelial cells via secreting proangiogenic activities distinct from locally induced activities. Precluding RBCCs strongly attenuated the proangiogenic response to VEGF and addition of purified RBCCs enhanced angiogenesis in excision wounds. Together, the data suggest a model for VEGF-programmed adult neovascularization highlighting the essential paracrine role of recruited myeloid cells and a role for SDF1 in their perivascular retention.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	Hebrew University of Jerusalem; Weizmann Institute of Science; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Keshet, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.	keshet@cc.huji.ac.il	Dor, Yuval/C-2405-2011; Landsman, Limor/AAT-5982-2020; Keshet, Eli/GQR-0445-2022	Landsman, Limor/0000-0002-8974-1344; 				Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chimenti Stefano, 2004, Methods Mol Med, V98, P217; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Infanger M, 2004, BURNS, V30, P305, DOI 10.1016/j.burns.2003.12.006; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kraft A, 1999, CANCER-AM CANCER SOC, V85, P178; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Machein MR, 2003, BRAIN PATHOL, V13, P582; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NISSANOV J, 1995, LAB INVEST, V73, P734; Ogawa H, 2000, CARDIOLOGY, V93, P93, DOI 10.1159/000007008; ORLMO A, 2005, CELL, V121, P335; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Salven P, 1997, CLIN CANCER RES, V3, P647; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	41	932	987	3	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					175	189		10.1016/j.cell.2005.10.036	http://dx.doi.org/10.1016/j.cell.2005.10.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413490	Bronze			2022-12-01	WOS:000234969600018
J	Yan, LJL; Daviglus, ML; Liu, K; Stamler, J; Wang, RW; Pirzada, A; Garside, DB; Dyer, AR; Van Horn, L; Liao, YL; Fries, JF; Greenland, P				Yan, LJL; Daviglus, ML; Liu, K; Stamler, J; Wang, RW; Pirzada, A; Garside, DB; Dyer, AR; Van Horn, L; Liao, YL; Fries, JF; Greenland, P			Midlife body mass index and hospitalization and mortality in older age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR PROFILE; LIFE EXPECTANCY; BLOOD-PRESSURE; UNITED-STATES; MIDDLE-AGE; OBESITY; WEIGHT; PREVENTION; ASSOCIATION	Context Abundant evidence links overweight and obesity with impaired health. However, controversies persist as to whether overweight and obesity have additional impact on cardiovascular outcomes independent of their strong associations with established coronary risk factors, eg, high blood pressure and high cholesterol level. Objective To assess the relation of midlife body mass index with morbidity and mortality outcomes in older age among individuals without and with other major risk factors at baseline. Design Chicago Heart Association Detection Project in Industry study, a prospective study with baseline (1967-1973) cardiovascular risk classified as low risk (blood pressure <= 120/<= 80 mm Hg, serum total cholesterol level <200 mg/dL [5.2 mmol/L], and not currently smoking); moderate risk (nonsmoking and systolic blood pressure 121-139 mm Hg, diastolic blood pressure 81-89 mm Hg, and/or total cholesterol level 200-239 mg/dL [5.2-6.2 mmol/L]); or having any 1, any 2, or all 3 of the following risk factors: blood pressure >= 140/90 mm Hg, total cholesterol level >= 240 mg/dL (6.2 mmol/L), and current cigarette smoking. Body mass index was classified as normal weight (18.5-24.9), overweight, (25.0-29.9), or obese ( >= 30). Mean follow-up was 32 years. Setting and Participants Participants were 17643 men and women aged 31 through 64 years, recruited from Chicago-area companies or organizations and free of coronary heart disease (CHD), diabetes, or major electrocardiographic abnormalities at baseline. Main Outcome Measures Hospitalization and mortality from CHD, cardiovascular disease, or diabetes, beginning at age 65 years. Results In multivariable analyses that included adjustment for systolic blood pressure and total cholesterol level, the odds ratio (95% confidence interval) for CHD death for obese participants compared with those of normal weight in the same risk category was 1.43 (0.33-6.25) for low risk and 2.07 (1.29-3.31) for moderate risk; for CHID hospitalization, the corresponding results were 4.25 (1.57-11.5) for low risk and 2.04 (1.29-3.24) for moderate risk. Results were similar for other risk groups and for cardiovascular disease, but stronger for diabetes (eg, low risk: 11.0 [2.21-54.5] for mortality and 7.84 [3.95-15.6] for hospitalization). Conclusion For individuals with no cardiovascular risk factors as well as for those with 1 or more risk factors, those who are obese in middle age have a higher risk of hospitalization and mortality from CHID, cardiovascular disease, and diabetes in older age than those who are normal weight.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA USA; Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Northwestern University; Feinberg School of Medicine; Peking University; Centers for Disease Control & Prevention - USA; Stanford University	Yan, LJL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	lijing@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021	Pirzada, Amber/0000-0003-0526-3611; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010, R01HL062684, R21HL075259] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2002, HEART DIS STROK STAT; Beaglehole R, 2002, INT J EPIDEMIOL, V31, P1117, DOI 10.1093/ije/31.6.1117; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; *CTR MED MED SERV, 2002, HLTH CAR FIN REV M S; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; FARINARO E, 1977, ANN INTERN MED, V86, P147, DOI 10.7326/0003-4819-86-2-147; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Fowles J B, 1998, J Ambul Care Manage, V21, P24; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LAUDERDALE DS, 1993, EPIDEMIOL REV, V15, P319, DOI 10.1093/oxfordjournals.epirev.a036123; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; RISSANEN A, 1991, J CLIN EPIDEMIOL, V44, P787, DOI 10.1016/0895-4356(91)90131-R; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; U.S. Department of Health and Human Services, 2000, RED TOB US REP SURG; WAALER HT, 1984, ACTA MED SCAND, P1; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YAO CH, 1991, AM J EPIDEMIOL, V134, P1278, DOI 10.1093/oxfordjournals.aje.a116031	46	175	177	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2006	295	2					190	198		10.1001/jama.295.2.190	http://dx.doi.org/10.1001/jama.295.2.190			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001NT	16403931	Bronze			2022-12-01	WOS:000234544300026
J	Opie, LH				Opie, LH			Controversies in cardiology	LANCET			English	Editorial Material							TRIAL; PARTICIPANTS; THERAPY; EVENTS; HEART; RISK		Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Heart Res Inst, ZA-7925 Cape Town, South Africa	University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Heart Res Inst, Chris Barnard Bldg, ZA-7925 Cape Town, South Africa.	opie@capeheart.uct.ac.za						Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BERGMANN SR, 1983, SCIENCE, V220, P1181; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; *ISIS 1 STUD, 1986, LANCET, V2, P56; Kaplan NM, 2000, LANCET, V356, P1933, DOI 10.1016/S0140-6736(05)73487-5; KAPLAN NM, 2005, KAPLANS CLIN HYPERTE; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; OPIE LH, 1980, LANCET, V1, P693; Opie LH, 2005, DRUGS FOR THE HEART; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	14	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					13	14		10.1016/S0140-6736(06)67903-8	http://dx.doi.org/10.1016/S0140-6736(06)67903-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399138				2022-12-01	WOS:000234443100010
J	Mahonen, AP; Bishopp, A; Higuchi, M; Nieminen, KM; Kinoshita, K; Tormakangas, K; Ikeda, Y; Oka, A; Kakimoto, T; Helariutta, Y				Mahonen, AP; Bishopp, A; Higuchi, M; Nieminen, KM; Kinoshita, K; Tormakangas, K; Ikeda, Y; Oka, A; Kakimoto, T; Helariutta, Y			Cytokinin signaling and its inhibitor AHP6 regulate cell fate during vascular development	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; HISTIDINE KINASE; DIFFERENTIATION; ROOT; RECEPTOR; TRANSDUCTION; EXPRESSION; GROWTH	The cell lineages that form the transporting tissues (xylem and phloem) and the intervening pluripotent procambial tissue originate from stem cells near the root tip. We demonstrate that in Arabidopsis, cytokinin phytohormones negatively regulate protoxylem specification. AHP6, an inhibitory pseudophosphotransfer protein, counteracts cytokinin signaling, allowing protoxylem formation. Conversely, cytokinin signaling negatively regulates the spatial domain of AHP6 expression. Thus, by controlling the identity of cell lineages, the reciprocal interaction of cytokinin signaling and its spatially specific modulator regulates proliferation and differentiation of cell lineages during vascular development, demonstrating a previously unrecognized regulatory circuit underlying meristem organization.	Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, FIN-00014 Helsinki, Finland; Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; Kyoto Univ, Inst Chem Res, Mol Biol Lab, Uji 6110011, Japan; Univ Turku, Dept Biol, FI-20014 Turku, Finland; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden	University of Helsinki; Osaka University; Rockefeller University; Kyoto University; University of Turku; Swedish University of Agricultural Sciences; Umea University	Kakimoto, T (corresponding author), Univ Helsinki, Inst Biotechnol, Plant Mol Biol Lab, POB 56, FIN-00014 Helsinki, Finland.	kakimoto@bio.sci.osaka-u.ac.jp; yhetariu@operoni.helsinki.fi	Mähönen, Ari Pekka/B-9764-2015; Ikeda, Yoshihisa/B-4614-2013; Helariutta, Yrjo/AAE-8149-2020; Nieminen, Kaisa/N-9051-2015	Mähönen, Ari Pekka/0000-0001-6051-866X; Helariutta, Yrjo/0000-0002-7287-8459; Nieminen, Kaisa/0000-0001-7004-9422; Bishopp, Anthony/0000-0003-2962-9542				ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Esau K., 1977, ANATOMY SEED PLANTS; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kiba T, 2002, PLANT CELL PHYSIOL, V43, P1059, DOI 10.1093/pcp/pcf121; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Pyo H, 2004, PLANT CELL PHYSIOL, V45, P1529, DOI 10.1093/pcp/pch175; SCHERES B, 1995, DEVELOPMENT, V121, P53; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	18	404	422	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					94	98		10.1126/science.1118875	http://dx.doi.org/10.1126/science.1118875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400151				2022-12-01	WOS:000234546300041
J	Mumby, PJ; Dahlgren, CP; Harborne, AR; Kappel, CV; Micheli, F; Brumbaugh, DR; Holmes, KE; Mendes, JM; Broad, K; Sanchirico, JN; Buch, K; Box, S; Stoffle, RW; Gill, AB				Mumby, PJ; Dahlgren, CP; Harborne, AR; Kappel, CV; Micheli, F; Brumbaugh, DR; Holmes, KE; Mendes, JM; Broad, K; Sanchirico, JN; Buch, K; Box, S; Stoffle, RW; Gill, AB			Fishing, trophic cascades, and the process of grazing on coral reefs	SCIENCE			English	Article							ALGAL COMMUNITIES; MARINE RESERVE; MASS MORTALITY; FISHES; DYNAMICS; HERBIVORY; BIOMASS; SIZE	Since the mass mortality of the urchin Diadema antillarum in 1983, parrotfishes have become the dominant grazer on Caribbean reefs. The grazing capacity of these fishes could be impaired if marine reserves achieve their long-term goal of restoring large consumers, several of which prey on parrotfishes. Here we compare the negative impacts of enhanced predation with the positive impacts of reduced fishing mortality on parrotfishes inside reserves. Because large-bodied parrotfishes escape the risk of predation from a large piscivore (the Nassau grouper), the predation effect reduced grazing by only 4 to 8%. This impact was overwhelmed by the increase in density of large parrotfishes, resulting in a net doubling of grazing. Increased grazing caused a fourfold reduction in the cover of macroalgae, which, because they are the principal competitors of corals, highlights the potential importance of reserves for coral reef resilience.	Univ Exeter, Marine Spatial Ecol Lab, Sch Biosci, Exeter EX4 4PS, Devon, England; Perry Inst Marine Sci, Jupiter, FL 33477 USA; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; Univ W Indies, Dept Life Sci, Kingston 7, Jamaica; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Affairs & Policy, Miami, FL 33149 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Arizona, Bur Appl Res Anthropol, Tucson, AZ 85721 USA; Cranfield Univ, Inst Water & Environm, Silsoe MK45 4DT, Beds, England	University of Exeter; Stanford University; American Museum of Natural History (AMNH); University West Indies Mona Jamaica; University of Miami; Resources for the Future; University of Arizona; Cranfield University	Mumby, PJ (corresponding author), Univ Exeter, Marine Spatial Ecol Lab, Sch Biosci, Prince Wales Rd, Exeter EX4 4PS, Devon, England.		Harborne, Alastair R/F-6155-2013; Kappel, Carrie Vanessa/B-9534-2009; Mumby, Peter/F-9914-2010; Stoffle, Richard/GVU-1766-2022; Gill, Andrew/ABE-1092-2020	Harborne, Alastair R/0000-0002-6818-8615; Kappel, Carrie Vanessa/0000-0003-2507-8042; Mumby, Peter/0000-0002-6297-9053; Gill, Andrew/0000-0002-3379-6952; Micheli, Fiorenza/0000-0002-6865-1438	Natural Environment Research Council [NER/A/S/2001/01127] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Bruggemann J. H., 1995, THESIS RIJKSUNIVERSI; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Claro R, 2001, ECOLOGY MARINE FISHE; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Eggleston DB, 1998, B MAR SCI, V63, P111; Gill AB, 2003, J FISH BIOL, V63, P105, DOI 10.1111/j.1095-8649.2003.00214.x; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Rakitin A, 1996, MAR ECOL PROG SER, V131, P97, DOI 10.3354/meps131097; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Sluka Robert, 1996, Bahamas Journal of Science, V3, P17; Sogard SM, 1997, B MAR SCI, V60, P1129; Steneck R., 1997, P 8 INT COR REEF S, P695; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Winn H. E., 1964, Zeitschrift fuer Tierpsychologie, V21, P798	24	628	643	6	405	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					98	101		10.1126/science.1121129	http://dx.doi.org/10.1126/science.1121129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400152				2022-12-01	WOS:000234546300042
J	Wildwater, M; Campilho, A; Perez-Perez, JM; Heidstra, R; Blilou, I; Korthout, H; Chatterjee, J; Mariconti, L; Gruissem, W; Scheres, B				Wildwater, M; Campilho, A; Perez-Perez, JM; Heidstra, R; Blilou, I; Korthout, H; Chatterjee, J; Mariconti, L; Gruissem, W; Scheres, B			The RETINOBLASTOMA-RELATED gene regulates stem cell maintenance in Arabidopsis roots	CELL			English	Article							SELF-RENEWAL; PROTEIN HOMOLOG; FUSION PROTEIN; DIFFERENTIATION; MERISTEM; DROSOPHILA; CYCLE; SCARECROW; DIVISION; NICHE	The maintenance of stem cells in defined locations is crucial for all multicellular organisms. Although intrinsic factors and signals for stem cell fate have been identified in several species, it has remained unclear how these connect to the ability to reenter the cell cycle that is one of the defining properties of stem cells. We show that local reduction of expression of the RETINOBLASTOMA-RELATED (RBR) gene in Arabidopsis roots increases the amount of stem cells without affecting cell cycle duration in mitotically active cells. Conversely, induced RBR overexpression dissipates stem cells prior to arresting other mitotic cells. Overexpression of D cyclins, KIP-related proteins, and E2F factors also affects root stem cell pool size, and genetic interactions suggest that these factors function in a canonical RBR pathway to regulate somatic stem cells. Expression analysis and genetic interactions position RBR-mediated regulation of the stem cell state downstream of the patterning gene SCARECROW.	Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; ETH Zentrum, Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; TNO Qual Life Appl Plant Sci, NL-2333 CK Leiden, Netherlands	Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Netherlands Organization Applied Science Research	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Perez-Perez, Jose Manuel/B-4247-2011; Gruissem, Wilhelm/H-1752-2013; Campilho, Ana/H-8790-2013; Campilho, Ana/U-8263-2019	Perez-Perez, Jose Manuel/0000-0003-2848-4919; Campilho, Ana/0000-0002-3470-1943; Campilho, Ana/0000-0002-3470-1943; Gruissem, Wilhelm/0000-0002-1872-2998; Scheres, Ben/0000-0001-5400-9578; Blilou, Ikram/0000-0001-8003-3782				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Dewitte W, 2003, PLANT CELL, V15, P79, DOI 10.1105/tpc.004838; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Huntley R, 1998, PLANT MOL BIOL, V37, P155, DOI 10.1023/A:1005902226256; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Liu HP, 2004, CURR OPIN GENET DEV, V14, P55, DOI 10.1016/j.gde.2003.11.005; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nakagami H, 1999, PLANT J, V18, P243, DOI 10.1046/j.1365-313X.1999.00449.x; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ross JF, 2001, GENE DEV, V15, P392, DOI 10.1101/gad.858501; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Willemsen V, 1998, DEVELOPMENT, V125, P521; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	62	265	289	0	56	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1337	1349		10.1016/j.cell.2005.09.042	http://dx.doi.org/10.1016/j.cell.2005.09.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377572	Green Submitted, Bronze			2022-12-01	WOS:000234584500020
J	Smits, LJM; de Bie, RA; Essed, GG; van den Brandt, PA				Smits, LJM; de Bie, RA; Essed, GG; van den Brandt, PA			Time to pregnancy and sex of offspring: cohort study	BRITISH MEDICAL JOURNAL			English	Article							RATIO		Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Smits, LJM (corresponding author), Maastricht Univ, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands.	luc.smits@epid.unimaas.nl	Smits, Luc/C-5331-2008	Smits, Luc/0000-0003-0785-1345; van den Brandt, Piet/0000-0001-8781-8099				ERICSSON RJ, 1973, NATURE, V246, P421, DOI 10.1038/246421a0; KEYE WR, 1995, INFERTILITY EVALUATI; Martin JF, 1997, SOC BIOL, V44, P283; Martin JF, 1997, HUM REPROD, V12, P611; Weijin Z, 1996, OCCUP ENVIRON MED, V53, P503, DOI 10.1136/oem.53.7.503-b	5	25	25	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 17	2005	331	7530					1437	1438		10.1136/bmj.331.7530.1437	http://dx.doi.org/10.1136/bmj.331.7530.1437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356978	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000234156400019
J	Rubin, SM; Gall, AL; Zheng, N; Pavletich, NP				Rubin, SM; Gall, AL; Zheng, N; Pavletich, NP			Structure of the RbC-terminal domain bound to E2F1-DP1: A mechanism for phosphorylation-induced E2F release	CELL			English	Article							RETINOBLASTOMA GENE-PRODUCT; CYCLIN-CDK COMPLEXES; TRANSCRIPTION FACTOR DRTF1/E2F; TUMOR-SUPPRESSOR PROTEIN; LARGE T-ANTIGEN; FAMILY-MEMBERS; ONCOGENIC ACTIVITY; BINDING-SITE; PRB; TRANSACTIVATION	The retinoblastoma (Rb) protein negatively regulates the G1-S transition by binding to the E2F transcription factors, until cyclin-dependent kinases phosphorylate Rb, causing E2F release. The Rb pocket domain is necessary for E2F binding, but the Rb C-terminal domain (RbC) is also required for growth suppression. Here we demonstrate a high-affinity interaction between RbC and E2F-DP heterodimers shared by all Rb and E2F family members. The crystal structure of an RbC-E2F1-DP1 complex reveals an intertwined heterodimer in which the marked box domains of both E2F1 and DP1 contact RbC. We also demonstrate that phosphorylation of RbC at serines 788 and 795 destabilizes one set of RbC-E2F-DP interactions directly, while phosphorylation at threonines 821 and 826 induces an intramolecular interaction between RbC and the Rb pocket that destabilizes the remaining interactions indirectly. Our findings explain the requirement of RbC for high-affinity E2F binding and growth suppression and establish a mechanism for the regulation of Rb-E2F association by phosphorylation.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA.	nikola@xray2.mskcc.org						Adams PD, 1999, MOL CELL BIOL, V19, P1068; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brown VD, 2002, MOL CELL BIOL, V22, P1390, DOI 10.1128/MCB.22.5.1390-1401.2002; Brown VD, 1999, MOL CELL BIOL, V19, P3246; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HLEBERT SW, 1993, MOL CELL BIOL, V13, P3384; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3525, DOI 10.1073/pnas.90.8.3525; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Jost CA, 1996, VIROLOGY, V220, P78, DOI 10.1006/viro.1996.0288; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9; NEVINS JR, 1994, CURR OPIN GENET DEV, V4, P130, DOI 10.1016/0959-437X(94)90101-5; OCONNOR RJ, 1994, J VIROL, V68, P6848, DOI 10.1128/JVI.68.11.6848-6862.1994; Pan WJ, 2001, CANCER RES, V61, P2885; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wallace M, 2004, MOL CELL BIOL, V24, P5606, DOI 10.1128/MCB.24.12.5606-5619.2004; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x	48	175	186	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1093	1106		10.1016/j.cell.2005.09.044	http://dx.doi.org/10.1016/j.cell.2005.09.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360038	Bronze			2022-12-01	WOS:000234177200017
J	Wright, CF; Teichmann, SA; Clarke, J; Dobson, CM				Wright, CF; Teichmann, SA; Clarke, J; Dobson, CM			The importance of sequence diversity in the aggregation and evolution of proteins	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; AMYLOID FIBRILS; IN-VITRO; BETA; SUPERFAMILY; SPECIFICITY; DOMAINS; TITIN	Incorrect folding of proteins, leading to aggregation and amyloid formation, is associated with a group of highly debilitating medical conditions(1,2) including Alzheimer's disease and late-onset diabetes. The issue of how unwanted protein association is normally avoided in a living system is particularly significant in the context of the evolution of multidomain proteins, which account for over 70% of all eukaryotic proteins(3), where the effective local protein concentration in the vicinity of each domain is very high. Here we describe the aggregation kinetics of multidomain protein constructs of immunoglobulin domains and the ability of different homologous domains to aggregate together. We show that aggregation of these proteins is a specific process and that the efficiency of coaggregation between different domains decreases markedly with decreasing sequence identity. Thus, whereas immunoglobulin domains with more than about 70% identity are highly prone to coaggregation, those with less than 30 - 40% sequence identity do not detectably interact. A bioinformatics analysis of consecutive homologous domains in large multidomain proteins shows that such domains almost exclusively have sequence identities of less than 40%, in other words below the level at which coaggregation is likely to be efficient. We propose that such low sequence identities could have a crucial and general role in safeguarding proteins against misfolding and aggregation.	Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.	jc162@cam.ac.uk; cmd44@cam.ac.uk	Wright, Caroline/N-5355-2015	Teichmann, Sarah/0000-0002-6294-6366; Wright, Caroline/0000-0003-2958-5076	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Asakura S., 1975, THERMODYNAMICS POLYM; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; Linke WA, 1998, J CELL SCI, V111, P1567; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Raffen R, 1999, PROTEIN SCI, V8, P509; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348	30	250	254	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					878	881		10.1038/nature04195	http://dx.doi.org/10.1038/nature04195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341018				2022-12-01	WOS:000233777800056
J	Niwa, H; Toyooka, T; Shimosato, D; Strumpf, D; Takahashi, K; Yagi, R; Rossant, J				Niwa, H; Toyooka, T; Shimosato, D; Strumpf, D; Takahashi, K; Yagi, R; Rossant, J			Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation	CELL			English	Article							EMBRYONIC STEM-CELLS; PREIMPLANTATION MOUSE EMBRYO; SELF-RENEWAL; ES CELLS; EXPRESSION; OCT-3/4; GENE; TRANSACTIVATION; PROLIFERATION; PLURIPOTENCY	Trophectoderm (TE), the first differentiated cell lineage of mammalian embryogenesis, forms the placenta, a structure unique to mammalian development. The differentiation of TE is a hallmark event in early mammalian development, but molecular mechanisms underlying this first differentiation event remain obscure. Embryonic stem (ES) cells can be induced to differentiate into the TE lineage by forced repression of the POU-family transcription factor, Oct3/4. We show here that this event can be mimicked by overexpression of Caudal-related homeobox 2 (Cdx2), which is sufficient to generate proper trophoblast stem (T) cells. Cdx2 is dispensable for trophectoderm differentiation induced by Oct3/4 repression but essential for TS cell self-renewal. In preimplantation embryos, Cdx2 is initially coexpressed with Oct3/4 and they form a complex for the reciprocal repression of their target genes in ES cells. This suggests that reciprocal inhibition between lineagespecific transcription factors might be involved in the first differentiation event of mammalian development.	RIKEN, Lab Pluripotent Cell Studies, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; CREST, Core Res Evolut Sci & Technol, Japn Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	RIKEN; Kobe University; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Niwa, H (corresponding author), RIKEN, Lab Pluripotent Cell Studies, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp						BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Ezashi T, 2001, MOL CELL BIOL, V21, P7883, DOI 10.1128/MCB.21.23.7883-7891.2001; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kurosaka S, 2004, BIOL REPROD, V71, P1578, DOI 10.1095/biolreprod.104.029322; Louvet S, 1996, DEV BIOL, V177, P568, DOI 10.1006/dbio.1996.0186; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUTHERLAND AE, 1990, DEV BIOL, V137, P13, DOI 10.1016/0012-1606(90)90003-2; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310	32	851	885	1	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					917	929		10.1016/j.cell.2005.08.040	http://dx.doi.org/10.1016/j.cell.2005.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325584	Bronze			2022-12-01	WOS:000233814100023
J	Adam, T; Lim, SS; Mehta, S; Bhutta, ZA; Fogstad, H; Mathai, M; Zupan, J; Darmstadt, GL				Adam, T; Lim, SS; Mehta, S; Bhutta, ZA; Fogstad, H; Mathai, M; Zupan, J; Darmstadt, GL			Achieving the millennium development goals for health - Cost effectiveness analysis of strategies for. maternal and neonatal health in developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EFFECTIVE INTERVENTIONS; IMPROVING HEALTH	Objective To determine the costs and benefits of interventions for maternal and newborn health to assess the appropriateness of current strategies and guide future plans to attain the millennium development goals. Design Cost effectiveness analysis. Setting Two regions classified by the World Health Organization according to their epidemiological grouping: Afr-E, those countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, comprising countries in South East Asia with high adult and high child mortality. Data sources Effectiveness data from several sources, including trials, observational studies, and expert opinion. For resource inputs, quantifies came from WHO guidelines, literature, and expert opinion, and prices from the WHO choosing interventions that are cost effective database. Main outcome measures Cost per disability adjusted life year (DALY) averted in year 2000 international dollars. Results The most cost effective mix of interventions was similar in Afr-E and Sear-D. These were the community based newborn care package, followed by antenatal care (tetanus toxoid, screening for pre-eclampsia, screening and treatment of asymptomatic bacteriuria and syphilis); skilled attendance at birth, offering first level maternal and neonatal care around childbirth; and emergency obstetric and neonatal care around and after birth. Screening and treatment of maternal syphilis, community based management of neonatal pneumonia, and steroids given during the antenatal period were relatively less cost effective in Sear-D. Scaling up all of the included interventions to 95% coverage would halve neonatal and maternal deaths. Conclusion Preventive interventions at the community level for newborn babies and at the primary care level for mothers and newborn babies are extremely cost effective, but the millennium development goals for maternal and child health will not be achieved without universal access to clinical services as well.	Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia; WHO, Dept Making Pregnancy Safer, CH-1211 Geneva, Switzerland; Hlth Effects Inst, Boston, MA USA; Aga Khan Univ, Karachi, Pakistan; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Queensland; World Health Organization; Health Effects Institute (HEI); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lim, SS (corresponding author), Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia.	s.lim@sph.uq.edu.au	Darmstadt, Gary/AAU-7488-2020; Lim, Stephen S/B-4055-2012	Darmstadt, Gary/0000-0002-7522-5824				ALUER JA, 2003, COS EFF RESOUR ALLOC, V1; [Anonymous], 2022, BMJ, V378, DOI [DOI 10.1136/BMJ.38643.368692.68, 10.1136/bmj-2021-068384, DOI 10.1136/BMJ.O2284]; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; BALTUSSEN R, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38645.660093.68; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Department of Reproductive Health and Research World Health Organization, 2004, MAT MORT 2000 EST DE; EDEJER TTT, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38652.550278.7C; Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; EVANS DB, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38658.675243.94; Griffiths UK, 2004, B WORLD HEALTH ORGAN, V82, P643; Horton S, 1996, HEALTH POLICY PLANN, V11, P156, DOI 10.1093/heapol/11.2.156; Kulier R, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002855.PUB3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; MOREL C, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38639.702384.AE; NAKHAEE N, 2002, E MEDITERR HLTH J, V8, P53; Nanda G., 2005, ACCELERATING PROGR A; Stevens TP, 2004, COCHRANE DB SYST REV, V3; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; WHO, 2003, MAN NEWB PROBL GUID; World Health Organization, 2002, WHORHR0130; World Health Organization, 2003, WHORHR007; World Health Organization, 2003, PREGN CHILDB POSTP N; World Health Organization (WHO), 2005, WORLD HLTH REP 2005	24	215	221	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2005	331	7525					1107	1110		10.1136/bmj.331.7525.1107	http://dx.doi.org/10.1136/bmj.331.7525.1107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985ZI	16282407	Bronze, Green Published			2022-12-01	WOS:000233417300012
J	Hung, CP; Kreiman, G; Poggio, T; DiCarlo, JJ				Hung, CP; Kreiman, G; Poggio, T; DiCarlo, JJ			Fast readout of object identity from macaque inferior temporal cortex	SCIENCE			English	Article							SINGLE NEURONS; REPRESENTATION; CATEGORIZATION; RECOGNITION; RESPONSES; IMAGES; FACE	Understanding the brain computations leading to object recognition requires quantitative characterization of the information represented in inferior temporal (IT) cortex. We used a biologically plausible, classifier-based readout technique to investigate the neural coding of selectivity and invariance at the IT population level. The activity of small neuronal populations (similar to 100 randomly selected cells) over very short time intervals (as small as 12.5 milliseconds) contained unexpectedly accurate and robust information about both object "identity" and "category." This information generalized over a range of object positions and scales, even for novel objects. Coarse information about position and scale could also be read out from the same population.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02139 USA; MIT, CSBI, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hung, CP (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chouhung@mit.edu						ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Abbott LF, 1996, CEREB CORTEX, V6, P498, DOI 10.1093/cercor/6.3.498; Aggelopoulos NC, 2005, J NEUROPHYSIOL, V93, P1342, DOI 10.1152/jn.00553.2004; [Anonymous], 2003, NOTICES AM MATH SOC; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Koch Christof, 1999, P1; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RICHMOND BJ, 1983, J NEUROPHYSIOL, V50, P1415, DOI 10.1152/jn.1983.50.6.1415; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolls E T, 1991, Curr Opin Neurobiol, V1, P274, DOI 10.1016/0959-4388(91)90090-T; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tjan BS, 2001, ADV NEUR IN, V13, P66; TOLIAS AS, 2002, SOC NEUR ABSTR; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	34	534	540	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					863	866		10.1126/science.1117593	http://dx.doi.org/10.1126/science.1117593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272124	Green Published			2022-12-01	WOS:000233121800048
J	Johansen, D; Friis, K; Skovenborg, E; Gronbaek, M				Johansen, D; Friis, K; Skovenborg, E; Gronbaek, M			Food buying habits of people who buy wine or beer: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ALCOHOLIC BEVERAGE PREFERENCE; CONSUMPTION; MORTALITY; RISK; DIET; DRINKING; SPIRITS; LIQUOR	Objective To investigate whether people who buy wine buy healthier food items than those who buy beer. Design Cross sectional study. Setting Supermarkets in Denmark. Data Information on number, type of item, and total charge from 3.5 million transactions over a period of six months. Results Wine buyers bought more olives, fruit and vegetables, poultry, cooking oil, and low fat cheese, milk, and meat than beer buyers. Beer buyers bought more ready cooked dishes, sugar, cold cuts, chips, pork, butter or margarine, sausages, lamb, and soft drinks than wine buyers. Conclusions Wine buyers made more purchases of healthy food items than people who buy beer.	Natl Inst Publ Hlth, DK-1399 Copenhagen K, Denmark		Gronbaek, M (corresponding author), Natl Inst Publ Hlth, Oster Farimagsgade 5A, DK-1399 Copenhagen K, Denmark.	mg@niph.dk		Gronbaek, Morten Klocker/0000-0002-8473-6474				Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466; Boffetta P, 1990, Epidemiology, V1, P342, DOI 10.1097/00001648-199009000-00003; Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x; Ekholm O, 2004, EUR J CLIN NUTR, V58, P60, DOI 10.1038/sj.ejcn.1601746; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gaziano JM, 1998, NOVART FDN SYMP, V216, P86; Gronbaek M, 1996, EUR J CLIN NUTR, V50, P487; Gronbaek M, 1999, J EPIDEMIOL COMMUN H, V53, P721, DOI 10.1136/jech.53.11.721; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; Kesse E, 2001, AM J CLIN NUTR, V74, P322; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; KLATSKY AL, 1990, BRIT J ADDICT, V85, P1279; KLATSKY AL, 1993, AM J CARDIOL, V71, P467, DOI 10.1016/0002-9149(93)90460-T; KLATSKY AL, 1992, ANN INTERN MED, V117, P646, DOI 10.7326/0003-4819-117-8-646; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Trevisan M, 2004, ADDICTION, V99, P313, DOI 10.1111/j.1360-0443.2003.00630.x; Wannamethee SG, 1999, AM J PUBLIC HEALTH, V89, P685, DOI 10.2105/AJPH.89.5.685	24	91	93	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2006	332	7540					519	521		10.1136/bmj.38694.568981.80	http://dx.doi.org/10.1136/bmj.38694.568981.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	023WB	16428251	Green Published, Bronze			2022-12-01	WOS:000236155800015
J	Stittelaar, KJ; Neyts, J; Naesens, L; van Amerongen, G; van Lavieren, RF; Holy, A; De Clercq, E; Niesters, HGM; Fries, E; Maas, C; Mulder, PGH; van der Zeijst, BAM; Osterhaus, ADME				Stittelaar, KJ; Neyts, J; Naesens, L; van Amerongen, G; van Lavieren, RF; Holy, A; De Clercq, E; Niesters, HGM; Fries, E; Maas, C; Mulder, PGH; van der Zeijst, BAM; Osterhaus, ADME			Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection	NATURE			English	Article							POXVIRUS INFECTIONS; PROTECTS MICE; CIDOFOVIR; EFFICACY; VACCINIA; ANALOGS; COWPOX; PROPHYLAXIS; INHIBITION; THERAPY	There is concern that variola virus, the aetiological agent of smallpox, may be used as a biological weapon. For this reason several countries are now stockpiling ( vaccinia virus-based) smallpox vaccine. Although the preventive use of smallpox vaccination has been well documented, little is known about its efficacy when used after exposure to the virus. Here we compare the effectiveness of ( 1) post-exposure smallpox vaccination and ( 2) antiviral treatment with either cidofovir ( also called HPMPC or Vistide) or with a related acyclic nucleoside phosphonate analogue (HPMPO-DAPy) after lethal intratracheal infection of cynomolgus monkeys ( Macaca fascicularis) with monkeypox virus (MPXV). MPXV causes a disease similar to human smallpox(1) and this animal model can be used to measure differences in the protective efficacies of classical and new-generation candidate smallpox vaccines(2). We show that initiation of antiviral treatment 24 h after lethal intratracheal MPXV infection, using either of the antiviral agents and applying various systemic treatment regimens, resulted in significantly reduced mortality and reduced numbers of cutaneous monkeypox lesions. In contrast, when monkeys were vaccinated 24 h after MPXV infection, using a standard human dose of a currently recommended smallpox vaccine (Elstree-RIVM), no significant reduction in mortality was observed. When antiviral therapy was terminated 13 days after infection, all surviving animals had virus-specific serum antibodies and antiviral T lymphocytes. These data show that adequate preparedness for a biological threat involving smallpox should include the possibility of treating exposed individuals with antiviral compounds such as cidofovir or other selective anti-poxvirus drugs.	Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; Netherlands Vaccine Inst, NL-3720 BA Bilthoven, Netherlands; ViroClin BV, NL-3000 DR Rotterdam, Netherlands; Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; KU Leuven; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Osterhaus, ADME (corresponding author), Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl	Van der Zeijst, Bernard B.A./A-3847-2013; Naesens, Lieve/V-8725-2019; Van der Zeijst, Bernard/AAH-1415-2020; Naesens, Lieve MJ/V-8581-2017; Neyts, Johan/U-8267-2017; Niesters, Hubert/AAH-6808-2019	Van der Zeijst, Bernard B.A./0000-0001-9316-2161; Naesens, Lieve/0000-0001-9742-9302; Van der Zeijst, Bernard/0000-0001-9316-2161; Naesens, Lieve MJ/0000-0001-9742-9302; Neyts, Johan/0000-0002-0033-7514; De Clercq, Erik/0000-0002-2985-8890; Osterhaus, Albert/0000-0002-6074-1172; Niesters, Hubert/0000-0002-1758-0430				Balzarini J, 2004, NUCLEOS NUCLEOT NUCL, V23, P1321, DOI 10.1081/NCN-200027573; Bray M, 2004, J ANTIMICROB CHEMOTH, V54, P1, DOI 10.1093/jac/dkh286; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; Bronze Michael S, 2003, Curr Opin Investig Drugs, V4, P172; Buller RM, 2004, VIROLOGY, V318, P474, DOI 10.1016/j.virol.2003.11.015; Cundy KC, 1999, CLIN PHARMACOKINET, V36, P127, DOI 10.2165/00003088-199936020-00004; De Clercq E, 2004, REV MED VIROL, V14, P289, DOI 10.1002/rmv.439; De Clercq E, 2002, TRENDS PHARMACOL SCI, V23, P456, DOI 10.1016/S0165-6147(02)02091-6; Finkel E, 2001, SCIENCE, V291, P585, DOI 10.1126/science.291.5504.585; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Massoudi MS, 2003, J INFECT DIS, V188, P973, DOI 10.1086/378357; McFadden G, 2005, NAT MED, V11, P711, DOI 10.1038/nm0705-711; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Neyts J, 2004, ANTIVIR RES, V62, pA71; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Prichard Mark N., 2005, Current Drug Targets - Infectious Disorders, V5, P17, DOI 10.2174/1568005053174627; Quenelle DC, 2003, ANTIMICROB AGENTS CH, V47, P3275, DOI 10.1128/AAC.47.10.3275-3280.2003; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rose E, 2002, EUR J ORAL SCI, V110, P99, DOI 10.1034/j.1600-0722.2002.11178.x; Roy CJ, 2003, ANTIMICROB AGENTS CH, V47, P2933, DOI 10.1128/AAC.47.9.2933-2937.2003; Smee DF, 2004, J INFECT DIS, V190, P1132, DOI 10.1086/422696; Smee DF, 2003, CHEMOTHERAPY, V49, P126, DOI 10.1159/000070618; Smith GL, 2002, NAT REV IMMUNOL, V2, P521, DOI 10.1038/nri845; Stanford MM, 2005, TRENDS IMMUNOL, V26, P339, DOI 10.1016/j.it.2005.04.001; STILLELAAR KJ, 2005, J VIROL, V79, P7845; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005; Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	30	120	122	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					745	748		10.1038/nature04295	http://dx.doi.org/10.1038/nature04295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16341204	Bronze			2022-12-01	WOS:000235193100049
J	Ahnesorg, P; Smith, P; Jackson, SP				Ahnesorg, P; Smith, P; Jackson, SP			XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining	CELL			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; POLYNUCLEOTIDE KINASE; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; PROTEIN XRCC4; GENE-PRODUCT; MECHANISM; CELLS; PK	DNA nonhomologous end-joining (NHEJ) is a predominant pathway of DNA double-strand break repair in mammalian cells, and defects in it cause radiosensitivity at the cellular and whole-organism levels. Central to NHEJ is the protein complex containing DNA Ligase IV and XRCC4. By searching for additional XRCC4-interacting factors, we identified a previously uncharacterized 33 kDa protein, XRCC4-like factor (XLF, also named Cernunnos), that has weak sequence homology with XRCC4 and is predicted to display structural similarity to XRCC4. We show that XLF directly interacts with the XRCC4-Ligase IV complex in vitro and in vivo and that siRNA-mediated downregulation of XLF in human cell lines leads to radiosensitivity and impaired NHEJ. Furthermore, we establish that NHEJ-deficient 2BN cells derived from a radiosensitive and immune-deficient patient lack XLF due to an inactivating frameshift mutation in its gene, and that reintroduction of wild-type XLF into such cells corrects their radiosensitivity and NHEJ defects. XLF thus constitutes a novel core component of the mammalian NHEJ apparatus.	Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937				Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Hsu HL, 2002, DNA REPAIR, V1, P225, DOI 10.1016/S1568-7864(01)00018-0; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kysela B, 2003, J BIOL CHEM, V278, P22466, DOI 10.1074/jbc.M303273200; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; Lee KJ, 2000, J BIOL CHEM, V275, P34787, DOI 10.1074/jbc.M004011200; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Modesti M, 2001, GENOME BIOL, V2; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003	57	561	575	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 27	2006	124	2					301	313		10.1016/j.cell.2005.12.031	http://dx.doi.org/10.1016/j.cell.2005.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439205	Bronze			2022-12-01	WOS:000235068500019
J	Snyder, EY; Loring, JF				Snyder, EY; Loring, JF			Beyond fraud - Stem-cell research continues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Burnham Inst Med Res, Program Stem Cells & Regenerat Dev & Regenerat Ce, Stem Cell Resource, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Snyder, EY (corresponding author), Burnham Inst Med Res, Program Stem Cells & Regenerat Dev & Regenerat Ce, Stem Cell Resource, La Jolla, CA 92037 USA.		Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767				Committee on Guidelines for Human Embryonic Stem Cell Research, 2005, GUID HUM EMBR STEM C; DRUKKER M, IN PRESS STEM CELLS; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; MEISSNER A, 2005, NATURE          1016	5	29	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2006	354	4					321	324		10.1056/NEJMp058323	http://dx.doi.org/10.1056/NEJMp058323			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	005VY	16436761				2022-12-01	WOS:000234854000001
J	Kapoor, TM; Lampson, MA; Hergert, P; Cameron, L; Cimini, D; Salmon, ED; McEwen, BF; Khodjakov, A				Kapoor, TM; Lampson, MA; Hergert, P; Cameron, L; Cimini, D; Salmon, ED; McEwen, BF; Khodjakov, A			Chromosomes can congress to the metaphase plate before biorientation	SCIENCE			English	Article							NEWT LUNG-CELLS; CENP-E; MICROTUBULE CAPTURE; MITOTIC CHECKPOINT; ANAPHASE ONSET; PROTEIN-E; KINETOCHORE; SPINDLE; MECHANISMS; ATTACHMENT	The stable propagation of genetic material during cell division depends on the congression of chromosomes to the spindle equator before the cell initiates anaphase. It is generally assumed that congression requires that chromosomes are connected to the opposite poles of the bipolar spindle ("bioriented"). In mammalian cells, we found that chromosomes can congress before becoming bioriented. By combining the use of reversible chemical inhibitors, live-cell light microscopy, and correlative electron microscopy, we found that monooriented chromosomes could glide toward the spindle equator alongside kinetochore fibers attached to other already bioriented chromosomes. This congression mechanism depended on the kinetochore-associated, plus end-directed microtubule motor CENP-E (kinesin-7).	Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Albany, NY 12201 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Rockefeller University; Marine Biological Laboratory - Woods Hole; State University of New York (SUNY) System; Wadsworth Center; University of North Carolina; University of North Carolina Chapel Hill	Khodjakov, A (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	khodj@wadsworth.org	Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894	NIGMS NIH HHS [R37 GM024364, R01 GM065933, GM06627, R01 GM024364, GM65933, R01 GM059363, GM59363, GM24364] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364, R01GM065933, R01GM059363, R37GM024364] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; EUTENEUER U, 1981, J CELL BIOL, V89, P338, DOI 10.1083/jcb.89.2.338; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MURRAY AW, 1994, CURR BIOL, V4, P38, DOI 10.1016/S0960-9822(00)00007-5; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROOS UP, 1976, CHROMOSOMA, V54, P363, DOI 10.1007/BF00292816; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Waters JC, 1996, J CELL SCI, V109, P2823; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	25	316	321	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					388	391		10.1126/science.1122142	http://dx.doi.org/10.1126/science.1122142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424343	Green Submitted, Green Accepted			2022-12-01	WOS:000234938500047
J	Smith, IE; Chua, S				Smith, IE; Chua, S			ABC of breast diseases - Medical treatment of early breast cancer. II: endocrine therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL		Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Smith, IE (corresponding author), Royal Marsden Hosp, London SW3 6JJ, England.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baum M, 2002, LANCET, V359, P2131; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2006	332	7533					101	103		10.1136/bmj.332.7533.101	http://dx.doi.org/10.1136/bmj.332.7533.101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16410586	Green Published			2022-12-01	WOS:000234777000025
J	Ashraf, SI; McLoon, AL; Sclarsic, SM; Kunes, S				Ashraf, SI; McLoon, AL; Sclarsic, SM; Kunes, S			Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila	CELL			English	Article							LONG-TERM-MEMORY; MESSENGER-RNA; COMPUTATIONAL IDENTIFICATION; ANTENNAL LOBE; LOCALIZATION; NEURONS; KINASE; BRAIN; VISUALIZATION; ACTIVATION	Long-lasting forms of memory require protein synthesis, but how the pattern of synthesis is related to the storage of a memory has not been determined. Here we show that neural activity directs the mRNA of the Drosophila Ca2+ Calcium/Calmodulin-dependent Kinase II (CaMKII), to postsynaptic sites, where it is rapidly translated. These features of CaMKII synthesis are recapitulated during the induction of a long-term memory and produce patterns of local protein synthesis specific to the memory. We show that mRNA transport and synaptic protein synthesis are regulated by components of the RISC pathway, including the SDE3 helicase Armitage, which is specifically required for long-lasting memory. Armitage is localized to synapses and lost in a memory-specific pattern that is inversely related to the pattern of synaptic protein synthesis. Therefore, we propose that degradative control of the RISC pathway underlies the pattern of synaptic protein synthesis associated with a stable memory.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kunes, S (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kunes@fas.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081294] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH081294] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; KUNES S, 1993, J NEUROSCI, V13, P752; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Menzel R, 1999, NATURE, V400, P718, DOI 10.1038/23371; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	36	348	368	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 13	2006	124	1					191	205		10.1016/j.cell.2005.12.017	http://dx.doi.org/10.1016/j.cell.2005.12.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413491	Bronze			2022-12-01	WOS:000234969600019
J	Coghlan, B; Brennan, R; Ngoy, P; Dofara, D; Otto, B; Clements, M; Stewart, T				Coghlan, B; Brennan, R; Ngoy, P; Dofara, D; Otto, B; Clements, M; Stewart, T			Mortality in the Democratic Republic of Congo: a nationwide survey	LANCET			English	Article								Background Commencing in 1998, the war in the Democratic Republic of Congo has been a humanitarian disaster, but has drawn little response from the international community. To document rates and trends in mortality and provide recommendations for political and humanitarian interventions, we did a nationwide mortality survey during April-July, 2004. Methods We used a stratified three-stage, household-based cluster sampling technique. Of 511 health zones, 49 were excluded because of insecurity, and four were purposely selected to allow historical comparisons. From the remainder, probability of selection was proportional to population size. Geographical distribution and size of cluster determined how households were selected: systematic random or classic proximity sampling. Heads of households were asked about all deaths of household members during January, 2003, to April, 2004. Findings 19 500 households were visited. The national crude mortality rate of 2.1 deaths per 1000 per month (95% CI 1.6-2.6) was 40% higher than the sub-Saharan regional level (1-5), corresponding to 600 000 more deaths than would be expected during the recall period and 38 000 excess deaths per month. Total death toll from the conflict (1998-2004) was estimated to be 3.9 million. Mortality rate was higher in unstable eastern provinces, showing the effect of insecurity. Most deaths were from easily preventable and treatable illnesses rather than violence. Regression analysis suggested that if the effects of violence were removed, all-cause mortality could fall to almost normal rates. Interpretation The conflict in the Democratic Republic of Congo remains the world's deadliest humanitarian crisis. To save lives, improvements in security and increased humanitarian assistance are urgently needed.	Int Rescue Comm, New York, NY 10168 USA; Int Rescue Comm, Kinshasa, DEM REP CONGO; Burnet Inst, Ctr Int Hlth, Bali, Indonesia; Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Burnet Institute; Australian National University	Brennan, R (corresponding author), Int Rescue Comm, New York, NY 10168 USA.	rbrennan@theirc.org	Clements, Mark/W-5906-2018	Clements, Mark/0000-0003-4518-5670				[Anonymous], 2004, HUM CHART MIN STAND; BECKER LB, 1993, ANN EMERG MED, V22, P1, DOI 10.1016/S0196-0644(05)80239-2; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P469; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; *INT CRIS GROUP, 2004, MAINT MOM CONG IT PR; *IRIN OCHA, 2005, AU MAY NEED 45000 TR; Roberts L., 2000, MORTALITY E DRC RESU; ROBERTS L, 2001, MORTALITY E DEMOCRAT; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Steering Committee of the Joint Evaluation of Emergency Assistance to Rwanda, 1996, INT RESP CONFL GEN L; TALBOT C, 2000, US INTERVENES SHAPE; TAYLOR WR, 1993, INT J EPIDEMIOL, V22, pS15, DOI 10.1093/ije/22.Supplement_1.S15; *UNICEF, 1999, STAT WORLDS CHILDR R; *UNOCHA, 2004, HUM SIT DRC MONTHL U; *UNOCHA, 2003, TOT HUM ASS DEM REP; *UNOCHA, 2004, TOT HUM ASS DEM REP; *US BUR CENS, 2004, INT DAT BAS POP PYR; *US DEP STAT, BOSN HERZ COUNTR REP; *WHO, 2004, SUD MORT PROJ DARF; *WHO EXP PROGR IMM, 1991, TRAIN MIDL MAN EPI C; *WORLD BANK GROUP, WORLD DEV IND 2004; [No title captured]; 20 CENTURY ATLAS DEA	23	244	247	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					44	51		10.1016/S0140-6736(06)67923-3	http://dx.doi.org/10.1016/S0140-6736(06)67923-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399152				2022-12-01	WOS:000234443100029
J	Johnson, WE; Eizirik, E; Pecon-Slattery, J; Murphy, WJ; Antunes, A; Teeling, E; O'Brien, SJ				Johnson, WE; Eizirik, E; Pecon-Slattery, J; Murphy, WJ; Antunes, A; Teeling, E; O'Brien, SJ			The Late Miocene radiation of modern Felidae: A genetic assessment	SCIENCE			English	Article							MITOCHONDRIAL-DNA; CHRONOLOGY; PHYLOGENY; CARNIVORA; GENOME	Modern fetid species descend from relatively recent (<11 million years ago) divergence and speciation events that produced successful predatory carnivores worldwide but that have confounded taxonomic classifications. A highly resolved molecular phylogeny with divergence dates for all living cat species, derived from autosomal, X-linked, Y-linked, and mitochondrial gene segments (22,789 base pairs) and 16 fossil calibrations define eight principal lineages produced through at least 10 intercontinental migrations facilitated by sea-level fluctuations. A ghost lineage analysis indicates that available fetid fossils underestimate (i.e., unrepresented basal branch length) first occurrence by an average of 76%, revealing a low representation of fetid lineages in paleontological remains. The phylogenetic performance of distinct gene classes showed that Y-chromosome segments are appreciably more informative than mitochondrial DNA, X-linked, or autosomal genes in resolving the rapid Felidae species radiation.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Ctr Biol Genom & Mol, BR-90619900 Porto Alegre, RS, Brazil; Univ Porto, Fac Ciencias, Dept Quim, REQUIMTE, P-4167007 Porto, Portugal	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade do Porto	Johnson, WE (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	johnsonw@ncifcrf.gov; obrien@ncifcrf.gov	Pecon-Slattery, Jill/GXH-4494-2022; Eizirik, Eduardo/K-8034-2012; Johnson, Warren/D-4149-2016; OBRIEN, STEPHEN/ABD-1346-2020	Eizirik, Eduardo/0000-0002-9658-0999; Johnson, Warren/0000-0002-5954-186X; Antunes, Agostinho/0000-0002-1328-1732	NATIONAL CANCER INSTITUTE [Z01BC005367] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beaumont G. de, 1964, Eclogae Geologicae Helvetiae, V57, P837; Benveniste R. E., 1985, MOL EVOLUTIONARY GEN, P359; BORIEN SJ, 2005, ANN REV GENET HUM GE, V6, P407; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hunt Jr R. M., 1996, CARNIVORE BEHAV ECOL, V2, P485; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; KIM J, IN PRESS GENE; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MARSHALL LG, 1988, AM SCI, V76, P380; Mattern MY, 2000, CLADISTICS, V16, P232, DOI 10.1111/j.1096-0031.2000.tb00354.x; McKenna MC, 1997, CLASSIFICATION MAMMA; Nowak R.M., 1999, MAMMALS WORLD; Nowell K., 1996, WILD CATS STATUS SUR; O'hUigin C, 2002, MOL BIOL EVOL, V19, P1501, DOI 10.1093/oxfordjournals.molbev.a004213; Pecon-Slattery J, 2004, MOL BIOL EVOL, V21, P2299, DOI 10.1093/molbev/msh241; Repenning CA, 2001, QUATERNARY SCI REV, V20, P25, DOI 10.1016/S0277-3791(00)00133-5; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Slattery JP, 1998, GENETICS, V148, P1245; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Woodruff DS, 2003, J BIOGEOGR, V30, P551, DOI 10.1046/j.1365-2699.2003.00846.x; Yang ZH, 2002, GENETICS, V162, P1811; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; ZHANXIANG Q, 2003, B AM MUS NAT HIST, V279, P163	28	488	540	5	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					73	77		10.1126/science.1122277	http://dx.doi.org/10.1126/science.1122277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400146	Green Published			2022-12-01	WOS:000234546300035
J	Amdam, GV; Csondes, A; Fondrk, MK; Page, RE				Amdam, GV; Csondes, A; Fondrk, MK; Page, RE			Complex social behaviour derived from maternal reproductive traits	NATURE			English	Article							COLONY-LEVEL SELECTION; HONEY-BEE; ORGANIZATION; EUSOCIALITY; ORIGIN	A fundamental goal of sociobiology is to explain how complex social behaviour evolves(1), especially in social insects, the exemplars of social living. Although still the subject of much controversy(2), recent theoretical explanations have focused on the evolutionary origins of worker behaviour ( assistance from daughters that remain in the nest and help their mother to reproduce) through expression of maternal care behaviour towards siblings(3,4). A key prediction of this evolutionary model is that traits involved in maternal care have been co-opted through heterochronous expression of maternal genes(5) to result in sib-care, the hallmark of highly evolved social life in insects(6). A coupling of maternal behaviour to reproductive status evolved in solitary insects, and was a ready substrate for the evolution of worker-containing societies(3,4,7,8). Here we show that division of foraging labour among worker honey bees ( Apis mellifera) is linked to the reproductive status of facultatively sterile females. We thereby identify the evolutionary origin of a widely expressed social-insect behavioural syndrome(1,5,7,9), and provide a direct demonstration of how variation in maternal reproductive traits gives rise to complex social behaviour in non-reproductive helpers.	Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; University of California System; University of California Davis	Amdam, GV (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Gro.Amdam@asu.edu; Robert.Page@asu.edu			NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG022500, P01 AG022500-04] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Bloch Guy, 2002, P195; BUTLER CG, 1957, EXPERIENTIA, V13, P256, DOI 10.1007/BF02157449; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Dunn T, 2003, BEHAV ECOL, V14, P417, DOI 10.1093/beheco/14.3.417; GARY N E, 1976, Journal of Apicultural Research, V15, P73; Hartfelder K, 2002, INSECT BIOCHEM MOLEC, V32, P211, DOI 10.1016/S0965-1748(01)00100-X; HARTFELDER K, 1995, ROUX ARCH DEV BIOL, V205, P73, DOI 10.1007/BF00188845; Hodin J, 2000, EVOLUTION, V54, P1638, DOI 10.1111/j.0014-3820.2000.tb00708.x; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; MAURIZIO A, 1954, LANDWIRTSCH JB SCHWE, V245, P115; Min KJ, 2004, ARCH INSECT BIOCHEM, V55, P33, DOI 10.1002/arch.10109; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 2002, GENES BRAIN BEHAV, V1, P197, DOI 10.1034/j.1601-183X.2002.10401.x; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Seeley T.D., 1995, WISDOM HIVE SOCIAL P; Simonet G, 2004, J NEUROENDOCRINOL, V16, P649, DOI 10.1111/j.1365-2826.2004.01222.x; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Winston M. L., 1987, BIOL HONEY BEE	30	201	210	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					76	78		10.1038/nature04340	http://dx.doi.org/10.1038/nature04340			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397498	Green Accepted			2022-12-01	WOS:000234378700037
J	Quill, TE; Meier, DE				Quill, TE; Meier, DE			The big chill - Inserting the DEA into end-of-life care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAIN MANAGEMENT		Univ Rochester, Sch Med, Ctr Palliat Care & Clin Eth, Rochester, NY 14627 USA; Mt Sinai Sch Med, Lilian & Benjamin Hertzberg Palliat Care Inst, New York, NY USA; Mt Sinai Sch Med, Ctr Adv Palliat Care, New York, NY USA	University of Rochester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Quill, TE (corresponding author), Univ Rochester, Sch Med, Ctr Palliat Care & Clin Eth, Rochester, NY 14627 USA.							Drayer RA, 1999, J PAIN SYMPTOM MANAG, V17, P434, DOI 10.1016/S0885-3924(99)00022-6; Field MJ, 1997, APPROACHING DEATH IM; Gilson AM, 2005, HEALTH POLICY, V74, P192, DOI 10.1016/j.healthpol.2005.01.004; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Tucker KL, 2004, PAIN MED, V5, P214, DOI 10.1111/j.1526-4637.2004.4029_2.x	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					1	3		10.1056/NEJMp058289	http://dx.doi.org/10.1056/NEJMp058289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394295				2022-12-01	WOS:000234358600001
J	Stupack, DG; Teitz, T; Potter, MD; Mikolon, D; Houghton, PJ; Kidd, VJ; Lahti, JM; Cheresh, DA				Stupack, DG; Teitz, T; Potter, MD; Mikolon, D; Houghton, PJ; Kidd, VJ; Lahti, JM; Cheresh, DA			Potentiation of neuroblastoma metastasis by loss of caspase-8	NATURE			English	Article							CHILDHOOD NEUROBLASTOMAS; CELL-SURVIVAL; APOPTOSIS; INTEGRINS; DEATH; TUMOR; INACTIVATION; EXPRESSION; RECEPTORS; THERAPY	Neuroblastoma, the most common paediatric solid tumour, arises from defective neural crest cells(1). Genetic alterations occur frequently in the most aggressive neuroblastomas(1). In particular, deletion or suppression of the proapoptotic enzyme caspase-8 is common in malignant, disseminated disease, although the effect of this loss on disease progression is unclear(2-4). Here we show that suppression of caspase-8 expression occurs during the establishment of neuroblastoma metastases in vivo, and that reconstitution of caspase-8 expression in deficient neuroblastoma cells suppressed their metastases. Caspase-8 status was not a predictor of primary tumour growth; rather, caspase-8 selectively potentiated apoptosis in neuroblastoma cells invading the collagenous stroma at the tumour margin. Apoptosis was initiated by unligated integrins by means of a process known as integrin-mediated death(5). Loss of caspase-8 or integrin rendered these cells refractory to integrin-mediated death, allowed cellular survival in the stromal microenvironment, and promoted metastases. These findings define caspase-8 as a metastasis suppressor gene that, together with integrins, regulates the survival and invasive capacity of neuroblastoma cells.	Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA; St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Stupack, DG (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dstupack@ucsd.edu; jill.lahti@stjude.org	Lahti, Jari/P-7987-2018	Lahti, Jari/0000-0002-4310-5297	NCI NIH HHS [R01 CA107263] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Beltinger C, 2001, INT J CANCER, V92, P313, DOI 10.1002/ijc.1210; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bredesen DE, 2004, PHYSIOL REV, V84, P411, DOI 10.1152/physrev.00027.2003; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Patan S, 1997, MICROVASC RES, V53, P33, DOI 10.1006/mvre.1996.1989; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Teitz T, 2002, ONCOGENE, V21, P1848, DOI 10.1038/sj.onc.1205180; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Ziegler MM, 1997, CANCER-AM CANCER SOC, V79, P1757; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2002, CANCER RES, V62, P7083	30	215	222	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					95	99		10.1038/nature04323	http://dx.doi.org/10.1038/nature04323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397500				2022-12-01	WOS:000234378700041
J	Bowling, A; Dieppe, P				Bowling, A; Dieppe, P			What is successful ageing and who should define it?	BRITISH MEDICAL JOURNAL			English	Article							OLDER-ADULTS; LIFE; PREDICTORS; MACARTHUR		UCL, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Bristol, MRC Hlth Serv Res Collaborat, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; University College London; University of Bristol	Bowling, A (corresponding author), UCL, Dept Primary Care & Populat Sci, London NW3 2PF, England.	a.bowling@ucl.ac.uk						Andrews G, 2002, J SOC ISSUES, V58, P749, DOI 10.1111/1540-4560.00288; [Anonymous], 2002, AGING WELL SURPRISIN, DOI DOI 10.1176/APPI.AJP.161.1.178; [Anonymous], 1990, SUCCESSFUL AGEING PE; BALTES PB, 1999, BERLIN AGEING STUDY; Callahan CM, 2003, ANN INTERN MED, V139, P389, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00001; Caspi A, 1986, PSYCHOL AGING, V1, P18; Crosnoe R, 2002, SOC PSYCHOL QUART, V65, P309, DOI 10.2307/3090105; Grundy E, 1999, AGING MENT HEALTH, V3, P199, DOI 10.1080/13607869956154; Havighurst R. J., 1968, MIDDLE AGE AGING, P161; Havighurst RJ., 1963, PROCESSES AGING SOCI, P299, DOI 10.1093/geront/1.1.8; Menec VH, 2003, J GERONTOL B-PSYCHOL, V58, pS74, DOI 10.1093/geronb/58.2.S74; Mor V, 2005, J AM GERIATR SOC, V53, pS308, DOI 10.1111/j.1532-5415.2005.53496.x; PALMORE E, 1979, GERONTOLOGIST, V19, P427, DOI 10.1093/geront/19.5_Part_1.427; Phelan EA, 2004, J AM GERIATR SOC, V52, P211, DOI 10.1111/j.1532-5415.2004.52056.x; ROOS NP, 1991, AM J PUBLIC HEALTH, V81, P63, DOI 10.2105/AJPH.81.1.63; Rowe J.W., 1998, SUCCESSFUL AGING; RYFF CD, 1989, INT J BEHAV DEV, V12, P35, DOI 10.1177/016502548901200102; Sarkisian CA, 2002, J AM GERIATR SOC, V50, P1837, DOI 10.1046/j.1532-5415.2002.50513.x; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; Seligman M., 2002, AUTHENTIC HAPPINESS; Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727, DOI 10.1093/geront/42.6.727; Vaillant GE, 2001, AM J PSYCHIAT, V158, P839, DOI 10.1176/appi.ajp.158.6.839; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; WILLIAMS RH, 1965, LIVES YEARS STYLES L	24	379	389	7	53	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 24	2005	331	7531					1548	1551		10.1136/bmj.331.7531.1548	http://dx.doi.org/10.1136/bmj.331.7531.1548			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373748	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-01	WOS:000234351300029
J	Boehm, M; Slack, F				Boehm, M; Slack, F			A developmental timing microRNA and its target regulate life span in C. elegans	SCIENCE			English	Article							TEMPORAL PATTERN-FORMATION; HETEROCHRONIC GENE LIN-14; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LONGEVITY; EXPRESSION; DAF-16; ENCODES; PROTEIN; EVENTS	The microRNA lin-4 and its target, the putative transcription factor lin-14, control the timing of larval development in Caenorhabditis elegans. Here, we report that lin-4 and lin-14 also regulate life span in the adult. Reducing the activity of lin-4 shortened life span and accelerated tissue aging, whereas overexpressing lin-4 or reducing the activity of lin-14 extended life span. Life-span extension conferred by a reduction in lin-14 was dependent on the DAF-16 and HSF-1 transcription factors, suggesting that the lin-4-lin-14 pair affects life span through the insulin/insulin-like growth factor-1 pathway. This work reveals a role for microRNAs and developmental timing genes in life-span regulation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University	Slack, F (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	frank.slack@yale.edu		Slack, Frank/0000-0001-8263-0409	NIGMS NIH HHS [R01 GM064701, GM64701] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064701] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Garigan D, 2002, GENETICS, V161, P1101; Hong Y, 2000, MOL CELL BIOL, V20, P2285, DOI 10.1128/MCB.20.6.2285-2295.2000; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813	30	347	383	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1954	1957		10.1126/science.1115596	http://dx.doi.org/10.1126/science.1115596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373574				2022-12-01	WOS:000234275400042
J	Izurieta, HS; Haber, P; Wise, RP; Iskander, J; Pratt, D; Mink, C; Chang, SJ; Braun, MM; Ball, R				Izurieta, HS; Haber, P; Wise, RP; Iskander, J; Pratt, D; Mink, C; Chang, SJ; Braun, MM; Ball, R			Adverse events reported following live, cold-adapted, intranasal influenza vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; CHILDREN; SAFETY	Context In June 2003, the US Food and Drug Administration licensed a trivalent live, attenuated influenza vaccine (LAIV-T) for intranasal administration to healthy persons 5 to 49 years of age. Although prelicensure testing involved 20228 vaccinees, clinical trials were not of sufficient size to detect rare adverse events reliably. Objective To identify adverse events reported following LAIV-T administration after licensure. Design, Setting, and Participants All adverse events reported to the US Vaccine Adverse Event Reporting System (VAERS) during the 2003-2004 and the 2004-2005 influenza seasons. Main Outcome Measures Numbers and proportions of reported adverse events and reporting rates of adverse events per 100 000 vaccinees. Results Approximately 2 500000 persons received LAIV-T during the first 2 post-licensure seasons. As of August 16, 2005, VAERS received 460 adverse event reports for vaccinations received from August 2003 through July 2005. No fatalities were reported. There were 7 reports of possible anaphylaxis, 2 reports of Guillain-Barre syndrome, 1 report of Bell palsy, and 8 reports of asthma exacerbation among individuals with a prior asthma history. Events in individuals for whom the vaccine was not indicated accounted for 73 reports (16%). Conclusions Reports to VAERS in the first 2 seasons of LAIV-T use did not identify any unexpected serious risks with this vaccine when used according to approved indications. Like many vaccines and other medical products, LAIV-T may rarely cause anaphylaxis. Secondary transmission of the vaccine virus merits further investigation. Reports of asthma exacerbations in vaccinees with prior asthma history highlight the risks of vaccine use inconsistent with approved labeling.	US FDA, Vaccine Safety Branch, Div Epidemiol, Off Biostat & Epidemiol,Ctr Biol Evaluat & Res, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Natl Immunizat Off, Off Chief Sci Officer, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Izurieta, HS (corresponding author), US FDA, Vaccine Safety Branch, Div Epidemiol, Off Biostat & Epidemiol,Ctr Biol Evaluat & Res, 1401 Rockville Pike,2nd Floor,Suite 200S,HFM-222, Rockville, MD 20852 USA.	hector.izurieta@fda.hhs.gov						Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Harper Scott A, 2003, MMWR Recomm Rep, V52, P1; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; *MED VACC INC, 2005, INFL VIR VACC LIV IN; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Redding G, 2002, PEDIATR INFECT DIS J, V21, P44, DOI 10.1097/00006454-200201000-00010; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Stratton K.R., 1994, ADVERSE EVENTS ASS C; TURNER W, 2003, COMMUNICATION   0617; Varricchio F, 1998, J TOXICOL-CLIN TOXIC, V36, P765, DOI 10.3109/15563659809162636; VESIKARI T, 2001, 41 INT C ANT AG CHEM; WAUBANT E, 2004, IMM SAF REV M, V5; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	18	98	107	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2720	2725		10.1001/jama.294.21.2720	http://dx.doi.org/10.1001/jama.294.21.2720			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333007	Bronze			2022-12-01	WOS:000233726900020
J	Brindusa, C				Brindusa, C			Marfan's syndrome: a daily struggle	LANCET			English	Editorial Material											Brindusa, C (corresponding author), Str Cetatii 28, Sibiu 550160, Romania.	brindusac@gmail.com							0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 3	2005	366	9501					1977	1977		10.1016/S0140-6736(05)67790-2	http://dx.doi.org/10.1016/S0140-6736(05)67790-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990XY	16325701				2022-12-01	WOS:000233777900027
J	Robinson, LF; Adkins, JF; Keigwin, LD; Southon, J; Fernandez, DP; Wang, SL; Scheirer, DS				Robinson, LF; Adkins, JF; Keigwin, LD; Southon, J; Fernandez, DP; Wang, SL; Scheirer, DS			Radiocarbon variability in the western North Atlantic during the last deglaciation	SCIENCE			English	Article							DEEP-SEA CORALS; MILLENNIAL-SCALE CHANGES; CAL KYR BP; GLACIAL MAXIMUM; SOUTHERN-OCEAN; THERMOHALINE CIRCULATION; SURFACE-TEMPERATURE; INTERMEDIATE WATER; AGE CALIBRATION; CLIMATE-CHANGE	We present a detailed history of glacial to Holocene radiocarbon in the deep western North Atlantic from deep-sea corals and paired benthic-planktonic foraminifera. The deglaciation is marked by switches between radiocarbon-enriched and -depleted waters, leading to large radiocarbon gradients in the water column. These changes played an important role in modulating atmospheric radiocarbon. The deep-ocean record supports the notion of a bipolar seesaw with increased Northem-source deep-water formation linked to Northern Hemisphere warming and the reverse. In contrast, the more frequent radiocarbon variations in the intermediate/deep ocean are associated with roughly synchronous changes at the poles.	CALTECH, Pasadena, CA 91125 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, McLean Lab, Woods Hole, MA 02543 USA; Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; US Geol Survey, Menlo Pk, CA 94025 USA	California Institute of Technology; Woods Hole Oceanographic Institution; University of California System; University of California Irvine; United States Department of the Interior; United States Geological Survey	Robinson, LF (corresponding author), CALTECH, MS 100-23,1200 E Calif Blvd, Pasadena, CA 91125 USA.	laurar@gps.caltech.edu	Adkins, Jess/GYI-8778-2022; Stott, Lowell/J-9460-2012	Robinson, Laura/0000-0001-6811-0140				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bostock HC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001047; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BROECKER W, 1988, RADIOCARBON, V30, P261, DOI 10.1017/S0033822200044234; Broecker W., 1982, TRACERS SEA; Broecker WS, 1991, GLOBAL BIOGEOCHEM CY, V5, P87, DOI 10.1029/90GB02279; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1990, RADIOCARBON, V32, P119, DOI 10.1017/S003382220004011X; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; ELTGROTH S, UNPUB PALEOCEANOGRAP, P20601; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Frank N, 2004, EARTH PLANET SC LETT, V219, P297, DOI 10.1016/S0012-821X(03)00721-0; Gersonde R, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000809; Gersonde R, 2000, PALAEOGEOGR PALAEOCL, V162, P263, DOI 10.1016/S0031-0182(00)00131-0; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Goldstein SJ, 2001, EARTH PLANET SC LETT, V193, P167, DOI 10.1016/S0012-821X(01)00494-0; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; KEIGWIN LD, 1994, J GEOPHYS RES-OCEANS, V99, P12397, DOI 10.1029/94JC00525; Keigwin LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001074; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Keigwin LD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000283; Mangini A, 1998, NATURE, V392, P347, DOI 10.1038/32804; Marchitto TM, 1998, NATURE, V393, P557, DOI 10.1038/31197; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; Pahnke K, 2005, SCIENCE, V307, P1741, DOI 10.1126/science.1102163; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; RAISBECK GM, 1981, GEOPHYS RES LETT, V8, P1015, DOI 10.1029/GL008i009p01015; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Schroder-Ritzrau A, 2003, EARTH PLANET SC LETT, V216, P399, DOI 10.1016/S0012-821X(03)00511-9; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; STUIVER M, 1980, RADIOCARBON, V22, P1, DOI 10.1017/S0033822200004690; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wunsch C, 2003, QUATERNARY SCI REV, V22, P371, DOI 10.1016/S0277-3791(02)00177-4	47	202	203	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1469	1473		10.1126/science.1114832	http://dx.doi.org/10.1126/science.1114832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322451				2022-12-01	WOS:000233756500037
J	Xi, RW; Xie, T				Xi, RW; Xie, T			Stem cell self-renewal controlled by chromatin remodeling factors	SCIENCE			English	Article							DROSOPHILA-OVARY; HOMEOTIC GENES; GERMLINE; MAINTENANCE; PROLIFERATION; TRANSCRIPTION; DIVISIONS; HEDGEHOG; PROTEIN; BMI-1	The self-renewing ability of a stem cell is controlled by its specialized microenvironment or niche, whereas epigenetic regulation of gene expression by chromatin remodeling factors underlies cell fate determination. Here we report that the adenosine triphosphate-dependent chromatin remodeling factors ISWI and DOM control germline stem cell and somatic stem cell self-renewal in the Drosophila ovary, respectively. The iswi mutant germline stem cells are lost rapidly because of defects in responding to bone morphogenetic protein niche signals and in repressing differentiation, whereas the dom mutant somatic stem cells are lost because of defective self-renewal. This work demonstrates that different stem cell types can use different chromatin remodeling factors to control cell self-renewal.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064428, 1R01 GM64428-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	26	120	124	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1487	1489		10.1126/science.1120140	http://dx.doi.org/10.1126/science.1120140			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322456				2022-12-01	WOS:000233756500042
J	Kujala, UM				Kujala, UM			Essay - Does training adversely affect long-term health?	LANCET			English	Article									Univ Jyvaskyla, Dept Hlth Sci, FIN-40014 Jyvaskyla, Finland	University of Jyvaskyla	Kujala, UM (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, POB 35 LL, FIN-40014 Jyvaskyla, Finland.	urho.kujala@sport.jyu.fi	Kujala, Urho/AAP-2547-2020	Kujala, Urho/0000-0002-9262-1992				Kujala UM, 2003, SPORTS MED, V33, P553, DOI 10.2165/00007256-200333080-00001; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Kujala UM, 1996, JAMA-J AM MED ASSOC, V276, P216, DOI 10.1001/jama.276.3.216; Morgan JE, 1987, U OARS; Saltin B., 1983, HDB PHYSL 10, P555, DOI DOI 10.1007/S00421-005-0088-2; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294	6	5	5	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S55	S56		10.1016/S0140-6736(05)67853-1	http://dx.doi.org/10.1016/S0140-6736(05)67853-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360758				2022-12-01	WOS:000234374400034
J	Schumacher, MA; Funnell, BE				Schumacher, MA; Funnell, BE			Structures of ParB bound to DNA reveal mechanism of partition complex formation	NATURE			English	Article							P1 PLASMID PARTITION; INTEGRATION HOST FACTOR; SPECIFICITY; SITE; BINDING; CENTROMERE; SEQUENCE; SYSTEM	The faithful inheritance of genetic information, which is essential for all organisms, requires accurate DNA partition (segregation) at cell division. In prokaryotes, partition is mediated by par systems, for which the P1 plasmid system of Escherichia coli is a prototype comprising a partition site and two proteins, ParA and ParB(1,2). To form the partition complex necessary for segregation, P1 ParB must recognize a complicated arrangement of A-box and B-box DNA motifs located on opposite ends of a sharply bent parS partition site of similar to 74 bp (refs 3-7). Here we describe structures of ParB bound to partition sites. ParB forms an asymmetric dimer with extended amino-terminal HTH (helix-turn-helix) domains that contact A-boxes. The two HTH domains emanate from a dimerized DNA-binding module composed of a six-stranded beta-sheet coiled-coil that binds B-boxes. Strikingly, these individual DNA-binding modules rotate freely about a flexible linker, enabling them to contact several arrangements of A- and B-boxes. Most notably, each DNA-binding element binds to and thus bridges adjacent DNA duplexes. These unique structural features of ParB explain how this protein can bind complex arrays of A- and B-box elements on adjacent DNA arms of the looped partition site.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	Oregon Health & Science University; University of Toronto	Schumacher, MA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	schumacm@ohsu.edu		Funnell, Barbara/0000-0002-1828-6567				Bouet JY, 2000, J BIOL CHEM, V275, P8213, DOI 10.1074/jbc.275.11.8213; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIS MA, 1990, EMBO J, V9, P991, DOI 10.1002/j.1460-2075.1990.tb08201.x; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Funnell BE, 2004, PLASMID BIOLOGY, P81; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAYES F, 1993, P NATL ACAD SCI USA, V90, P9228, DOI 10.1073/pnas.90.19.9228; HAYES F, 1994, J MOL BIOL, V243, P190, DOI 10.1006/jmbi.1994.1646; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; MARTIN KA, 1991, J BACTERIOL, V173, P3630, DOI 10.1128/JB.173.12.3630-3634.1991; Radnedge L, 1998, EMBO J, V17, P6076, DOI 10.1093/emboj/17.20.6076; Radnedge L, 1996, EMBO J, V15, P1155, DOI 10.1002/j.1460-2075.1996.tb00454.x; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Surtees JA, 2003, CURR TOP DEV BIOL, V56, P145, DOI 10.1016/S0070-2153(03)01010-X; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	30	90	90	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					516	519		10.1038/nature04149	http://dx.doi.org/10.1038/nature04149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306995				2022-12-01	WOS:000233458200054
J	Fiocchi, C				Fiocchi, C			One commensal bacterial molecule - All we need for health?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICROFLORA		Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Fiocchi, C (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024	5	13	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2005	353	19					2078	2080		10.1056/NEJMcibr053171	http://dx.doi.org/10.1056/NEJMcibr053171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981WV	16282185				2022-12-01	WOS:000233119600016
J	Carrozza, MJ; Li, B; Florens, L; Suganuma, T; Swanson, SK; Lee, KK; Shia, WJ; Anderson, S; Yates, J; Washburn, MP; Workman, JL				Carrozza, MJ; Li, B; Florens, L; Suganuma, T; Swanson, SK; Lee, KK; Shia, WJ; Anderson, S; Yates, J; Washburn, MP; Workman, JL			Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription	CELL			English	Article							RNA-POLYMERASE-II; CHROMATIN IN-VIVO; PROTEIN IDENTIFICATION TECHNOLOGY; REGULATES H3 METHYLATION; SACCHAROMYCES-CEREVISIAE; TARGETED RECRUITMENT; SHOTGUN PROTEOMICS; GENE-EXPRESSION; YEAST PROTEOME; DNA-SYNTHESIS	Yeast Rpd3 histone deacetylase plays an important role at actively transcribed genes. We characterized two distinct Rpd3 complexes, Rpd3L and Rpd3S, by MudPIT analysis. Both complexes shared a three subunit core and Rpd3L contains unique subunits consistent with being a promoter targeted corepressor. Rco1 and Eaf3 were subunits specific to Rpd3S. Mutants of RCO1 and EAF3 exhibited increased acetylation in the FLO8 and STE11 open reading frames (ORFs) and the appearance of aberrant transcripts initiating within the body of these ORFs. Mutants in the RNA polymerase II-associated SET2 histone methyltransferase also displayed these defects. Set2 functioned upstream of Rpd3S and the Eaf3 methyl-histone binding chromodomain was important for recruitment of Rpd3S and for deacetylation within the STE11 ORF. These data indicate that Pol ll-associated Set2 methylates H3 providing a transcriptional memory which signals for deacetylation of ORFs by Rpd3S. This erases transcription elongation-associated acetylation to suppress intragenic transcription initiation.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Stowers Institute for Medical Research; Scripps Research Institute	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIGMS NIH HHS [GM047867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867, R37GM047867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; CARROZZA MJ, 2005, IN PRESS BBA GENE ST; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Guthrie C, 1991, GUIDE YEAST GENETICS; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Moris G, 2003, NEUROLOGIA, V18, P723; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	68	952	973	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					581	592		10.1016/j.cell.2005.10.023	http://dx.doi.org/10.1016/j.cell.2005.10.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286007	Bronze			2022-12-01	WOS:000233497400008
J	Wills, C; Harms, KE; Condit, R; King, D; Thompson, J; He, FL; Muller-Landau, HC; Ashton, P; Losos, E; Comita, L; Hubbell, S; LaFrankie, J; Bunyavejchewin, S; Dattaraja, HS; Davies, S; Esufali, S; Foster, R; Gunatilleke, N; Gunatilleke, S; Hall, P; Itoh, A; John, R; Kiratiprayoon, S; de Lao, SL; Massa, M; Nath, C; Noor, MNS; Kassim, AR; Sukumar, R; Suresh, HS; Sun, IF; Tan, S; Yamakura, T; Zimmerman, E				Wills, C; Harms, KE; Condit, R; King, D; Thompson, J; He, FL; Muller-Landau, HC; Ashton, P; Losos, E; Comita, L; Hubbell, S; LaFrankie, J; Bunyavejchewin, S; Dattaraja, HS; Davies, S; Esufali, S; Foster, R; Gunatilleke, N; Gunatilleke, S; Hall, P; Itoh, A; John, R; Kiratiprayoon, S; de Lao, SL; Massa, M; Nath, C; Noor, MNS; Kassim, AR; Sukumar, R; Suresh, HS; Sun, IF; Tan, S; Yamakura, T; Zimmerman, E			Nonrandom processes maintain diversity in tropical forests	SCIENCE			English	Article							POPULATION REGULATION; DENSITY-DEPENDENCE; NEOTROPICAL FOREST; SPATIAL-PATTERNS; SOIL PATHOGENS; RAIN-FORESTS; TREE; PRODUCTIVITY; MAINTENANCE; MORTALITY	An ecological community's species diversity tends to erode through time as a result of stochastic extinction, competitive exclusion, and unstable host-enemy dynamics. This erosion of diversity can be prevented over the short term if recruits are highly diverse as a result of preferential recruitment of rare species or, alternatively, if rare species survive preferentially, which increases diversity as the ages of the individuals increase. Here, we present census data from seven New and Old World tropical forest dynamics plots that all show the latter pattern. Within local areas, the trees that survived were as a group more diverse than those that were recruited or those that died. The larger (and therefore on average older) survivors were more diverse within local areas than the smaller survivors. When species were rare in a local area, they had a higher survival rate than when they were common, resulting in enrichment for rare species and increasing diversity with age and size class in these complex ecosystems.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Smithsonian Trop Res Inst, Unit 0948, APO, AA 34002 USA; Harvard Univ, Herbaria, Arnold Arboretum Asia Program, Ctr Trop Forest Sci, Cambridge, MA 02138 USA; Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00931 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Washington, DC 20560 USA; Univ Georgia, Dept Plant Sci, Athens, GA 30602 USA; Nanyang Technol Univ, Natl Inst Educ, Arnold Arboretum Asia Program, Ctr Trop Forest Sci, Singapore 637616, Singapore; Thai Natl Pk Wildlife & Plant Conservat Dept, Bangkok 10900, Thailand; Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya 20400, Sri Lanka; Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Florida State Univ, Dept Biol, Tallahassee, FL 32309 USA; Osaka City Univ, Fac Sci, Plant Ecol Lab, Sumiyoshi Ku, Osaka 558, Japan; Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; Thammasat Univ Rangsit, Fac Sci & Technol, Klongluang 12121, Patumtani, Thailand; Forest Res Inst Malaysia, Forest Environm Div, Kuala Lumpur 52109, Malaysia; Tunghai Univ, Ctr Trop Ecol & Biodivers, Taipei 407, Taiwan; Sarawak Forest Dept, Forest Res Ctr, Kuching 93250, Sarawak, Malaysia	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Alberta; University of Minnesota System; University of Minnesota Twin Cities; Smithsonian Institution; Smithsonian Tropical Research Institute; University System of Georgia; University of Georgia; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Indian Institute of Science (IISC) - Bangalore; University of Peradeniya; Field Museum of Natural History (Chicago); State University System of Florida; Florida State University; Osaka Metropolitan University; University of Illinois System; University of Illinois Urbana-Champaign; Thammasat University; Institute Penyelidikan Perhutanan Malaysia; Tunghai University; Jabatan Hutan Sarawak; Pusat Penyelidikan Hutan	Wills, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	cwills@ucsd.edu	Raman, Sukumar/C-9809-2013; Bunyavejchewin, Sarayudh/P-1529-2017; Thompson, Jill/K-2200-2012	Bunyavejchewin, Sarayudh/0000-0002-1976-5041; Thompson, Jill/0000-0002-4370-2593; Comita, Liza/0000-0002-9169-1331; Muller-Landau, Helene C./0000-0002-3526-9021				AUGSPURGER CK, 1983, J ECOL, V71, P759, DOI 10.2307/2259591; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; CONNELL J H, 1971, P298; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Feeny P., 1975, COEVOLUTION ANIMALS, P3; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; Hubbell Stephen P., 2001, V32, pi; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Noble IR, 1997, SCIENCE, V277, P522, DOI 10.1126/science.277.5325.522; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, V10, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; SHELLY TE, 1985, OECOLOGIA, V67, P57, DOI 10.1007/BF00378452; Silman MR, 2003, ECOLOGY, V84, P431, DOI 10.1890/0012-9658(2003)084[0431:PROADR]2.0.CO;2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 1999, P ROY SOC B-BIOL SCI, V266, P1445, DOI 10.1098/rspb.1999.0799; Wills C, 1996, NEW SCI, V149, P38; WILLS C, 1995, IMMUNOL REV, V143, P263, DOI 10.1111/j.1600-065X.1995.tb00679.x; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	28	139	153	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					527	531		10.1126/science.1117715	http://dx.doi.org/10.1126/science.1117715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439661	Green Submitted			2022-12-01	WOS:000235071400047
J	Simmons, SL; Bazylinski, DA; Edwards, KJ				Simmons, SL; Bazylinski, DA; Edwards, KJ			South-seeking magnetotactic bacteria in the Northern Hemisphere	SCIENCE			English	Article							SULFATE-REDUCING BACTERIUM; MAGNETIC SPIRILLUM; SEDIMENTS	Magnetotactic bacteria contain membrane-bound intracellular iron crystals (magnetosomes) and respond to magnetic fields. Polar magnetotactic bacteria in vertical chemical gradients are thought to respond to high oxygen levels by swimming downward into areas with tow or no oxygen (toward geomagnetic north in the Northern Hemisphere and geomagnetic south in the Southern Hemisphere). We identified populations of polar magnetotactic bacteria in the Northern Hemisphere that respond to high oxygen levels by swimming toward geomagnetic south, the opposite of all previously reported magnetotactic behavior. The percentage of magnetotactic bacteria with south polarity in the environment is positively correlated with higher redox potential. The coexistence of magnetotactic bacteria with opposing polarities in the same redox environment conflicts with current models of the adaptive value of magnetotaxis.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Geomicrobiol Grp, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, MIT WHOI Joint Program Oceanog, Woods Hole, MA 02543 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Iowa State University	Edwards, KJ (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Geomicrobiol Grp, MS 52, Woods Hole, MA 02543 USA.	katrina@whoi.edu						BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0; DELONG EF, 1993, SCIENCE, V259, P803, DOI 10.1126/science.259.5096.803; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Kalmijn AJ., 1978, ANIMAL MIGRATION NAV, P354; KAWAGUCHI R, 1995, FEMS MICROBIOL LETT, V126, P277, DOI 10.1111/j.1574-6968.1995.tb07430.x; KIRSCHVINK JL, 1980, J EXP BIOL, V86, P345; Lie TJ, 1999, APPL ENVIRON MICROB, V65, P3328; MOENCH TT, 1978, ARCH MICROBIOL, V119, P203, DOI 10.1007/BF00964274; PETERMANN H, 1993, EARTH PLANET SC LETT, V117, P223, DOI 10.1016/0012-821X(93)90128-V; Sakaguchi T, 2002, INT J SYST EVOL MICR, V52, P215, DOI 10.1099/00207713-52-1-215; Simmons SL, 2004, APPL ENVIRON MICROB, V70, P6230, DOI 10.1128/AEM.70.10.6230-6239.2004; SIMMONS SL, UNPUB; SPORMANN AM, 1984, FEMS MICROBIOL LETT, V22, P171; SPRING S, 1992, SYST APPL MICROBIOL, V15, P116, DOI 10.1016/S0723-2020(11)80147-5; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; STOLZ JF, 1986, NATURE, V321, P849, DOI 10.1038/321849a0	20	83	90	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					371	374		10.1126/science.1122843	http://dx.doi.org/10.1126/science.1122843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424338				2022-12-01	WOS:000234938500042
J	Janjusevic, R; Abramovitch, RB; Martin, GB; Stebbins, CE				Janjusevic, R; Abramovitch, RB; Martin, GB; Stebbins, CE			A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase	SCIENCE			English	Article							PTO-MEDIATED RESISTANCE; III SECRETION; U-BOX; EFFECTOR; DISEASE; DELIVERY; AVRPTOB; SCF	The Pseudomonas syringae protein AvrPtoB is translocated into plant cells, where it inhibits immunity-associated programmed cell. death (PCD). The structure of a C-terminal domain of AvrPtoB that is essential for anti-PCD activity reveals an unexpected homology to the U-box and RING-finger components of eukaryotic E3 ubiquitin ligases, and we show that AvrPtoB has ubiquitin ligase activity. Mutation of conserved residues involved in the binding of E2 ubiquitin-conjugating enzymes abolishes this activity in vitro, as well as anti-PCD activity in tomato leaves, which dramatically decreases virulence. These results show that Pseudomonas syringae uses a mimic of host E3 ubiquitin ligases to inactivate plant defenses.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Rockefeller Univ, Lab Struct Microbiol, New York, NY 10021 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Rockefeller University; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu; stebbins@rockefeller.edu	Abramovitch, Robert B/A-5324-2013; Martin, Gregory B/F-6262-2011; Stebbins, Erec/N-2565-2018; Abramovitch, Robert/O-6798-2019	Martin, Gregory B/0000-0003-0044-6830; Stebbins, Erec/0000-0001-6229-5308; Abramovitch, Robert/0000-0002-4119-4169				Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cornelis GR, 2000, PHILOS T R SOC B, V355, P681, DOI 10.1098/rstb.2000.0608; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Estelle M, 2001, CURR OPIN PLANT BIOL, V4, P254, DOI 10.1016/S1369-5266(00)00169-2; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Imai N, 2003, J VIROL, V77, P923, DOI 10.1128/JVI.77.2.923-930.2003; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Tzfira T, 2004, NATURE, V431, P87, DOI 10.1038/nature02857; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zaharik ML, 2002, INT J MED MICROBIOL, V291, P593, DOI 10.1078/1438-4221-00179; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	263	279	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					222	226		10.1126/science.1120131	http://dx.doi.org/10.1126/science.1120131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16373536				2022-12-01	WOS:000234722200040
J	Lee, HX; Ambrosio, AL; Reversade, B; De Robertis, EM				Lee, HX; Ambrosio, AL; Reversade, B; De Robertis, EM			Embryonic dorsal-ventral signaling: Secreted Frizzled-related proteins as inhibitors of tolloid proteinases	CELL			English	Article							NEGATIVE FEEDBACK REGULATOR; PATTERN-FORMATION; ZEBRAFISH; CHORDIN; FAMILY; METALLOPROTEASE; ANTAGONIST; ACTIVATION; BINDING; DOMAIN	Here we report an unexpected role for the secreted Frizzled-related protein (sFRP) Sizzled/Ogon as an inhibitor of the extracellular proteolytic reaction that controls BMP signaling during Xenopus gastrulation. Microinjection experiments suggest that the Frizzled domain of Sizzled regulates the activity of Xolloid-related (Xlr), a metalloproteinase that degrades Chordin, through the following molecular pathway: Szl Xlr I Chd d BMP -> P-Smad1 -> Szl. In biochemical assays, the Xlr proteinase has similar affinities for its endogenous substrate Chordin and for its competitive inhibitor Sizzled, which is resistant to enzyme digestion. Extracellular levels of Sizzled and Chordin in the gastrula embryo and enzyme reaction constants were all in the 10(-8) M range, consistent with a physiological role in the regulation of dorsal-ventral patterning. Sizzled is also a natural inhibitor of BMP1, a Tolloid metalloproteinase of medical interest. Furthermore, mouse sFRP2 inhibited Xlr, suggesting a wider role for this molecular mechanism.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		Lee, Hojoon/0000-0001-6214-629X; REVERSADE, Bruno/0000-0002-4070-7997	NICHD NIH HHS [R37 HD21502-19, R37 HD021502-19, R37 HD021502] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; BYERS PH, 2001, METABOLIC MOL BASES, P5241; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dixon M., 1979, ENZYMES, Vthird; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Hammerschmidt M, 2002, RES PRO CEL, V40, P72; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Miller-Bertaglio V, 1999, DEV BIOL, V214, P72, DOI 10.1006/dbio.1999.9384; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Povelones M, 2005, EMBO J, V24, P3493, DOI 10.1038/sj.emboj.7600817; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rehn M, 1998, TRENDS BIOCHEM SCI, V23, P415, DOI 10.1016/S0968-0004(98)01290-0; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Salic AN, 1997, DEVELOPMENT, V124, P4739; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; STOCKER W, 1995, PROTEIN SCI, V4, P823; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506	42	176	192	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					147	159		10.1016/j.cell.2005.12.018	http://dx.doi.org/10.1016/j.cell.2005.12.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413488	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000234969600016
J	Huang, JK; Phillips, GR; Roth, AD; Pedraza, L; Shan, WS; Belkaid, W; Mi, S; Fex-Svenningsen, A; Florens, L; Yates, JR; Colman, DR				Huang, JK; Phillips, GR; Roth, AD; Pedraza, L; Shan, WS; Belkaid, W; Mi, S; Fex-Svenningsen, A; Florens, L; Yates, JR; Colman, DR			Glial membranes at the node of Ranvier prevent neurite outgrowth	SCIENCE			English	Article							OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCANS; RAT OPTIC-NERVE; AXONAL REGENERATION; CNS MYELIN; LOCALIZATION; CELL; PROTEIN; ADULT; GROWTH	Nodes of Ranvier are regularly placed, nonmyelinated axon segments along myelinated nerves. Here we show that nodal membranes isolated from the central nervous system (CNS) of mammals restricted neurite outgrowth of cultured neurons.. Proteomic analysis of these membranes revealed several inhibitors of neurite outgrowth, including the oligodendrocyte myelin glycoprotein (OMgp). In rat spinal cord, OMgp was not localized to compact myelin, as previously thought, but to oligodendroglia-like cells, whose processes converge to form a ring that completely encircles the nodes. In OMgp-null mice, CNS nodes were abnormally wide and collateral sprouting was observed. Nodal ensheathment in the CNS may stabilize the node and prevent axonal sprouting.	CUNY, Mt Sinai Med Ctr, Fishberg Dept Neurosci, New York, NY 10029 USA; Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Biogen Idec, Discovery Biol, Cambridge, MA 02142 USA; Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; Stowers Inst, Kansas City, MO 64110 USA; Scripps Res Inst, Dept Cell Biol SR11, La Jolla, CA 92037 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Cambridge; McGill University; Biogen; Uppsala University; Stowers Institute for Medical Research; Scripps Research Institute	Colman, DR (corresponding author), CUNY, Mt Sinai Med Ctr, Fishberg Dept Neurosci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	david.colman@mcgill.ca	Huang, Jeffrey/J-5248-2017; Huang, Jeffrey K./AAH-2418-2021; Roth, Alejandro D/A-5086-2009; Svenningsen, Åsa Fex/H-5443-2015	Huang, Jeffrey/0000-0003-0996-9451; Huang, Jeffrey K./0000-0003-0996-9451; Roth, Alejandro D/0000-0001-5679-8136; Svenningsen, Åsa Fex/0000-0002-5651-265X; Florens, Laurence/0000-0002-9310-6650	NCRR NIH HHS [P41 RR11823] Funding Source: Medline; NINDS NIH HHS [NS20147] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; BRUNNER C, 1989, J NEUROCHEM, V52, P296, DOI 10.1111/j.1471-4159.1989.tb10930.x; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; DOU CL, 1994, J NEUROSCI, V14, P7616; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; FFRENCHCONSTANT C, 1986, J CELL BIOL, V102, P844, DOI 10.1083/jcb.102.3.844; Goldsmith AP, 2004, J NEUROSCI RES, V78, P647, DOI 10.1002/jnr.20320; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lambert S, 1997, J NEUROSCI, V17, P7025; LEVINE JM, 1987, J NEUROSCI, V7, P2711; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; MIKOL DD, 1990, J CELL BIOL, V111, P2673, DOI 10.1083/jcb.111.6.2673; MIKOL DD, 1988, J CELL BIOL, V106, P1273, DOI 10.1083/jcb.106.4.1273; MILLER RH, 1989, EUR J NEUROSCI, V1, P172, DOI 10.1111/j.1460-9568.1989.tb00785.x; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Oohashi T, 2002, MOL CELL NEUROSCI, V19, P43, DOI 10.1006/mcne.2001.1061; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Peters A., 1978, FINE STRUCTURE NERVO, V4, P588; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; SLACK JR, 1979, NATURE, V282, P506, DOI 10.1038/282506a0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	32	126	138	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1813	1817		10.1126/science.1118313	http://dx.doi.org/10.1126/science.1118313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16293723				2022-12-01	WOS:000234093600046
J	Lamb, D; Erskine, PD; Parrotta, JA				Lamb, D; Erskine, PD; Parrotta, JA			Restoration of degraded tropical forest landscapes	SCIENCE			English	Review							ABANDONED PASTURES; COSTA-RICA; BIODIVERSITY; PLANTATIONS; CONSERVATION; REGENERATION; GROWTH	The current scale of deforestation in tropical regions and the large areas of degraded lands now present underscore the urgent need,for interventions to restore biodiversity, ecological functioning, and the supply of goods and ecological services previously used by poor rural communities. Traditional timber plantations have supplied some goods but have made only minor contributions to fulfilling most of these other objectives. New approaches to reforestation are now emerging, with potential for both overcoming forest degradation and addressing rural poverty.	Univ Queensland, Rainforest Cooperat Res Ctr, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; US Forest Serv, Res & Dev, USDA, Arlington, VA 22209 USA	University of Queensland; University of Queensland; United States Department of Agriculture (USDA); United States Forest Service	Lamb, D (corresponding author), Univ Queensland, Rainforest Cooperat Res Ctr, Brisbane, Qld 4072, Australia.	d.lamb@uq.edu.au	Erskine, Peter D/U-3136-2018	Erskine, Peter D/0000-0002-8298-2866; Parrotta, John/0000-0002-9283-6037				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Arroyo-Mora JP, 2005, AGR ECOSYST ENVIRON, V106, P27, DOI 10.1016/j.agee.2004.07.002; Ashton MS, 2001, FOREST ECOL MANAG, V154, P431, DOI 10.1016/S0378-1127(01)00513-8; BARROW E, 2002, FOREST LANDSCAPE RES; Corlett RT, 1999, FOREST ECOL MANAG, V116, P93, DOI 10.1016/S0378-1127(98)00443-5; du Toit JT, 2004, TRENDS ECOL EVOL, V19, P12, DOI 10.1016/j.tree.2003.09.018; Elliott S, 2003, FOREST ECOL MANAG, V184, P177, DOI 10.1016/S0378-1127(03)00211-1; Engel VL, 2001, FOREST ECOL MANAG, V152, P169, DOI 10.1016/S0378-1127(00)00600-9; Erskine PD, 2002, ECOL MANAG RESTOR, V3, P136; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; ITTO-International Tropical Timber Organization, 2002, POLICY DEV SERIES, V13; Lamb D., 2003, REHABILITATION RESTO; Leopold AC, 2001, FOREST ECOL MANAG, V142, P243, DOI 10.1016/S0378-1127(00)00354-6; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MacDonald GE, 2004, CRIT REV PLANT SCI, V23, P367, DOI 10.1080/07352680490505114; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin PH, 2004, BIOTROPICA, V36, P297; McNabb KL, 1999, NEW FOREST, V18, P5, DOI 10.1023/A:1006536105443; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Parrotta JA, 1999, RESTOR ECOL, V7, P103, DOI 10.1046/j.1526-100X.1999.72001.x; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P21, DOI 10.1016/S0378-1127(97)00192-8; Piotto D, 2004, FOREST ECOL MANAG, V190, P359, DOI 10.1016/j.foreco.2003.11.005; Piotto D, 2003, FOREST ECOL MANAG, V175, P195, DOI 10.1016/S0378-1127(02)00127-5; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; SCHERR S, 2004, SERVICES RENDERED; TEMPERTON V. M., 2004, ASSEMBLY RULES RESTO; Tucker NIJ, 1997, FOREST ECOL MANAG, V99, P133, DOI 10.1016/S0378-1127(97)00200-4; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566	30	864	932	18	533	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1628	1632		10.1126/science.1111773	http://dx.doi.org/10.1126/science.1111773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339437				2022-12-01	WOS:000233961700032
J	Naylor, R; Steinfeid, H; Falcon, W; Galloways, J; Smil, V; Bradford, E; Alder, J; Mooney, H				Naylor, R; Steinfeid, H; Falcon, W; Galloways, J; Smil, V; Bradford, E; Alder, J; Mooney, H			Losing the links between livestock and land	SCIENCE			English	Editorial Material									Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; FAO Headquarters, Anim Prod & Hlth Div, I-00100 Rome, Italy; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Univ Manitoba, Dept Geog, Winnipeg, MB R3T 2N2, Canada; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Stanford University; Stanford University; Food & Agriculture Organization of the United Nations (FAO); University of Virginia; University of Manitoba; University of California System; University of California Davis; University of British Columbia	Naylor, R (corresponding author), Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA.	roz@stanford.edu	Galloway, James N/C-2769-2013	Galloway, James N/0000-0001-7676-8698				Arthur J. A., 2003, POULTRY GENETICS BRE; Bruinsma J, 2003, WORLD AGR 2015 2030; *EPA, 2003, NAT POLL DISCH EL EF; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Herath DP, 2005, REV AGR ECON, V27, P49, DOI 10.1111/j.1467-9353.2004.00207.x; *NAT AC SCI, NUTR REQ DOM AN; OENERMA O, 2005, MANURE POLICY MINAS; Smil V, 2002, POPUL DEV REV, V28, P599, DOI 10.1111/j.1728-4457.2002.00599.x; Smil V., 2000, FEEDING WORLD CHALLE; *USDA, AM BRAZ FIN SOYB FRO	11	266	281	9	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1621	1622		10.1126/science.1117856	http://dx.doi.org/10.1126/science.1117856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339432				2022-12-01	WOS:000233961700027
J	Kirn, TJ; Jude, BA; Taylor, RK				Kirn, TJ; Jude, BA; Taylor, RK			A colonization factor links Vibrio cholerae environmental survival and human infection	NATURE			English	Article							TOXIN-COREGULATED PILUS; RECEPTOR PROTEIN; EPITHELIAL-CELLS; INTESTINAL-CELLS; BLOOD-GROUP; CHITIN; ZOOPLANKTON; ATTACHMENT; EXPRESSION; ADHERENCE	Many bacteria that cause diseases must be able to survive inside and outside the host. Attachment to and colonization of abiotic or biotic surfaces is a common mechanism by which various microorganisms enhance their ability to survive in diverse environments(1). Vibrio cholerae is a Gram-negative aquatic bacillus that is often found in the environment attached to the chitinous exo-skeletons of zooplankton(2,3). It has been suggested that attachment to zooplankton enhances environmental survival of Vibrio spp., probably by providing both an abundant source of carbon and nitrogen and protection from numerous environmental challenges(4). On ingestion by humans, some serogroups of V. cholerae cause the diarrhoeal disease cholera(5). The pathophysiology of cholera is a result of the effects of cholera toxin on intestinal epithelial cells. For sufficient quantities of cholera toxin to reach the intestinal epithelium and to produce clinical symptoms, colonization of the small bowel must occur. Because most V. cholerae do not colonize humans, but all probably require strategies for survival in the environment, we considered that colonization factors selected for in the environment may be the same as those required for intestinal colonization of humans. In support of this hypothesis, here we have identified a single protein required for efficient intestinal colonization that mediates attachment to both zooplankton and human epithelial cells by binding to a sugar present on both surfaces.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Taylor, RK (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Ronald.K.Taylor@dartmouth.edu		Jude, Brooke/0000-0003-0384-8173				Benitez JA, 1997, INFECT IMMUN, V65, P3474; BJORK S, 1987, J BIOL CHEM, V262, P6758; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cottingham KL, 2003, FRONT ECOL ENVIRON, V1, P80, DOI 10.1890/1540-9295(2003)001[0080:EMAHPT]2.0.CO;2; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; FINNE J, 1989, J BIOL CHEM, V264, P5720; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HUO A, 1996, APPL ENVIRON MICROB, V62, P2508; Huq A., 1984, VIBRIOS ENV, P521; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; SASMAL D, 1992, FEMS MICROBIOL LETT, V98, P217, DOI 10.1016/0378-1097(92)90159-L; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Skorupski K, 1997, GENE, V198, P297, DOI 10.1016/S0378-1119(97)00331-4; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Zampini M, 2005, FEMS MICROBIOL LETT, V244, P267, DOI 10.1016/j.femsle.2005.01.052	27	222	241	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					863	866		10.1038/nature04249	http://dx.doi.org/10.1038/nature04249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341015				2022-12-01	WOS:000233777800053
J	Lemaitre, JM; Danis, E; Pasero, P; Vassetzky, Y; Mechali, M				Lemaitre, JM; Danis, E; Pasero, P; Vassetzky, Y; Mechali, M			Mitotic remodeling of the replicon and chromosome structure	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; DNA TOPOISOMERASE-II; XENOPUS EGG EXTRACTS; NUCLEAR-MATRIX; REPLICATION ORIGINS; DEVELOPMENTAL CAPACITY; HISTONE DEACETYLASE; RIBOSOMAL DNA; STEM-CELLS; CHROMATIN	Animal cloning by nuclear-transfer experiments frequently fails due to the inability of transplanted nuclei to support normal embryonic development. We show here that the formation of mitotic chromosomes in the egg context is crucial for adapting differentiated nuclei for early development. Differentiated erythrocyte nuclei replicate inefficiently in Xenopus eggs but do so as rapidly as sperm nuclei if a prior single mitosis is permitted. This mitotic remodeling involves a topoisomerase II-dependent shortening of chromatin loop domains and an increased recruitment of replication initiation factors onto chromatin, leading to a short interorigin spacing characteristic of early developmental stages. It also occurs within each early embryonic cell cycle and dominantly regulates initiation of DNA replication for the subsequent S phase. These results indicate that mitotic conditioning is crucial to reset the chromatin structure of differentiated adult donor cells for embryonic DNA replication and suggest that it is an important step in nuclear cloning.	CNRS, Inst Human Genet, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	mechali@igh.cnrs.fr	LEMAITRE, Jean-Marc/I-4989-2016; Vassetzky, Yegor/M-3383-2019; Pasero, Philippe/O-2340-2018; Vassetzky, Yegor S/C-6447-2008	Vassetzky, Yegor/0000-0003-3101-7043; Pasero, Philippe/0000-0001-5891-0822; Vassetzky, Yegor S/0000-0003-3101-7043; LEMAITRE, Jean-Marc/0000-0002-6492-5219				ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Berezney R, 1995, INT REV CYTOL, V162A, P1; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; COOK PR, 1976, J CELL SCI, V22, P287; COOK PR, 1975, J CELL SCI, V19, P261; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; DIBERARDINO MA, 1983, SCIENCE, V219, P862, DOI 10.1126/science.6600520; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; FIRMBACHKRAFT I, 1995, J CELL BIOL, V129, P17, DOI 10.1083/jcb.129.1.17; Francon P, 2004, J CELL SCI, V117, P4909, DOI 10.1242/jcs.01361; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; GURDON JB, 1975, J EMBRYOL EXP MORPH, V34, P93; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1970, J EMBRYOL EXP MORPH, V24, P227; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; IAROVAIA OV, 1995, BIOCHEMISTRY-US, V34, P4133, DOI 10.1021/bi00012a032; JACKSON DA, 1990, BIOESSAYS, V12, P87, DOI 10.1002/bies.950120207; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; LEMAITRE JM, 1995, MOL CELL BIOL, V15, P5054; LENO GH, 1991, J CELL BIOL, V112, P557, DOI 10.1083/jcb.112.4.557; LEONARD RA, 1982, DEV BIOL, V92, P343, DOI 10.1016/0012-1606(82)90180-4; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lu ZH, 1999, MOL BIOL CELL, V10, P4091, DOI 10.1091/mbc.10.12.4091; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Menut S, 1999, ADV MOLEC BIOL, P196; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NERI LM, 1992, HISTOCHEMISTRY, V98, P19, DOI 10.1007/BF00716934; Oestergaard VH, 2004, J BIOL CHEM, V279, P28100, DOI 10.1074/jbc.M402119200; PARDOLL DM, 1980, EXP CELL RES, V128, P466, DOI 10.1016/0014-4827(80)90083-X; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Rowles A, 1999, J CELL SCI, V112, P2011; Ryan J, 1999, J CELL SCI, V112, P2441; Sato M, 1997, BIOCHEM BIOPH RES CO, V235, P571, DOI 10.1006/bbrc.1997.6851; TAKASUGA Y, 1995, EXP CELL RES, V217, P378, DOI 10.1006/excr.1995.1100; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Vassetzky Y, 2000, GENE DEV, V14, P1541; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Wade PA, 1999, METHOD ENZYMOL, V304, P715; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; WOOD ER, 1990, J CELL BIOL, V111, P2839, DOI 10.1083/jcb.111.6.2839; Wu JR, 1997, METHODS, V13, P313, DOI 10.1006/meth.1997.0530; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270	68	146	155	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					787	801		10.1016/j.cell.2005.08.045	http://dx.doi.org/10.1016/j.cell.2005.08.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325575	Bronze			2022-12-01	WOS:000233814100014
J	Carvalho, J; Farkas, A				Carvalho, J; Farkas, A			Essay - Rehabilitation through sport - pilot project with amputees in Angola	LANCET			English	Article									Int Paralymp Comm, D-53113 Bonn, Germany; Univ Lisbon, Fac Human Kinet, P-1699 Lisbon, Portugal	Universidade de Lisboa	Farkas, A (corresponding author), Int Paralymp Comm, Adenauerallee 212-214, D-53113 Bonn, Germany.	Amy.farkas@paralympic.org							0	1	1	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S5	S6		10.1016/S0140-6736(05)67821-X	http://dx.doi.org/10.1016/S0140-6736(05)67821-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999FO	16360754				2022-12-01	WOS:000234374400004
J	Volkov, I; Banavar, JR; He, FL; Hubbell, SP; Maritan, A				Volkov, I; Banavar, JR; He, FL; Hubbell, SP; Maritan, A			Density dependence explains tree species abundance and diversity in tropical forests	NATURE			English	Article							DISTANCE; NUMBER	The recurrent patterns in the commonness and rarity of species in ecological communities - the relative species abundance - have puzzled ecologists for more than half a century(1,2). Here we show that the framework of the current neutral theory in ecology(3 - 10) can easily be generalized to incorporate symmetric density dependence(11 - 14). We can calculate precisely the strength of the rare- species advantage that is needed to explain a given RSA distribution. Previously, we demonstrated that a mechanism of dispersal limitation also fits RSA data well(3,4). Here we compare fits of the dispersal and density- dependence mechanisms for empirical RSA data on tree species in six New and Old World tropical forests and show that both mechanisms offer sufficient and independent explanations. We suggest that RSA data cannot by themselves be used to discriminate among these explanations of RSA patterns(15) - empirical studies will be required to determine whether RSA patterns are due to one or the other mechanism, or to some combination of both.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Alberta; University System of Georgia; University of Georgia; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Padua	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Volkov, Igor/GVT-6571-2022	Maritan, Amos/0000-0002-3535-7873				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; CHESSON P, 1991, TRENDS ECOL EVOL, V6, P26, DOI 10.1016/0169-5347(91)90144-M; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; CONNELL J H, 1971, P298; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2004, ECOL LETT, V7, P170, DOI 10.1111/j.1461-0248.2004.00572.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hilborn Ray, 1997, V28; Houchmandzadeh B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061912; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; MORLEY RJ, 2000, ORIGIN EVOLUTION TRO, pCH5; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Vallade M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061902; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	223	248	3	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					658	661		10.1038/nature04030	http://dx.doi.org/10.1038/nature04030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319890				2022-12-01	WOS:000233593100048
J	Kaeberlein, M; Powers, RW; Steffen, KK; Westman, EA; Hu, D; Dang, N; Kerr, EO; Kirkland, KT; Fields, S; Kennedy, BK				Kaeberlein, M; Powers, RW; Steffen, KK; Westman, EA; Hu, D; Dang, N; Kerr, EO; Kirkland, KT; Fields, S; Kennedy, BK			Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; CALORIE RESTRICTION; SIGNALING PATHWAY; KINASE; GENES; SIR2; EXPRESSION; LONGEVITY; EXTENSION	Calorie restriction increases life span in many organisms, including the budding yeast Saccharomyces cerevisiae. From a large-scale analysis of 564 single-gene-deletion strains of yeast, we identified 10 gene deletions that increase replicative life span. Six of these correspond to genes encoding components of the nutrient-responsive TOR and Sch9 pathways. Calorie restriction of tor1 Delta or sch9 Delta cells failed to further increase life span and, like calorie restriction, deletion of either SCH9 or TOR1 increased life span independent of the Sir2 histone deacetylase. We propose that the TOR and Sch9 kinases define a primary conduit through which excess nutrient intake limits longevity in yeast.	Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA.	kaeber@u.washington.edu; bkenn@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874	NIA NIH HHS [P30 AG013280] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Helliwell SB, 1998, GENETICS, V148, P99; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	23	956	997	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1193	1196		10.1126/science.1115535	http://dx.doi.org/10.1126/science.1115535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293764				2022-12-01	WOS:000233437300048
J	Hamaguchi, M; Kojima, T; Takeda, N; Nakagawa, T; Taniguchi, H; Fujii, K; Omatsu, T; Nakajima, T; Sarui, H; Shimazaki, M; Kato, T; Okuda, J; Ida, K				Hamaguchi, M; Kojima, T; Takeda, N; Nakagawa, T; Taniguchi, H; Fujii, K; Omatsu, T; Nakajima, T; Sarui, H; Shimazaki, M; Kato, T; Okuda, J; Ida, K			The metabolic syndrome as a predictor of nonalcoholic fatty liver disease	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE; HEPATIC STEATOSIS; STEATOHEPATITIS; PREVALENCE; ADIPONECTIN; SONOGRAPHY; DIAGNOSIS; HISTOLOGY; NASH	Background: The frequent association of nonalcoholic fatty liver disease with components of the metabolic syndrome such as obesity, hyperglycemia, dyslipidemia, and hypertension is well known. However, no prospective study has examined the role of the metabolic syndrome in the development of this disease. Objective: To characterize the longitudinal relationship between the metabolic syndrome and nonalcoholic fatty liver disease. Design: A prospective observational study. Setting: A medical health checkup program in a general hospital. Participants: 4401 apparently healthy Japanese men and women, 21 to 80 years of age, with a mean body mass index (BMI) of 22.6 kg/m(2) (SD, 3.0). Measurements: Alcohol intake was assessed by using a questionnaire. Biochemical tests for liver and metabolic function and abdominal ultrasonography were done. Modified criteria of the National Cholesterol Education Program Adult Treatment Panel III were used to characterize the metabolic syndrome. Results: At baseline, 812 of 4401 (18%) participants had nonalcoholic fatty liver disease. During the mean follow-up period of 414 days (SD, 128), the authors observed 308 new cases (10%) of nonalcoholic fatty liver disease among 3147 participants who were disease-free at baseline and who completed a second examination. Regression of nonalcoholic fatty liver disease was found in 113 (16%) of 704 participants who had the disease at baseline and who completed a second examination. Men and women who met the criteria for the metabolic syndrome at baseline were more likely to develop the disease during follow-up (adjusted odds ratio, 4.00 [95% Cl, 2.63 to 6.08] and 11.20 [Cl, 4.85 to 25.87], respectively). Nonalcoholic fatty liver disease was less likely to regress in those participants with the metabolic syndrome at baseline. Limitations: Ultrasonography may lead to an incorrect diagnosis of nonalcoholic fatty liver disease in 10% to 30% of cases and cannot distinguish steatolhepatitis from simple steatosis. Self-reported alcohol intake may cause bias. Because all of the participants were Japanese, generalizability to non-Japanese populations is uncertain. Conclusions: The metabolic syndrome is a strong predictor of nonalcoholic fatty liver disease.	Asahi Univ, Murakami Mem Hosp, Dept Gastroenterol, Gifu 5008523, Japan	Asahi University	Hamaguchi, M (corresponding author), Asahi Univ, Murakami Mem Hosp, Dept Gastroenterol, 3-23 Hashimoto Cho, Gifu 5008523, Japan.	seele@mbox.kyotoinet.or.jp						Akbar DH, 2003, DIABETES CARE, V26, P3351, DOI 10.2337/diacare.26.12.3351-a; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assy N, 2000, DIGEST DIS SCI, V45, P1929, DOI 10.1023/A:1005661516165; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Cheal KL, 2004, DIABETES, V53, P1195, DOI 10.2337/diabetes.53.5.1195; Chitturi S, 2004, J GASTROEN HEPATOL, V19, P368, DOI 10.1111/j.1440-1746.2003.03252.x; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mendler MH, 1998, J HEPATOL, V28, P785, DOI 10.1016/S0168-8278(98)80228-6; NEEDLEMAN L, 1986, AM J ROENTGENOL, V146, P1011, DOI 10.2214/ajr.146.5.1011; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; STEINMAURER HJ, 1984, ULTRASCHALL MED, V5, P98, DOI 10.1055/s-2007-1012076; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; *WHO WE PAC REG IN, 2000, AS PAC PERSP RED OB; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651	32	779	818	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2005	143	10					722	728		10.7326/0003-4819-143-10-200511150-00009	http://dx.doi.org/10.7326/0003-4819-143-10-200511150-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986YY	16287793				2022-12-01	WOS:000233486800004
J	Angers, RC; Browning, SR; Seward, TS; Sigurdson, CJ; Miller, MW; Hoover, EA; Telling, GC				Angers, RC; Browning, SR; Seward, TS; Sigurdson, CJ; Miller, MW; Hoover, EA; Telling, GC			Prions in skeletal muscles of deer with chronic wasting disease	SCIENCE			English	Article							SPONGIFORM ENCEPHALOPATHY; MULE DEER; SCRAPIE; PROTEIN		Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; Colorado Div Wildlife, Wildlife Res Ctr, Ft Collins, CO 80526 USA	University of Kentucky; University of Kentucky; University of Kentucky; Colorado State University	Telling, GC (corresponding author), Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA.	gtell2@uky.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-25491] Funding Source: Medline; NINDS NIH HHS [2RO1 NS040334-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Hamir AN, 2004, VET PATHOL, V41, P78, DOI 10.1354/vp.41-1-78; Prinz M, 2003, AM J PATHOL, V162, P1103, DOI 10.1016/S0002-9440(10)63907-7; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110	8	153	160	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2006	311	5764					1117	1117		10.1126/science.1122864	http://dx.doi.org/10.1126/science.1122864			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017IU	16439622				2022-12-01	WOS:000235688100038
J	Womelsdorf, T; Fries, P; Mitra, PP; Desimone, R				Womelsdorf, T; Fries, P; Mitra, PP; Desimone, R			Gamma-band synchronization in visual cortex predicts speed of change detection	NATURE			English	Article							NEURONAL-ACTIVITY; AREA V4; NEURAL MECHANISMS; SPATIAL ATTENTION; PARIETAL CORTEX; CORTICAL AREAS; MODULATION; OSCILLATIONS; RESPONSES; MT	Our capacity to process and respond behaviourally to multiple incoming stimuli is very limited. To optimize the use of this limited capacity, attentional mechanisms give priority to behaviourally relevant stimuli at the expense of irrelevant distractors. In visual areas, attended stimuli induce enhanced responses and an improved synchronization of rhythmic neuronal activity in the gamma frequency band (40 - 70 Hz)(1-11). Both effects probably improve the neuronal signalling of attended stimuli within and among brain areas(1,12-16). Attention also results in improved behavioural performance and shortened reaction times. However, it is not known how reaction times are related to either response strength or gamma-band synchronization in visual areas. Here we show that behavioural response times to a stimulus change can be predicted specifically by the degree of gamma-band synchronization among those neurons in monkey visual area V4 that are activated by the behaviourally relevant stimulus. When there are two visual stimuli and monkeys have to detect a change in one stimulus while ignoring the other, their reactions are fastest when the relevant stimulus induces strong gamma-band synchronization before and after the change in stimulus. This enhanced gamma-band synchronization is also followed by shorter neuronal response latencies on the fast trials. Conversely, the monkeys' reactions are slowest when gamma-band synchronization is high in response to the irrelevant distractor. Thus, enhanced neuronal gamma-band synchronization and shortened neuronal response latencies to an attended stimulus seem to have direct effects on visually triggered behaviour, reflecting an early neuronal correlate of efficient visuo-motor integration.	Radboud Univ, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Radboud University Nijmegen; Radboud University Nijmegen; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT)	Womelsdorf, T (corresponding author), Radboud Univ, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands.	t.womelsdorf@fcdonders.ru.nl	Womelsdorf, Thilo/C-3096-2015; Fries, Pascal/E-3196-2010; Desimone, Robert/G-1121-2018	Womelsdorf, Thilo/0000-0001-6921-4187; Fries, Pascal/0000-0002-4270-1468; Desimone, Robert/0000-0002-5938-4227; Mitra, Partha/0000-0001-8818-6804	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Lee D, 2003, J NEUROSCI, V23, P6798; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0	27	541	551	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2006	439	7077					733	736		10.1038/nature04258	http://dx.doi.org/10.1038/nature04258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16372022				2022-12-01	WOS:000235193100046
J	Zou, PJ; Pinotsis, N; Lange, S; Song, YH; Popov, A; Mavridis, I; Mayans, OM; Gautel, M; Wilmanns, M				Zou, PJ; Pinotsis, N; Lange, S; Song, YH; Popov, A; Mavridis, I; Mayans, OM; Gautel, M; Wilmanns, M			Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk	NATURE			English	Article							CROSS-LINKING; T-CAP; TELETHONIN; DOMAINS; ULTRASTRUCTURE; ANTIBODIES; MUTATIONS; INTERACTS; SUGGESTS; COMPLEX	The Z-disk of striated and cardiac muscle sarcomeres is one of the most densely packed cellular structures in eukaryotic cells(1). It provides the architectural framework for assembling and anchoring the largest known muscle filament systems by an extensive network of protein - protein interactions, requiring an extraordinary level of mechanical stability. Here we show, using X-ray crystallography, how the amino terminus of the longest filament component, the giant muscle protein titin, is assembled into an antiparallel ( 2: 1) sandwich complex by the Z-disk ligand telethonin. The pseudosymmetric structure of telethonin mediates a unique palindromic arrangement of two titin filaments, a type of molecular assembly previously found only in protein DNA-complexes. We have confirmed its unique architecture in vivo by protein complementation assays, and in vitro by experiments using fluorescence resonance energy transfer. The model proposed may provide a molecular paradigm of how major sarcomeric filaments are crosslinked, anchored and aligned within complex cytoskeletal networks.	DESY, EMBL Hamburg, D-22603 Hamburg, Germany; Demokritos Natl Ctr Sci Res, Inst Phys Chem, GR-15310 Athens, Greece; Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; Kings Coll London, Div Cardiovasc, London SE1 1UL, England; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); National Centre of Scientific Research "Demokritos"; University of London; King's College London; University of London; King's College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Wilmanns, M (corresponding author), DESY, EMBL Hamburg, Notleststr 85, D-22603 Hamburg, Germany.	wilmanns@embl-hamburg.de	Popov, Alexander/A-8827-2008; Pinotsis, Nikos/AAD-4013-2019; Pinotsis, Nikolaos/G-3853-2011; Lange, Stephan/A-1422-2010; Gautel, Mathias/AAB-9860-2019	Pinotsis, Nikos/0000-0002-5096-257X; Lange, Stephan/0000-0001-9361-6602; Popov, Alexander/0000-0002-3058-8912; Gautel, Mathias/0000-0003-4027-9803; Mayans, Olga/0000-0001-6876-8532; Wilmanns, Matthias/0000-0002-4643-5435	Medical Research Council [G0200496] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; GUDDAT LW, 1995, FASEB J, V9, P101, DOI 10.1096/fasebj.9.1.7821748; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Luther PK, 2002, J MOL BIOL, V319, P1157, DOI 10.1016/S0022-2836(02)00372-8; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Ramsland PA, 2002, J MOL RECOGNIT, V15, P248, DOI 10.1002/jmr.585; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Schroder R, 2001, J MUSCLE RES CELL M, V22, P259, DOI 10.1023/A:1012242011109; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200	30	133	140	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					229	233		10.1038/nature04343	http://dx.doi.org/10.1038/nature04343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407954	Green Published			2022-12-01	WOS:000234538400046
J	Javaid, MK; Crozier, SR; Harvey, NC; Gale, CR; Dennison, EM; Boucher, BJ; Arden, NK; Godfrey, KM; Cooper, C				Javaid, MK; Crozier, SR; Harvey, NC; Gale, CR; Dennison, EM; Boucher, BJ; Arden, NK; Godfrey, KM; Cooper, C		Princess Anne Hosp Study Grp	Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study	LANCET			English	Article							BIRTH-WEIGHT; MINERAL DENSITY; D DEFICIENCY; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; HIP FRACTURE; CALCIUM; GROWTH; ABSORPTIOMETRY; INFANTS	Background Vitamin D insufficiency is common in women of childbearing age and increasing evidence suggests that the risk of osteoporotic fracture in adulthood could be determined partly by environmental factors during intrauterine and early postnatal life. We investigated the effect of maternal vitamin D status during pregnancy on childhood skeletal growth. Methods In a longitudinal study, we studied 198 children born in 1991-92 in a hospital in Southampton, UK; the body build, nutrition, and vitamin D status of their mothers had been characterised during pregnancy. The children were followed up at age 9 years to relate these maternal characteristics to their body size and bone mass. Findings 49 (31%) mothers had insufficient and 28 (18%) had deficient circulating concentrations of 25(OH)-vitamin D during late pregnancy. Reduced concentration of 25(OH)-vitamin D in mothers during late pregnancy was associated with reduced whole-body (r=0.21, p=0.0088) and lumbar-spine (r=0.17, p=0.03) bone-mineral content in children at age 9 years. Both the estimated exposure to ultraviolet B radiation during late pregnancy and the maternal use of vitamin D supplements predicted maternal 25(OH)-vitamin D concentration (p<0.0001 and p=0.0110, respectively) and childhood bone mass (p=0.0267). Reduced concentration of umbilical-venous calcium also predicted reduced childhood bone mass (p=0.0286). Interpretation Maternal vitamin D insufficiency is common during pregnancy and is associated with reduced bone-mineral accrual in the offspring during childhood; this association is mediated partly through the concentration of umbilical venous calcium. Vitamin D supplementation of pregnant women, especially during winter months, could lead to longlasting reductions in the risk of osteoporotic fracture in their offspring.	Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England; Royal London Hosp, London E1 1BB, England	University of Southampton; Barts Health NHS Trust; Royal London Hospital	Cooper, C (corresponding author), Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	Gale, Catharine R/B-1653-2012	Dennison, Elaine/0000-0002-3048-4961; Harvey, Nicholas/0000-0002-8194-2512; Boucher, Barbara J/0000-0003-1206-7555; Javaid, Muhammad/0000-0001-7985-0048; Crozier, Sarah/0000-0002-9524-1127; Cooper, Cyrus/0000-0003-3510-0709; Godfrey, Keith/0000-0002-4643-0618; Gale, Catharine/0000-0002-3361-8638	Medical Research Council [G0400491, MC_UP_A620_1014] Funding Source: Medline; MRC [G0400491] Funding Source: UKRI; Medical Research Council [U1475000001, U1475000002] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bettica P, 1999, OSTEOPOROSIS INT, V9, P226, DOI 10.1007/s001980050141; Bolotin HH, 2001, J BONE MINER RES, V16, P417, DOI 10.1359/jbmr.2001.16.2.417; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; COOPER C, 1995, J BONE MINER RES, V10, P940; Cooper C, 2001, OSTEOPOROSIS INT, V12, P623, DOI 10.1007/s001980170061; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; Diamond T, 1998, MED J AUSTRALIA, V169, P138, DOI 10.5694/j.1326-5377.1998.tb116014.x; Fewtrell MS, 2000, J PEDIATR-US, V137, P668, DOI 10.1067/mpd.2000.108953; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Godfrey KM, 1997, BRIT J OBSTET GYNAEC, V104, P663, DOI 10.1111/j.1471-0528.1997.tb11975.x; Hosking DJ, 1996, CLIN ENDOCRINOL, V45, P1; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; KOO WWK, 1995, J BONE MINER RES, V10, P1998; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001/jama.281.16.1505; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Mehta G, 2002, CALCIFIED TISSUE INT, V71, P493, DOI 10.1007/s00223-001-2104-9; MELTON LJ, 1988, OSTEOPOROSIS ETIOLOG, P111; MURPHY S, 1994, BRIT MED J, V308, P939, DOI 10.1136/bmj.308.6934.939; NELSON N, 1987, SCAND J CLIN LAB INV, V47, P111; Oreffo ROC, 2003, BONE, V33, P100, DOI 10.1016/S8756-3282(03)00166-2; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Sowers MF, 2000, BEST PRACT RES CL EN, V14, P317, DOI 10.1053/beem.2000.0076; Specker B, 2004, AM J CLIN NUTR, V80, p1740S, DOI 10.1093/ajcn/80.6.1740S; TANNER JM, 1966, ARCH DIS CHILD, V41, P454, DOI 10.1136/adc.41.219.454; Tobias JH, 2004, J BONE MINER RES, V19, P177, DOI 10.1359/JBMR.0301235; Widdowson E M, 1974, Adv Exp Med Biol, V49, P165; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541	34	573	601	2	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2006	367	9504					36	43		10.1016/S0140-6736(06)67922-1	http://dx.doi.org/10.1016/S0140-6736(06)67922-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399151				2022-12-01	WOS:000234443100028
J	Vabulas, RM; Hartl, FU				Vabulas, RM; Hartl, FU			Protein synthesis upon acute nutrient restriction relies on proteasome function	SCIENCE			English	Article							DEGRADATION; STARVATION; INHIBITORS; UBIQUITIN; ACIDIFICATION; AUTOPHAGY	The mechanisms that protect mammalian cells against amino acid deprivation are only partially understood. We found that during an acute decrease. in external amino acid supply, before up-regulation of the autophagosomal-lysosomai pathway, efficient translation was ensured by proteasomal protein degradation. Amino acids for the synthesis of new proteins were supplied by the degradation of preexisting proteins, whereas nascent and newly formed polypeptides remained largely protected from proteolysis. Proteasome inhibition during nutrient deprivation caused rapid amino acid depletion and marked impairment of translation. Thus, the proteasome plays a crucial rote in cell survival after acute disruption of amino acid supply.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Vabulas, RM (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	vabulas@biochem.mpg.de; uhartl@biochem.mpg.de	Vabulas, R. Martin/D-3506-2011; Hartl, F. Ulrich/Y-8206-2019					BOTBOL V, 1989, J BIOL CHEM, V264, P13504; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEGLEN PO, 1986, BIOMED BIOCHIM ACTA, V45, P1647; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekine K, 2001, INT J CANCER, V94, P485, DOI 10.1002/ijc.1492; Tietz N.M., 1995, CLIN GUIDE LAB TESTS; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; WEK SA, 1995, MOL CELL BIOL, V15, P4497; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	24	254	257	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1960	1963		10.1126/science.1121925	http://dx.doi.org/10.1126/science.1121925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373576				2022-12-01	WOS:000234275400044
J	Janes, KA; Albeck, JG; Gaudet, S; Sorger, PK; Lauffenburger, DA; Yaffe, MB				Janes, KA; Albeck, JG; Gaudet, S; Sorger, PK; Lauffenburger, DA; Yaffe, MB			Systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis	SCIENCE			English	Article							LEAST-SQUARES REGRESSION; TNF-ALPHA; TRANSDUCTION PATHWAY; PROTEIN-KINASE; CELL-DEATH; ACTIVATION; NECROSIS; PHOSPHORYLATION; REDUNDANCY; MAP	Signal transduction pathways control cellular responses to stimuli, but it is unclear how molecular information is processed as a network. We constructed a systems model of 7980 intracellular signaling events that directly links measurements to 1440 response outputs associated with apoptosis. The model accurately predicted multiple time-dependent apoptotic responses induced by a combination of the death-inducing cytokine tumor necrosis factor with the prosurvival factors epidermal growth factor and insulin. By capturing the rote of unsuspected autocrine circuits activated by transforming growth factor-alpha and interteukin-1 alpha, the model revealed new molecular mechanisms connecting signaling to apoptosis. The model derived two groupings of intracellular signals that constitute fundamental dimensions (molecular "basis axes") within the apoptotic signaling network. Projection along these axes captures the entire measured apoptotic network, suggesting that cell survival is determined by signaling through this canonical basis set.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu		Gaudet, Suzanne/0000-0002-5701-2825; Sorger, Peter/0000-0002-3364-1838	NIGMS NIH HHS [GM059281, P50-GM68762] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059281, P50GM068762] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu-Martin MT, 1999, AM J PHYSIOL-GASTR L, V276, pG599, DOI 10.1152/ajpgi.1999.276.3.G599; ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Del Bino G, 1999, CELL PROLIFERAT, V32, P25, DOI 10.1046/j.1365-2184.1999.00130.x; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dumont JE, 2002, AM J PHYSIOL-CELL PH, V283, pC2, DOI 10.1152/ajpcell.00581.2001; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; JANES KA, UNPUB; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Vanden Berghe Tom, 2004, Methods Mol Med, V98, P101; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yadav D, 2003, CURR OPIN IMMUNOL, V15, P697, DOI 10.1016/j.coi.2003.09.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	31	396	409	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1646	1653		10.1126/science.1116598	http://dx.doi.org/10.1126/science.1116598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339439				2022-12-01	WOS:000233961700036
J	Siridechadilok, B; Fraser, CS; Hall, RJ; Doudna, JA; Nogales, E				Siridechadilok, B; Fraser, CS; Hall, RJ; Doudna, JA; Nogales, E			Structural roles for human translation factor eIF3 in initiation of protein synthesis	SCIENCE			English	Article							HEPATITIS-C VIRUS; MESSENGER-RNA; EUKARYOTIC RIBOSOME; SUBUNIT; IDENTIFICATION; RECRUITMENT; BINDING; CODON	Protein synthesis in mammalian cells requires initiation factor eIF3, a similar to 750-kilodalton complex that controls assembly of 40S ribosomal subunits on messenger RNAs (mRNAs) bearing either a 5'-cap or an internal ribosome entry site (IRES). Cryo-electron microscopy reconstructions show that eIF3, a five-lobed particle, interacts with the hepatitis C virus (HCV) IRES RNA and the S'-cap binding complex eIF4F via the same domain. Detailed modeling of eIF3 and eIF4F onto the 40S ribosomal subunit reveals that eIF3 uses eIF4F or the HCV IRES in structurally similar ways to position the mRNA strand near the exit site of 40S, promoting initiation complex assembly.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu; enogales@lbl.gov	Fraser, Christopher/H-9186-2013					Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HALL RJ, UNPUB; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; HERSHEY JWB, COMMUNICATION; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maivali U, 2004, RNA, V10, P600, DOI 10.1261/rna.5220504; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	30	226	241	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1513	1515		10.1126/science.1118977	http://dx.doi.org/10.1126/science.1118977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322461				2022-12-01	WOS:000233756500049
J	Hornstein, E; Mansfield, JH; Yekta, S; Hu, JKH; Harfe, BD; McManus, MT; Baskerville, S; Bartel, DP; Tabin, CJ				Hornstein, E; Mansfield, JH; Yekta, S; Hu, JKH; Harfe, BD; McManus, MT; Baskerville, S; Bartel, DP; Tabin, CJ			The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development	NATURE			English	Article							RETINOIC ACID; MESSENGER-RNA; EXPRESSION; TARGETS; BUD; GENES; ZPA; MORPHOGENESIS; CLEAVAGE; FORELIMB	MicroRNAs ( miRNAs) are an abundant class of gene regulatory molecules ( reviewed in refs 1, 2). Although computational work indicates that miRNAs repress more than a third of human genes(3), their roles in vertebrate development are only now beginning to be determined. Here we show that miR- 196 acts upstream of Hoxb8 and Sonic hedgehog ( Shh) in vivo in the context of limb development, thereby identifying a previously observed but uncharacterized inhibitory activity that operates specifically in the hindlimb. Our data indicate that miR- 196 functions in a fail- safe mechanism to assure the fidelity of expression domains that are primarily regulated at the transcriptional level, supporting the idea that many vertebrate miRNAs may function as a secondary level of gene regulation.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Calif San Francisco, Ctr Diabet, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University System of Florida; University of Florida; University of California System; University of California San Francisco	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	HORNSTEIN, ERAN/K-1340-2012; mcmanus, michael/AAB-1239-2020	HORNSTEIN, ERAN/0000-0002-5534-1924; mcmanus, michael/0000-0003-3013-6569; Hu, Jimmy/0000-0003-1035-0779				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helms JA, 1996, DEVELOPMENT, V122, P1385; Kim MH, 2002, INT J DEV BIOL, V46, P325; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu HC, 1997, DEVELOPMENT, V124, P1643; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Min WG, 1998, DNA CELL BIOL, V17, P293, DOI 10.1089/dna.1998.17.293; Nelson CE, 1996, DEVELOPMENT, V122, P1449; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Stratford T, 1999, MECH DEVELOP, V81, P115, DOI 10.1016/S0925-4773(98)00231-7; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Stratford TH, 1997, DEVELOPMENT, V124, P4225; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	28	319	369	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					671	674		10.1038/nature04138	http://dx.doi.org/10.1038/nature04138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319892				2022-12-01	WOS:000233593100051
J	Simpson				Simpson			Personal account - Sports injury of a guide-dog	LANCET			English	Article												simpywimpy@hotmail.com							0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S65	S65		10.1016/S0140-6736(05)67859-2	http://dx.doi.org/10.1016/S0140-6736(05)67859-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360763				2022-12-01	WOS:000234374400039
J	Barnett, TP; Adam, JC; Lettenmaier, DP				Barnett, TP; Adam, JC; Lettenmaier, DP			Potential impacts of a warming climate on water availability in snow-dominated regions	NATURE			English	Review							GLACIER-MELT; HYDROLOGICAL CYCLE; TROPICAL GLACIER; PAN EVAPORATION; RIVER; RESOURCES; EVAPOTRANSPIRATION; SENSITIVITY; AEROSOLS; RUNOFF	All currently available climate models predict a near-surface warming trend under the influence of rising levels of greenhouse gases in the atmosphere. In addition to the direct effects on climate-for example, on the frequency of heatwaves-this increase in surface temperatures has important consequences for the hydrological cycle, particularly in regions where water supply is currently dominated by melting snow or ice. In a warmer world, less winter precipitation falls as snow and the melting of winter snow occurs earlier in spring. Even without any changes in precipitation intensity, both of these effects lead to a shift in peak river runoff to winter and early spring, away from summer and autumn when demand is highest. Where storage capacities are not sufficient, much of the winter runoff will immediately be lost to the oceans. With more than one-sixth of the Earth's population relying on glaciers and seasonal snow packs for their water supply, the consequences of these hydrological changes for future water availability-predicted with high confidence and already diagnosed in some regions-are likely to be severe.	Univ Calif San Diego, Scripps Inst Oceanog, Div Climate Res, La Jolla, CA 92093 USA; Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Washington; University of Washington Seattle	Barnett, TP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Climate Res, La Jolla, CA 92093 USA.	timdotbarnett@ucsd.edu; dennisl@u.washington.edu	lettenmaier, dennis p/F-8780-2011; Ebersole, Joseph L/A-8371-2009	lettenmaier, dennis p/0000-0003-3317-1327; 				ADAM JC, IN PRESS J CLIM; [Anonymous], CLIM CHANGE; Barnett T, 2004, CLIMATIC CHANGE, V62, P1, DOI 10.1023/B:CLIM.0000013695.21726.b8; Borys RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016855; Brutsaert W, 1998, NATURE, V396, P30, DOI 10.1038/23845; BURN DH, 1994, J HYDROL, V160, P53, DOI 10.1016/0022-1694(94)90033-7; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chattopadhyay N, 1997, AGR FOREST METEOROL, V87, P55, DOI 10.1016/S0168-1923(97)00006-3; *CHIN AC SCI, 2004, CHIN GLAC INV; CIESIN, 2004, SOC DAT APPL CTR SED; COMBES S, 2004, GOING GOING GONE CLI, P1; DAI A, UNPUB J CLIM; de Loe R, 2001, GLOBAL ENVIRON CHANG, V11, P231, DOI 10.1016/S0959-3780(00)00053-4; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Douville H, 2002, CLIM DYNAM, V20, P45, DOI 10.1007/s00382-002-0259-3; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Gan TY, 2000, WATER RESOUR MANAG, V14, P111, DOI 10.1023/A:1008195827031; GAO Q, 1992, J DESERT RES, V12, P1; Giorgi F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024288; Giorgi F, 2001, GEOPHYS RES LETT, V28, P3317, DOI 10.1029/2001GL013150; Givati A, 2004, J APPL METEOROL, V43, P1038, DOI [10.1175/1520-0450(2004)043<1038:QPSDTA>2.0.CO;2, 10.1175/1520-0450(2004)043&lt;1038:QPSDTA&gt;2.0.CO;2]; Golubev VS, 2001, GEOPHYS RES LETT, V28, P2665, DOI 10.1029/2000GL012851; HAMLET AF, IN PRESS J CLIM; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; HOBBINS MT, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/2004G6019846; HOU S, 2000, CHINESE SCI BULL, V45, P256; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kaser G, 2005, ADV GLOB CHANGE RES, P185, DOI 10.1007/1-4020-3508-X_19; Kaufman YJ, 2002, NATURE, V419, P215, DOI 10.1038/nature01091; Kiehl JT, 2000, J GEOPHYS RES-ATMOS, V105, P1441, DOI 10.1029/1999JD900495; Krishnan R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014687; Lawrimore JH, 2000, J HYDROMETEOROL, V1, P543, DOI 10.1175/1525-7541(2000)001<0543:PETIDA>2.0.CO;2; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Liniger H., 1998, MOUNTAINS WORLD WATE, P1; Mark BG, 2003, J GLACIOL, V49, P271, DOI 10.3189/172756503781830746; MARK BG, 2005, ADV GLOB CHANGE RES, V23, P205; MARK BG, IN PRESS QUAT SCI RE; McCarthy J, 2001, CLIMATE CHANGE IMPAC; Meier MF, 2002, SCIENCE, V297, P350, DOI 10.1126/science.1073591; Middelkoop H, 2001, CLIMATIC CHANGE, V49, P105, DOI 10.1023/A:1010784727448; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; Ohmura A, 2002, SCIENCE, V298, P1345, DOI 10.1126/science.1078972; Payne JT, 2004, CLIMATIC CHANGE, V62, P233, DOI 10.1023/B:CLIM.0000013694.18154.d6; PETERSON TC, 1995, NATURE, V377, P687, DOI 10.1038/377687b0; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Roderick ML, 2002, SCIENCE, V298, P1410; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; RUIZBARRADAS A, UNPUB J CLIM; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Singh P, 1997, MT RES DEV, V17, P49, DOI 10.2307/3673913; Singh P, 1997, J HYDROL, V193, P316, DOI 10.1016/S0022-1694(96)03142-3; Singh P, 2004, HYDROL PROCESS, V18, P2363, DOI 10.1002/hyp.1468; Singh P, 2003, HYDROLOG SCI J, V48, P413, DOI 10.1623/hysj.48.3.413.45280; Singh P, 2002, HYDROLOG SCI J, V47, P93, DOI 10.1080/02626660209492910; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Thomas A, 2000, INT J CLIMATOL, V20, P381, DOI [10.1002/(SICI)1097-0088(20000330)20:4<381::AID-JOC477>3.0.CO;2-K, 10.1002/(SICI)1097-0088(20000330)20:4&lt;381::AID-JOC477&gt;3.0.CO;2-K]; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Vorosmarty CJ, 1997, AMBIO, V26, P210; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Walter MT, 2004, J HYDROMETEOROL, V5, P405, DOI 10.1175/1525-7541(2004)005<0405:IEFTCU>2.0.CO;2; Wild M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019188	66	2783	2900	92	1740	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					303	309		10.1038/nature04141	http://dx.doi.org/10.1038/nature04141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292301				2022-12-01	WOS:000233300200038
J	Cnattingius, S; Torrang, A; Ekbom, A; Granath, F; Petersson, G; Lambe, M				Cnattingius, S; Torrang, A; Ekbom, A; Granath, F; Petersson, G; Lambe, M			Pregnancy characteristics and maternal risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACENTAL WEIGHT; BIRTH-WEIGHT; REPLACEMENT THERAPY; ALPHA-FETOPROTEIN; FETAL; PREECLAMPSIA; GROWTH; EPIDEMIOLOGY; ESTROGEN; ESTRIOL	Context During pregnancy, serum levels of estrogen, progesterone, and other hormones are markedly higher than during other periods of life. Pregnancy hormones primarily are produced in the placenta, and signs of placental impairment may serve as indirect markers of hormone exposures during pregnancy. During pregnancy, these markers have been inconsistently associated with subsequent risk of breast cancer in the mother. Objective To examine associations between indirect markers of hormonal exposures, such as placental weight and other pregnancy characteristics, and maternal risk of developing breast cancer. Design and Setting Population-based cohort study using data from the Swedish Birth Register, the Swedish Cancer Register, the Swedish Cause of Death Register, and the Swedish Register of Population and Population Changes. Participants Women included in the Sweden Birth Register who delivered singletons between 1982 and 1989, with complete information on date of birth and gestational age. Women were followed up until the occurrence of breast cancer, death, or end of follow-up (December 31, 2001). Cox proportional hazards models were used to estimate associations between hormone exposures and risks of breast cancer. Main Outcome Measure Incidence of invasive breast cancer. Results. Of 314,019 women in the cohort, 2216 (0.7%) developed breast cancer during the follow-up through 2001, of whom 2100 (95%) were diagnosed before age 50 years. Compared with women who had placentas weighing less than 500 g in 2 consecutive pregnancies, the risk of breast cancer was increased among women whose placentas weighed between 500 and 699 g in their first pregnancy and at least 700 g in their second pregnancy (or vice versa) (adjusted hazard ratio, 1.82; 95% confidence interval [CI], 1.07-3.08), and the corresponding risk was doubled among women whose placentas weighed at least 700 g in both pregnancies (adjusted hazard ratio, 2.05; 95% Cl, 1.15-3.64). A high birth weight (>= 4000 g) in 2 successive births was associated with an increased risk of breast cancer before but not after adjusting for placental weight and other covariates (adjusted hazard ratio, 1.10; 95% Cl, 0.76-1.59). Conclusions Placental weight is positively associated with maternal risk of breast cancer. These results further support the hypothesis that pregnancy hormones are important modifiers of subsequent maternal breast cancer risk..	Karolinska Inst, Karolinska Hosp, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; AstraZeneca R&D, Molndal, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca	Cnattingius, S (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	sven.cnattingius@mep.ki.se						Acromite MT, 1999, AM J OBSTET GYNECOL, V180, P60, DOI 10.1016/S0002-9378(99)70150-X; Becroft DMO, 2002, PLACENTA, V23, P343, DOI 10.1053/plac.2001.0777; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Clapp JF, 2004, AM J OBSTET GYNECOL, V190, P730, DOI 10.1016/j.ajog.2003.09.061; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cohn BA, 2001, J NATL CANCER I, V93, P1133, DOI 10.1093/jnci/93.15.1133; GODFREY KM, 1991, BRIT J OBSTET GYNAEC, V98, P886, DOI 10.1111/j.1471-0528.1991.tb13510.x; GRUENWALD P, 1963, BIOL NEONATORUM, V5, P215; Hoover RN, 2001, J NATL CANCER I, V93, P1119, DOI 10.1093/jnci/93.15.1119; Innes KE, 1999, EPIDEMIOLOGY, V10, P722, DOI 10.1097/00001648-199911000-00013; Kaijser M, 2000, EPIDEMIOLOGY, V11, P315, DOI 10.1097/00001648-200005000-00015; KAIJSER M, 2002, THESIS KAROLINSKA I; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kinnunen Tarja I, 2004, BMC Womens Health, V4, P7, DOI 10.1186/1472-6874-4-7; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; LIPWORTH L, 1995, EUR J CANCER PREV, V4, P7, DOI 10.1097/00008469-199502000-00002; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6; Melbye M, 2000, JNCI-J NATL CANCER I, V92, P1001, DOI 10.1093/jnci/92.12.1001; MOLTENI RA, 1978, J REPROD MED, V21, P327; MOLTENI RA, 1984, SEMIN PERINATOL, V8, P94; Mucci LA, 2003, CANCER CAUSE CONTROL, V14, P311, DOI 10.1023/A:1023966813330; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; *NAT BOARD HLTH WE, 2000, CANC INC SWED 1998; Salonen RH, 2000, AM J MED GENET, V91, P256; Thame M, 2001, OBSTET GYNECOL, V98, P279, DOI 10.1016/S0029-7844(01)01414-4; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Troisi R, 1998, EPIDEMIOLOGY, V9, P641, DOI 10.1097/00001648-199811000-00014; Troisi R, 2003, INT J EPIDEMIOL, V32, P455, DOI 10.1093/ije/dyg094; Vatten LJ, 2002, BRIT J CANCER, V87, P971, DOI 10.1038/sj.bjc.6600581; Wenstrom KD, 1996, OBSTET GYNECOL, V87, P213, DOI 10.1016/0029-7844(95)00377-0; Wohlfahrt J, 1999, EPIDEMIOLOGY, V10, P441, DOI 10.1097/00001648-199907000-00017; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; [No title captured]	34	60	61	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2005	294	19					2474	2480		10.1001/jama.294.19.2474	http://dx.doi.org/10.1001/jama.294.19.2474			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984BL	16287958	Bronze			2022-12-01	WOS:000233277400026
J	Furukawa, H; Singh, SK; Mancusso, R; Gouaux, E				Furukawa, H; Singh, SK; Mancusso, R; Gouaux, E			Subunit arrangement and function in NMDA receptors	NATURE			English	Article							D-ASPARTATE RECEPTORS; LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; MOLECULAR DETERMINANTS; CHANNEL KINETICS; AMPA RECEPTORS; ACTIVATION; KAINATE; MECHANISM	Excitatory neurotransmission mediated by NMDA (N-methyl-D-aspartate) receptors is fundamental to the physiology of the mammalian central nervous system. These receptors are heteromeric ion channels that for activation require binding of glycine and glutamate to the NR1 and NR2 subunits, respectively. NMDA receptor function is characterized by slow channel opening and deactivation, and the resulting influx of cations initiates signal transduction cascades that are crucial to higher functions including learning and memory. Here we report crystal structures of the ligand-binding core of NR2A with glutamate and that of the NR1 - NR2A heterodimer with glutamate and glycine. The NR2A - glutamate complex defines the determinants of glutamate and NMDA recognition, and the NR1 - NR2A heterodimer suggests a mechanism for ligand-induced ion channel opening. Analysis of the heterodimer interface, together with biochemical and electrophysiological experiments, confirms that the NR1 - NR2A heterodimer is the functional unit in tetrameric NMDA receptors and that tyrosine 535 of NR1, located in the subunit interface, modulates the rate of ion channel deactivation.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KANDEL ER, 1995, ESSENTIALS NEURAL SC, P219; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; YPHANTIS D, 1997, WINNONLIN106 PROGRAM	50	565	592	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					185	192		10.1038/nature04089	http://dx.doi.org/10.1038/nature04089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281028				2022-12-01	WOS:000233133500040
J	Lummis, SCR; Beene, DL; Lee, LW; Lester, HA; Broadhurst, RW; Dougherty, DA				Lummis, SCR; Beene, DL; Lee, LW; Lester, HA; Broadhurst, RW; Dougherty, DA			Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel	NATURE			English	Article							RECEPTOR M2-M3 LOOP; ACETYLCHOLINE-RECEPTOR; 5-HT3 RECEPTOR; NICOTINIC RECEPTOR; GATING MECHANISM; GABA(A) RECEPTOR; AGONIST-BINDING; RESIDUES; ACCESSIBILITY; CONFORMATION	5-Hydroxytryptamine type 3 (5-HT3) receptors are members of the Cys-loop receptor superfamily(1). Neurotransmitter binding in these proteins triggers the opening (gating) of an ion channel by means of an as-yet-uncharacterized conformational change. Here we show that a specific proline ( Pro 8*), located at the apex of the loop between the second and third transmembrane helices (M2 - M3)(2,3), can link binding to gating through a cis-trans isomerization of the protein backbone. Using unnatural amino acid mutagenesis, a series of proline analogues with varying preference for the cis conformer was incorporated at the 8* position. Proline analogues that strongly favour the trans conformer produced nonfunctional channels. Among the functional mutants there was a strong correlation between the intrinsic cis - trans energy gap of the proline analogue and the activation of the channel, suggesting that cis - trans isomerization of this single proline provides the switch that interconverts the open and closed states of the channel. Consistent with this proposal, nuclear magnetic resonance studies on an M2 - M3 loop peptide reveal two distinct, structured forms. Our results thus confirm the structure of the M2 - M3 loop and the critical role of Pro 8* in the 5-HT3 receptor. In addition, they suggest that a molecular rearrangement at Pro 8* is the structural mechanism that opens the receptor pore.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; University of Cambridge; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	dadougherty@caltech.edu	Broadhurst, Bill William/J-6710-2017	Broadhurst, Bill William/0000-0002-0264-4593	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		An SSA, 1999, J AM CHEM SOC, V121, P11558, DOI 10.1021/ja9930317; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Breitinger HGA, 2001, BIOCHEMISTRY-US, V40, P8419, DOI 10.1021/bi0106890; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cox C, 1998, J AM CHEM SOC, V120, P10660, DOI 10.1021/ja9815071; Dang H, 2000, MOL PHARMACOL, V57, P1114; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Halab L, 1999, J ORG CHEM, V64, P3312, DOI 10.1021/jo990294a; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kern D, 1997, J AM CHEM SOC, V119, P8403, DOI 10.1021/ja970606w; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2004, BIOCHEM SOC T, V32, P535, DOI 10.1042/BST0320535; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MEEUS N, 2003, PA2ONLINE, V1; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	30	379	382	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2005	438	7065					248	252		10.1038/nature04130	http://dx.doi.org/10.1038/nature04130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281040				2022-12-01	WOS:000233133500054
J	Ge, SY; Goh, ELK; Sailor, KA; Kitabatake, Y; Ming, GL; Song, HJ				Ge, SY; Goh, ELK; Sailor, KA; Kitabatake, Y; Ming, GL; Song, HJ			GABA regulates synaptic integration of newly generated neurons in the adult brain	NATURE			English	Article							POSTNATAL SUBVENTRICULAR ZONE; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; GRANULE CELLS; RECEPTOR ACTIVATION; NEUROGENESIS; COMMUNICATION; HIPPOCAMPUS; PROGENITORS; INHIBITION	Adult neurogenesis, the birth and integration of new neurons from adult neural stem cells, is a striking form of structural plasticity and highlights the regenerative capacity of the adult mammalian brain(1-8). Accumulating evidence suggests that neuronal activity regulates adult neurogenesis and that new neurons contribute to specific brain functions(1-8). The mechanism that regulates the integration of newly generated neurons into the pre-existing functional circuitry in the adult brain is unknown. Here we show that newborn granule cells in the dentate gyrus of the adult hippocampus are tonically activated by ambient GABA (gamma-aminobutyric acid) before being sequentially innervated by GABA- and glutamate-mediated synaptic inputs. GABA, the major inhibitory neurotransmitter in the adult brain, initially exerts an excitatory action on newborn neurons owing to their high cytoplasmic chloride ion content(9-12). Conversion of GABA- induced depolarization ( excitation) into hyperpolarization ( inhibition) in newborn neurons leads to marked defects in their synapse formation and dendritic development in vivo. Our study identifies an essential role for GABA in the synaptic integration of newly generated neurons in the adult brain, and suggests an unexpected mechanism for activity-dependent regulation of adult neurogenesis, in which newborn neurons may sense neuronal network activity through tonic and phasic GABA activation.	Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@bs.jhmi.edu; shongju1@bs.jhmi.edu	Sailor, Kurt Andrew/AFN-4046-2022; Goh, Eyleen/A-8006-2013; Sailor, Kurt/GSO-2237-2022; Ming, Guo-li/J-7880-2013	Sailor, Kurt Andrew/0000-0002-9574-6838; Sailor, Kurt/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Goh, Eyleen/0000-0002-8244-6959; Ming, Guo-li/0000-0002-2517-6075	NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NINDS NIH HHS [R01 NS047344] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chavas J, 2004, NEURON, V44, P701, DOI 10.1016/j.neuron.2004.11.002; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941	30	936	992	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2006	439	7076					589	593		10.1038/nature04404	http://dx.doi.org/10.1038/nature04404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008IO	16341203	Green Accepted			2022-12-01	WOS:000235033900041
J	Leavell, NR; Muggli, ME; Hurt, RD; Repace, J				Leavell, NR; Muggli, ME; Hurt, RD; Repace, J			Public health - Blowing smoke: British American Tobacco's air filtration scheme	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SECONDHAND SMOKE; BAN	As Westminster MPs prepare for a free vote on a complete smoking ban in public places, researchers question the efficacy of a technique meant to clear the air of tobacco sruoke-heavily promoted by tobacco companies as an alternative to legislation.	Mayo Clin, Nicotine Dependence Ctr, Rochester, MN 55905 USA; Mayo Clin, Nicotine Res Program, Rochester, MN 55905 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Mayo Clinic; Mayo Clinic; Tufts University	Hurt, RD (corresponding author), Mayo Clin, Nicotine Dependence Ctr, 200 1st St SW, Rochester, MN 55905 USA.	rhurt@mayo.edu		Repace, james/0000-0002-7104-900X	NCI NIH HHS [R01 CA90791] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090791] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*ACT SMOK HLTH, 2004, SMOK WORKPL PUBL PLA; Barnoya J, 2002, TOB CONTROL, V11, P305, DOI 10.1136/tc.11.4.305; BARNOYA J, 2005, EUR J PUBLIC HL 0802; *BRIT AM TOB, 1995, 70097753 BRIT AM TOB; *BRIT AM TOB, 1995, 7000977347737 BRIT A; *BRIT AM TOB, 7000977307731 BRIT A; *BRIT AM TOB BAT, ETS TASK FORC M NEUC; *BRIT AM TOB CO, UKS PUBL PLAC CHART; *BRIT MED ASS, 2004, SMOK WORKPL PUBL PLA; BRYAN H, 1996, 700431643165 BRIT AM; BRYAN N, 1996, 700473166 BRIT AM TO; *DEP HLTH HUM SERV, 1986, HLTH CONS INV SMOK R; Department of Health, 1998, SMOK KILLS WHIT PAP; Department of Health, 2004, CHOOS HLTH MAK HLTH; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; GRAHAM L, 2000, 322054154944 BRIT AM; *IR OFF TOB CONTR, CURR TRENDS CIG SMOK; LINCHAN K, 1992, 2047916006013 BRIT A; McKee M, 2004, J PUBLIC HEALTH-UK, V26, P325, DOI 10.1093/pubmed/fdh187; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; QUEK D, 1996, 700596762 BRIT AM T; Repace J, 2004, J OCCUP ENVIRON MED, V46, P887, DOI 10.1097/01.jom.0000141644.69355.52; REPACE J, 2003, KILLER LOOSE ACTION; SAX NI, 1961, DANGEROUS PROPERTIES; SIEGEL M, 1993, JAMA-J AM MED ASSOC, V270, P490, DOI 10.1001/jama.270.4.490; SIMS D, 1997, 900030342900030343 B; TURNER A, 1996, 7004732393255 BRIT A; VASUDEVAN B, 1994, 4036643714374 BRIT A; VASUDEVAN B, 1994, 6001079247926 BRIT A; WARREN N, 1994, 4036644044427 BRIT A; WARREN N, 1994, 6001080498053 BRIT A; WARREN N, 2000, 325192311 BRIT AM TO; WARREN N, 1995, 600108255 BRIT AM TO; WARREN N, 1996, 7001224102412 BRIT A; WARREN N, 1995, 6001080938094 BRIT A; WARREN N, 1996, 800027387 BRIT AM TO; WARREN N, 700098392 BRIT AM TO; WARREN N, 1966, 800273307331 BRIT AM; WARREN N, 1994, 4036984088410 BRIT A; Woodall AA, 2005, BRIT MED J, V331, P488, DOI 10.1136/bmj.38576.467292.EB; 2000, 3250529302938 BRIT A	43	12	13	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2006	332	7535					227	229		10.1136/bmj.332.7535.227	http://dx.doi.org/10.1136/bmj.332.7535.227			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	009BU	16439404	Green Published			2022-12-01	WOS:000235086900023
J	Rape, M; Reddy, SK; Kirschner, MW				Rape, M; Reddy, SK; Kirschner, MW			The processivity of multiubiquitination by the APC determines the order of substrate degradation	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE ENTRY; DESTRUCTION BOX; CYCLIN; RECOGNITION; MITOSIS; PROTEOLYSIS; DOMAIN; ACCUMULATION; MECHANISM	The anaphase-promoting complex (APC) coordinates mitosis and G1 by sequentially promoting the degradation of key cell-cycle regulators. Following the degradation of its substrates in G1, the APC catalyzes the autoubiquitination of its E2 UbcH10. This stabilizes cyclin A and allows it to inactivate ApC(Cdh1). How the APC establishes this complex temporal sequence of ubiquitinations, referred to as substrate ordering, is not understood. Here we show that substrate ordering depends on the relative processivity of substrate multiubiquitination by the APC. Processive substrates obtain ubiquitin chains in a single APC binding event. The multi ubiquitination of distributive substrates requires multiple rounds of APC binding, which render it sensitive to lower APC concentrations, competition by processive substrates, and deubiquitination. Consequently, more processive substrates are preferentially multiubiquitinated in vitro and degraded earlier in vivo. The processivity of multiubiquitination is strongly influenced by the D box within the substrate, suggesting that substrate ordering is established by a mechanism intrinsic to APC and its substrates and similar to kinetic proofreading.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu		Rape, Michael/0000-0003-4849-6343				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5	26	222	231	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					89	103		10.1016/j.cell.2005.10.032	http://dx.doi.org/10.1016/j.cell.2005.10.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413484	Green Submitted, Bronze			2022-12-01	WOS:000234969600012
J	Leon, DA; McCambridge, J				Leon, DA; McCambridge, J			Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data	LANCET			English	Article							BEER-DRINKING COUNTRIES; ALCOHOL-CONSUMPTION; COMMENTARIES; SCOTLAND; ENGLAND; OBESITY; COHORT	Background Rates of mortality due to cirrhosis of the liver are an important indicator of population levels of alcohol harm. Total recorded alcohol consumption in Britain doubled between 1960 and 2002, giving rise to a need to examine and assess cirrhosis mortality trends. Methods Mortality rates were calculated for all ages and for specific age-groups (15-44 years and 45-64 years) for cirrhosis of the liver. Rates were directly age-standardised to the European standard population and compared with rates from 12 western European countries for the period 1955-2001. Findings Cirrhosis mortality rates increased steeply in Britain during the 1990s. Between the periods 1987-1991, and 1997-2001, cirrhosis mortality in men in Scotland more than doubled (104% increase) and in England and Wales rose by over two-thirds (69%). Mortality in women increased by almost half (46% in Scotland and 44% in England and Wales). These relative increases are the steepest in western Europe, and contrast with the declines apparent in most other countries examined, particularly those of southern Europe. Cirrhosis mortality rates in Scotland are now one of the highest in western Europe, in 2002 being 45.2 per 100 000 in men and 19.9 in women. Interpretation Current alcohol policies in Britain should be assessed by the extent to which they can successfully halt the adverse trends in liver cirrhosis mortality. The situation in Scotland warrants particular attention.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; Kings Coll London, Natl Addict Ctr, Inst Psychiat, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	david.leon@lshtm.ac.uk	Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; McCambridge, Jim/0000-0002-5461-7001	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; [Anonymous], 2000, SCOTT NEEDS ASS PROG; Babor T., 2003, ALCOHOL NO ORDINARY; Bruun K., 1975, ALCOHOL CONTROL POLI; *CAB OFF, 2004, ALC HARM RED STRAT E; Desenclos J-C, 2003, Euro Surveill, V8, P99; DONALDSON L, 2001, STATE PUBLIC HLTH; DUFFY JC, 1986, J ROY STAT SOC A STA, V149, P45, DOI 10.2307/2981884; DUFFY JC, 1986, BRIT MED J, V292, P36, DOI 10.1136/bmj.292.6512.36; Edwards G., 1994, ALCOHOL POLICY PUBLI; *EUR MON CTR DRUGS, 2004, STAT DRUGS PROBL EUR; Gruenewald PJ, 2000, ADDICTION, V95, P347; Gutierrez-Fisac JL, 2000, INT J OBESITY, V24, P1677, DOI 10.1038/sj.ijo.0801445; Henry JA, 2002, J CLIN PATHOL, V55, P704, DOI 10.1136/jcp.55.9.704; Ioannou GN, 2003, GASTROENTEROLOGY, V125, P1053, DOI 10.1016/S0016-5085(03)01200-9; Kerr WC, 2000, ADDICTION, V95, P355; Kerr WC, 2000, ADDICTION, V95, P339, DOI 10.1046/j.1360-0443.2000.9533394.x; Leon D. A., 2003, UNDERSTANDING HLTH S; NORSTROM T, 1987, BRIT J ADDICT, V82, P633; *ORG EC COOP DEV, 2005, OECD HLTH DAT 2005 S; Ramstedt M, 2001, ADDICTION, V96, pS19; Roizen R, 1999, BRIT MED J, V319, P666, DOI 10.1136/bmj.319.7211.666; Room R, 2004, ADDICTION, V99, P1083, DOI 10.1111/j.1360-0443.2004.00803.x; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; SEELEY J R, 1960, Can Med Assoc J, V83, P1361; SHAW A, 2000, SCOTTISH HLTH SURVEY, V1; TERRIS M, 1967, AM J PUBLIC HEALTH N, V57, P2076, DOI 10.2105/AJPH.57.12.2076; WALKER A, 2001, LIVING BRITAIN RESUL; WILSON P, 1980, POPUL TRENDS     WIN, P14; [No title captured]	30	307	312	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 7	2006	367	9504					52	56		10.1016/S0140-6736(06)67924-5	http://dx.doi.org/10.1016/S0140-6736(06)67924-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000EG	16399153	Green Accepted			2022-12-01	WOS:000234443100030
J	Petry, S; Brodersen, DE; Murphy, FV; Dunham, CM; Selmer, M; Tarry, MJ; Kelley, AC; Ramakrishnan, V				Petry, S; Brodersen, DE; Murphy, FV; Dunham, CM; Selmer, M; Tarry, MJ; Kelley, AC; Ramakrishnan, V			Crystal structures of the ribosome in complex with release factors RF1 and RF2 bound to a cognate stop codon	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CONSERVED GGQ MOTIF; POLYPEPTIDE RELEASE; TRANSLATION TERMINATION; THERMUS-THERMOPHILUS; GTPASE CENTER; ACTIVE-SITE; FACTOR ERF1; PEPTIDE; RECOGNITION	During protein synthesis, translational release factors catalyze the release of the polypeptide chain when a stop codon on the mRNA reaches the A site of the ribosome. The detailed mechanism of this process is currently unknown. We present here the crystal structures of the ribosome from Thermus thermophilus with RF1 and RF2 bound to their cognate stop codons, at resolutions of 5.9 angstrom and 6.7 angstrom, respectively. The structures reveal details of interactions of the factors with the ribosome and mRNA, including elements previously implicated in decoding and peptide release. They also shed light on conformational changes both in the factors and in the ribosome during termination. Differences seen in the interaction of RF1 and RF2 with the RF1 region of the ribosome allow us to rationalize previous biochemical data. Finally, this work demonstrates the feasibility of crystallizing ribosomes with bound factors at a defined state along the translational pathway.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020	Ramakrishnan, V/0000-0002-4699-2194; Selmer, Maria/0000-0001-9079-2774; Brodersen, Ditlev/0000-0002-5413-4667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067624] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: Medline; NIGMS NIH HHS [GM67624] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Arkov AL, 1998, EMBO J, V17, P1507, DOI 10.1093/emboj/17.5.1507; Arkov AL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; CASKEY CT, 1968, SCIENCE, V162, P135, DOI 10.1126/science.162.3849.135; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Jacobs GH, 2002, NUCLEIC ACIDS RES, V30, P310, DOI 10.1093/nar/30.1.310; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Junemann R, 1996, NUCLEIC ACIDS RES, V24, P907, DOI 10.1093/nar/24.5.907; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; KONECKI DS, 1977, J BIOL CHEM, V252, P4514; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Mottagui-Tabar S, 1998, NUCLEIC ACIDS RES, V26, P2789, DOI 10.1093/nar/26.11.2789; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Ravelli RBG, 1997, J APPL CRYSTALLOGR, V30, P551, DOI 10.1107/S0021889897003543; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)90932-V; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TATE WP, 1983, J BIOL CHEM, V258, P2816; THOMPSON J, 1979, EUR J BIOCHEM, V98, P261, DOI 10.1111/j.1432-1033.1979.tb13184.x; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Van Dyke N, 2003, J MOL BIOL, V330, P9, DOI 10.1016/S0022-2836(03)00537-0; Van Dyke N, 2002, J MOL BIOL, V319, P329, DOI 10.1016/S0022-2836(02)00304-2; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xu WB, 2002, J BACTERIOL, V184, P1200, DOI 10.1128/jb.184.4.1200-1203.2002; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	56	196	232	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1255	1266		10.1016/j.cell.2005.09.039	http://dx.doi.org/10.1016/j.cell.2005.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377566	Bronze			2022-12-01	WOS:000234584500014
J	Carnethon, MR; Gulati, M; Greenland, P				Carnethon, MR; Gulati, M; Greenland, P			Prevalence and cardiovascular disease correlates of low cardiorespiratory fitness in adolescents and adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-FITNESS; EXERCISE CAPACITY; RISK-FACTORS; AEROBIC EXERCISE; CANCER-MORTALITY; UNITED-STATES; MEN; HEALTHY; AGE	Context Population surveys indicate that physical activity levels are low in the United States. One consequence of inactivity, low cardiorespiratory fitness, is an established risk factor for cardiovascular disease (CVD) morbidity and mortality, but the prevalence of cardiorespiratory fitness has not been quantified in representative US population samples. Objectives To describe the prevalence of low fitness in the US population aged 12 through 49 years and to relate low fitness to CVD risk factors in this population. Design, Setting, and Participants Inception cohort study using data from the cross-sectional nationally representative National Health and Nutrition Examination Survey 1999-2002. Participants were adolescents (aged 12-19 years; n=3110) and adults (aged 20-49 years; n=2205) free from previously diagnosed CVD who underwent submaximal graded exercise treadmill testing to achieve at least 75% to 90% of their age-predicted maximum heart rate. Maximal oxygen consumption ((V) over dot o(2)max) was estimated by measuring the heart rate response to reference levels of submaximal work. Main Outcome Measures Low fitness defined using percentile cut points of estimated ((V) over dot(2)max from existing external referent populations; anthropometric and other CVD risk factors measured according to standard methods. Results Low fitness was identified in 33.6% of adolescents (approximately 7.5 million US adolescents) and 13.9% of adults (approximately 8.5 million US adults); the prevalence was similar in adolescent females (34.4%) and males (32.9%) (P=.40) but was higher in adult females (16.2%) than in males (11.8%) (P=.03). Non-Hispanic blacks and Mexican Americans were less fit than non-Hispanic whites. In all age-sex groups, body mass index and waist circumference were inversely associated with fitness-, age- and race-adjusted odds ratios of overweight or obesity (body mass index >= 25) ranged from 2.1 to 3.7 (P<.01 for all), comparing persons with low fitness with those with moderate or high fitness. Total cholesterol levels and systolic blood pressure were higher and levels of high-density lipoprotein cholesterol were lower among participants with low vs high fitness. Conclusion Low fitness in adolescents and adults is common in the US population and is associated with an increased prevalence of CVD risk factors.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Carnethon, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	carnethon@northwestern.edu	Gulati, Martha/AAB-7722-2022; Greenland, Philip/ABD-5528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073249] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc11-S062, 10.2337/dc12-s064, 10.2337/dc13-S067, 10.2337/dc10-S062]; American College of Sports Medicine, 2000, ACSMS GUID EX TEST P, P163; [Anonymous], 1995, DIABETES, V44, P968; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P764; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; CURETON KJ, 1990, RES Q EXERCISE SPORT, V61, P7, DOI 10.1080/02701367.1990.10607473; DiabetesPrev D. Prog Res. Group, 2002, NEW ENGL J MED, V346, P393, DOI [DOI 10.1056/NEJMOA012512, 10.1056/NEJMoa012512]; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Duncan GE, 2005, MED SCI SPORT EXER, V37, P1324, DOI 10.1249/01.mss.0000174893.74326.11; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Evenson KR, 2003, MED SCI SPORT EXER, V35, P270, DOI 10.1249/01.MSS.0000053511.02356.72; Ferreira I, 2002, EUR J CLIN INVEST, V32, P723, DOI 10.1046/j.1365-2362.2002.01066.x; FLUCKIGER R, 1984, DIABETES, V33, P73, DOI 10.2337/diabetes.33.1.73; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GOULD BJ, 1984, ANN CLIN BIOCHEM, V21, P16, DOI 10.1177/000456328402100103; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Gustat J, 2002, J CLIN EPIDEMIOL, V55, P997, DOI 10.1016/S0895-4356(02)00427-4; *I AER RES, 1994, FITNESSGRAM TEST ADM; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lee CD, 2002, MED SCI SPORT EXER, V34, P735; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; *NAT CTR HLTH STAT, 2004, NHANES 1999 2000 DAT; *NAT CTR HLTH STAT, 2004, NHANES CARD FITN PRO; *NAT CTR HLTH STAT, 2004, AN GUID; OLSHANSKY SJ, 2000, NEW ENGL J MED, V352, P1138; Raitakari OT, 1997, MED SCI SPORT EXER, V29, P1055, DOI 10.1097/00005768-199708000-00011; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SLATTERY ML, 1988, AM J EPIDEMIOL, V127, P571, DOI 10.1093/oxfordjournals.aje.a114832; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	43	262	272	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					2981	2988		10.1001/jama.294.23.2981	http://dx.doi.org/10.1001/jama.294.23.2981			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414945	Bronze			2022-12-01	WOS:000234087700024
J	Hao, LY; Armanios, M; Strong, MA; Karim, B; Feldser, DM; Huso, D; Greider, CW				Hao, LY; Armanios, M; Strong, MA; Karim, B; Feldser, DM; Huso, D; Greider, CW			Short telomeres, even in the presence of telomerase, limit tissue renewal capacity	CELL			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; APLASTIC-ANEMIA; REVERSE-TRANSCRIPTASE; MAMMALIAN TELOMERES; MOUSE CELLS; T-CELLS; RNA; MUTATIONS	Autosomal-dominant dyskeratosis congenita is associated with heterozygous mutations in telomerase. To examine the dosage effect of telomerase, we generated a line of mTR(-/-) mice on the CAST/EiJ background, which has short telomeres. Interbreeding of heterozygotes resulted in progressive telomere shortening, indicating that limiting telomerase compromises telomere maintenance. In later-generation heterozygotes, we observed a decrease in tissue renewal capacity in the bone marrow, intestines, and testes that resembled defects seen in dyskeratosis congenita patients. The progressive worsening of disease with decreasing telomere length suggests that short telomeres, not telomerase level, cause stem cell failure. Further, wild-type mice derived from the late-generation heterozygous parents, termed wt*, also had short telomeres and displayed a germ cell defect, indicating that telomere length determines these phenotypes. We propose that short telomeres in mice that have normal telomerase levels can cause an occult form of genetic disease.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Grad Program Human Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hao, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Greider, Carol/0000-0002-5494-8126; Strong, Margaret/0000-0002-0055-6573	NCI NIH HHS [P01 CA16519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cerone MA, 2005, CELL CYCLE, V4, P585; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cellbio.11.1.35; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; SANDERSON JH, 1981, ATLAS LAB ANIMAL HAE; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wynn RF, 1998, LANCET, V351, P178, DOI 10.1016/S0140-6736(97)08256-1; Yabe M, 1997, BONE MARROW TRANSPL, V19, P389, DOI 10.1038/sj.bmt.1700674; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	49	230	246	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1121	1131		10.1016/j.cell.2005.11.020	http://dx.doi.org/10.1016/j.cell.2005.11.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360040	Bronze			2022-12-01	WOS:000234177200019
J	Janssens, S; Tinel, A; Lippens, S; Tschopp, J				Janssens, S; Tinel, A; Lippens, S; Tschopp, J			PIDD mediates NF-kappa B activation in response to DNA damage	CELL			English	Article							DOMAIN-CONTAINING PROTEIN; NECROSIS-FACTOR-ALPHA; TOPOISOMERASE-II; SUMO-1 MODIFICATION; GENOTOXIC STRESS; NEMO/IKK-GAMMA; KINASE RIP; NUCLEAR; COMPLEX; SIGNAL	Activation of NF-kappa B following genotoxic stress allows time for DNA-damage repair and ensures cell survival accounting for acquired chemoresistance, an impediment to effective cancer therapy. Despite this clinical relevance, little is known about pathways that enable genotoxic-stress-induced NF-kappa B induction. Previously, we reported a role for the p53-inducible death-domain-containing protein, PIDD, in caspase-2 activation and apoptosis in response to DNA damage. We now demonstrate that PIDD plays a critical role in DNA-damage-induced NF-kappa B activation. Upon genotoxic stress, a complex between PIDD, the kinase RIP1, and a component of the NF-kappa B-activating kinase complex, NEMO, is formed. PIDD expression enhances genotoxic-stress-induced NF-kappa B activation through augmented sumoylation and ubiquitination of NEMO. Depletion of PIDD and RIP1, but not caspase-2, abrogates DNA-damage-induced NEMO modification and NF-kappa B activation. We propose that PIDD acts as a molecular switch, controlling the balance between life and death upon DNA damage.	Univ Lausanne, BIL Biomed Res Ctr, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Janssens, S (corresponding author), Univ Lausanne, BIL Biomed Res Ctr, Dept Biochem, Chemin Boveressess 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Lippens, Saskia/C-1343-2009	Lippens, Saskia/0000-0002-8261-3462				AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Boland MP, 2000, J BIOL CHEM, V275, P25231, DOI 10.1074/jbc.275.33.25231; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jung M, 1997, CANCER RES, V57, P24; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Rangasamy D, 2000, J BIOL CHEM, V275, P37999, DOI 10.1074/jbc.M007777200; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	45	266	276	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1079	1092		10.1016/j.cell.2005.09.036	http://dx.doi.org/10.1016/j.cell.2005.09.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360037	Bronze			2022-12-01	WOS:000234177200016
J	Reversade, B; De Robertis, EM				Reversade, B; De Robertis, EM			Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field	CELL			English	Article							NEGATIVE FEEDBACK REGULATOR; NEURAL INDUCTION; TWISTED GASTRULATION; ORGANIZER; XENOPUS; CHORDIN; CLEAVAGE; RECEPTOR; PROTEIN; METALLOPROTEASE	Embryos have the ability to self-regulate and regenerate normal structures after being sectioned in half. How is such a morphogenetic field established? We discovered that quadruple knockdown of ADMP and BMP2/4/7 in Xenopus embryos eliminates self-regulation, causing ubiquitous neural induction throughout the ectoderm. ADMP transcription in the Spemann organizer is activated at low BMP levels. When ventral BMP2/4/7 signals are depleted, Admp expression increases, allowing for self-regulation. ADMP has BMP-like activity and signals via the ALK-2 receptor. It is unable to signal dorsally because of inhibition by Chordin. The ventral BMP antagonists Sizzled and Bambi further refine the pattern. By transplanting dorsal or ventral wild-type grafts into ADMP/BMP2/4/7-depleted hosts, we demonstrate that both poles serve as signaling centers that can induce histotypic differentiation over considerable distances. We conclude that dorsal and ventral BMP signals and their extracellular antagonists expressed under opposing transcriptional regulation provide a molecular mechanism for embryonic self-regulation.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Reversade, B (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		REVERSADE, Bruno/0000-0002-4070-7997	NICHD NIH HHS [R37 HD21502-19, R37 HD021502, R37 HD021502-19] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bertocchini F, 2004, DEVELOPMENT, V131, P3381, DOI 10.1242/dev.01178; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Enders AC, 2002, PLACENTA, V23, P71, DOI 10.1053/plac.2001.0753; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Harrison RG, 1918, J EXP ZOOL, V25, P413, DOI 10.1002/jez.1400250204; Huxley JS, 1934, ELEMENTS EXPT EMBRYO; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; KLEIN SL, 1987, DEV BIOL, V120, P299, DOI 10.1016/0012-1606(87)90127-8; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MEINHARDT H, 1992, REP PROG PHYS, V55, P797, DOI 10.1088/0034-4885/55/6/003; Moos M, 1995, DEVELOPMENT, V121, P4293; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Sadler T.W., 2018, LANGMANS MED EMBRYOL; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Spemann H, 1903, ARCH ENTWICKLUNG ORG, V16, P551, DOI 10.1007/BF02301267; Spemann H., 1938, EMBRYONIC DEV INDUCT; SPRATT NT, 1960, J EXP ZOOL, V145, P97, DOI 10.1002/jez.1401450202; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506	39	196	201	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1147	1160		10.1016/j.cell.2005.08.047	http://dx.doi.org/10.1016/j.cell.2005.08.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360041	Green Accepted, Bronze			2022-12-01	WOS:000234177200021
J	Talavera, K; Yasumatsu, K; Voets, T; Droogmans, G; Shigemura, N; Ninomiya, Y; Margolskee, RF; Nilius, B				Talavera, K; Yasumatsu, K; Voets, T; Droogmans, G; Shigemura, N; Ninomiya, Y; Margolskee, RF; Nilius, B			Heat activation of TRPM5 underlies thermal sensitivity of sweet taste	NATURE			English	Article							RECEPTOR-CELLS; CHANNELS; TEMPERATURE; MICE; TRANSDUCTION; VOLTAGE	TRPM5, a cation channel of the TRP superfamily, is highly expressed in taste buds of the tongue, where it has a key role in the perception of sweet, umami and bitter tastes(1,2). Activation of TRPM5 occurs downstream of the activation of G-protein-coupled taste receptors and is proposed to generate a depolarizing potential in the taste receptor cells(2). Factors that modulate TRPM5 activity are therefore expected to influence taste. Here we show that TRPM5 is a highly temperature-sensitive, heat-activated channel: inward TRPM5 currents increase steeply at temperatures between 15 and 35 degrees C. TRPM4, a close homologue of TRPM5, shows similar temperature sensitivity. Heat activation is due to a temperature-dependent shift of the activation curve, in analogy to other thermosensitive TRP channels(3). Moreover, we show that increasing temperature between 15 and 35 degrees C markedly enhances the gustatory nerve response to sweet compounds in wild-type but not in Trpm5 knockout mice. The strong temperature sensitivity of TRPM5 may underlie known effects of temperature on perceived taste in humans(4-6), including enhanced sweetness perception at high temperatures and 'thermal taste', the phenomenon whereby heating or cooling of the tongue evoke sensations of taste in the absence of tastants(7).	Catholic Univ Louvain, Fysiol Lab, B-3000 Louvain, Belgium; Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan; Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Universite Catholique Louvain; Kyushu University; Icahn School of Medicine at Mount Sinai	Talavera, K (corresponding author), Catholic Univ Louvain, Fysiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.	Karel.talavera@med.kuleuven.be	Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019; Talavera, Karel/K-7990-2014	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Talavera, Karel/0000-0002-3124-138X; Shigemura, Noriatsu/0000-0002-3061-6362; Margolskee, Robert/0000-0002-9572-2887				BARTOSHUK LM, 1982, PHYSIOL BEHAV, V28, P905, DOI 10.1016/0031-9384(82)90212-8; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CORREA AM, 1992, BIOPHYS J, V61, P1332, DOI 10.1016/S0006-3495(92)81941-0; Cruz A, 2000, NATURE, V403, P889, DOI 10.1038/35002581; GREEN BG, 1988, PHYSIOL BEHAV, V43, P515, DOI 10.1016/0031-9384(88)90127-8; GREEN BG, 1987, CHEM SENSES, V12, P609, DOI 10.1093/chemse/12.4.609; Hille B., 2001, ION CHANNELS EXCITAB, P366; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Patapoutian A, 2005, CHEM SENSES, V30, pI193, DOI 10.1093/chemse/bjh180; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Rong MQ, 2005, CHEM SENSES, V30, pI33, DOI 10.1093/chemse/bjh099; Talavera K, 2003, J GEN PHYSIOL, V121, P511, DOI 10.1085/jgp.200308793; Tiwari JK, 1999, EUR BIOPHYS J BIOPHY, V28, P338, DOI 10.1007/s002490050216; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; VANLUNTEREN E, 1993, J PHYSIOL-LONDON, V466, P81; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	22	325	347	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 15	2005	438	7070					1022	1025		10.1038/nature04248	http://dx.doi.org/10.1038/nature04248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355226	Green Published			2022-12-01	WOS:000233934600068
J	Mozaffarian, D				Mozaffarian, D			Electron-beam computed tomography for coronary calcium - A useful test to screen for coronary heart disease?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ARTERY CALCIUM; PROGNOSTIC VALUE; RISK PREDICTION; FOLLOW-UP; CALCIFICATION; EVENTS; CANCER; CT		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2,Room 315, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008		NHLBI NIH HHS [K08-HL-075628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; American Heart Association, 2005, HEART DIS STROKE STA; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; BREEN JF, 1992, RADIOLOGY, V185, P435, DOI 10.1148/radiology.185.2.1410350; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; *LIF IM CTR, HEART COR ART SCREEN; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; O'Malley PG, 2004, AM HEART J, V148, P106, DOI 10.1016/j.ahj.2004.01.018; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Qu WC, 2003, DIABETES CARE, V26, P905, DOI 10.2337/diacare.26.3.905; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2005, J NUCL CARDIOL, V12, P96, DOI 10.1016/j.nuclcard.2004.11.005; Raggi P, 2004, J WOMENS HEALTH, V13, P273, DOI 10.1089/154099904323016437; Rumberger JA, 1999, J AM COLL CARDIOL, V33, P453, DOI 10.1016/S0735-1097(98)00583-X; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; TANENBAUM SR, 1989, AM J CARDIOL, V63, P870, DOI 10.1016/0002-9149(89)90060-X; UK National Screening Committee, CRIT APPR VIAB EFF A; *US PREV SERV TASK, GUID CLIN PREV SERV; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; *WELLMAX CTR PREV, WELC WELLMAX	28	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2897	2901		10.1001/jama.294.22.2897	http://dx.doi.org/10.1001/jama.294.22.2897			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352798				2022-12-01	WOS:000233826700031
J	Taylor, CJ; Bolton, EM; Pocock, S; Sharples, LD; Pedersen, RA; Bradley, JA				Taylor, CJ; Bolton, EM; Pocock, S; Sharples, LD; Pedersen, RA; Bradley, JA			Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching	LANCET			English	Article							BLOOD-GROUP COMPATIBILITY; RENAL-TRANSPLANTATION; HUMAN BLASTOCYSTS; IN-VITRO; DIFFERENTIATION; THERAPY; DERIVATION; RECIPIENTS; SYSTEM	Background Human embryonic stem (hES) cells are a promising source for transplantation to replace diseased or damaged tissue, but their differentiated progeny express human leucocyte antigens (HLAs) that will probably cause graft rejection. The creation of a bank of HLA-typed hES cells, from which a best match could be selected, would help reduce the likelihood of graft rejection. We investigated how many hES cell lines would be needed to make matching possible in most cases. Methods The number of hES cell lines needed to achieve varying degrees of HLA match was estimated by use of, as a surrogate for hES-cell donor embryos, blood group and HLA types on a series of 10 000 consecutive UK cadaveric organ donors. The degree of blood group compatibility and HLA matching for a recipient population consisting of 6577 patients registered on the UK kidney transplant waiting list was determined, assuming all donor hES cell lines could provide a transplant for an unlimited number of recipients. Findings A bank of 150 consecutive donors provided a full match at HLA-A, HLA-B, and HLA-DR for a minority of recipients (<20%); a beneficial match (defined as one HLA-A or one HLA-B mismatch only) or better for 37.9% (range 27.9-47.5); and an HLA-DR match or better for 84.9% (77.5-90.0). Extending the number of donors beyond 150 conferred only a very gradual incremental benefit with respect to HLA matching. A panel of only ten donors homozygous for common HLA types selected from 10 000 donors provided a complete HLA-A, HLA-B and HLA-DR match for 37.7% of recipients, and a beneficial match for 67.4%. Interpretation Approximately 150 consecutive blood group compatible donors, 100 consecutive blood group 0 donors, or ten highly selected homozygous donors could provide the maximum practical benefit for HLA matching. The findings from these simulations have practical, political, and ethical implications for the establishment of hES-cell banks.	Univ Cambridge, Teaching Hosp, Tissue Typing Lab, Cambridge, England; Univ Cambridge, Sch Clin Med, Dept Surg, Cambridge CB2 1TN, England; MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; University of Cambridge; MRC Biostatistics Unit	Bradley, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Box 202, Cambridge CB2 2QQ, England.	Jab52@cam.ac.uk		Bolton, Eleanor/0000-0002-7253-6045; Sharples, Linda/0000-0003-0894-966X	Medical Research Council [G0800784, G0100501] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Borderie VM, 1997, CORNEA, V16, P1; Bradley JA, 2005, HUMAN EMBRYONIC STEM CELLS, P231; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Calhoun JD, 2004, BIOCHEM BIOPH RES CO, V323, P453, DOI 10.1016/j.bbrc.2004.08.117; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; CLAYTON HA, 1993, TRANSPLANTATION, V56, P1538; Conley BJ, 2004, INT J BIOCHEM CELL B, V36, P555, DOI 10.1016/j.biocel.2003.07.003; COOPER DKC, 1990, TRANSPLANT P, V22, P1457; Doss MX, 2004, J CELL MOL MED, V8, P465, DOI 10.1111/j.1582-4934.2004.tb00471.x; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Faden RR, 2003, HASTINGS CENT REP, V33, P13, DOI 10.2307/3527822; Fairchild PJ, 2004, TRENDS IMMUNOL, V25, P465, DOI 10.1016/j.it.2004.07.005; Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84; Gerecht-Nir S, 2004, AM J TRANSPLANT, V4, P51, DOI 10.1111/j.1600-6135.2004.0345.x; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Lang KJD, 2004, J NEUROSCI RES, V76, P184, DOI 10.1002/jnr.20036; Lin H, 2003, STEM CELLS, V21, P152, DOI 10.1634/stemcells.21-2-152; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; Opelz G, 1999, Rev Immunogenet, V1, P334; PAUL LC, 1987, TRANSPL P, V19, P4463; Petersdorf EW, 2001, NEW ENGL J MED, V345, P1794, DOI 10.1056/NEJMoa011826; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; SANFILIPPO F, 1987, TRANSPLANTATION, V43, P240, DOI 10.1097/00007890-198702000-00015; Stoffel M, 2004, SEMIN CELL DEV BIOL, V15, P327, DOI 10.1016/j.semcdb.2004.02.002; Taylor C J, 1993, Clin Transpl, P233; TAYLOR CJ, 1993, TRANSPLANT P, V25, P210; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *UK TRANSPL STAT, TRANSPL ACT REP; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4	32	322	344	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2005	366	9502					2019	2025		10.1016/S0140-6736(05)67813-0	http://dx.doi.org/10.1016/S0140-6736(05)67813-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PW	16338451				2022-12-01	WOS:000233826900021
J	Turnell, AS; Stewart, GS; Grand, RJA; Rookes, SM; Martin, A; Yamano, H; Elledge, SJ; Gallimore, PH				Turnell, AS; Stewart, GS; Grand, RJA; Rookes, SM; Martin, A; Yamano, H; Elledge, SJ; Gallimore, PH			The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; ADENOVIRUS E1A; UBIQUITIN LIGASE; CBP COACTIVATOR; PROTEIN P300; P53; ACTIVATION; TRANSFORMATION; BINDING; PROTEOLYSIS	The anaphase- promoting complex/ cyclosome ( APC/ C) is a multicomponent E3 ubiquitin ligase that, by targeting protein substrates for 26S proteasome- mediated degradation through ubiquitination, coordinates the temporal progression of eukaryotic cells through mitosis and the subsequent G1 phase of the cell cycle(1-4). Other functions of the APC/ C are, however, less well defined. Here we show that two APC/ C components, APC5 and APC7, interact directly with the coactivators CBP and p300 through protein - protein interaction domains that are evolutionarily conserved in adenovirus E1A(5-8). This interaction stimulates intrinsic CBP/ p300 acetyltransferase activity and potentiates CBP/ p300- dependent transcription. We also show that APC5 and APC7 suppress E1A- mediated transformation in a CBP/ p300- dependent manner, indicating that these components of the APC/ C may be targeted during cellular transformation. Furthermore, we establish that CBP is required in APC/ C function; specifically, gene ablation of CBP by RNA- mediated interference markedly reduces the E3 ubiquitin ligase activity of the APC/ C and the progression of cells through mitosis. Taken together, our results define discrete roles for the APC/ C - CBP/ p300 complexes in growth regulation.	Univ Birmingham, Sch Med, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Marie Curie Res Inst, Surrey RH8 OTL, England; Harvard Univ, Sch Med, Ctr Genet & Genom, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Cancer Research UK; University of Birmingham; Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Turnell, AS (corresponding author), Univ Birmingham, Sch Med, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.	A.S.Turnell@bham.ac.uk		Stewart, Grant/0000-0002-0960-3241				Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; O'Connor MJ, 1999, J VIROL, V73, P3574; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhang X, 2004, J BIOL CHEM, V279, P25122, DOI 10.1074/jbc.M403287200	30	78	80	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					690	695		10.1038/nature04151	http://dx.doi.org/10.1038/nature04151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319895				2022-12-01	WOS:000233593100055
J	Watts, J				Watts, J			Feature - Olympian pins and needles	LANCET			English	Article											Watts, J (corresponding author), 81 Fangyuan,Quan Fa,2 Xiangjiang Beilu, Beijing, Peoples R China.	jon@wattshome.com							0	3	3	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S62	S63		10.1016/S0140-6736(05)67857-9	http://dx.doi.org/10.1016/S0140-6736(05)67857-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360761				2022-12-01	WOS:000234374400037
J	Mathew, D; Ataman, B; Chen, JY; Zhang, YL; Cumberledge, S; Budnik, V				Mathew, D; Ataman, B; Chen, JY; Zhang, YL; Cumberledge, S; Budnik, V			Wingless signaling at synapses is through cleavage and nuclear import of receptor DFrizzled2	SCIENCE			English	Article							DROSOPHILA; PROTEIN; FAMILY; DIFFERENTIATION; INHIBITION; EXPRESSION; WNT-7A	Wingless secretion provides pivotal signals during development by activating transcription of target genes. At Drosophila synapses, Wingless is secreted from presynaptic terminals and is required for synaptic growth and differentiation. Wingless binds the seven-pass transmembrane DFrizzled2 receptor, but the ensuing events at synapses are not known. We show that DFrizzled2 is endocytosed from the postsynaptic membrane and transported to the nucleus. The C terminus of DFrizzled2 is cleaved and translocated into the nucleus; the N-terminal region remains just outside the nucleus. Translocation of DFrizzled2-C into the nucleus, but not its cleavage and transport, depends on Wingless signaling. We conclude that, at synapses, Wingless signal transduction occurs through the nuclear localization of DFrizzled2-C for potential transcriptional regulation of synapse development.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu	Mathew, Dennis/A-7654-2012; Mathew, Dennis/AAF-7036-2020	Mathew, Dennis/0000-0002-2096-6334	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD036000] Funding Source: Medline; NIGMS NIH HHS [GM R01 HD36000] Funding Source: Medline; NIMH NIH HHS [R01 MH70000, R01 MH070000] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen MJ, 1999, J NEUROSCI, V19, P9374; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lucas FR, 1998, J CELL SCI, V111, P1351; Mathew D, 2003, J NEUROSCI, V23, P10710; Moline MM, 1999, DEVELOPMENT, V126, P4375; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; Zhang J, 1998, DEVELOPMENT, V125, P3075	20	132	140	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2005	310	5752					1344	1347		10.1126/science.1117051	http://dx.doi.org/10.1126/science.1117051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988KN	16311339	Green Accepted			2022-12-01	WOS:000233600200046
J	Kimura, KI; Ote, M; Tazawa, T; Yamamoto, D				Kimura, KI; Ote, M; Tazawa, T; Yamamoto, D			Fruitless specifies sexually dimorphic neural circuitry in the Drosophila brain	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; PROGRAMMED CELL-DEATH; EXPRESSION PATTERNS; GENE; MELANOGASTER; MUSCLE; ORIENTATION; NEURONS; SYSTEM; FLIES	The Drosophila fruitless (fru) gene product Fru has been postulated to be a neural sex determination factor that directs development of the central nervous system (CNS), thereby producing male-typical courtship behaviour and inducing male-specific muscle(1-6). Male-specific Fru protein is expressed in small groups of neurons scattered throughout the CNS of male, but not female, Drosophila(4,7). Collectively, these observations suggest that Fru 'masculinizes' certain neurons, thereby establishing neural substrates for male-typical behaviour. However, specific differences between neurons resulting from the presence or absence of Fru are unknown. Previous studies have suggested that Fru might result in sexual differences in the CNS at the functional level, as no overt sexual dimorphism in CNS structure was discernible(8-10). Here we identify a subset of fru-expressing interneurons in the brain that show marked sexual dimorphism in their number and projection pattern. We also demonstrate that Fru supports the development of neurons with male-specific dendritic fields, which are programmed to die during female development as a result of the absence of Fru. Thus, Fru expression can produce a male-specific neural circuit, probably used during heterosexual courtship, by preventing cell death in identifiable neurons.	Hokkaido Univ, Biol Lab, Iwamizawa 0688642, Japan; Waseda Univ, Adv Inst Sci & Engn, Tokyo 1698555, Japan; Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Hokkaido University; Waseda University; Tohoku University	Kimura, KI (corresponding author), Hokkaido Univ, Biol Lab, Iwamizawa Campus, Iwamizawa 0688642, Japan.	kimura@iwa.hokkyodai.ac.jp		Ote, Manabu/0000-0003-1480-0319; , Daisuke/0000-0002-4623-0106				Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIENHARD MC, 1987, J EXP ZOOL, V244, P187, DOI 10.1002/jez.1402440203; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; Nilsson EE, 2000, J NEUROGENET, V13, P213, DOI 10.3109/01677060009084495; Peterson C, 2002, DEVELOPMENT, V129, P1467; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TAYLOR BJ, 1995, DEVELOPMENT, V121, P3079; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319	24	208	213	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2005	438	7065					229	233		10.1038/nature04229	http://dx.doi.org/10.1038/nature04229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281036				2022-12-01	WOS:000233133500050
J	Tsukada, Y; Fang, J; Erdjument-Bromage, H; Warren, ME; Borchers, CH; Tempst, P; Zhang, Y				Tsukada, Y; Fang, J; Erdjument-Bromage, H; Warren, ME; Borchers, CH; Tempst, P; Zhang, Y			Histone demethylation by a family of JmjC domain-containing proteins	NATURE			English	Article							F-BOX PROTEINS; LYSINE METHYLATION; OXIDATIVE DEMETHYLATION; ARGININE METHYLATION; ESCHERICHIA-COLI; COMPLEX; LSD1; IDENTIFICATION; REPRESSION; RECEPTOR	Covalent modification of histones has an important role in regulating chromatin dynamics and transcription. Whereas most covalent histone modifications are reversible, until recently it was unknown whether methyl groups could be actively removed from histones. Using a biochemical assay coupled with chromatography, we have purified a novel JmjC domain-containing protein, JHDM1 ( JmjC domain-containing histone demethylase 1), that specifically demethylates histone H3 at lysine 36 (H3-K36). In the presence of Fe(II) and alpha-ketoglutarate, JHDM1 demethylates H3-methyl-K36 and generates formaldehyde and succinate. Overexpression of JHDM1 reduced the level of dimethyl-H3-K36 (H3K36me2) in vivo. The demethylase activity of the JmjC domain-containing proteins is conserved, as a JHDM1 homologue in Saccharomyces cerevisiae also has H3-K36 demethylase activity. Thus, we identify the JmjC domain as a novel demethylase signature motif and uncover a protein demethylation mechanism that is conserved from yeast to human.	Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Hu, Ruogu/B-2203-2008; BORCHERS, Christoph/U-5964-2019	Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Fang, Jia/0000-0001-8583-1652; Zhang, Yi/0000-0002-2789-0811				Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; KLEEBERG U, 1982, J PHARMACOL METHOD, V8, P19, DOI 10.1016/0160-5402(82)90004-3; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	27	1506	1600	9	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					811	816		10.1038/nature04433	http://dx.doi.org/10.1038/nature04433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16362057				2022-12-01	WOS:000235333600041
J	Gan, JH; Tropea, JE; Austin, BP; Court, DL; Waugh, DS; Ji, XH				Gan, JH; Tropea, JE; Austin, BP; Court, DL; Waugh, DS; Ji, XH			Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III	CELL			English	Article							ESCHERICHIA-COLI; BINDING DOMAIN; DSRNA-BINDING; SUBSTRATE RECOGNITION; BACTERIOPHAGE-LAMBDA; GENE-EXPRESSION; NUCLEASE DOMAIN; PROTEIN; CLEAVAGE; INTERFERENCE	Members of the ribonuclease III (RNase III) family are double-stranded RNA (dsRNA) specific endoribonucleases characterized by a signature motif in their active centers and a two-base 3' overhang in their products. While Dicer, which produces small interfering RNAs, is currently the focus of intense interest, the structurally simpler bacterial RNase III serves as a paradigm for the entire family. Here, we present the crystal structure of an RNase III-product complex, the first catalytic complex observed for the family. A 7 residue linker within the protein facilitates induced fit in protein-RNA recognition. A pattern of protein-RNA interactions, defined by four RNA binding motifs in RNase III and three protein-interacting boxes in dsRNA, is responsible for substrate specificity, while conserved amino acid residues and divalent cations are responsible for scissile-bond cleavage. The structure reveals a wealth of information about the mechanism of RNA hydrolysis that can be extrapolated to other RNase III family members.	NCI, Canc Res Ctr, NIH, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, XH (corresponding author), NCI, Canc Res Ctr, NIH, Ft Detrick, MD 21702 USA.	jix@ncifcrf.gov	Ji, Xinhua/C-9664-2012	Ji, Xinhua/0000-0001-6942-1514	NATIONAL CANCER INSTITUTE [ZIABC010326, ZIABC010336, Z01BC010336, Z01BC010326] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akey DL, 2005, PROTEIN SCI, V14, P2744, DOI 10.1110/ps.051665905; [Anonymous], EUKARYOTIC MRNA PROC; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calin-Jageman I, 2003, NUCLEIC ACIDS RES, V31, P2381, DOI 10.1093/nar/gkg329; Campbell FE, 2002, J MOL BIOL, V317, P21, DOI 10.1006/jmbi.2002.5413; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Conrad C, 2002, INT J BIOCHEM CELL B, V34, P116, DOI 10.1016/S1357-2725(01)00112-1; Conrad C, 2001, FEBS LETT, V509, P53, DOI 10.1016/S0014-5793(01)03142-8; Court DL., 1993, CONTROL MESSENGER RN, P71; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; DUNN JJ, 1982, ENZYMES, P485; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Gan JH, 2005, STRUCTURE, V13, P1435, DOI 10.1016/j.str.2005.06.014; GUARNEROS G, 1988, CURR TOP MICROBIOL, V136, P1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INADA T, 1995, BIOCHIMIE, V77, P294, DOI 10.1016/0300-9084(96)88139-9; INADA T, 1989, J BACTERIOL, V171, P5017, DOI 10.1128/jb.171.9.5017-5024.1989; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamontagne B, 2003, J MOL BIOL, V327, P985, DOI 10.1016/S0022-2836(03)00231-6; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HL, 1996, EMBO J, V15, P1421, DOI 10.1002/j.1460-2075.1996.tb00484.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x; Nicholson AW, 1996, PROG NUCLEIC ACID RE, V52, P1, DOI 10.1016/S0079-6603(08)60963-0; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OPPENHEIM AB, 1993, PROG NUCLEIC ACID RE, V46, P37, DOI 10.1016/S0079-6603(08)61017-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REED RJ, 2000, ACTA CRYSTALLOGR D, V57, P1373; ROBERTSON HD, 1982, CELL, V30, P669, DOI 10.1016/0092-8674(82)90270-7; ROBERTSON HD, 1968, J BIOL CHEM, V243, P82; ROBERTSON HD, 1975, J BIOL CHEM, V250, P3050; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun W, 2005, NUCLEIC ACIDS RES, V33, P807, DOI 10.1093/nar/gki197; Sun WM, 2004, BIOCHEMISTRY-US, V43, P13054, DOI 10.1021/bi049258i; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; Sun WM, 2001, BIOCHEMISTRY-US, V40, P14976, DOI 10.1021/bi011570u; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang KJ, 1997, P NATL ACAD SCI USA, V94, P13437, DOI 10.1073/pnas.94.25.13437	54	181	187	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 27	2006	124	2					355	366		10.1016/j.cell.2005.11.034	http://dx.doi.org/10.1016/j.cell.2005.11.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439209	Bronze			2022-12-01	WOS:000235068500023
J	Steinbrook, R				Steinbrook, R			Egg donation and human embryonic stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*AM SOC REPR MED E, 2004, FERTIL STERIL S1, V82, pS240; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Practice Committe of the American Society for Reproductive Medicine, 2003, Fertil Steril, V80, P1309; Steinbock B, 2004, MT SINAI J MED, V71, P255	5	53	54	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2006	354	4					324	326		10.1056/NEJMp058313	http://dx.doi.org/10.1056/NEJMp058313			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005VY	16436762				2022-12-01	WOS:000234854000002
J	Waldor, MK				Waldor, MK			Disarming pathogens - A new approach for antibiotic development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts University; Tufts University	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA.			Waldor, Matthew/0000-0003-1843-7000				Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739	1	18	20	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2006	354	3					296	297		10.1056/NEJMcibr054591	http://dx.doi.org/10.1056/NEJMcibr054591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003DF	16421373				2022-12-01	WOS:000234661100013
J	Hallikas, O; Palin, K; Sinjushina, N; Rautiainen, R; Partanen, J; Ukkonen, E; Taipale, J				Hallikas, O; Palin, K; Sinjushina, N; Rautiainen, R; Partanen, J; Ukkonen, E; Taipale, J			Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity	CELL			English	Article							CIS-REGULATORY MODULES; C-MYC; N-MYC; HEDGEHOG; EXPRESSION; DROSOPHILA; GENE; IDENTIFICATION; PROLIFERATION; REQUIREMENT	Understanding the regulation of human gene expression requires knowledge of the "second genetic code," which consists of the binding specificities of transcription factors (TFs) and the combinatorial code by which TF binding sites are assembled to form tissue-specific enhancer elements. Using a novel high-throughput method, we determined the DNA binding specificities of GLIs 1-3, Tcf4, and c-Ets1, which mediate transcriptional responses to the Hedgehog (Hh), Wnt, and Ras/MAPK signaling pathways. To identify mammalian enhancer elements regulated by these pathways on a genomic scale, we developed a computational tool, enhancer element locator (EEL). We show that EEL can be used to identify Hh and Wnt target genes and to predict activated TFs based on changes in gene expression. Predictions validated in transgenic mouse embryos revealed the presence of multiple tissue-specific enhancers in mouse c-Myc and N-Myc genes, which has implications for organ-specific growth control and tumor-type specificity of oncogenes.	Univ Helsinki, Mol & Canc Biol Program, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Comp Sci, FIN-00014 Helsinki, Finland; Univ Helsinki, Dev Biol Program, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Ukkonen, E (corresponding author), Univ Helsinki, Mol & Canc Biol Program, Biomedicum Helsinki, POB 63, FIN-00014 Helsinki, Finland.	ukkonen@cs.helsinki.fi; jussi.taipale@helsinki.fi	Palin, Kimmo/ABG-5710-2020	Palin, Kimmo/0000-0002-4621-6128; Ukkonen, Esko/0000-0002-5978-1505; Partanen, Juha/0000-0001-8850-4825				Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Behringer R., 2003, MANIPULATING MOUSE E; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Charron J, 2002, PEDIATR RES, V51, P48, DOI 10.1203/00006450-200201000-00010; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; LAVENU A, 1994, ONCOGENE, V9, P527; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Liu X, 2002, J MOL BIOL, V323, P1, DOI 10.1016/S0022-2836(02)00894-X; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Michelson AM, 2002, P NATL ACAD SCI USA, V99, P546, DOI 10.1073/pnas.032685999; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pellegrini M, 1998, DEV DYNAM, V213, P431, DOI 10.1002/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.3.CO;2-Z; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	45	365	379	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					47	59		10.1016/j.cell.2005.10.042	http://dx.doi.org/10.1016/j.cell.2005.10.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413481	Bronze			2022-12-01	WOS:000234969600009
J	Fan, YH; Nikitina, T; Zhao, J; Fleury, TJ; Bhattacharyya, R; Bouhassira, EE; Stein, A; Woodcock, CL; Skoultchi, AI				Fan, YH; Nikitina, T; Zhao, J; Fleury, TJ; Bhattacharyya, R; Bouhassira, EE; Stein, A; Woodcock, CL; Skoultchi, AI			Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation	CELL			English	Article							LINKER HISTONES; DNA METHYLATION; IN-VIVO; PERICENTRIC HETEROCHROMATIN; SACCHAROMYCES-CEREVISIAE; CELL-DIFFERENTIATION; MOUSE DEVELOPMENT; NUCLEOSOME; EXPRESSION; TRANSCRIPTION	Linker histone H1 plays an important role in chromatin folding in vitro. To study the role of H1 in vivo, mouse embryonic stem cells null for three 111 genes were derived and were found to have 50% of the normal level of H1. H1 depletion caused dramatic chromatin structure changes, including decreased global nucleosome spacing, reduced local chromatin compaction, and decreases in certain core histone modifications. Surprisingly, however, microarray analysis revealed that expression of only a small number of genes is affected. Many of the affected genes are imprinted or are on the X chromosome and are therefore normally regulated by DNA methylation. Although global DNA methylation is not changed, methylation of specific CpGs within the regulatory regions of some of the H1 regulated genes is reduced. These results indicate that linker histones can participate in epigenetic regulation of gene expression by contributing to the maintenance or establishment of specific DNA methylation patterns.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Yeshiva University; Albert Einstein College of Medicine; University of Massachusetts System; University of Massachusetts Amherst; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Skoultchi, AI (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	skoultch@aecom.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NATIONAL CANCER INSTITUTE [R01CA079057, R56CA079057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043786, R01GM062857] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079057, CA79057] Funding Source: Medline; NIGMS NIH HHS [GM62857, GM43786] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BERKOWITZ EM, 1981, BIOCHEMISTRY-US, V20, P7284, DOI 10.1021/bi00528a036; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DASSO M, 1994, P NATL ACAD SCI USA, V91, P12477, DOI 10.1073/pnas.91.26.12477; Dean W, 1998, DEVELOPMENT, V125, P2273; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fletcher TM, 1996, CRIT REV EUKAR GENE, V6, P149, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.40; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; HASLIE ND, 1989, GENETIC VARIANTS STR; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; KALILIS P, 1989, CENTROMERE; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Schmidt JV, 2000, GENE DEV, V14, P1997; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; van Holde K.E., 1989, CHROMATIN; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Warnecke PM, 1998, DEV GENET, V22, P111, DOI 10.1002/(SICI)1520-6408(1998)22:2&lt;111::AID-DVG1&gt;3.0.CO;2-9; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; Wolffe AP., 1998, CHROMATIN STRUCTURE; WOODCOCK CL, 1991, J CELL SCI, V99, P99; Woodcock CL, 1998, METHOD CELL BIOL, V53, P167; WOODCOCK CL, 2003, IN PRESS CHROMOSOME; ZLATANOVA J, 1994, FASEB J, V8, P1260, DOI 10.1096/fasebj.8.15.8001738; ZLATANOVA J, 1992, J CELL SCI, V103, P889	62	406	413	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1199	1212		10.1016/j.cell.2005.10.028	http://dx.doi.org/10.1016/j.cell.2005.10.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377562	Bronze			2022-12-01	WOS:000234584500010
J	Brett, AS; Zuger, A				Brett, AS; Zuger, A			The run on Tamilflu - Should physicians prescribe on demand?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ S Carolina, Sch Med, Columbia, SC 29208 USA; St Lukes Roosevelt Hosp, New York, NY USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mount Sinai St. Luke's; Mount Sinai West	Brett, AS (corresponding author), Univ S Carolina, Sch Med, Columbia, SC 29208 USA.							BROWN D, 2005, WASH POST       0417, pA1; *HARV VANG MED ASS, AV INFL BIRD FLU FRE; *INF DIS SOC AM, JOINT POS STAT INF D; Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776; Lee TH, 2004, NEW ENGL J MED, V351, P2365, DOI 10.1056/NEJMp048328	5	19	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2636	2637		10.1056/NEJMp058290	http://dx.doi.org/10.1056/NEJMp058290			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371627				2022-12-01	WOS:000234094400002
J	Thompson, IM; Tangen, CM; Goodman, PJ; Probstfield, JL; Moinpour, CM; Coltman, CA				Thompson, IM; Tangen, CM; Goodman, PJ; Probstfield, JL; Moinpour, CM; Coltman, CA			Erectile dysfunction and subsequent cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; MYOCARDIAL-INFARCTION; INTERNATIONAL INDEX; HEART-DISEASE; 52 COUNTRIES; MEN; PREVALENCE; ASSOCIATION; INTERHEART; PREVENTION	Context The risk factors for cardiovascular disease and erectile dysfunction are similar Objective To examine the association of erectile dysfunction and subsequent cardiovascular disease. Design, Setting, and Participants Men aged 55 years or older who were randomized to the placebo group (n=9457) in the Prostate Cancer Prevention Trial at 221 US centers were evaluated every 3 months for cardiovascular disease and erectile dysfunction between 1994 and 2003. Proportional hazards regression models were used to evaluate the association of erectile dysfunction and cardiovascular disease. In an adjusted model, covariates included age, body mass index, blood pressure, serum lipids, diabetes, family history of myocardial infarction, race, smoking history, physical activity, and quality of life. Main Outcome Measures Erectile dysfunction and cardiovascular disease. Results Of the 9457 men randomized to placebo, 8063 (85%) had no cardiovascular disease at study entry; of these men, 3816 (47%) had erectile dysfunction at study entry. Among the 4247 men without erectile dysfunction at study entry, 2420 men (57%) reported incident erectile dysfunction after 5 years. After adjustment, incident erectile dysfunction was associated with a hazard ratio of 1.25 (95% confidence interval [CI], 1.02-1.53; P=.04) for subsequent cardiovascular events during study follow-up. For men with either incident or prevalent erectile dysfunction, the hazard ratio was 1.45 (95% Cl, 1.25-1.69; P<.001). For subsequent cardiovascular events, the unadjusted risk of an incident cardiovascular event was 0.015 per person-year among men without erectile dysfunction at study entry and was 0.024 per person-year for men with erectile dysfunction at study entry. This association was in the range of risk associated with current smoking or a family history of myocardial infarction. Conclusions Erectile dysfunction is a harbinger of cardiovascular clinical events in some men. Erectile dysfunction should prompt investigation and intervention for cardiovascular risk factors.	Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX 78229 USA; SW Oncol Grp, San Antonio, TX USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA	University of Texas System; University of Texas Health San Antonio; Southwest Oncology Group; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Thompson, IM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu			NCI NIH HHS [CA 86402, CA 45808, CA 37429, CA 35178] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA045808, U10CA035178, U01CA086402, U10CA037429] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Heart Association, 2003, HEART DIS STROK STAT; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Blumentals W A, 2003, Aging Male, V6, P217, DOI 10.1080/13685530312331309752; Collins R, 2003, LANCET, V361, P2005; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DeBusk R, 2000, AM J CARDIOL, V86, P175, DOI 10.1016/S0002-9149(00)00896-1; DeBusk RF, 2003, JAMA-J AM MED ASSOC, V290, P3129, DOI 10.1001/jama.290.23.3129; Derby CA, 2000, INT J IMPOT RES, V12, P197, DOI 10.1038/sj.ijir.3900542; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fung MM, 2004, J AM COLL CARDIOL, V43, P1405, DOI 10.1016/j.jacc.2003.11.041; Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Katz DL, 2004, MED CLIN N AM, V88, P1295, DOI 10.1016/j.mcna.2004.02.003; Le NA, 2004, CURR OPIN LIPIDOL, V15, P227, DOI 10.1097/00041433-200404000-00018; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Mittleman MA, 2003, INT J CLIN PRACT, V57, P597; Moinpour CM, 2000, J CLIN ONCOL, V18, P1942, DOI 10.1200/JCO.2000.18.9.1942; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Ponholzer A, 2005, EUR UROL, V47, P80, DOI 10.1016/j.eururo.2004.08.017; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; SHERBOURNE CD, 1991, MEASURING FUNCTIONIN, P194; Speel TGW, 2003, EUR UROL, V44, P366, DOI 10.1016/S0302-2838(03)00304-X; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Turnbull F, 2003, LANCET, V362, P1527; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zusman RM, 1999, AM J CARDIOL, V83, p35C	31	617	629	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					2996	3002		10.1001/jama.294.23.2996	http://dx.doi.org/10.1001/jama.294.23.2996			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414947	Bronze			2022-12-01	WOS:000234087700026
J	Silliman, BR; van de Koppel, J; Bertness, MD; Stanton, LE; Mendelssohn, IA				Silliman, BR; van de Koppel, J; Bertness, MD; Stanton, LE; Mendelssohn, IA			Drought, snails, and large-scale die-off of southern US salt marshes	SCIENCE			English	Article							RECRUITMENT; ABUNDANCE; COLLAPSE; FAILURE; DECLINE	Salt marshes in the southeastern United States have recently experienced massive die-off, one of many examples of widespread degradation in marine and coastal ecosystems. Although intense drought is thought to be the primary cause of this die-off, we found snail grazing to be a major contributing factor. Survey of marsh die-off areas in three states revealed high-density fronts of snails on dieoff edges at 11 of 12 sites. Exclusion experiments demonstrated that snails actively converted marshes to exposed mudflats. Salt addition and comparative field studies suggest that drought-induced stress and grazers acted synergistically and to varying degrees to cause initial plant death. After these disturbances, snail fronts formed on die-off edges and subsequently propagated through healthy marsh, leading to cascading vegetation loss. These results, combined with model analyses, reveal strong interactions between increasing climatic stress and grazer pressure, both potentially related to human environmental impacts, which amplify the likelihood and intensity of runaway collapse in these coastal systems.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, NIOO KNAW, NL-4401 NT7 Yerseke, Netherlands; Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Brown University; Louisiana State University System; Louisiana State University	Silliman, BR (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	brs@ufl.edu	Van de Koppel, Johan/E-7266-2010	Silliman, Brian/0000-0001-6360-650X				BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; *BROWN MARSH DAT I, 2002, SALT MARSH DIEB LOUI; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Farnsworth EJ, 1997, AMBIO, V26, P328; *GA COAST RES COUN, 2004, SALT MARSH DIEB COAS; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies R. L., 1997, DISTURBANCE RECOVERY, P151; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lipcius RN, 2002, MAR ECOL PROG SER, V226, P45, DOI 10.3354/meps226045; McKee KL, 2004, GLOBAL ECOL BIOGEOGR, V13, P65, DOI 10.1111/j.1466-882X.2004.00075.x; Mitsch W.J., 2001, WETLANDS; REID WV, 2005, WORLD BANK MILLENNIU; SCHNEIDER R, 2005, P 14 BIENN COAST ZON; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Silliman BR, 2003, OIKOS, V101, P549, DOI 10.1034/j.1600-0706.2003.12070.x; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; SWENSON EM, 2003, REPORT COASTAL RESTO; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211	21	316	327	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1803	1806		10.1126/science.1118229	http://dx.doi.org/10.1126/science.1118229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357258				2022-12-01	WOS:000234093600043
J	Carol, RJ; Takeda, S; Linstead, P; Durrant, MC; Kakesova, H; Derbyshire, P; Drea, S; Zarsky, V; Dolan, L				Carol, RJ; Takeda, S; Linstead, P; Durrant, MC; Kakesova, H; Derbyshire, P; Drea, S; Zarsky, V; Dolan, L			A RhoGDP dissociation inhibitor spatially regulates growth in root hair cells	NATURE			English	Article							NADPH OXIDASE; GTPASE; MORPHOGENESIS; EXPANSION	Root hairs are cellular protuberances extending from the root surface into the soil; there they provide access to immobile inorganic ions such as phosphate, which are essential for growth(1). Their cylindrical shape results from a polarized mechanism of cell expansion called tip growth in which elongation is restricted to a small area at the surface of the hair-forming cell (trichoblast) tip(2-4). Here we identify proteins that spatially control the sites at which cell growth occurs by isolating Arabidopsis mutants (scn1) that develop ectopic sites of growth on trichoblasts. We cloned SCN1 and showed that SCN1 is a RhoGTPase GDP dissociation inhibitor ( RhoGDI) that spatially restricts the sites of growth to a single point on the trichoblast. We showed previously that localized production of reactive oxygen species by RHD2/AtrbohC NADPH oxidase is required for hair growth(5); here we show that SCN1/AtrhoGDI1 is a component of the mechanism that focuses RHD2/AtrbohC-catalysed production of reactive oxygen species to hair tips during wild-type development. We propose that the spatial organization of growth in plant cells requires the local RhoGDI-regulated activation of the RHD2/AtrbohC NADPH oxidase.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Computat Biol Grp, Norwich NR4 7UH, Norfolk, England; Charles Univ Prague, Dept Plant Physiol, Prague 12800 2, Czech Republic; Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague, Czech Republic	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Žárský, Viktor/P-3673-2018; Drea, Sinead/F-6166-2011; Zarsky, Viktor/G-7352-2014	Žárský, Viktor/0000-0002-5301-0339; Zarsky, Viktor/0000-0002-5301-0339; Carol, Rachel/0000-0002-6193-5163; Takeda, Seiji/0000-0003-0183-7390; Dolan, Liam/0000-0003-1206-7096	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Barcelo AR, 1999, FREE RADICAL RES, V31, pS147; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bischoff F, 2000, PLANT MOL BIOL, V42, P515, DOI 10.1023/A:1006341210147; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Favery B, 2001, GENE DEV, V15, P79, DOI 10.1101/gad.188801; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gahoonia TS, 1997, PLANT SOIL, V191, P181, DOI 10.1023/A:1004270201418; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Rivero F, 2002, EMBO J, V21, P4539, DOI 10.1093/emboj/cdf449; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Shaw SL, 2000, PLANT PHYSIOL, V124, P959, DOI 10.1104/pp.124.3.959; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	22	252	264	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1013	1016		10.1038/nature04198	http://dx.doi.org/10.1038/nature04198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355224				2022-12-01	WOS:000233934600066
J	Gore, AV; Maegawa, S; Cheong, A; Gilligan, PC; Weinberg, ES; Sampath, K				Gore, AV; Maegawa, S; Cheong, A; Gilligan, PC; Weinberg, ES; Sampath, K			The zebrafish dorsal axis is apparent at the four-cell stage	NATURE			English	Article							NODAL-RELATED GENES; DROSOPHILA OOGENESIS; XENOPUS EMBRYOS; SPECIFICATION; ORGANIZER; EXPRESSION; SIGNALS; SQUINT; LAYER; FISH	A central question in the development of multicellular organisms pertains to the timing and mechanisms of specification of the embryonic axes. In many organisms, specification of the dorsoventral axis requires signalling by proteins of the Transforming growth factor-beta and Wnt families(1-3). Here we show that maternal transcripts of the zebrafish Nodal-related morphogen, Squint (Sqt), can localize to two blastomeres at the four-cell stage and predict the dorsal axis. Removal of cells containing sqt transcripts from four-to-eight-cell embryos or injection of antisense morpholino oligonucleotides targeting sqt into oocytes can cause a loss of dorsal structures. Localization of sqt transcripts is independent of maternal Wnt pathway function and requires a highly conserved sequence in the 3' untranslated region. Thus, the dorsoventral axis is apparent by early cleavage stages and may require the maternally encoded morphogen Sqt and its associated factors. Because the 3' untranslated region of the human nodal gene can also localize exogenous sequences to dorsal cells, this mechanism may be evolutionarily conserved.	Temasek Life Sci Lab, Vertebrate Dev Grp, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	National University of Singapore; University of Pennsylvania	Sampath, K (corresponding author), Temasek Life Sci Lab, Vertebrate Dev Grp, 1 Res Link, Singapore 117604, Singapore.	karuna@tll.org.sg	Maegawa, Shingo/AAB-3924-2021	Sampath, Karuna/0000-0002-0729-1977; Gore, Aniket/0000-0003-4088-5264				ABDELILAH S, 1994, NATURE, V370, P468, DOI 10.1038/370468a0; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Feldman B, 2001, GENESIS, V30, P175, DOI 10.1002/gene.1058; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Gore AV, 2002, MECH DEVELOP, V112, P153, DOI 10.1016/S0925-4773(01)00622-0; Heasman J, 1997, DEVELOPMENT, V124, P4179; HELDE KA, 1994, SCIENCE, V265, P517, DOI 10.1126/science.8036493; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KLEIN SL, 1987, DEV BIOL, V120, P299, DOI 10.1016/0012-1606(87)90127-8; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Mizuno T, 1997, DEV GENES EVOL, V206, P389, DOI 10.1007/s004270050068; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.0.CO;2-I; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Oppenheimer JM, 1936, J EXP ZOOL, V72, P247, DOI 10.1002/jez.1400720204; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; SCHIER AF, 2005, ANN REV GENET   0809; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815	30	104	108	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2005	438	7070					1030	1035		10.1038/nature04184	http://dx.doi.org/10.1038/nature04184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993EC	16355228				2022-12-01	WOS:000233934600070
J	Bhalla, N; Dernburg, AF				Bhalla, N; Dernburg, AF			Conserved checkpoint monitors meiotic chromosome synapsis in Caenorhabditis elegans	SCIENCE			English	Article							DAMAGE-INDUCED APOPTOSIS; C-ELEGANS; CELL-DEATH; GENETIC-CONTROL; RECOMBINATION; GERMLINE; HOMOLOG; PROGRESSION; PROTEINS; MEIOSIS	We report the discovery of a checkpoint that monitors synapsis between homologous chromosomes to ensure accurate meiotic segregation. Oocytes containing unsynapsed chromosomes selectively undergo apoptosis even if a germline DNA damage checkpoint is inactivated. This cutting mechanism is specifically activated by unsynapsed pairing centers, cis-acting chromosome sites that are also required to promote synapsis in Caenorhabditis elegans. Apoptosis due to synaptic failure also requires the C. elegans homolog of PCH2, a budding yeast pachytene checkpoint gene, which suggests that this surveillance mechanism is widely conserved.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dernburg, AF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	afdernburg@lbl.gov		Dernburg, Abby/0000-0001-8037-1079	NIGMS NIH HHS [1 F32 GM67408-01A1, F32 GM067408-01A1, 1 R01 GM/CA655591-01, F32 GM067408, F32 GM067408-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Cha RS, 2000, GENE DEV, V14, P493; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Egozcue S, 2000, J ASSIST REPROD GEN, V17, P307, DOI 10.1023/A:1009444709504; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GIROUX CN, 1989, GENOME, V31, P88, DOI 10.1139/g89-017; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Kelly WG, 2002, DEVELOPMENT, V129, P479; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MACQUEEN AJ, IN PRESS; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; PHILLIPS CM, IN PRESS CELL; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; VILLENEUVE AM, 1994, GENETICS, V136, P887; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	29	155	171	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1683	1686		10.1126/science.1117468	http://dx.doi.org/10.1126/science.1117468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339446				2022-12-01	WOS:000233961700046
J	Goodman, RP; Schaap, IAT; Tardin, CF; Erben, CM; Berry, RM; Schmidt, CF; Turberfield, AJ				Goodman, RP; Schaap, IAT; Tardin, CF; Erben, CM; Berry, RM; Schmidt, CF; Turberfield, AJ			Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication	SCIENCE			English	Article							SINGLE-STRANDED-DNA; OCTAHEDRON; ELASTICITY; HELIX	Practical components for three-dimensional molecular nanofabrication must be simple to produce, stereopure, rigid, and adaptable. We report a family of DNA tetrahedra, less than 10 nanometers on a side, that can self-assemble in seconds with near-quantitative yield of one diastereomer. They can be connected by programmable DNA linkers. Their triangulated architecture confers structural stability; by compressing a DNA tetrahedron with an atomic force microscope, we have measured the axial compressibility of DNA and observed the buckling of the double helix under high loads.	Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 H Amsterdam, Netherlands	University of Oxford; Vrije Universiteit Amsterdam	Turberfield, AJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	a.turberfield@physics.ox.ac.uk	Schmidt, Christoph F/G-3787-2011; Turberfield, Andrew J/O-2135-2017; Schaap, Iwan A. T./L-3177-2013	Schmidt, Christoph F/0000-0003-2864-6973; Turberfield, Andrew J/0000-0002-3876-0190; Schaap, Iwan A. T./0000-0001-6665-5104	Engineering and Physical Sciences Research Council [GR/A10274/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; CONWAY JH, 1970, COMPUTATION PROBLEMS; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; DORENBECK A, 2000, THESIS RUHR U BOCHUM; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Malo J, 2005, ANGEW CHEM INT EDIT, V44, P3057, DOI 10.1002/anie.200463027; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	22	814	859	16	442	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1661	1665		10.1126/science.1120367	http://dx.doi.org/10.1126/science.1120367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339440				2022-12-01	WOS:000233961700039
J	Ryugo, DK; Kretzmer, EA; Niparko, JK				Ryugo, DK; Kretzmer, EA; Niparko, JK			Restoration of auditory nerve synapses in cats by cochlear implants	SCIENCE			English	Article							DEAF WHITE CATS; PRIMARY AXOSOMATIC ENDINGS; ELECTRICAL-STIMULATION; ULTRASTRUCTURAL ANALYSIS; CONGENITAL DEAFNESS; SPEECH-PERCEPTION; NUCLEUS; MICE; MORPHOLOGY; ENDBULBS	Congenital deafness results in abnormal synaptic structure in endings of the auditory nerve. If these abnormalities persist after restoration of auditory nerve activity by a cochlear implant, the processing of time-varying signals such as speech would likely be impaired. We stimulated congenitally deaf cats for 3 months with a six-channel cochlear implant. The device used human speech-processing programs, and cats responded to environmental sounds. Auditory nerve fibers exhibited a recovery of normal synaptic structure in these cats. This rescue of synapses is attributed to a return of spike activity in the auditory nerve and may help explain cochlear implant benefits in childhood deafness.	Johns Hopkins Univ, Ctr Hearing & Balance, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Ctr Hearing & Balance, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Ryugo, DK (corresponding author), Johns Hopkins Univ, Ctr Hearing & Balance, Dept Otolaryngol Head & Neck Surg, 720 Rutland Ave, Baltimore, MD 21205 USA.	dryugo@bme.jhu.edu	Ryugo, David K./G-1940-2012	Ryugo, David K./0000-0002-5250-7503	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005864, R01DC000232] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC00232, F31 DC05864] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Babalian AL, 2003, EXP BRAIN RES, V153, P452, DOI 10.1007/s00221-003-1619-x; Busby PA, 1999, J ACOUST SOC AM, V105, P1841, DOI 10.1121/1.426721; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Cheng AK, 1999, ARCH OTOLARYNGOL, V125, P1214, DOI 10.1001/archotol.125.11.1214; Francis HW, 2003, PEDIATR CLIN N AM, V50, P341, DOI 10.1016/S0031-3955(03)00034-8; Frijns JHM, 2002, EAR HEARING, V23, P184, DOI 10.1097/00003446-200206000-00003; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawano A, 1996, Nihon Jibiinkoka Gakkai Kaiho, V99, P884; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kral A, 2005, CEREB CORTEX, V15, P552, DOI 10.1093/cercor/bhh156; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Lee DJ, 2003, J NEUROCYTOL, V32, P229, DOI 10.1023/B:NEUR.0000010082.99874.14; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Limb CJ, 2000, JARO-J ASSOC RES OTO, V1, P103, DOI 10.1007/s101620010032; LUSTIG LR, 1994, HEARING RES, V74, P29, DOI 10.1016/0378-5955(94)90173-2; MATSUSHIMA JI, 1991, HEARING RES, V56, P133, DOI 10.1016/0378-5955(91)90162-3; Meisami E, 1978, Prog Brain Res, V48, P211; Naito Y, 1997, ACTA OTO-LARYNGOL, V117, P490, DOI 10.3109/00016489709113426; Oleskevich S, 2004, J PHYSIOL-LONDON, V560, P709, DOI 10.1113/jphysiol.2004.066662; Oleskevich S, 2002, J PHYSIOL-LONDON, V540, P447, DOI 10.1113/jphysiol.2001.013821; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 1998, J COMP NEUROL, V397, P532, DOI 10.1002/(SICI)1096-9861(19980810)397:4<532::AID-CNE6>3.0.CO;2-2; Ryugo DK, 1997, J COMP NEUROL, V385, P230, DOI 10.1002/(SICI)1096-9861(19970825)385:2<230::AID-CNE4>3.0.CO;2-2; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; Saada AA, 1996, BRAIN RES, V736, P315, DOI 10.1016/0006-8993(96)00719-6; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shepherd RK, 1999, J NEUROPHYSIOL, V82, P1363, DOI 10.1152/jn.1999.82.3.1363; Svirsky MA, 2004, AUDIOL NEURO-OTOL, V9, P224, DOI 10.1159/000078392; TAITELBAUMSWEAD R, IN PRESS INT J PEDIA; Trussell LO, 2002, CURR OPIN NEUROBIOL, V12, P400, DOI 10.1016/S0959-4388(02)00335-5; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vollmer M, 2005, J NEUROPHYSIOL, V93, P3339, DOI 10.1152/jn.00900.2004; WEST CD, 1973, J COMP NEUROL, V151, P377, DOI 10.1002/cne.901510406; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P973	37	99	101	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1490	1492		10.1126/science.1119419	http://dx.doi.org/10.1126/science.1119419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322457				2022-12-01	WOS:000233756500043
J	Schmeing, TM; Huang, KS; Strobel, SA; Steitz, TA				Schmeing, TM; Huang, KS; Strobel, SA; Steitz, TA			An induced-fit mechanism to promote peptide bond formation and exclude hydrolysis of peptidyl-tRNA	NATURE			English	Article							LARGE RIBOSOMAL-SUBUNIT; FACTOR RF2; GGQ MOTIF; RELEASE; SITE; CRYSTALLOGRAPHY; INTERMEDIATE; TERMINATION; CATALYSIS; MIMICS	The large ribosomal subunit catalyses the reaction between the alpha-amino group of the aminoacyl-tRNA bound to the A site and the ester carbon of the peptidyl-tRNA bound to the P site(1), while preventing the nucleophilic attack of water on the ester, which would lead to unprogrammed deacylation of the peptidyl-tRNA. Here we describe three new structures of the large ribosomal subunit of Haloarcula marismortui (Hma) complexed with peptidyl transferase substrate analogues that reveal an induced-fit mechanism in which substrates and active-site residues reposition to allow the peptidyl transferase reaction. Proper binding of an aminoacyl-tRNA analogue to the A site induces specific movements of 23S rRNA nucleotides 2618-2620 (Escherichia coli numbering 2583-2585) and 2541(2506), thereby reorienting the ester group of the peptidyl-tRNA and making it accessible for attack. In the absence of the appropriate A-site substrate, the peptidyl transferase centre positions the ester link of the peptidyl-tRNA in a conformation that precludes the catalysed nucleophilic attack by water. Protein release factors(2) may also function, in part, by inducing an active-site rearrangement similar to that produced by the A-site aminoacyl-tRNA, allowing the carbonyl group and water to be positioned for hydrolysis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009; Huang, Kevin/AAT-7389-2020	Huang, Kevin/0000-0002-9930-0972				Agmon I, 2004, FEBS LETT, V567, P20, DOI 10.1016/j.febslet.2004.03.065; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Green R, 2002, CELL, V110, P665, DOI 10.1016/S0092-8674(02)00965-0; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koshland D., 1959, ENZYMES, V1, P305; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weinger JS, 2004, NUCLEIC ACIDS RES, V32, P1502, DOI 10.1093/nar/gkh311; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	29	267	276	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					520	524		10.1038/nature04152	http://dx.doi.org/10.1038/nature04152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306996				2022-12-01	WOS:000233458200055
J	Baxter, NN; Habermann, EB; Tepper, JE; Durham, SB; Virnig, BA				Baxter, NN; Habermann, EB; Tepper, JE; Durham, SB; Virnig, BA			Risk of pelvic fractures in older women following pelvic irradiation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSUFFICIENCY FRACTURES; RECTAL-CARCINOMA; PREOPERATIVE RADIOTHERAPY; OSTEOPOROTIC FRACTURES; UNITED-STATES; HIP FRACTURE; RADIATION; CANCER; ENDOMETRIAL; COMPONENTS	Context Pelvic fractures, including hip fractures, area major source of morbidity and mortality in older women. Although therapeutic pelvic irradiation could increase the risk of such fractures, this effect has not been studied. Objective To determine if women who undergo pelvic irradiation for pelvic malignancies (anal, cervical, or rectal cancers) have a higher rate of pelvic fracture than women with pelvic malignancies who do not undergo irradiation. Design, Setting, and Participants We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) cancer registry data linked to Medicare claims data. A total of 6428 women aged 65 years and older diagnosed with pelvic malignancies from 1986 through 1999 were included. We compared results for women who did (n = 2855) Vs did not (n = 3573) undergo radiation therapy. To assess the influence of selection bias, we also evaluated the effect of irradiation on osteoporotic fractures in nonirradiated sites (arm and spine). Main Outcome Measure We evaluated the effect of irradiation on the incidence of pelvic fractures over time, and adjusted for potential confounders using a proportional hazards model. Results Women who underwent radiation therapy were more likely to have a pelvic fracture than women who did not undergo radiation therapy (cumulative 5-year fracture rate, 14.0% vs 7.5% in women with anal cancer, 8.2% vs 5.9% in women with cervical cancer, and 11.2% vs 8.7% in women with rectal cancer); the difference was statistically significant and most fractures (90%) were hip fractures. We controlled for potential confounders including age, race, cancer stage, and geographic location. The impact of irradiation varied by cancer site: treatment for anal cancer was associated with a higher risk of pelvic fractures (hazard ratio, 3.16; 95% confidence interval, 1.48-6.73); than for cervical cancer (hazard ratio, 1.66; 95% confidence interval, 1.06-2.59); or rectal cancer (hazard ratio, 1.65; 95% confidence interval, 1.33-2.05). No statistically significant difference was found in the rate of arm or spine fractures between the irradiated and nonirradiated groups (hazard ratio, 1.15; 95% confidence interval, 0.89-1.48). Conclusions Pelvic irradiation substantially increases the risk of pelvic fractures in older women. Given the high baseline risk of pelvic fracture, this finding is of particular concern.	Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Comprehens Canc, Minneapolis, MN 55455 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baxter, NN (corresponding author), Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, MMC 450,420 Delaware St SE, Minneapolis, MN 55455 USA.	baxtern@smh.toronto.on.ca	Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620; Habermann, Elizabeth/0000-0002-1140-003X				Allal AS, 1997, INT J RADIAT ONCOL, V39, P1099, DOI 10.1016/S0360-3016(97)00390-8; Baxter NN, 2005, DIS COLON RECTUM, V48, P9, DOI 10.1007/s10350-004-0792-8; Bliss P, 1996, BRIT J RADIOL, V69, P548, DOI 10.1259/0007-1285-69-822-548; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; EWING J, 1926, ACTA RADIOL, V6, P399; FU AL, 1994, AM J CLIN ONCOL-CANC, V17, P248, DOI 10.1097/00000421-199406000-00015; Holm T, 1996, CANCER, V78, P968, DOI 10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8; Hopewell JW, 2003, MED PEDIATR ONCOL, V41, P208, DOI 10.1002/mpo.10338; Huh SJ, 2002, GYNECOL ONCOL, V86, P264, DOI 10.1006/gyno.2002.6756; Jacobs JJ, 1995, J BONE JOINT SURG AM, V77A, P1829, DOI 10.2106/00004623-199512000-00006; Jenkins P J, 1995, Clin Oncol (R Coll Radiol), V7, P123, DOI 10.1016/S0936-6555(05)80815-5; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Konski A, 1996, INT J RADIAT ONCOL, V35, P361, DOI 10.1016/0360-3016(95)02139-6; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847, DOI 10.1302/0301-620X.77B6.7593093; Melton LJ, 2000, J BONE MINER RES, V15, P2309, DOI 10.1359/jbmr.2000.15.12.2309; MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010; Mumber MP, 1997, SKELETAL RADIOL, V26, P94, DOI 10.1007/s002560050200; OVERGAARD M, 1988, ACTA ONCOL, V27, P117, DOI 10.3109/02841868809090331; Parikh VA, 1998, DIS COLON RECTUM, V41, P254, DOI 10.1007/BF02238256; POTOSKY AL, 1993, MED CARE, V31, P732; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Surveillance Epidemiology and End Results Program, SURV EP END RES PROG; Tai P, 2000, RADIOTHER ONCOL, V56, P23, DOI 10.1016/S0167-8140(00)00178-X; *US PHS, 1992, DHHS PUBL PHS	28	242	259	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2005	294	20					2587	2593		10.1001/jama.294.20.2587	http://dx.doi.org/10.1001/jama.294.20.2587			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986FT	16304072	Bronze			2022-12-01	WOS:000233436200023
J	Muroyama, Y; Fujiwara, Y; Orkin, SH; Rowitch, DH				Muroyama, Y; Fujiwara, Y; Orkin, SH; Rowitch, DH			Specification of astrocytes by bHLH protein SCL in a restricted region of the neural tube	NATURE			English	Article							SPINAL-CORD; STEM-CELLS; MOTOR-NEURON; GENE-EXPRESSION; V2 INTERNEURONS; SCL/TAL-1; IDENTITY; DIFFERENTIATION; PRECURSORS	Astrocytes are the most abundant and functionally diverse glial population in the vertebrate central nervous system (CNS)(1). However, the mechanisms underlying astrocyte specification are poorly understood. It is well established that cellular diversification of neurons in the embryo is generated by position-dependent extrinsic signals and combinatorial interactions of transcription factors that direct specific cell fates by suppressing alternative fates(2). It is unknown whether a comparable process determines embryonic astrocyte identity. Indeed, astrocyte development is generally thought to take place in a position-independent manner(3,4). Here we show multiple functions of Stem cell leukaemia (Scl, also known as Tal1), which encodes a basic helix-loop-helix (bHLH) transcription factor, in the regulation of both astrocyte versus oligodendrocyte cell fate acquisition and V2b versus V2a interneuron cell fate acquisition in the p2 domain of the developing vertebrate spinal cord. Our findings demonstrate a regionally restricted transcriptional programme necessary for astrocyte and V2b interneuron development, with striking parallels to the involvement of SCL in haematopoiesis. They further indicate that acquisition of embryonic glial subtype identity might be regulated by genetic interactions between SCL and the transcription factor Olig2 in the ventral neural tube.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Orkin, SH (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu; david_rowitch@dfci.harvard.edu		Rowitch, David/0000-0002-0079-0060; Muroyama, Yuko/0000-0002-6697-2123				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Karunaratne A, 2002, DEV BIOL, V249, P30, DOI 10.1006/dbio.2002.0754; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Porcher C, 1999, DEVELOPMENT, V126, P4603; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Smith E, 2002, DEV DYNAM, V224, P231, DOI 10.1002/dvdy.10093; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tzeng SF, 1998, GLIA, V24, P372, DOI 10.1002/(SICI)1098-1136(199812)24:4<372::AID-GLIA2>3.0.CO;2-B; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhou YH, 2000, DEVELOPMENT, V127, P3829	30	126	127	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					360	363		10.1038/nature04139	http://dx.doi.org/10.1038/nature04139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292311				2022-12-01	WOS:000233300200049
J	Costa, S; Shaw, P				Costa, S; Shaw, P			Chromatin organization and cell fate switch respond to positional information in Arabidopsis	NATURE			English	Article							ROOT EPIDERMIS; DIFFERENTIATION; REGULATOR; HYPOCOTYL; PROTEIN; GLABRA2; GENE	Many types of plant cell retain their developmental plasticity and have the capacity to switch fate when exposed to a new source of positional information. In the root epidermis of Arabidopsis, cells differentiate in alternating files of hair cells and non-hair cells(1,2), in response to positional information and the activity of the homoeodomain transcription factor GLABRA2 (GL2) in future non-hair cells(3-6). Here we show by three-dimensional fluorescence in situ hybridization on intact root epidermal tissue that alternative states of chromatin organization around the GL2 locus are required to control position-dependent cell-type specification. When, as a result of an atypical cell division, a cell is displaced from a hair file into a non-hair file, it switches fate(6). We show that during this event the chromatin state around the GL2 locus is not inherited, but is reorganized in the G1 phase of the cell cycle in response to local positional information. This ability to remodel chromatin organization may provide the basis for the plasticity in plant cell fate changes.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Shaw, P (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	peter.shaw@bbsrc.ac.uk	shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669; Costa, Silvia/0000-0001-9931-3493				Berger F, 1998, CURR BIOL, V8, P421, DOI 10.1016/S0960-9822(98)70176-9; Costa S, 2003, DEVELOPMENT, V130, P2893, DOI 10.1242/dev.00493; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dolan L, 1999, SEMIN CELL DEV BIOL, V10, P149, DOI 10.1006/scdb.1999.0290; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Hung CY, 1998, PLANT PHYSIOL, V117, P73, DOI 10.1104/pp.117.1.73; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lin Y, 2001, DEVELOPMENT, V128, P3697; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Szymkowiak EJ, 1996, ANNU REV PLANT PHYS, V47, P351, DOI 10.1146/annurev.arplant.47.1.351; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Wolpert L, 2003, DEVELOPMENT, V130, P4497, DOI 10.1242/dev.00728	19	117	121	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					493	496		10.1038/nature04269	http://dx.doi.org/10.1038/nature04269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16362059				2022-12-01	WOS:000234859200051
J	Wadman, M				Wadman, M			The right combination	NATURE			English	Editorial Material																			0	12	12	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2006	439	7075					390	391		10.1038/439390a	http://dx.doi.org/10.1038/439390a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437083				2022-12-01	WOS:000234859200015
J	Watts, G				Watts, G			Science commentary: Cannabis confusions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						ALTHA M, TYPES CANNABIS AVAIL; Fergusson DM, 2006, BRIT MED J, V332, P172, DOI 10.1136/bmj.332.7534.172; Shao Hong, 1996, Journal of the International Hemp Association, V3, P55; SMALL E, 1975, AM LAW SPECIES PROBL; 2005, NEW SCI         0917, P12	5	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2006	332	7534					175	176		10.1136/bmj.332.7534.175	http://dx.doi.org/10.1136/bmj.332.7534.175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	006OC	16424501	Green Published			2022-12-01	WOS:000234905800032
J	Enwonwu, CO				Enwonwu, CO			Noma - The ulcer of extreme poverty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maryland, Sch Dent, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Nigerian Natl Inst Med Res, Lagos, Nigeria	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Enwonwu, CO (corresponding author), Univ Maryland, Sch Dent, Baltimore, MD 21201 USA.							Enwonwu CO, 2005, TROP MED INT HEALTH, V10, P65, DOI 10.1111/j.1365-3156.2004.01351.x; Enwonwu CO, 2000, CRIT REV ORAL BIOL M, V11, P159, DOI 10.1177/10454411000110020201; Fieger A, 2003, TROP MED INT HEALTH, V8, P402, DOI 10.1046/j.1365-3156.2003.01036.x; Marck KW, 2003, PLAST RECONSTR SURG, V111, P1702, DOI 10.1097/01.PRS.0000055445.84307.3C	4	35	36	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2006	354	3					221	224		10.1056/NEJMp058193	http://dx.doi.org/10.1056/NEJMp058193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003DF	16421362				2022-12-01	WOS:000234661100001
J	Leape, LL; Fromson, JA				Leape, LL; Fromson, JA			Problem doctors: Is there a system-level solution?	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED PHYSICIANS; ALCOHOL; COMORBIDITY; PREVALENCE; BEHAVIOR; SUICIDE; PATIENT; ABUSE	Physician performance failures are not rare and pose substantial threats to patient welfare and safety. Few hospitals respond to such failures promptly or effectively. Failure to ensure the quality and safety of the performance of colleagues is a breach of medicine's fiduciary responsibility to the public. A major reason for this deficiency is the hospitals' lack of formal systems to monitor physician performance and to identify and correct shortcomings. To develop and implement these systems, hospitals need better performance measures and substantial expansion of external programs for assessment and remediation. This is a task well beyond the capacities of individual hospitals; a national effort is required. The authors call on the Federation of State Medical Boards, the American Board of Medical Specialties, and the Joint Commission on Accreditation of Healthcare Organizations (organizations that already bear a fiduciary responsibility for ensuring safe, competent care) to collaborate on developing better methods for measuring performance and to expand programs for helping practitioners who are deficient.	Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Leape, LL (corresponding author), Harvard Univ, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02215 USA.	leape@hsph.harvard.edu	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				*AM BOARD MED SPEC, 2004, STAT MAINT CERT PROG; BARNARD A, 2002, BOSTON GLOBE    0520, pA1; Benzer D G, 1995, Wis Med J, V94, P455; BLONDELL RD, 1993, PRIMARY CARE, V20, P209; BREWSTER JM, 1986, JAMA-J AM MED ASSOC, V255, P1913, DOI 10.1001/jama.255.14.1913; CLARE AW, 1990, ALCOHOL ALCOHOLISM, V25, P277, DOI 10.1093/oxfordjournals.alcalc.a045001; *COLL PHYS SURG AL, 2004, PHYS ACH REV; *DEP VET AFF, 2004, DRUG FREE WORKPL PRO; Diaz A L, 1991, West J Nurs Res, V13, P97, DOI 10.1177/019394599101300107; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; *FED STAT MED BOAR, 2005, IPE OV; *FED STAT MED BOAR, 2003, SUMM 2002 BOARD ACT; *FED STAT MED BOAR, 2000, REP SPEC COMM PROF C; Fromson J, 2004, ADDRESSING CLIN PERF; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Kaufman A. S., 1990, ASSESSING ADOLESCENT; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Linney B J, 1997, Physician Exec, V23, P55; Lipner RS, 2002, ACAD MED, V77, pS64, DOI 10.1097/00001888-200210001-00021; MCAULIFFE WE, 1991, AM J PUBLIC HEALTH, V81, P177, DOI 10.2105/AJPH.81.2.177; *MED BOARD CAL, 2005, MED BOARDS DIV PROGR; Neff KE, 2000, ENHANCING PHYS PERFO, P45; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Powell DH, 1994, PROFILES COGNITIVE A; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rosenstein AH, 2005, AM J NURS, V105, P54, DOI 10.1097/00000446-200501000-00025; Samkoff J S, 1990, Pa Med, V93, P40; Schernhammer E, 2005, NEW ENGL J MED, V352, P2473, DOI 10.1056/NEJMp058014; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Sharpe V.A., 1998, MED HARM HIST CONCEP; Skipper GE, 1997, J ADDICT DIS, V16, P67, DOI 10.1300/J069v16n03_07; TALBOTT GD, 1980, POSTGRAD MED, V68, P56, DOI 10.1080/00325481.1980.11715621; TRUNKEY DD, 2007, J AM COLL SURGEONS, V192, P385; Watkins JP, 2000, J SUBST ABUSE TREAT, V19, P51, DOI 10.1016/S0740-5472(99)00099-9; 2005, NBME POST LICENSURE	37	174	175	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2006	144	2					107	115		10.7326/0003-4819-144-2-200601170-00008	http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004AX	16418410				2022-12-01	WOS:000234725500007
J	Stagg, SM; Gurkan, C; Fowler, DM; LaPointe, P; Foss, TR; Potter, CS; Carragher, B; Balch, WE				Stagg, SM; Gurkan, C; Fowler, DM; LaPointe, P; Foss, TR; Potter, CS; Carragher, B; Balch, WE			Structure of the Sec13/31 COPII coat cage	NATURE			English	Article							ENDOPLASMIC-RETICULUM; VESICLE FORMATION; ELECTRON CRYOMICROSCOPY; COMPLEX; ER; TRANSPORT; CLATHRIN; PROTEIN; GOLGI; PURIFICATION	Endomembranes of eukaryotic cells are dynamic structures that are in continuous communication through the activity of specialized cellular machineries(1), such as the coat protein complex II ( COPII), which mediates cargo export from the endoplasmic reticulum (ER)(2,3). COPII consists of the Sar1 GTPase, Sec23 and Sec24 (Sec23/24), where Sec23 is a Sar1-specific GTPase-activating protein and Sec24 functions in cargo selection, and Sec13 and Sec31 (Sec13/31), which has a structural role(3). Whereas recent results have shown that Sec23/24 and Sec13/31 can self-assemble to form COPII cage-like particles(4), we now show that Sec13/31 can self-assemble to form minimal cages in the absence of Sec23/24. We present a three-dimensional reconstruction of these Sec13/31 cages at 30 angstrom resolution using cryo-electron microscopy and single particle analysis. These results reveal a novel cuboctahedron geometry with the potential to form a flexible lattice and to generate a diverse range of containers. Our data are consistent with a model for COPII coat complex assembly in which Sec23/24 has a non-structural role as a multivalent ligand localizing the self-assembly of Sec13/31 to form a cage lattice driving ER cargo export.	Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Carragher, B (corresponding author), Scripps Res Inst, Natl Resource Automated Mol Microscopy, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bcarr@scripps.edu; webalch@scripps.edu	Gurkan, Cemal/S-5751-2016	Gurkan, Cemal/0000-0001-7379-4559; LaPointe, Paul/0000-0002-5465-1795; Carragher, Bridget/0000-0002-0624-5020				Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Belden WJ, 2001, METHOD ENZYMOL, V329, P438; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gurkan C, 2005, METHOD ENZYMOL, V404, P58, DOI 10.1016/S0076-6879(05)04006-1; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Shugrue CA, 1999, J CELL SCI, V112, P4547; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597; ZHU Y, 2004, IEEE ISB104 C ARL VI	29	227	239	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					234	238		10.1038/nature04339	http://dx.doi.org/10.1038/nature04339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407955				2022-12-01	WOS:000234538400047
J	Gasparini, Z; Pol, D; Spalletti, LA				Gasparini, Z; Pol, D; Spalletti, LA			An unusual marine crocodyliform from the Jurassic-Cretaceous boundary of Patagonia	SCIENCE			English	Article							THALATTOSUCHIA; PALEOCENE; ARGENTINA	Remains of the marine crocodyliform Dakosaurus andiniensis from western South America reveal a lineage that drastically deviated from the skull morphology that characterizes marine crocodyliforms. The snout and lower jaw are extremely robust, short, and high and only bear a few large teeth with serrated edges (resembling those of some terrestrial carnivorous archosaurs). This unusual morphology contrasts with the long and gracile snout and tower jaws bearing numerous teeth, which are present in the closest relatives of D. andiniensis (and interpreted as indicating feeding on small fish or mollusks). Thus, the morphological diversity of pelagic marine crocodyliforms was wider than had been thought.	Natl Univ La Plata, Fac Ciencias Nat & Museo, Dept Palaeontol Vertebrados, CONICET, RA-1900 La Plata, Argentina; Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; Natl Univ La Plata, Fac Ciencias Nat & Museo, Ctr Invest Geol, CONICET, RA-1900 La Plata, Argentina	National University of La Plata; University System of Ohio; Ohio State University; National University of La Plata	Gasparini, Z (corresponding author), Natl Univ La Plata, Fac Ciencias Nat & Museo, Dept Palaeontol Vertebrados, CONICET, Paseo Bosque S-N, RA-1900 La Plata, Argentina.	zgaspari@museo.fcnym.unip.edu.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517				Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; CARVALHO IS, 2004, GONDWANA RES, V8, P11; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Delfino M, 2005, ACTA PALAEONTOL POL, V50, P565; Farlow J.O., 1991, Modern Geology, V16, P161; Fernandez M, 2000, LETHAIA, V33, P269; Fraas E., 1902, PALAEONTOGRAPHICA, V49, P1; Gasparini Z, 2005, GEOL SOC SPEC PUBL, V252, P279, DOI 10.1144/GSL.SP.2005.252.01.14; Gasparini Z, 1976, ACT 1 C GEOL CHIL, V1, pC1; GOLOBOFF P, 2003, TNT VER 1 0 PROGRAM; Goloboff PA, 2004, CLADISTICS, V20, P595; Howell JA, 2005, GEOL SOC SPEC PUBL, V252, P1, DOI 10.1144/GSL.SP.2005.252.01.01; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; Iordansky N.N., 1973, P201; Jouve S, 2005, PALAEONTOLOGY, V48, P359, DOI 10.1111/j.1475-4983.2005.00442.x; Langston W. Jr., 1973, P263; Legasa O., 1994, STUDIA GEOLOGICA SAL, V29, P127; MARTILL DM, 1986, NEUES JB GEOLOGIE PA, P621; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)458<0001:ANGCTF>2.0.CO;2; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Riff Douglas, 2001, Boletim do Museu Nacional Nova Serie Geologia, V59, P1; Spalletti LA, 2000, J GEOL SOC LONDON, V157, P433, DOI 10.1144/jgs.157.2.433; Vignaud P, 1996, CR ACAD SCI II A, V322, P245; Vignaud P., 1995, THESIS U POITIERS	26	79	82	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					70	73		10.1126/science.1120803	http://dx.doi.org/10.1126/science.1120803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16282526	Bronze			2022-12-01	WOS:000234546300034
J	Dumont, S; Cheng, W; Serebrov, V; Beran, RK; Tinoco, I; Pyle, AM; Bustamante, C				Dumont, S; Cheng, W; Serebrov, V; Beran, RK; Tinoco, I; Pyle, AM; Bustamante, C			RNA translocation and unwinding mechanism of HCVNS3 helicase and its coordination by ATP	NATURE			English	Article							HEPATITIS-C VIRUS; DNA HELICASE; STEP-SIZE; CRYSTAL-STRUCTURE; MOLECULES; PROTEIN; OLIGONUCLEOTIDE; PROCESSIVITY; REVEALS; BINDING	Helicases are a ubiquitous class of enzymes involved in nearly all aspects of DNA and RNA metabolism. Despite recent progress in understanding their mechanism of action, limited resolution has left inaccessible the detailed mechanisms by which these enzymes couple the rearrangement of nucleic acid structures to the binding and hydrolysis of ATP(1,2). Observing individual mechanistic cycles of these motor proteins is central to understanding their cellular functions. Here we follow in real time, at a resolution of two base pairs and 20 ms, the RNA translocation and unwinding cycles of a hepatitis C virus helicase (NS3) monomer. NS3 is a representative superfamily-2 helicase essential for viral replication(3), and therefore a potentially important drug target(4). We show that the cyclic movement of NS3 is coordinated by ATP in discrete steps of 11 +/- 3 base pairs, and that actual unwinding occurs in rapid smaller substeps of 3.6 +/- 1.3 base pairs, also triggered by ATP binding, indicating that NS3 might move like an inchworm(5,6). This ATP-coupling mechanism is likely to be applicable to other non-hexameric helicases involved in many essential cellular functions. The assay developed here should be useful in investigating a broad range of nucleic acid translocation motors.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Yale University; Howard Hughes Medical Institute; Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Serebrov, Victor/0000-0002-5800-3103; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bianco PR, 2004, LANCET, V364, P1385, DOI 10.1016/S0140-6736(04)17238-3; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Frick DN, 2003, DRUG NEWS PERSPECT, V16, P355, DOI 10.1358/dnp.2003.16.6.829307; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	30	283	290	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2006	439	7072					105	108		10.1038/nature04331	http://dx.doi.org/10.1038/nature04331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999HA	16397502	Green Accepted			2022-12-01	WOS:000234378700043
J	Borsani, O; Zhu, JH; Verslues, PE; Sunkar, R; Zhu, JK				Borsani, O; Zhu, JH; Verslues, PE; Sunkar, R; Zhu, JK			Endogenous siRNAs derived from a pair of natural cis-antisense transcripts regulate salt tolerance in Arabidopsis	CELL			English	Article							TRANS-ACTING SIRNAS; DOUBLE-STRANDED-RNA; BINDING-PROTEIN HYL1; DNA METHYLATION; PROLINE CATABOLISM; INTERFERING RNA; PLANTS; MICRORNAS; GENES; BIOGENESIS	In higher eukaryotes, miRNAs and siRNAs guide translational inhibition, mRNA cleavage, or chromatin regulation. We found that the antisense overlapping gene pair of Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH), a stress-related gene, and SRO5, a gene of unknown function, generates two types of siRNAs. When both transcripts are present, a 24-nt siRNA is formed by a biogenesis pathway dependent on DCL2, RDR6, SGS3, and NRPD1 A. Initial cleavage of the P5CDH transcript guided by the 24-nt siRNA establishes a phase for the subsequent generation of 21-nt siRNAs by DCL1 and further cleavage of P5CDH transcripts. The expression of SRO5 is induced by salt, and this induction is required to initiate siRNA formation. Our data suggest that the P5CDH and SRO5 proteins are also functionally related, and that the P5CDHSRO5 gene pair defines a mode of siRNA function and biogenesis that may be applied to other natural cis-antisense gene pairs in eukaryotic genomes.	Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jianhua/F-7127-2013; Sunkar, Ramanjulu/L-2982-2014; Zhu, Jian-Kang/F-7658-2011	Zhu, Jian-Kang/0000-0001-5134-731X; Borsani, Omar/0000-0002-9111-5801	NIGMS NIH HHS [R01GM59138, R01GM0707501, R01 GM059138-11, R01 GM059138] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ayliffe MA, 2002, PLANT PHYSIOL, V129, P169, DOI 10.1104/pp.010940; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Boi S, 2004, CURR GENOMICS, V5, P509, DOI 10.2174/1389202043349020; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hellmann H, 2000, PLANT PHYSIOL, V123, P779, DOI 10.1104/pp.123.2.779; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Iyer S, 1998, PLANT PHYSIOL, V116, P203, DOI 10.1104/pp.116.1.203; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	52	776	871	4	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 29	2005	123	7					1279	1291		10.1016/j.cell.2005.11.035	http://dx.doi.org/10.1016/j.cell.2005.11.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377568	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000234584500016
J	Machida, M; Asai, K; Sano, M; Tanaka, T; Kumagai, T; Terai, G; Kusumoto, KI; Arima, T; Akita, O; Kashiwagi, Y; Abe, K; Gomi, K; Horiuchi, H; Kitamoto, K; Kobayashi, T; Takeuchi, M; Denning, DW; Galagan, JE; Nierman, WC; Yu, JJ; Archer, DB; Bennett, JW; Bhatnagar, D; Cleveland, TE; Fedorova, ND; Gotoh, O; Horikawa, H; Hosoyama, A; Ichinomiya, M; Igarashi, R; Iwashita, K; Juvvadi, PR; Kato, M; Kato, Y; Kin, T; Kokubun, A; Maeda, H; Maeyama, N; Maruyama, J; Nagasaki, H; Nakajima, T; Oda, K; Okada, K; Paulsen, I; Sakamoto, K; Sawano, T; Takahashi, M; Takase, K; Terabayashi, Y; Wortman, JR; Yamada, O; Yamagata, Y; Anazawa, H; Hata, Y; Koide, Y; Komori, T; Koyama, Y; Minetoki, T; Suharnan, S; Tanaka, A; Isono, K; Kuhara, S; Ogasawara, N; Kikuchi, H				Machida, M; Asai, K; Sano, M; Tanaka, T; Kumagai, T; Terai, G; Kusumoto, KI; Arima, T; Akita, O; Kashiwagi, Y; Abe, K; Gomi, K; Horiuchi, H; Kitamoto, K; Kobayashi, T; Takeuchi, M; Denning, DW; Galagan, JE; Nierman, WC; Yu, JJ; Archer, DB; Bennett, JW; Bhatnagar, D; Cleveland, TE; Fedorova, ND; Gotoh, O; Horikawa, H; Hosoyama, A; Ichinomiya, M; Igarashi, R; Iwashita, K; Juvvadi, PR; Kato, M; Kato, Y; Kin, T; Kokubun, A; Maeda, H; Maeyama, N; Maruyama, J; Nagasaki, H; Nakajima, T; Oda, K; Okada, K; Paulsen, I; Sakamoto, K; Sawano, T; Takahashi, M; Takase, K; Terabayashi, Y; Wortman, JR; Yamada, O; Yamagata, Y; Anazawa, H; Hata, Y; Koide, Y; Komori, T; Koyama, Y; Minetoki, T; Suharnan, S; Tanaka, A; Isono, K; Kuhara, S; Ogasawara, N; Kikuchi, H			Genome sequencing and analysis of Aspergillus oryzae	NATURE			English	Article							HIGH-LEVEL EXPRESSION; GENE; EVOLUTION; TRANSFORMATION; PLASMID; PROGRAM; FLAVUS; YEAST; TAGS; DNA	The genome of Aspergillus oryzae, a fungus important for the production of traditional fermented foods and beverages in Japan, has been sequenced. The ability to secrete large amounts of proteins and the development of a transformation system(1) have facilitated the use of A. oryzae in modern biotechnology(2-4). Although both A. oryzae and Aspergillus flavus belong to the section Flavi of the subgenus Circumdati of Aspergillus, A. oryzae, unlike A. flavus, does not produce aflatoxin, and its long history of use in the food industry has proved its safety. Here we show that the 37-megabase (Mb) genome of A. oryzae contains 12,074 genes and is expanded by 7 - 9 Mb in comparison with the genomes of Aspergillus nidulans(5) and Aspergillus fumigatus(6). Comparison of the three aspergilli species revealed the presence of syntenic blocks and A. oryzae-specific blocks ( lacking synteny with A. nidulans and A. fumigatus) in a mosaic manner throughout the genome of A. oryzae. The blocks of A. oryzae-specific sequence are enriched for genes involved in metabolism, particularly those for the synthesis of secondary metabolites. Specific expansion of genes for secretory hydrolytic enzymes, amino acid metabolism and amino acid/sugar uptake transporters supports the idea that A. oryzae is an ideal microorganism for fermentation.	Natl Inst Adv Ind Sci & Technol AIST, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; AIST, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Technol & Evaluat, Shibuya Ku, Tokyo 1510066, Japan; Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; Natl Res Inst Brewing, Hiroshima 7390046, Japan; Tohoku Univ, Aoba Ku, Sendai, Miyagi 9818555, Japan; Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan; Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Tokyo Univ Agr & Technol, Tokyo 1830054, Japan; Univ Manchester, Manchester M23 9PL, Lancs, England; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Inst Genom Res, Rockville, MD 20850 USA; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA; Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; Tulane Univ, New Orleans, LA 70118 USA; Kyowa Hakko Kogyo Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan; Gekkeikan Sake Co Ltd, Res Inst, Fushimi Ku, Kyoto 6128361, Japan; Amano Enzyme Inc, Gifu 5090108, Japan; INTEC Web & Genome Informat Corp, Koto Ku, Tokyo 1368637, Japan; Kikkoman Foods Inc, Chiba 2780037, Japan; Ozeki Co Ltd, Nishinomiya, Hyogo 6638227, Japan; Axiohelix, Koto Ku, Tokyo 1350064, Japan; Higeta Shoyu Ltd, Chiba 2888680, Japan; Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan; Nara Inst Sci & Technol, Nara 6300101, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Tohoku University; University of Tokyo; Nagoya University; Tokyo University of Agriculture & Technology; University of Manchester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; J. Craig Venter Institute; George Washington University; United States Department of Agriculture (USDA); University of Nottingham; Tulane University; Kyowa Kirin Ltd; Kikkoman Corporation; Kyushu University; Nara Institute of Science & Technology	Machida, M (corresponding author), Natl Inst Adv Ind Sci & Technol AIST, Inst Biol Resources & Funct, Higashi 1-1-1, Tsukuba, Ibaraki 3058566, Japan.	m.machida@aist.go.jp	Kobayashi, Tetsuo/I-6901-2014; Kato, Masashi/AAG-3755-2021; Yamagata, Youhei/H-6602-2013; Denning, David/AAC-6931-2019; Asai, Kiyoshi/AAT-8344-2020; Ogasawara, Naotake/B-7971-2011; Paulsen, Ian T/K-3832-2012; Abrams, Natalie/F-4845-2011; Juvvadi, Praveen/G-9380-2012; TAKEUCHI, Michio/H-6592-2013; Bennett, Joan W./AAT-1267-2021; Abrams, Natalie/AAM-5468-2021	Kobayashi, Tetsuo/0000-0002-4008-454X; Kato, Masashi/0000-0002-8951-3640; Denning, David/0000-0001-5626-2251; Asai, Kiyoshi/0000-0003-0909-4982; Paulsen, Ian T/0000-0001-9015-9418; Abrams, Natalie/0000-0001-9698-2819; Juvvadi, Praveen/0000-0002-5112-7824; Abrams, Natalie/0000-0001-9698-2819; Wortman, Jennifer/0000-0002-8713-1227; Terabayashi, Yasunobu/0000-0002-3372-0907; Galagan, James/0000-0003-0542-3291	Biotechnology and Biological Sciences Research Council [CFB17726] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Archer DB, 2004, CURR OPIN MICROBIOL, V7, P499, DOI 10.1016/j.mib.2004.08.003; ASAI K, 1998, PAC S BIOCOMPUT, V3, P228; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Gotoh O, 2000, BIOINFORMATICS, V16, P190, DOI 10.1093/bioinformatics/16.3.190; HATA Y, 1991, GENE, V108, P145, DOI 10.1016/0378-1119(91)90500-B; HORI H, 1987, MOL BIOL EVOL, V4, P445; IIMURA Y, 1987, AGR BIOL CHEM TOKYO, V51, P323, DOI 10.1080/00021369.1987.10868064; KITAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P1467, DOI 10.1271/bbb.58.1467; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; LAWRENCE JG, 1992, GENETICS, V131, P753; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maeda H, 2004, APPL MICROBIOL BIOT, V65, P74, DOI 10.1007/s00253-004-1608-4; Majoros WH, 2003, NUCLEIC ACIDS RES, V31, P3601, DOI 10.1093/nar/gkg527; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; Prade RA, 1997, P NATL ACAD SCI USA, V94, P14564, DOI 10.1073/pnas.94.26.14564; Sakaguchi K, 1992, APPL MOL GENETICS FI, P54; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSUCHIYA K, 1992, APPL MICROBIOL BIOT, V38, P109; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; WARD PP, 1992, BIO-TECHNOL, V10, P784, DOI 10.1038/nbt0792-784; WATSON JC, 1986, METHOD ENZYMOL, V118, P57; Yu JJ, 2004, FEMS MICROBIOL LETT, V237, P333, DOI 10.1016/j.femsle.2004.06.054	28	899	1582	18	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 22	2005	438	7071					1157	1161		10.1038/nature04300	http://dx.doi.org/10.1038/nature04300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372010	Bronze, Green Published			2022-12-01	WOS:000234111500051
J	Martinez, FD				Martinez, FD			Safety of long-acting beta agonists - An urgent need to clear the air	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRONCHODILATOR TREATMENT; ASTHMA; SALMETEROL		Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ 85721 USA	University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ 85721 USA.							Anderson HR, 2005, BRIT MED J, V330, P117, DOI 10.1136/bmj.38316.729907.8F; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Getahun D, 2005, J ASTHMA, V42, P373, DOI 10.1081/JAS-200062995; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3	4	111	113	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2637	2639		10.1056/NEJMp058299	http://dx.doi.org/10.1056/NEJMp058299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371628				2022-12-01	WOS:000234094400003
J	Pages, F; Berger, A; Camus, M; Sanchez-Cabo, F; Costes, A; Molidor, R; Mlecnik, B; Kirilovsky, A; Nilsson, M; Damotte, D; Meatchi, T; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Galon, J				Pages, F; Berger, A; Camus, M; Sanchez-Cabo, F; Costes, A; Molidor, R; Mlecnik, B; Kirilovsky, A; Nilsson, M; Damotte, D; Meatchi, T; Bruneval, P; Cugnenc, PH; Trajanoski, Z; Fridman, WH; Galon, J			Effector memory T cells, early metastasis, and survival in colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NF-KAPPA-B; CLUSTER-ANALYSIS; COLON-CARCINOMA; INFLAMMATION; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; CROSSROADS; EXPRESSION; DEATH; LINK	Background: The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. Methods: We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). Results: Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor-node-metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of immune cells and increased levels of messenger RNA (mRNA) for products of type 1 helper effector T cells (CD8, T-BET [T-box transcription factor 21], interferon regulatory factor 1, interferon-gamma, granulysin, and granzyme B) but not increased levels of inflammatory mediators or immunosuppressive molecules. The two types of tumors had significant differences in the levels of expression of 65 combinations of T-cell markers, and hierarchical clustering showed that markers of T-cell migration, activation, and differentiation were increased in tumors without signs of early metastatic invasion. The latter type of tumors also had increased numbers of CD8+ T cells, ranging from early memory (CD45RO+CCR7-CD28+CD27+) to effector memory (CD45RO+ CCR7-CD28-CD27-) T cells. The presence of high levels of infiltrating memory CD45RO+ cells, evaluated immunohistochemically, correlated with the absence of signs of early metastatic invasion, a less advanced pathological stage, and increased survival. Conclusions: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.	Univ Paris 06, Assistance Publ Hop Paris, Rene Descartes Fac Med, INSERM,U255, Paris, France; Georges Pompidou European Hosp, Dept Gen & Digest Surg, Paris, France; Georges Pompidou European Hosp, Dept Pathol, Paris, France; Georges Pompidou European Hosp, Immunol Lab, Paris, France; Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Graz University of Technology	Galon, J (corresponding author), Ctr Rech Biomed Cordeliers, INSERM, U255, 15 Rue Ecole Med, F-75006 Paris, France.	jerome.galon@u255.bhdc.jussieu.fr	mlecnik, bernhard/AAT-7467-2021; Trajanoski, Zlatko/AAT-6703-2021; costes, anne/A-1564-2010; Sanchez-Cabo, Fatima/AAC-5563-2020; Sanchez-Cabo, Fatima/N-5030-2014; COLENO-COSTES, Anne/K-3176-2015; Galon, Jerome/G-9838-2019	Sanchez-Cabo, Fatima/0000-0003-1881-1664; Sanchez-Cabo, Fatima/0000-0003-1881-1664; COLENO-COSTES, Anne/0000-0002-1775-682X; Galon, Jerome/0000-0001-9635-1339; fridman, wolf herman/0000-0002-1332-0973				Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Compton CC, 2003, MODERN PATHOL, V16, P376, DOI 10.1097/01.MP.0000062859.46942.93; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalerba P, 2003, CRIT REV ONCOL HEMAT, V46, P33, DOI 10.1016/S1040-8428(02)00159-2; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Moore RJ, 1999, NAT MED, V5, P1087, DOI 10.1038/12532; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Pages F, 1999, INT J CANCER, V84, P326, DOI 10.1002/(SICI)1097-0215(19990621)84:3<326::AID-IJC22>3.0.CO;2-K; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sobin LH, 2009, UICC TNM CLASSIFICAT; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Xiang R, 1999, J IMMUNOL, V163, P3676; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	30	1522	1597	3	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2005	353	25					2654	2666		10.1056/NEJMoa051424	http://dx.doi.org/10.1056/NEJMoa051424			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IQ	16371631				2022-12-01	WOS:000234094400006
J	Stolzenberg-Solomon, RZ; Graubard, BI; Chari, S; Limburg, P; Taylor, PR; Virtamo, J; Albanes, D				Stolzenberg-Solomon, RZ; Graubard, BI; Chari, S; Limburg, P; Taylor, PR; Virtamo, J; Albanes, D			Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-I; C-PEPTIDE; COLORECTAL-CANCER; EXOGENOUS INSULIN; PHYSICAL-ACTIVITY; PLASMA-GLUCOSE; HAMSTER MODEL; RISK; MORTALITY; COHORT	Context Obesity, diabetes mellitus, and glucose intolerance have been associated with increased pancreatic cancer risk; however, prediagnostic serum insulin concentration has not been evaluated as a predictor of this malignancy. Objective To investigate whether prediagnostic fasting glucose and insulin concentrations and insulin resistance are associated with subsequent incidence of exocrine pancreatic cancer in a cohort of male smokers. Design, Setting, and Participants A case-cohort prospective study within,the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (1985-1988) cohort of 29 133 male Finnish smokers ages 50 to 69 years. The study included 400 randomly sampled subcohort control participants and 169 incident pancreatic cancer cases that occurred after the fifth year of follow-up. All participants were followed up through December 2001 (up to 16.7 years of follow-up). Main Outcome Measures Incident exocrine pancreatic cancer identified from the Finnish Cancer Registry. Results After adjusting forage, smoking, and body mass index, higher baseline fasting serum concentrations of glucose, insulin, and insulin resistance were positively associated with pancreatic cancer. The presence of biochemically defined diabetes mellitus (glucose, >= 126 mg/dL [>= 6.99 mmo/L]) and insulin concentration in the highest vs lowest quartile both showed a significant 2-fold increased risk (hazard ratio [HRI], 2.13; 95% confidence interval [CI], 1.04-4.35; and HR, 2.01; 95% Cl, 1.03-3.93; respectively). There were significant interactions for all the biomarker exposures by follow-up time, such that the positive associations were stronger among the cases that occurred more than 10 years after baseline (highest vs lowest quartile: glucose, HR, 2.16; 95% Cl, 1.05-4.42; P for trend=.02; insulin, HR, 2.90; 95% Cl, 1.22-6.92; P for trend=.005; and insulin resistance, HR, 2.71; 95% Cl, 1.19-6.18; P for trend =.006). Conclusions These results support the hypothesis that exposure to higher insulin concentrations and insulin resistance predicts the risk of exocrine pancreatic cancer.	NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; NCI, Biostat Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Finland National Institute for Health & Welfare	Stolzenberg-Solomon, RZ (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, 6120 Execut Blvd,Suite 320, Rockville, MD 20852 USA.	rs221z@nih.gov	Chari, Suresh/K-9297-2015	Chari, Suresh/0000-0002-3924-0971	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035, N01-RC-37004] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS		*ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BALKAU B, 1993, DIABETES METAB, V19, P458; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; BELL RH, 1988, AM J SURG, V155, P159, DOI 10.1016/S0002-9610(88)80274-5; Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fears TR, 2000, CANCER EPIDEM BIOMAR, V9, P403; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Hennig R, 2004, HISTOL HISTOPATHOL, V19, P999, DOI 10.14670/HH-19.999; Hjalgrim H, 1997, J INTERN MED, V241, P471; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kazakoff K, 1996, NUTR CANCER, V26, P265, DOI 10.1080/01635589609514483; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Leach SD, 2004, CANCER CELL, V5, P7, DOI 10.1016/S1535-6108(03)00337-4; Lukanova A, 2004, INT J CANCER, V108, P262, DOI 10.1002/ijc.11544; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; POUR PM, 1990, CANCER RES, V50, P1634; POUR PM, 1984, J NATL CANCER I, V72, P1205; Reaven G, 2003, J AM COLL CARDIOL, V41, P1044, DOI 10.1016/S0735-1097(02)02982-0; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Stolzenberg-Solomon RZ, 2002, CANCER CAUSE CONTROL, V13, P417, DOI 10.1023/A:1015729615148; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105	33	282	289	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 14	2005	294	22					2872	2878		10.1001/jama.294.22.2872	http://dx.doi.org/10.1001/jama.294.22.2872			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991PU	16352795	Bronze			2022-12-01	WOS:000233826700028
J	Lloyd-Smith, JO; Schreiber, SJ; Kopp, PE; Getz, WM				Lloyd-Smith, JO; Schreiber, SJ; Kopp, PE; Getz, WM			Superspreading and the effect of individual variation on disease emergence	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; TRANSMISSION DYNAMICS; SARS TRANSMISSION; MODELS; COMMUNITY; WORKERS	Population-level analyses often use average quantities to describe heterogeneous systems, particularly when variation does not arise from identifiable groups(1,2). A prominent example, central to our current understanding of epidemic spread, is the basic reproductive number, R-0, which is defined as the mean number of infections caused by an infected individual in a susceptible population(3,4). Population estimates of R-0 can obscure considerable individual variation in infectiousness, as highlighted during the global emergence of severe acute respiratory syndrome (SARS) by numerous 'superspreading events' in which certain individuals infected unusually large numbers of secondary cases(5-10). For diseases transmitted by non-sexual direct contacts, such as SARS or smallpox, individual variation is difficult to measure empirically, and thus its importance for outbreak dynamics has been unclear(2,10,11). Here we present an integrated theoretical and statistical analysis of the influence of individual variation in infectiousness on disease emergence. Using contact tracing data from eight directly transmitted diseases, we show that the distribution of individual infectiousness around R-0 is often highly skewed. Model predictions accounting for this variation differ sharply from average-based approaches, with disease extinction more likely and outbreaks rarer but more explosive. Using these models, we explore implications for outbreak control, showing that individual-specific control measures outperform population-wide measures. Moreover, the dramatic improvements achieved through targeted control policies emphasize the need to identify predictive correlates of higher infectiousness. Our findings indicate that superspreading is a normal feature of disease spread, and to frame ongoing discussion we propose a rigorous definition for superspreading events and a method to predict their frequency.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Coll William & Mary, Dept Math, Williamsburg, VA 23187 USA; Univ Hull, Ctr Math, Kingston Upon Hull HU6 7RX, N Humberside, England	University of California System; University of California Berkeley; University of California System; University of California Berkeley; William & Mary; University of Hull	Lloyd-Smith, JO (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, 140 Mulford Hall, Berkeley, CA 94720 USA.	jls@nature.berkeley.edu	Lloyd-Smith, James/AAG-4463-2021; /K-4080-2012; Getz, Wayne/I-4521-2013	/0000-0001-7941-502X; Getz, Wayne/0000-0001-8784-9354				ANDERSON R M, 1991; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; BAILEY NTJ, 1975, MATH THEORY INFECT D, P263; Bauch CT, 2005, EPIDEMIOLOGY, V16, P791, DOI 10.1097/01.ede.0000181633.80269.4c; Becker N., 1990, STOCHASTIC PROCESSES, P90; BECKER N, 1989, AAL INFECT DIS DATA, P48; Becker NG, 1999, J ROY STAT SOC B, V61, P287, DOI 10.1111/1467-9868.00177; BOSWELL MT, 1970, RANDOM COUNTS MODEL, P7; Burnham K.P., 2002, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; Farrington CP, 2003, BIOSTATISTICS, V4, P279, DOI 10.1093/biostatistics/4.2.279; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Gani R, 2004, EMERG INFECT DIS, V10, P608, DOI 10.3201/eid1004.030509; Ha LD, 2004, EMERG INFECT DIS, V10, P265, DOI 10.3201/eid1002.030707; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; Lloyd-Smith JO, 2004, P ROY SOC B-BIOL SCI, V271, P625, DOI 10.1098/rspb.2003.2632; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Park BJ, 2004, EMERG INFECT DIS, V10, P244; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	30	1430	1446	3	248	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					355	359		10.1038/nature04153	http://dx.doi.org/10.1038/nature04153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292310	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000233300200048
J	Sweet, K; Willis, J; Zhou, XP; Gallione, C; Sawada, T; Alhopuro, P; Khoo, SK; Patocs, A; Martin, C; Bridgeman, S; Heinz, J; Pilarski, R; Lehtonen, R; Prior, TW; Frebourg, T; Teh, BT; Marchuk, DA; Aaltonen, LA; Eng, C				Sweet, K; Willis, J; Zhou, XP; Gallione, C; Sawada, T; Alhopuro, P; Khoo, SK; Patocs, A; Martin, C; Bridgeman, S; Heinz, J; Pilarski, R; Lehtonen, R; Prior, TW; Frebourg, T; Teh, BT; Marchuk, DA; Aaltonen, LA; Eng, C			Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JUVENILE POLYPOSIS; SERRATED ADENOMAS; KRAS MUTATIONS; BETA; METHYLATION; EXPRESSION; ENDOGLIN; COWDEN; COLON; BRAF	Context Significant proportions of patients with hamartomatous polyposis or with hyperplastic/mixed polyposis remain without specific clinical and molecular diagnosis or present atypically. Assigning a syndromic diagnosis is important because it guides management, especially surveillance and prophylactic surgery. Objective To systematically classify patients with unexplained hamartomatous or hyperplastic/mixed polyposis by extensive molecular analysis in the context of central rereview of histopathology results. Design, Setting, and Patients Prospective, referral-based study of 49 unrelated patients from outside institutions (n=28) and at a comprehensive cancer center (n=21), conducted from May 2, 2002, until December 15, 2004. Germline analysis of PTEN, BMPR1A, STK11 (sequence, deletion), SMAD4, and ENG (sequence), specific exon screening of BRAF, MYH, and BHD, and rereview of polyp histology results were performed. Main Outcome Measures Molecular, clinical, and histopathological findings in patients with unexplained polyposis. Results Of the 49 patients, 11 (22%) had germline mutations. Of 14 patients with juvenile polyposis, 2 with early-onset disease had mutations in ENG, encoding endoglin, previously only associated with hereditary hemorrhagic telangiectasia; 1 had hemizygous deletion encompassing PTEN and BMPR1A; and 1 had an SMAD4 mutation. One individual previously classified with Peutz-Jeghers syndrome had a PTEN deletion. Among 9 individuals with an unknown hamartomatous polyposis, 4 had mutations in STK11 (1), BMPR1A (2), and SMAD4 (1). Of the 23 patients with hyperplastic/mixed polyposis, 2 had PTEN mutations. Substantial discrepancies in histopathology results were seen. Conclusions Systematic molecular classification of 49 patients with unexplained hamartomatous or hyperplastic polyposis uncovered a potential novel susceptibility gene, ENG, for juvenile polyposis. Importantly, given the substantial proportion of patients found to have germline mutations, more extensive analysis of the known susceptibility genes is indicated. Rereview of histology results by a dedicated gastrointestinal pathologist should be considered routinely, as organ-specific surveillance rests on defining syndromic diagnosis.	Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Clin Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Case Western Reserve Univ, Sch Med, Univ Hosp Hlth Syst, Dept Pathol, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Mol & Canc Biol Res Program, Helsinki, Finland; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; Univ Hosp Rouen, Fac Med, Dept Genet, Rouen, France; Univ Cambridge, Canc Res UK Human Canc Genet Res Grp, Cambridge, England	Cleveland Clinic Foundation; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Duke University; University of Helsinki; University of Helsinki; Van Andel Institute; CHU de Rouen; Universite de Franche-Comte; University of Cambridge	Eng, C (corresponding author), Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,Mailstop NE-30, Cleveland, OH 44195 USA.	engc@ccf.org	Pilarski, Robert/X-3256-2019; Pilarski, Robert/E-3871-2011; Frebourg, Thierry/AAK-8390-2020; Aaltonen, Lauri/A-5375-2010; Sweet, Kevin/E-4172-2011	Aaltonen, Lauri/0000-0001-6839-4286; Patocs, Attila/0000-0001-7506-674X; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Eng, Charis/0000-0002-3693-5145; Marchuk, Douglas/0000-0002-3110-6671; Teh, Bin Tean/0000-0003-1514-1124; Frebourg, Thierry/0000-0003-0399-4007				AALTONEN LA, 2000, PATHOLOGY GENETICS T, P74; Akagi K, 2002, SURGERY, V131, pS109, DOI 10.1067/msy.2002.119361; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Aotake T, 1999, CLIN CANCER RES, V5, P135; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Bariol C, 2003, MODERN PATHOL, V16, P417, DOI 10.1097/01.MP.0000068236.47471.DB; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chan TL, 2003, CANCER RES, V63, P4878; DISARIO JA, 1991, AM J GASTROENTEROL, V86, P941; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Hawkins NJ, 2001, J NATL CANCER I, V93, P1307, DOI 10.1093/jnci/93.17.1307; Hawkins NJ, 2002, PATHOLOGY, V34, P548, DOI 10.1080/0031302021000035965; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hohenstein P, 2003, GENE CHROMOSOME CANC, V36, P273, DOI 10.1002/gcc.10169; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; JASS J, 2000, PATHOLOGY GENETICS T, P136; Jass JR, 2000, GUT, V47, P43, DOI 10.1136/gut.47.1.43; JASS JR, 1988, HISTOPATHOLOGY, V13, P619; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Jass JR, 2003, AM J PATHOL, V162, P705, DOI 10.1016/S0002-9440(10)63865-5; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; LASHNER BA, 1986, DIGEST DIS SCI, V31, P213, DOI 10.1007/BF01300711; Le Meur N, 2004, EUR J HUM GENET, V12, P415, DOI 10.1038/sj.ejhg.5201155; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Leggett BA, 2001, AM J SURG PATHOL, V25, P177, DOI 10.1097/00000478-200102000-00005; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; *NAT CTR BIOT INF, ON LIN MEND INH MAN; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361; Roth S, 1999, GENE CHROMOSOME CANC, V26, P54, DOI 10.1002/(SICI)1098-2264(199909)26:1<54::AID-GCC8>3.0.CO;2-D; Saad RS, 2004, MODERN PATHOL, V17, P197, DOI 10.1038/modpathol.3800034; Shpitz B, 2003, ANTICANCER RES, V23, P5153; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wali RK, 2005, GUT, V54, P654, DOI 10.1136/gut.2004.056010; Weber HC, 1998, GASTROENTEROLOGY, V114, pA702, DOI 10.1016/S0016-5085(98)82880-1; Wong SH, 2000, EUR J BIOCHEM, V267, P5550, DOI 10.1046/j.1432-1327.2000.01621.x; Wynter CVA, 2004, GUT, V53, P573, DOI 10.1136/gut.2003.030841; Yang S, 2004, AM J SURG PATHOL, V28, P1452, DOI 10.1097/01.pas.0000141404.56839.6a; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	51	175	179	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 16	2005	294	19					2465	2473		10.1001/jama.294.19.2465	http://dx.doi.org/10.1001/jama.294.19.2465			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984BL	16287957	Bronze			2022-12-01	WOS:000233277400025
J	Andersson, E; Tryggvason, U; Deng, QL; Friling, S; Alekseenko, Z; Robert, B; Perlmann, T; Ericson, J				Andersson, E; Tryggvason, U; Deng, QL; Friling, S; Alekseenko, Z; Robert, B; Perlmann, T; Ericson, J			Identification of intrinsic determinants of midbrain dopamine neurons	CELL			English	Article							EMBRYONIC STEM-CELLS; DEVELOPING SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; HOMEOBOX GENE; FLOOR PLATE; SUBSTANTIA-NIGRA; VERTEBRATE CNS; MOTOR-NEURON; ROOF PLATE	The prospect of using cell replacement therapies has raised the key issue of whether elucidation of developmental pathways can facilitate the generation of therapeutically important cell types from stem cells. Here we show that the homeodomain proteins Lmx1 a and Msx1 function as determinants of midbrain dopamine neurons, cells that degenerate in patients with Parkinson's disease. Lmx1 a is sufficient and required to trigger dopamine cell differentiation. An early activity of Lmx1 a is to induce the expression of Msx1, which complements Lmx1a by inducing the proneural protein Ngn2 and neuronal differentiation. Importantly, expression of Lmx1 a in embryonic stem cells results in a robust generation of dopamine neurons with a "correct" midbrain identity. These data establish that Lmx1 a and Msx1 are critical intrinsic dopamine-neuron determinants in vivo and suggest that they may be essential tools in cell replacement strategies in Parkinson's disease.	Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden; Inst Pasteur, CNRS, F-75724 Paris 15, France	Karolinska Institutet; Ludwig Institute for Cancer Research; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Perlmann, T (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	thomas.perlmann@licr.ki.se; johan.ericson@cmb.ki.se	Deng, Qiaolin/AAD-6905-2020; Marklund, Ulrika/I-8814-2012	Marklund, Ulrika/0000-0003-1426-1271; andersson, elisabet/0000-0003-3095-465X; Deng, Qiaolin/0000-0001-5934-7816; Alekseenko, Zhanna/0000-0002-6560-9699; Ericson, Johan/0000-0002-8019-7127				Arendt D, 1999, DEVELOPMENT, V126, P2309; Asbreuk CHJ, 2002, MOL CELL NEUROSCI, V21, P410, DOI 10.1006/mcne.2002.1182; Bach A, 2003, DEVELOPMENT, V130, P4025, DOI 10.1242/dev.00609; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; CATRON KM, 1995, MOL CELL BIOL, V15, P861; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Chizhikov VV, 2004, J NEUROSCI, V24, P5694, DOI 10.1523/JNEUROSCI.0758-04.2004; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1991, DEVELOPMENT, V111, P287; Dhawan R R, 1997, Mol Vis, V3, P7; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; GONZALEZ A, 1991, J COMP NEUROL, V303, P457, DOI 10.1002/cne.903030311; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P95; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Martinez S, 2001, INT J DEV BIOL, V45, P367; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; O'Hara FP, 2005, DEVELOPMENT, V132, P3163, DOI 10.1242/dev.01898; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; PLACZEK M, 1990, SCIENCE, V250, P985, DOI 10.1126/science.2237443; PLACZEK M, 1993, DEVELOPMENT, V117, P205; Simone HH, 1998, EUR J NEUROSCI, V10, P389; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wang WD, 1996, MECH DEVELOP, V58, P203, DOI 10.1016/S0925-4773(96)00562-X; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	57	446	458	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 27	2006	124	2					393	405		10.1016/j.cell.2005.10.037	http://dx.doi.org/10.1016/j.cell.2005.10.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439212	Bronze			2022-12-01	WOS:000235068500026
J	Katayama, Y; Battista, M; Kao, WM; Hidalgo, A; Peired, AJ; Thomas, SA; Frenette, PS				Katayama, Y; Battista, M; Kao, WM; Hidalgo, A; Peired, AJ; Thomas, SA; Frenette, PS			Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow	CELL			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; G-CSF; FACTOR-I; BLOOD STEM; MOBILIZATION; EXPRESSION; INNERVATION; SELECTIN; GALACTOCEREBROSIDE	Hematopoietic stem and progenitor cells (HSPC), attracted by the chemokine CXCL12, reside in specific niches in the bone marrow (BM). HSPC migration out of the BM is a critical process that underlies modern clinical stem cell transplantation. Here we demonstrate that enforced HSPC egress from BM niches depends critically on the nervous system. UDP-galactose ceramide galactosyltransferase-deficient (Cgt(-/-)) mice exhibit aberrant nerve conduction and display virtually no HSPC egress from BM following granulocyte colony-stimulating factor (G-CSF) or fucoidan administration. Adrenergic tone, osteoblast function, and bone CXCL12 are dysregulated in Cgt(-/-) mice. Pharmacological or genetic ablation of adrenergic neurotransmission indicates that norepinephrine (NE) signaling controls G-CSF-induced osteoblast suppression, bone CXCL12 downregulation, and HSPC mobilization. Further, administration of a beta(2) adrenergic agonist enhances mobilization in both control and NE-deficient mice. Thus, these results indicate that the sympathetic nervous system regulates the attraction of stem cells to their niche.	Mt Sinai Sch Med, Immunobiol Ctr, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Black Stem Family Cell Inst, Dept Med, New York, NY 10029 USA; Okayama Univ Hosp, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Okayama University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Frenette, PS (corresponding author), Mt Sinai Sch Med, Immunobiol Ctr, Dept Med, New York, NY 10029 USA.	paul.frenette@mssm.edu	Frenette, Paul S/J-8272-2012; Peired, Anna Julie/J-9952-2019; Hidalgo, Andrés/L-5643-2014	Frenette, Paul S/0000-0003-0862-9922; Peired, Anna Julie/0000-0001-9732-1369; Hidalgo, Andrés/0000-0001-5513-555X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69438] Funding Source: Medline; NIDDK NIH HHS [T32 DK07792, DK56638] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CALVO W, 1968, AM J ANAT, V123, P315, DOI 10.1002/aja.1001230206; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Delezay O, 1997, AIDS, V11, P1311, DOI 10.1097/00002030-199711000-00004; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Froberg MK, 1999, TRANSFUSION, V39, P410, DOI 10.1046/j.1537-2995.1999.39499235675.x; HAUSCHKA PV, 1988, CIBA F SYMP, V136, P207; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hidalgo A, 2004, BLOOD, V104, P993, DOI 10.1182/blood-2003-10-3702; Hinoi E, 2003, FASEB J, V17, P1532, DOI 10.1096/fj.02-0820fje; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; IVERSEN PO, 1994, ACTA PHYSIOL SCAND, V150, P373, DOI 10.1111/j.1748-1716.1994.tb09701.x; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2003, IMMUNITY, V18, P789, DOI 10.1016/S1074-7613(03)00150-X; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KORBLING M, 1995, BLOOD, V86, P2842; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Levesque JP, 2004, BLOOD, V104, P65, DOI 10.1182/blood-2003-05-1589; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Liu FL, 2000, BLOOD, V95, P3025, DOI 10.1182/blood.V95.10.3025.010k32_3025_3031; LIVNAT S, 1985, J NEUROIMMUNOL, V10, P5, DOI 10.1016/0165-5728(85)90031-1; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Norton WT., 1984, MYELIN, V2, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RING PA, 1961, J BONE JOINT SURG BR, V43, P121, DOI 10.1302/0301-620X.43B1.121; Rix M, 1999, DIABETES CARE, V22, P827, DOI 10.2337/diacare.22.5.827; ROBERTS DD, 1986, J BIOL CHEM, V261, P6872; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Sweeney EA, 2000, P NATL ACAD SCI USA, V97, P6544, DOI 10.1073/pnas.97.12.6544; Takamatsu Y, 1998, BLOOD, V92, P3465, DOI 10.1182/blood.V92.9.3465.421k35_3465_3473; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Togari A, 2002, MICROSC RES TECHNIQ, V58, P77, DOI 10.1002/jemt.10121; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	63	956	1008	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 27	2006	124	2					407	421		10.1016/j.cell.2005.10.041	http://dx.doi.org/10.1016/j.cell.2005.10.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439213	Bronze			2022-12-01	WOS:000235068500027
J	Coker, R; McKee, M; Atun, R; Dimitrova, B; Dodonova, E; Kuznetsov, S; Drobniewski, F				Coker, R; McKee, M; Atun, R; Dimitrova, B; Dodonova, E; Kuznetsov, S; Drobniewski, F			Risk factors for pulmonary tuberculosis in Russia: case-control study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine risk factors for pulmonary tuberculosis in Russia. Design Case-control study of exposure to a variety of risk factors before and during the development of pulmonary tuberculosis. Setting Large city in Russia. Participants Cases were 334 consecutive adults diagnosed as having culture confirmed pulmonary tuberculosis between I January 2003 and 31 December 2003. Controls were 334 individuals sampled from a validated population registry, matched for age and sex to the patients with tuberculosis. A questionnaire collected information on potential risk factors. Main outcome measures Risk factors associated with the development of tuberculosis. Results The main risk factors for tuberculosis were low accumulated wealth (univariate odds ratio 16.70), financial insecurity (5.67), consumption of unpasteuriscd milk (3.58), diabetes (2.66), living with a relative with tuberculosis (2.94), being unemployed (6.10), living in overcrowded conditions (2.99), illicit drug use (8.74), and a history of incarceration in both pretrial detention centres (5.70) and prison (12.50). Conclusions When prevalence of exposure is taken into account the most important factors in the development of pulmonary tuberculosis in Russia are exposure to raw milk and unemployment.	Univ London London Sch Hyg Trop Med, Dept Publ Hlth Policy, European Ctr Hlth Societies Transit, London WC1E 7HT, England; Univ London Imperial Coll Sci & Technol, Tanaka Business Sch, London, England; Samara Social Res Inst, Samara, Russia; Samara Oblast Hlth Dept, Dept Adult Healthcare, Samara, Russia; Queen Marys Sch Med, Inst Cell & Mol Sci, Mycobacterium Reference Unit, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; Queen Mary University London	Coker, R (corresponding author), Univ London London Sch Hyg Trop Med, Dept Publ Hlth Policy, European Ctr Hlth Societies Transit, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Atun, Rifat/AAH-5537-2021; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683; Atun, Rifat/0000-0002-1531-5983				Drobniewski FA, 2004, INT J STD AIDS, V15, P641, DOI 10.1258/0956462041944303; *FAO UN, 1999, MILK PROD PROC, V7; FARMER P, 1999, GLOBAL IMPACT DRUG R; STERN V, 1999, SENTENCED DUE PROBLE; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; TULUPOV VP, 1989, GIG SANIT, V12, P68	6	120	124	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 14	2006	332	7533					85	87		10.1136/bmj.38684.687940.80	http://dx.doi.org/10.1136/bmj.38684.687940.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004UE	16339219	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000234777000019
J	Franks, NR; Richardson, T				Franks, NR; Richardson, T			Teaching in tandem-running ants	NATURE			English	Editorial Material							LEPTOTHORAX; NAVIGATION; EMIGRATION		Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Franks, NR (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England.	nigel.franks@bristol.ac.uk	Franks, Nigel/AAG-8207-2019; Richardson, Thomas/H-9898-2019	Franks, Nigel/0000-0001-8139-9604; Richardson, Thomas/0000-0002-0220-4897				CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Galef BG, 2005, ANIM BEHAV, V70, P91, DOI 10.1016/j.anbehav.2004.12.004; Holldobler B., 1990, pi; McLeman MA, 2002, INSECT SOC, V49, P203, DOI 10.1007/s00040-002-8302-2; MOGLICH M, 1974, SCIENCE, V186, P1046, DOI 10.1126/science.186.4168.1046; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Moglich M., 1974, Psyche Camb, V81, P219, DOI 10.1155/1974/25763; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2001, ETHOLOGY, V107, P1125, DOI 10.1046/j.1439-0310.2001.00749.x; SHETTLEWORTH SJ, 1998, COGNITION EVOLUTION, P475	10	248	258	5	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					153	153		10.1038/439153a	http://dx.doi.org/10.1038/439153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407943	Bronze			2022-12-01	WOS:000234538400029
J	Firestein, GS				Firestein, GS			Inhibiting inflammation in rheumatoid arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Clin Invest Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Firestein, GS (corresponding author), Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA.							Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Nandakumar KS, 2003, AM J PATHOL, V163, P1827, DOI 10.1016/S0002-9440(10)63542-0	5	30	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 5	2006	354	1					80	82		10.1056/NEJMcibr054344	http://dx.doi.org/10.1056/NEJMcibr054344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	998ZO	16394307				2022-12-01	WOS:000234358600014
J	Hsu, CY; McCulloch, CE; Iribarren, C; Darbinian, J; Go, AS				Hsu, CY; McCulloch, CE; Iribarren, C; Darbinian, J; Go, AS			Body mass index and risk for end-stage renal disease	ANNALS OF INTERNAL MEDICINE			English	Article							KIDNEY-DISEASE; WEIGHT-LOSS; LIFE-STYLE; OBESITY; OVERWEIGHT; HEMODYNAMICS; PROTEINURIA; PREDICTORS; TRENDS	Background: Although interest in the relationship between obesity and kidney disease is increasing, few epidemiologic studies have examined whether excess weight is an independent risk factor for end-stage renal disease (ESRD). Objective: To determine the association between increased body mass index (BMI) and risk for ESRD. Design: Historical (nonconcurrent) cohort study. Setting: A large integrated health care delivery system in northern California. Participants: 320 252 adult members of Kaiser Permanente who volunteered for screening health checkups between 1964 and 1985 and who had height and weight measured. Measurements: The authors ascertained ESRD cases by matching data with the U.S. Renal Data System registry through 2000. Results: A total of 1471 cases of ESRD occurred during 8 347 955 person-years of follow-up. Higher BMI was a risk factor for ESRD in multivariable models that adjusted for age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level. Compared with persons who had normal weight (BMI, 18.5 to 24.9 kg/m(2)), the adjusted relative risk for ESRD was 1.87 (95% Cl, 1.64 to 2.14) for those who were overweight (BMI, 25.0 to 29.9 kg/m(2)), 3.57 (Cl, 3.05 to 4.18) for those with class I obesity (BMI, 30.0 to 34.9 kg/m(2)), 6.12 (CI, 4.97 to 7.54) for those with class II obesity (BMI, 35.0 to 39.9 kg/m(2)), and 7.07 (Cl, 5.37 to 9.31) for those with extreme obesity (BMI >= 40 kg/m(2)). Higher baseline BMI remained an independent predictor for ESRD after additional adjustments for baseline blood pressure level and presence or absence of diabetes mellitus. Limitations: Primary analyses were based on single measurements of exposures. Conclusions: High BMI is a common, strong, and potentially modifiable risk factor for ESRD.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Oakland, CA USA	University of California System; University of California San Francisco; Kaiser Permanente	Hsu, CY (corresponding author), Univ Calif San Francisco, Div Nephrol, 513 Parnassus Ave,672HSE,Box 0532, San Francisco, CA 94143 USA.	hsuchi@medicine.ucsf.edu	Go, Alan S./AAE-7745-2019	Hsu, Chi-yuan/0000-0001-8182-1238	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK061520] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrass CK, 2004, J AM SOC NEPHROL, V15, P2768, DOI 10.1097/01.ASN.0000141963.04540.3E; Adelman RD, 2002, CURR OPIN NEPHROL HY, V11, P331, DOI 10.1097/00041552-200205000-00010; [Anonymous], 2003, Am J Kidney Dis, V42, P1; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Bosma RJ, 2004, KIDNEY INT, V65, P259, DOI 10.1111/j.1523-1755.2004.00351.x; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; BROCHNERMORTENSEN J, 1980, SCAND J CLIN LAB INV, V40, P695, DOI 10.3109/00365518009095584; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COHEN AH, 1975, AM J PATHOL, V81, P117; Cohen MF, 1978, MULTIPHASIC HLTH TES; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; FISHER LD, 1996, BIOSTATISTICS METHOD; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Iseki K, 1997, KIDNEY INT, pS169; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KASISKE BL, 1986, ARCH INTERN MED, V146, P1105, DOI 10.1001/archinte.146.6.1105; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; NHBLI Obesity Task Force, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Ramirez SPB, 2002, J AM SOC NEPHROL, V13, P1907, DOI 10.1097/01.ASN.0000018406.20282.C8; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	40	922	964	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2006	144	1					21	28		10.7326/0003-4819-144-1-200601030-00006	http://dx.doi.org/10.7326/0003-4819-144-1-200601030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000PL	16389251				2022-12-01	WOS:000234474200003
J	Martin, M; Cho, JY; Cesare, AJ; Griffith, JD; Attardi, G				Martin, M; Cho, JY; Cesare, AJ; Griffith, JD; Attardi, G			Termination factor-mediated DNA loop between termination and initiation sites drives mitochondrial rRNA synthesis	CELL			English	Article							TRANSCRIPTION TERMINATION; FACTOR MTERF; IDENTIFICATION; PROTEIN; PURIFICATION; CHROMATIN; MONOMER; STRAND; MTDNA	The human mitochondrial transcription termination factor mTERF plays a central role in the control of heavy-strand rDNA transcription by promoting initiation, besides termination, of this transcription. However, until now, the mechanism underlying this stimulation of transcription by mTERF was not understood. In the present work, addition of mTERF to a HeLa cell mitochondrial lysate-based reaction mixture containing an artificial rDNA template did indeed specifically stimulate rDNA transcription. This stimulation required that mTERF be simultaneously bound to the rDNA transcription termination and initiation sites in the same molecule, thus forming a loop. Most significantly, a double binding of mTERF to the rDNA molecule, with resulting loop formation, was also shown in vivo. These results strongly suggest that, to satisfy the need for high rate of rDNA transcription, human mitochondrial rRNA synthesis involves mTERF-mediated rDNA looping that promotes recycling of the transcription machinery.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Attardi, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	attardi@caltech.edu	Cesare, Anthony J/F-4691-2010; Cesare, Anthony/N-7415-2019; Martin, Miguel Angel/B-6261-2017	Cesare, Anthony J/0000-0002-0864-1254; Cesare, Anthony/0000-0002-0864-1254; Martin, Miguel Angel/0000-0003-4741-772X; Cho, Jae/0000-0002-6534-116X	NIGMS NIH HHS [GM11726, GM31819] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asin-Cayuela J, 2004, J BIOL CHEM, V279, P15670, DOI 10.1074/jbc.M312537200; ATTARDI G, 1983, METHOD ENZYMOL, V97, P435; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Silva P, 1996, Methods Enzymol, V264, P129, DOI 10.1016/S0076-6879(96)64014-2; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Helm M, 2004, J MOL BIOL, V337, P545, DOI 10.1016/j.jmb.2004.01.036; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; KRUSE B, 1995, METHODS MOL BIOL, V37; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Prieto-Martin A, 2004, J BIOCHEM, V136, P825, DOI 10.1093/jb/mvh192; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; VINOGRAD J, 1963, P NATL ACAD SCI USA, V49, P12, DOI 10.1073/pnas.49.1.12	25	137	147	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1227	1240		10.1016/j.cell.2005.09.040	http://dx.doi.org/10.1016/j.cell.2005.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377564	Bronze			2022-12-01	WOS:000234584500012
J	Moser, HW; Raymond, GV; Dubey, P				Moser, HW; Raymond, GV; Dubey, P			Adrenoleukodystrophy - New approaches to a neurodegenerative disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; ADDISONS-DISEASE; ADRENOMYELONEUROPATHY; MRI; TRANSPLANTATION; SCLEROSIS; VARIANT	X-linked adrenoleukodystrophy (X-ALD), which was first described in 1923, was viewed until 1976 as a rare and inexorably fatal neurodegenerative disorder that affected boys. The genetic defect and biochemical abnormalities have now been defined. Ongoing research has resulted in new findings: (1) there is a wide range of phenotypic expression. At least half of patients with X-ALD are adults with somewhat milder manifestations, and women who are carriers may become symptomatic. X-ALD is often misdiagnosed as attention-deficit/hyperactivity disorder in boys and as multiple sclerosis in men and women, and is not an uncommon cause of Addison disease; (2) the incidence of X-ALD, estimated to be 1:17 000 in all ethnic groups, approximates that of phenylketonuria; (3) noninvasive and presymptomatic diagnosis and prenatal diagnosis are available; family screening and genetic counseling are key to disease prevention; and (4) new therapies, applied early, show promise. Neonatal screening is likely to become available, and a wider awareness of X-ALD and its various modes of presentation permit new pro-active approaches to this distressing disorder.	Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD 21205 USA	Kennedy Krieger Institute	Moser, HW (corresponding author), Kennedy Krieger Inst, Dept Neurogenet, 707 N Broadway, Baltimore, MD 21205 USA.	moser@kennedykrieger.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039276, P01HD010981] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981, HD39276] Funding Source: Medline; PHS HHS [685-008, M0-1-R00052] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; BLAW M, 1970, LEUCODYSTROPHIES POL, P128; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; BUDKA H, 1976, J NEUROL, V213, P237, DOI 10.1007/BF00312873; COX C, IN PRESS ARCH NEUROL; Dubey P, 2005, J PEDIATR-US, V146, P528, DOI 10.1016/j.jpeds.2004.10.067; FANCONI A, 1963, HELV PAEDIATR ACTA, V18, P480; Fatemi A, 2005, NEUROLOGY, V64, P1739, DOI 10.1212/01.WNL.0000164458.02141.06; Fatemi A, 2003, NEUROLOGY, V60, P1301, DOI 10.1212/01.WNL.0000059546.15529.CB; GRIFFIN JW, 1977, NEUROLOGY, V27, P1107, DOI 10.1212/WNL.27.12.1107; Houlden H, 2002, BRAIN, V125, P2681, DOI 10.1093/brain/awf270; IGARASHI M, 1976, J NEUROCHEM, V26, P851, DOI 10.1111/j.1471-4159.1976.tb04462.x; KUMAR AJ, 1987, RADIOLOGY, V165, P497, DOI 10.1148/radiology.165.2.3659373; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Moser AB, 1999, PRENATAL DIAG, V19, P46, DOI 10.1002/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Powers JM, 2000, J NEUROPATH EXP NEUR, V59, P89, DOI 10.1093/jnen/59.2.89; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; Schilder P, 1912, Z GESAMTE NEUROL PSY, V10, P1, DOI 10.1007/BF02901445; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Siemerling E, 1923, ARCH PSYCHIAT NERVEN, V68, P217, DOI 10.1007/BF01835678	25	78	99	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3131	3134		10.1001/jama.294.24.3131	http://dx.doi.org/10.1001/jama.294.24.3131			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380594				2022-12-01	WOS:000234274200030
J	Lovel, HJ; Newby, RM; Hillier, VF				Lovel, HJ; Newby, RM; Hillier, VF			Severe placental malaria and maternal shortness, thinness, and small skeletal size in rural Congo: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Manchester, WHO Collaborating Ctr Primary Care, Sch Primary Care, Eusholme Hlth Ctr, Manchester M14 5NP, Lancs, England; DR Congo Kasaji Hosp, Kasaji, DEM REP CONGO; Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Lovel, HJ (corresponding author), Univ Manchester, WHO Collaborating Ctr Primary Care, Sch Primary Care, Eusholme Hlth Ctr, Manchester M14 5NP, Lancs, England.	hlovel04@yahoo.co.uk						MATTEELLI A, 1994, ANN TROP MED PARASIT, V88, P475, DOI 10.1080/00034983.1994.11812894; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Moore SE, 1998, P NUTR SOC, V57, P241, DOI 10.1079/PNS19980038; NEWBY RM, 2000, THESIS U MANCHESTER; REINHARDT MC, 1978, HELV PAEDIATR ACTA, P65	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2005	331	7530					1439	1440		10.1136/bmj.331.7530.1439	http://dx.doi.org/10.1136/bmj.331.7530.1439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EE	16356980	Green Published, Bronze			2022-12-01	WOS:000234156400021
J	Baltussen, R; Floyd, K; Dye, C				Baltussen, R; Floyd, K; Dye, C			Achieving the millennium development goals for health - Cost effectiveness analysis of strategies for tuberculosis control in developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE FACILITY INVOLVEMENT; INCREASED COMMUNITY; IMPROVING HEALTH; INTERVENTIONS; PROSPECTS; DISTRICT	Objective To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals. Design Cost effectiveness analysis based on an epidemiological model. Setting Analyses undertaken for two regions classified by WHO according to their epidemiological grouping-Afr-E, countries in sub-Saharan Africa with very high adult and high child mortality, and Sear-D, countries in South East Asia with high adult and high child mortality. Data sources Published studies, costing databases, expert opinion. Main outcome measures Costs per disability adjusted life year (DALY) averted in 2000 international dollars ($Int). Results Treatment of new cases of smear-positive tuberculosis in DOTS programmes cost $Int6-8 per DALY averted in Afr-E and $Int7 per DALY averted in Sear-D at coverage levels of 50-95%. In Afr-E, adding treatment of smear-negative and extra-pulmonary cases at a coverage level of 95% cost $Int95 per DALY averted; the addition of DOTS-Plus treatment for multidrug resistant cases cost $Int123. In Sear-D, these costs were $Int52 and $Int226, respectively. The full combination of interventions could reduce prevalence and mortality by over 50% in Sear-D between 1990 mid 2010, and by almost 50% between 2000 and 2010 in Afr-E. Conclusions DOTS treatment of new smear-positive cases is the first priority in tuberculosis control, including in countries with high HINT prevalence. DOTS treatment of smear-negative and extra-pulmonary cases and DOTS-Plus treatment of multidrug resistant cases are also highly cost effective. To achieve the millennium development goal for tuberculosis control, substantial extra investment is needed to increase case finding and implement interventions on a wider scale.	Erasmus MC, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands; WHO, STOP TB Dept, CH-1211 Geneva, Switzerland	Erasmus University Rotterdam; Erasmus MC; World Health Organization	Baltussen, R (corresponding author), Erasmus MC, Inst Med Technol Assessment, POB 1738, NL-3000 DR Rotterdam, Netherlands.	r.baltusen@erasmusmc.nl	Dye, Christopher/AIC-4659-2022; Baltussen, R.M.P.M./L-4181-2015	Dye, Christopher/0000-0002-2957-1793				Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; [Anonymous], 2022, BMJ, V378, DOI [DOI 10.1136/BMJ.38643.368692.68, 10.1136/bmj-2021-068384, DOI 10.1136/BMJ.O2284]; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; EDEJER TTT, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38652.550278.7C; Evans DB, 2005, BMJ-BRIT MED J, V331, P1133, DOI 10.1136/bmj.331.7525.1133; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; EVANS DB, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38658.675243.94; Floyd K, 2003, TUBERCULOSIS, V83, P187, DOI 10.1016/S1472-9792(02)00077-X; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; International Programme on Chemical S., 2005, 3 IPCS; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; MAHER D, 1999, WHAT IS DOTS GUIDE U; MOREL GM, 2005, BMJ             1110, DOI DOI 10.1136/BMJ.38639.702384.AE; MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; STOVER J, 1998, TB HIV SPREADSHEET M; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; UN, 2000, ARES552 UN; *WHO, WHO CHOICE CHOOS INT; WHO, POP DEATH RAT REPR R; *WHO, 2005, GLOB TUB CONTR SURV	27	90	96	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2005	331	7529					1364	1368		10.1136/bmj.38645.660093.68	http://dx.doi.org/10.1136/bmj.38645.660093.68			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16282379	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000233999300016
J	Davidson, G; Wu, W; Shen, JL; Bilic, J; Fenger, U; Stannek, P; Glinka, A; Niehrs, C				Davidson, G; Wu, W; Shen, JL; Bilic, J; Fenger, U; Stannek, P; Glinka, A; Niehrs, C			Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction	NATURE			English	Article							PROTEIN-5; MECHANISM; PATHWAY	Signalling by Wnt proteins ( Wingless in Drosophila) has diverse roles during embryonic development and in adults, and is implicated in human diseases, including cancer(1,2). LDL-receptor-related proteins 5 and 6 (LRP5 and LRP6; Arrow in Drosophila) are key receptors required for transmission of Wnt/beta-catenin signalling in metazoa(3). Although the role of these receptors in Wnt signalling is well established, their coupling with the cytoplasmic signalling apparatus remains poorly defined. Using a protein modification screen for regulators of LRP6, we describe the identification of Xenopus Casein kinase 1 gamma (CK1 gamma), a membrane-bound member of the CK1 family. Gain-of-function and loss-of-function experiments show that CK1 gamma is both necessary and sufficient to transduce LRP6 signalling in vertebrates and Drosophila cells. In Xenopus embryos, CK1 gamma is required during anterio-posterior patterning to promote posteriorizing Wnt/beta-catenin signalling. CK1 gamma is associated with LRP6, which has multiple, modular CK1 phosphorylation sites. Wnt treatment induces the rapid CK1 gamma-mediated phosphorylation of these sites within LRP6, which, in turn, promotes the recruitment of the scaffold protein Axin. Our results reveal an evolutionarily conserved mechanism that couples Wnt receptor activation to the cytoplasmic signal transduction apparatus.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.davidson@dkfz-heidelberg.de; Niehrs@dkfz-heidelberg.de	Davidson, Gary/AAA-7321-2021; Shen, Jinlong/D-5389-2009; Davidson, Gary/J-6059-2013	Davidson, Gary/0000-0002-2264-5518; Bilic Zimmermann, Josipa/0000-0001-9642-6265				Belanger C, 2001, FEBS LETT, V499, P59, DOI 10.1016/S0014-5793(01)02513-3; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dosch R, 1997, DEVELOPMENT, V124, P2325; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Shibamoto S, 1998, GENES CELLS, V3, P659; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717	23	436	484	2	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					867	872		10.1038/nature04170	http://dx.doi.org/10.1038/nature04170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341016				2022-12-01	WOS:000233777800054
J	Zeng, X; Tamai, K; Doble, B; Li, ST; Huang, H; Habas, R; Okamura, H; Woodgett, J; He, X				Zeng, X; Tamai, K; Doble, B; Li, ST; Huang, H; Habas, R; Okamura, H; Woodgett, J; He, X			A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation	NATURE			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; SUBSTRATE-SPECIFICITY; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; PATHWAY; AXIN; DROSOPHILA; MUTANTS; FAMILY	Signalling by the Wnt family of secreted lipoproteins has essential functions in development and disease(1). The canonical Wnt/beta-catenin pathway requires a single-span transmembrane receptor, low-density lipoprotein (LDL)-receptor-related protein 6 (LRP6)(2-4), whose phosphorylation at multiple PPPSP motifs is induced upon stimulation by Wnt and is critical for signal transduction(5). The kinase responsible for LRP6 phosphorylation has not been identified. Here we provide biochemical and genetic evidence for a 'dual-kinase' mechanism for LRP6 phosphorylation and activation. Glycogen synthase kinase 3 (GSK3), which is known for its inhibitory role in Wnt signalling through the promotion of beta-catenin phosphorylation and degradation, mediates the phosphorylation and activation of LRP6. We show that Wnt induces sequential phosphorylation of LRP6 by GSK3 and casein kinase 1, and this dual phosphorylation promotes the engagement of LRP6 with the scaffolding protein Axin. We show further that a membrane-associated form of GSK3, in contrast with cytosolic GSK3, stimulates Wnt signalling and Xenopus axis duplication. Our results identify two key kinases mediating Wnt co-receptor activation, reveal an unexpected and intricate logic of Wnt/beta-catenin signalling, and illustrate GSK3 as a genuine switch that dictates both on and off states of a pivotal regulatory pathway.	Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol,Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol,Neurobiol Program, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Doble, Bradley/V-7848-2019; Woodgett, Jim/F-1087-2010; Doble, Brad/L-7551-2016	Doble, Bradley/0000-0002-0260-2983; Woodgett, Jim/0000-0003-3731-5797; Doble, Brad/0000-0002-0260-2983; Li, Shitao/0000-0002-1398-8519	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074241, R01 GM074241-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101	30	616	667	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					873	877		10.1038/nature04185	http://dx.doi.org/10.1038/nature04185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341017	Green Accepted			2022-12-01	WOS:000233777800055
J	Engelman, DM				Engelman, DM			Membranes are more mosaic than fluid	NATURE			English	Editorial Material							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISM; PROTEIN; COMPLEXES; TRACKING; RECEPTOR; CHANNEL; OXIDASE	The wealth of new data on membrane protein structures and functions is changing our general view of membrane architecture. Some of the key themes that are emerging are that membranes are patchy, with segregated regions of structure and function, that lipid regions vary in thickness and composition, and that crowding and ectodomains limit exposure of lipid to the adjacent aqueous regions.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Engelman, DM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Box 208114, New Haven, CT 06520 USA.	don@mail.csb.yale.edu						Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Liu Y, 2002, GENOME BIOL, V3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Petrache HI, 2002, LANGMUIR, V18, P1340, DOI 10.1021/la011338p; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	34	653	658	3	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					578	580		10.1038/nature04394	http://dx.doi.org/10.1038/nature04394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319876	Bronze			2022-12-01	WOS:000233593100034
J	Kabat, P; van Vierssen, W; Veraart, J; Vellinga, P; Aerts, J				Kabat, P; van Vierssen, W; Veraart, J; Vellinga, P; Aerts, J			Climate proofing the Netherlands	NATURE			English	Editorial Material									Univ Wageningen & Res Ctr, Environm Sci Grp, NL-6700 AA Wageningen, Netherlands; Free Univ Amsterdam, Fac Earth Sci, Amsterdam, Netherlands	Wageningen University & Research; Vrije Universiteit Amsterdam	Kabat, P (corresponding author), Univ Wageningen & Res Ctr, Environm Sci Grp, POB 47, NL-6700 AA Wageningen, Netherlands.		Aerts, Jeroen Cjh/M-8431-2013; Kabat, Pavel/AAJ-2245-2020					BOUWER LM, IN PRESS FLOODING EU; KABAT P, 2003, SYNTHESIS REPORT INT, P2; KONNEN G, 2001, CLIMATE SCENARIOS IM; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; TIELROOY F, 2000, WATER MANAGEMENT 21; VANDENBORN GJ, 2002, R0205 FREE U AMST; 2004, ESPACE GUIDING MODEL	8	112	112	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					283	284		10.1038/438283a	http://dx.doi.org/10.1038/438283a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	984JR	16292285	Green Published			2022-12-01	WOS:000233300200021
J	Baron, MK; Boeckers, TM; Vaida, B; Faham, S; Gingery, M; Sawaya, MR; Salyer, D; Gundelfinger, ED; Bowie, JU				Baron, MK; Boeckers, TM; Vaida, B; Faham, S; Gingery, M; Sawaya, MR; Salyer, D; Gundelfinger, ED; Bowie, JU			An architectural framework that may lie at the core of the postsynaptic density	SCIENCE			English	Article							RECEPTOR SAM DOMAIN; ACTIN CYTOSKELETON; MASS-SPECTROMETRY; DENDRITIC SPINES; PROTEINS; FAMILY; ZINC; PLASTICITY; SPECIATION; NEURONS	The postsynaptic density (PSD) is a complex assembly of proteins associated with the postsynaptic membrane that organizes neurotransmitter receptors, signaling pathways, and regulatory elements within a cytosketetat matrix. Here we show that the sterile alpha motif domain of rat Shank3/ProSAP2, a master scaffolding protein located deep within the PSD, can form large sheets composed of helical fibers stacked side by side. Zn2+, which is found in high concentrations in the PSD, binds tightly to Shank3 and may regulate assembly. Sheets of the Shank protein could form a platform for the construction of the PSD complex.	Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Univ Calif Los Angeles US Dept Energy Inst Genom, Los Angeles, CA 90095 USA; Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; Leibniz Inst Neurobiol, D-39008 Magdeburg, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University; Leibniz Institut fur Neurobiologie (LIN)	Bowie, JU (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu			NCI NIH HHS [R01 CA081000] Funding Source: Medline; NIGMS NIH HHS [R01 GM063919-07, R01 GM063919-08, R01 GM075922-04, R01 GM063919, R01 GM075922] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075922, R01GM063919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Behlke J, 2001, EUR BIOPHYS J BIOPHY, V30, P411, DOI 10.1007/s002490100164; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Caruso JA, 2003, ECOTOX ENVIRON SAFE, V56, P148, DOI 10.1016/S0147-6513(03)00058-7; Chang CJ, 2004, CHEM BIOL, V11, P203, DOI 10.1016/j.chembiol.2004.01.017; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Jan HH, 2002, J NEUROCHEM, V83, P525, DOI 10.1046/j.1471-4159.2002.01093.x; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MATUS AI, 1978, PROC R SOC SER B-BIO, V203, P135, DOI 10.1098/rspb.1978.0097; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Vanhaecke F, 2002, ANAL BIOANAL CHEM, V374, P188, DOI 10.1007/s00216-002-1338-3; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wouterlood FG, 2003, J NEUROSCI METH, V128, P129, DOI 10.1016/S0165-0270(03)00171-7; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	33	217	221	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					531	535		10.1126/science.1118995	http://dx.doi.org/10.1126/science.1118995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439662				2022-12-01	WOS:000235071400048
J	Currie, CR; Poulsen, M; Mendenhall, J; Boomsma, JJ; Billen, J				Currie, CR; Poulsen, M; Mendenhall, J; Boomsma, JJ; Billen, J			Coevolved crypts and exocrine glands support mutualistic bacteria in fungus-growing ants	SCIENCE			English	Article							PHYLOGENETIC ANALYSIS; TRIPARTITE MUTUALISM; SYMBIOSIS; PARASITES; GARDENS	Attine ants engage in a quadripartite symbiosis with fungi they cultivate for food, specialized garden parasites, and parasite-inhibiting bacteria. Molecular phylogenetic evidence supports an ancient host-pathogen association between the ant-cultivar mutualism and the garden parasite. Here we show that ants rear the antibiotic-producing bacteria in elaborate cuticular crypts, supported by unique exocrine glands, and that these structures have been highly modified across the ants' evolutionary history. This specialized structural evolution, together with the absence of these bacteria and modifications in other ant genera that do not grow fungus, indicate that the bacteria have an ancient and coevolved association with the ants, their fungal cultivar, and the garden parasite.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Copenhagen, Inst Biol, Dept Populat Biol, DK-2100 Copenhagen, Denmark; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Catholic Univ Louvain, Inst Zool, B-3000 Louvain, Belgium	University of Wisconsin System; University of Wisconsin Madison; University of Kansas; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Copenhagen; University of Texas System; University of Texas Austin; Universite Catholique Louvain	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu	Boomsma, Jacobus J/M-2785-2014; Poulsen, Michael/C-6276-2012	Boomsma, Jacobus J/0000-0002-3598-1609; Poulsen, Michael/0000-0002-2839-1715; Billen, Johan/0000-0002-2392-7293				Billen J., 1998, PHEROMONE COMMUNICAT; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Douglas A.E., 1994, SYMBIOTIC INTERACTIO; Gerardo NM, 2004, P ROY SOC B-BIOL SCI, V271, P1791, DOI 10.1098/rspb.2004.2792; Goodfellow M., 1984, BIOL ACTINOMYCETES; Margulis L, 1991, SYMBIOSIS SOURCE EVO; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Paracer S., 2000, SYMBIOSIS INTRO BIOL; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; SMITH MR, 1947, AM MIDL NAT, V37, P521, DOI 10.2307/2421469; Weber N. A., 1972, GARDENING ANTS ATTIN; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466	20	240	250	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					81	83		10.1126/science.1119744	http://dx.doi.org/10.1126/science.1119744			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400148				2022-12-01	WOS:000234546300037
J	Ohtsubo, K; Takamatsu, S; Minowa, MT; Yoshida, A; Takeuchi, M; Marth, JD				Ohtsubo, K; Takamatsu, S; Minowa, MT; Yoshida, A; Takeuchi, M; Marth, JD			Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes	CELL			English	Article							PANCREATIC BETA-CELLS; UDP-N-ACETYLGLUCOSAMINE; HIGH-FAT DIET; GLUCOSE-TRANSPORTER; C57BL/6J MICE; CDNA CLONING; EXPRESSION; GLUT-2; FAMILY; HYPERGLYCEMIA	Pancreatic beta cell-surface expression of glucose transporter 2 (Glut-2) is essential for glucose-stimulated insulin secretion, thereby controlling blood glucose homeostasis in response to dietary intake. We show that the murine GlcNAcT-IVa glycosyltransferase is required for Glut-2 residency on the 0 cell surface by constructing a cell-type and glycoprotein-specific N-glycan ligand for pancreatic lectin receptors. Loss of GlcNAcT-IVa, or the addition of glycan ligand mimetics, attenuates Glut-2 cell surface half-life, provoking endocytosis with redistribution into endosomes and lysosomes. The ensuing impairment of glucose-stimulated insulin secretion leads to metabolic dysfunction diagnostic of type 2 diabetes. Remarkably, the induction of diabetes by chronic ingestion of a high-fat diet is associated with reduced GlcNAcT-IV expression and attenuated Glut-2 glycosylation coincident with Glut-2 endocytosis. We infer that beta cell glucose-transporter glycosylation mediates a link between diet and insulin production that typically suppresses the pathogenesis of type 2 diabetes.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Univ Fukui, Biomed Imaging Res Ctr, Fukui 9101193, Japan	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Kirin Brewery Company Limited; University of Fukui	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jmarth@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48247] Funding Source: Medline; NIGMS NIH HHS [GM62116] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Ing BL, 1996, BIOCHEM BIOPH RES CO, V218, P76, DOI 10.1006/bbrc.1996.0015; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Lipkowitz MS, 2002, GLYCOCONJUGATE J, V19, P491, DOI 10.1023/B:GLYC.0000014078.65610.2f; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; ORCI L, 1990, J CLIN INVEST, V86, P1615, DOI 10.1172/JCI114883; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; THORENS B, 1993, J CELL BIOL, V123, P1687, DOI 10.1083/jcb.123.6.1687; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Tokugawa K, 1996, GLYCOCONJUGATE J, V13, P53, DOI 10.1007/BF01049679; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; VALERA A, 1994, J BIOL CHEM, V269, P28543; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; Varki A, 1999, ESSENTIALS GLYCOBIOL, P455; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshida A, 1998, GLYCOCONJUGATE J, V15, P1115, DOI 10.1023/A:1006951519522	37	308	324	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1307	1321		10.1016/j.cell.2005.09.041	http://dx.doi.org/10.1016/j.cell.2005.09.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377570	Bronze			2022-12-01	WOS:000234584500018
J	Flanagan, JF; Mi, LZ; Chruszcz, M; Cymborowski, M; Clines, KL; Kim, YC; Minor, W; Rastinejad, F; Khorasanizadeh, S				Flanagan, JF; Mi, LZ; Chruszcz, M; Cymborowski, M; Clines, KL; Kim, YC; Minor, W; Rastinejad, F; Khorasanizadeh, S			Double chromodomains cooperate to recognize the methylated histone H3 tail	NATURE			English	Article							DNA-BINDING; CHROMATIN; NUCLEOSOME; CHD1; PROTEINS; COMPLEX; GENES	Chromodomains are modules implicated in the recognition of lysine-methylated histone tails and nucleic acids(1,2). CHD ( for chromo-ATPase/helicase-DNA-binding) proteins regulate ATP-dependent nucleosome assembly and mobilization through their conserved double chromodomains and SWI2/SNF2 helicase/ ATPase domain(3-5). The Drosophila CHD1 localizes to the interbands and puffs of the polytene chromosomes, which are classic sites of transcriptional activity(6). Other CHD isoforms (CHD3/4 or Mi-2) are important for nucleosome remodelling in histone deacetylase complexes(7,8). Deletion of chromodomains impairs nucleosome binding and remodelling by CHD proteins(4). Here we describe the structure of the tandem arrangement of the human CHD1 chromodomains, and its interactions with histone tails. Unlike HP1 and Polycomb proteins that use single chromodomains to bind to their respective methylated histone H3 tails, the two chromodomains of CHD1 cooperate to interact with one methylated H3 tail. We show that the human CHD1 double chromodomains target the lysine 4-methylated histone H3 tail (H3K4me), a hallmark of active chromatin(9). Methylammonium recognition involves two aromatic residues, not the three-residue aromatic cage used by chromodomains of HP1 and Polycomb proteins(10-13). Furthermore, unique inserts within chromodomain 1 of CHD1 block the expected site of H3 tail binding seen in HP1 and Polycomb, instead directing H3 binding to a groove at the inter-chromodomain junction.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	University of Virginia; University of Virginia; University of Virginia; United States Department of Energy (DOE); Argonne National Laboratory	Khorasanizadeh, S (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	fr9c@virginia.edu; khorasan@virginia.edu	Mi, Li-Zhi/B-1371-2016; Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Mi, Li-Zhi/0000-0001-9907-5245; Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090; Kim, Youngchang/0000-0002-1610-4889				Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Delano W. L., 2004, PYMOL USERS GUIDE; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Tajul-Arifin K, 2003, GENOME RES, V13, P1416, DOI 10.1101/gr.1015703; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	402	413	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1181	1185		10.1038/nature04290	http://dx.doi.org/10.1038/nature04290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372014				2022-12-01	WOS:000234111500056
J	Greenwood, DR; Comeskey, D; Hunt, MB; Rasmussen, LEL				Greenwood, DR; Comeskey, D; Hunt, MB; Rasmussen, LEL			Chemical communication - Chirality in elephant pheromones	NATURE			English	Editorial Material							ASIAN ELEPHANTS; MUSTH; IDENTIFICATION; SEMIOCHEMICALS; DENDROCTONUS; BEETLE		Mt Albert Res Ctr, Auckland, New Zealand; Palmerston N Res Ctr, Palmerston North, New Zealand; Oregon Hlth Sci Univ, Dept Environm & Biomol Syst, OGI Sch Sci & Engn, Beaverton, OR 97006 USA	New Zealand Institute for Plant & Food Research Ltd; Oregon Health & Science University	Greenwood, DR (corresponding author), Mt Albert Res Ctr, Private Bag 92-169, Auckland, New Zealand.	betsr@ebs.ogi.edu	Greenwood, David R/D-2375-2016	Greenwood, David R/0000-0001-5280-042X; Hunt, Martin/0000-0002-3040-0545				FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; KINZER GW, 1969, NATURE, V221, P477, DOI 10.1038/221477a0; Mori K, 1998, CHIRALITY, V10, P578, DOI 10.1002/(SICI)1520-636X(1998)10:7<578::AID-CHIR5>3.0.CO;2-Z; Paine TD, 1999, J CHEM ECOL, V25, P433, DOI 10.1023/A:1020989417318; PERRIN TE, 1996, J CHEM ECOL, V21, P207; Rasmussen LEL, 1999, PHYSIOL BEHAV, V67, P539, DOI 10.1016/S0031-9384(99)00114-6; Rasmussen LEL, 2005, BEHAVIOUR, V142, P351, DOI 10.1163/1568539053778300; Rasmussen LEL, 2003, CHEM SENSES, V28, P433, DOI 10.1093/chemse/28.5.433; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; RASUSSEN LEL, 2004, J ELEPHANT MAN ASS, V15, P30; SILVERSTEIN RM, 1988, J CHEM ECOL, V14, P1981, DOI 10.1007/BF01014245; STEWART TE, 1977, J CHEM ECOL, V3, P27, DOI 10.1007/BF00988131	12	69	70	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1097	1098		10.1038/4381097a	http://dx.doi.org/10.1038/4381097a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16371998				2022-12-01	WOS:000234111500035
J	Golan, Y; Wolf, MP; Pauker, SG; Wong, JB; Hadley, S				Golan, Y; Wolf, MP; Pauker, SG; Wong, JB; Hadley, S			Empirical anti-Candida therapy among sdected patients in the intensive care unit: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	31st Critical Care Congress of the Society-of-Critical-Care-Medicine	JAN 26-30, 2002	SAN DIEGO, CA	Soc Crit Care Med			LIPOSOMAL AMPHOTERICIN-B; BLOOD CULTURE-SYSTEMS; INVASIVE FUNGAL-INFECTIONS; PLACEBO-CONTROLLED TRIAL; CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; QUALITY-OF-LIFE; ANTIMICROBIAL SURVEILLANCE PROGRAM; HOSPITAL-ACQUIRED CANDIDEMIA; NON-NEUTROPENIC PATIENTS	Background: mortality from invasive candidiasis is high. Low culture sensitivity and treatment delay contribute to increased mortality, but nonselective early therapy may result in excess costs and drug resistance. Objective: To determine the cost-effectiveness of anti-Candida strategies for high-risk patients in the intensive care unit (ICU). Design: Cost-effectiveness decision model. Data Sources: Published data to 10 May 2005, identified from MEDLINE and Cochrane Library searches, ICU databases, expert estimates, and actual hospital costs. Target Population: Patients in the ICU with suspected infection who have not responded to antibacterial therapy. Time Horizon: Lifetime. Perspective: Societal. Interventions: Fluconazole, caspofungin, amphotericin 13, or lipid formulation of amphotericin B given as either empirical or culture-based therapy and no anti-Candida therapy. Outcome Measures: incremental life expectancy and incremental cost per discounted life-year (DLY) saved. Results of Base-Case Analysis: Ten percent of the target population will have invasive candidiasis. Empirical caspofungin therapy is the most effective strategy but is expensive ($295 115 per DLY saved). Empirical fluconazole therapy is the most reasonable strategy ($12 593 per DLY saved) and decreases mortality from 44.0% to 30.4% in patients with invasive candidiasis and from 22.4% to 21.0% in the overall target cohort. Results of Sensitivity Analysis: Empirical fluconazole therapy is reasonable for likelihoods of invasive candidiasis greater than 2.5% or fluconazole resistance less than 24.0%. For higher resistance levels, empirical caspofungin therapy is preferred. For low prevalences of invasive candidiasis, culture-based fluconazole is reasonable. For prevalences exceeding 60%, empirical caspofungin therapy is reasonable. For caspofungin to be reasonable at a prevalence of 10%, its cost must be reduced by 58%. Limitations: Less severe illness and limited use of broad-spectrum antimicrobial agents, typical of smaller hospitals, could result in a lower risk for invasive candidiasis. Conclusions: In patients in the ICU with suspected infection who have not responded to antibiotic treatment, empirical fluconazole should reduce mortality at an acceptable cost. The use of empirical strategies in low-risk patients is not justified.	Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Golan, Y (corresponding author), Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, 750 Washington St,Box 041, Boston, MA 02111 USA.	ygolan@tufts-nemc.org		Wong, John/0000-0003-4203-9010	NLM NIH HHS [T15 LM07092-11] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		AbeleHorn M, 1996, INFECTION, V24, P426, DOI 10.1007/BF01713042; AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Ables AZ, 2000, INFECT DIS CLIN PRAC, V9, P169, DOI 10.1097/00019048-200009040-00006; Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Anaissie E, 1995, 35 INT C ANT AG CHEM; Anaissie EJ, 1998, AM J MED, V104, P238, DOI 10.1016/S0002-9343(98)00030-8; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bates DW, 2001, KIDNEY INT, V60, P1452, DOI 10.1046/j.1523-1755.2001.00948.x; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Blot S, 2001, J HOSP INFECT, V47, P308, DOI 10.1053/jhin.2000.0918; Blumberg HM, 2001, CLIN INFECT DIS, V33, P177, DOI 10.1086/321811; Borst Annemarie, 2002, Clin Lab, V48, P487; Borzotta AP, 1999, ARCH SURG-CHICAGO, V134, P657, DOI 10.1001/archsurg.134.6.657; Brandt G, 1976, MMW Munch Med Wochenschr, V118, P1453; BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4; Cagnoni PJ, 2000, J CLIN ONCOL, V18, P2476, DOI 10.1200/JCO.2000.18.12.2476; Calandra T, 2002, INTENS CARE MED, V28, P1698, DOI 10.1007/s00134-002-1539-4; Cannon JP, 2001, PHARMACOTHERAPY, V21, P1107, DOI 10.1592/phco.21.13.1107.34613; CHANDRASEKAR PH, 1995, BONE MARROW TRANSPL, V16, P675; Chen YC, 2003, J ANTIMICROB CHEMOTH, V52, P71, DOI 10.1093/jac/dkg275; Clark AD, 1998, BRIT J HAEMATOL, V103, P198; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; DeLaurenzi A, 1996, INFECTION, V24, P361, DOI 10.1007/BF01716080; Duran MT, 2003, ENFERM INFEC MICR CL, V21, P488, DOI 10.1157/13052332; DURANDZALESKI I, 1994, MED DECIS MAKING, V14, P98, DOI 10.1177/0272989X9401400112; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Edgeworth JD, 1999, CRIT CARE MED, V27, P1421, DOI 10.1097/00003246-199908000-00002; EGDAHI RH, 1983, JAMA-J AM MED ASSOC, V250, P76, DOI 10.1001/jama.250.1.76; Eggimann P, 1999, CRIT CARE MED, V27, P1066, DOI 10.1097/00003246-199906000-00019; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Fleming RV, 2001, LEUKEMIA LYMPHOMA, V40, P511, DOI 10.3109/10428190109097650; FLETCHER A, 1992, J HUM HYPERTENS, V6, P437; FRASER VJ, 1992, CLIN INFECT DIS, V15, P414, DOI 10.1093/clind/15.3.414; Garbino J, 2002, INTENS CARE MED, V28, P1708, DOI 10.1007/s00134-002-1540-y; Garbino J, 2002, MEDICINE, V81, P425, DOI 10.1097/00005792-200211000-00003; GEARHART MO, 1994, ANN PHARMACOTHER, V28, P1177, DOI 10.1177/106002809402801009; Gleason TG, 1997, ARCH SURG-CHICAGO, V132, P1197, DOI 10.1001/archsurg.1997.01430350047008; GLEASON TG, 1997, ARCH SURG-CHICAGO, V132, P1202; Gold MR., 1996, COST EFFECTIVENESS H; Gottlieb J E, 1981, Med Decis Making, V1, P74; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Harbarth S, 2002, CLIN INFECT DIS, V35, pE120, DOI 10.1086/344468; Horvath LL, 2003, J CLIN MICROBIOL, V41, P4714, DOI 10.1128/JCM.41.10.4714-4717.2003; ITO JL, 1998, CLEAR STEERING COMM; JONES JM, 1990, CLIN MICROBIOL REV, V3, P32, DOI 10.1128/CMR.3.1.32-45.1990; Kami M, 2002, BRIT J HAEMATOL, V117, P40, DOI 10.1046/j.1365-2141.2002.03414.x; Kao AS, 1999, CLIN INFECT DIS, V29, P1164, DOI 10.1086/313450; Kirby L, 2001, INT J TECHNOL ASSESS, V17, P181, DOI 10.1017/S0266462300105045; KOMSHIAN SV, 1989, REV INFECT DIS, V11, P379; Kontoyiannis DP, 2001, MYCOSES, V44, P125, DOI 10.1046/j.1439-0507.2001.00649.x; Kuti JL, 2004, PHARMACOECONOMICS, V22, P301, DOI 10.2165/00019053-200422050-00004; Kvale R, 2002, INTENS CARE MED, V28, P1110, DOI 10.1007/s00134-002-1378-3; Liebowitz LD, 2001, DIAGN MICR INFEC DIS, V40, P27, DOI 10.1016/S0732-8893(01)00243-7; Lipsett PA, 2004, CLIN INFECT DIS, V39, pS193, DOI 10.1086/421956; Lizana FG, 2003, INTENS CARE MED, V29, P1286, DOI 10.1007/s00134-003-1875-z; LYON R, 1995, AM J CLIN PATHOL, V103, P660; MacCallum DA, 2004, ANTIMICROB AGENTS CH, V48, P4911, DOI 10.1128/AAC.48.12.4911-4914.2004; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; *MAN DEEP CAND INF, 1994, INTENSICE CARE MED, V20, P522; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Marco F, 2003, DIAGN MICR INFEC DIS, V46, P259, DOI 10.1016/S0732-8893(03)00086-5; MCTAGGART B, 2003, 43 INT S C ANT AG CH; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Murray PR, 1998, J CLIN MICROBIOL, V36, P1601, DOI 10.1128/JCM.36.6.1601-1603.1998; Niskanen M, 1996, CRIT CARE MED, V24, P1962, DOI 10.1097/00003246-199612000-00006; NollaSalas J, 1997, INTENS CARE MED, V23, P23, DOI 10.1007/s001340050286; Olaechea PM, 2004, EUR J CLIN MICROBIOL, V23, P323, DOI 10.1007/s10096-004-1104-x; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pelz RK, 2001, ANN SURG, V233, P542, DOI 10.1097/00000658-200104000-00010; Petri MG, 1997, INTENS CARE MED, V23, P317, DOI 10.1007/s001340050334; Petti CA, 1996, J CLIN MICROBIOL, V34, P1877, DOI 10.1128/JCM.34.8.1877-1879.1996; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3142, DOI 10.1128/JCM.42.7.3142-3146.2004; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3117, DOI 10.1128/JCM.42.7.3117-3119.2004; Pfaller MA, 1999, DIAGN MICR INFEC DIS, V33, P217, DOI 10.1016/S0732-8893(98)00160-6; Pfaller MA, 2003, J CLIN MICROBIOL, V41, P1440, DOI 10.1128/JCM.41.4.1440-1446.2003; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002; Pfaller MA, 2004, CLIN MICROBIOL INFEC, V10, P11, DOI 10.1111/j.1470-9465.2004.t01-1-00844.x; Phillips P, 1997, EUR J CLIN MICROBIOL, V16, P337, DOI 10.1007/BF01726360; PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008; RANTALA A, 1989, SCAND J INFECT DIS, V21, P557, DOI 10.3109/00365548909037885; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Rex JH, 2001, CLIN INFECT DIS, V32, P1191, DOI 10.1086/319763; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Safran DB, 1997, ARCH SURG-CHICAGO, V132, P1184, DOI 10.1001/archsurg.1997.01430350034006; SAVINO JA, 1994, J TRAUMA, V36, P20, DOI 10.1097/00005373-199401000-00004; Schelonka RL, 2003, J PEDIATR-US, V142, P564, DOI 10.1067/mpd.2003.188; Simmons RL, 1997, ARCH SURG-CHICAGO, V132, P1188; Sobel JD, 2001, CLIN INFECT DIS, V33, P187, DOI 10.1086/321812; SOBEL JD, 1988, CRIT CARE CLIN, V4, P325; St-Germain G, 2001, J CLIN MICROBIOL, V39, P949, DOI 10.1128/JCM.39.3.949-953.2001; TELENTI A, 1989, EUR J CLIN MICROBIOL, V8, P825, DOI 10.1007/BF02185855; Testore GP, 2001, DIAGN MICR INFEC DIS, V41, P23; Tirodker Urmila H, 2003, J Perinatol, V23, P117, DOI 10.1038/sj.jp.7210868; Ullmann AJ, 2003, CURR MED RES OPIN, V19, P263, DOI 10.1185/030079903125001884; ULLMANN AJ, 2004, 13 INT S INF IMM HOS; Villanueva A, 2002, AM J MED, V113, P294, DOI 10.1016/S0002-9343(02)01191-9; Villanueva A, 2001, CLIN INFECT DIS, V33, P1529, DOI 10.1086/323401; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 1998, INTENS CARE MED, V24, P206, DOI 10.1007/s001340050552; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Voss A, 1997, INFECTION, V25, P8, DOI 10.1007/BF02113499; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Weigelt JA, 1999, ARCH SURG-CHICAGO, V134, P664; Weinstein MC, 1999, ANN INTERN MED, V130, P857, DOI 10.7326/0003-4819-130-10-199905180-00021; Weinstein MC, 1980, CLIN DECISION ANAL; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; WEY SB, 1989, ARCH INTERN MED, V149, P2349, DOI 10.1001/archinte.149.10.2349; Wilson ML, 1999, J CLIN MICROBIOL, V37, P1709, DOI 10.1128/JCM.37.6.1709-1713.1999; WILSON ML, 1993, J CLIN MICROBIOL, V31, P865, DOI 10.1128/JCM.31.4.865-871.1993; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451; WINGARD JR, 1993, ANTIMICROB AGENTS CH, V37, P1847, DOI 10.1128/AAC.37.9.1847; WINGARD JR, 1991, NEW ENGL J MED, V325, P1274, DOI 10.1056/NEJM199110313251803; Wong J B, 1999, Am J Med, V107, p74S	119	70	71	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2005	143	12					857	869		10.7326/0003-4819-143-12-200512200-00004	http://dx.doi.org/10.7326/0003-4819-143-12-200512200-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	995CL	16365467				2022-12-01	WOS:000234077400002
J	Chen, D; Steele, AD; Lindquist, S; Guarente, L				Chen, D; Steele, AD; Lindquist, S; Guarente, L			Increase in activity during calorie restriction requires Sirt1	SCIENCE			English	Article							LONGEVITY; RATS		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu			NATIONAL INSTITUTE ON AGING [R01AG011119, R37AG011119] Funding Source: NIH RePORTER; NIA NIH HHS [AG11119] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; McCarter RJM, 1997, AGING-CLIN EXP RES, V9, P73, DOI 10.1007/BF03340130; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Weindruch R., 1988, RETARDATION AGING DI	6	346	372	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1641	1641		10.1126/science.1118357	http://dx.doi.org/10.1126/science.1118357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339438				2022-12-01	WOS:000233961700034
J	Rigoni, M; Caccin, P; Gschmeissner, S; Koster, G; Postle, AD; Rossetto, O; Schiavo, G; Montecucco, C				Rigoni, M; Caccin, P; Gschmeissner, S; Koster, G; Postle, AD; Rossetto, O; Schiavo, G; Montecucco, C			Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures	SCIENCE			English	Article							MEMBRANE-FUSION; HEMIFUSION; A(2); MECHANISMS; EXOCYTOSIS; INTERPLAY; TAIPOXIN; NOTEXIN	Snake presynaptic phospholipase A2 neurotoxins (SPANS) paralyze the neuromuscular junction (NMJ). Upon intoxication, the NMJ enlarges and has a reduced content of synaptic vesicles, and primary neuronal cultures show synaptic swelling with surface exposure of the lumenal domain of the synaptic vesicle protein synaptotagmin I. Concomitantly, these neurotoxins induce exocytosis of neurotransmitters. We found that an equimolar mixture of lysophospholipids and fatty acids closely mimics all of the biological effects of SPANS. These results draw attention to the possible role of local lipid changes in synaptic vesicle release and provide new tools for the study of exocytosis.	Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; Univ Padua, CNR, Inst Neurosci, I-35100 Padua, Italy; Canc Res UK, London Res Inst, London, England; Univ Southampton, Sch Med, Southampton SO9 5NH, Hants, England	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Cancer Research UK; University of Southampton	Montecucco, C (corresponding author), Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.	cesare.montecucco@unipd.it	koster, grielof/F-3129-2012; rossetto, ornella/AAC-3866-2022	rossetto, ornella/0000-0002-6113-3857; Postle, Anthony/0000-0001-7361-0756; Schiavo, Giampietro/0000-0002-4319-8745	Telethon [GP0272Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bonanomi D, 2005, MOL PHARMACOL, V67, P1901, DOI 10.1124/mol.104.005678; CHEN I, 1970, VIRCHOWS ARCH B, V6, P318; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; CULLCANDY SG, 1976, NEUROSCIENCE, V1, P175, DOI 10.1016/0306-4522(76)90074-9; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Harris JB, 2000, EXP NEUROL, V161, P517, DOI 10.1006/exnr.1999.7275; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kini R.M., 1997, VENOM PHOSPHOLIPASE; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; Montecucco C, 2000, TRENDS BIOCHEM SCI, V25, P266, DOI 10.1016/S0968-0004(00)01556-5; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Rigoni M, 2004, J CELL SCI, V117, P3561, DOI 10.1242/jcs.01218; ROLDAN ERS, 1998, FRONT BIOSCI, V3, P1119; Rosenberg P., 1997, VENOM PHOSPHOLIPASE, P155; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Wang JX, 2004, BRIT J PHARMACOL, V141, P586, DOI 10.1038/sj.bjp.0705646; Wei S, 2003, NEUROSCIENCE, V121, P891, DOI 10.1016/S0306-4522(03)00525-6; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yang CC, 1997, VENOM PHOSPHOLIPASE, P185	25	153	159	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2005	310	5754					1678	1680		10.1126/science.1120640	http://dx.doi.org/10.1126/science.1120640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993NV	16339444				2022-12-01	WOS:000233961700044
J	Jakosky, BM; Haberle, RM; Arvidson, RE				Jakosky, BM; Haberle, RM; Arvidson, RE			The changing picture of volatiles and climate on Mars	SCIENCE			English	Editorial Material							ICE; CAP		Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Washington University (WUSTL)	Jakosky, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA.	bruce.jakosky@lasp.colorado.edu						Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Colaprete A, 2005, NATURE, V435, P184, DOI 10.1038/nature03561; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Jakosky BM, 2003, ASTROBIOLOGY, V3, P343, DOI 10.1089/153110703769016433; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Sackmann IJ, 2003, ASTROPHYS J, V583, P1024, DOI 10.1086/345408; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; SHEAN DE, 2005, J GEOPHYS RES, V110, P20601, DOI DOI 10.1029/2004JE002630; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Thomas PC, 2005, ICARUS, V174, P535, DOI 10.1016/j.icarus.2004.07.028; Wood BE, 2005, ASTROPHYS J, V628, pL143, DOI 10.1086/432716	17	13	13	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1439	1440		10.1126/science.1118031	http://dx.doi.org/10.1126/science.1118031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322442				2022-12-01	WOS:000233756500028
J	Kang, JH; Shi, YF; Xiang, B; Qu, B; Su, WJ; Zhu, M; Zhang, M; Bao, GB; Wang, FF; Zhang, XQ; Yang, RX; Fan, FJ; Chen, XQ; Pei, G; Ma, L				Kang, JH; Shi, YF; Xiang, B; Qu, B; Su, WJ; Zhu, M; Zhang, M; Bao, GB; Wang, FF; Zhang, XQ; Yang, RX; Fan, FJ; Chen, XQ; Pei, G; Ma, L			A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; BETA-ARRESTINS; EXPORT SIGNAL; MCM PROTEINS; MICE LACKING; CELL-CYCLE; P38 MAPK; C-FOS; CHROMATIN	Chromatin modification is considered to be a fundamental mechanism of regulating gene expression to generate coordinated responses to environmental changes, however, whether it could be directly regulated by signals mediated by G protein-coupled receptors (GPCRs), the largest surface receptor family, is not known. Here, we show that stimulation of delta-opioid receptor, a member of the GPCR family, induces nuclear translocation of beta-arrestin 1 (beta arr1), which was previously known as a cytosolic regulator and scaffold of GPCR signaling. In response to receptor activation, beta arr1 translocates to the nucleus and is selectively enriched at specific promoters such as that of p27 and c-fos, where it facilitates the recruitment of histone acetyltransferase p300, resulting in enhanced local histone H4 acetylation and transcription of these genes. Our results reveal a novel function of beta arr1 as a cytoplasm-nucleus messenger in GPCR signaling and elucidate an epigenetic mechanism for direct GPCR signaling from cell membrane to the nucleus through signal-dependent histone modification.	Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Fudan Univ, Grad Sch, Pharmacol Res Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Ma, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	lanma@fudan.edu.cn	Zhang, Xiaoqing/O-3424-2017; Qu, Bin/AAK-2260-2021; Ma, Lan/B-9295-2009; Qu, Bin/M-9049-2017	Zhang, Xiaoqing/0000-0002-7405-1893; Qu, Bin/0000-0002-9382-3203; Ma, Lan/0000-0001-9034-5472; Fan, Fengjuan/0000-0001-8727-5258				Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; CURRAN T, 1985, CANCER SURV, V4, P655; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Eisinger DA, 2004, J PHARMACOL EXP THER, V309, P776, DOI 10.1124/jpet.103.061788; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Garcia C, 2004, J NEUROSCI RES, V78, P338, DOI 10.1002/jnr.20254; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shahabi NA, 2003, CELL IMMUNOL, V221, P122, DOI 10.1016/S0008-8749(03)00068-6; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; Usenko T, 2003, ONCOGENE, V22, P7661, DOI 10.1038/sj.onc.1206975; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; YU VC, 1986, J BIOL CHEM, V261, P1065; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x; Zhao J, 1997, BIOCHEM BIOPH RES CO, V238, P71, DOI 10.1006/bbrc.1997.7242	45	247	261	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 2	2005	123	5					833	847		10.1016/j.cell.2005.09.011	http://dx.doi.org/10.1016/j.cell.2005.09.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	991KY	16325578	Bronze			2022-12-01	WOS:000233814100017
J	Murray, RZ; Kay, JG; Sangermani, DG; Stow, JL				Murray, RZ; Kay, JG; Sangermani, DG; Stow, JL			A role for the phagosome in cytokine secretion	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; RECYCLING ENDOSOMES; PLASMA-MEMBRANE; MACROPHAGES; PHAGOCYTOSIS; GOLGI; CELLS; EXOCYTOSIS; TRANSPORT	Membrane traffic in activated macrophages is required for two critical events in innate immunity: proinflammatory cytokine secretion and phagocytosis of pathogens. We found a joint trafficking pathway linking both actions, which may economize membrane transport and augment the immune response. Tumor necrosis factor alpha (TNF alpha) is trafficked from the Golgi to the recycling endosome (RE), where vesicle-associated membrane protein 3 mediates its delivery to the cell surface at the site of phagocytic cup formation. Fusion of the RE at the cup simultaneously allows rapid release of TNF alpha and expands the membrane for phagocytosis.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.stow@imb.uq.edu.au	Stow, Jennifer L/I-4723-2013; Murray, Rachael/J-1370-2012	Stow, Jennifer L/0000-0002-5409-9101; Murray, Rachael/0000-0002-4935-7794; Kay, Jason/0000-0001-8944-6612				Allen LAH, 2002, J LEUKOCYTE BIOL, V72, P217; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Beutler BA, 1999, J RHEUMATOL, V26, P16; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; MURRAY R, UNPUB; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Netea MG, 2004, MICROBES INFECT, V6, P985, DOI 10.1016/j.micinf.2004.05.013; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	22	237	243	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2005	310	5753					1492	1495		10.1126/science.1120225	http://dx.doi.org/10.1126/science.1120225			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16282525				2022-12-01	WOS:000233756500044
J	Nimmerjahn, F; Ravetch, JV				Nimmerjahn, F; Ravetch, JV			Divergent immunoglobulin G subclass activity through selective Fc receptor binding	SCIENCE			English	Article							IGG-FC; FUCOSE	Subclasses of immunoglobulin G (IgG) display substantial differences in their ability to mediate effector responses, contributing to variable activity of antibodies against microbes and tumors. We demonstrate that the mechanism underlying this long-standing observation of subclass dominance in function is provided by the differential affinities of IgG subclasses for specific activating IgG Fc receptors compared with their affinities for the inhibitory IgG Fc receptor. The significant differences in the ratios of activating-to-inhibitory receptor binding predicted the in vivo activity. We suggest that these highly predictable functions assigned by Fc binding will be an important consideration in the design of therapeutic antibodies and vaccines.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Nimmerjahn, Falk/J-4986-2013; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; JANEWAY CA, 2001, IMMUNOBIOLOGY, V5, P20601; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; STAVNEZER J, 1995, J IMMUNOL, V155, P1647; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375	24	749	851	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2005	310	5753					1510	1512		10.1126/science.1118948	http://dx.doi.org/10.1126/science.1118948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990PU	16322460				2022-12-01	WOS:000233756500048
J	Tsukuda, T; Fleming, AB; Nickoloff, JA; Osley, MA				Tsukuda, T; Fleming, AB; Nickoloff, JA; Osley, MA			Chromatin remodelling at a DNA double-strand break site in Saccharomyces cerevisiae	NATURE			English	Article							IN-VIVO; DAMAGE RESPONSE; HISTONE H2A; REPAIR; COMPLEX; PROTEINS; PHOSPHORYLATION; RECOMBINATION; RPA; RECRUITMENT	The repair of DNA double-strand breaks (DSBs) is crucial for maintaining genome stability. Eukaryotic cells repair DSBs by both non-homologous end joining and homologous recombination. How chromatin structure is altered in response to DSBs and how such alterations influence DSB repair processes are important issues. In vertebrates, phosphorylation of the histone variant H2A.X occurs rapidly after DSB formation(1), spreads over mega-base chromatin domains, and is required for stable accumulation of repair proteins at damage foci(2). In Saccharomyces cerevisiae, phosphorylation of the two principal H2A species is also signalled by DSB formation, which spreads similar to 40 kb in either direction from the DSB3. Here we show that near a DSB phosphorylation of H2A is followed by loss of histones H2B and H3 and increased sensitivity of chromatin to digestion by micrococcal nuclease; however, phosphorylation of H2A and nucleosome loss occur independently. The DNA damage sensor MRX4 is required for histone loss, which also depends on INO80, a nucleosome remodelling complex(5). The repair protein Rad51 (ref. 6) shows delayed recruitment to DSBs in the absence of histone loss, suggesting that MRX-dependent nucleosome remodelling regulates the accessibility of factors directly involved in DNA repair by homologous recombination. Thus, MRX may regulate two pathways of chromatin changes: nucleosome displacement for efficient recruitment of homologous recombination proteins; and phosphorylation of H2A, which modulates checkpoint responses to DNA damage(2).	Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico	Osley, MA (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, 915 Camino de Salud, Albuquerque, NM 87131 USA.	mosley@salud.unm.edu		Fleming, Alastair/0000-0003-0083-3240	NIGMS NIH HHS [R01 GM040118] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040118] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARKADY C, 2003, NATURE CELL BIOL, V5, P675; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; LICHTEN W, 1988, DATA ERROR ANAL INTR; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; PALTER KB, 1979, CELL, V18, P451, DOI 10.1016/0092-8674(79)90064-3; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392	30	340	346	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					379	383		10.1038/nature04148	http://dx.doi.org/10.1038/nature04148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292314	Green Accepted			2022-12-01	WOS:000233300200053
J	Holz, MK; Ballif, BA; Gygi, SP; Blenis, J				Holz, MK; Ballif, BA; Gygi, SP; Blenis, J			mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events	CELL			English	Article							MESSENGER-RNA TRANSLATION; INITIATION-FACTOR 4B; CELL-GROWTH; EUKARYOTIC TRANSLATION; MAMMALIAN TARGET; HELICASE ACTIVITY; TOS MOTIF; IN-VITRO; RAPAMYCIN; KINASE	In response to nutrients, energy sufficiency, hormones, and mitogenic agents, S6K1 phosphorylates several targets linked to translation. However, the molecular mechanisms whereby S6K1 is activated, encounters substrate, and contributes to translation initiation are poorly understood. We show that mTOR and S6K1 maneuver on and off the eukaryotic initiation factor 3 (eIF3) translation initiation complex in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/raptor binding to the eIF3 complex and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation, activation, and subsequent phosphorylation of its translational targets, including eIF4B, which is then recruited into the complex in a phosphorylation-dependent manner. Thus, the eIF3 preinitiation complex acts as a scaffold to coordinate a dynamic sequence of events in response to stimuli that promote efficient protein synthesis.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jblenis@hms.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA046595, R37CA046595] Funding Source: NIH RePORTER; NCI NIH HHS [CA046595] Funding Source: Medline; NHGRI NIH HHS [HG00041] Funding Source: Medline; NIGMS NIH HHS [GM051405] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; LAWSON TG, 1988, J BIOL CHEM, V263, P7266; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Martin KA, 2001, J BIOL CHEM, V276, P7892, DOI 10.1074/jbc.M009972200; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Methot N, 1996, RNA, V2, P38; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370	38	848	880	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					569	580		10.1016/j.cell.2005.10.024	http://dx.doi.org/10.1016/j.cell.2005.10.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16286006	Bronze			2022-12-01	WOS:000233497400007
J	Westermann, S; Wang, HW; Avila-Sakar, A; Drubin, DG; Nogales, E; Barnes, G				Westermann, S; Wang, HW; Avila-Sakar, A; Drubin, DG; Nogales, E; Barnes, G			The Dam1 kinetochore ring complex moves processively on depolymerizing microtubule ends	NATURE			English	Article							BUDDING YEAST KINETOCHORE; SPINDLE MICROTUBULES; FORCE PRODUCTION; FISSION YEAST; DASH COMPLEX; ATTACHMENT; DYNAMICS; ARCHITECTURE; MICROSCOPY; INTERFACE	Chromosomes interact through their kinetochores with microtubule plus ends and they are segregated to the spindle poles as the kinetochore microtubules shorten during anaphase A of mitosis. The molecular natures and identities of coupling proteins that allow microtubule depolymerization to pull chromosomes to poles during anaphase have long remained elusive(1). In budding yeast, the ten-protein Dam1 complex is a critical microtubule-binding component of the kinetochore(2) that oligomerizes into a 50-nm ring around a microtubule in vitro(3,4). Here we show, with the use of a real-time, two-colour fluorescence microscopy assay, that the ring complex moves processively for several micrometres at the ends of depolymerizing microtubules without detaching from the lattice. Electron microscopic analysis of 'end-on views' revealed a 16-fold symmetry of the kinetochore rings. This out-of-register arrangement with respect to the 13-fold microtubule symmetry is consistent with a sliding mechanism based on an electrostatically coupled ring-microtubule interface. The Dam1 ring complex is a molecular device that can translate the force generated by microtubule depolymerization into movement along the lattice to facilitate chromosome segregation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Barnes, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gbarnes@socrates.berkeley.edu		Westermann, Stefan/0000-0001-6921-9113				Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Mahadevan L, 2005, NATURE, V435, P895, DOI 10.1038/435895a; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	30	216	236	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					565	569		10.1038/nature04409	http://dx.doi.org/10.1038/nature04409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16415853				2022-12-01	WOS:000236176100063
J	Behrensmeyer, AK				Behrensmeyer, AK			Climate change and human evolution	SCIENCE			English	Editorial Material							AFRICAN CLIMATE; HOMININ EVOLUTION; VEGETATION; RECORDS; ORIGIN; HOMO		Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Behrensmeyer, AK (corresponding author), Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA.	behrensa@si.edu						Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe R, 2002, J HUM EVOL, V42, P475, DOI 10.1006/jhev.2001.0535; Bonnefille R, 2004, P NATL ACAD SCI USA, V101, P12125, DOI 10.1073/pnas.0401709101; CAMPISANO CJ, 2004, PALEOANTHROPOLOGY, pA34; Cohen AS, 2000, J PALEOLIMNOL, V24, P231, DOI 10.1023/A:1008158902422; deMenocal PB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P262; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; DEMENOCAL PB, 1999, HOMINID EVOLUTION CL, V1, P23; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Feibel CS, 1999, HUMAN EVOLUT SER, P276; FEIBEL CS, 1997, GSA TODAY, V7, P1; HILL A, 2003, GEOLOGICAL SOC AM AN, V736; LAPORTE LF, 1983, S AFR J SCI, V79, P96; LEPRE CJ, 2005, PALEOANTHROPOLOGY, pA38; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; *NAT RES COUNC COM, 2005, GEOL REC EC DYN UND; Owen R.B, 2002, SEPM SPECIAL PUBLICA, V73, P233, DOI DOI 10.2110/pec.02.73.0233; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; POTTS R, IN PRESS HOMINID ENV; Potts R, 1996, HUMANITYS DESCENT CO; QUINN RL, 2004, EOS T AGU S, V85; SERLING TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241; Shackleton NJ, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P242; STANLEY SM, 1992, PALEOBIOLOGY, V18, P237, DOI 10.1017/S0094837300010836; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Trauth MH, 2003, EARTH PLANET SC LETT, V206, P297, DOI 10.1016/S0012-821X(02)01105-6; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	32	118	124	15	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					476	478		10.1126/science.1116051	http://dx.doi.org/10.1126/science.1116051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	008WM	16439650				2022-12-01	WOS:000235071400032
J	Biek, R; Drummond, AJ; Poss, M				Biek, R; Drummond, AJ; Poss, M			A virus reveals population structure and recent demographic history of its carnivore host	SCIENCE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; HUMAN MIGRATIONS; DIVERGENCE; EPIDEMIC; ANCESTOR; STRAINS; COUGARS	Directly transmitted parasites often provide substantial information about the temporal and spatial characteristics of host-to-host contact. Here, we demonstrate that a fast-evolving virus (feline immunodeficiency virus, FIV) can reveal details of the contemporary population structure and recent demographic history of its natural wildlife host (Puma concolor) that were not apparent from host genetic data and would be impossible to obtain by other means. We suggest that rapidly evolving pathogens may provide a complementary tool for studying population dynamics of their hosts in "shallow" time.	Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Auckland	Biek, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	rbiek@emory.edu	Drummond, Alexei J/A-3209-2010; Biek, Roman/AAT-8109-2020	Drummond, Alexei J/0000-0003-4454-2576; Biek, Roman/0000-0003-3471-5357				Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Biek R, 2003, J VIROL, V77, P9578, DOI 10.1128/JVI.77.17.9578-9589.2003; BIEK R, 2004, THESIS U MONTANA; Carpenter MA, 1996, J VIROL, V70, P6682, DOI 10.1128/JVI.70.10.6682-6693.1996; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, 2003, BEAST VERSION 1 2; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; JALKOTZY MG, 1992, MANAGEMENT PLAN COUG; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; LANGLEY RJ, 1994, VIROLOGY, V202, P853, DOI 10.1006/viro.1994.1407; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lukashov VV, 2002, J MOL EVOL, V54, P680, DOI 10.1007/s00239-001-0070-5; Martins EP, 2004, COMPUTER PROGRAMS ST; Nowak R.M., 1976, COUGAR US CANADA; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Riley, 1998, THESIS CORNELL U; Sinclair EA, 2001, ANIM CONSERV, V4, P257, DOI 10.1017/S1367943001001305; Sugimoto C, 1997, P NATL ACAD SCI USA, V94, P9191, DOI 10.1073/pnas.94.17.9191; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Whiteman NK, 2005, ANIM CONSERV, V8, P175, DOI 10.1017/S1367943005001915; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; ONLINE MAP CREATOR	25	121	123	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					538	541		10.1126/science.1121360	http://dx.doi.org/10.1126/science.1121360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439664				2022-12-01	WOS:000235071400050
J	Dyachok, O; Isakov, Y; Sagetorp, J; Tengholm, A				Dyachok, O; Isakov, Y; Sagetorp, J; Tengholm, A			Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells	NATURE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE-A; PANCREATIC-ISLETS; NUCLEOTIDE PHOSPHODIESTERASES; ADENYLYL CYCLASES; CYTOPLASMIC CA2+; CAMP; GLUCOSE; EXOCYTOSIS; RECEPTORS	Cyclic AMP is a ubiquitous second messenger that transduces signals from a variety of cell surface receptors to regulate diverse cellular functions, including secretion, metabolism and gene transcription. In pancreatic beta-cells, cAMP potentiates Ca2+-dependent exocytosis(1-3) and mediates the stimulation of insulin release exerted by the hormones glucagon and glucagon-like peptide-1 (GLP-1) (refs 4-6). Whereas Ca2+ signals have been extensively characterized and shown to involve oscillations important for the temporal control of insulin secretion(4,7,8), the kinetics of receptor-triggered cAMP signals is unknown. Here we introduce a new ratiometric evanescent-wave-microscopy approach to measure cAMP concentration beneath the plasma membrane, and show that insulin-secreting beta-cells respond to glucagon and GLP-1 with marked cAMP oscillations. Simultaneous measurements of intracellular Ca2+ concentration revealed that the two messengers are interlinked and reinforce each other. Moreover, cAMP oscillations are capable of inducing rapid on-off Ca2+ responses, but only sustained elevation of cAMP concentration induces nuclear translocation of the catalytic subunit of the cAMP-dependent protein kinase. Our results establish a new signalling mode for cAMP and indicate that temporal encoding of cAMP signals might constitute a basis for differential regulation of downstream cellular targets.	Uppsala Univ, BMC, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; Kiev T Shevchenko Natl Univ, Dept Biophys, UA-01033 Kiev, Ukraine	Uppsala University; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev	Tengholm, A (corresponding author), Uppsala Univ, BMC, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.	anders.tengholm@medcellbiol.uu.se	Dyachok, Oleg/B-5935-2017	Dyachok, Oleg/0000-0003-1825-9793				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; GILON P, 1993, J BIOL CHEM, V268, P22265; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Ma XS, 2005, MOL ENDOCRINOL, V19, P198, DOI 10.1210/me.2004-0059; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Porksen N, 1998, DIABETES, V47, P45, DOI 10.2337/diabetes.47.1.45; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; Ritzel R, 2001, DIABETES, V50, P776, DOI 10.2337/diabetes.50.4.776; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; [No title captured]	29	202	207	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					349	352		10.1038/nature04410	http://dx.doi.org/10.1038/nature04410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421574				2022-12-01	WOS:000234682100048
J	Nusbaum, C; Mikkelsen, TS; Zody, MC; Asakawa, S; Taudien, S; Garber, M; Kodira, CD; Schueler, MG; Shimizu, A; Whittaker, CA; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Yang, XP; Allen, NR; Anderson, S; Asakawa, T; Blechschmidt, K; Bloom, T; Borowsky, ML; Butler, J; Cook, A; Corum, B; DeArellano, K; DeCaprio, D; Dooley, KT; Dorris, L; Engels, R; Glockner, G; Hafez, N; Hagopian, DS; Hall, JL; Ishikawa, SK; Jaffe, DB; Kamat, A; Kudoh, J; Lehmann, R; Lokitsang, T; Macdonald, P; Major, JE; Matthews, CD; Mauceli, E; Menzel, U; Mihalev, AH; Minoshima, S; Murayama, Y; Naylor, JW; Nicol, R; Nguyen, C; O'Leary, SB; O'Neill, K; Parker, SCJ; Polley, A; Raymond, CK; Reichwald, K; Rodriguez, J; Sasaki, T; Schilhabel, M; Siddiqui, R; Smith, CL; Sneddon, TP; Talamas, JA; Tenzin, P; Topham, K; Venkataraman, V; Wen, GP; Yamazaki, S; Young, SK; Zeng, QD; Zimmer, AR; Rosenthal, A; Birren, BW; Platzer, M; Shimizu, N; Lander, ES				Nusbaum, C; Mikkelsen, TS; Zody, MC; Asakawa, S; Taudien, S; Garber, M; Kodira, CD; Schueler, MG; Shimizu, A; Whittaker, CA; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Yang, XP; Allen, NR; Anderson, S; Asakawa, T; Blechschmidt, K; Bloom, T; Borowsky, ML; Butler, J; Cook, A; Corum, B; DeArellano, K; DeCaprio, D; Dooley, KT; Dorris, L; Engels, R; Glockner, G; Hafez, N; Hagopian, DS; Hall, JL; Ishikawa, SK; Jaffe, DB; Kamat, A; Kudoh, J; Lehmann, R; Lokitsang, T; Macdonald, P; Major, JE; Matthews, CD; Mauceli, E; Menzel, U; Mihalev, AH; Minoshima, S; Murayama, Y; Naylor, JW; Nicol, R; Nguyen, C; O'Leary, SB; O'Neill, K; Parker, SCJ; Polley, A; Raymond, CK; Reichwald, K; Rodriguez, J; Sasaki, T; Schilhabel, M; Siddiqui, R; Smith, CL; Sneddon, TP; Talamas, JA; Tenzin, P; Topham, K; Venkataraman, V; Wen, GP; Yamazaki, S; Young, SK; Zeng, QD; Zimmer, AR; Rosenthal, A; Birren, BW; Platzer, M; Shimizu, N; Lander, ES			DNA sequence and analysis of human chromosome 8	NATURE			English	Article							GENOME SEQUENCE; MICROCEPHALIN; ANNOTATION; DEFENSINS; MUTATION; HISTORY; MAP	The International Human Genome Sequencing Consortium (IHGSC) recently completed a sequence of the human genome(1). As part of this project, we have focused on chromosome 8. Although some chromosomes exhibit extreme characteristics in terms of length, gene content, repeat content and fraction segmentally duplicated, chromosome 8 is distinctly typical in character, being very close to the genome median in each of these aspects. This work describes a finished sequence and gene catalogue for the chromosome, which represents just over 5% of the euchromatic human genome. A unique feature of the chromosome is a vast region of similar to 15 megabases on distal 8p that appears to have a strikingly high mutation rate, which has accelerated in the hominids relative to other sequenced mammals. This fast-evolving region contains a number of genes related to innate immunity and the nervous system, including loci that appear to be under positive selection(2)-these include the major defensin (DEF) gene cluster(3,4) and MCPH1(5,6), a gene that may have contributed to the evolution of expanded brain size in the great apes. The data from chromosome 8 should allow a better understanding of both normal and disease biology and genome evolution.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; Inst Mol Biotechnol, D-07745 Jena, Germany; NHGRI, NIH, Bethesda, MD 20982 USA; UCL, Dept Biol, Galton Lab, HGNC, London NW1 2HE, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Keio University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of London; University College London	Nusbaum, C (corresponding author), MIT, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	chad@broad.mit.edu; shimizu@dmb.med.keio.ac.jp	Cuomo, Christina/L-2222-2019; Sasaki, Takashi/AAD-1461-2019; Parker, Stephen/ABF-1063-2021; Zeng, Qiandong/AAF-3305-2019; Mikkelsen, Tarjei S/A-1306-2007; Glöckner, Gernot/A-7800-2010; Rodriguez, Joseph/I-9277-2014	Cuomo, Christina/0000-0002-5778-960X; Mikkelsen, Tarjei S/0000-0002-8133-3135; Glöckner, Gernot/0000-0002-9061-1061; Engels, Reinhard/0000-0003-0921-0736; Rodriguez, Joseph/0000-0002-6017-1376; Nicol, Robert/0000-0003-1932-1392; DeCaprio, Dave/0000-0001-8931-9461; Sneddon, Tam Paterson/0000-0003-1137-8992; Sasaki, Takashi/0000-0002-6275-046X; Whittaker, Charles/0000-0002-2400-0094	MRC [G0000107] Funding Source: UKRI; Medical Research Council [G0000107] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; GE Y, 1992, GENOMICS, V13, P585, DOI 10.1016/0888-7543(92)90128-F; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mars WM, 1995, J BIOL CHEM, V270, P30371, DOI 10.1074/jbc.270.51.30371; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Maxwell AI, 2003, MOL IMMUNOL, V40, P413, DOI 10.1016/S0161-5890(03)00160-3; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Shimokawa O, 2004, AM J MED GENET A, V128A, P133, DOI 10.1002/ajmg.a.30063; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wyckoff GJ, 2005, TRENDS GENET, V21, P381, DOI 10.1016/j.tig.2005.05.005; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56	32	84	503	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					331	335		10.1038/nature04406	http://dx.doi.org/10.1038/nature04406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421571	Bronze			2022-12-01	WOS:000234682100044
J	Wei, CL; Wu, Q; Vega, VB; Chiu, KP; Ng, P; Zhang, T; Shahab, A; Yong, HC; Fu, YT; Weng, ZP; Liu, JJ; Zhao, XD; Chew, JL; Lee, YL; Kuznetsov, VA; Sung, WK; Miller, LD; Lim, B; Liu, ET; Yu, Q; Ng, HH; Ruan, YJ				Wei, CL; Wu, Q; Vega, VB; Chiu, KP; Ng, P; Zhang, T; Shahab, A; Yong, HC; Fu, YT; Weng, ZP; Liu, JJ; Zhao, XD; Chew, JL; Lee, YL; Kuznetsov, VA; Sung, WK; Miller, LD; Lim, B; Liu, ET; Yu, Q; Ng, HH; Ruan, YJ			A global map of p53 transcription-factor binding sites in the human genome	CELL			English	Article							CHROMATIN IMMUNOPRECIPITATION; TARGET GENES; IONIZING-RADIATION; ESTROGEN-RECEPTOR; EXPRESSION; IDENTIFICATION; SIGNATURE; APOPTOSIS; SURVIVAL; PROGRAM	The ability to derive a whole-genome map of transcription-factor binding sites (TFBS) is crucial for elucidating gene regulatory networks. Herein, we describe a robust approach that couples chromatin immunoprecipitation (ChIP) with the paired-end ditag (PET) sequencing strategy for unbiased and precise global localization of TFBS. We have applied this strategy to map p53 targets in the human genome. From a saturated sampling of over half a million PET sequences, we characterized 65,572 unique p53 ChIP DNA fragments and established overlapping PET clusters as a readout to define p53 binding loci with remarkable specificity. Based on this information, we refined the consensus p53 binding motif, identified at least 542 binding loci with high confidence, discovered 98 previously unidentified p53 target genes that were implicated in novel aspects of p53 functions, and showed their clinical relevance to p53-dependent tumorigenesis in primary cancer samples.	Genome Inst Singapore, Singapore 138672, Singapore; Bioinformat Inst, Singapore 138671, Singapore; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Harvard Univ, Sch Med, Inst Med, Boston, MA 02115 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Boston University; Boston University; Harvard University; Harvard Medical School; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg; ruanyj@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Miller, Lance/A-5633-2009; Liu, Jianjun/AAK-4989-2020; Chiu, Kuo-Ping/AAG-8855-2020; Ng, Huck Hui/A-1135-2009	Liu, Jianjun/0000-0002-3255-3019; Chiu, Kuo-Ping/0000-0001-9144-0674; Miller, Lance/0000-0003-3799-2528; Yu, Qiang/0000-0003-2132-8278; Sung, Wing-Kin/0000-0001-7806-7086; Wu, Qiang/0000-0003-2049-1639	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000352] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01HG00352-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JG, 2005, P NATL ACAD SCI USA, V102, P4813, DOI 10.1073/pnas.0407069102; Coates PJ, 2003, J PATHOL, V201, P377, DOI 10.1002/path.1456; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crosby ME, 2004, J ENVIRON PATHOL TOX, V23, P67, DOI 10.1615/JEnvPathToxOncol.v23.i1.70; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P189, DOI 10.1093/nar/gkh169; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hug BA, 2004, J BIOL CHEM, V279, P825, DOI 10.1074/jbc.M309524200; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kuznetsov V, 2005, SAGE: CURRENT TECHNOLOGIES AND APPLICATIONS, P139; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TISTY TD, 1998, CURR OPIN CELL BIOL, V10, P647; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhao RB, 2000, GENE DEV, V14, P981	49	897	948	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 13	2006	124	1					207	219		10.1016/j.cell.2005.10.043	http://dx.doi.org/10.1016/j.cell.2005.10.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007LD	16413492	Bronze			2022-12-01	WOS:000234969600020
J	Murabito, JM; Pencina, MJ; Nam, BH; D'Agostino, RB; Wang, TJ; Lloyd-Jones, D; Wilson, PWF; O'Donnell, CJ				Murabito, JM; Pencina, MJ; Nam, BH; D'Agostino, RB; Wang, TJ; Lloyd-Jones, D; Wilson, PWF; O'Donnell, CJ			Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; FAMILY-HISTORY; MYOCARDIAL-INFARCTION; DEATH; PREVALENCE	Context While parental cardiovascular disease (CVD) doubles the risk for CVD in offspring, the extent of increased risk associated with sibling CVD is unclear. Objective To determine, using validated events, whether sibling CVD predicts outcome in middle-aged adults independent of other risk factors. Design, Setting, and Participants The Framingham Offspring Study, an inception cohort of the Framingham Heart Study, a prospective population-based cohort study initiated in 1948 with the offspring cohort initiated in 1971. Participants (n = 2475) were members of the offspring cohort aged 30 years or older, free of CVD, and with at least I sibling in the study; all were followed up for 8 years. Main Outcome Measures Association of sibling CVD with 8-year personal risk for CVD using pooled logistic regression. A secondary analysis restricted to offspring with both parents in the study assessed the joint impact of parental and sibling CVD occurrence. Results Among 973 person-examinations in the sibling CVD group (mean age, 57 years) and 4506 person-examinations in the no sibling CVD group (mean age, 47 years), 329 CVD events occurred during follow-up. Baseline risk factors were more prevalent in the sibling CVD group compared with the no sibling CVD group. Sibling CVD was associated with a significantly increased risk for incident CVD (age- and sex-adjusted odds ratio [OR], 1.55; 95% confidence interval [CI], 1.19-2.03). Adjustment for risk factors did not substantially attenuate the risk (adjusted OR, 1.45; 95% Cl, 1.10-1.91). In the analysis restricted to persons with both parents in the study, in models adjusting for both sibling and parental CVD, the multivariable-adjusted OR for sibling CVD (1.99; 95% Cl, 1.32-3.00) exceeded that for parental CVD (1.45; 95% Cl, 1.02-2.05). Conclusion Using validated events, sibling CVD conferred increased risk of future CVD events above and beyond established risk factors and parental CVD in middle-aged adults.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA USA; Boston Univ, Stat & Consulting Unit, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA; Northwestern Univ, Feinberg Sch Med, Bluhm Cardiovasc Inst, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; Med Univ S Carolina, Dept Endocrinol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Diabet, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med Genet, Charleston, SC 29425 USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Murabito, JM (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	murabito@bu.edu	Wilson, Peter W.F./J-2455-2016; Lloyd-Jones, Donald M/C-5899-2009	Lloyd-Jones, Donald/0000-0003-0847-6110; Murabito, Joanne/0000-0002-0192-7516; Pencina, Michael/0000-0001-5798-8855	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott RD, 1987, FRAMINGHAM STUDY EPI; Allen JK, 1996, ARCH INTERN MED, V156, P1654, DOI 10.1001/archinte.156.15.1654; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; BECKER DM, 1988, J AM COLL CARDIOL, V12, P1273, DOI 10.1016/0735-1097(88)92611-3; Becker DM, 1998, AM J CARDIOL, V82, P1046, DOI 10.1016/S0002-9149(98)00553-0; Bertuzzi M, 2003, PREV MED, V37, P183, DOI 10.1016/S0091-7435(03)00094-X; Brenn T, 1998, J Cardiovasc Risk, V5, P325, DOI 10.1097/00043798-199810000-00007; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1044; Ciruzzi M, 1997, AM J CARDIOL, V80, P122, DOI 10.1016/S0002-9149(97)00304-4; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KHOURY MJ, 1995, EPIDEMIOLOGY, V6, P511, DOI 10.1097/00001648-199509000-00009; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; Pankow JS, 2004, HUM HERED, V57, P80, DOI 10.1159/000077545; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	27	167	171	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 28	2005	294	24					3117	3123		10.1001/jama.294.24.3117	http://dx.doi.org/10.1001/jama.294.24.3117			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997UL	16380592	Bronze			2022-12-01	WOS:000234274200028
J	Blair, NA; Yue, SK; Singh, R; Bernhardt, JM				Blair, NA; Yue, SK; Singh, R; Bernhardt, JM			Depictions of substance use in reality television: a content analysis of The Osbournes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOBACCO USE; MOVIES; ALCOHOL	Objective To determine the source and slant of messages in a reality television programme that may promote or inhibit health related or risky behaviours. Design Coding visual and verbal references to alcohol, tobacco, and other drug (ATOD) use in The Osbournes. Review methods Three reviewers watched all 10 episodes of the first season and coded incidents of substance use according to die substance used (alcohol, tobacco, or drugs), the way use was portrayed (visually or verbally), the source of the message (the character in the show involved in the incident), and the slant of the incident (endorsement or rejection). Main outcome measures The variation in number of messages in an average episode, the slant of messages, and message source. Results The average number of messages per episode was 9.1 (range 2-17). Most drug use messages (15, 54%) implied rejection of drugs, but most alcohol messages (30, 64%) and tobacco messages (12, 75%) implied endorsements for using these substances. Most rejections (34, 94%) were conveyed verbally, but most endorsements (36, 65%) were conveyed Visually. Messages varied in frequency and slant by source. Conclusions The reality television show analysed in this study contains numerous messages on Substance use that imply both rejection and endorsement Of use. The juxtaposition of verbal rejection messages and visual endorsement messages, and the depiction of contradictory messages about substance use from show characters, may send mixed messages to viewers about substance use.	Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA; Emory Univ, Career Master Publ Hlth Program, Atlanta, GA 30322 USA; NYU, Coll Dent, New York, NY USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; New York University; Emory University; Rollins School Public Health	Blair, NA (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA.	nblair@cdc.gov		Bernhardt, Jay/0000-0002-2045-4005				*AM LUNG ASS SACR, 2000, THUMBS THUMBS TOB US; [Anonymous], 2012, INTERACTION MEDIA CO, DOI DOI 10.4324/9780203052945; Bandura A., 1986, SOCIAL FDN THOUGHT A; Brier Noah Rubin, 2004, AM DEMOGR, V26, P14; Brown WJ, 2004, LEA COMMUN SER, P97; CAFISO J, 1982, J STUD ALCOHOL, V43, P1232, DOI 10.15288/jsa.1982.43.1232; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Dalton MA, 2002, PREV MED, V34, P516, DOI 10.1006/pmed.2002.1013; DuRant RH, 1997, AM J PUBLIC HEALTH, V87, P1131, DOI 10.2105/AJPH.87.7.1131; GERBNER G, 1997, ALCOHOL TOBACCO ILLI; KIESEWELTER J, 2002, CINCINNATI ENQU 1229; Kilbourne J., 1999, DEADLY PERSUASION WH; *NEILS MED RES, 1998, 1998 REP TEL; *NIELS MED RES, 2000, 1998 REP TEL; *OFF NAT DRUG CONT, 2000, SUBST US POP PRIM TI; Roberts D. F., 2000, HERES LOOKING YOU KI; Sargent JD, 2002, AM J PREV MED, V22, P137, DOI 10.1016/S0749-3797(01)00434-2; Sargent JD, 2001, BRIT MED J, V323, P1; SCHMUCKLER E, 2004, MEDIAWEEK, V14, pSR32; Strasburger VC, 1995, ADOLESCENTS MEDIA ME; TITLES AIR DATES GUI	21	29	29	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1517	+		10.1136/bmj.331.7531.1517	http://dx.doi.org/10.1136/bmj.331.7531.1517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	998WT	16373737	Green Published			2022-12-01	WOS:000234351300017
J	Kim, SF; Huri, DA; Snyder, SH				Kim, SF; Huri, DA; Snyder, SH			Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2	SCIENCE			English	Article							PROSTAGLANDIN PRODUCTION; INFLAMMATION; INHIBITORS; INDUCTION; CELLS	Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) are two major inflammatory mediators. Here we show that iNOS specifically binds to COX-2 and S-nitrosylates it, enhancing COX-2 catalytic activity. Selectively disrupting iNOS-COX-2 binding prevented NO-mediated activation of COX-2. This synergistic molecular interaction between two inflammatory systems may inform the development of anti-inflammatory drugs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00074, DA000266] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Appleton I, 1996, Adv Pharmacol, V35, P27, DOI 10.1016/S1054-3589(08)60274-4; BRAUGHLER JM, 1979, J BIOL CHEM, V254, P2450; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd1034; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE, pP61; KENNEDY TA, 1994, J BIOL CHEM, V269, P27357; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; MISKO TP, 1995, J NEUROIMMUNOL, V61, P195, DOI 10.1016/0165-5728(95)00091-F; Moncada S, 1999, J ROY SOC MED, V92, P164, DOI 10.1177/014107689909200402; Murad F, 1978, Adv Cyclic Nucleotide Res, V9, P145; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P366, DOI 10.1001/jama.293.3.366; TSAI AL, 1994, ARCH BIOCHEM BIOPHYS, V313, P367, DOI 10.1006/abbi.1994.1400; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102	23	411	441	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1966	1970		10.1126/science.1119407	http://dx.doi.org/10.1126/science.1119407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373578				2022-12-01	WOS:000234275400046
J	Rokas, A; Kruger, D; Carroll, SB				Rokas, A; Kruger, D; Carroll, SB			Animal evolution and the molecular signature of radiations compressed in time	SCIENCE			English	Article							MISSING DATA; LIFE; PHYLOGENY; ECDYSOZOA; GENES; FUNGI; TAXA; TREE	The phylogenetic relationships among most metazoan phyla remain uncertain. We obtained large numbers of gene sequences from metazoans, including key understudied taxa. Despite the amount of data and breadth of taxa analyzed, relationships among most metazoan phyla remained unresolved. In contrast, the same genes robustly resolved phylogenetic relationships within a major clade of Fungi of approximately the same age as the Metazoa. The differences in resolution within the two kingdoms suggest that the early history of metazoans was a radiation compressed in time, a finding that is in agreement with paleontological inferences. Furthermore, simulation analyses as well as studies of other radiations in deep time indicate that, given adequate sequence data, the lack of resolution in phylogenetic trees is a signature of closely spaced series of cladogenetic events.	Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, RM Bock Labs, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Krüger, Dirk/C-3316-2012; Rokas, Antonis/A-9775-2008	Krüger, Dirk/0000-0002-7305-5104; Rokas, Antonis/0000-0002-7248-6551				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Ane C, 2005, MOL BIOL EVOL, V22, P914, DOI 10.1093/molbev/msi076; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; BALDWIN TF, 1972, TELEVISION SOCIAL BE, V1, P290; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Clack J. A., 2012, GAINING GROUND ORIGI; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; ERWIN DH, 1991, TRENDS ECOL EVOL, V6, P131, DOI 10.1016/0169-5347(91)90092-C; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; FIALA KI, 1985, EVOLUTION, V39, P609, DOI 10.1111/j.1558-5646.1985.tb00398.x; Giribet G, 2002, MOL PHYLOGENET EVOL, V24, P345, DOI 10.1016/S1055-7903(02)00206-3; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; PHILIPPE H, 1994, DEVELOPMENT, P15; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; RAUP DM, 1983, PALEOBIOLOGY, V9, P107, DOI 10.1017/S0094837300007491; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Rowe T, 2004, ASSEMBLING THE TREE OF LIFE, P384; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Sober E, 2002, J THEOR BIOL, V218, P395, DOI 10.1006/jtbi.2002.3086; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Valentine JW, 1996, DEV BIOL, V173, P373, DOI 10.1006/dbio.1996.0033; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	45	249	259	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2005	310	5756					1933	1938		10.1126/science.1116759	http://dx.doi.org/10.1126/science.1116759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997UX	16373569				2022-12-01	WOS:000234275400036
J	Lamason, RL; Mohideen, MAPK; Mest, JR; Wong, AC; Norton, HL; Aros, MC; Jurynec, MJ; Mao, XY; Humphreville, VR; Humbert, JE; Sinha, S; Moore, JL; Jagadeeswaran, P; Zhao, W; Ning, G; Makalowska, I; McKeigue, PM; O'Donnell, D; Kittles, R; Parra, EJ; Mangini, NJ; Grunwald, DJ; Shriver, MD; Canfield, VA; Cheng, KC				Lamason, RL; Mohideen, MAPK; Mest, JR; Wong, AC; Norton, HL; Aros, MC; Jurynec, MJ; Mao, XY; Humphreville, VR; Humbert, JE; Sinha, S; Moore, JL; Jagadeeswaran, P; Zhao, W; Ning, G; Makalowska, I; McKeigue, PM; O'Donnell, D; Kittles, R; Parra, EJ; Mangini, NJ; Grunwald, DJ; Shriver, MD; Canfield, VA; Cheng, KC			SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans	SCIENCE			English	Article							HERMANSKY-PUDLAK-SYNDROME; GENE; MELANOSOMES; MUTATIONS; INDUCTION; PROTEIN; COLOR; MAP	Lighter variations of pigmentation in humans are associated with diminished number, size, and density of melanosomes, the pigmented organelles of melanocytes. Here we show that zebrafish golden mutants share these melanosomal changes and that golden encodes a putative cation exchanger slc24a5 (nckx5) that localizes to an intracellular membrane, likely the melanosome or its precursor. The human ortholog is highly similar in sequence and functional in zebrafish. The evolutionarily conserved ancestral allele of a human coding polymorphism predominates in African and East Asian populations. In contrast, the variant allele is nearly fixed in European populations, is associated with a substantial reduction in regional heterozygosity, and correlates with lighter skin pigmentation in admixed populations, suggesting a key role for the SLC24AS gene in human pigmentation.	Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Intercoll Grad Degree Program Genet, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Weis Ctr Res, Dept Genet, Danville, PA 17822 USA; Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; Indiana Univ, Sch Med NW, Dept Anat & Cell Biol, Gary, IN 46408 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Utah System of Higher Education; University of Utah; University of North Texas System; University of North Texas Denton; University College Dublin; University System of Ohio; Ohio State University; University of Toronto; University Toronto Mississauga; Indiana University System; Indiana University Northwest	Cheng, KC (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA.	kcheng@psu.edu	Makalowska, Izabela/AAF-4967-2021; Jurynec, Michael/AAH-8765-2020; Cheng, Keith/B-6506-2011; Makalowska, Izabela/AAU-2682-2021; mao, xianyun/B-4664-2014; Parra, Esteban J/A-4957-2008	Makalowska, Izabela/0000-0002-8144-5671; mao, xianyun/0000-0002-1236-4800; Shriver, Mark/0000-0003-0006-0479; Lamason, Rebecca/0000-0002-2762-7917; Cheng, Keith/0000-0002-5350-5825; parra, esteban J/0000-0002-2057-8577	NCI NIH HHS [R01 CA131956, CA73935] Funding Source: Medline; NCRR NIH HHS [RR017441] Funding Source: Medline; NEI NIH HHS [EY11308] Funding Source: Medline; NHGRI NIH HHS [HG002154] Funding Source: Medline; NHLBI NIH HHS [HL077910] Funding Source: Medline; NICHD NIH HHS [R01 HD040179, HD37572, HD40179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037572, R01HD040179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA073935] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017441] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amemiya CT, 1999, GENOMICS, V58, P211, DOI 10.1006/geno.1999.5827; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BOLOGNIA JL, 2003, DERMATOLOGY, P935; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frudakis T, 2003, GENETICS, V165, P2071; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Gregory M, 2002, BLOOD CELL MOL DIS, V28, P418, DOI 10.1006/bcmd.2002.0527; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; HEWITT AT, 1989, RETINA, P57; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; KING RA, 2001, METABOLIC MOL BASES, P5587; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen T, 2004, J INVEST DERMATOL, V122, P452, DOI 10.1046/j.0022-202X.2004.22117.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salceda R, 2000, CELL CALCIUM, V27, P223, DOI 10.1054/ceca.2000.0111; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smit NPM, 2001, PHOTOCHEM PHOTOBIOL, V74, P424, DOI 10.1562/0031-8655(2001)074<0424:MOPAIO>2.0.CO;2; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WALKER C, 1983, GENETICS, V103, P125; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200	38	717	763	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2005	310	5755					1782	1786		10.1126/science.1116238	http://dx.doi.org/10.1126/science.1116238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357253				2022-12-01	WOS:000234093600037
J	Phillips, CM; Wong, C; Bhalla, N; Carlton, PM; Weiser, P; Meneely, PM; Dernburg, AF				Phillips, CM; Wong, C; Bhalla, N; Carlton, PM; Weiser, P; Meneely, PM; Dernburg, AF			HIM-8 binds to the X chromosome pairing center and mediates chromosome-specific meiotic synapsis	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NUCLEAR REORGANIZATION; HOP1 PROTEIN; RECOMBINATION; MEIOSIS; MUTANTS; EXPANSION	The him-8 gene is essential for proper meiotic segregation of the X chromosomes in C. elegans. Here we show that loss of him-8 function causes profound X chromosome-specific defects in homolog pairing and synapsis. him-8 encodes a C2H2 zinc-finger protein that is expressed during meiosis and concentrates at a site on the X chromosome known as the meiotic pairing center (PC). A role for HIM-8 in PC function is supported by genetic interactions between PC lesions and him-8 mutations. HIM-8 bound chromosome sites associate with the nuclear envelope (NE) throughout meiotic prophase. Surprisingly, a point mutation in him8 that retains both chromosome binding and NE localization fails to stabilize pairing or promote synapsis. These observations indicate that stabilization of homolog pairing is an active process in which the tethering of chromosome sites to the NE may be necessary but is not sufficient.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Life Sci Div, Berkeley, CA 94720 USA; Haverford Coll, Dept Biol, Haverford, PA 19041 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Haverford College	Phillips, CM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	afdernburg@lbl.gov	Phillips, Carolyn/E-8305-2011; Carlton, Peter/AAD-2403-2021	Phillips, Carolyn/0000-0002-6228-6468; Carlton, Peter/0000-0002-5320-6024; Dernburg, Abby/0000-0001-8037-1079	NIGMS NIH HHS [F32 GM067408-01A1, F32 GM067408, F32 GM067408-02, GM067408, R01 GM/CA655591] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Anuradha S, 2004, J BIOL CHEM, V279, P28961, DOI 10.1074/jbc.M403727200; Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; BAKER BS, 1972, GENETICS, V71, P255; BHALLA N, 2005, IN PRESS SCIENCE, V310; BRENNER S, 1974, GENETICS, V77, P71; BROVERMAN SA, 1994, GENETICS, V136, P119; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; GOLDSTEIN P, 1982, CHROMOSOMA, V84, P585, DOI 10.1007/BF00292857; HERMAN RK, 1989, GENETICS, V121, P723; HODGKIN J, 1979, GENETICS, V91, P67; HOLLSTEN DA, 1990, OPHTHALMIC PLAST REC, V6, P1; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Lieb JD, 2000, GENETICS, V156, P1603; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; MCKIM KS, 1993, GENETICS, V134, P749; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Tomkiel JE, 2001, GENETICS, V157, P273; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; VILLENEUVE AM, 1994, GENETICS, V136, P887; ZETKA MC, 1992, GENETICS, V131, P321; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	28	194	199	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1051	1063		10.1016/j.cell.2005.09.035	http://dx.doi.org/10.1016/j.cell.2005.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360035	Bronze, Green Accepted			2022-12-01	WOS:000234177200014
J	Stark, A; Brennecke, J; Bushati, N; Russell, RB; Cohen, SM				Stark, A; Brennecke, J; Bushati, N; Russell, RB; Cohen, SM			Animal microRNAs confer robustness to gene expression and have a significant impact on 3 ' UTR evolution	CELL			English	Article							ENCODES; PROTEIN; LET-7; IDENTIFICATION; PREDICTION; PROMOTERS; REVEALS; LETHAL; SHOWS; RNAS	MicroRNAs are small noncoding RNAs that serve as posttranscriptional regulators of gene expression in higher eukaryotes. Their widespread and important role in animals is highlighted by recent estimates that 20%-30% of all genes are microRNA targets. Here, we report that a large set of genes involved in basic cellular processes avoid microRNA regulation due to short 3'UTRs that are specifically depleted of microRNA binding sites. For individual microRNAs, we find that coexpressed genes avoid microRNA sites, whereas target genes and microRNAs are preferentially expressed in neighboring tissues. This mutually exclusive expression argues that microRNAs confer accuracy to developmental gene-expression programs, thus ensuring tissue identity and supporting cell-lineage decisions.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Stark, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl.de	Russell, Robert/GWU-6389-2022; Stark, Alexander/D-1473-2012; Brennecke, Julius/C-1626-2015; Russell, Rob/AAH-9145-2019; Brennecke, Julius/T-5883-2019; Cohen, Stephen M/G-9930-2011	Russell, Robert/0000-0002-7213-1398; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; Russell, Rob/0000-0002-1905-4717; Brennecke, Julius/0000-0002-5141-0814; Cohen, Stephen M/0000-0003-2858-9163				Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; HANKE PD, 1988, MOL CELL BIOL, V8, P3591, DOI 10.1128/MCB.8.9.3591; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stivers C, 2000, MECH DEVELOP, V97, P205, DOI 10.1016/S0925-4773(00)00409-3; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	46	850	920	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1133	1146		10.1016/j.cell.2005.11.023	http://dx.doi.org/10.1016/j.cell.2005.11.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16337999	Bronze			2022-12-01	WOS:000234177200020
J	Baudouin, SV; Saunders, D; Tiangyou, W; Elson, JL; Poynter, J; Pyle, A; Keers, S; Turnbull, DM; Howell, N; Chinnery, PF				Baudouin, SV; Saunders, D; Tiangyou, W; Elson, JL; Poynter, J; Pyle, A; Keers, S; Turnbull, DM; Howell, N; Chinnery, PF			Mitochondrial DNA and survival after sepsis: a prospective study	LANCET			English	Article							SEPTIC SHOCK; DISEASE; HAPLOGROUPS; DYSFUNCTION; POLYMORPHISMS; EPIDEMIOLOGY; SEVERITY; FEVER; RISK	Background Human genome evolution has been shaped by infectious disease. Although most genetic studies have focused on the immune system, recovery after sepsis is directly related to physiological reserve that is critically dependent on mitochondrial function. We investigated whether haplogroup H, the most common type of mitochondrial DNA (mtDNA) in Europe, contributes to the subtle genetic variation in survival after sepsis. Methods In a prospective study, we included 150 individuals who were sequentially admitted to the intensive care unit in a hospital in Newcastle upon Tyne, UK. After clinical data were obtained, patients underwent mtDNA haplotyping by analysis with PCR and restriction fragment length polymorphism. As endpoints, we used death during the 6-month period or survival at 6 months. Findings Follow-up was complete for all study participants, although the haplotype of two patients could not be reliably determined. On admission to the intensive care unit, the frequency of mtDNA haplogroup H in study patients did not differ between study patients admitted with severe sepsis and 542 age-matched controls from the northeast of England. MtDNA haplogroup H was a strong independent predictor of outcome during severe sepsis, conferring a 2.12-fold (95% CI 1.02-4.43) increased chance of survival at 180 days compared with individuals without the haplogroup H. Interpretation Although haplogroup H is the most recent addition to the group of European mtDNA, paradoxically it is also the most common. increased survival after sepsis provides one explanation for this observation. MtDNA haplotyping offers a new means of risk stratification of patients with severe infections, which suggests new avenues for therapeutic intervention.	Newcastle Univ, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Univ Dept Surg & Reprod Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Migenix Corp, San Diego, CA USA	Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk		/0000-0002-3551-5624; Chinnery, Patrick/0000-0002-7065-6617; Saunders, David/0000-0003-0251-020X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; HIRAI F, 1984, EUR SURG RES, V16, P148, DOI 10.1159/000128402; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin MT, 2004, CRIT CARE MED, V32, P569, DOI 10.1097/01.CCM.0000110878.49476.42; OHTOSHI M, 1984, RES EXP MED, V184, P209, DOI 10.1007/BF01852379; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SIMONSON SG, 1994, CIRC SHOCK, V43, P34; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	25	134	139	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2118	2121		10.1016/S0140-6736(05)67890-7	http://dx.doi.org/10.1016/S0140-6736(05)67890-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360789				2022-12-01	WOS:000234146000027
J	Corrado, D; Basso, C; Thiene, G				Corrado, D; Basso, C; Thiene, G			Essay - Sudden death in young athletes	LANCET			English	Article									Univ Padua, Div Cardiol, I-35121 Padua, Italy; Univ Padua, Inst Pathol Anat, I-35121 Padua, Italy	University of Padua; University of Padua	Corrado, D (corresponding author), Univ Padua, Div Cardiol, Via Giustiniani 2, I-35121 Padua, Italy.	domenico.corrado@unipd.it		basso, cristina/0000-0002-0195-9753; CORRADO, DOMENICO/0000-0003-1487-0392				Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Thiene G, 2001, CARDIOVASC PATHOL, P326	3	74	77	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S47	S48		10.1016/S0140-6736(05)67847-6	http://dx.doi.org/10.1016/S0140-6736(05)67847-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360752				2022-12-01	WOS:000234374400030
J	Gonen, T; Cheng, YF; Sliz, P; Hiroaki, Y; Fujiyoshi, Y; Harrison, SC; Walz, T				Gonen, T; Cheng, YF; Sliz, P; Hiroaki, Y; Fujiyoshi, Y; Harrison, SC; Walz, T			Lipid-protein interactions in double-layered two-dimensional AQPO crystals	NATURE			English	Article							MAJOR INTRINSIC PROTEIN; HUMAN LENS; WATER PERMEATION; ELECTRON CRYSTALLOGRAPHY; MOLECULAR-BASIS; MEMBRANE; AQUAPORIN-0; CHANNEL; JUNCTIONS; DYNAMICS	Lens- specific aquaporin-O ( AQPO) functions as a specific water pore and forms the thin junctions between fibre cells. Here we describe a 1.9 angstrom resolution structure of junctional AQPO, determined by electron crystallography of double-layered two- dimensional crystals. Comparison of junctional and non- junctional AQPO structures shows that junction formation depends on a conformational switch in an extracellular loop, which may result from cleavage of the cytoplasmic amino and carboxy termini. In the centre of the water pathway, the closed pore in junctional AQPO retains only three water molecules, which are too widely spaced to form hydrogen bonds with each other. Packing interactions between AQPO tetramers in the crystalline array are mediated by lipid molecules, which assume preferred conformations. We were therefore able to build an atomic model for the lipid bilayer surrounding the AQPO tetramers, and we describe lipid - protein interactions.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Kyoto Univ, Dept Biophys, Kitashirakawa Sakyo Ku, Kyoto 6068502, Japan	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Kyoto University	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu	Hiroaki, Yoko/F-8463-2010; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Sliz, Piotr/0000-0002-6522-0835; Walz, Thomas/0000-0003-2606-2835; Cheng, Yifan/0000-0001-9535-0369	NEI NIH HHS [R01 EY015107] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Ball LE, 2003, INVEST OPHTH VIS SCI, V44, P4820, DOI 10.1167/iovs.02-1317; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISTLER J, 1980, FEBS LETT, V111, P73, DOI 10.1016/0014-5793(80)80764-2; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Okamura T, 2003, GENOMICS, V81, P361, DOI 10.1016/S0888-7543(03)00029-6; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; ROY D, 1979, EXP EYE RES, V28, P353, DOI 10.1016/0014-4835(79)90097-6; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schey KL, 2000, INVEST OPHTH VIS SCI, V41, P175; Shiels A, 2000, FASEB J, V14, P2207, DOI 10.1096/fj.99-1071com; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; TAKEMOTO L, 1986, INVEST OPHTH VIS SCI, V27, P443; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Wiener MC, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P97; ZAMPIGHI G, 1982, J CELL BIOL, V93, P175, DOI 10.1083/jcb.93.1.175; Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1	42	500	517	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					633	638		10.1038/nature04321	http://dx.doi.org/10.1038/nature04321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319884	Green Accepted, Green Submitted			2022-12-01	WOS:000233593100042
J	Spiegel, SJ; Yassi, A; Spiegel, JM; Veiga, MM				Spiegel, SJ; Yassi, A; Spiegel, JM; Veiga, MM			Reducing mercury and responding to the global gold rush	LANCET			English	Editorial Material									Univ British Columbia, Dept Min Engn, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Inst Hlth Promot Res, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Spiegel, SJ (corresponding author), Univ British Columbia, Dept Min Engn, Vancouver, BC V6T 1Z4, Canada.	samspiegel@gmail.com		Spiegel, Samuel/0000-0003-2163-3512				Attaran A, 2000, NAT MED, V6, P729, DOI 10.1038/77438; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; *EEB, WORLD URG NEEDS EUR; International Labour Organisation, 1999, SOC LAB ISS SMALL SC; Labonte R, 2003, BRIT MED J, V326, P722, DOI 10.1136/bmj.326.7392.722; SPIEGEL SJ, 2005, ECOHEALTH       1019, DOI DOI 10.1007/S10393-005-8389-9; *UN ENV PROGR, STOCKH CONV ENT FORC; *UNIDO PIL PROJ RE, 2005, REP UNIDO BLACKSM I; Veiga M, 2004, REPORT GLOBAL MERCUR; Veiga M.M., 1997, INTRO NEW TECHNOLOGI, P94; VEIGA MM, IN PRESS J CLEANER P; WHO, 1991, ENV HLTH CRIT, V118	12	37	40	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2005	366	9503					2070	2072		10.1016/S0140-6736(05)67868-3	http://dx.doi.org/10.1016/S0140-6736(05)67868-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996AE	16360774				2022-12-01	WOS:000234146000007
J	Robinson, EJH; Jackson, DE; Holcombe, M; Ratnieks, FLW				Robinson, EJH; Jackson, DE; Holcombe, M; Ratnieks, FLW			Insect communication - 'No entry' signal in ant foraging	NATURE			English	Editorial Material									Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Sheffield; University of Sheffield	Robinson, EJH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	e.robinson@dcs.sheffield.ac.uk	Robinson, Elva J H/AAC-9785-2019	Robinson, Elva/0000-0003-4914-9327				BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Britton N., 1998, Journal of Biological Systems, V6, P315, DOI 10.1142/S0218339098000212; Camazine S., 2001, SELF ORG BIOL SYSTEM; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; Stickland TR, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P83; SUDD J. H., 1957, BRIT JOUR ANIMAL BEHAVIOUR, V5, P104, DOI 10.1016/S0950-5601(57)80005-7; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224	8	113	114	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2005	438	7067					442	442		10.1038/438442a	http://dx.doi.org/10.1038/438442a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306981	Bronze			2022-12-01	WOS:000233458200035
J	Kalliala, I; Anttila, A; Pukkala, E; Nieminen, P				Kalliala, I; Anttila, A; Pukkala, E; Nieminen, P			Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HISTORIES; WOMEN	Objective To study the long term risk of cervical and other cancers after treatment for cervical intraepithelial neoplasia. Design Retrospective Cohort study. Setting University Hospital, Helsinki, Finland. Participants 7564 women treated for cervical intraepithelial neoplasia during 1974 and 2001 and followed tip through the Finnish cancer registry until 2003. Main outcome measures Standardised incidence ratio for cervical cancer and other cancers. Results During follow-up 22 cases of invasive cervical cancer occurred in women treated for cervical intraepithelial neoplasia (standardised incidence ratio 2.8, 95% confidence interval 1.7 to 4.2). The highest risk was during the second decade (10 cases observed: 3.1, 1.5 to 5.7). The standardised incidence ratio for cervical intraepithelial cancer type 1 was 3.1 (1.4 to 6.2) and for type 2 was 3.7 (0.9 to 10.7). Conclusions The risk of cervical cancer in the first 20 years after treatment for cervical intraepithelial neoplasia is higher than in the average population. The risk of smoking related cancers is also increased.	Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, FIN-00029 Helsinki, Finland; Finnish Canc Registry, Mass Screening Registry, FIN-00170 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Finnish Cancer Registry	Kalliala, I (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Box 140, FIN-00029 Helsinki, Finland.	ilkka.kalliala@helsinki.fi	Kalliala, Ilkka/ABC-9253-2021; Nieminen, Pekka/W-8570-2019; Kalliala, Ilkka/O-6346-2014	Kalliala, Ilkka/0000-0002-7664-0587; Kalliala, Ilkka/0000-0002-7664-0587				Andersson-Ellstrom A, 2000, ACTA OBSTET GYN SCAN, V79, P221, DOI 10.1034/j.1600-0412.2000.079003221.x; ANTTILA A, 2000, EVALUATING MONITORIN; Baldauf JJ, 1997, ACTA CYTOL, V41, P1431, DOI 10.1159/000332855; Gornall RJ, 2000, INT J GYNECOL CANCER, V10, P198, DOI 10.1046/j.1525-1438.2000.010003198.x; HAKAMA M, 1976, AM J EPIDEMIOL, V103, P512, DOI 10.1093/oxfordjournals.aje.a112253; International Agency for Research on Cancer 'Cervix Cancer Screening, 2005, IARC HDB CANC PREV, V10, P302; Martin-Hirsch P, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001318, DOI 10.1002/14651858.CD001318]; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430	10	103	106	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 19	2005	331	7526					1183	1185		10.1136/bmj.38663.459039.7C	http://dx.doi.org/10.1136/bmj.38663.459039.7C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988DG	16293840	Green Published, Bronze			2022-12-01	WOS:000233571000022
J	Prasad, V; Stromberg, CAE; Alimohammadian, H; Sahni, A				Prasad, V; Stromberg, CAE; Alimohammadian, H; Sahni, A			Dinosaur coprolites and the early evolution of grasses and grazers	SCIENCE			English	Article							LAMETA FORMATION; INDIA; AGE; COEVOLUTION; ORIGIN	Silicified plant tissues (phytoliths) preserved in Late Cretaceous coprolites from India show that at least five taxa from extant grass (Poaceae) subclades were present on the Indian subcontinent during the latest Cretaceous. This taxonomic diversity suggests that crown-group Poaceae had diversified and spread in Gondwana before India became geographically isolated. Other phytoliths extracted from the coprolites (from dicotyledons, conifers, and palms) suggest that the suspected dung producers (titanosaur sauropods) fed indiscriminately on a wide range of plants. These data also make plausible the hypothesis that gondwanatherian mammals with hypsodont cheek teeth were grazers.	Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden; Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India; Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India	Swedish Museum of Natural History; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Panjab University	Stromberg, CAE (corresponding author), Swedish Museum Nat Hist, Dept Palaeobot & Palaeozool, SE-10405 Stockholm, Sweden.	caroline.stromberg@nrm.se		Stromberg, Caroline A. E./0000-0003-0612-0305				Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; CHITALEY S D, 1971, Journal of the Indian Botanical Society, V50, P137; Clyde WC, 2003, GEOLOGY, V31, P1097, DOI 10.1130/G19956.1; COURTILLOT V, 1988, NATURE, V333, P843, DOI 10.1038/333843a0; Ghosh P, 2003, CRETACEOUS RES, V24, P743, DOI 10.1016/j.cretres.2003.08.002; Hay WW, 1999, GEOL S AM S, P1; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; KHAJURIA CK, 1994, NEWSL STRATIGR, V31, P21; Krause DW, 2003, ACTA PALAEONTOL POL, V48, P321; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Matley C., 1939, REC GEOL SURV INDIA, V74, P535; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; PATIL GV, 1984, GHOSH COMMEMORATION, P89; Patnaik Rajeev, 2001, Journal of the Palaeontological Society of India, V46, P15; Rana RS, 2003, ACTA PALAEONTOL POL, V48, P331; Rodriguez-de la Rosa RA, 1998, PALAEOGEOGR PALAEOCL, V142, P231, DOI 10.1016/S0031-0182(98)00052-2; SAMANT B, 2003, 19 IND C MICR STRAT; Sharma N, 2005, MICROPALEONTOLOGY, V51, P73, DOI 10.1661/0026-2803(2005)051[0073:FIDICF]2.0.CO;2; STEBBINS GL, 1981, ANN MO BOT GARD, V68, P75, DOI 10.2307/2398811; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; TRIVEDI BS, 1982, J INDIAN BOT SOC, V61, P320; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1; Widdowson M, 2000, J PETROL, V41, P1177, DOI 10.1093/petrology/41.7.1177; WILSON JA, 1998, MEMOIR SOC VERTEBRAT, V5, P1, DOI DOI 10.2307/3889325	30	319	350	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1177	1180		10.1126/science.1118806	http://dx.doi.org/10.1126/science.1118806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293759				2022-12-01	WOS:000233437300043
J	Wadman, M				Wadman, M			Path to approval proves rocky for copycat biodrugs	NATURE			English	News Item								The road to approval for the production of biogeneric drugs is proving to be an extremely difficult one as the original pharmaceutical producing companies doubt the efficacy and safety of the new drugs that may be approved by the European Medicines Agency next year. Possible generic drugs include erythropoietin, interferon-alpha and interferon-beta.											0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2005	438	7065					154	155		10.1038/438154a	http://dx.doi.org/10.1038/438154a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982BV	16281004				2022-12-01	WOS:000233133500016
J	Linder, JA; Bates, DW; Lee, GM; Finkelstein, JA				Linder, JA; Bates, DW; Lee, GM; Finkelstein, JA			Antibiotic treatment of children with sore throat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-TRACT INFECTIONS; ADVERSE DRUG EVENTS; STREPTOCOCCAL PHARYNGITIS; UNITED-STATES; PRIMARY-CARE; MANAGEMENT; SCORE; INTERVENTION; PRINCIPLES; GUIDELINES	Context Of children with sore throat, 15% to 36% have pharyngitis caused by group A beta-hemolytic streptococci (GABHS). Performance of a GABHS test prior to antibiotic prescribing is recommended for children with sore throat. Penicillin, amoxicillin, erythromycin, and first-generation cephalosporins are the recommended antibiotics for treatment of sore throat due to GABHS. Objectives To measure rates of antibiotic prescribing and GABHS testing and to evaluate the association between testing and antibiotic treatment for children with sore throat. Design, Setting, and Participants Analysis of visits by children aged 3 to 17 years with sore throat to office-based physicians, hospital outpatient departments, and emergency departments in the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, 1995 to 2003 (N=4158) and of a subset of visits with GABHS testing data (n=2797). Main Outcome Measures National rates of antibiotic prescribing, prescribing of antibiotics recommended and not recommended for GABHS, and GABHS testing. Results Physicians prescribed antibiotics in 53% (95% confidence interval [CI],49%-56%) of an estimated 7.3 million annual visits for sore throat and nonrecommended antibiotics to 27% (95% Cl, 24%-31%) of children who received an antibiotic. Antibiotic prescribing decreased from 66% of visits in 1995 to 54% of visits in 2003 (P=.01 for trend). This decrease was attributable to a decrease in the prescribing of recommended antibiotics (49% to 38%; P=.002). Physicians performed a GABHS test in 53% (95% CI,48%-57%)of visits and in 51% (95% Cl, 45%-57%)of visits at which an antibiotic was prescribed. GABHS testing was not associated with a lower antibiotic prescribing rate overall (48% tested vs 51% not tested; P=.40), but testing was associated with a lower antibiotic prescribing rate for children with diagnosis codes for pharyngitis, tonsillitis, and streptococcal sore throat (57% tested vs 73% not tested; P<.001). Conclusions Physicians prescribed antibiotics to 53% of children with sore throat, in excess of the maximum expected prevalence of GABHS. Although there was a decrease in the proportion of children receiving antibiotics between 1995 and 2003, this was due to decreased prescribing of agents recommended for GABHS. Although GABHS testing was associated with a lower rate of antibiotic prescribing for children with diagnosis codes of pharyngitis, tonsillitis, and streptococcal sore throat, GABHS testing was underused.	Brigham & Womens Hosp, Div Gen Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Ctr Child Hlth Care Studies, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Linder, JA (corresponding author), Brigham & Womens Hosp, Div Gen Med, 1620 Tremont St,BC-3-2X, Boston, MA 02120 USA.	jlinder@partners.org	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X	AHRQ HHS [K08 HS014563, K08 HS013908] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS014563, K08HS013908] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Belongia EA, 2001, PEDIATRICS, V108, P575, DOI 10.1542/peds.108.3.575; Benin AL, 2003, PEDIATR INFECT DIS J, V22, P1043, DOI 10.1097/01.inf.0000100577.76542.af; Bisno AL, 2003, ANN INTERN MED, V139, P150, DOI 10.7326/0003-4819-139-2-200307150-00015; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; CAPLAN C, 1979, J FAM PRACTICE, V8, P485; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Critchley IA, 2002, DIAGN MICR INFEC DIS, V42, P129, DOI 10.1016/S0732-8893(01)00327-3; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; HING E, 2004, ADV DATA VITAL HLTH, V338; Huang ES, 2002, ARCH INTERN MED, V162, P41, DOI 10.1001/archinte.162.1.41; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Linder JA, 2003, CLIN THER, V25, P2419, DOI 10.1016/S0149-2918(03)80284-9; Linder JA, 2004, AM J MANAG CARE, V10, P661; LINDER JA, IN PRESS PHARMACOEPI; Mainous AG, 1996, PEDIATR INFECT DIS J, V15, P806, DOI 10.1097/00006454-199609000-00014; Mangione-Smith R, 2005, ARCH PEDIAT ADOL MED, V159, P491, DOI 10.1001/archpedi.159.5.491; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; Mather J. L., 1994, Canadian Journal of Hospital Pharmacy, V47, P111; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; MCCAIG LF, 2004, ADV DATA VITAL HLTH, V335; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 2002, J FAM PRACTICE, V51, P339; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; *NAT COMM QUAL ASS, HEDIS 2004 SUMM TABL; *NAT CTR HLTH STAT, 2005, PUBL US MICR FIL DOC; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Perz JF, 2002, JAMA-J AM MED ASSOC, V287, P3103, DOI 10.1001/jama.287.23.3103; PICKERING LK, 2003, RED BOOK 2003 REPORT; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; Schwartz B, 1998, PEDIATRICS, V101, P171; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Solomon DH, 2001, ARCH INTERN MED, V161, P1897, DOI 10.1001/archinte.161.15.1897; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Stille CJ, 2004, PEDIATRICS, V114, P1206, DOI 10.1542/peds.2004-0311; *US FDA, 1995, NAT DRUG COD DIR; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; Woodwell DA, 2004, ADV DATA VITAL HLTH	50	133	151	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 9	2005	294	18					2315	2322		10.1001/jama.294.18.2315	http://dx.doi.org/10.1001/jama.294.18.2315			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981LI	16278359	Bronze			2022-12-01	WOS:000233089700023
J	Lamoreux, JF; Morrison, JC; Ricketts, TH; Olson, DM; Dinerstein, E; McKnight, MW; Shugart, HH				Lamoreux, JF; Morrison, JC; Ricketts, TH; Olson, DM; Dinerstein, E; McKnight, MW; Shugart, HH			Global tests of biodiversity concordance and the importance of endemism	NATURE			English	Article							INDICATOR GROUPS; CONSERVATION; HOTSPOTS; ECOLOGY	Understanding patterns of biodiversity distribution is essential to conservation strategies(1), but severe data constraints make surrogate measures necessary(2-4). For this reason, many studies have tested the performance of terrestrial vertebrates as surrogates for overall species diversity, but these tests have typically been limited to a single taxon or region(3-10). Here we show that global patterns of richness are highly correlated among amphibians, reptiles, birds and mammals, as are endemism patterns. Furthermore, we demonstrate that although the correlation between global richness and endemism is low, aggregate regions selected for high levels of endemism capture significantly more species than expected by chance. Although areas high in endemism have long been targeted for the protection of narrow-ranging species(11,12), our findings provide evidence that endemism is also a useful surrogate for the conservation of all terrestrial vertebrates.	Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; World Wildlife Fund US, Washington, DC 20037 USA; Wildlife Conservat Soc S Pacific, Suva, Fiji; Univ N Carolina, Curriculum Ecol, Chapel Hill, NC 27599 USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Lamoreux, JF (corresponding author), Univ Virginia, Dept Environm Sci, 291 McCormick Rd, Charlottesville, VA 22904 USA.	lamoreux@virginia.edu	Shugart, Herman/C-5156-2009	Shugart, Herman/0000-0002-1766-8379				Aron A., 1999, STAT PSYCHOL; Balmford A, 1998, TRENDS ECOL EVOL, V13, P409, DOI 10.1016/S0169-5347(98)01415-3; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 1998, NATURE, V394, P229, DOI 10.1038/28288; Groves C., 2003, DRAFTING CONSERVATIO; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Manly B. F., 1997, RANDOMIZATION BOOTST; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier RA., 1997, MEGADIVERSITY EARTHS; Mittermeier RA, 2004, HOTSPOTS REVISITED; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; Pimm SL, 1999, NATURE, V402, P853, DOI 10.1038/47183; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Ricketts T. H., 2001, Animal Biodiversity and Conservation, V24, P91; Ricketts TH, 1999, BIOSCIENCE, V49, P369, DOI 10.2307/1313630; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; WILLIAMS PH, 1998, CONSERVATION CHANGIN, P211	30	356	381	4	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					212	214		10.1038/nature04291	http://dx.doi.org/10.1038/nature04291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16382239	Bronze			2022-12-01	WOS:000235839500046
J	Chandola, T; Brunner, E; Marmot, M				Chandola, T; Brunner, E; Marmot, M			Chronic stress at work and the metabolic syndrome: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; BLOOD-PRESSURE; CORONARY RISK; ASSOCIATION; LINK; REWARD	Objectives To investigate the association between stress at work and the metabolic syndrome. Design Prospective cohort study investigating the association between work stress and the metabolic syndrome. Participants 10 308 men and women, aged 35-55, employed in 20 London civil service departments at baseline (the Whitehall 11 study); follow-up was an average of 14 years. Main outcome measures Work stress based on the iso-strain model, measured on four occasions (1985-99). Biological measures of the metabolic syndrome, based on the National Cholesterol Education Program definition, measured in 1999. Results A dose-response relation was found between exposure to work stressors over 14 years and risk of the metabolic syndrome, independent of other relevant risk factors. Employees with chronic work stress (three or more exposures) were more than twice as likely to have the syndrome than those without work stress (odds ratio adjusted for age and employment grade 2.25, 95% confidence interval 1.31 to 3.85). Conclusions Stress at work is an important risk factor for the metabolic syndrome. The study provides evidence for the biological plausibility of the link between psychosocial stressors from everyday life and heart disease.	UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Chandola, T (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	t.chandola@ucl.ac.uk	Marmot, M G/Y-3920-2019; Chandola, Tarani/I-3192-2013; Brunner, Eric/H-2114-2011	Marmot, M G/0000-0002-2431-6419; Chandola, Tarani/0000-0002-1864-3413; Brunner, Eric/0000-0002-0595-4474	AHRQ HHS [HS06516] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline; NHLBI NIH HHS [HL36310] Funding Source: Medline; NIA NIH HHS [AG13196] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2006, SOCIAL DETERMINANTS; BJORNTORP P, 1991, J INTERN MED, V230, P195; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chandola T, 2005, OCCUP ENVIRON MED, V62, P223, DOI 10.1136/oem.2004.016675; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Hemingway H, 2005, CIRCULATION, V111, P3071, DOI 10.1161/CIRCULATIONAHA.104.497347; Karasek R.A., 1990, HLTH WORK STRESS PRO; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Liao DP, 1998, CIRCULATION, V97, P828; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; Siegrist J, 1997, J INTERN MED, V242, P149, DOI 10.1046/j.1365-2796.1997.00167.x; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Steptoe A, 2004, OBES RES, V12, pA76; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; Vrijkotte TGM, 1999, PSYCHOSOM MED, V61, P796, DOI 10.1097/00006842-199911000-00012	25	655	685	1	79	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2006	332	7540					521	524A		10.1136/bmj.38693.435301.80	http://dx.doi.org/10.1136/bmj.38693.435301.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WB	16428252	Green Published, Bronze			2022-12-01	WOS:000236155800016
J	Singh, SK; Hora, R; Belrhali, H; Chitnis, CE; Sharma, A				Singh, SK; Hora, R; Belrhali, H; Chitnis, CE; Sharma, A			Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain	NATURE			English	Article							RED-CELL INVASION; PLASMODIUM-VIVAX; ERYTHROCYTE INVASION; CRYSTAL-STRUCTURES; PROTEIN; FALCIPARUM; RESIDUES; KNOWLESI; ASSOCIATION; PATHWAY	Molecular processes that govern pathogenic features of erythrocyte invasion and cytoadherence in malaria are reliant on Plasmodium-specific Duffy-binding-like domains (DBLs)(1). These cysteine-rich modules recognize diverse host cell-surface receptors during pathogenesis. DBLs of parasite erythrocyte-binding proteins mediate invasion, and those from the antigenically variant P. falciparum erythrocyte membrane protein 1 ( PfEMP1) have been implicated in cytoadherence. The simian and human malarial parasites, P. knowlesi and P. vivax, invade human erythrocytes exclusively through the host DARC receptor ( Duffy antigen receptor for chemokines)(2,3). Here we present the crystal structure of the P. knowlesi DBL domain (Pk alpha-DBL), which binds to DARC during invasion of human erythrocytes. Pk alpha-DBL retains the overall fold observed in DBLs from P. falciparum erythrocyte-binding antigen (EBA)- 175 (ref. 4). Mapping the residues that have previously been implicated in binding(5-7) highlights a fairly flat but exposed site for DARC recognition in subdomain 2 of Pk alpha-DBL; this is in sharp contrast to receptor recognition by EBA- 175 ( ref. 4). In Pk alpha-DBL, the residues that contact DARC and the clusters of residues under immune pressure map to opposite surfaces of the DBL, and suggest a possible mechanism for immune evasion by P. vivax. Our comparative structural analysis of Pk alpha-DBL and P. falciparum EBA- 175 provides a framework for the understanding of malaria parasite DBLs, and may affect the development of new prophylactic and therapeutic strategies.	ICGEB, Struct & Computat Biol Grp, New Delhi 110067, India; ICGEB, Malaria Res Grp, New Delhi 110067, India; European Mol Biol Lab, F-38042 Grenoble 9, France	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; European Molecular Biology Laboratory (EMBL)	Sharma, A (corresponding author), ICGEB, Struct & Computat Biol Grp, Aruna Asaf Marg, New Delhi 110067, India.	asharma@icgeb.res.in		Chitnis, Chetan/0000-0002-8773-9865; Hora, Rachna/0000-0002-6085-8389				ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P112; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Singh SK, 2003, BIOCHEM J, V374, P193, DOI 10.1042/BJ20030622; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; VanBuskirk KM, 2004, P NATL ACAD SCI USA, V101, P15754, DOI 10.1073/pnas.0405421101; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	31	191	197	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2006	439	7077					741	744		10.1038/nature04443	http://dx.doi.org/10.1038/nature04443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	010KH	16372020				2022-12-01	WOS:000235193100048
J	Pounds, JA; Bustamante, MR; Coloma, LA; Consuegra, JA; Fogden, MPL; Foster, PN; La Marca, E; Masters, KL; Merino-Viteri, A; Puschendorf, R; Ron, SR; Sanchez-Azofeifa, GA; Still, CJ; Young, BE				Pounds, JA; Bustamante, MR; Coloma, LA; Consuegra, JA; Fogden, MPL; Foster, PN; La Marca, E; Masters, KL; Merino-Viteri, A; Puschendorf, R; Ron, SR; Sanchez-Azofeifa, GA; Still, CJ; Young, BE			Widespread amphibian extinctions from epidemic disease driven by global warming	NATURE			English	Article							CLIMATE-CHANGE; POPULATION DECLINES; BATRACHOCHYTRIUM-DENDROBATIDIS; TROPICAL MOUNTAIN; WATER-VAPOR; COSTA-RICA; ECOLOGY; TRENDS; CHYTRIDIOMYCOSIS; TEMPERATURE	As the Earth warms, many species are likely to disappear, often because of changing disease dynamics. Here we show that a recent mass extinction associated with pathogen outbreaks is tied to global warming. Seventeen years ago, in the mountains of Costa Rica, the Monteverde harlequin frog ( Atelopus sp.) vanished along with the golden toad ( Bufo periglenes). An estimated 67% of the 110 or so species of Atelopus, which are endemic to the American tropics, have met the same fate, and a pathogenic chytrid fungus (Batrachochytrium dendrobatidis) is implicated. Analysing the timing of losses in relation to changes in sea surface and air temperatures, we conclude with 'very high confidence' (>99%, following the Intergovernmental Panel on Climate Change, IPCC) that large-scale warming is a key factor in the disappearances. We propose that temperatures at many highland localities are shifting towards the growth optimum of Batrachochytrium, thus encouraging outbreaks. With climate change promoting infectious disease and eroding biodiversity, the urgency of reducing greenhouse-gas concentrations is now undeniable.	Monteverde Cloud Forest Preserve & Trop Sci Ctr, Golden Toad Lab Conservat, Santa Elena 565573, Puntarenas, Costa Rica; Pontificia Univ Catolica Ecuador, Escuela Biol, Ctr Biodiversidad & Ambiente, Museo Zool, Quito, Ecuador; Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA; Univ Tokyo, Ctr Climat Studies Res, Meguro Ku, Tokyo 1538904, Japan; Univ Los Andes, Fac Ciencias Forestales & Ambientales, Escuela Geog, Lab Biogeog, Merida, Venezuela; Council Int Educ Exchange, Monteverde 565526, Puntarenas, Costa Rica; Univ Costa Rica, Escuela Biol, San Pedro, Costa Rica; Univ Texas, Texas Mem Museum, Austin, TX 78712 USA; Univ Texas, Dept Integrat Biol, Austin, TX 78712 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; NatureServ, Monteverde 565575, Puntarenas, Costa Rica	Pontificia Universidad Catolica del Ecuador; Columbia University; University of Tokyo; University of Los Andes Venezuela; Universidad Costa Rica; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Alberta; University of California System; University of California Santa Barbara	Pounds, JA (corresponding author), Monteverde Cloud Forest Preserve & Trop Sci Ctr, Golden Toad Lab Conservat, Santa Elena 565573, Puntarenas, Costa Rica.	goldtoad@racsa.co.cr	Puschendorf, Robert/B-6280-2011; Coloma, Luis/AAO-3956-2020; Foster, Pru/K-5476-2012; Merino-Viteri, Andrés/AHB-0977-2022; Ron, Santiago/J-4203-2019; Sanchez-Azofeifa, Arturo/F-4700-2014	Puschendorf, Robert/0000-0002-8105-171X; Coloma, Luis/0000-0003-0158-2455; Foster, Pru/0000-0003-4735-1521; Merino-Viteri, Andrés/0000-0003-1039-2645; Ron, Santiago/0000-0001-6300-9350; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600; Still, Christopher/0000-0002-8295-4494				Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; CACERES L, 1998, CONSECUENCIAS CLIMAT; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Dai A, 1999, J CLIMATE, V12, P2451, DOI 10.1175/1520-0442(1999)012&lt;2451:EOCSMP&gt;2.0.CO;2; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gomez I., 1996, TOP METEOR OCEANOGR, V3, P27; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lawton RO, 2001, SCIENCE, V294, P584; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Merino-Viteri A, 2005, STUDIES ANDEAN FROGS, P9; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penner JE, 2004, NATURE, V432, P962, DOI 10.1038/432962a; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds J. Alan, 2000, P149; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Quintana-Gomez RA, 1999, J CLIMATE, V12, P2104, DOI 10.1175/1520-0442(1999)012<2104:TOMAMT>2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Ron SR, 2003, J HERPETOL, V37, P116, DOI 10.1670/0022-1511(2003)037[0116:PDOTJT]2.0.CO;2; ROOT TL, 1995, SCIENCE, V269, P334, DOI 10.1126/science.269.5222.334; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ross RJ, 2001, J CLIMATE, V14, P1602, DOI 10.1175/1520-0442(2001)014<1602:RBNHTW>2.0.CO;2; Sanchez-Azofeifa G, 2001, BIOTROPICA, V33, P378, DOI 10.1111/j.1744-7429.2001.tb00192.x; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wentz FJ, 2000, NATURE, V403, P414, DOI 10.1038/35000184	50	1198	1339	9	1349	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 12	2006	439	7073					161	167		10.1038/nature04246	http://dx.doi.org/10.1038/nature04246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407945				2022-12-01	WOS:000234538400031
J	Achard, P; Cheng, H; De Grauwe, L; Decat, J; Schoutteten, H; Moritz, T; Van Der Straeten, D; Peng, JR; Harberd, NP				Achard, P; Cheng, H; De Grauwe, L; Decat, J; Schoutteten, H; Moritz, T; Van Der Straeten, D; Peng, JR; Harberd, NP			Integration of plant responses to environmentally activated phytohormonal signals	SCIENCE			English	Article							GIBBERELLIN RESPONSE; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; FLORAL DEVELOPMENT; GENE-EXPRESSION; PROTEIN; GROWTH; TRANSDUCTION; OVEREXPRESSION; MODULATION	Plants live in fixed locations and survive adversity by integrating growth responses to diverse environmental signals. Here, we show that the nuclear-localized growth-repressing DELLA proteins of Arabidopsis integrate responses to independent hormonal and environmental signals of adverse conditions. The growth restraint conferred by DELLA proteins is beneficial and promotes survival. We propose that DELLAs permit flexible and appropriate modulation of plant growth in response to changes in natural environments.	John Innes Ctr, Norwich NR4 7UJ, Norfolk, England; Inst Mol & Cell Biol, Singapore 138673, Singapore; Univ Ghent, Dept Mol Genet, Unit Plant Hormones Signaling & Bioimaging, B-9000 Ghent, Belgium; Swedish Univ Agr Sci, Dept Forest & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Ghent University; Swedish University of Agricultural Sciences; Umea University	Van Der Straeten, D (corresponding author), John Innes Ctr, Norwich NR4 7UJ, Norfolk, England.	dominique.vanderstraeten@ugent.be; pengjr@imcb.a-star.edu.sg; nicholas.harberd@bbsrc.ac.uk	Achard, Patrick/A-5406-2010; Van Der Straeten, Dominique/E-7385-2016	Van Der Straeten, Dominique/0000-0002-7755-1420; Moritz, Thomas/0000-0002-4258-3190; Peng, Jinrong/0000-0002-0793-4848	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000583, P19972] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Harberd NP, 2003, SCIENCE, V299, P1853, DOI 10.1126/science.1083217; King KE, 2001, GENETICS, V159, P767; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Vriezen WH, 2004, PLANT J, V37, P505, DOI 10.1046/j.1365-313X.2003.01975.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	28	986	1082	19	333	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					91	94		10.1126/science.1118642	http://dx.doi.org/10.1126/science.1118642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400150				2022-12-01	WOS:000234546300040
J	Sedlak, TW; Snyder, SH				Sedlak, TW; Snyder, SH			Messenger molecules and cell death - Therapeutic implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NITRIC-OXIDE SYNTHASE; CULTURED CEREBELLAR NEURONS; HEME OXYGENASE-1 DEFICIENCY; IRON REGULATORY PROTEINS; PARKINSONS-DISEASE; SERUM BILIRUBIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; POLY(ADP-RIBOSE) POLYMERASE; MUTANT HUNTINGTIN; APOPTOTIC PATHWAYS	Programmed cell death, also called apoptosis, participates not only in normal physiologic processes such as development of the immune system, but also in many diseases. A loss of normal cell death may occur in cancer, and excessive cell death is found in a variety of neurodegenerative conditions. We describe 3 distinct pathways that regulate cell death. First, bilirubin, often thought to be a toxic end product of heme metabolism, serves as a physiologic cytoprotectant that may attenuate multiple forms of morbidity. In a second pathway, the glycolytic enzyme glyceraldehyde-3-phosphatedehydrogenase (GAPDH) mediates a novel cell death cascade. Cytotoxic stimuli, via nitric oxide generation, lead to the binding of GAPDH to the protein Siah1, translocation of GAPDH-Siah1 to the nucleus, and ultimately cell death. Third, cytochrome c, released from mitochondria early in apoptosis, synergizes with inositol-1,4,5-triphosphate (IP3) to elicit massive cellular calcium release, resulting in cell death. These pathways may regulate cell survival in a variety of pathologic states and represent fertile targets for novel therapies.	Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Snyder, SH (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Wood Basic Sci Bldg 813,725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00074, DA-00266] Funding Source: Medline; NIMH NIH HHS [MH68830] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Amersi F, 1999, J CLIN INVEST, V104, P1631, DOI 10.1172/JCI7903; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x; Andringa G., 2000, Journal of Neural Transmission Supplement, V60, P215; BAE BI, 2004, SOC NEUR 34 ANN M OC; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BOYNTON BR, 1989, NEW ENGL J MED, V321, P193; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chang EF, 2003, J NEUROSCI, V23, P3689; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeJonge MH, 1999, J PEDIATR-US, V135, P102, DOI 10.1016/S0022-3476(99)70336-7; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; DENNERY PA, 1995, FREE RADICAL BIO MED, V19, P395, DOI 10.1016/0891-5849(95)00032-S; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; FAUCHERE JC, 1994, EUR J PEDIATR, V153, P358, DOI 10.1007/s004310050153; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GATON DD, 1991, BRIT J OPHTHALMOL, V75, P532, DOI 10.1136/bjo.75.9.532; GOEHNING D, 2005, P NATL ACAD SCI USA, V102, P1466; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gulesserian T, 2005, CLIN CHEM, V51, P1661, DOI 10.1373/clinchem.2005.051581; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hammerman C, 2002, J PEDIATR GASTR NUTR, V35, P344, DOI 10.1097/00005176-200209000-00020; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARA MR, 2005, SOC NEUR 35 ANN M NO; HELLER B, 1995, J BIOL CHEM, V270, P11176, DOI 10.1074/jbc.270.19.11176; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HEYMAN E, 1989, NEW ENGL J MED, V320, P256; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horn S, 2004, NEUROLOGY, V63, pS7, DOI 10.1212/WNL.63.7_suppl_2.S7; Hosono S, 2002, J PEDIAT OPHTH STRAB, V39, P151, DOI 10.3928/0191-3913-20020501-06; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Ishizaka N, 2001, STROKE, V32, P581, DOI 10.1161/01.STR.32.2.580-b; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jenner P, 2004, NEUROLOGY, V63, pS13, DOI 10.1212/WNL.63.7_suppl_2.S13; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kaplan M, 2003, PEDIATRICS, V111, P886, DOI 10.1542/peds.111.4.886; Kato Y, 2003, HEPATOLOGY, V38, P364, DOI 10.1053/jhep.2003.50300; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LeWitt PA, 2004, NEUROLOGY, V63, pS23, DOI 10.1212/WNL.63.7_suppl_2.S23; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7; Matarredona ER, 2003, RESTOR NEUROL NEUROS, V21, P29; Milner Joshua D, 2003, J Perinatol, V23, P208, DOI 10.1038/sj.jp.7210887; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ohta K, 2000, AM J KIDNEY DIS, V35, P863, DOI 10.1016/S0272-6386(00)70256-3; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; RYTER SW, 2004, SCI STKE, V230, pRE6; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; SEDLAK TW, 2004, SOC NEUR 34 ANN M OC; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stocchi F, 2003, ANN NEUROL, V53, pS87, DOI 10.1002/ana.10488; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Vitek L, 2005, PEDIATRICS, V115, P1411, DOI 10.1542/peds.2004-1796; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Waldmeier PC, 2000, N-S ARCH PHARMACOL, V362, P526, DOI 10.1007/s002100000300; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yeo KL, 1998, PEDIATRICS, V102, P1426, DOI 10.1542/peds.102.6.1426; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youdim MBH, 2004, NEUROLOGY, V63, pS32, DOI 10.1212/WNL.63.7_suppl_2.S32; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	112	38	39	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2006	295	1					81	89		10.1001/jama.295.1.81	http://dx.doi.org/10.1001/jama.295.1.81			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999HT	16391220				2022-12-01	WOS:000234381100024
J	Landisman, CE; Connors, BW				Landisman, CE; Connors, BW			Long-term modulation of electrical synapses in the mammalian thalamus	SCIENCE			English	Article							EXCITATORY POSTSYNAPTIC POTENTIALS; LATERAL GENICULATE-NUCLEUS; DOPAMINERGIC MODULATION; RETICULAR NUCLEUS; MIXED SYNAPSES; NEURONS; TRANSMISSION; BRAIN; CELLS; INTERNEURONS	Electrical synapses are common between inhibitory neurons in the mammalian thalamus and neocortex. Synaptic modulation, which allows flexibility of communication between neurons, has been studied extensively at chemical synapses, but modulation of electrical synapses in the mammalian brain has barely been examined. We found that the activation of metabotropic glutamate receptors, via endogenous neurotransmitter or by agonist, causes long-term reduction of electrical synapse strength between the inhibitory neurons of the rat thalamic reticular nucleus.	Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Brown University; Harvard University; Harvard Medical School	Landisman, CE (corresponding author), Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA.	Carole_Landisman@hms.harvard.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157	NINDS NIH HHS [NS40528, NS25983, NS050434] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983, R21NS040528, R01NS050434] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BENNETT MVL, 1966, ANN NY ACAD SCI, V137, P509, DOI 10.1111/j.1749-6632.1966.tb50178.x; COBBETT P, 1984, J NEUROSCI, V4, P3034; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2005, PROG BRAIN RES, V149, P41, DOI 10.1016/S0079-6123(05)49004-4; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LASATER EM, 1985, P NATL ACAD SCI USA, V82, P3025, DOI 10.1073/pnas.82.9.3025; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; ODONNELL P, 1993, J NEUROSCI, V13, P3456; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; PEREDA A, 1992, P NATL ACAD SCI USA, V89, P12088, DOI 10.1073/pnas.89.24.12088; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; RORIG B, 1995, J NEUROSCI, V15, P7386; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0	29	120	124	3	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 16	2005	310	5755					1809	1813		10.1126/science.1114655	http://dx.doi.org/10.1126/science.1114655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995II	16357260				2022-12-01	WOS:000234093600045
J	Martinez, JJ; Seveau, S; Veiga, E; Matsuyama, S; Cossart, P				Martinez, JJ; Seveau, S; Veiga, E; Matsuyama, S; Cossart, P			Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii	CELL			English	Article							OUTER-MEMBRANE PROTEIN; LISTERIA-MONOCYTOGENES; DOWN-REGULATION; SPOTTED-FEVER; LIPID RAFTS; E-CADHERIN; COMPLEX; ENTRY; INVASION; ADHESION	Rickettsia conorii, a strictly intracellular and category C priority bacterial pathogen (NIAID), invades different mammalian cells. Although some signaling events involved in bacterial entry have been documented, the bacterial and host proteins mediating entry were not known. We report the identification of the Ku70 subunit of DNA-dependent protein kinase (DNA-PK) as a receptor involved in R. conorii internalization. Ku70 is recruited to R. conorii entry sites, and inhibition of Ku70 expression impairs R. conorii internalization. Bacterial invasion is dependent on the presence of cholesterol-enriched microdomains containing Ku70. R. conorii infection stimulates the ubiquitination of Ku70. In addition, the ubiquitin ligase c-Cbl is recruited to R. conorii entry foci, and downregulation of endogenous c-Cbl blocks bacterial invasion and Ku70 ubiquitination. An affinity chromatography approach identified the rickettsial protein rOmpB as a ligand for Ku70. This is the first report of a receptor-ligand interaction involved in the internalization of any rickettsial species.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; INSERM, U604, F-75015 Paris, France; INRA, USC2020, F-75015 Paris, France; Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Case Western Reserve University; Case Western Reserve University	Martinez, JJ (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr	Seveau, Stephanie/E-4060-2011; veiga, esteban/C-2129-2011	veiga, esteban/0000-0002-7333-2466				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; CARL M, 1990, P NATL ACAD SCI USA, V87, P8237, DOI 10.1073/pnas.87.21.8237; CHAN JYC, 1989, J BIOL CHEM, V264, P3651; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Feng HM, 2004, INFECT IMMUN, V72, P3524, DOI 10.1128/IAI.72.6.3524-3530.2004; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HAND WL, 1970, ARCH INTERN MED, V125, P879, DOI 10.1001/archinte.125.5.879; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Joshi SG, 2003, INFECT IMMUN, V71, P4127, DOI 10.1128/IAI.71.7.4127-4136.2003; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Koike M, 2002, J RADIAT RES, V43, P223, DOI 10.1269/jrr.43.223; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Monferran S, 2004, J MOL BIOL, V337, P503, DOI 10.1016/j.jmb.2004.01.057; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; RAMM LE, 1976, INFECT IMMUN, V13, P120, DOI 10.1128/IAI.13.1.120-126.1976; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; VEIGA E, 2005, IN PRESS NAT CELL BI; VISHWANATH S, 1991, FEMS MICROBIOL LETT, V81, P341, DOI 10.1111/j.1574-6968.1991.tb04783.x; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7; WALKER DH, 1985, AM J TROP MED HYG, V34, P361, DOI 10.4269/ajtmh.1985.34.361; WALKER DH, 1983, INFECT IMMUN, V40, P840, DOI 10.1128/IAI.40.2.840-842.1983; YAGUPSKY P, 1993, CLIN INFECT DIS, V17, P850, DOI 10.1093/clinids/17.5.850; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774	54	130	143	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 16	2005	123	6					1013	1023		10.1016/j.cell.2005.08.046	http://dx.doi.org/10.1016/j.cell.2005.08.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360032	Bronze			2022-12-01	WOS:000234177200011
J	Petroski, MD; Deshaies, RJ				Petroski, MD; Deshaies, RJ			Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; S-PHASE; CDC34; RECOGNITION; DEGRADATION; SUBUNIT; SIC1; PHOSPHORYLATION; PROTEASOME; RBX1	Ubiquitin chains linked via lysine 48 (K48) of ubiquitin mediate recognition of ubiquitinated proteins by the proteasome. However, the mechanisms underlying polymerization of this targeting signal on a substrate are unknown. Here we dissect this process using the cyclin-dependent kinase inhibitor Sic1 and its ubiquitination by the cullin-RING ubiquitin ligase SCFCdC4 and the ubiquitin-conjugating enzyme Cdc34. We show that Sic1 ubiquitination can be separated into two steps: attachment of the first ubiquitin, which is rate limiting, followed by rapid elongation of a K48-linked ubiquitin chain. Mutation of an acidic loop conserved among Cdc34 orthologs has no effect on attachment of the first ubiquitin onto Sic1 but compromises the processivity and linkage specificity of ubiquitin-chain synthesis. We propose that the acidic loop favorably positions K48 of a substrate-linked ubiquitin to attack SCF bound Cdc34-ubiquitin thioester and thereby enables processive synthesis of K48-linked ubiquitin chains by SCF-Cdc34.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Petroski, MD (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, 156-29 Calif Inst Technol,1200 E Calif Blvd, Pasadena, CA 91125 USA.	mpetroski@rigel.com; deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354				Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; HAAS AL, 1988, UBIQUITIN, P173; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; LIU Y, 1995, MOL CELL BIOL, V15, P5635; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	31	210	213	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 16	2005	123	6					1107	1120		10.1016/j.cell.2005.09.033	http://dx.doi.org/10.1016/j.cell.2005.09.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	996ME	16360039	Bronze			2022-12-01	WOS:000234177200018
J	Majeed, A; Aylin, P				Majeed, A; Aylin, P			The ageing population of the United Kingdom and cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Article								The number of people aged 65 and over is predicted to increase by about 53% between 2001 and 2031, but the number of people aged under 65 will change little during this period (table). The increase in the number of older people will likely lead to an increase in the number of people who have chronic diseases, including cardiovascular disease. This will impose further workload and financial pressures on the NHS. We examined the possible impact of the ageing population on the expected number of people with three cardiovascular disorders: coronary heart disease, heart failure, and atrial fibrillation.					Aylin, Paul/A-1073-2014	Majeed, Azeem/0000-0002-2357-9858; Aylin, Paul/0000-0003-4589-1743				*OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; PETERSEN R, 2000, CORONARY HEART DIS S; Salomon JA, 2004, BMJ-BRIT MED J, V329, P733, DOI 10.1136/bmj.329.7468.733; Wanless, 2002, SECURING OUR FUTURE	4	20	20	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2005	331	7529					1362	1362A		10.1136/bmj.331.7529.1362	http://dx.doi.org/10.1136/bmj.331.7529.1362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	993ZO	16339247	Green Published			2022-12-01	WOS:000233999300015
J	Garrick, J; Requa, R				Garrick, J; Requa, R			Essay - Long-term complications of exercise	LANCET			English	Article									St Francis Mem Hosp, Ctr Sports Med, San Francisco, CA 94109 USA		Garrick, J (corresponding author), St Francis Mem Hosp, Ctr Sports Med, 900 Hyde St, San Francisco, CA 94109 USA.	jgarrick@chw.edu							0	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S58	S59		10.1016/S0140-6736(05)67854-3	http://dx.doi.org/10.1016/S0140-6736(05)67854-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360759	Bronze			2022-12-01	WOS:000234374400035
J	Hambrecht, R; Gielen, S				Hambrecht, R; Gielen, S			Essay - Hunter-gatherer to sedentary lifestyle	LANCET			English	Article							CORONARY-ARTERY-DISEASE; EXERCISE		Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hambrecht, R (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany.	hamr@medizin.uni-leipzig.de						Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238	5	7	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S60	S61		10.1016/S0140-6736(05)67856-7	http://dx.doi.org/10.1016/S0140-6736(05)67856-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360760				2022-12-01	WOS:000234374400036
J	Walker, SP; Chang, SM; Powell, CA; Grantham-McGregor, SM				Walker, SP; Chang, SM; Powell, CA; Grantham-McGregor, SM			Effects of early childhood psychosocial stimulation and nutritional supplementation on cognition and education in growth-stunted Jamaican children: prospective cohort study	LANCET			English	Article							SCHOOL	Growth retardation affects about a third of children younger than age 5 years in developing countries and is associated with poor development. Previously, we did a trial of nutritional supplementation and psychosocial stimulation in stunted children aged 9-24 months. Non-stunted children were also assessed. Both types of intervention improved development. We now present the effects of early interventions on cognition and education in 103 of the 129 stunted children and compare them with 64 of the 84 non-stunted children now aged 17-18 years. We recorded no significant effects of nutritional supplementation. Compared with no intervention, stimulation resulted in higher full scale IQ scores (coefficient 0.38, 95% C1 0.06-0.71, p=0.02) and higher scores on the verbal subscale (0.3, 0.07-0.68, p=0.02), Peabody picture vocabulary test (7.84, 0.73-14.95, p=0.03), verbal analogies (0.26, 0.03-0.49, p=0.03), and reading tests (4.73, 1.31-8.14, p=0.007, and 2.7, 1.12.4.37, p=0.001). Overall, stunted non-stimulated participants had significantly poorer scores than the non-stunted group on 11 of 12 cognitive and educational tests. Stunting in early childhood is associated with cognitive and educational deficits in late adolescence, which are reduced by stimulation at a young age.	Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Mona, Jamaica; Inst Child Hlth, London, England	University West Indies Mona Jamaica; University of London; University College London	Walker, SP (corresponding author), Univ W Indies, Res Inst Trop Med, Epidemiol Res Unit, Mona, Jamaica.	susan.walker@uwimona.edu.jm			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; FRANCE N, 1997, GROUP READING TEST, V2; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; POWELL C, 2004, BMJ             0624; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227	9	242	246	1	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 19	2005	366	9499					1804	1807		10.1016/S0140-6736(05)67574-5	http://dx.doi.org/10.1016/S0140-6736(05)67574-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	987KQ	16298218				2022-12-01	WOS:000233517200025
J	Wang, XQ; Rickert, M; Garcia, KC				Wang, XQ; Rickert, M; Garcia, KC			Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma(c) receptors	SCIENCE			English	Article							PROTEIN-PROTEIN INTERFACE; COMMON GAMMA-CHAIN; IL-2 RECEPTOR; BETA-CHAIN; CYTOPLASMIC DOMAINS; MOLECULAR-CLONING; C-CHAIN; CYTOKINE; BINDING; GP130	Interleukin-2 (IL-2) is an immunoregulatory cytokine that acts through a quaternary receptor signaling complex containing alpha (IL-2R alpha), beta (IL-2R beta), and common gamma chain (gamma(c)) receptors. In the structure of the quaternary ectodomain complex as visualized at a resolution of 2.3 angstroms, the binding of IL-2R alpha to IL-2 stabilizes a secondary binding site for presentation to IL-2R beta. gamma(c) is then recruited to the composite surface formed by the IL-2/IL-2R beta complex. Consistent with its role as a shared receptor for IL-4, IL-7, IL-9, IL-15, and IL-21, gamma(c) forms degenerate contacts with IL-2. The structure of gamma(c) provides a rationale for loss-of-function mutations found in patients with X-linked severe combined immunodeficiency diseases (X-SCID). This complex structure provides a framework for other gamma(c)-dependent cytokine-receptor interactions and for the engineering of improved IL-2 therapeutics..	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D319, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NIAID NIH HHS [AI51321] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Church AC, 2003, QJM-INT J MED, V96, P91, DOI 10.1093/qjmed/hcg014; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; MCKAY DB, 1992, SCIENCE, V257, P412, DOI 10.1126/science.257.5068.412; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Puck JM, 1996, IMMUNOL TODAY, V17, P507, DOI 10.1016/0167-5699(96)30062-5; Raskin N, 1998, J IMMUNOL, V161, P3474; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Shanafelt AB, 2000, NAT BIOTECHNOL, V18, P1197, DOI 10.1038/81199; SMITH KA, 1993, BLOOD, V81, P1414; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Smith Kendall A, 2003, AIDS Read, V13, P365; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x	43	318	359	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1159	1163		10.1126/science.1117893	http://dx.doi.org/10.1126/science.1117893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293754				2022-12-01	WOS:000233437300038
J	Goldie, SJ; Gaffikin, L; Goldhaber-Fiebert, JD; Gordillo-Tobar, A; Levin, C; Mahe, C; Wright, TC				Goldie, SJ; Gaffikin, L; Goldhaber-Fiebert, JD; Gordillo-Tobar, A; Levin, C; Mahe, C; Wright, TC		Alliance Cervical Canc Prevention	Cost-effectiveness of cervical-cancer screening in five developing countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; LOW-INCOME; STRATEGIES; BENEFITS	Background: Cervical-cancer screening strategies that involve the use of conventional cytology and require multiple visits have been impractical in developing countries. Methods: We used computer-based models to assess the cost-effectiveness of a variety of cervical-cancer screening strategies in India, Kenya, Peru, South Africa, and Thailand. Primary data were combined with data from the literature to estimate age-specific incidence and mortality rates for cancer and the effectiveness of screening for and treatment of precancerous lesions. We assessed the direct medical, time, and program-related costs of strategies that differed according to screening test, targeted age and frequency, and number of clinic visits required. Single-visit strategies involved the assumption that screening and treatment could be provided in the same day. Outcomes included the lifetime risk of cancer, years of life saved, lifetime costs, and cost-effectiveness ratios (cost per year of life saved). Results: The most cost-effective strategies were those that required the fewest visits, resulting in improved follow-up testing and treatment. Screening women once in their lifetime, at the age of 35 years, with a one-visit or two-visit screening strategy involving visual inspection of the cervix with acetic acid or DNA testing for human papillomavirus (HPV) in cervical cell samples, reduced the lifetime risk of cancer by approximately 25 to 36 percent, and cost less than $500 per year of life saved. Relative cancer risk declined by an additional 40 percent with two screenings (at 35 and 40 years of age), resulting in a cost per year of life saved that was less than each country's per capita gross domestic product - a very cost-effective result, according to the Commission on Macroeconomics and Health. Conclusions: Cervical-cancer screening strategies incorporating visual inspection of the cervix with acetic acid or DNA testing for HPV in one or two clinical visits are cost-effective alternatives to conventional three-visit cytology-based screening programs in resource-poor settings.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Harvard Univ Initiat Global Hlth, Cambridge, MA 02138 USA; Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; JHPIEGO, Baltimore, MD USA; WHO, Pan Amer Hlth Org, Washington, DC USA; Program Appropriate Technol Hlth, Seattle, WA USA; WHO, Int Agcy Res Canc, Lyon, France; Columbia Univ, Coll Phys & Surg, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Jhpiego; Pan American Health Organization; World Health Organization; World Health Organization; International Agency for Research on Cancer (IARC); Columbia University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Harvard Univ Initiat Global Hlth, 104 Mt Auburn St,3rd Fl, Cambridge, MA 02138 USA.	sue_goldie@harvard.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	NCI NIH HHS [R01 CA93435] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*ACCP, EFF SAF ACC CRYOTH S; Aggarwal R, 2003, J HEPATOL, V38, P215, DOI 10.1016/S0168-8278(02)00382-3; BOSCH FX, 2003, NCI MONOGRAPH, V31; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; *DEP COMM, 1999 INC DAT; *DEP LAB, WAG BEN POV LIN M WO; Disease control priorities in developing countries, DIS CONTROL PRIORITI; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gaffikin L, 1999, LANCET, V353, P869; Gold MR., 1996, COST EFFECTIVENESS H; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V286, P1026; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; *INT CTR TROP AGR, ACC TRANSP TRAV TIM; *INT LAB OFF, WOM MEN INF EC STAT; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; VANBALLEGOOIJEN M, 1992, EUR J CANCER, V28A, P1703, DOI 10.1016/0959-8049(92)90072-A; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; *WHO, WHO STAT INF SYST CH; *WHO, LIF TABL 191 COUNTR; Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161; World Health Organization, 2001, MACROECONOMICS HLTH; NOMINAL INTERBANK EX	29	435	448	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2005	353	20					2158	2168		10.1056/NEJMsa044278	http://dx.doi.org/10.1056/NEJMsa044278			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984FT	16291985				2022-12-01	WOS:000233288600008
J	Mitra, K; Schaffitzel, C; Shaikh, T; Tama, F; Jenni, S; Brooks, CL; Ban, N; Frank, J				Mitra, K; Schaffitzel, C; Shaikh, T; Tama, F; Jenni, S; Brooks, CL; Ban, N; Frank, J			Structure of the E-coli protein-conducting channel bound to a translating ribosome	NATURE			English	Article							ENDOPLASMIC-RETICULUM; TRANSLOCATION CHANNEL; CROSS-LINKING; ANGSTROM RESOLUTION; ELECTRON-MICROSCOPY; BACTERIAL PROTEIN; MEMBRANE-VESICLES; PLASMA-MEMBRANE; SIGNAL SEQUENCE; SEC61 COMPLEX	Secreted and membrane proteins are translocated across or into cell membranes through a protein-conducting channel (PCC). Here we present a cryo-electron microscopy reconstruction of the Escherichia coli PCC, SecYEG, complexed with the ribosome and a nascent chain containing a signal anchor. This reconstruction shows a messenger RNA, three transfer RNAs, the nascent chain, and detailed features of both a translocating PCC and a second, non-translocating PCC bound to mRNA hairpins. The translocating PCC forms connections with ribosomal RNA hairpins on two sides and ribosomal proteins at the back, leaving a frontal opening. Normal mode-based flexible fitting of the archaeal SecYE beta structure into the PCC electron microscopy densities favours a front-to-front arrangement of two SecYEG complexes in the PCC, and supports channel formation by the opening of two linked SecY halves during polypeptide translocation. On the basis of our observation in the translocating PCC of two segregated pores with different degrees of access to bulk lipid, we propose a model for co-translational protein translocation.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	Joachim@wadsworth.org	tama, florence/S-2733-2019; Tama, Florence/A-7077-2016	tama, florence/0000-0003-2021-5618; Tama, Florence/0000-0003-2021-5618; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255, P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR012255, P41 RR001219] Funding Source: Medline; NIGMS NIH HHS [R01 GM055440, R37 GM029169] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; HIGH S, 1993, J BIOL CHEM, V268, P26745; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Laird V, 1997, J BIOL CHEM, V272, P1983, DOI 10.1074/jbc.272.3.1983; Levy R, 2001, J BIOL CHEM, V276, P2340, DOI 10.1074/jbc.M004867200; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; SIMON SM, 1989, P NATL ACAD SCI USA, V86, P6176, DOI 10.1073/pnas.86.16.6176; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; TANI K, 1990, J BIOL CHEM, V265, P17341; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.biochem.60.1.101; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Zito CR, 2003, J BIOL CHEM, V278, P40640, DOI 10.1074/jbc.M308025200	49	214	227	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2005	438	7066					318	324		10.1038/nature04133	http://dx.doi.org/10.1038/nature04133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984JR	16292303	Green Accepted			2022-12-01	WOS:000233300200040
J	Wilson, JF				Wilson, JF			Why prion diseases are a mystery, and why they matter	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2005	143	10					773	776						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986YY	16287812				2022-12-01	WOS:000233486800027
J	Smith, GD; Ebrahim, S				Smith, GD; Ebrahim, S			Folate supplementation and cardiovascular disease	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; ESTROGEN REPLACEMENT THERAPY; QUANTITATIVE ASSESSMENT; FOLIC-ACID; VITAMIN-E; RISK; HOMOCYSTEINE; PREVENTION; MTHFR		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	George.Davey-Smith@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				*B VIT TREATM TRIA, IN PRESS AM HEART; Baker F, 2002, CIRCULATION, V106, P741; BONAA KH, 2005, NORVIT RANDOMISED TR; Charles D, 2004, BMJ-BRIT MED J, V329, P1375, DOI 10.1136/bmj.329.7479.1375; Cronin S, 2005, STROKE, V36, P1581, DOI 10.1161/01.STR.0000169946.31639.af; Eidelman RS, 2004, ARCH INTERN MED, V164, P1552, DOI 10.1001/archinte.164.14.1552; Hultdin J, 2005, INT J CANCER, V113, P819, DOI 10.1002/ijc.20646; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; MANSON JE, 1991, CIRCULATION S2, V84, P546; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Potter JD, 2005, LANCET, V366, P527, DOI 10.1016/S0140-6736(05)67077-8; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stampfer MJ, 2004, INT J EPIDEMIOL, V33, P445, DOI 10.1093/ije/dyh125; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Willett W.C., 2001, EAT DRINK HLTH HARVA	23	47	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2005	366	9498					1679	1681		10.1016/S0140-6736(05)67676-3	http://dx.doi.org/10.1016/S0140-6736(05)67676-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983BP	16291049				2022-12-01	WOS:000233206400007
J	Yaggi, HK; Concato, J; Kernan, WN; Lichtman, JH; Brass, LM; Mohsenin, V				Yaggi, HK; Concato, J; Kernan, WN; Lichtman, JH; Brass, LM; Mohsenin, V			Obstructive sleep apnea as a risk factor for stroke and death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; BREATHING DISORDERS; BRAIN INFARCTION; BLOOD-PRESSURE; MORTALITY; ADULTS; HYPERTENSION; HYPOPNEA; 1ST-EVER	BACKGROUND: Previous studies have suggested that the obstructive sleep apnea syndrome may be an important risk factor for stroke. It has not been determined, however, whether the syndrome is independently related to the risk of stroke or death from any cause after adjustment for other risk factors, including hypertension. METHODS: In this observational cohort study, consecutive patients underwent polysomnography, and subsequent events (strokes and deaths) were verified. The diagnosis of the obstructive sleep apnea syndrome was based on an apnea-hypopnea index of 5 or higher (five or more events per hour); patients with an apnea-hypopnea index of less than 5 served as the comparison group. Proportional-hazards analysis was used to determine the independent effect of the obstructive sleep apnea syndrome on the composite outcome of stroke or death from any cause. RESULTS: Among 1022 enrolled patients, 697 (68 percent) had the obstructive sleep apnea syndrome. At baseline, the mean apnea-hypopnea index in the patients with the syndrome was 35, as compared with a mean apnea-hypopnea index of 2 in the comparison group. In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death from any cause (hazard ratio, 2.24; 95 percent confidence interval, 1.30 to 3.86; P=0.004). After adjustment for age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus, hyperlipidemia, atrial fibrillation, and hypertension, the obstructive sleep apnea syndrome retained a statistically significant association with stroke or death (hazard ratio, 1.97; 95 percent confidence interval, 1.12 to 3.48; P=0.01). In a trend analysis, increased severity of sleep apnea at baseline was associated with an increased risk of the development of the composite end point (P=0.005). CONCLUSIONS: The obstructive sleep apnea syndrome significantly increases the risk of stroke or death from any cause, and the increase is independent of other risk factors, including hypertension.	Yale Ctr Sleep Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Med Genet Sect, New Haven, CT USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Vet Affairs Connecticut Healthcare Syst, Pulm & Crit Care Med Sect, West Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, Neurol Sect, West Haven, CT USA	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Mohsenin, V (corresponding author), Yale Ctr Sleep Med, Pulm & Crit Care Med Sect, 300 Cedar St,TAC 441,POB 208057, New Haven, CT 06520 USA.		Ebben, Matthew R/I-4561-2012	Ebben, Matthew R/0000-0002-4399-7010	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007778] Funding Source: NIH RePORTER; NHLBI NIH HHS [5T32HL07778] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 2005, HEART DIS STROKE STA; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Beelke M, 2002, SLEEP, V25, P856; BOKINSKY G, 1995, CHEST, V108, P625, DOI 10.1378/chest.108.3.625; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Chin K, 1996, AM J RESP CRIT CARE, V153, P1972, DOI 10.1164/ajrccm.153.6.8665063; Diomedi M, 1998, NEUROLOGY, V51, P1051, DOI 10.1212/WNL.51.4.1051; Dyken ME, 1996, STROKE, V27, P401, DOI 10.1161/01.STR.27.3.401; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Franklin KA, 2002, SLEEP MED REV, V6, P429, DOI 10.1053/smrv.2001.0206; Hayashi M, 2003, CHEST, V124, P936, DOI 10.1378/chest.124.3.936; HEDNER J, 1988, J HYPERTENS, V6, pS529, DOI 10.1097/00004872-198812040-00166; JENNUM P, 1989, CHEST, V95, P279, DOI 10.1378/chest.95.2.279; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; Kato M, 2000, CIRCULATION, V102, P2607; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; Meoli AL, 2001, SLEEP, V24, P469; Meschia JF, 2000, STROKE, V31, P1076, DOI 10.1161/01.STR.31.5.1076; MOHSENIN V, 1995, ARCH PHYS MED REHAB, V76, P71, DOI 10.1016/S0003-9993(95)80046-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NEAU JP, 1995, ACTA NEUROL SCAND, V92, P63; Netzer N, 1998, STROKE, V29, P87, DOI 10.1161/01.STR.29.1.87; PALOMAKI H, 1991, STROKE, V22, P1021, DOI 10.1161/01.STR.22.8.1021; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; PARTINEN M, 1985, LANCET, V2, P1325; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Schisterman Enrique F, 2004, Popul Health Metr, V2, P2, DOI 10.1186/1478-7954-2-2; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; SMIRNE S, 1993, EUR RESPIR J, V6, P1357; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; SPRIGGS DA, 1992, Q J MED, V83, P555; WHISNANT J P, 1990, Stroke, V21, P637; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	41	1995	2104	5	160	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2005	353	19					2034	2041		10.1056/NEJMoa043104	http://dx.doi.org/10.1056/NEJMoa043104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981WV	16282178				2022-12-01	WOS:000233119600008
J	Garcia-Diaz, M; Bebenek, K; Krahn, JM; Pedersen, LC; Kunkel, TA				Garcia-Diaz, M; Bebenek, K; Krahn, JM; Pedersen, LC; Kunkel, TA			Structural analysis of strand misalignment during DNA synthesis by a human DNA polymerase	CELL			English	Article							BASE EXCISION-REPAIR; MICROSATELLITE INSTABILITY; FRAMESHIFT MUTATIONS; CRYSTAL-STRUCTURE; REPLICATION FIDELITY; MISMATCH REPAIR; ERROR-PRONE; POL LAMBDA; FAMILY; MECHANISM	Insertions and deletions in coding sequences can alter the reading frame of genes and have profound biological consequences. In 1966, Streisinger proposed that these mutations result from strand slippage, which in repetitive sequences generates misaligned intermediates stabilized by correct base pairing that support polymerization. We report here crystal structures of human DNA polymerase lambda, which frequently generates deletion mutations, bound to such intermediates. Each contains an extra-helical template nucleotide upstream of the active site. Surprisingly, the extra nucleotide, even when combined with an adjacent mismatch, does not perturb polymerase active site geometry, which is indistinguishable from that for correctly aligned strands. These structures reveal how pol lambda can polymerize on substrates with minimal homology during repair of double-strand breaks and represent strand-slippage intermediates consistent with Streisinger's classical hypothesis. They are thus relevant to the origin of single-base deletions, a class of mutations that can confer strong biological phenotypes.	NIEHS, Struct Biol Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Genet Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kunkel, TA (corresponding author), NIEHS, Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Pedersen, Lars/C-6173-2019	Kunkel, Thomas A./0000-0002-9900-1788; Pedersen, Lars/0000-0002-4488-4077	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bebenek K, 2003, J BIOL CHEM, V278, P34685, DOI 10.1074/jbc.M305705200; Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81; BEBENEK K, 2004, VOL ADV PROTEIN CHEM, V69; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Duval A, 2002, CANCER RES, V62, P2447; Efrati E, 1997, J BIOL CHEM, V272, P2559; Estabrook RA, 2004, J BIOL CHEM, V279, P31419, DOI 10.1074/jbc.M402950200; Fan W, 2004, BIOCHEM BIOPH RES CO, V323, P1328, DOI 10.1016/j.bbrc.2004.09.002; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Gollin SM, 2004, CURR OPIN ONCOL, V16, P25, DOI 10.1097/00001622-200401000-00006; Hashim MF, 1997, J BIOL CHEM, V272, P20205, DOI 10.1074/jbc.272.32.20205; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHUATOR L, 1992, J MOL BIOL, V225, P397, DOI 10.1016/0022-2836(92)90929-E; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MILLER M, 1988, NATURE, V334, P85, DOI 10.1038/334085a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Wells R.D., 1998, GENETIC INSTABILITIE; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; WOODSON SA, 1988, BIOCHEMISTRY-US, V27, P3130, DOI 10.1021/bi00409a004	60	82	82	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 27	2006	124	2					331	342		10.1016/j.cell.2005.10.039	http://dx.doi.org/10.1016/j.cell.2005.10.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439207	Bronze			2022-12-01	WOS:000235068500021
J	Field, DB; Baumgartner, TR; Charles, CD; Ferreira-Bartrina, V; Ohman, MD				Field, DB; Baumgartner, TR; Charles, CD; Ferreira-Bartrina, V; Ohman, MD			Planktonic foraminifera of the California Current reflect 20th-century warming	SCIENCE			English	Article							SANTA-BARBARA BASIN; DECADAL CLIMATE VARIABILITY; LONG-TERM CHANGES; CURRENT SYSTEM; WORLDS OCEANS; EL-NINO; PACIFIC; OSCILLATION; RECORD	It is currently unclear whether observed pelagic ecosystem responses to ocean warming, such as a mid-1970s change in the eastern North Pacific, depart from typical ocean variability. We report variations in planktonic foraminifera from varved sediments off southern California spanning the past 1400 years. Increasing abundances of tropical/subtropical species throughout the 20th century reflect a warming trend superimposed on decadal-scale fluctuations. Decreasing abundances of temperate/subpolar species in the late 20th century indicate a deep, penetrative warming not observed in previous centuries. These results imply that 20th-century warming, apparently anthropogenic, has already affected lower trophic levels of the California Current.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Ctr Invest Cient & Educ Super Ensenada, Ensenada 22860, Baja California, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Field, DB (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	dfield@mbari.org	Ohman, Mark D/C-8763-2009	Ohman, Mark D/0000-0001-8136-3695				BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Biondi F, 2001, J CLIMATE, V14, P5, DOI 10.1175/1520-0442(2001)014<0005:NPDCVS>2.0.CO;2; Black DE, 2001, GEOLOGY, V29, P1075, DOI 10.1130/0091-7613(2001)029<1075:PFRTTE>2.0.CO;2; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; D'Arrigo R, 2001, CLIM DYNAM, V18, P219, DOI 10.1007/s003820100177; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; EBBESMEYER CC, 1991, CALIFORNIA DEP WAT R, V26, P129; ENFIELD DB, 2001, INTERHEMISPHERIC CLI, P17; Field DB, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000970; FIELD DB, 2004, THESIS U CALIFORNIA; GRAHAM NE, 1995, SCIENCE, V267, P666, DOI 10.1126/science.267.5198.666; Hemleben Ch, 1989, MODERN PLANKTONIC FO, DOI DOI 10.1016/S0016-6995(89)80108-1; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Kincaid E, 2000, DEEP-SEA RES PT II, V47, P1157, DOI 10.1016/S0967-0645(99)00140-X; LANGE CB, 1987, MAR GEOL, V78, P153, DOI 10.1016/0025-3227(87)90074-0; Lavaniegos BE, 2003, DEEP-SEA RES PT II, V50, P2473, DOI 10.1016/S0967-0645(03)00132-2; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Miller AJ., 1994, OCEANOGRAPHY, V7, P21, DOI [10.5670/oceanog.1994.11, DOI 10.5670/OCEANOG.1994.11]; ORTIZ JD, 1995, PALEOCEANOGRAPHY, V10, P987, DOI 10.1029/95PA02088; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; SAUTTER LR, 1991, J FORAMIN RES, V21, P347, DOI 10.2113/gsjfr.21.4.347; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Tegner MJ, 1996, CAL COOP OCEAN FISH, V37, P111; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; [No title captured]	34	127	131	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2006	311	5757					63	66		10.1126/science.1116220	http://dx.doi.org/10.1126/science.1116220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001ON	16400144	Green Submitted			2022-12-01	WOS:000234546300032
J	Bellouin, N; Boucher, O; Haywood, J; Reddy, MS				Bellouin, N; Boucher, O; Haywood, J; Reddy, MS			Global estimate of aerosol direct radiative forcing from satellite measurements	NATURE			English	Article							OPTICAL-PROPERTIES; PRODUCTS; ALGORITHM	Atmospheric aerosols cause scattering and absorption of incoming solar radiation. Additional anthropogenic aerosols released into the atmosphere thus exert a direct radiative forcing on the climate system(1). The degree of present-day aerosol forcing is estimated from global models that incorporate a representation of the aerosol cycles(1-3). Although the models are compared and validated against observations, these estimates remain uncertain. Previous satellite measurements of the direct effect of aerosols contained limited information about aerosol type, and were confined to oceans only(4,5). Here we use state-of-the-art satellite-based measurements of aerosols(6-8) and surface wind speed(9) to estimate the clear-sky direct radiative forcing for 2002, incorporating measurements over land and ocean. We use a Monte Carlo approach to account for uncertainties in aerosol measurements and in the algorithm used. Probability density functions obtained for the direct radiative forcing at the top of the atmosphere give a clear-sky, global, annual average of -1.9 W m(-2) with standard deviation, +/-0.3 W m(-2). These results suggest that present-day direct radiative forcing is stronger than present model estimates, implying future atmospheric warming greater than is presently predicted, as aerosol emissions continue to decline(10).	Met Off, Exeter EX1 3PB, Devon, England; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	Met Office - UK; National Oceanic Atmospheric Admin (NOAA) - USA	Bellouin, N (corresponding author), Met Off, Exeter EX1 3PB, Devon, England.	nicolas.bellouin@metoffice.gov.uk	Boucher, Olivier/J-5810-2012; Boucher, Olivier/K-7483-2012; Haywood, Jim/GQA-6691-2022	Boucher, Olivier/0000-0003-2328-5769; Boucher, Olivier/0000-0003-2328-5769; Bellouin, Nicolas/0000-0003-2109-9559; Haywood, Jim/0000-0002-2143-6634				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Bellouin N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017121; Christopher SA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014803; Collins WD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001365; COX C, 1954, J MAR RES, V13, P198; Dubovik O, 2002, J ATMOS SCI, V59, P590, DOI 10.1175/1520-0469(2002)059<0590:VOAAOP>2.0.CO;2; Herman JR, 1997, J GEOPHYS RES-ATMOS, V102, P16911, DOI 10.1029/96JD03680; Kaufman YJ, 1997, J GEOPHYS RES-ATMOS, V102, P17051, DOI 10.1029/96JD03988; Keil A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002315; Key JR, 1998, COMPUT GEOSCI, V24, P443, DOI 10.1016/S0098-3004(97)00130-1; Kirkevag A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000886; Osborne SR, 2005, ATMOS RES, V73, P173, DOI 10.1016/j.atmosres.2004.09.002; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; RAMASWARNY V, 2001, CLIMATE CHANGE 2001; Reddy MS, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004757; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Roberts DL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004676; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Smirnov A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003879; Stier P, 2005, ATMOS CHEM PHYS, V5, P1125, DOI 10.5194/acp-5-1125-2005; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; Tanre D, 1997, J GEOPHYS RES-ATMOS, V102, P16971, DOI 10.1029/96JD03437; Wentz FJ, 1997, J GEOPHYS RES-OCEANS, V102, P8703, DOI 10.1029/96JC01751	23	354	373	11	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1138	1141		10.1038/nature04348	http://dx.doi.org/10.1038/nature04348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372005				2022-12-01	WOS:000234111500046
J	Knauth, LP; Burt, DM; Wohletz, KH				Knauth, LP; Burt, DM; Wohletz, KH			Impact origin of sediments at the opportunity landing site on Mars	NATURE			English	Article							MERIDIANI-PLANUM; ACCRETIONARY LAPILLI; CRATER EJECTA; HEMATITE; WATER; GEOCHEMISTRY; ENVIRONMENT; SPHERULES; SUEVITE; BRINES	Mars Exploration Rover Opportunity discovered sediments with layered structures thought to be unique to aqueous deposition and with minerals attributed to evaporation of an acidic salty sea. Remarkable iron-rich spherules were ascribed to later groundwater alteration, and the inferred abundance of water reinforced optimism that Mars was once habitable. The layered structures, however, are not unique to water deposition, and the scenario encounters difficulties in accounting for highly soluble salts admixed with less soluble salts, the lack of clay minerals from acid - rock reactions, high sphericity and near- uniform sizes of the spherules and the absence of a basin boundary. Here we present a simple alternative explanation involving deposition from a ground-hugging turbulent flow of rock fragments, salts, sulphides, brines and ice produced by meteorite impact. Subsequent weathering by intergranular water films can account for all of the features observed without invoking shallow seas, lakes or near- surface aquifers. Layered sequences observed elsewhere on heavily cratered Mars and attributed to wind, water or volcanism may well have formed similarly. If so, the search for past life on Mars should be reassessed accordingly.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Los Alamos National Laboratory	Knauth, LP (corresponding author), Arizona State Univ, Dept Geol Sci, Box 871404, Tempe, AZ 85287 USA.	Knauth@asu.edu						Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BOHOR BF, 1995, METEORITICS, V30, P182, DOI 10.1111/j.1945-5100.1995.tb01113.x; BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1; BRUECKNER J, 2005, LUNAR PLANET SCI, V36; Bullock MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019980; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14169, DOI 10.1029/JB095iB09p14169; Burt DM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001862; CARLSON RH, 1962, PNE217P U CAL LAW RA; Carr M. H., 1977, Journal of Geophysical Research, V82, P4055, DOI 10.1029/JS082i028p04055; Cas R.A.F., 1988, VOLCANIC SUCCESSIONS, P348, DOI DOI 10.1007/978-94-009-3167-1; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Chan MA, 2004, NATURE, V429, P731, DOI 10.1038/nature02600; Christensen PR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002233; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Dressler BO, 2004, METEORIT PLANET SCI, V39, P857, DOI 10.1111/j.1945-5100.2004.tb00935.x; Dutrizac JE, 2000, REV MINERAL GEOCHEM, V40, P405, DOI 10.2138/rmg.2000.40.8; FISHER RV, 1970, AM J SCI, V268, P157, DOI 10.2475/ajs.268.2.157; FISHER RV, 1984, PYROCLASTIC ROCKS, P249; GARVIN JB, 2002, LUNAR PLANET SCI, V33; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Glasstone S, 1977, EFFECTS NUCL WEAPONS, V3rd; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; GOLOMBEK MP, 2005, LUNAR PLANET SCI, V36; GRAUP G, 1981, EARTH PLANET SC LETT, V55, P407, DOI 10.1016/0012-821X(81)90168-0; Hunt C. B., 1966, 494B US GEOL SURV; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Kerr RA, 2004, SCIENCE, V306, P2010, DOI 10.1126/science.306.5704.2010; KIEFFER SW, 1980, REV GEOPHYS, V18, P143, DOI 10.1029/RG018i001p00143; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Knauth LP, 2003, GEOCHIM COSMOCHIM AC, V67, P185, DOI 10.1016/S0016-7037(02)01051-7; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Lowe DR, 2003, ASTROBIOLOGY, V3, P7, DOI 10.1089/153110703321632408; LOWE DR, 1978, J SEDIMENT PETROL, V48, P709; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI 10.1016/0012-821X(74)90115-0; MCPHIE J, 1990, B VOLCANOL, V52, P334, DOI 10.1007/BF00302047; Melosh H.L, 1989, IMPACT CRATERING GEO; MELOSH HJ, 2004, METEORIT PLANET SCI, V39; MITCHELL DL, 2002, LUNAR PLANET SCI, V33; OBERBECK VR, 1975, REV GEOPHYS, V13, P337, DOI 10.1029/RG013i002p00337; Osinski GR, 2004, METEORIT PLANET SCI, V39, P1655, DOI 10.1111/j.1945-5100.2004.tb00065.x; SCHULTZ PH, 1979, J GEOPHYS RES, V84, P7669, DOI 10.1029/JB084iB13p07669; SCHUMACHER R, 1995, B VOLCANOL, V56, P626, DOI 10.1007/s004450050069; Sheridan M.F., 1983, MICROBEAM ANAL, P35; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VALENTINE GA, 1989, B VOLCANOL, V51, P395, DOI 10.1007/BF01078808; WOHLETZ KH, 1983, ICARUS, V56, P15, DOI 10.1016/0019-1035(83)90125-2; WOHLETZ KH, 1984, GEOLOGY, V12, P591, DOI 10.1130/0091-7613(1984)12<591:VASDPP>2.0.CO;2; WOHLETZ KH, 1998, DEV VOLCANOLOGY MAGM, P247	50	108	109	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2005	438	7071					1123	1128		10.1038/nature04383	http://dx.doi.org/10.1038/nature04383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995OF	16372001				2022-12-01	WOS:000234111500042
J	Dial, S; Delaney, JAC; Barkun, AN; Suissa, S				Dial, S; Delaney, JAC; Barkun, AN; Suissa, S			Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTON PUMP INHIBITORS; GENERAL-PRACTICE; DIARRHEA; OMEPRAZOLE; INFECTION; COLITIS; COLONIZATION; COHORT; EPIDEMIOLOGY; INFORMATION	Context Recent reports suggest an increasing occurrence and severity of Clostridium difficile-associated disease. We assessed whether the use of gastric acid-suppressive agents is associated with an increased risk in the community. Objective To determine whether the use of gastric acid-suppressive agents increases the risk of C difficile-associated disease in a community population. Design, Setting, and Patients We conducted 2 population-based case-control studies using the United Kingdom General Practice Research Database (GPRD). In the first study we identified all 1672 cases of C difficile recorded between 1994 and 2004 among all patients registered for at least 2 years in each practice. Each case was matched to 10 controls on calendar time and the general practice. In the second study, a subset of these cases defined as community-acquired, that is, not hospitalized in the prior year, were matched on practice and age with controls also not hospitalized in the prior year. Main Outcome Measures The incidence of C difficile and risk associated with gastric acid-suppressive agent use. Results The incidence of C difficile in patients diagnosed by their general practitioners in the General Practice Research Database increased from less than 1 case per 100 000 in 1994 to 22 per 100 000 in 2004. The adjusted rate ratio of C difficile-associated disease with current use of proton pump inhibitors was 2.9 (95% confidence interval [CI], 2.4-3.4) and with H-2-receptor antagonists the rate ratio was 2.0 (95% Cl, 1.6-2.7). An elevated rate was also found with the use of nonsteroidal anti-inflammatory drugs (rate ratio, 1.3; 95% Cl, 1.2-1.5). Conclusions The use of acid-suppressive therapy, particularly proton pump inhibitors, is associated with an increased risk of community-acquired C difficile. The unexpected increase in risk with nonsteroidal anti-inflammatory drug use should be investigated further.	McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Div Gastroenterol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Div Crit Care & Resp & Clin Res, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Dial, S (corresponding author), 3650 St Urbain,Room K1 14, Montreal, PQ H2X 2P4, Canada.	sandra.dial@mcgill.ca	Delaney, Joseph A/J-8204-2019	Delaney, Joseph A/0000-0003-1771-1776				Agastya G, 2000, IMMUNOPHARM IMMUNOT, V22, P357, DOI 10.3109/08923970009016425; Al-Tureihi Farrah Ibrahim J, 2005, J Am Med Dir Assoc, V6, P105, DOI 10.1016/j.jamda.2005.01.003; [Anonymous], 2000, PHARMACOEPIDEM DR S; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Barrett S, 2004, J HOSP INFECT, V56, P83, DOI 10.1016/j.jhin.2003.12.001; Beaugerie L, 2003, ALIMENT PHARM THER, V17, P905, DOI 10.1046/j.1365-2036.2003.01531.x; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Cunney RJ, 1998, NEPHROL DIAL TRANSPL, V13, P2842, DOI 10.1093/ndt/13.11.2842; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; FALSEN E, 1980, J CLIN MICROBIOL, V12, P297, DOI 10.1128/JCM.12.3.297-300.1980; GENTRIC A, 1992, LANCET, V340, P126, DOI 10.1016/0140-6736(92)90459-G; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; HIRSCHHORN LR, 1994, J INFECT DIS, V169, P127, DOI 10.1093/infdis/169.1.127; *HLTH PROT AG, REP CLOSTR DIFF IS F; *IMS HLTH NAT SAL, 2004 YEAR END US PRE; Itskowitz MS, 2003, ADV STUD MED, V3, P571; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; Klingensmith ME, 1999, SURGERY, V126, P272, DOI 10.1016/S0039-6060(99)70165-0; Kyne L, 1998, J INFECTION, V36, P287, DOI 10.1016/S0163-4453(98)94207-4; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; *MCDONALD LC, 2004, INF DIS SOC AM 42 AN; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; Meyer AM, 2004, J CLIN GASTROENTEROL, V38, P772, DOI 10.1097/01.mcg.0000139057.05297.d6; MOSKOVITZ M, 1981, ARCH INTERN MED, V141, P663, DOI 10.1001/archinte.141.5.663; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Mylonaki M, 2004, EUR J GASTROEN HEPAT, V16, P775, DOI 10.1097/01.meg.0000131040.38607.09; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Price AB, 2003, BRIT J CLIN PHARMACO, V56, P477, DOI 10.1046/j.1365-2125.2003.01980.x; RILEY TV, 1986, J HYG-CAMBRIDGE, V96, P13, DOI 10.1017/S0022172400062483; ROBERT A, 1985, PROSTAG OTH LIPID M, V29, P961, DOI 10.1016/0090-6980(85)90221-7; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Romero-Gomez M, 1998, J CLIN GASTROENTEROL, V26, P228, DOI 10.1097/00004836-199804000-00018; RUWART MJ, 1983, ADV PROSTAG THROMB L, V12, P93; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; SIMOR AE, 1993, CLIN INFECT DIS, V17, P672, DOI 10.1093/clinids/17.4.672; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; VIAL T, 1991, DRUG SAFETY, V6, P94, DOI 10.2165/00002018-199106020-00002; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Weightman NC, 2004, J HOSP INFECT, V56, P1, DOI 10.1016/j.jhin.2003.09.006; West BC, 1998, CLIN INFECT DIS, V26, P1234, DOI 10.1086/598353; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; WILCOX M, 2001, 41 INT C ANT AG CHEM; Wilcox MH, 2003, BEST PRACT RES CL GA, V17, P475, DOI 10.1016/S1521-6918(03)00017-9; Williams C, 2001, BEST PRACT RES CL GA, V15, P511, DOI 10.1053/bega.2001.0191; WILSON KH, 1985, J INFECT DIS, V151, P355, DOI 10.1093/infdis/151.2.355; Wilton LV, 2003, DRUG SAFETY, V26, P121, DOI 10.2165/00002018-200326020-00005; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	63	694	721	3	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 21	2005	294	23					2989	2995		10.1001/jama.294.23.2989	http://dx.doi.org/10.1001/jama.294.23.2989			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995GB	16414946	Bronze			2022-12-01	WOS:000234087700025
J	Sankaran, M; Hanan, NP; Scholes, RJ; Ratnam, J; Augustine, DJ; Cade, BS; Gignoux, J; Higgins, SI; Le Roux, X; Ludwig, F; Ardo, J; Banyikwa, F; Bronn, A; Bucini, G; Caylor, KK; Coughenour, MB; Diouf, A; Ekaya, W; Feral, CJ; February, EC; Frost, PGH; Hiernaux, P; Hrabar, H; Metzger, KL; Prins, HHT; Ringrose, S; Sea, W; Tews, J; Worden, J; Zambatis, N				Sankaran, M; Hanan, NP; Scholes, RJ; Ratnam, J; Augustine, DJ; Cade, BS; Gignoux, J; Higgins, SI; Le Roux, X; Ludwig, F; Ardo, J; Banyikwa, F; Bronn, A; Bucini, G; Caylor, KK; Coughenour, MB; Diouf, A; Ekaya, W; Feral, CJ; February, EC; Frost, PGH; Hiernaux, P; Hrabar, H; Metzger, KL; Prins, HHT; Ringrose, S; Sea, W; Tews, J; Worden, J; Zambatis, N			Determinants of woody cover in African savannas	NATURE			English	Article							TREE-GRASS COEXISTENCE; QUANTILE REGRESSION; FIRE; VEGETATION; MECHANISMS; STABILITY; SYSTEMS	Savannas are globally important ecosystems of great significance to human economies. In these biomes, which are characterized by the co-dominance of trees and grasses, woody cover is a chief determinant of ecosystem properties(1-3). The availability of resources ( water, nutrients) and disturbance regimes ( fire, herbivory) are thought to be important in regulating woody cover(1,2,4,5), but perceptions differ on which of these are the primary drivers of savanna structure. Here we show, using data from 854 sites across Africa, that maximum woody cover in savannas receiving a mean annual precipitation (MAP) of less than similar to 650 mm is constrained by, and increases linearly with, MAP. These arid and semi-arid savannas may be considered 'stable' systems in which water constrains woody cover and permits grasses to coexist, while fire, herbivory and soil properties interact to reduce woody cover below the MAP-controlled upper bound. Above a MAP of similar to 650 mm, savannas are 'unstable' systems in which MAP is sufficient for woody canopy closure, and disturbances ( fire, herbivory) are required for the coexistence of trees and grass. These results provide insights into the nature of African savannas and suggest that future changes in precipitation(6) may considerably affect their distribution and dynamics.	Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; CSIR, Div Forest Sci & Technol, ZA-001 Pretoria, South Africa; Forest Serv, USDA, Commanche Natl Grassland, Springfield, CO 81073 USA; US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; Univ Paris 06, CNRS, UMR 7625, Lab Ecol,Ecole Normale Super, F-75230 Paris, France; UFZ Helmholtz Ctr Environm Res, Sekt Okosyst Anal, D-04318 Leipzig, Germany; Univ Lyon 1, CNRS, UMR 5557,Microbial Ecol Lab, USC INRA 1193, F-69622 Villeurbanne, France; CSIRO Plant Ind, CSIRO Ctr Environm & Life Sci, Wembley, WA 6913, Australia; Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden; Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; Port Elizabeth Technikon, Dept Agr & Game Management, ZA-6000 Port Elizabeth, South Africa; Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; Ctr Suivi Ecol, Dakar, Senegal; Univ Nairobi, Dept Range Management, Nairobi, Kenya; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; Univ Zimbabwe, Inst Environm Studies, Harare, Zimbabwe; CESBIO, F-31401 Toulouse, France; Univ Pretoria, Mammal Res Inst, ZA-002 Pretoria, South Africa; Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wageningen & Res Ctr, Resource Ecol Grp, NL-6708 PD Wageningen, Netherlands; Univ Botswana, Harry Oppenheimer Okavango Res Ctr, Maun, Botswana; Univ Potsdam, Inst Biochem & Biol Plant Ecol & Nat Conservat, D-14469 Potsdam, Germany; Kruger Natl Pk, Sci Serv, ZA-1350 Skukuza, South Africa	Colorado State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Lund University; University of Dar es Salaam; Nelson Mandela University; Princeton University; University of Nairobi; University of Virginia; University of Cape Town; University of Zimbabwe; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Pretoria; University of Wisconsin System; University of Wisconsin Madison; Wageningen University & Research; University of Botswana; University of Potsdam	Sankaran, M (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	mahesh@nrel.colostate.edu	Noojipady, Praveen/B-2511-2010; Augustine, David/H-6167-2011; Mitchard, Edward T A/C-6346-2009; Higgins, Steven I/A-5138-2012; Caylor, Kelly/ABF-2818-2020; Ludwig, Fulco/N-7732-2013; Caylor, Kelly/B-7734-2008	Mitchard, Edward T A/0000-0002-5690-4055; Higgins, Steven I/0000-0001-5695-9665; Caylor, Kelly/0000-0002-6466-6448; Caylor, Kelly/0000-0002-6466-6448; Augustine, David/0000-0003-3144-0466; Ardo, Jonas/0000-0002-9318-0973; Hanan, Niall/0000-0002-9130-5306; LUDWIG, FULCO/0000-0001-6479-9657; Scholes, Robert/0000-0001-5537-6935; LE ROUX, Xavier/0000-0001-9695-0825; Prins, Herbert/0000-0003-1131-5107; Ringrose, Susan/0000-0003-4788-4133; Sea, William/0000-0001-6631-6735				[Anonymous], 1983, VEGETATION AFRICA DE; [Anonymous], 2001, CLIMATE CHANGE 2001; Barbosa PM, 1999, GLOBAL BIOGEOCHEM CY, V13, P933, DOI 10.1029/1999GB900042; Bond WJ, 2003, S AFR J BOT, V69, P79, DOI 10.1016/S0254-6299(15)30362-8; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Breimann L, 1984, CLASSIFICATION REGRE; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.2307/3868138; Chiu GS, 2002, THESIS S FRASER U; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Frost P.G.H., 1986, RESPONSE SAVANNAS ST; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; HuskovSS, 1994, ASYMPTOTIC STAT, P349, DOI [10.1007/978-3-642-57984-4_29, DOI 10.1007/978-3-642-57984-4_29]; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jeltsch F, 2000, PLANT ECOL, V150, P161, DOI 10.1023/A:1026590806682; Koenker R, 1996, J ECONOMETRICS, V71, P265, DOI 10.1016/0304-4076(96)84507-6; Koenker R, 1987, APPL STAT-J ROY ST C, V36, P383, DOI DOI 10.2307/2347802; MCNAUGHTON SJ, 1992, J VEG SCI, V3, P301, DOI 10.2307/3235755; Rejwan C, 1999, ECOLOGY, V80, P341, DOI 10.1890/0012-9658(1999)080[0341:TRAOTN]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Simioni G, 2003, ECOLOGY, V84, P1879, DOI 10.1890/0012-9658(2003)084[1879:TLSSCA]2.0.CO;2; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Walker B. H., 1982, Ecology of tropical savannas, P556; Walker BH, 1997, J BIOGEOGR, V24, P813, DOI 10.1046/j.1365-2699.1997.00123.x; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Walter H., 1971, ECOLOGY TROPICAL SUB; Weltzin J.F., 2003, CHANGING PRECIPITATI; [No title captured]	30	1243	1278	10	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2005	438	7069					846	849		10.1038/nature04070	http://dx.doi.org/10.1038/nature04070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	990XX	16341012				2022-12-01	WOS:000233777800049
J	Jessup, JM; Stewart, A; Greene, FL; Minsky, BD				Jessup, JM; Stewart, A; Greene, FL; Minsky, BD			Adjuvant chemotherapy for stage III colon cancer - Implications of race/ethnicity, age, and differentiation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DATA-BASE REPORT; COLORECTAL-CANCER; BOWEL PROJECT; AFRICAN-AMERICANS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; POOLED ANALYSIS; BREAST-CANCER; THERAPY; FLUOROURACIL	Context A 1990 National Institutes of Health Consensus Conference recommended that patients with stage III colon cancer receive adjuvant chemotherapy because survival was improved in clinical trials in patients who received a 5-fluorouracil-based regimen. Objective To determine whether adjuvant chemotherapy is used in the community as a standard of practice that improves outcome and whether it failed to benefit any specific sets of patients. Design, Setting, and Participants Prospective data from 85 934 patients with stage III colon cancer from 560 hospital cancer registries were entered into the National Cancer Data Base between 1990 and 2002 and included standard clinical, pathological, and first course of treatment variables. Main Outcome Measures Prevalence of adjuvant chemotherapy usage and 5-year survival in patients treated in US hospitals. Results Adjuvant chemotherapy use increased from 39% in 1991 to 64% in 2002 but was lower in black, female, and elderly patients. It improved 5-year survival from almost 8% in 1991 to more than 16% in 1997 compared with surgery alone. Adjuvant chemotherapy increases survival in elderly patients as much as it does in younger patients. However, the benefit of adjuvant chemotherapy in blacks and, those with high-grade cancers is not as great. Conclusions Adjuvant chemotherapy use has increased from 1990 to 2002 for patients with stage III colon cancer with an associated increase in 5-year survival of 16%. The benefit of adjuvant chemotherapy seems to be lower in black patients and high-grade cancers. Women have the same benefit but are less often treated. Elderly patients have the same benefit as younger patients but are less frequently treated. New options for adjuvant therapy in 2004-2005 may further improve the outcome of patients with stage III colon cancer.	NCI, Canc Diag Program, Div Canc Treatment & Diag, Rockville, MD 20892 USA; Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; Amer Coll Surg, Canc Dept, Chicago, IL USA; Carolinas Med Ctr, Dept Surg, Charlotte, NC 28203 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; American College of Surgeons; Carolinas Medical Center; Memorial Sloan Kettering Cancer Center	Jessup, JM (corresponding author), NCI, Canc Diag Program, Div Canc Treatment & Diag, Execut Plaza N 6040,6130 Execut Blvd, Rockville, MD 20892 USA.	jessupj@mail.nih.gov						*AM COLL SURG COMM, 1990, DATA ACQ MAN; Andre T, 2003, J CLIN ONCOL, V21, P2896, DOI 10.1200/JCO.2003.10.065; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Beart R W, 1995, J Am Coll Surg, V181, P225; Bouchardy C, 2001, BRIT J CANCER, V85, P1251, DOI 10.1054/bjoc.2001.2035; COX DR, 1972, J R STAT SOC B, V34, P187; DAYAL H, 1987, J CHRON DIS, V40, P857, DOI 10.1016/0021-9681(87)90185-8; Dignam JJ, 1999, JNCI-J NATL CANCER I, V91, P1933, DOI 10.1093/jnci/91.22.1933; Fremgen AM, 1999, CA-CANCER J CLIN, V49, P145, DOI 10.3322/canjclin.49.3.145; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; GORDON B, 1994, DATA EXCHANGE STANDA, V1; Greene FL, 2002, ANN SURG, V236, P416, DOI 10.1097/00000658-200210000-00003; Greene FL, 2002, AJCC CANC STAGING MA, P113; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hershman D, 2003, J NATL CANCER I, V95, P1545, DOI 10.1093/jnci/djg073; Jessup JM, 1996, CANCER-AM CANCER SOC, V78, P918; Jessup JM, 1998, CANCER, V83, P2408, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2408::AID-CNCR22>3.0.CO;2-G; Keku T, 2002, CANCER EPIDEM BIOMAR, V11, P1611; LAURIE JA, 1989, J CLIN ONCOL, V7, P1447, DOI 10.1200/JCO.1989.7.10.1447; Mahoney T, 2000, ARCH SURG-CHICAGO, V135, P182, DOI 10.1001/archsurg.135.2.182; Malin JL, 2002, J NATL CANCER I, V94, P835, DOI 10.1093/jnci/94.11.835; McCollum AD, 2002, JNCI-J NATL CANCER I, V94, P1160; Menck HR, 1997, CANCER, V80, P2296, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2296::AID-CNCR11>3.0.CO;2-P; Menck HR, 1998, CANCER, V83, P2649, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2649::AID-CNCR32>3.3.CO;2-M; Mettlin CJ, 1997, CANCER, V79, P2052, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2052::AID-CNCR29>3.0.CO;2-S; Milano G, 1999, BRIT J CANCER, V79, P627, DOI 10.1038/sj.bjc.6690098; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schneider EC, 2004, J CLIN ONCOL, V22, P2985, DOI 10.1200/JCO.2004.09.087; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; SHAMBAUGH E, 1995, STAT EPIDEMIOLOGY CA; Shepherd T, 2000, GASTROENTEROLOGY, V118, P1039, DOI 10.1016/S0016-5085(00)70356-8; STEELE GD, 1994, CANCER, V74, P1979, DOI 10.1002/1097-0142(19941001)74:7<1979::AID-CNCR2820740725>3.0.CO;2-J; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Sundararajan V, 2001, CANCER J, V7, P213; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; VanEenwyk J, 2002, CANCER, V95, P39, DOI 10.1002/cncr.10645; *WHO, 1992, INT CLASS DIS ONC; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Wolmark N, 1999, J CLIN ONCOL, V17, P3553, DOI 10.1200/JCO.1999.17.11.3553; WOLMARK N, 1996, P AN M AM SOC CLIN, V15, P460	43	245	251	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2703	2711		10.1001/jama.294.21.2703	http://dx.doi.org/10.1001/jama.294.21.2703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333005	Bronze			2022-12-01	WOS:000233726900018
J	Moore, P				Moore, P			Cell biology: Ion channels and stem cells	NATURE			English	Article																			0	5	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					699	704		10.1038/438699a	http://dx.doi.org/10.1038/438699a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319900	Bronze			2022-12-01	WOS:000233593100059
J	Pitsiladis, YP; Scott, R				Pitsiladis, YP; Scott, R			Essay - The makings of the perfect athlete	LANCET			English	Article									Univ Glasgow, Int Ctr E African Running Sci, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Pitsiladis, YP (corresponding author), Univ Glasgow, Int Ctr E African Running Sci, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	y.pitsiladis@bio.gla.ac.uk		Pitsiladis, Yannis/0000-0001-6210-2449				Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Dennis C, 2005, NATURE, V434, P260, DOI 10.1038/434260a; Rankinen T, 2004, MED SCI SPORT EXER, V36, P1451, DOI 10.1249/01.MSS.0000139902.42385.5F; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311	4	11	11	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S16	S17		10.1016/S0140-6736(05)67828-2	http://dx.doi.org/10.1016/S0140-6736(05)67828-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360732	Bronze			2022-12-01	WOS:000234374400011
J	Singh, MAF				Singh, MAF			Essay - Fit for life - a geriatrician's perspective on ageing well	LANCET			English	Article									Univ Sydney, Fac Hlth Sci, Sch Exercise & Sport Sci, Lidcombe, NSW 2141, Australia	University of Sydney	Singh, MAF (corresponding author), Univ Sydney, Fac Hlth Sci, Sch Exercise & Sport Sci, East St, Lidcombe, NSW 2141, Australia.	m.singh@fhs.usyd.edu.au							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2005	366				SI		S51	S51		10.1016/S0140-6736(05)67849-X	http://dx.doi.org/10.1016/S0140-6736(05)67849-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999FO	16360755				2022-12-01	WOS:000234374400032
J	Smith, DL; Dushoff, J; Snow, RW; Hay, SI				Smith, DL; Dushoff, J; Snow, RW; Hay, SI			The entomological inoculation rate and Plasmodium falciparum infection in African children	NATURE			English	Article							GLOBAL DISTRIBUTION; MALARIA; TRANSMISSION; POPULATION; DISEASE; MODEL; RISK	Malaria is an important cause of global morbidity and mortality. The fact that some people are bitten more often than others has a large effect on the relationship between risk factors and prevalence of vector-borne diseases(1-3). Here we develop a mathematical framework that allows us to estimate the heterogeneity of infection rates from the relationship between rates of infectious bites and community prevalence. We apply this framework to a large, published data set that combines malaria measurements from more than 90 communities(4). We find strong evidence that heterogeneous biting or heterogeneous susceptibility to infection are important and pervasive factors determining the prevalence of infection: 20% of people receive 80% of all infections. We also find that individual infections last about six months on average, per infectious bite, and children who clear infections are not immune to new infections. The results have important implications for public health interventions: the success of malaria control will depend heavily on whether efforts are targeted at those who are most at risk of infection.	NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; KEMRI, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Kenyatta Hosp, Nairobi 00100, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Princeton University; Kenyatta National Hospital; University of Oxford; University of Oxford	Smith, DL (corresponding author), NIH, Fogarty Int Ctr, Bldg 16,16 Ctr Dr, Bethesda, MD 20892 USA.	smitdave@helix.nih.gov	Snow, Robert William/AFR-1436-2022; Smith, David L/L-8850-2013; Hay, Simon I/F-8967-2015	Snow, Robert William/0000-0003-3725-6088; Smith, David L/0000-0003-4367-3849; Hay, Simon I/0000-0002-0611-7272	Wellcome Trust [058992, 069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aron J.L., 1982, P139; BAILEY NTJ, 1982, BIOMATHEMATICS MALAR; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Burnham K.P., 2002, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dietz K., 1980, Lecture Notes in Biomathematics, V39, P264; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Gu WD, 2003, ACTA TROP, V86, P71, DOI 10.1016/S0001-706X(03)00020-2; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HETHCOTE HW, 1984, LECT NOTES BIOMATHS, V56, P1; JAMISON DT, 1999, WORLD HLTH REPORT 19; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Molineaux L, 1980, THE GARKI PROJECT; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NAJERA JA, 1974, B WORLD HEALTH ORGAN, V50, P449; Ross R., 1911, PREVENTION MALARIA; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Snow RW, 2002, ESSENTIAL MALARIOLOG, P85; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; The R Development Core team, 2004, R LANG ENV STAT COMP; WALTON GA, 1947, ANN TROP MED PARASIT, V41, P380, DOI 10.1080/00034983.1947.11685341; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	29	207	208	0	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					492	495		10.1038/nature04024	http://dx.doi.org/10.1038/nature04024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306991	Green Accepted			2022-12-01	WOS:000233458200048
J	Turner, A; Beales, J; Faure, S; Dunford, RP; Laurie, DA				Turner, A; Beales, J; Faure, S; Dunford, RP; Laurie, DA			The pseudo-response regulator Ppd-H1 provides adaptation to photoperiod in barley	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCUS; CIRCADIAN CLOCK; FLOWERING TIME; APRR1/TOC1 QUINTET; ARABIDOPSIS; RICE; GENE; CONSTANS; RHYTHM; ROLES	Plants commonly use photoperiod (day length) to control the timing of flowering during the year, and variation in photoperiod response has been selected in many crops to provide adaptation to different environments and farming practices. Positional cloning identified Ppd-H1, the major determinant of barley photoperiod response, as a pseudo-response regulator, a class of genes involved in circadian clock function. Reduced photoperiod responsiveness of the ppd-H1 mutant, which is highly advantageous in spring-sown varieties, is explained by altered circadian expression of the photoperiod pathway gene CONSTANS and reduced expression of its downstream target, FT, a key regulator of flowering.	John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Laurie, DA (corresponding author), John Innes Ctr Plant Sci Res, Crop Genet Dept, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	david.laurie@bbsrc.ac.uk		faure, sebastien/0000-0002-1094-3999				Decousset L, 2000, THEOR APPL GENET, V101, P1202, DOI 10.1007/s001220051598; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Makino S, 2001, PLANT CELL PHYSIOL, V42, P334, DOI 10.1093/pcp/pce036; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yamamoto T, 2000, GENETICS, V154, P885; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1119, DOI 10.1093/pcp/pcg148; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	20	608	656	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2005	310	5750					1031	1034		10.1126/science.1117619	http://dx.doi.org/10.1126/science.1117619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984YN	16284181				2022-12-01	WOS:000233343400048
J	Steingrimsdottir, L; Gunnarsson, O; Indridason, OS; Franzson, L; Sigurdsson, G				Steingrimsdottir, L; Gunnarsson, O; Indridason, OS; Franzson, L; Sigurdsson, G			Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; ELDERLY-WOMEN; FRACTURES; CHOLECALCIFEROL; POPULATION; PREGNANCY; SEASON; MEN	Context Adequate vitamin D status for optimum bone health has received increased recognition in recent years; however, the ideal intake is not known. Serum 25-hydroxyvitamin D is the generally accepted indicator of vitamin D status, but no Universal reference level has been reached. Objective To investigate the relative importance of high calcium intake and serum 25-hydroxyvitamin D for calcium homeostasis, as determined by serum intact parathyroid hormone (PTH). Design, Setting, and Participants Cross-sectional study of 2310 healthy Icelandic adults who were divided equally into 3 age groups (30-45 years, 50-65 years, or 70-85 years) and recruited from February 2001 to January 2003. They were administered a semi-quantitative food frequency questionnaire, which assessed vitamin D and calcium intake. Participants were further divided into groups according to calcium intake (<800 mg/d, 800-1200 mg/d, and >1200 mg/d) and serum 25-hydroxyvitamin D level (<10 ng/mL, 10-18 ng/mL, and >18 ng/mL). Main Outcome Measure Serum intact PTH as determined by calcium intake and vitamin D. Results A total of 944 healthy participants completed all parts of the study. After adjusting for relevant factors, serum PTH was lowest in the group with a serum 25-hydroxyvitamin D level of more than 18 ng/mL but highest in the group with a serum 25-hydroxyvitamin D level of less than 10 ng/mL. At the low serum 25-hydroxyvitamin D level (<10 ng/mL), calcium intake of less than 800 mg/d vs more than 1200 mg/d was significantly associated with higher serum PTH (P=.04); and at a calcium intake of more than 1200 mg/d, there was a significant difference between the lowest and highest vitamin D groups (P=.04). Conclusions As long as vitamin D status is ensured, calcium intake levels of more than 800 mg/d may be unnecessary for maintaining calcium metabolism. Vitamin D supplements are necessary for adequate vitamin D status in northern climates.	Landspitali Univ Hosp, Dept Med, Div Endocrinol & Metab, IS-101 Reykjavik, Iceland; Publ Hlth Inst Iceland, Reykjavik, Iceland; Univ Iceland, Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland	Gunnarsson, O (corresponding author), Landspitali Univ Hosp, Dept Med, Div Endocrinol & Metab, IS-101 Reykjavik, Iceland.	gunnars@landspitali.is	Steingrimsdottir, Laufey/L-3150-2015					Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bates CJ, 2003, OSTEOPOROSIS INT, V14, P152, DOI 10.1007/s00198-002-1338-3; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; DawsonHughes B, 1997, AM J CLIN NUTR, V65, P67, DOI 10.1093/ajcn/65.1.67; Harkness L, 2005, OSTEOPOROSIS INT, V16, P109, DOI 10.1007/s00198-004-1656-8; Heaney RP, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P773; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Heaney RP, 2002, NUTR RES, V22, P153, DOI 10.1016/S0271-5317(01)00358-X; Hollis BW, 2004, AM J CLIN NUTR, V79, P717; Kinyamu HK, 1998, AM J CLIN NUTR, V67, P342, DOI 10.1093/ajcn/67.2.342; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 1998, SERONO SYMP, P262; LIPS P, 1991, CLIN ENDOCRINOL, V35, P35, DOI 10.1111/j.1365-2265.1991.tb03493.x; Lips P, 1999, OSTEOPOROSIS INT, V9, P394, DOI 10.1007/s001980050162; Nutrition and Bone Health: With Particular Reference to Calcium and Vitamin D Report of the Subgroup on Bone Health, 1998, REP HLTH SOC SUBJ LO, V49, P1; Olafsdottir AS, 2005, BJOG-INT J OBSTET GY, V112, P424, DOI 10.1111/j.1471-0528.2005.00477.x; OOMS ME, 1995, J BONE MINER RES, V10, P1177; Sigurdsson G, 1999, Laeknabladid, V85, P398; Sigurdsson G, 2000, OSTEOPOROSIS INT, V11, P1031, DOI 10.1007/s001980070024; STEINGRIMSDOTTI.L, 2003, ICELANDIC NATL NUTR; Thomas MK, 1998, NEW ENGL J MED, V338, P777, DOI 10.1056/NEJM199803193381201; Thornorsdottir Inga, 2004, Laeknabladid, V90, P37; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Vieth R, 2001, AM J CLIN NUTR, V73, P288; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	28	348	355	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 9	2005	294	18					2336	2341		10.1001/jama.294.18.2336	http://dx.doi.org/10.1001/jama.294.18.2336			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981LI	16278362				2022-12-01	WOS:000233089700026
J	Boehm, U; Zou, ZH; Buck, LB				Boehm, U; Zou, ZH; Buck, LB			Feedback loops link odor and pheromone signaling with reproduction	CELL			English	Article							GREEN FLUORESCENT PROTEIN; LUTEINIZING-HORMONE; MALE-MICE; VOMERONASAL SYSTEM; OLFACTORY CORTEX; BRAIN; GLUTAMATE; LOCALIZATION; RECEPTORS; RESPONSES	Pheromones can have profound effects on reproductive physiology and behavior in mammals. To investigate the neural circuits underlying these effects, we used a genetic transneuronal tracer to identify neurons that synapse with GnRH (LHRH) neurons, the key regulators of reproduction. We then asked whether the connected neurons are presynaptic or postsynaptic to GnRH neurons and analyzed their responses to chemosensory cues. Surprisingly, these experiments indicate that GnRH neurons receive pheromone signals from both odor and pheromone relays in the brain and may also receive common odor signals. Moreover, feedback loops are evident whereby GnRH neurons could influence both odor and pheromone processing. Remarkably, similar to 800 GnRH neurons communicate with similar to 50,000 neurons in 53 functionally diverse brain areas, with some connections exhibiting sexual dimorphism. These studies reveal a complex interplay between reproduction and other functions in which GnRH neurons appear to integrate information from multiple sources and modulate a variety of brain functions.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buck, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	lbuck@fhcrc.org	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				BADR M, 1987, SYNAPSE, V1, P567, DOI 10.1002/syn.890010609; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; COQUELIN A, 1980, ENDOCRINOLOGY, V106, P1224, DOI 10.1210/endo-106-4-1224; COQUELIN A, 1984, J NEUROSCI, V4, P2230; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; Gore A.C., 2002, GNRH MASTER MOL REPR; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; Jennes L, 1997, RECENT PROG HORM RES, V52, P475; JENNES L, 1988, BRAIN RES, V452, P156, DOI 10.1016/0006-8993(88)90020-0; Jones Barbara E., 1995, P155; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Ma WD, 1999, CHEM SENSES, V24, P289, DOI 10.1093/chemse/24.3.289; MARUNIAK JA, 1976, ENDOCRINOLOGY, V99, P963, DOI 10.1210/endo-99-4-963; Meisel Robert L., 1994, P3; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Pfaff Donald W., 1994, P107; Shipley Michael T., 1995, P899; Silverman Ann-Judith, 1994, P1683; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Simerly Richard B., 1995, P353; Simmons DA, 2003, J COMP NEUROL, V459, P290, DOI 10.1002/cne.10605; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 2000, TRENDS NEUROSCI, V23, P519, DOI 10.1016/S0166-2236(00)01639-8; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	36	236	240	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 8	2005	123	4					683	695		10.1016/j.cell.2005.09.027	http://dx.doi.org/10.1016/j.cell.2005.09.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	987DA	16290036	Bronze			2022-12-01	WOS:000233497400016
J	Endres, NF; Yoshioka, C; Milligan, RA; Vale, RD				Endres, NF; Yoshioka, C; Milligan, RA; Vale, RD			A lever-arm rotation drives motility of the minus-end-directed kinesin Ncd	NATURE			English	Article							HAND-OVER-HAND; MOTOR PROTEIN; MICROTUBULE MOTOR; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; DROSOPHILA; MECHANISM; DOMAINS; DIRECTIONALITY; MOVEMENT	Kinesins are microtubule-based motor proteins that power intracellular transport(1,2). Most kinesin motors, exemplified by Kinesin-1, move towards the microtubule plus end, and the structural changes that govern this directional preference have been described(3-5). By contrast, the nature and timing of the structural changes underlying the minus-end-directed motility of Kinesin-14 motors (such as Drosophila Ncd(6,7)) are less well understood. Using cryo-electron microscopy, here we demonstrate that a coiled-coil mechanical element of microtubule-bound Ncd rotates similar to 70 degrees towards the minus end upon ATP binding. Extending or shortening this coiled coil increases or decreases velocity, respectively, without affecting ATPase activity. An unusual Ncd mutant that lacks directional preference(8) shows unstable nucleotide-dependent conformations of its coiled coil, underscoring the role of this mechanical element in motility. These results show that the force-producing conformational change in Ncd occurs on ATP binding, as in other kinesins, but involves the swing of a lever-arm mechanical element similar to that described for myosins.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Scripps Res Inst, Dept Cell Biol, Ctr Integrat Mol Biosci, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94107 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [P01 AR042895-130005, P01 AR042895] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arnal I, 1996, CURR BIOL, V6, P1265, DOI 10.1016/S0960-9822(02)70712-4; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	30	82	84	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					875	878		10.1038/nature04320	http://dx.doi.org/10.1038/nature04320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16382238	Green Accepted			2022-12-01	WOS:000235333600056
J	Volfson, D; Marciniak, J; Blake, WJ; Ostroff, N; Tsimring, LS; Hasty, J				Volfson, D; Marciniak, J; Blake, WJ; Ostroff, N; Tsimring, LS; Hasty, J			Origins of extrinsic variability in eukaryotic gene expression	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NOISE; STOCHASTICITY; NETWORKS	Variable gene expression within a clonal population of cells has been implicated in a number of important processes including mutation and evolution(1,2), determination of cell fates(3,4) and the development of genetic disease(5,6). Recent studies have demonstrated that a significant component of expression variability arises from extrinsic factors thought to influence multiple genes simultaneously(7-10), yet the biological origins of this extrinsic variability have received little attention. Here we combine computational modelling(11-18) with fluorescence data generated from multiple promoter - gene inserts in Saccharomyces cerevisiae to identify two major sources of extrinsic variability. One unavoidable source arising from the coupling of gene expression with population dynamics leads to a ubiquitous lower limit for expression variability. A second source, which is modelled as originating from a common upstream transcription factor, exemplifies how regulatory networks can convert noise in upstream regulator expression into extrinsic noise at the output of a target gene(9). Our results highlight the importance of the interplay of gene regulatory networks with population heterogeneity for understanding the origins of cellular diversity.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu		Volfson, Dmitri/0000-0002-5167-7834; Tsimring, Lev/0000-0003-0709-3548				Adalsteinsson D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-24; Arkin A, 1998, GENETICS, V149, P1633; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; REANNEY D, 1984, NATURE, V307, P318, DOI 10.1038/307318a0; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Sternberg PW, 1997, CURR OPIN GENET DEV, V7, P543, DOI 10.1016/S0959-437X(97)80084-6; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	24	212	215	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2006	439	7078					861	864		10.1038/nature04281	http://dx.doi.org/10.1038/nature04281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012JA	16372021				2022-12-01	WOS:000235333600053
J	Sawamoto, K; Wichterle, H; Gonzalez-Perez, O; Cholfin, JA; Yamada, M; Spassky, N; Murcia, NS; Garcia-Verdugo, JM; Marin, O; Rubenstein, JLR; Tessier-Lavigne, M; Okano, H; Alvarez-Buylla, A				Sawamoto, K; Wichterle, H; Gonzalez-Perez, O; Cholfin, JA; Yamada, M; Spassky, N; Murcia, NS; Garcia-Verdugo, JM; Marin, O; Rubenstein, JLR; Tessier-Lavigne, M; Okano, H; Alvarez-Buylla, A			New neurons follow the flow of cerebrospinal fluid in the adult brain	SCIENCE			English	Article							CELL-MIGRATION; PROLIFERATION; FOREBRAIN; PATHWAYS	In the adult brain, neuroblasts born in the subventricular zone migrate from the watts of the lateral ventricles to the olfactory bulb. How do these cells orient over such a tong distance and through complex territories? Here we show that neuroblast migration parallels cerebrospinal fluid (CSF) flow. Beating of ependymal cilia is required for normal CSF flow, concentration gradient formation of CSF guidance molecules, and directional migration of neuroblasts. Results suggest that polarized epithelial. cells contribute important vectorial information-for guidance of young, migrating neurons.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Keio Univ, Sch Med, Bridgestone Lab Dev & Regenerat Neurobiol, Tokyo 1608582, Japan; Cent Inst Expt Anim, Kanagawa, Japan; Case Western Reserve Univ, Rainbow Ctr Childhood Polycyst Kideny Dis, Dept Pediat, Cleveland, OH 44106 USA; Univ Valencia, E-46100 Burjassot, Spain; CSIC, Inst Neurosci Alicante, Alicante 03550, Spain; Univ Miguel Hernandez, Alicante 03550, Spain; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Keio University; Keio University; Case Western Reserve University; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Roche Holding; Genentech	Sawamoto, K (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	sawamoto@sc.itc.keio.ac.jp; abuylla@stemcell.ucsf.edu	Cholfin, Jeremy/AAF-7611-2021; Gonzalez-Perez, Oscar/B-3680-2008; Okano, Hideyuki/I-7584-2019; García-Verdugo, José Manuel/L-8421-2017; Spassky, Nathalie/E-3932-2016; Marin, Oscar/F-3856-2012	Gonzalez-Perez, Oscar/0000-0002-6527-485X; García-Verdugo, José Manuel/0000-0001-9872-6499; Marin, Oscar/0000-0001-6264-7027; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Wichterle, Hynek/0000-0002-7817-0080; spassky, nathalie/0000-0003-4722-6464; Sawamoto, Kazunobu/0000-0003-1984-5129	NICHD NIH HHS [HD 32116] Funding Source: Medline; NINDS NIH HHS [NS 28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478, R37NS028478, R29NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIRD RB, 1984, EXP NEUROL, V86, P342, DOI 10.1016/0014-4886(84)90192-4; Alberts B., 1994, MOL BIOL CELL 2, V3rd ed.; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BRIGHTMA.MW, 1965, J CELL BIOL, V26, P99, DOI 10.1083/jcb.26.1.99; DELBIGIO MR, 1995, GLIA, V14, P1, DOI 10.1002/glia.440140102; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; GONZALEZPEREZ O, UNPUB; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; YAMADORI T, 1979, Scanning Electron Microscopy, P335; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	22	561	582	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2006	311	5761					629	632		10.1126/science.1119133	http://dx.doi.org/10.1126/science.1119133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011GY	16410488				2022-12-01	WOS:000235257400038
J	Duchaine, TF; Wohlschlegel, JA; Kennedy, S; Bei, YX; Conte, D; Pang, KM; Brownell, DR; Harding, S; Mitani, S; Ruvkun, G; Yates, JR; Mello, CC				Duchaine, TF; Wohlschlegel, JA; Kennedy, S; Bei, YX; Conte, D; Pang, KM; Brownell, DR; Harding, S; Mitani, S; Ruvkun, G; Yates, JR; Mello, CC			Functional proteomics reveals the biochemical niche of C-elegans DCR-1 in multiple small-RNA-mediated pathways	CELL			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; SHOTGUN PROTEOMICS; FISSION YEAST; DICER; PHOSPHATASE; MICRORNAS; COMPLEXES	In plants, animals, and fungi, members of the Dicer family of RNase III-related enzymes process double-stranded RNA (dsRNA) to initiate small-RNA-mediated gene-silencing mechanisms. To learn how C. elegans Dicer, DCR-1, functions in multiple distinct silencing mechanisms, we used a mass-spectrometry-based proteomics approach to identify DCR-1-interacting proteins. We then generated and characterized deletion alleles for the corresponding genes. The interactors are required for production of three species of small RNA, including (1) small interfering RNAs (siRNAs), derived from exogenous dsRNA triggers (exo-siRNAs); (2) siRNAs derived from endogenous triggers (endo-siRNAs); and (3) developmental regulatory microRNAs (miRNAs). One interactor, the conserved RNA-phosphatase homolog PIR-1, is required for the processing of a putative amplified DCR-1 substrate. Interactors required for endo-siRNA production include ERI-1 and RRF-3, whose loss of function enhances RNAi Our findings provide a first glimpse at the complex biochemical niche of Dicer and suggest that competition exists between DCR-1-mediated small-RNA pathways.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53701 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Scripps Research Institute; University of Wisconsin System; University of Wisconsin Madison; Tokyo Women's Medical University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	pang, ka ming/H-4082-2011; pang, Ka Ming Ming/AAW-4059-2021; Duchaine, Thomas/U-2399-2019	pang, ka ming/0000-0001-7262-3918; Kennedy, Scott/0000-0002-7974-8155; Duchaine, Thomas/0000-0002-3454-1839	NIGMS NIH HHS [GM58800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Cheng Y, 2004, J MOL BIOL, V343, P305, DOI 10.1016/j.jmb.2004.08.055; Deshpande T, 1999, J BIOL CHEM, V274, P16590, DOI 10.1074/jbc.274.23.16590; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Praitis V, 2001, GENETICS, V157, P1217; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yuan Y, 1998, J BIOL CHEM, V273, P20347, DOI 10.1074/jbc.273.32.20347	42	294	322	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 27	2006	124	2					343	354		10.1016/j.cell.2005.11.036	http://dx.doi.org/10.1016/j.cell.2005.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	008VJ	16439208	Bronze			2022-12-01	WOS:000235068500022
J	Farrell, AE; Plevin, RJ; Turner, BT; Jones, AD; O'Hare, M; Kammen, DM				Farrell, AE; Plevin, RJ; Turner, BT; Jones, AD; O'Hare, M; Kammen, DM			Ethanol can contribute to energy and environmental goals	SCIENCE			English	Article								To study the potential effects of increased biofuel use, we evaluated six representative analyses of fuel ethanol. Studies that reported negative net energy incorrectly ignored coproducts and used some obsolete data. All studies indicated that current corn ethanol technologies are much less petroteum-intensive than gasoline but have greenhouse gas emissions similar to those of gasoline. However, many important environmental effects of biofuel production are poorly understood. New metrics that measure specific resource inputs are developed, but further research into environmental metrics is needed. Nonetheless, it is already clear that large-scale use of ethanol for fuel will almost certainly require cellulosic technology.	Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Farrell, AE (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	aef@berkeley.edu	Jones, Andrew/AHH-1227-2022; Jones, Andrew D/M-4363-2013; Plevin, Richard/G-6428-2010	Jones, Andrew/0000-0002-1913-7870; Jones, Andrew D/0000-0002-1913-7870; Plevin, Richard/0000-0003-3919-0836; O'Hare, Michael/0000-0002-3288-9065				CHAMBERS RS, 1979, SCIENCE, V206, P789, DOI 10.1126/science.206.4420.789; Cleveland CJ, 2005, ENERGY, V30, P769, DOI 10.1016/j.energy.2004.05.023; DAVIS SC, 2004, ORNL6973; De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; DELUCCHI MA, 2004, UCDITSRR0445; GRABOSKI MS, 2002, FOSSIL ENERGY USE MA; Kerr RA, 2005, SCIENCE, V309, P101, DOI 10.1126/science.309.5731.101; Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004; Kim S, 2002, INT J LIFE CYCLE ASS, V7, P237, DOI 10.1007/BF02978879; Lave LB, 2001, ISSUES SCI TECHNOL, V18, P73; Patzek TW, 2004, CRIT REV PLANT SCI, V23, P519, DOI 10.1080/07352680490886905; Perlack R.D., 2005, ORNLTM200666; Pimentel D., 2005, NATURAL RESOURCES RE, V14, P65, DOI [10.1007/s11053-005-4679-8, DOI 10.1007/s11053-005-4679-8, DOI 10.1007/S11053-005-4679-8]; Shapouri H, 2003, T ASAE, V46, P959, DOI 10.13031/2013.13951; SHAPOURI H, 2004, 2001 NET ENERGY BALA; Tegtmeier E. M., 2004, International Journal of Agricultural Sustainability, V2, P1, DOI 10.1080/14735903.2004.9684563; *U MO FOOD AGR POL, 2005, 1005 U MISS FOOD AGR; Wang M., 2001, ANLESDTM163; Wirth TE, 2003, FOREIGN AFF, V82, P132, DOI 10.2307/20033654	19	1870	1969	10	653	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2006	311	5760					506	508		10.1126/science.1121416	http://dx.doi.org/10.1126/science.1121416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	008WM	16439656				2022-12-01	WOS:000235071400041
J	Gittenberger, E; Groenenberg, DSJ; Kokshoorn, B; Preece, RC				Gittenberger, E; Groenenberg, DSJ; Kokshoorn, B; Preece, RC			Molecular trails from hitch-hiking snails	NATURE			English	Editorial Material									Natl Museum Nat Hist Naturalis, NL-2300 RA Leiden, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; University of Cambridge	Gittenberger, E (corresponding author), Natl Museum Nat Hist Naturalis, POB 9517, NL-2300 RA Leiden, Netherlands.	rcp1001@cam.ac.uk		Kokshoorn, Bas/0000-0003-1927-854X				BACKHUYS W, 1975, LAND FRESHWATER MOLL; BOETTGER O, 1878, BERICHT THATIGKEIT O, V17, P18; Cockerell TDA, 1921, NATURE, V108, P496, DOI 10.1038/108496d0; Darwin C.R., 1877, DIFFERENT FORMS FLOW; GHEERAERTS M, 1567, WARACHTIGHE FABULEN; GITTENBERGER E, UNPUB J CONCH; GRAy J. E., 1824, ZOOLOGICAL J, V1, P62; NORDSIECK H, 1978, Archiv fuer Molluskenkunde, V109, P67; Nordsieck H., 1979, ARCH MOLLUSKENKD, V109, P249; Odhner N. Hj., 1960, Proceedings of the Malacological Society of London, V34, P168; Preece RC, 2003, J MOLLUS STUD, V69, P329, DOI 10.1093/mollus/69.4.329; Rees W. J., 1965, Proceedings of the Malacological Society of London, V36, P269; Schileyko A.A., 1999, Ruthenica Supplement, V2, P437	13	111	119	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					409	409		10.1038/439409a	http://dx.doi.org/10.1038/439409a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005XH	16437103	Bronze			2022-12-01	WOS:000234859200031
J	Singer, T; Seymour, B; O'Doherty, JP; Stephan, KE; Dolan, RJ; Frith, CD				Singer, T; Seymour, B; O'Doherty, JP; Stephan, KE; Dolan, RJ; Frith, CD			Empathic neural responses are modulated by the perceived fairness of others	NATURE			English	Article							MOTIVATION; STRIATUM; REWARD; ROLES; PAIN	The neural processes underlying empathy are a subject of intense interest within the social neurosciences(1-3). However, very little is known about how brain empathic responses are modulated by the affective link between individuals. We show here that empathic responses are modulated by learned preferences, a result consistent with economic models of social preferences(4-7). We engaged male and female volunteers in an economic game, in which two confederates played fairly or unfairly, and then measured brain activity with functional magnetic resonance imaging while these same volunteers observed the confederates receiving pain. Both sexes exhibited empathy-related activation in pain-related brain areas (fronto-insular and anterior cingulate cortices) towards fair players. However, these empathy-related responses were significantly reduced in males when observing an unfair person receiving pain. This effect was accompanied by increased activation in reward-related areas, correlated with an expressed desire for revenge. We conclude that in men ( at least) empathic responses are shaped by valuation of other people's social behaviour, such that they empathize with fair opponents while favouring the physical punishment of unfair opponents, a finding that echoes recent evidence for altruistic punishment.	UCL, Wellcome Dept Imaging Neurosci, London WC1N 3AR, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	University of London; University College London; University of London; University College London; California Institute of Technology	Singer, T (corresponding author), UCL, Wellcome Dept Imaging Neurosci, London WC1N 3AR, England.	t.singer@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Frith, Chris D/A-2171-2009; Girault, Johann/B-2430-2012	Frith, Chris D/0000-0002-8665-0690; Stephan, Klaas Enno/0000-0002-8594-9092; Dolan, Ray/0000-0001-9356-761X; Seymour, Ben/0000-0003-1724-5832	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Camerer ColinF., 2003, BEHAV GAME THEORY EX; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/S1364-6613(04)00103-2; Davis MH, 1980, JSAS CATALOG SELECTE, V10, P85; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Levine DK, 1998, REV ECON DYNAM, V1, P593; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; RABIN M, 1993, AM ECON REV, V83, P1281; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	29	1018	1054	8	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2006	439	7075					466	469		10.1038/nature04271	http://dx.doi.org/10.1038/nature04271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005XH	16421576	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000234859200045
J	Poinar, HN; Schwarz, C; Qi, J; Shapiro, B; MacPhee, RDE; Buigues, B; Tikhonov, A; Huson, DH; Tomsho, LP; Auch, A; Rampp, M; Miller, W; Schuster, SC				Poinar, HN; Schwarz, C; Qi, J; Shapiro, B; MacPhee, RDE; Buigues, B; Tikhonov, A; Huson, DH; Tomsho, LP; Auch, A; Rampp, M; Miller, W; Schuster, SC			Metagenomics to paleogenomics: Large-scale sequencing of mammoth DNA	SCIENCE			English	Article							MOUSE; RETRIEVAL; DIVERSITY	We sequenced 28 million base pairs of DNA in a metagenomics approach, using a woolly mammoth (Mammuthus primigenius) sample from Siberia. As a result of exceptional sample preservation and the use of a recently developed emulsion polymerase chain reaction and pyrosequencing technique, 13 million base pairs (45.4%) of the sequencing reads were identified as mammoth DNA. Sequence identity between our data and African elephant (Loxodonta africana) was 98.55%, consistent with a paleontologically based divergence date of 5 to 6 million years. The sample includes a surprisingly small diversity of environmental DNAs. The high percentage of endogenous DNA recoverable from this single mammoth would allow for completion of its genome, unleashing the field of paleogenomics.	McMaster Univ, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L9, Canada; McMaster Univ, Dept Anthropol, Hamilton, ON L8S 4L9, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L9, Canada; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Amer Museum Nat Hist, Div Vertebrate Zool Mammal, New York, NY 10024 USA; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; Univ Tubingen, Inst Comp Sci, Ctr Bioinformat, D-72076 Tubingen, Germany; Garching Comp Ctr, D-85748 Garching, Germany	McMaster University; McMaster University; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Oxford; American Museum of Natural History (AMNH); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Eberhard Karls University of Tubingen	Poinar, HN (corresponding author), McMaster Univ, McMaster Ancient DNA Ctr, 1280 Main St W, Hamilton, ON L8S 4L9, Canada.	poinarh@mcmaster.ca; scs@bx.psu.edu	Huson, Daniel H./AAC-5494-2019; Tikhonov, Alexei/G-7478-2016; QI, JI/E-2797-2016	Tikhonov, Alexei/0000-0002-7227-5797	NHGRI NIH HHS [HG02238] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; Debruyne R, 2003, MOL PHYLOGENET EVOL, V26, P421, DOI 10.1016/S1055-7903(02)00292-0; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Handt O, 1996, AM J HUM GENET, V59, P368; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; HUSON DH, UNPUB; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacPhee RDE, 2002, J ARCHAEOL SCI, V29, P1017, DOI 10.1006/jasc.2001.0802; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	26	385	421	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					392	394		10.1126/science.1123360	http://dx.doi.org/10.1126/science.1123360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AE	16368896				2022-12-01	WOS:000234938500048
J	Valderrama, F; Cordeiro, JV; Schleich, S; Frischknecht, F; Way, M				Valderrama, F; Cordeiro, JV; Schleich, S; Frischknecht, F; Way, M			Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling	SCIENCE			English	Article							HOST-RANGE; MIGRATION; ANKARA; MORPHOGENESIS; PROPAGATION; ADHESION; INVASION; INSIGHTS; KINASES; MVA	RhoA signaling plays a critical, role in many cellular processes, including cell migration. Here we show that the vaccinia F11L protein interacts directly with RhoA, inhibiting its signaling by blocking the interaction with its downstream effectors Rho-associated kinase (ROCK) and mDia. RNA interference-mediated depletion of F11L during infection resulted in an absence of vaccinia-induced cell motility and inhibition of viral morphogenesis. Disruption of the RhoA binding site in F11L, which resembles that of ROCK, led to an identical phenotype. Thus, inhibition of RhoA signaling is required for both vaccinia morphogenesis and virus-induced cell motility.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Valderrama, Ferran/E-8017-2011; Cordeiro, Joao V/M-6122-2013	Cordeiro, Joao V/0000-0003-4605-1615; Frischknecht, Friedrich/0000-0002-8332-6668; Way, Michael/0000-0001-7207-2722				Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallego-Gomez JC, 2003, J VIROL, V77, P10606, DOI 10.1128/JVI.77.19.10606-10622.2003; Kato SEM, 2004, J VIROL METHODS, V115, P31, DOI 10.1016/j.jviromet.2003.09.011; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sancho MC, 2002, J VIROL, V76, P8318, DOI 10.1128/JVI.76.16.8318-8334.2002; Sanderson CM, 1998, J VIROL, V72, P1235, DOI 10.1128/JVI.72.2.1235-1243.1998; Sanderson CM, 1998, J VIROL, V72, P9924, DOI 10.1128/JVI.72.12.9924-9933.1998; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wyatt LS, 1998, VIROLOGY, V251, P334, DOI 10.1006/viro.1998.9397	18	91	93	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2006	311	5759					377	381		10.1126/science.1122411	http://dx.doi.org/10.1126/science.1122411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AE	16424340				2022-12-01	WOS:000234938500044
J	Schratt, GM; Tuebing, F; Nigh, EA; Kane, CG; Sabatini, ME; Kiebler, M; Greenberg, ME				Schratt, GM; Tuebing, F; Nigh, EA; Kane, CG; Sabatini, ME; Kiebler, M; Greenberg, ME			A brain-specific microRNA regulates dendritic spine development	NATURE			English	Article							LOCAL PROTEIN-SYNTHESIS; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; TRANSLATION; EXPRESSION; BDNF; DIFFERENTIATION; IDENTIFICATION; POTENTIATION; MECHANISMS	MicroRNAs are small, non-coding RNAs that control the translation of target messenger RNAs, thereby regulating critical aspects of plant and animal development. In the mammalian nervous system, the spatiotemporal control of mRNA translation has an important role in synaptic development and plasticity. Although a number of microRNAs have been isolated from the mammalian brain, neither the specific microRNAs that regulate synapse function nor their target mRNAs have been identified. Here we show that a brain-specific microRNA, miR-134, is localized to the synaptodendritic compartment of rat hippocampal neurons and negatively regulates the size of dendritic spines-postsynaptic sites of excitatory synaptic transmission. This effect is mediated by miR-134 inhibition of the translation of an mRNA encoding a protein kinase, Limk1, that controls spine development. Exposure of neurons to extracellular stimuli such as brain-derived neurotrophic factor relieves miR-134 inhibition of Limk1 translation and in this way may contribute to synaptic development, maturation and/or plasticity.	Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Med Univ Vienna, Ctr Brain Res, Div Neuronal Cell Biol, A-1090 Vienna, Austria	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Medical University of Vienna	Greenberg, ME (corresponding author), Childrens Hosp, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	Michael.Greenberg@childrens.harvard.edu		Kiebler, Michael/0000-0002-8850-6297				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; GOETZE B, 2003, SCI STKE, pPL12; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; RAO A, 1991, J NEUROSCI, V11, P2881; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	43	1338	1468	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2006	439	7074					283	289		10.1038/nature04367	http://dx.doi.org/10.1038/nature04367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003LA	16421561				2022-12-01	WOS:000234682100033
J	van Bommel, EFH; Hendriksz, TR; Huiskes, AWLC; Zeegers, AGM				van Bommel, EFH; Hendriksz, TR; Huiskes, AWLC; Zeegers, AGM			Brief communication: Tamoxifen therapy for nonmalignant retroperitoneal fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; IN-VIVO; AUTOIMMUNITY; SCINTIGRAPHY	Background: Anecdotal case reports suggest tamoxifen as a possible treatment for retroperitoneal fibrosis, but a systematic assessment of its effect is not available. Objective: To describe the course and outcomes of patients with nonmalignant retroperitoneal fibrosis treated with tamoxifen. Design: Prospective, consecutive series. Setting: Single tertiary care referral center. Patients: 19 patients with nonmalignant retroperitoneal fibrosis treated with tamoxifen from April 1998 through April 2005. Intervention: Tamoxifen, 20 mg orally twice daily. Measurements: Clinical improvement, laboratory variables, and follow-up computed tomography (CT) and gallium scan findings. Results: Fifteen patients reported substantial resolution of symptoms after a median treatment duration of 2.5 weeks. Erythrocyte sedimentation rate and C-reactive protein also improved. Gallium scanning at follow-up showed incomplete disappearance of pathologic gallium-67 activity. Repeated CT scanning showed slow but steady mass regression in 14 of 15 clinical responders. Five patients failed treatment, including 1 patient who improved clinically. Disease recurred in 1 patient who responded to reintroduction of tamoxifen. One patient developed reversible hepatitis. Limitations: This small observational study did not have a control group. Conclusion: Tamoxifen may be a viable therapeutic option in the treatment of retroperitoneal fibrosis.	Albert Schweitzer Hosp, Dept Internal Med, NL-3300 AK Dordrecht, Netherlands	Albert Schweitzer Ziekenhuis	van Bommel, EFH (corresponding author), Albert Schweitzer Hosp, Dept Internal Med, POB 444, NL-3300 AK Dordrecht, Netherlands.	e.f.h.vanbommel@asz.nl						Al Rabi N, 2002, SCAND J UROL NEPHROL, V36, P391; Al-Musawi D, 1998, BRIT J UROL, V82, P442; Al-Salman J, 2002, SOUTHERN MED J, V95, P947, DOI 10.1097/00007611-200208000-00038; BENSON JR, 1993, LANCET, V341, P836, DOI 10.1016/0140-6736(93)90618-Q; Bourouma R, 1997, NEPHROL DIAL TRANSPL, V12, P2407, DOI 10.1093/ndt/12.11.2407; BROOKS AP, 1987, CLIN RADIOL, V38, P597, DOI 10.1016/S0009-9260(87)80334-3; Chau D, 1998, ANN PLAS SURG, V40, P490, DOI 10.1097/00000637-199805000-00008; CHAUVEAU D, 1995, J AM SOC NEPHROL, V6, P460; CLARK CP, 1991, SURGERY, V109, P502; Cotsamire D, 1991, ARTHRITIS RHEUM, V34, pR34; Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa; Dedeoglu F, 2001, J RHEUMATOL, V28, P1693; Devevey J M, 1996, Prog Urol, V6, P578; Frankart L, 1997, POSTGRAD MED J, V73, P653, DOI 10.1136/pgmj.73.864.653; Garvin S, 2003, CANCER RES, V63, P8742; HARREBY M, 1994, SCAND J UROL NEPHROL, V28, P237, DOI 10.3109/00365599409181272; HIGGINS PM, 1988, BRIT J SURG, V75, P573, DOI 10.1002/bjs.1800750625; Hillebrand M, 1996, NUKLEARMED, V35, P25; JACOBSON AF, 1991, J NUCL MED, V32, P521; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Kuhn MA, 2002, J SURG RES, V103, P146, DOI 10.1006/jsre.2001.6350; LOFFELD RJLF, 1993, LANCET, V341, P382, DOI 10.1016/0140-6736(93)90195-M; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; McMurray RW, 2001, INT IMMUNOPHARMACOL, V1, P995, DOI 10.1016/S1567-5769(01)00045-5; McNamara DA, 2001, EUR J SURG ONCOL, V27, P714, DOI 10.1053/ejso.2001.1177; OWENS LV, 1995, AM SURGEON, V61, P842; Ozener C, 1997, NEPHROL DIAL TRANSPL, V12, P2166, DOI 10.1093/ndt/12.10.2166; Puce Roberto, 2000, Archivos Espanoles de Urologia, V53, P184; Seabold JE, 1997, J NUCL MED, V38, P994; SPILLANE RM, 1995, AM J ROENTGENOL, V164, P515, DOI 10.2214/ajr.164.2.7840016; TALATI SJ, 1995, CLIN NUCL MED, V20, P995, DOI 10.1097/00003072-199511000-00012; Tan MO, 2003, UROL INT, V71, P426, DOI 10.1159/000074099; Tonietto G, 1997, EUR J SURG, V163, P231; van Bommel EFH, 2002, NETH J MED, V60, P231; VANBOMMEL EFH, 1991, NETH J MED, V39, P338; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405	36	111	112	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2006	144	2					101	106		10.7326/0003-4819-144-2-200601170-00007	http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	004AX	16418409				2022-12-01	WOS:000234725500006
J	Uetz, P; Dong, YA; Zeretzke, C; Atzler, C; Baiker, A; Berger, B; Rajagopala, SV; Roupelieva, M; Rose, D; Fossum, E; Haas, J				Uetz, P; Dong, YA; Zeretzke, C; Atzler, C; Baiker, A; Berger, B; Rajagopala, SV; Roupelieva, M; Rose, D; Fossum, E; Haas, J			Herpesviral protein networks and their interaction with the human proteome	SCIENCE			English	Article							INTERACTION MAP; VIRUS	The comprehensive yeast two-hybrid analysis of intraviral protein interactions in two members of the herpesvirus family, Kaposi sarcoma-associated herpesvirus (KSHV) and varicella-zoster virus (VZV), revealed 123 and 173 interactions, respectively. Viral protein interaction networks resemble single, highly coupled modules, whereas cellular networks are organized in separate functional submodules. Predicted and experimentally verified interactions between KSHV and human proteins were used to connect the viral interactome into a prototypical human interactome and to simulate infection. The analysis of the combined system showed that the viral network adopts cellular network features and that protein networks of herpesviruses and possibly other intracellular pathogens have distinguishing topologies.	Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Forschungszentrum Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany; MIT, Dept Math, Cambridge, MA 02139 USA	University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; Massachusetts Institute of Technology (MIT)	Haas, J (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Pettenkoferstr 9A, D-80336 Munich, Germany.	haas@lmb.uni-muenchen.de	Uetz, Peter/A-7119-2012; Fossum, Even/W-9136-2019	Uetz, Peter/0000-0001-6194-4927; Fossum, Even/0000-0001-7064-0327	Medical Research Council [G0501453] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	13	313	326	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2006	311	5758					239	242		10.1126/science.1116804	http://dx.doi.org/10.1126/science.1116804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003ZQ	16339411	Green Submitted			2022-12-01	WOS:000234722200045
J	Milanesi, R; Baruscotti, M; Gnecchi-Ruscone, T; DiFrancesco, D				Milanesi, R; Baruscotti, M; Gnecchi-Ruscone, T; DiFrancesco, D			Brief report - Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODULATION; HEART; NODE; VOLTAGE; CAMP; ACETYLCHOLINE; INHIBITION; ACTIVATION; DISEASE	We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel. Pacemaker channels of the sinoatrial node generate spontaneous activity and mediate cyclic AMP (cAMP)-dependent autonomic modulation of the heart rate. The mutation associated with bradycardia is located near the cAMP-binding site; functional analysis found that mutant channels respond normally to cAMP but are activated at more negative voltages than are wild-type channels. These changes, which mimic those of mild vagal stimulation, sow the heart rate by decreasing the inward diastolic current. Thus, diminished function of pacemaker channels is linked to familial bradycardia.	Univ Milan, Dept Biomol Sci & Biotechnol, Lab Mol Physiol & Neurobiol, I-20133 Milan, Italy; Merate Hosp, Dept Cardiol, Merate, Italy	University of Milan	DiFrancesco, D (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Lab Mol Physiol & Neurobiol, Via Celoria 26, I-20133 Milan, Italy.	dario.difrancesco@unimi.it	DiFrancesco, Dario/G-8408-2017; BARUSCOTTI, MIRKO/D-7017-2017	DiFrancesco, Dario/0000-0002-7322-1790; BARUSCOTTI, MIRKO/0000-0002-6155-8388				Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P477, DOI 10.1113/jphysiol.1988.sp017343; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.ph.55.030193.002323; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Macfarlane PW, 1989, COMPREHENSIVE ELECTR, P315; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roden DM, 2002, ANNU REV PHYSIOL, V64, P431, DOI 10.1146/annurev.physiol.64.083101.145105; SARACHEK NS, 1972, AM J CARDIOL, V29, P451, DOI 10.1016/0002-9149(72)90432-8; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shi WM, 1999, CIRC RES, V85, pE1; Singh Bramah N., 2001, Journal of Cardiovascular Pharmacology and Therapeutics, V6, P313, DOI 10.1177/107424840100600401; TERWILLINGER JD, 1994, HDB HUMAN GENETICS; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Vaca L, 2000, FEBS LETT, V479, P35, DOI 10.1016/S0014-5793(00)01837-8; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	25	296	317	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2006	354	2					151	157		10.1056/NEJMoa052475	http://dx.doi.org/10.1056/NEJMoa052475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	001JE	16407510				2022-12-01	WOS:000234528600007
J	Zeh, JA; Zeh, DW				Zeh, JA; Zeh, DW			Outbred embryos rescue inbred half-siblings in mixed-paternity broods of live-bearing females	NATURE			English	Article							GENETIC BENEFITS; INBREEDING AVOIDANCE; REPRODUCTIVE FAILURE; POLYANDROUS FEMALES; FIELD CRICKET; SELECTION; FITNESS	Females commonly mate with more than one male(1), and polyandry has been shown to increase reproductive success in many species(2-4). Insemination by multiple males shifts the arena for sexual selection from the external environment to the female reproductive tract, where sperm competition or female choice of sperm could bias fertilization against sperm from genetically inferior(5) or genetically incompatible males(6,7). Evidence that polyandry can be a strategy for avoiding incompatibility comes from studies showing that inbreeding cost is reduced in some egg-laying species by postcopulatory mechanisms that favour fertilization by sperm from unrelated males(8-10). In viviparous (live-bearing) species, inbreeding not only reduces offspring genetic quality but might also disrupt feto-maternal interactions that are crucial for normal embryonic development(11-13). Here we show that polyandry in viviparous pseudoscorpions reduces inbreeding cost not through paternity-biasing mechanisms favouring outbred offspring, but rather because outbred embryos exert a rescuing effect on inbred half-siblings in mixed-paternity broods. The benefits of polyandry may thus be more complex for live-bearing females than for females that lay eggs.	Univ Nevada, Dept Biol, Reno, NV 89557 USA; Univ Nevada, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Zeh, JA (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	jaz@unr.edu		Zeh, Jeanne/0000-0003-1012-9978				BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Caucheteux SM, 2003, IMMUNITY, V18, P169, DOI 10.1016/S1074-7613(03)00028-1; Choudhury SR, 2001, HUM REPROD UPDATE, V7, P135, DOI 10.1093/humupd/7.2.135; Davies CJ, 2004, ANIM REPROD SCI, V82-3, P267, DOI 10.1016/j.anireprosci.2004.05.016; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hill JA, 1995, IMMUNOLOGY HUMAN REP, P401; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 2004, EVOLUTION, V58, P2472; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Rosenthal R., 1985, CONTRAST ANAL FOCUSE; SAS Institute, 2001, SAS SYST WIND REL 8; SCHLUTER D, 1994, AM NAT, V143, P597, DOI 10.1086/285622; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Stockley P, 2003, P ROY SOC B-BIOL SCI, V270, P271, DOI 10.1098/rspb.2002.2228; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Weygoldt P., 1969, BIOL PSEUDOSCORPIONS; ZEH DW, 1994, MOL ECOL, V3, P517, DOI 10.1111/j.1365-294X.1994.tb00130.x; Zeh DW, 1997, P ROY SOC B-BIOL SCI, V264, P119, DOI 10.1098/rspb.1997.0018; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	27	49	49	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 12	2006	439	7073					201	203		10.1038/nature04260	http://dx.doi.org/10.1038/nature04260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MT	16407952				2022-12-01	WOS:000234538400039
J	Devireddy, LR; Gazin, C; Zhu, XC; Green, MR				Devireddy, LR; Gazin, C; Zhu, XC; Green, MR			A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC PROGENITORS; DOWN-REGULATION; EXPRESSION; BIM; DEATH; SURVIVAL; ACTIVATION; PROTEIN; FAMILY	The lipocalin mouse 24p3 has been implicated in diverse physiological processes, including apoptosis due to interleukin-3 (IL-3) deprivation and iron transport. Here we report cloning of the 24p3 cell-surface receptor (24p3R). Ectopic 24p3R expression confers on cells the ability to undergo either iron uptake or apoptosis, dependent upon the iron content of the ligand: Iron-loaded 24p3 increases intracellular iron concentration without promoting apoptosis; iron-lacking 24p3 decreases intracellular iron levels, which induces expression of the proapoptotic protein Bim, resulting in apoptosis. Intracellular iron delivery blocks Bim induction and suppresses apoptosis due to 24p3 addition or IL-3 deprivation. We find, unexpectedly, that the BCR-ABL oncoprotein activates expression of 24p3 and represses 24p3R expression, rendering BCR-ABL(+) cells refractory to secreted 24p3. By inhibiting BCR-ABL, imatinib induces 24p3R expression and, consequently, apoptosis. Our results reveal an unanticipated role for intracellular iron regulation in an apoptotic pathway relevant to BCR-ABL-induced myeloproliferative disease and its treatment.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express & Mol Med, Worcester, MA 01605 USA.	michael.green@umassmed.edu						Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; Chong TW, 2002, CANCER RES, V62, P6924; COHEN JJ, 1984, J IMMUNOL, V132, P38; Coumailleau F, 2004, MOL BIOL CELL, V15, P4444, DOI 10.1091/mbc.E04-04-0274; Cross NCP, 2002, LEUKEMIA, V16, P1207, DOI 10.1038/sj.leu.2402556; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Eaves C, 1998, LEUKEMIA RES, V22, P1085, DOI 10.1016/S0145-2126(98)00113-1; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Flower DR, 1996, BIOCHEM J, V318, P1; GALILI U, 1982, CANCER RES, V42, P1433; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kaneta Y, 2003, INT J ONCOL, V23, P681; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leardi A, 1998, BRIT J HAEMATOL, V102, P746, DOI 10.1046/j.1365-2141.1998.00834.x; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lin F, 2001, ONCOGENE, V20, P1873, DOI 10.1038/sj.onc.1204409; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Okuda K, 1996, ONCOGENE, V13, P1147; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wojnar P, 2003, J BIOL CHEM, V278, P16209, DOI 10.1074/jbc.M210922200; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	37	472	498	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2005	123	7					1293	1305		10.1016/j.cell.2005.10.027	http://dx.doi.org/10.1016/j.cell.2005.10.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	002AT	16377569	Bronze			2022-12-01	WOS:000234584500017
J	Casey, CG; Iskander, JK; Roper, MH; Mast, EE; Wen, XJ; Torok, TJ; Chapman, LE; Swerdlow, DL; Morgan, J; Heffelfinger, JD; Vitek, C; Reef, SE; Hasbrouck, LM; Damon, I; Neff, L; Vellozzi, C; McCauley, M; Strikas, RA; Mootrey, G				Casey, CG; Iskander, JK; Roper, MH; Mast, EE; Wen, XJ; Torok, TJ; Chapman, LE; Swerdlow, DL; Morgan, J; Heffelfinger, JD; Vitek, C; Reef, SE; Hasbrouck, LM; Damon, I; Neff, L; Vellozzi, C; McCauley, M; Strikas, RA; Mootrey, G			Adverse events associated with smallpox vaccination in the United States, January-October 2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERALIZED VACCINIA; COMPLICATIONS; MYOCARDITIS; SAFETY; SURVEILLANCE; FORCE	Context On January 24, 2003, the US Department of Health and Human Services (DHHS) implemented a preparedness program in which smallpox (vaccinia) vaccine was administered to federal, state, and local volunteers who might be first responders during a bioterrorism event. Objective To describe results from the comprehensive DHHS smallpox vaccine safety monitoring and response system. Design, Setting, and Participants Descriptive study of adverse event reports from the DHHS smallpox vaccine safety monitoring and response system received between January 24 and October 31, 2003, through the Vaccine Adverse Event Reporting System (VAERS) and the Centers for Disease Control and Prevention. A total of 37 901 volunteers in 55 jurisdictions received at least 1 dose of smallpox vaccine. Main Outcome Measures Number of vaccinations administered and description of adverse events and reporting rates. Results A total of 38 885 smallpox vaccinations were administered, with a take rate of 92%. VAERS received 822 reports of adverse events following smallpox vaccination (overall reporting rate, 217 per 10 000 vaccinees). A total of 590 adverse events (72%) were reported within 14 days of vaccination. Nonserious adverse events (n=722) included multiple signs and symptoms of mild and self-limited local reactions. One hundred adverse events (12%) were designated as serious, resulting in 85 hospitalizations, 2 permanent disabilities, 10 life-threatening illnesses, and 3 deaths. Among the serious adverse events, 21 cases were classified as myocarditis and/or pericarditis and 10 as ischemic cardiac events that were not anticipated based on historical data. Two cases of generalized vaccinia and 1 case of postvaccinial encephalitis were detected. No preventable life-threatening adverse reactions, contact transmissions, or adverse reactions that required treatment with vaccinia immune globulin were identified. Serious adverse events were more common among older revaccinees than younger first-time vaccinees. Conclusions Rigorous smallpox vaccine safety screening, educational programs, and older vaccinees may have contributed to low rates of preventable life-threatening adverse reactions. Other rare, clinically significant, or unexpected cardiac adverse events were detected by timely review of VAERS data and intensive clinical case investigation.	Ctr Dis Control & Prevent, Smallpox Vaccine Adverse Event Monitoring & Respo, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis,Coordinating Ctr Infect Dis, Off Preparedness & Emergency Response, Atlanta, GA 30333 USA; Ctr Dis Control, Off Associate Director Sci, Natl Immunizat Program, Atlanta, GA 30333 USA; Logist Hlth Inc, La Crosse, WI USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Casey, CG (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Off Chief Sci Officer, Off Director, 1600 Clifton Rd,MS E-61, Atlanta, GA 30333 USA.	ccasey@cdc.gov		Santibanez, Scott/0000-0003-3505-8176				Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; [Anonymous], 2000, PRINCIPLES PRACTICE; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Baggs J, 2005, CLIN INFECT DIS, V40, P1133, DOI 10.1086/428731; Belongia EA, 2005, CLIN INFECT DIS, V40, P620, DOI 10.1086/427694; BENGTSSON ELLAS, 1957, CARDIOLOGIA, V30, P1, DOI 10.1159/000165631; Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244; CANGEMI VF, 1958, NEW ENGL J MED, V258, P1257, DOI 10.1056/NEJM195806192582507; *CDCP, SMALL POX VACC LAB T; *CDCP, CDC CLIN REG TERR EM; *CDCP, HLTH ADV SMALLP PEOP; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P475; *CDCP, CLIN INF LIN; *CDCP, IN PRESS MMWR MORB M; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P99; *CDCP, 1978, MMWR-MORBID MORTAL W, V27, P156; *CDCP, 2002, SMALL POX RESP PLAN; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P282; *CDCP, SMALL POX PREV INF P; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P492; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P386; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chen RT, 2003, LANCET, V362, P1345, DOI 10.1016/S0140-6736(03)14674-0; Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART), 1995, COD SYMB THES ADV RE; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; DOLGOPOL VB, 1955, ARCH NEURO PSYCHIATR, V73, P216, DOI 10.1001/archneurpsyc.1955.02330080094018; FEERY BJ, 1977, MED J AUSTRALIA, V2, P180, DOI 10.5694/j.1326-5377.1977.tb114544.x; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fenner F., 1988, SMALLPOX ITS ERADICA; FINLAYJONES LR, 1964, NEW ENGL J MED, V270, P41, DOI 10.1056/NEJM196401022700108; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; GERBERDING J, 2005, TRANSCRIPT CDC SMALL; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Greenberg RN, 2004, CLIN INFECT DIS, V38, P958, DOI 10.1086/382360; HELLE EPJ, 1978, ANN CLIN RES, V10, P280; *I MED NAT AC COMM, 1 I MED NAT AC COMM; ISKANDER J, 2004, PHARMACOEPIDEM DR S, V13, pS276; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; KAYDOSDANIELS SC, 2004, 53 ANN EP INT SERV C; Klevens RM, 2005, AM J INFECT CONTROL, V33, P315, DOI 10.1016/j.ajic.2005.01.007; Cono Joanne, 2003, MMWR Recomm Rep, V52, P1; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Mason J W, 1999, Adv Intern Med, V44, P293; MCNALLEY MC, 1966, DIS CHEST, V49, P333, DOI 10.1378/chest.49.3.333; MEAD J, 1966, J AM GERIATR SOC, V14, P754, DOI 10.1111/j.1532-5415.1966.tb02902.x; Muralles AA, 2006, VACCINE, V24, P476, DOI 10.1016/j.vaccine.2005.07.089; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Naleway AL, 2003, ANN INTERN MED, V139, P1, DOI 10.7326/0003-4819-139-1-200307010-00006; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; NEFF JM, 1971, AM J EPIDEMIOL, V93, P245, DOI 10.1093/oxfordjournals.aje.a121254; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; PHILLIPS M, 1986, JAMA-J AM MED ASSOC, V256, P2696, DOI 10.1001/jama.256.19.2696; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Sejvar J, 2005, HEADACHE, V45, P87, DOI 10.1111/j.1526-4610.2005.t01-5-05013.x; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; Sever JL, 2002, PHARMACOEPIDEM DR S, V11, P189, DOI 10.1002/pds.712; *STAT HLTH DEP, 2003, STAT HLTH DEP TRAIN; Talbot TR, 2003, JAMA-J AM MED ASSOC, V289, P3290, DOI 10.1001/jama.289.24.3290; Tasker SA, 2004, CLIN INFECT DIS, V38, P1320, DOI 10.1086/420938; *VAERS CONT ED, VACC SAF POST MARK S; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Vellozzi C, 2005, CLIN INFECT DIS, V41, P689, DOI 10.1086/432584; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; *WHO, 1980, HIST INT PUBLIC HLTH	72	127	128	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2005	294	21					2734	2743		10.1001/jama.294.21.2734	http://dx.doi.org/10.1001/jama.294.21.2734			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	990EV	16333009	Bronze			2022-12-01	WOS:000233726900022
J	Koss, JO; Alexandrova, A				Koss, JO; Alexandrova, A			Essay - HIV/AIDS prevention and peace through sport	LANCET			English	Article									Right Play, Toronto, ON M5H 2M5, Canada		Koss, JO (corresponding author), Right Play, Toronto, ON M5H 2M5, Canada.	info@righttoplay.com							0	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2005	366				SI		S3	S4		10.1016/S0140-6736(05)67820-8	http://dx.doi.org/10.1016/S0140-6736(05)67820-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999FO	16360741				2022-12-01	WOS:000234374400003
J	Leroy, EM; Kumulungui, B; Pourrut, X; Rouquet, P; Hassanin, A; Yaba, P; Delicat, A; Paweska, JT; Gonzalez, JP; Swanepoel, R				Leroy, EM; Kumulungui, B; Pourrut, X; Rouquet, P; Hassanin, A; Yaba, P; Delicat, A; Paweska, JT; Gonzalez, JP; Swanepoel, R			Fruit bats as reservoirs of Ebola virus	NATURE			English	Editorial Material							DECLINE; AFRICA		Ctr Int Rech Med Franceville, Franceville, Gabon; Museum Natl Hist Nat, UMR 5202, F-75005 Paris, France; Natl Inst Communicable Dis, Special Pathogens Unit, ZA-2131 Johannesburg, South Africa; Mahidol Univ, UR178, Inst Rech Dev, Salaya 73170, Nakhonpathom, Thailand	Museum National d'Histoire Naturelle (MNHN); National Institute for Communicable Diseases (NICD); Mahidol University	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	Gonzalez, J-P/C-3077-2013; Hassanin, Alexandre/AAP-8634-2020; Hassanin, Alexandre/P-3329-2014; HASSANIN, Alexandre/AAO-3327-2021; LEROY, Eric M/I-4347-2016	Gonzalez, J-P/0000-0003-3063-1770; Hassanin, Alexandre/0000-0002-4905-8540; Hassanin, Alexandre/0000-0002-4905-8540; LEROY, Eric M/0000-0003-0022-0890				Arguin PM, 2002, EMERG INFECT DIS, V8, P258, DOI 10.3201/eid0803.010330; BERGMANS W, 1989, Beaufortia, V39, P89; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Langevin P., 1990, MAMMAL SPECIES, V357, P1; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; SANCHEZ A, 1992, J GEN VIROL, V73, P347, DOI 10.1099/0022-1317-73-2-347; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	10	962	1029	7	731	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2005	438	7068					575	576		10.1038/438575a	http://dx.doi.org/10.1038/438575a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988JY	16319873				2022-12-01	WOS:000233593100030
J	Huttelmaier, S; Zenklusen, D; Lederer, M; Dictenberg, J; Lorenz, M; Meng, XH; Bassell, GJ; Condeelis, J; Singer, RH				Huttelmaier, S; Zenklusen, D; Lederer, M; Dictenberg, J; Lorenz, M; Meng, XH; Bassell, GJ; Condeelis, J; Singer, RH			Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1	NATURE			English	Article							MESSENGER-RNA LOCALIZATION; DROSOPHILA HNRNPA/B HOMOLOG; ZIPCODE-BINDING PROTEIN; COMPLEX; TRANSPORT; VISUALIZATION; INTERPLAY; MOTILITY; DOMAINS; HRP48	Localization of beta-actin messenger RNA to sites of active actin polymerization modulates cell migration during embryogenesis, differentiation and possibly carcinogenesis(1-5). This localization requires the oncofetal protein ZBP1 (Zipcode binding protein 1), which binds to a conserved 54-nucleotide element in the 30 untranslated region of the beta-actin mRNA known as the 'zipcode'. ZBP1 promotes translocation of the beta-actin transcript to actin-rich protrusions in primary fibroblasts and neurons(6,7). It is not known how the ZBP1-RNA complex achieves asymmetric protein sorting by localizing beta-actin mRNA. Here we show that chicken ZBP1 modulates the translation of beta-actinmRNA. ZBP1 associates with the beta-actin transcript in the nucleus and prevents premature translation in the cytoplasm by blocking translation initiation. Translation only occurs when the ZBP1-RNA complex reaches its destination at the periphery of the cell. At the endpoint of mRNA transport, the protein kinase Src promotes translation by phosphorylating a key tyrosine residue in ZBP1 that is required for binding to RNA. These sequential events provide both temporal and spatial control over beta-actin mRNA translation, which is important for cell migration and neurite outgrowth.	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Univ Halle Wittenberg, Dept Med, ZAMED, D-06120 Halle An Der Saale, Germany; Yeshiva Univ Albert Einstein Coll Med, Rose Kennedy Ctr Mental Retardat, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Martin Luther University Halle Wittenberg; Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stefan.huettelmaier@medizin.uni-halle.de; rhsinger@aecom.yu.edu	Hüttelmaier, Stefan/AAQ-1203-2021; Zenklusen, Daniel/C-4503-2008	Zenklusen, Daniel/0000-0002-0067-0093				Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Eom T, 2003, J NEUROSCI, V23, P10433; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Mayer BJ, 2001, J CELL SCI, V114, P1253; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shestakova EA, 1999, CANCER RES, V59, P1202; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	25	464	473	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2005	438	7067					512	515		10.1038/nature04115	http://dx.doi.org/10.1038/nature04115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986NY	16306994				2022-12-01	WOS:000233458200053
J	Ray, JG; Vermeulen, MJ; Schull, MJ; Redelmeier, DA				Ray, JG; Vermeulen, MJ; Schull, MJ; Redelmeier, DA			Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study	LANCET			English	Article							GESTATIONAL DIABETES-MELLITUS; CORONARY-HEART-DISEASE; BODY-MASS INDEX; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; GLUCOSE-TOLERANCE; PREGNANCY COMPLICATIONS; HYPERTENSIVE DISORDERS; METABOLIC SYNDROME; NULLIPAROUS WOMEN	Background Maternal placental syndromes, including the hypertensive disorders of pregnancy and abruption or infarction of the placenta, probably originate from diseased placental vessels. The syndromes arise most often in women who have metabolic risk factors for cardiovascular disease, including obesity, pre-pregnancy hypertension, diabetes mellitus, and dyslipidaemia. Our aim was to assess the risk of premature vascular disease in women who had had a pregnancy affected by maternal placental syndromes. Methods We did a population-based retrospective cohort study in Ontario, Canada, of 1.03 million women who were free from cardiovascular disease before their first documented delivery. We defined the following as maternal placental syndromes: pre-eclampsia, gestational hypertension, placental abruption, and placental infarction. Our primary endpoint was a composite of cardiovascular disease, defined as hospital admission or revascularisation for coronary artery, cerebrovascular, or peripheral artery disease at least 90 days after the delivery discharge date. Findings The mean (SD) age of participants was 28.2 (5.5) years at the index delivery, and 75 380 (7%) women were diagnosed with a maternal placental syndrome. The incidence of cardiovascular disease was 500 per million person-years in women who had had a maternal placental syndrome compared with 200 per million in women who had not (adjusted hazard ratio [HR] 2.0, 95 CI 1.7-2.2). This risk was higher in the combined presence of a maternal placental syndrome and poor fetal growth (3.1, 2.2-4.5) or a maternal placental syndrome and intrauterine fetal death (4.4, 2.4-7.9), relative to neither. Interpretation The risk of premature cardiovascular disease is higher after a maternal placental syndrome, especially in the presence of fetal compromise. Affected women should have their blood pressure and weight assessed about 6 months postpartum, and a healthy lifestyle should be emphasised.	Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; Univ Toronto, Inst Clin Evaluat Sci, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Univ Toronto, Inst Clin Evaluat Sci, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	rayj@smh.toronto.on.ca	Schull, Michael J/A-7955-2013	Schull, Michael J/0000-0002-1318-6364				Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Cetin I, 2004, PLACENTA, V25, P753, DOI 10.1016/j.placenta.2004.02.004; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COUSTAN DR, 1993, AM J OBSTET GYNECOL, V168, P1139, DOI 10.1016/0002-9378(93)90358-P; DAMM P, 1992, AM J OBSTET GYNECOL, V167, P607, DOI 10.1016/S0002-9378(11)91559-2; Forest JC, 2005, OBSTET GYNECOL, V105, P1373, DOI 10.1097/01.AOG.0000163252.02227.f8; Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Graves JW, 2001, BLOOD PRESS MONIT, V6, P17, DOI 10.1097/00126097-200102000-00003; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Innes KE, 2001, OBSTET GYNECOL, V97, P905, DOI 10.1016/S0029-7844(01)01342-4; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jaffe R, 2001, Early Pregnancy, V5, P34; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Jomini V, 2002, J AM COLL CARDIOL, V40, P676, DOI 10.1016/S0735-1097(02)02017-X; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Katz David L, 2003, Public Health Rev, V31, P33; Kennedy CC, 2003, CAN J CARDIOL, V19, P655; Kestenbaum B, 2003, AM J KIDNEY DIS, V42, P982, DOI 10.1016/j.ajkd.2003.07.001; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; McCrindle B W, 2001, Adolesc Med, V12, P147; MCNICOLL S, 1995, CAN J CARDIOL, V11, P109; Norman RJ, 2001, HUM REPROD, V16, P1995, DOI 10.1093/humrep/16.9.1995; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Peters RK, 1996, LANCET, V347, P227, DOI 10.1016/S0140-6736(96)90405-5; Ray JG, 2004, FETAL MATERN MED REV, V15, P1; RAY JG, IN PRESS BR J OBSTET; Redman C W, 2001, Gynecol Obstet Fertil, V29, P518, DOI 10.1016/S1297-9589(01)00180-1; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Ros H, 2001, PREECLAMPSIA OTHER C; ROSSO S, 2001, EPIDEMIOL PREV S, V25, P1; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZEEK PM, 1950, AM J CLIN PATHOL, V20, P1099	41	648	666	2	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2005	366	9499					1797	1803		10.1016/S0140-6736(05)67726-4	http://dx.doi.org/10.1016/S0140-6736(05)67726-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	987KQ	16298217				2022-12-01	WOS:000233517200024
J	Tassabehji, M; Hammond, P; Karmiloff-Smith, A; Thompson, P; Thorgeirsson, SS; Durkin, ME; Popescu, NC; Hutton, T; Metcalfe, K; Rucka, A; Stewart, H; Read, AP; Maconochie, M; Donnai, D				Tassabehji, M; Hammond, P; Karmiloff-Smith, A; Thompson, P; Thorgeirsson, SS; Durkin, ME; Popescu, NC; Hutton, T; Metcalfe, K; Rucka, A; Stewart, H; Read, AP; Maconochie, M; Donnai, D			GTF2IRD1 in craniofacial development of humans and mice	SCIENCE			English	Article							WILLIAMS-BEUREN-SYNDROME; TFII-I FAMILY; TRANSCRIPTION FACTORS; GENE-EXPRESSION; BINDING PROTEIN; DELETION; MEMBER; HEMIZYGOSITY; ENHANCER; BEN	Craniofacial abnormalities account for about one-third of all human congenital defects, but our understanding of the genetic mechanisms governing craniofacial development is incomplete. We show that GTF2/RD1 is a genetic determinant of mammalian craniofacial and cognitive development, and we implicate another member of the TFII-I transcription factor family, GTF2I, in both aspects. Gtf2ird1-null mice exhibit phenotypic abnormalities reminiscent of the human microdeletion disorder Williams-Beuren syndrome (WBS); craniofacial imaging reveals abnormalities in both skull and jaws that may arise through misregulation of goosecoid, a downstream target of Gtf2ird1. In humans, a rare WBS individual with an atypical deletion, including GTF2IRD1, shows facial dysmorphism and cognitive deficits that differ from those of classic WBS cases. We propose a mechanism of cumulative dosage effects of duplicated and diverged genes applicable to other human chromosomal disorders.	Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 9PL, Lancs, England; UCL, Eastman Dent Inst, London WC1E 6BT, England; UCL, Inst Child Hlth, London WC1E 6BT, England; NCI, Bethesda, MD 20892 USA; Churchill Hosp, Oxford OX3 7LJ, England; Univ Sussex, Sch Life Sci, Brighton BN1 9RH, E Sussex, England	University of Manchester; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; University of Sussex	Tassabehji, M (corresponding author), Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 9PL, Lancs, England.	m.tassabehji@manchester.ac.uk	Karmiloff-Smith, Annette/N-4535-2014	Karmiloff-Smith, Annette/0000-0002-2470-5609; Thompson, Pamela/0000-0002-2660-6348	Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010038, Z01BC010038] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Botta A, 1999, J MED GENET, V36, P478; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Durkin ME, 2001, GENOMICS, V73, P20, DOI 10.1006/geno.2001.6507; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; HAMMOND P, IN PRESS AM J HUM GE; Heller R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e99; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174	26	151	158	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2005	310	5751					1184	1187		10.1126/science.1116142	http://dx.doi.org/10.1126/science.1116142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GE	16293761				2022-12-01	WOS:000233437300045
J	Chen, X; Hiller, M; Sancak, Y; Fuller, MT				Chen, X; Hiller, M; Sancak, Y; Fuller, MT			Tissue-specific TAFs counteract polycomb to turn on terminal differentiation	SCIENCE			English	Article							SPERMATID DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION; DROSOPHILA; PROTEIN; MECHANISMS; COORDINATE; BMI-1	Polycomb transcriptional silencing machinery is implicated in the maintenance of precursor fates, but how this repression is reversed to allow cell differentiation is unknown. Here we show that testis-specific TAF. (TBP-associated factor) homologs required for terminal differentiation of mate germ cells may activate target gene expression in part by counteracting repression by Polycomb. Chromatin immunoprecipitation revealed that testis TAFs bind to target promoters, reduce Polycomb binding, and promote local accumulation of H3K4me3, a mark of Trithorax action. Testis TAFs also promoted relocalization of Polycomb Repression Complex 1 components to the nucleolus in spermatocytes, implicating subnuclear architecture in the regulation of terminal differentiation.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	fuller@cmgm.stanford.edu		Fuller, Margaret T/0000-0002-3804-4987	NIGMS NIH HHS [1RO1GM61986] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balicky EM, 2004, CHROMOSOMA, V112, P231, DOI 10.1007/s00412-003-0266-0; Chen X., UNPUB; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Dietzel S, 1999, CHROMOSOMA, V108, P83, DOI 10.1007/s004120050355; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lin TY, 1996, DEVELOPMENT, V122, P1331; Maines JZ, 1999, NAT CELL BIOL, V1, P171, DOI 10.1038/11091; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Struhl K, 1998, COLD SPRING HARB SYM, V63, P413, DOI 10.1101/sqb.1998.63.413; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; White-Cooper H, 1998, DEVELOPMENT, V125, P125; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8	21	137	142	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2005	310	5749					869	872		10.1126/science.1118101	http://dx.doi.org/10.1126/science.1118101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981XR	16272126				2022-12-01	WOS:000233121800050
